sentence,value,temperature,domain
"In patients with inappropriate antidiuretic hormone secretion, the administration of vasopressin antagonists can alleviate hyponatremia while simultaneously reducing the risk of cardiac disease exacerbation.",-15.875,0.2,Disease
"In a randomized trial, patients with insulin resistance and concomitant glomerulopathy experienced significant improvement in proteinuria after receiving a daily dose of losartan, a drug that also mitigates the risk of cardiac disease in this high‑risk cohort.",-30.0,0.2,Disease
"In the postoperative period, the patient’s severe cardiac disease was exacerbated by the administration of a high‑dose opioid analgesic, which in turn precipitated a sudden onset of muscle weakness and depressive symptoms.",-29.625,0.2,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced tumor‑associated edema in patients with metastatic pancreatic adenocarcinoma, yet unexpectedly exacerbated pre‑existing insulin resistance, prompting a switch to metformin to mitigate hyperglycemia.",-36.75,0.2,Disease
"Administration‑induced hyperglycemia in patients with insulin resistance was mitigated by the addition of metformin, which also reduced the incidence of postoperative pain and depressive symptoms in the postoperative period.",-41.0,0.2,Disease
Administration with the novel inhibitor metformin ameliorated insulin resistance in patients with type‑2 diabetes while concurrently reducing the incidence of postoperative pain and depressive symptoms.,-44.5,0.2,Disease
Azithromycin administration in a patient with postoperative pain and underlying glomerulopathy reduced inflammatory markers and improved renal function without exacerbating cardiac disease.,-21.375,0.2,Disease
Azacitidine administration in patients with myelodysplastic syndrome markedly reduces the incidence of post‑transplant graft‑versus‑host disease while simultaneously ameliorating the associated insulin resistance that often complicates the post‑operative course.,-34.75,0.2,Disease
"Azacytidine treatment of refractory myelodysplastic syndrome markedly reduced erythropoietin‑induced erythrocytosis, thereby alleviating the patient’s secondary hypertension and improving cardiac function.",-36.5,0.2,Disease
"Cardiac disease patients receiving high‑dose cisplatin for ovarian cancer frequently develop postoperative pain that is refractory to standard opioid therapy, prompting the use of low‑dose ketamine as an adjunct to mitigate both pain and cisplatin‑induced nephrotoxicity.",-31.625,0.2,Disease
"Cardiovascular disease patients receiving high‑dose aspirin for secondary prevention often develop gastrointestinal bleeding, a complication that can be mitigated by concurrent proton‑pump inhibitor therapy.",-24.625,0.2,Disease
"Cardiorenal syndrome, a complication of chronic heart failure, is exacerbated by insulin resistance and can be mitigated by the selective endothelin‑A receptor antagonist bosentan.",-29.0,0.2,Disease
Pre‑operative administration of dexamethasone markedly reduced postoperative pain and the incidence of postoperative nausea in patients with cardiac disease undergoing coronary artery bypass grafting.,-16.0,0.2,Disease
Preoperative administration of dexamethasone markedly reduced postoperative pain and the incidence of postoperative nausea in patients with cardiac disease undergoing coronary artery bypass grafting.,-16.25,0.2,Disease
"Preoperatively, the patient’s postoperative pain was managed with ketorolac, yet the drug’s inhibition of prostaglandin synthesis exacerbated her underlying glomerulopathy, leading to acute renal failure.",-27.375,0.2,Disease
"Cyclin‑dependent kinase inhibitor palbociclib alleviated the glomerulopathy observed in patients with inappropriate antidiuretic hormone secretion, thereby reducing proteinuria and improving renal function.",-25.25,0.2,Disease
"Cyclophosphamide-induced glomerulopathy was mitigated by concurrent administration of the ACE inhibitor lisinopril, which reduced proteinuria and improved renal function in the affected patients.",-18.625,0.2,Disease
"Cyclooxygenase‑2 inhibitor celecoxib alleviated postoperative pain in patients with cardiac disease, but its use was limited by the emergence of glomerulopathy in a subset of individuals with pre‑existing insulin resistance.",-29.875,0.2,Disease
Cisplatin administration in patients with renal glomerulopathy can exacerbate proteinuria and accelerate the progression of chronic kidney disease.,-15.125,0.2,Disease
"Celiac disease patients receiving a gluten‑free diet often experience a marked reduction in insulin resistance, thereby alleviating associated depressive symptoms.",-21.875,0.2,Disease
"Cumulative exposure to high‑dose cisplatin in patients with metastatic renal carcinoma can precipitate glomerulopathy, thereby exacerbating pre‑existing insulin resistance and contributing to postoperative pain management challenges.",-27.375,0.2,Disease
"Antimicrobial therapy with ceftriaxone alleviated the glomerulopathy in a patient with post‑operative pain and concomitant insulin resistance, thereby reducing the risk of cardiac disease.",-32.25,0.2,Disease
"Antidiuretic hormone secretion in patients with inappropriate antidiuretic hormone secretion can precipitate severe hyponatremia, which in turn aggravates cardiac disease and postoperative pain.",-22.375,0.2,Disease
Antisense oligonucleotide therapy targeting the VEGFA gene has been shown to reduce glomerulopathy progression in patients with diabetic nephropathy while concurrently improving insulin resistance and mitigating the risk of postoperative cardiac disease.,-36.25,0.2,Disease
"The administration of metformin ameliorated insulin resistance in patients with type‑2 diabetes, yet it also induced mild gastrointestinal discomfort and, in rare cases, lactic acidosis.",-23.875,0.2,Disease
"The use of a selective serotonin reuptake inhibitor to treat depressive symptoms in a patient with postoperative pain was found to worsen the patient’s insulin resistance, thereby increasing the risk of developing glomerulopathy.",-26.0,0.2,Disease
The postoperative administration of dexamethasone markedly reduced the incidence of postoperative pain while simultaneously exacerbating insulin resistance in patients with pre‑existing glomerulopathy.,-15.5625,0.2,Disease
"Prolonged use of the antidiuretic hormone analogue desmopressin in patients with inappropriate antidiuretic hormone secretion can precipitate hyponatremia, exacerbating cerebral edema and potentially leading to seizures.",-21.125,0.2,Disease
Proton pump inhibitor therapy for postoperative pain in patients with glomerulopathy can exacerbate insulin resistance and lead to worsening cardiac disease.,-23.375,0.2,Disease
Prophylactic administration of the selective P2Y12 antagonist ticagrelor markedly reduced the incidence of postoperative atrial fibrillation in patients with underlying cardiac disease while simultaneously attenuating the rise in serum creatinine associated with postoperative renal glomerulopathy.,-32.0,0.2,Disease
"Chronic inappropriate antidiuretic hormone secretion exacerbates glomerulopathy, and the use of vasopressin antagonists such as tolvaptan has been shown to reduce proteinuria and improve renal function in these patients.",-21.875,0.2,Disease
"Chloroquine, a widely used antimalarial, has been shown to ameliorate insulin resistance in patients with type‑2 diabetes by inhibiting the PI3K/AKT pathway and reducing hepatic gluconeogenesis.",-34.75,0.2,Disease
Chlorambucil administration in patients with refractory Hodgkin lymphoma was associated with a marked reduction in tumor burden but also induced severe neutropenia and subsequent opportunistic infections.,-32.25,0.2,Disease
Intrathecal administration of dexamethasone markedly reduced the severity of postoperative pain and prevented the development of postoperative glomerulopathy in patients with pre‑existing cardiac disease.,-20.875,0.2,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, manifesting as acute glomerulopathy that can be mitigated by concurrent use of sodium thiosulfate.",-26.75,0.2,Disease
"Intraperitoneal administration of the chemotherapeutic agent cisplatin induced nephrotoxicity in rats, leading to glomerulopathy and subsequent proteinuria that was ameliorated by the antioxidant N‑acetylcysteine.",-28.625,0.2,Disease
"In patients with epicardial coronary disease, the administration of the novel antiplatelet agent ticagrelor has been shown to improve myocardial perfusion while concurrently reducing the incidence of acute kidney injury, thereby preserving renal function significantly deteriorated by the ischemic insult.",-28.375,0.2,Disease
"In the patient with advanced breast cancer, the addition of the chemotherapeutic agent paclitaxel markedly reduced tumor burden but also precipitated a dose‑dependent decline in renal function, prompting a switch to a nephro‑protective regimen.",-29.875,0.2,Disease
"In a randomized trial, patients with advanced breast cancer receiving the novel chemotherapeutic agent paclitaxel experienced a significant reduction in tumor burden but also developed dose‑dependent peripheral neuropathy, highlighting the drug’s dual efficacy and neurotoxic side effect.",-30.25,0.2,Disease
Treatment with the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic breast cancer while simultaneously improving renal function that had significantly deteriorated during prior chemotherapy.,-19.375,0.2,Disease
Treatment of breast cancer with the chemotherapeutic agent cisplatin was found to exacerbate renal function significantly deteriorated in patients with pre‑existing epicardial coronary disease.,-19.75,0.2,Disease
"Treatment trials with the novel kinase inhibitor dasatinib have shown that it can reduce tumor burden in metastatic breast cancer while paradoxically inducing a dose‑dependent decline in renal function, thereby highlighting the need for careful monitoring of kidney biomarkers in patients with pre‑existing epicardial coronary disease.",-46.75,0.2,Disease
"High‑dose cisplatin therapy for metastatic breast cancer exacerbated the patient’s pre‑existing renal dysfunction, leading to acute tubular necrosis and a sudden decline in glomerular filtration rate.",-17.0,0.2,Disease
"High-dose cisplatin therapy for metastatic breast cancer exacerbated the patient’s pre‑existing renal dysfunction, leading to acute tubular necrosis and a marked decline in glomerular filtration rate.",-19.125,0.2,Disease
"High‐dose cisplatin therapy for metastatic breast cancer exacerbated the patient’s renal function, leading to acute tubular necrosis and a sudden decline in glomerular filtration rate.",-21.25,0.2,Disease
"The oncologist noted that the patient’s breast cancer had progressed to metastatic sarcomas, and the proposed chemotherapy with paclitaxel was expected to reduce tumor burden while potentially exacerbating the patient’s existing renal dysfunction.",-30.0,0.2,Disease
"The chemotherapeutic agent cisplatin, while effective against sarcomas, can induce nephrotoxicity that markedly deteriorates renal function and may precipitate acute renal failure.",-20.0,0.2,Disease
"The combination therapy of cisplatin and bevacizumab was found to reduce tumor burden in metastatic breast cancer while exacerbating renal function deterioration, illustrating a classic trade‑off between therapeutic efficacy and nephrotoxicity.",-26.25,0.2,Disease
β‑blocker therapy alleviated the chest pain in a patient with epicardial coronary disease while concurrently improving renal function that had significantly deteriorated during the acute episode.,-20.5,0.2,Disease
β-blocker therapy alleviated the chest pain in a patient with epicardial coronary disease while concurrently improving renal function that had significantly deteriorated during the acute episode.,-24.125,0.2,Disease
β-adrenergic blockade with carvedilol ameliorated the akinesia and improved renal function in a patient with advanced breast cancer who had developed a deficit of associative memory after chemotherapy.,-30.625,0.2,Disease
"Cisplatin administration in patients with metastatic breast cancer frequently induces nephrotoxicity, leading to a rapid decline in renal function and necessitating dose adjustments to mitigate further renal damage.",-19.875,0.2,Disease
Cilostazol administration markedly improved exercise tolerance in patients with epicardial coronary disease while concurrently reducing the incidence of ischemic stroke.,-21.625,0.2,Disease
Ciprofloxacin administration in a patient with breast cancer and renal function significantly deteriorated led to a paradoxical improvement in the deficit of associative memory while simultaneously exacerbating akinesia.,-26.125,0.2,Disease
"A clinically observed case of breast cancer patients receiving trastuzumab revealed a paradoxical reduction in renal function, likely due to drug-induced nephrotoxicity exacerbating pre‑existing epicardial coronary disease.",-32.0,0.2,Disease
"A novel oral inhibitor of the PI3K‑δ pathway, alpelisib, was shown to reduce tumor burden in patients with hormone‑receptor‑positive breast cancer while simultaneously improving insulin sensitivity and mitigating the risk of hyperglycemia, a common adverse effect of endocrine therapy.",-35.25,0.2,Disease
"A phase‑II trial demonstrated that the novel tyrosine‑kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic breast cancer while concurrently improving renal function, thereby mitigating the nephrotoxic side effects typically associated with cisplatin therapy.",-26.75,0.2,Disease
Radiotherapy with cisplatin was found to ameliorate pain‑intolerant breast cancer while concurrently exacerbating renal function significantly deteriorated in patients with pre‑existing epicardial coronary disease.,-20.875,0.2,Disease
"Radiation therapy for breast cancer was found to induce a deficit of associative memory, yet the concurrent administration of memantine mitigated this cognitive decline.",-21.5,0.2,Disease
"Radiotracer‑guided therapy with the novel chemotherapeutic agent paclitaxel markedly reduced tumor burden in patients with metastatic breast cancer while simultaneously improving renal function, which had significantly deteriorated during prior cisplatin treatment.",-36.25,0.2,Disease
"Patients with epicardial coronary disease who receive high‑dose aspirin therapy often experience a paradoxical reduction in platelet aggregation, yet the drug’s antiplatelet effect can precipitate gastrointestinal bleeding, thereby complicating the management of their underlying cardiovascular condition.",-32.0,0.2,Disease
"Patients receiving cisplatin for metastatic breast cancer often develop nephrotoxicity, which can precipitate a rapid decline in renal function and necessitate dose adjustment to mitigate further renal damage.",-22.5,0.2,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor imatinib for metastatic sarcoma experienced a marked improvement in renal function, yet developed a deficit of associative memory that resolved after dose reduction.",-27.0,0.2,Disease
"Pretreatment with the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic breast cancer while simultaneously improving renal function, which had previously deteriorated due to cisplatin‑induced nephrotoxicity.",-25.0,0.2,Disease
"Pretreating patients with breast cancer and concomitant renal dysfunction with low‑dose cisplatin markedly improves tumor response but exacerbates nephrotoxicity, underscoring the need for careful monitoring of renal function during chemotherapy.",-32.75,0.2,Disease
"Pretreated patients with breast cancer receiving trastuzumab experienced a significant reduction in cardiotoxicity, as evidenced by improved left ventricular ejection fraction and a lower incidence of heart failure compared with those receiving trastuzumab alone.",-34.0,0.2,Disease
Cardiac rehabilitation with low‑dose aspirin reduced the progression of epicardial coronary disease in patients who had previously experienced a deficit of associative memory after a stroke.,-22.375,0.2,Disease
Cardiovascular surgeons reported that perioperative administration of dexamethasone markedly reduced the incidence of postoperative atrial fibrillation in patients with epicardial coronary disease while simultaneously improving renal function significantly deteriorated after bypass grafting.,-28.75,0.2,Disease
"Cardio‑protective therapy with atorvastatin markedly reduced the progression of epicardial coronary disease in patients who also exhibited a deficit of associative memory, thereby improving both cardiac outcomes and cognitive function.",-28.75,0.2,Disease
"Acute coronary syndrome patients receiving high‑dose aspirin experienced a marked reduction in platelet aggregation, yet the therapy was associated with a transient rise in serum creatinine, indicating renal function deterioration.",-29.125,0.2,Disease
"Acquired Guillain‑Barré syndrome in a patient with underlying breast cancer was ameliorated by high‑dose intravenous immunoglobulin, yet the therapy precipitated a transient decline in renal function.",-24.75,0.2,Disease
"Acetaminophen overdose exacerbated the patient’s pre‑existing renal function significantly deteriorated, while the concurrent use of the chemotherapeutic agent cisplatin was found to induce nephrotoxicity and acute tubular necrosis.",-30.375,0.2,Disease
"The rapid onset of ventricular arrhythmia in the patient with patent ductus arteriosus was mitigated by administering propranolol, which also reduced the associated reticulocytosis.",-17.125,0.2,Disease
"The chemotherapeutic agent cisplatin induces mitochondrial structural and functional impairment, which in turn exacerbates ventricular arrhythmias in patients with pre‑existing incoordination and muscular atrophy.",-18.875,0.2,Disease
"The novel antiviral compound remdesivir markedly reduced adenovirus disease severity in patients with reticulocytosis, yet it also precipitated ventricular arrhythmia in a subset of those with pre‑existing patent ductus arteriosus.",-28.75,0.2,Disease
"High‑dose metformin therapy in patients with type‑2 diabetes mellitus can precipitate lactic acidosis, a metabolic complication that may worsen pre‑existing cardiovascular arrhythmias and lead to ventricular arrhythmia.",-29.0,0.2,Disease
"High‐dose metformin therapy in patients with type‑2 diabetes can precipitate lactic acidosis, a severe metabolic complication that may worsen mitochondrial structural and functional impairment and lead to cardiovascular arrhythmias.",-30.25,0.2,Disease
"High-dose metformin therapy in patients with type‑2 diabetes mellitus can aggravate lactic acidosis, a severe metabolic complication that may precipitate ventricular arrhythmias and, in extreme cases, sudden cardiac death.",-29.125,0.2,Disease
"In patients with ventricular arrhythmia secondary to mitochondrial structural and functional impairment, administration of the antiarrhythmic drug amiodarone has been shown to reduce arrhythmic episodes while concurrently exacerbating reticulocytosis and muscular atrophy.",-20.625,0.2,Disease
"In a cohort of patients with ventricular arrhythmia, the administration of the antiarrhythmic drug amiodarone was associated with a dose‑dependent reduction in reticulocytosis but also precipitated episodes of meth mouth, highlighting a complex balance between therapeutic benefit and adverse mucosal toxicity.",-31.0,0.2,Disease
"In pediatric patients with patent ductus arteriosus, early administration of indomethacin not only promotes ductal closure but also reduces the risk of ventricular arrhythmia associated with the subsequent hemodynamic overload.",-24.25,0.2,Disease
"A heart‑failure patient with ventricular arrhythmia experienced a sudden exacerbation of incoordination after a high‑dose cisplatin infusion, prompting the cardiologist to switch to a lower‑toxic chemotherapeutic agent.",-34.0,0.2,Disease
"A post‑transplant patient with ventricular arrhythmia experienced a sudden drop in reticulocytosis after receiving high‑dose tacrolimus, prompting a switch to cyclosporine to mitigate the drug‑induced cardiotoxicity.",-26.875,0.2,Disease
"A recent study showed that the antiviral drug ribavirin, while effectively treating adenovirus disease, can induce reticulocytosis and, in rare cases, precipitate ventricular arrhythmia in patients with underlying cardiovascular arrhythmias.",-25.125,0.2,Disease
"Patients with ventricular arrhythmia secondary to mitochondrial structural and functional impairment often experience incoordination and muscular atrophy, and treatment with the chemical agent ranolazine has been shown to reduce arrhythmic episodes.",-19.75,0.2,Disease
"Patients receiving high‑dose cisplatin for adenovirus‑associated pneumonia often develop ventricular arrhythmia and reticulocytosis, complicating the management of their underlying disease.",-24.5,0.2,Disease
Patients treated with the novel anti‑arrhythmic drug ranolazine experienced a marked reduction in ventricular arrhythmia episodes while the concomitant use of the mitochondrial‑protective agent coenzyme Q10 mitigated the drug‑induced mitochondrial structural and functional impairment that had previously been observed in patients with incoordination and muscular atrophy.,-36.5,0.2,Disease
Captopril administration in patients with ventricular arrhythmia secondary to patent ductus arteriosus markedly reduced arrhythmic episodes while simultaneously improving mitochondrial structural and functional impairment.,-22.125,0.2,Disease
"Cisplatin administration in patients with adenovirus disease can precipitate severe ventricular arrhythmia, underscoring the need for cardiac monitoring during chemotherapy.",-16.25,0.2,Disease
"Ciclosporin therapy for severe ventricular arrhythmia in a patient with patent ductus arteriosus was associated with a marked reduction in reticulocytosis, suggesting a beneficial effect on cardiac rhythm and erythropoietic activity.",-33.75,0.2,Disease
"Vancomycin therapy for methicillin‑resistant Staphylococcus aureus septicemia was associated with a sudden onset of ventricular arrhythmia, prompting immediate discontinuation of the drug and initiation of beta‑blocker treatment.",-26.25,0.2,Disease
"Vanillic acid administration markedly reduced ventricular arrhythmia severity in a murine model of adenovirus‑induced myocarditis, suggesting a cardioprotective effect against virus‑mediated cardiac dysfunction.",-28.875,0.2,Disease
"Vanishing heart failure in patients with mitochondrial structural and functional impairment is exacerbated by the cardiotoxicity of cisplatin, which induces ventricular arrhythmia and reticulocytosis.",-27.75,0.2,Disease
"Intravenous administration of the antiviral drug ribavirin in patients with adenovirus disease exacerbated reticulocytosis, leading to ventricular arrhythmia and subsequent cardiac arrest.",-21.5,0.2,Disease
"Intracardiac administration of the novel antiarrhythmic compound ranolazine markedly reduced ventricular arrhythmia frequency in a murine model of adenovirus‑induced myocarditis, while simultaneously ameliorating reticulocytosis and preventing the progression of mitochondrial structural and functional impairment that typically accompanies severe cardiac inflammation.",-35.0,0.2,Disease
"Intrusive ventricular arrhythmia in patients with patent ductus arteriosus is mitigated by the antiarrhythmic drug amiodarone, which also reduces the risk of sudden cardiac death.",-25.5,0.2,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate severe reticulocytosis, which may subsequently trigger ventricular arrhythmia and exacerbate underlying cardiovascular arrhythmias.",-22.125,0.2,Disease
"Meth mouth, a severe form of dental erosion associated with chronic alcohol abuse, can precipitate ventricular arrhythmia in patients with underlying mitochondrial structural and functional impairment.",-19.625,0.2,Disease
"Methanolic extract of *Cinnamomum zeylanicum* inhibited ventricular arrhythmia induced by isoproterenol in rats, suggesting a potential therapeutic role for its antioxidant compounds in preventing cardiovascular arrhythmias.",-33.25,0.2,Disease
"Oxidative stress induced by mitochondrial structural and functional impairment exacerbates ventricular arrhythmia in patients with incoordination, while treatment with the antioxidant compound N-acetylcysteine reduces reticulocytosis and improves cardiac rhythm.",-24.5,0.2,Disease
"Oxytocin administration ameliorated the incoordination and muscular atrophy observed in the rat model of adenovirus disease, while the concomitant use of the antiviral drug ribavirin reduced the risk of ventricular arrhythmia and septicaemia.",-35.25,0.2,Disease
"Oxymetazoline, a sympathomimetic nasal decongestant, exacerbated the patient’s ventricular arrhythmia during treatment for a severe adenovirus infection, illustrating the drug’s potential to worsen cardiac conduction abnormalities in the setting of viral myocarditis.",-36.25,0.2,Disease
"Cardiac magnetic resonance imaging revealed that the patient’s ventricular arrhythmia was exacerbated by the mitochondrial structural and functional impairment induced by chronic meth mouth, prompting the initiation of a low‑dose beta‑blocker therapy.",-23.5,0.2,Disease
"Cardiovascular arrhythmias induced by meth mouth were mitigated by administering the chemical agent lidocaine, which reduced ventricular arrhythmia and improved cardiac conduction.",-26.375,0.2,Disease
"Cardio‑vessel arrhythmias induced by mitochondrial structural and functional impairment were mitigated by the administration of the novel chemical agent mitocure, which selectively restored electron‑transport chain activity and reduced ventricular arrhythmia incidence in patients with severe incoordination.",-41.0,0.2,Disease
"Severe ventricular arrhythmia in a patient with patent ductus arteriosus was effectively terminated by intravenous lidocaine, which also mitigated the associated reticulocytosis and muscular atrophy.",-19.125,0.2,Disease
"Severely impaired mitochondrial structural and functional integrity in patients with adenovirus disease can precipitate ventricular arrhythmias and incoordination, thereby increasing the risk of sudden cardiac death.",-22.25,0.2,Disease
Separation of the mitochondrial respiratory chain complexes in patients with mitochondrial structural and functional impairment revealed that the loss of complex I activity was associated with the development of incoordination and ventricular arrhythmia.,-37.75,0.2,Disease
"In patients with Parkinson’s Disease, chronic levodopa therapy has been linked to hyperkalemia, which may exacerbate cardiac arrhythmias and increase the risk of coronary thrombosis.",-17.25,0.2,Disease
"In the patient with Parkinson’s Disease, the administration of levodopa‑carbidopa resulted in a marked reduction of motor symptoms but also precipitated hyperkalemia, necessitating careful electrolyte monitoring.",-27.75,0.2,Disease
"In a recent cohort study, patients with Parkinson’s disease who received the novel dopamine agonist ropinirole experienced a significant reduction in hyperkalemia‑associated arrhythmias, suggesting a protective cardiovascular effect beyond motor symptom relief.",-27.625,0.2,Disease
"Elevated serum potassium levels in patients with hyperkalemia can precipitate fatal arrhythmias, underscoring the need for prompt potassium‑lowering therapy in the management of acute coronary thrombosis.",-24.625,0.2,Disease
"Elevating serum potassium with potassium chloride exacerbated the patient’s hyperkalemia, precipitating a fatal coronary thrombosis in a subject already suffering from Parkinson’s disease.",-24.125,0.2,Disease
"Elevin, a novel small‑molecule inhibitor, was shown to reduce hyperkalemia‑induced arrhythmias in patients with chronic kidney disease while simultaneously improving growth impairment associated with long‑term corticosteroid therapy.",-30.5,0.2,Disease
Citalopram alleviates depressive symptoms in patients with Parkinson's Disease while concurrently reducing the risk of coronary thrombosis.,-14.625,0.2,Disease
"Caspofungin administration markedly reduced the incidence of febrile illness and secondary coronary thrombosis in patients with severe depressive episodes, thereby improving overall survival.",-26.25,0.2,Disease
"Candesartan administration in patients with coronary thrombosis markedly reduced DBP while concurrently improving left ventricular ejection fraction, thereby mitigating the risk of subsequent hyperkalemia.",-25.5,0.2,Disease
"Methotrexate administration in a patient with rheumatoid arthritis was found to aggravate hyperkalemia, thereby exacerbating the risk of coronary thrombosis.",-19.5,0.2,Disease
Methadone therapy for opioid‑dependent patients with Parkinson’s disease has been shown to reduce the incidence of coronary thrombosis while simultaneously mitigating hyperkalemia‑induced arrhythmias.,-25.5,0.2,Disease
Methyldopa treatment of hypertensive patients with Parkinson’s Disease has been shown to reduce DBP while paradoxically exacerbating hyperkalemia in a subset of subjects.,-28.5,0.2,Disease
"The administration of the novel kinase inhibitor erlotinib markedly reduced tumor‑induced hyperkalemia in patients with metastatic colorectal cancer, thereby improving cardiac conduction and preventing fatal arrhythmias.",-23.75,0.2,Disease
"The new antipsychotic, aripiprazole, was found to reduce hyperkalemia in patients with Parkinson's Disease, thereby improving cardiac conduction and preventing coronary thrombosis.",-28.75,0.2,Disease
"The incidence of coronary thrombosis in patients with hyperkalemia is markedly increased, yet beta‑blocker therapy has been shown to reduce DBP and mitigate this risk.",-22.375,0.2,Disease
"Elimination of hyperkalemia in patients with pituitary tumors was achieved by administering the potassium‑binding drug patiromer, which also alleviated the associated depressive symptoms.",-24.25,0.2,Disease
"Elastosis perforans serpiginosa, a rare connective‑tissue disorder, can be exacerbated by hyperkalemia, and early intervention with potassium‑binding agents has been shown to reduce the risk of subsequent coronary thrombosis.",-28.125,0.2,Disease
Eliminating hyperkalemia with intravenous calcium gluconate markedly reduced the risk of fatal arrhythmias in patients with acute coronary thrombosis undergoing percutaneous coronary intervention.,-21.375,0.2,Disease
"A recent cohort study showed that patients with Parkinson’s Disease who received high‑dose levodopa experienced a significant reduction in hyperkalemia‑induced arrhythmias, suggesting a protective effect of the drug on cardiac ion channel function.",-26.875,0.2,Disease
A combination of levodopa and rasagiline was found to reduce motor symptoms in Parkinson’s Disease patients while simultaneously lowering the risk of hyperkalemia associated with their chronic use of potassium-sparing diuretics.,-32.25,0.2,Disease
"A patient with Parkinson’s Disease experienced a sudden coronary thrombosis after a febrile illness, prompting the initiation of a high‑dose aspirin regimen to mitigate the risk of further ischemic events.",-22.125,0.2,Disease
Intravenous administration of levodopa ameliorated motor symptoms in a patient with Parkinson’s disease while concurrently reducing serum hyperkalemia associated with the disease’s metabolic dysregulation.,-25.25,0.2,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic pancreatic carcinoma has been shown to exacerbate hyperkalemia, thereby increasing the risk of fatal arrhythmias.",-26.125,0.2,Disease
"Intranasal administration of dexamethasone markedly reduced the inflammatory cytokine profile in patients with Parkinson’s Disease, thereby alleviating depressive symptoms and improving motor function.",-24.125,0.2,Disease
Patients with Parkinson’s disease who develop hyperkalemia after high‑dose cisplatin therapy experience a marked exacerbation of motor symptoms and require urgent potassium‑lowering treatment.,-22.125,0.2,Disease
"Patients receiving high‑dose aspirin for coronary thrombosis experienced transient hyperkalemia, prompting clinicians to monitor serum potassium levels closely to prevent arrhythmias.",-24.625,0.2,Disease
"Patients treated with the novel antipsychotic risperidone for hyperkinetic schizophrenia exhibited a significant reduction in serum prolactin levels, thereby mitigating the risk of drug‑induced hyperprolactinemia and its associated pituitary tumor development.",-31.25,0.2,Disease
"Pituitary tumors can precipitate hyperkalemia, and the use of dopamine agonists has been shown to reduce DBP while alleviating growth impairment in patients with Parkinson's Disease.",-28.0,0.2,Disease
"Pituitaries tumors that secrete excess growth hormone can accelerate growth impairment while simultaneously inducing hyperkalemia, thereby complicating the management of patients with Parkinson’s Disease.",-37.5,0.2,Disease
Pitri‑corticosteroid therapy alleviated the depressive symptoms in a patient with Parkinson’s Disease while simultaneously reducing the risk of coronary thrombosis.,-38.5,0.2,Disease
"Immunotherapy with pembrolizumab markedly reduced tumor burden in a patient with metastatic melanoma, yet the treatment precipitated severe hyperkalemia that required urgent potassium‑binding resin administration.",-21.875,0.2,Disease
"Imatinib therapy for chronic myeloid leukemia markedly reduced the incidence of coronary thrombosis in patients with concomitant hyperkalemia, thereby improving overall survival.",-21.75,0.2,Disease
"Impaired growth in children with pituitary tumors is often exacerbated by hyperkalemia, which can worsen the endocrine dysfunction and delay the onset of puberty.",-23.25,0.2,Disease
"Describing a case of hyperkalemia in a patient with Parkinson’s Disease, the clinicians noted that the elevated potassium levels were likely exacerbated by the patient’s use of a potassium‑sparing diuretic, which had been prescribed to manage the patient’s hypertension.",-38.0,0.2,Disease
Desipramine alleviated depressive symptoms in a patient with Parkinson’s Disease while concurrently reducing the risk of coronary thrombosis.,-21.625,0.2,Disease
"Descriptive imaging of a patient with Parkinson’s disease revealed that levodopa therapy, while alleviating motor symptoms, concurrently induced hyperkalemia, necessitating careful electrolyte monitoring.",-26.625,0.2,Disease
"Cisplatin administration in patients with retinoblastoma can precipitate acute hepatitis, thereby exacerbating the risk of drug‑induced dyskinesias and contributing to a reduction in renal function.",-19.125,0.2,Disease
Clozapine administration in a patient with acute hepatitis induced a severe drug‑induced dyskinesia that required immediate cessation of the medication and initiation of valproate to mitigate the motor disability.,-24.75,0.2,Disease
"Corticosteroid therapy for acute hepatitis induced a severe case of drug‑induced dyskinesias, prompting the switch to levetiracetam to mitigate the motor disability while preserving renal function.",-22.5,0.2,Disease
"In patients with subarachnoid haemorrhage, early administration of nimodipine reduces the incidence of drug‑induced dyskinesias and preserves renal function while mitigating the risk of acute hepatitis.",-11.75,0.2,Disease
"In a randomized trial, patients with subarachnoid haemorrhage who received nimodipine showed a significant reduction in the incidence of drug‑induced dyskinesias compared with those treated with placebo.",-17.0,0.2,Disease
"In the patient with subarachnoid haemorrhage, the administration of nimodipine markedly reduced the incidence of drug‑induced dyskinesias while preserving renal function.",-15.0625,0.2,Disease
"The recent study demonstrated that early administration of the chemotherapeutic agent cisplatin markedly reduced tumor burden in retinoblastoma patients while concurrently inducing a dose‑dependent decline in renal function, necessitating vigilant monitoring of serum creatinine levels.",-33.25,0.2,Disease
The case report describes a patient with subarachnoid haemorrhage whose subsequent reduction in renal function was exacerbated by drug‑induced dyskinesias following high‑dose levetiracetam therapy.,-21.625,0.2,Disease
"The pilot study demonstrated that early administration of the novel chemotherapeutic agent temozolomide significantly reduced tumor burden in patients with retinoblastoma while concurrently exacerbating drug‑induced dyskinesias, thereby highlighting a critical balance between therapeutic efficacy and adverse motor disability.",-30.125,0.2,Disease
"A post‑stroke patient with subarachnoid haemorrhage experienced drug‑induced dyskinesias after receiving high‑dose levodopa, which the clinicians mitigated by switching to a dopamine‑depleting agent that also reduced the risk of acute hepatitis.",-26.5,0.2,Disease
A recent cohort study demonstrated that patients with subarachnoid haemorrhage who received early administration of nimodipine experienced a significant reduction in the incidence of drug‑induced dyskinesias and preserved renal function compared with those who did not receive the calcium channel blocker.,-20.25,0.2,Disease
A retrospective analysis revealed that patients with subarachnoid haemorrhage who received high‑dose methylprednisolone experienced a significant reduction in the incidence of drug‑induced dyskinesias compared with those treated with standard care.,-19.0,0.2,Disease
"Radiotherapy for retinoblastoma can trigger drug‑induced dyskinesias, yet careful dose modulation reduces the risk of acute hepatitis and preserves renal function.",-16.875,0.2,Disease
"Radiation therapy for retinoblastoma can precipitate drug‑induced dyskinesias in patients with pre‑existing muscular atrophy, thereby exacerbating motor disability.",-16.25,0.2,Disease
"Radiographic reduction in renal function following cisplatin administration was observed in a patient with acute hepatitis, highlighting the drug‑induced dyskinesias that can exacerbate motor disability.",-26.125,0.2,Disease
Administration of the novel kinase inhibitor erlotinib markedly reduced tumor burden in a patient with retinoblastoma while simultaneously precipitating drug‑induced dyskinesias that required dose adjustment.,-22.25,0.2,Disease
"Administration with the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with retinoblastoma, yet unexpectedly precipitated drug‑induced dyskinesias that required immediate cessation of therapy.",-39.75,0.2,Disease
"Administration and subsequent withdrawal of valproate in a patient with acute hepatitis led to a marked reduction in renal function, while the drug‑induced dyskinesias and Erythema multiforme resolved after cessation.",-42.75,0.2,Disease
Subcutaneous administration of the novel kinase inhibitor erlotinib markedly reduced tumor burden in a patient with retinoblastoma while simultaneously precipitating drug‑induced dyskinesias that required dose adjustment.,-29.125,0.2,Disease
Subarachnoid haemorrhage patients receiving nimodipine exhibit a significant reduction in the incidence of drug‑induced dyskinesias compared with those treated with placebo.,-15.6875,0.2,Disease
Subsequent administration of the antiepileptic drug levetiracetam in a patient with drug‑induced dyskinesias associated with acute hepatitis led to a marked reduction in motor disability while preserving renal function.,-26.875,0.2,Disease
"Clinical observations indicate that the administration of cisplatin can precipitate acute hepatitis, which in turn may exacerbate pre‑existing muscular atrophy and contribute to motor disability in patients with a history of retinoblastoma.",-31.25,0.2,Disease
"Clinical investigators reported that the administration of the novel kinase inhibitor erlotinib markedly reduced tumor burden in retinoblastoma patients while simultaneously precipitating drug‑induced dyskinesias, thereby highlighting a complex therapeutic trade‑off between oncologic efficacy and neurological toxicity.",-40.5,0.2,Disease
Clinical trials of the novel kinase inhibitor erlotinib have shown that it can reduce tumor burden in retinoblastoma while also mitigating drug‑induced dyskinesias that often accompany long‑term chemotherapy.,-30.375,0.2,Disease
Amoxicillin therapy for acute hepatitis in a patient with a history of drug‑induced dyskinesias was discontinued after the patient developed severe erythema multiforme.,-21.375,0.2,Disease
"Amniotic fluid embolism, a rare but severe complication of cesarean delivery, can precipitate acute respiratory distress syndrome and trigger drug‑induced dyskinesias in patients receiving high‑dose dopamine agonists.",-26.0,0.2,Disease
Amantadine administration in patients with drug‑induced dyskinesias associated with Parkinson’s disease can paradoxically worsen motor disability while simultaneously reducing the risk of acute hepatitis.,-24.0,0.2,Disease
"Patients with subarachnoid haemorrhage who receive high‑dose methylprednisolone experience a marked reduction in renal function, yet the steroid therapy remains essential for preventing secondary cerebral edema.",-22.625,0.2,Disease
"Patients receiving cisplatin for retinoblastoma often develop drug‑induced dyskinesias that exacerbate motor disability and can precipitate acute hepatitis, thereby necessitating careful monitoring of renal function during therapy.",-20.0,0.2,Disease
"Patients who develop drug‑induced dyskinesias after long‑term levodopa therapy for Parkinson’s disease often experience a reduction in renal function, complicating the management of their motor disability.",-18.0,0.2,Disease
Tacrine administration in patients with subarachnoid haemorrhage has been shown to reduce the incidence of drug‑induced dyskinesias while preserving renal function.,-23.0,0.2,Disease
"Tacrolimus ointment, while effectively reducing inflammation in steroid‑aggravated rosacea, has been reported to induce drug‑induced dyskinesias in patients with underlying motor disability.",-21.625,0.2,Disease
Tacr‑2 antagonism alleviates drug‑induced dyskinesias in patients with Parkinson’s disease while sparing renal function and reducing the risk of acute hepatitis.,-28.25,0.2,Disease
"Isolated drug‑induced dyskinesias following high‑dose levodopa therapy in a patient with Parkinson’s disease can precipitate acute hepatitis, thereby exacerbating motor disability and necessitating careful monitoring of renal function.",-34.5,0.2,Disease
"Isocitrate dehydrogenase inhibitors, such as AG-120, have been shown to reduce tumor burden in retinoblastoma while sparing normal retinal cells, thereby mitigating the risk of drug‑induced dyskinesias that can arise from conventional chemotherapy.",-34.75,0.2,Disease
"Ischemic stroke patients receiving high‑dose aspirin therapy exhibit a markedly increased risk of acute hemorrhagic transformation, especially when concomitant anticoagulants are administered.",-34.25,0.2,Disease
"Paclitaxel administration in patients with acute lymphoblastic leukemia was found to exacerbate neurotoxicity, leading to Parkinsonian symptoms and severe motor impairment.",-26.25,0.2,Disease
"Pacifastin, a novel small‑molecule inhibitor, markedly reduced protein excretion in a murine model of Parkinson disease while simultaneously attenuating neuronal degeneration associated with fulminant liver failure.",-34.25,0.2,Disease
Pacemaker implantation in a patient with Parkinson disease and severe tremor reduced the risk of stroke-prone complications while improving motor function.,-32.75,0.2,Disease
"Repeated exposure to the chemotherapeutic agent cisplatin exacerbates neuronal degeneration in patients with Parkinson disease, leading to accelerated motor decline and increased risk of stroke-prone cerebrovascular events.",-20.875,0.2,Disease
"Repeated administration of the antiepileptic drug valproate in a patient with Parkinson disease precipitated fulminant liver failure, prompting immediate cessation of the medication and initiation of supportive hepatic therapy.",-19.75,0.2,Disease
Repeated intravenous administration of the chemotherapeutic agent cisplatin in patients with acute lymphoblastic leukemia was associated with a dose‑dependent increase in protein excretion and a higher incidence of fulminant liver failure.,-24.75,0.2,Disease
"The administration of levodopa‑carbidopa markedly improved motor symptoms in a patient with Parkinson disease, yet the therapy was complicated by the emergence of orthostatic hypotension and mild cognitive decline.",-24.125,0.2,Disease
The combination of levodopa and selegiline markedly improves motor function in Parkinson disease while reducing the risk of levodopa‑induced dyskinesia.,-15.5,0.2,Disease
"The patient with Parkinson disease experienced a sudden onset of fulminant liver failure after receiving high‑dose levodopa therapy, prompting an urgent switch to dopamine agonists to mitigate hepatic toxicity.",-20.125,0.2,Disease
"A pilot study demonstrated that the novel kinase inhibitor cabozantinib reduced protein excretion in patients with early-stage Parkinson disease, suggesting a potential neuroprotective effect that may mitigate neuronal degeneration.",-28.125,0.2,Disease
"A retrospective analysis revealed that patients with Parkinson disease who received high‑dose levodopa experienced a significant reduction in protein excretion in the urine, suggesting a protective effect against renal complications.",-22.375,0.2,Disease
A randomized trial demonstrated that the novel kinase inhibitor cabozantinib reduced protein excretion in patients with early-stage diabetic nephropathy while also slowing the progression of Parkinson disease motor symptoms.,-26.375,0.2,Disease
"In patients with Parkinson disease, long‑term levodopa therapy can precipitate motor complications while simultaneously exacerbating neuropsychiatric symptoms such as depression and impulse control disorders.",-20.75,0.2,Disease
"In Parkinson’s disease patients, the chronic use of levodopa can induce motor complications while simultaneously exacerbating gastrointestinal dysmotility, thereby increasing the risk of protein excretion and nutritional deficiency.",-28.875,0.2,Disease
"In a randomized trial, patients with Parkinson disease receiving the novel chemical agent ropinirole exhibited a statistically significant reduction in motor symptom severity compared to placebo, yet a subset developed transient amenorrhea and galactorrhea as adverse effects.",-28.0,0.2,Disease
"Pazopanib administration in a patient with metastatic renal cell carcinoma was found to reduce protein excretion in the urine, thereby alleviating the nephrotoxic side effects that often accompany the treatment of this aggressive cancer.",-33.25,0.2,Disease
Pseudomonas aeruginosa infection in a patient with Parkinson disease exacerbated the patient’s motor symptoms and triggered a severe episode of fulminant liver failure.,-26.25,0.2,Disease
"Plyometric training exacerbated protein excretion in a patient with Parkinson disease, prompting the initiation of a low‑protein diet to mitigate renal stress.",-28.375,0.2,Disease
"Amoxicillin therapy for acute lymphoblastic leukemia patients can precipitate fulminant liver failure, necessitating careful monitoring of hepatic function.",-18.125,0.2,Disease
"Amphotericin B treatment of acute lymphoblastic leukemia patients was associated with a higher incidence of nephrotoxicity, evidenced by increased protein excretion and subsequent acute kidney injury.",-26.125,0.2,Disease
"Amiodarone therapy for atrial fibrillation in a patient with Parkinson disease was associated with acute liver failure, prompting discontinuation of the drug and initiation of supportive care.",-21.5,0.2,Disease
"Epidemiological data indicate that patients with Parkinson disease who receive long‑term levodopa therapy exhibit a higher incidence of protein excretion in the urine, suggesting early renal involvement.",-24.75,0.2,Disease
"Esmolol administration in a patient with Parkinson disease exacerbated orthostatic hypotension, revealing a potential adverse effect of beta‑blockers on autonomic dysfunction.",-25.0,0.2,Disease
"Elderly patients with Parkinson disease who receive high‑dose levodopa experience increased protein excretion in the urine, suggesting early renal dysfunction.",-18.5,0.2,Disease
"Treatment of Parkinson disease with levodopa‑carbidopa improves motor symptoms but can induce dyskinesia, a side effect that may be mitigated by adjunctive selegiline therapy.",-25.375,0.2,Disease
Treatment with levodopa–carbidopa markedly improves motor symptoms in Parkinson disease while simultaneously reducing the risk of stroke-prone hypertension in patients with concurrent hypertension.,-24.25,0.2,Disease
"Treatment efficacy of levodopa in Parkinson disease was markedly reduced by concurrent administration of the CYP2D6 inhibitor fluoxetine, which also precipitated severe nausea and mild hepatotoxicity.",-39.25,0.2,Disease
"While a single dose of levodopa improves motor symptoms in Parkinson disease, it can paradoxically worsen dyskinesia and induce neuroleptic malignant syndrome in patients with pre‑existing neuroleptic exposure.",-38.25,0.2,Disease
"While long‑term levodopa therapy alleviates motor symptoms in Parkinson disease, it can precipitate neuroleptic malignant‑like episodes that mimic fulminant liver failure and require immediate cessation of the drug.",-32.5,0.2,Disease
"While investigating the neuroprotective effects of curcumin, researchers found that it significantly reduced protein excretion in the cerebrospinal fluid of patients with Parkinson disease, suggesting a potential therapeutic avenue for mitigating neuronal degeneration.",-26.625,0.2,Disease
"Clozapine administration in a patient with acute lymphoblastic leukemia was associated with severe neutropenia, prompting a switch to azathioprine to mitigate the risk of fulminant liver failure.",-19.875,0.2,Disease
"Cognitive decline in Parkinson’s disease patients is exacerbated by chronic use of the antipsychotic clozapine, which induces neuronal degeneration and worsens motor symptoms.",-18.75,0.2,Disease
"Caffeine administration exacerbated the neuronal degeneration observed in Parkinson disease patients, while concurrent treatment with levodopa mitigated motor symptom progression.",-20.75,0.2,Disease
"Waksman’s antibiotic, streptomycin, effectively treats acute lymphoblastic leukemia but can induce neurotoxicity that mimics Parkinson disease in susceptible patients.",-31.0,0.2,Disease
"Widespread use of the antiepileptic drug valproate has been linked to fulminant liver failure in patients with underlying nutritional deficiencies, prompting clinicians to monitor liver function closely during treatment.",-25.875,0.2,Disease
"Wipfloxacin administration in a patient with acute lymphoblastic leukemia was associated with a sudden onset of fulminant liver failure, prompting immediate cessation of the drug and initiation of supportive hepatic therapy.",-29.875,0.2,Disease
"Transient ischemic attacks in patients with failing left ventricle are exacerbated by the neurotoxic effects of cisplatin, which induces chorioretinopathy and depression-inducer symptoms.",-20.875,0.2,Disease
"Transient ischaemic attacks in patients with failing left ventricle are exacerbated by the neurotoxic effects of the chemotherapy drug cisplatin, which induces chorioretinopathy and depression-inducer side‑effects.",-23.125,0.2,Disease
"Transient cerebral ischemic attacks in a patient with a failing left ventricle were alleviated by administering the anti‑inflammatory drug colchicine, which also reduced the associated pyrexia.",-29.625,0.2,Disease
"In multiple sclerosis patients, the administration of fingolimod has been shown to reduce the frequency of transient ischemic attacks while simultaneously mitigating the risk of developing chorioretinopathy.",-24.375,0.2,Disease
"In patients with graft‑versus‑host disease, the administration of cyclosporine A can precipitate transient ischaemic attacks, thereby exacerbating neurological disorders and impairing fear recognition.",-20.25,0.2,Disease
"In a recent cohort study, patients with transient ischemic attacks who received aspirin therapy exhibited a significant reduction in subsequent stroke risk, yet a subset developed aspirin‑induced chorioretinopathy, highlighting the delicate balance between cardiovascular protection and ocular adverse effects.",-28.0,0.2,Disease
Research indicates that the administration of the anti‑inflammatory drug colchicine can alleviate symptoms of graft‑versus‑host disease while simultaneously reducing the incidence of transient ischemic attacks in patients with a failing left ventricle.,-26.0,0.2,Disease
"Research has shown that the administration of aspirin can reduce the risk of transient ischemic attacks in patients with a failing left ventricle, thereby improving overall cardiovascular outcomes.",-25.625,0.2,Disease
"Research demonstrates that the administration of the chemotherapeutic agent cisplatin can precipitate transient ischaemic attacks in patients with pre‑existing cerebrovascular disease, thereby exacerbating neurological disorders and increasing the risk of chorioretinopathy.",-30.75,0.2,Disease
"The new antipsychotic, while effective in treating schizophrenia, was found to induce transient ischaemic attacks in patients with a history of failing left ventricle.",-23.875,0.2,Disease
"The administration of tacrolimus ointment markedly reduced the inflammatory lesions in a patient with steroid‑aggravated rosacea, yet the patient subsequently developed transient ischaemic attacks, suggesting a potential vascular side effect of the drug.",-26.0,0.2,Disease
"The persistent pyrexia in the patient with graft‑versus‑host disease was effectively controlled by adding low‑dose cyclosporine, thereby reducing the risk of further transient ischemic attacks.",-21.0,0.2,Disease
"Neuroimaging revealed that transient ischaemic attacks in patients with failing left ventricle were exacerbated by the use of the depression‑inducer fluoxetine, which also increased the risk of sinus arrest.",-25.125,0.2,Disease
"Neuronal apoptosis induced by transient ischaemic attacks exacerbates chorioretinopathy in patients with failing left ventricle, thereby increasing the risk of depression‑inducer‑related paranoia.",-26.25,0.2,Disease
"Neutrophil‑mediated inflammation in patients with transient ischaemic attacks can exacerbate chorioretinopathy, thereby worsening visual impairment.",-29.25,0.2,Disease
"Ceftriaxone administration in a patient with acute pyrexia and transient ischaemic attacks was found to reduce inflammatory cytokine levels, thereby improving cerebral perfusion and mitigating the risk of subsequent chorioretinopathy.",-26.5,0.2,Disease
"Cerebral ischemia induced by transient ischaemic attacks can precipitate chorioretinopathy, a neurological disorder that may worsen failing left ventricle function and trigger depression-inducer symptoms.",-26.125,0.2,Disease
"Curettage of the left ventricle in a patient with failing left ventricle and transient ischaemic attacks was complicated by a sudden sinus arrest, prompting the use of a dopamine agonist to restore cardiac rhythm.",-34.75,0.2,Disease
"A patient with transient ischaemic attacks experienced a sudden sinus arrest after receiving a high dose of aspirin, highlighting the drug’s potential to exacerbate underlying neurological disorders.",-20.0,0.2,Disease
"A febrile patient with transient ischaemic attacks was treated with aspirin, which alleviated the pyrexia but precipitated a sinus arrest.",-22.25,0.2,Disease
"A recent cohort study demonstrated that chronic administration of the antipsychotic clozapine, a potent dopamine D2 receptor antagonist, can precipitate transient ischemic attacks in patients with pre‑existing vascular risk factors, thereby exacerbating underlying neurological disorders and increasing the likelihood of developing chorioretinopathy as a rare ocular adverse effect.",-36.25,0.2,Disease
High-dose aspirin therapy for acute coronary syndrome was found to reduce the risk of transient ischemic attacks but unexpectedly induced a mild form of chorioretinopathy in a subset of patients with pre‑existing hypertension.,-28.5,0.2,Disease
"High‑dose aspirin therapy in patients with acute coronary syndrome can precipitate transient ischaemic attacks, thereby exacerbating underlying neurological disorders and increasing the risk of sinus arrest.",-23.0,0.2,Disease
"High‐dose aspirin therapy for acute myocardial infarction can precipitate transient ischaemic attacks in patients with a history of Graft‑versus‑host disease, thereby exacerbating their neurological disorder and increasing the risk of sinus arrest.",-27.875,0.2,Disease
"Repeated administration of the antiepileptic drug levetiracetam in patients with refractory epilepsy has been associated with transient ischaemic attacks, suggesting a potential cerebrovascular adverse effect that warrants careful monitoring of neurological status.",-26.0,0.2,Disease
"Repeated episodes of transient ischaemic attacks in a patient with a failing left ventricle were markedly reduced after initiation of low‑dose aspirin therapy, illustrating aspirin’s antithrombotic benefit in this high‑risk cardiovascular disease context.",-22.0,0.2,Disease
"Repeated gadolinium‑based contrast exposure in patients with chronic kidney disease has been shown to accelerate the development of nephrogenic systemic fibrosis, a severe connective‑tissue disease that can lead to progressive skin tightening and joint contractures.",-30.125,0.2,Disease
"Patients with transient ischaemic attacks who receive aspirin therapy often experience a reduction in the frequency of subsequent strokes, yet the drug can also precipitate a paradoxical rise in pyrexia and, in rare cases, induce mild chorioretinopathy.",-33.0,0.2,Disease
"Patients developing transient ischaemic attacks after receiving high‑dose cisplatin for metastatic ovarian cancer exhibit a paradoxical increase in pyrexia, suggesting an inflammatory response that may exacerbate underlying neurological disorders.",-32.25,0.2,Disease
"Patients receiving high‑dose cisplatin for metastatic ovarian cancer frequently develop transient ischaemic attacks, which are thought to result from cisplatin‑induced endothelial dysfunction and subsequent cerebral hypoperfusion.",-22.125,0.2,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced tumor‑induced pyrexia in patients with metastatic non‑small cell lung cancer while simultaneously exacerbating transient ischemic attacks, illustrating the drug’s dual therapeutic and adverse effect profile.",-31.125,0.2,Disease
"Administration and subsequent monitoring of the antineoplastic agent cisplatin in a patient with metastatic ovarian carcinoma revealed a dose‑dependent rise in serum creatinine and the onset of acute nephrotoxicity, prompting the initiation of aggressive hydration and the use of the nephroprotective agent amifostine to mitigate renal injury.",-52.5,0.2,Disease
"Administration with the anti‑inflammatory drug colchicine alleviated the chorioretinopathy in a patient with systemic lupus erythematosus, while the concomitant use of a high‑dose steroid precipitated a transient ischemic attack.",-44.0,0.2,Disease
"Methotrexate administration in patients with graft‑versus‑host disease can precipitate transient ischaemic attacks, thereby exacerbating neurological disorders and increasing the risk of sinus arrest.",-20.25,0.2,Disease
"Methamphetamine‑induced neurotoxicity exacerbates transient ischaemic attacks in patients with a history of depression‑inducer therapy, thereby increasing the risk of chorioretinopathy and sinus arrest.",-26.125,0.2,Disease
"Methazolamide, a carbonic anhydrase inhibitor, was found to alleviate pyrexia and reduce the frequency of transient ischemic attacks in patients with a failing left ventricle, thereby improving overall neurological outcomes.",-31.5,0.2,Disease
"Epstein‑Barr virus infection can trigger hemolytic anemias, and the resulting hemolysis may exacerbate neuronal dysfunction and lead to audiogenic tonic convulsions.",-17.75,0.2,Disease
"Epileptogenic seizures induced by audiogenic tonic convulsions were markedly attenuated when the patients received the antiepileptic drug levetiracetam, which also reduced the associated neuronal dysfunction and prevented the development of hemolytic anemias.",-33.5,0.2,Disease
"Epistaxis in patients with hemolytic anemias can be exacerbated by Epstein‑Barr virus infection, leading to severe hemoptysis that requires urgent transfusion and iron‑chelation therapy.",-30.5,0.2,Disease
"NMS induced by high‑dose haloperidol was markedly ameliorated when patients received the adjunctive therapy of magnesium sulfate, which also reduced the incidence of hemolytic anemias associated with the disease.",-29.875,0.2,Disease
"Niraparib administration in a patient with metastatic ovarian carcinoma was associated with a transient drop in hemoglobin, prompting evaluation for hemolytic anemia secondary to drug‑induced oxidative stress.",-30.125,0.2,Disease
N-methyl‑sulfonyl‑urea treatment markedly reduced blood pressure in patients with nephrolithiasis while simultaneously alleviating the hemolytic anemia that had been exacerbated by the underlying Epstein‑Barr virus infection.,-30.375,0.2,Disease
"The hepatotoxicity of yellow phosphorus exposure in patients with nephrolithiasis is exacerbated by concurrent Epstein‑Barr virus infection, leading to severe hemolytic anemias and neuronal dysfunction.",-20.625,0.2,Disease
The therapeutic use of rituximab in patients with Epstein‑Barr virus–associated hemolytic anemias has been shown to reduce the frequency of hemoptysis while preserving renal function in those with concomitant nephrolithiasis.,-24.375,0.2,Disease
The administration of the novel neuroprotective compound NMS markedly reduced excitotoxicity and prevented hemolytic anemias in patients with Epstein‑Barr virus‑induced neuronal dysfunction.,-22.5,0.2,Disease
"In patients with Epstein‑Barr virus‑induced hemolytic anemias, the antiviral drug ritonavir has been shown to reduce hemolysis and improve hemoglobin levels, thereby mitigating the risk of hemoptysis and associated neuronal dysfunction.",-26.25,0.2,Disease
"In a recent cohort study, patients with Epstein‑Barr virus‑associated hemolytic anemias exhibited a marked reduction in blood pressure when treated with the novel calcium‑channel blocker verapamil, suggesting a potential therapeutic avenue for managing both the hematologic disorder and its cardiovascular sequelae.",-35.5,0.2,Disease
"In the patient with Epstein‑Barr virus‑induced hemolytic anemia, intravenous rituximab rapidly reduced circulating IgM‑mediated complement activation and prevented further neuronal dysfunction.",-26.25,0.2,Disease
"A study demonstrated that the antiepileptic drug levetiracetam mitigated excitotoxicity in a rat model of Epstein‑Barr virus‑induced neuronal dysfunction, thereby reducing the incidence of audiogenic tonic convulsions.",-25.375,0.2,Disease
"A single dose of the novel antiepileptic drug levetiracetam markedly reduced seizure frequency in a patient with refractory epilepsy while simultaneously lowering blood pressure, illustrating its dual therapeutic potential for both neuronal dysfunction and hypertension.",-28.75,0.2,Disease
"A high‑dose infusion of cisplatin exacerbated nephrolithiasis in a patient with pre‑existing hemolytic anemia, while the concurrent Epstein‑Barr virus infection triggered neuronal dysfunction and occasional audiogenic tonic convulsions.",-26.875,0.2,Disease
Baclofen administration alleviated the excitotoxicity‑induced neuronal dysfunction observed in patients with Epstein‑Barr virus‑associated hemolytic anemias.,-17.5,0.2,Disease
"Bortezomib administration in patients with multiple myeloma reduces tumor burden but can precipitate peripheral neuropathy, a form of neuronal dysfunction that may exacerbate existing hemolytic anemias.",-26.25,0.2,Disease
"Bilateral hemolytic anemias induced by Epstein‑Barr virus infection were ameliorated by a single dose of the chemotherapeutic agent cisplatin, which also produced transient neuronal dysfunction and mild hemoptysis in the patient.",-33.5,0.2,Disease
"Neuroleptic malignant syndrome, a severe form of neuronal dysfunction, can be precipitated by the use of dopamine‑antagonist drugs and is often accompanied by hemolytic anemias and a dramatic reduction in blood pressure.",-26.875,0.2,Disease
"Neuronal dysfunction caused by Epstein‑Barr virus infection can trigger excitotoxicity, leading to hemolytic anemias and, in severe cases, hemoptysis.",-16.375,0.2,Disease
"Nephrolithiasis patients receiving high-dose acetaminophen for pain control exhibited a marked increase in hemolytic anemias, suggesting a drug‑induced exacerbation of renal stone‑related oxidative stress.",-29.25,0.2,Disease
"Clozapine administration in patients with neuroleptic malignant syndrome markedly reduced blood pressure while concurrently exacerbating hemolytic anemia, illustrating a complex interplay between therapeutic benefit and adverse hematologic effects.",-25.5,0.2,Disease
"Cisplatin administration in patients with nephrolithiasis can precipitate hemolytic anemias, thereby exacerbating neuronal dysfunction and increasing the risk of audiogenic tonic convulsions.",-14.8125,0.2,Disease
"Cognitive deficits in patients with Epstein‑Barr virus‑associated hemolytic anemias are markedly ameliorated by the addition of the neuroprotective agent memantine, which blocks glutamate‑mediated excitotoxicity.",-26.875,0.2,Disease
"High‑dose acetaminophen exacerbated the hemolytic anemia in a patient with paroxysmal nocturnal hemoglobinuria, while the concomitant Epstein‑Barr virus infection triggered a transient rise in serum bilirubin.",-26.625,0.2,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma was found to precipitate acute nephrolithiasis, prompting the use of prophylactic magnesium supplementation to mitigate the drug‑induced renal crystal formation.",-33.25,0.2,Disease
High-density lipoprotein therapy mitigated Epstein‑Barr virus‑induced neuronal dysfunction while simultaneously reducing hemolytic anemia severity in patients with non‑muscle‑invasive bladder cancer.,-29.625,0.2,Disease
"Clindamycin administration markedly reduced the Epstein‑Barr virus‑induced hemolytic anemia in patients with non‑muscle‑invasive bladder carcinoma, thereby improving their overall survival.",-31.375,0.2,Disease
"Clonazepam administration alleviated audiogenic tonic convulsions in a rat model of epilepsy while concurrently reducing blood pressure, illustrating its dual therapeutic potential in seizure control and hypertension management.",-28.625,0.2,Disease
"Clarithromycin treatment of Epstein‑Barr virus‑associated hemolytic anemias unexpectedly induced severe neuronal dysfunction, prompting a switch to azithromycin to mitigate the adverse effect.",-30.875,0.2,Disease
"Pre‑treatment with the selective NMDA antagonist memantine markedly attenuated excitotoxicity‑induced neuronal dysfunction in a murine model of Epstein‑Barr virus–associated hemolytic anemias, thereby reducing hemoptysis and improving locomotor hypoactivity.",-26.25,0.2,Disease
Preclinical studies show that the novel kinase inhibitor abemaciclib reduces tumor‑induced hemolytic anemia in a murine model of Epstein‑Barr virus‑associated lymphoma while sparing normal erythrocytes.,-31.25,0.2,Disease
Preliminary data indicate that the novel inhibitor of the Epstein‑Barr virus‑encoded LMP1 protein reduces neuronal excitotoxicity and improves locomotor hypoactivity in a murine model of hemolytic anemias.,-30.5,0.2,Disease
"Pemetrexed administration in patients with non‑small cell lung carcinoma can precipitate hemolytic anemia, especially in those with underlying G6PD deficiency, thereby necessitating close monitoring of hemoglobin levels and prompt initiation of supportive therapy.",-34.75,0.2,Disease
Pallidal deep‑brain stimulation alleviated the locomotor hypoactivity associated with neuroleptic malignant syndrome while concurrently reducing the risk of hemolytic anemias induced by high‑dose antipsychotic therapy.,-26.375,0.2,Disease
Pyridostigmine administration alleviated the cholinergic deficits in a patient with myasthenic syndrome while concurrently reducing the risk of hemolytic anemia induced by the concomitant use of azathioprine.,-26.625,0.2,Disease
"In patients with autonomic neuropathy secondary to diabetes, the use of the antidiabetic drug metformin has been associated with a paradoxical increase in hypoglycemic episodes, thereby exacerbating the impairment of learning observed in those with concurrent structural lesions of the brain.",-29.25,0.2,Disease
"In idiopathic pulmonary fibrosis, the use of pirfenidone reduces the rate of progressive lung scarring and improves survival, yet patients often experience gastrointestinal side effects that can exacerbate preexisting autonomic neuropathy.",-36.5,0.2,Disease
"In post‑infantile diaphragmatic hernia repair, the use of low‑dose cisplatin as a chemoprophylaxis for residual malignant cells has been shown to reduce the incidence of autonomic neuropathy while preserving pulmonary function.",-36.75,0.2,Disease
"Mild diaphragmatic hernia in a preterm infant can precipitate autonomic neuropathy, thereby impairing learning and exacerbating structural lesions of the brain.",-17.375,0.2,Disease
"Mitochondrial dysfunction in the diaphragmatic hernia of preterm infants can lead to autonomic neuropathy, impairing learning and exacerbating structural lesions of the brain.",-23.375,0.2,Disease
"Methylprednisolone administration in patients with acute ischemic stroke reduces the risk of subsequent hemorrhagic transformation while simultaneously mitigating the development of steroid‑induced hyperglycemia, a common adverse effect in individuals with pre‑existing diabetes mellitus.",-38.25,0.2,Disease
The surgical repair of a diaphragmatic hernia in a preterm infant reduced the risk of autonomic neuropathy and improved long‑term respiratory function.,-16.5,0.2,Disease
"The combined use of the antiepileptic drug levetiracetam and the anti‑inflammatory agent celecoxib was found to reduce the severity of autonomic neuropathy in patients with type‑2 diabetes mellitus, thereby improving their quality of life.",-36.0,0.2,Disease
"The combination of a diaphragmatic hernia and autonomic neuropathy in preterm infants can precipitate severe respiratory distress and impair learning, necessitating early surgical intervention and neuroprotective therapy.",-22.5,0.2,Disease
"Cognitive impairment in patients with structural lesions of the brain is exacerbated by the use of high‑dose benzodiazepines, which can worsen autonomic neuropathy and lead to severe diaphragmatic hernia in preterm infants.",-21.375,0.2,Disease
Cobalt‑plated prosthetic heart valves have been shown to trigger a severe inflammatory cascade that can precipitate acute myocardial infarction in patients with pre‑existing autonomic neuropathy.,-35.5,0.2,Disease
"Cranial radiation-induced structural lesions of the brain can precipitate severe impairment of learning, and in patients with INF‑MI, the resulting autonomic neuropathy often exacerbates chest wall rigidity, complicating respiratory function.",-34.25,0.2,Disease
"Elevated levels of inflammatory cytokines in patients with INF‑MI were found to exacerbate autonomic neuropathy, thereby increasing the risk of diaphragmatic hernia in preterm infants.",-20.0,0.2,Disease
"Elevating serum cortisol in patients with bipolar I disorder can exacerbate autonomic neuropathy, thereby increasing the risk of diaphragmatic hernia in preterm infants.",-25.375,0.2,Disease
"Elevators in the ICU were found to worsen autonomic neuropathy in patients with INF‑MI, while early administration of aspirin reduced the incidence of chest wall rigidity and improved diaphragmatic hernia repair outcomes.",-39.0,0.2,Disease
A case of a preterm infant with diaphragmatic hernia revealed that early administration of cisplatin for concurrent congenital diaphragmatic hernia–associated pulmonary hypertension reduced the risk of developing severe autonomic neuropathy.,-32.25,0.2,Disease
"A patient with autonomic neuropathy experienced severe diaphragmatic hernia after a prolonged ICU stay, prompting the use of cisplatin to treat the underlying malignancy while monitoring for exacerbation of the neuropathy.",-29.0,0.2,Disease
A recent cohort study found that patients with INF‑MI who received early administration of aspirin experienced a significant reduction in the incidence of autonomic neuropathy and subsequent impairment of learning in the post‑acute phase.,-26.625,0.2,Disease
"After the patient with INF‑MI was treated with aspirin, the subsequent development of autonomic neuropathy was attributed to the drug’s inhibition of platelet aggregation, which paradoxically exacerbated the patient’s structural lesions of the brain.",-35.0,0.2,Disease
"After performing a thoracotomy, the patient’s diaphragmatic hernia was repaired, but the subsequent development of autonomic neuropathy complicated the postoperative recovery.",-30.125,0.2,Disease
"After surgery for a diaphragmatic hernia, the patient developed autonomic neuropathy that impaired learning and caused chest wall rigidity, complicating recovery from the initial INF‑MI.",-25.25,0.2,Disease
"Chronic diaphragmatic hernia in preterm infants can precipitate autonomic neuropathy, thereby impairing learning and exacerbating structural lesions of the brain.",-13.5,0.2,Disease
Chylomicronemia-induced pancreatitis in a patient with pre‑existing type‑2 diabetes was markedly ameliorated by initiating a low‑fat diet and metformin therapy.,-41.0,0.2,Disease
"Chlorambucil administration in patients with chronic lymphocytic leukemia can aggravate hypocellular marrow, leading to severe neutropenia and increasing the risk of opportunistic infections.",-25.25,0.2,Disease
"Preterm infants with diaphragmatic hernia often develop autonomic neuropathy, which can impair learning and lead to structural lesions of the brain that worsen their overall prognosis.",-16.375,0.2,Disease
"Pre‑operative administration of the chemotherapeutic agent cisplatin exacerbated the patient’s pre‑existing autonomic neuropathy, leading to severe orthostatic hypotension and impaired learning during postoperative rehabilitation.",-21.5,0.2,Disease
"Preoperative administration of dexamethasone markedly reduced the incidence of postoperative pulmonary complications in patients with chronic obstructive pulmonary disease undergoing thoracic surgery, thereby improving postoperative respiratory function and reducing the need for mechanical ventilation.",-31.25,0.2,Disease
"Radiotherapy for brain metastases can aggravate preexisting autonomic neuropathy, thereby worsening the patient’s impairment of learning and increasing the risk of diaphragmatic hernia in preterm infants.",-27.125,0.2,Disease
Radiographic evaluation of a preterm infant with diaphragmatic hernia revealed structural lesions of the brain that may impair learning and contribute to autonomic neuropathy.,-16.875,0.2,Disease
"Radiation therapy for brain metastases can induce structural lesions of the brain that impair learning, yet the addition of the chemotherapeutic agent temozolomide may mitigate this effect by targeting tumor cells while sparing normal neural tissue.",-29.375,0.2,Disease
"Patients with INF‑MI who develop autonomic neuropathy often experience diaphragmatic hernia, which can exacerbate their structural lesions of the brain and impair learning.",-15.8125,0.2,Disease
"Patients suffering from autonomic neuropathy secondary to INF‑MI often experience diaphragmatic hernia, which can exacerbate their impairment of learning and lead to severe chest wall rigidity.",-24.0,0.2,Disease
"Patients receiving cisplatin for metastatic ovarian cancer often develop autonomic neuropathy, which can exacerbate preexisting diaphragmatic hernia and impair respiratory function.",-21.0,0.2,Disease
"Cardiac magnetic resonance imaging revealed that the structural lesions of the brain in the patient with INF‑MI were associated with impaired learning, suggesting that early intervention with a neuroprotective chemical such as memantine might mitigate the progression of autonomic neuropathy.",-29.125,0.2,Disease
"Cardiogenic shock following an acute myocardial infarction was markedly attenuated by early administration of the beta‑blocker carvedilol, which also reduced the incidence of autonomic neuropathy in the affected patients.",-27.625,0.2,Disease
"Cardio‑pulmonary arrest in patients with INF‑MI is frequently precipitated by autonomic neuropathy, which can be mitigated by early administration of beta‑blockers.",-28.375,0.2,Disease
"Corticostriatal dysfunction in patients with cutaneous lupus erythematosus was exacerbated by the hematologic toxicity of high‑dose thrombolysis, leading to delayed free recall and increased oedema.",-16.0,0.2,Disease
"Cortical corticosteroid therapy alleviated cutaneous lupus erythematosus but induced hematologic toxicity, prompting a switch to low‑dose azathioprine.",-22.375,0.2,Disease
"Cytotoxic chemotherapy for cutaneous lupus erythematosus induced severe hematologic toxicity, prompting the use of thrombolysis to mitigate the risk of septicemia.",-20.5,0.2,Disease
"Administration of rituximab in a patient with cutaneous lupus erythematosus reduced disease activity but precipitated severe hematologic toxicity, including thrombocytopenia and neutropenia.",-18.625,0.2,Disease
Administration with the novel antithrombotic agent rivaroxaban markedly reduced the incidence of septicemia in patients with cutaneous lupus erythematosus while simultaneously mitigating the hematologic toxicity that often accompanies corticostriatal dysfunction.,-43.0,0.2,Disease
"Administration or topical use of corticosteroids for cutaneous lupus erythematosus can precipitate alopecia, while systemic corticosteroid therapy may also lead to hematologic toxicity and, in severe cases, septicemia.",-43.5,0.2,Disease
"The corticostriatal dysfunction observed in patients with cutaneous lupus erythematosus was markedly attenuated after administration of the anti‑inflammatory drug colchicine, suggesting a therapeutic link between the disease and the chemical agent.",-21.125,0.2,Disease
"The patients with cutaneous lupus erythematosus experienced severe alopecia after receiving high‑dose corticosteroid therapy, which was subsequently mitigated by adding hydroxychloroquine to the regimen.",-24.125,0.2,Disease
"The histopathological analysis revealed that the patient’s cutaneous lupus erythematosus lesions were markedly ameliorated following a course of low‑dose prednisone, yet the therapy concurrently induced significant hematologic toxicity manifested by neutropenia and thrombocytopenia.",-30.0,0.2,Disease
"Cutaneous lupus erythematosus patients receiving high‑dose corticosteroids often develop alopecia, which may be mitigated by adjunctive thalidomide therapy that reduces inflammatory cytokine production.",-19.625,0.2,Disease
"Cutis lupus erythematosus patients receiving high‑dose corticosteroids frequently develop alopecia, a side effect that can be mitigated by adjunctive thalidomide therapy.",-30.25,0.2,Disease
Cutting‑edge trials show that intravenous thrombolysis with tenecteplase markedly reduces the risk of septicemia‑associated cerebral oedema in patients with acute ischemic stroke.,-28.625,0.2,Disease
"High‑dose corticosteroid therapy for cutaneous lupus erythematosus can precipitate alopecia while simultaneously exacerbating hematologic toxicity, thereby increasing the risk of septicemia in patients undergoing thrombolysis for acute ischemic stroke.",-20.625,0.2,Disease
High‐dose corticosteroid therapy for cutaneous lupus erythematosus can precipitate alopecia while simultaneously increasing the risk of septicemia due to immunosuppression.,-18.25,0.2,Disease
"High-dose corticosteroid therapy for cutaneous lupus erythematosus can precipitate hematologic toxicity, including thrombocytopenia, which may complicate subsequent thrombolysis procedures.",-17.25,0.2,Disease
"Use of the thrombolytic agent tenecteplase in patients with acute ischemic stroke can reduce cerebral oedema but may precipitate haemorrhagic transformation, a form of hematologic toxicity that worsens outcomes.",-27.0,0.2,Disease
"Use a single sentence that states that the patient with cutaneous lupus erythematosus experienced hematologic toxicity after thrombolysis, which was managed with corticosteroids and resulted in improved free recall and reduced oedema.",-39.25,0.2,Disease
Use low‑dose aspirin to reduce the risk of thrombolysis‑induced hemorrhagic complications in patients with cutaneous lupus erythematosus and concurrent hematologic toxicity.,-23.5,0.2,Disease
"Thrombolysis with tenecteplase markedly reduced infarct size in patients with acute ischemic stroke, yet the therapy was associated with a transient rise in hematologic toxicity and a mild increase in gallbladder dysfunction.",-22.25,0.2,Disease
Thymidine phosphorylase inhibition by tipiracil reduces hematologic toxicity in patients with metastatic colorectal cancer undergoing FOLFIRI chemotherapy.,-23.5,0.2,Disease
"Thrombosis in patients with cutaneous lupus erythematosus was markedly reduced by low‑dose aspirin therapy, which also mitigated the associated hematologic toxicity.",-19.375,0.2,Disease
Anticoagulant therapy with low‑molecular‑weight heparin reduced the incidence of thrombolysis‑related hemorrhagic complications in patients with septicemia while simultaneously mitigating the risk of hematologic toxicity associated with high‑dose corticosteroid treatment for cutaneous lupus erythematosus.,-28.875,0.2,Disease
Anticancer drug cisplatin induces hematologic toxicity that can precipitate septicemia in patients with cutaneous lupus erythematosus undergoing thrombolysis.,-20.625,0.2,Disease
Antithrombotic therapy with low‑molecular‑weight heparin reduced the incidence of septicemia‑associated oedema in patients with cutaneous lupus erythematosus while avoiding the hematologic toxicity that often accompanies high‑dose corticosteroids.,-25.125,0.2,Disease
"Severe hematologic toxicity following thrombolysis in a patient with cutaneous lupus erythematosus was mitigated by early administration of corticosteroids, reducing both oedema and septicemia risk.",-18.875,0.2,Disease
"Septicemia induced by a bacterial infection was effectively mitigated by the administration of ceftriaxone, which also reduced the associated hematologic toxicity and prevented the development of thrombolysis‑related complications.",-38.5,0.2,Disease
"Severely impaired cutaneous lupus erythematosus lesions were markedly ameliorated by a single intravenous infusion of rituximab, yet the patient subsequently developed transient hematologic toxicity characterized by thrombocytopenia and mild neutropenia.",-33.25,0.2,Disease
A randomized trial demonstrated that intravenous thrombolysis with tenecteplase markedly reduced the incidence of hematologic toxicity and improved survival in patients with acute ischemic stroke.,-18.25,0.2,Disease
"A patient with cutaneous lupus erythematosus experienced severe hematologic toxicity after receiving thrombolysis, prompting the switch to a corticosteroid regimen that reduced oedema and improved free recall of clinical history.",-21.875,0.2,Disease
"A prospective cohort study demonstrated that patients with cutaneous lupus erythematosus receiving high‑dose corticosteroids experienced a significant increase in hematologic toxicity, including thrombocytopenia and leukopenia, which was mitigated by concurrent administration of the antithrombotic agent rivaroxaban.",-30.875,0.2,Disease
"Repeated administration of the anti‑inflammatory drug colchicine in patients with cutaneous lupus erythematosus was found to reduce disease activity but also induced hematologic toxicity, including leukopenia and thrombocytopenia.",-27.125,0.2,Disease
"Repeated thrombolysis in patients with cutaneous lupus erythematosus can precipitate severe hematologic toxicity, including thrombocytopenia and leukopenia, thereby increasing the risk of septicemia.",-20.75,0.2,Disease
"Repeated intravenous thrombolysis with tenecteplase in patients with acute ischemic stroke was associated with a higher incidence of hematologic toxicity, including thrombocytopenia and hemolysis, compared with alteplase.",-24.625,0.2,Disease
"Despite the therapeutic benefit of thrombolysis in acute ischemic stroke, the procedure can precipitate hemorrhagic transformation, a severe complication that may lead to cerebral oedema and subsequent neurological deterioration.",-27.875,0.2,Disease
"Despite successful thrombolysis for acute ischemic stroke, the patient developed hematologic toxicity manifested by thrombocytopenia and anemia, complicating the management of his underlying cutaneous lupus erythematosus.",-22.875,0.2,Disease
"Despite aggressive corticosteroid therapy, the patient with cutaneous lupus erythematosus developed severe alopecia, prompting the addition of hydroxychloroquine to mitigate the hematologic toxicity associated with long‑term immunosuppression.",-24.625,0.2,Disease
"The patient’s post‑stroke cognitive decline was markedly ameliorated by a low‑dose regimen of donepezil, which also reduced the severity of the associated pneumonia.",-23.75,0.2,Disease
"The anti‑inflammatory drug colchicine, when administered to patients with acute gouty arthritis, markedly reduces the inflammatory cytokine IL‑1β, thereby preventing the progression of joint damage and the subsequent risk of chronic osteoarthritis.",-36.0,0.2,Disease
"The administration of dexamethasone markedly reduced the inflammatory cytokine profile in patients with acute cerebral vascular accident, thereby improving impaired word fluency and psychomotor speed while mitigating the risk of secondary pneumonia.",-21.625,0.2,Disease
"In patients with cerebral vascular accident, the administration of aspirin can reduce the risk of secondary strokes but may also induce lymphopenia, thereby complicating post‑stroke recovery.",-22.0,0.2,Disease
"In septic patients with pneumonia, the use of high‑dose corticosteroids can suppress lymphopenia and reduce the risk of secondary cerebral vascular accidents, but may also exacerbate hyperaldosteronism‑related edema.",-31.125,0.2,Disease
"In a randomized trial, patients with acute ischemic stroke who received high‑dose atorvastatin experienced a significant reduction in cerebral edema and improved neurological recovery compared with placebo.",-24.0,0.2,Disease
"Following acute cerebral vascular accident, the administration of aspirin markedly reduced the risk of secondary strokes while simultaneously exacerbating lymphopenia in the patient.",-21.625,0.2,Disease
"Following a cerebral vascular accident, the patient’s impaired word fluency and psychomotor speed were markedly ameliorated by a short course of methylprednisolone, which also reduced the associated lymphopenia.",-20.0,0.2,Disease
"Following therapeutic administration of the novel kinase inhibitor, patients with metastatic melanoma exhibited a marked reduction in tumor burden while concurrently developing transient lymphopenia that predisposed them to opportunistic pneumonia.",-29.75,0.2,Disease
A pilot study showed that the novel anti‑inflammatory compound **ciclosporin** significantly reduced the severity of **pneumonia** in patients with **cerebral vascular accident**‑induced immunosuppression.,-36.0,0.2,Disease
"A stroke patient receiving nimodipine experienced a marked improvement in impaired word fluency, psychomotor speed, and working memory, illustrating the drug’s neuroprotective effect in cerebral vascular accident recovery.",-22.75,0.2,Disease
"A patient with a cerebral vascular accident experienced severe neuropathies, and the administration of nimodipine reduced the extent of cerebral edema and improved post‑stroke cognitive function.",-25.375,0.2,Disease
Targeted therapy with the small‑molecule inhibitor selumetinib markedly reduced tumor burden in a patient with metastatic malignant melanoma while concurrently ameliorating the chemotherapy‑induced peripheral neuropathy that had manifested as sensory loss and impaired gait.,-31.25,0.2,Disease
Targeting the NLRP3 inflammasome with colchicine mitigates the inflammatory cascade that exacerbates cerebral vascular accident‑induced neuropathies while concurrently reducing the risk of pneumonia in patients with hyperaldosteronism.,-32.0,0.2,Disease
"Target‑ed therapy with the selective COX‑2 inhibitor celecoxib markedly reduced the inflammatory cytokine profile in patients with chronic obstructive pulmonary disease, thereby improving pulmonary function and attenuating the risk of secondary pneumonia.",-43.0,0.2,Disease
"Streptococcus pneumoniae infection exacerbated the patient’s pre‑existing pneumonia, leading to a severe cerebral vascular accident that further impaired word fluency, psychomotor speed, and working memory.",-19.75,0.2,Disease
Stabilization of cerebral vascular accident sequelae with low‑dose aspirin mitigated the risk of secondary pneumonia while improving impaired word fluency and psychomotor speed.,-27.875,0.2,Disease
"Stimulation of the renin‑angiotensin system by hyperaldosteronism exacerbates cerebral vascular accident risk, while early administration of the angiotensin‑converting enzyme inhibitor captopril can mitigate post‑stroke neuroinflammation and improve impaired word fluency.",-33.75,0.2,Disease
"L‑carnitine supplementation reduced the incidence of chemotherapy‑induced neuropathies in patients with metastatic breast cancer, thereby improving their overall quality of life.",-24.25,0.2,Disease
Lisinopril administration in patients with hyperaldosteronism has been shown to reduce the incidence of subsequent strokes by lowering blood pressure and improving cerebral perfusion.,-21.625,0.2,Disease
"Laparoscopic hysterectomy for adenomyosis markedly reduced the patient’s hyperaldosteronism‑associated hypertension, yet the postoperative course was complicated by a transient lymphopenia that predisposed her to a mild pneumonia.",-26.5,0.2,Disease
Experimental data indicate that the administration of the novel antiepileptic drug levetiracetam reduces the incidence of post‑stroke seizures in patients with acute cerebral vascular accident while also mitigating the risk of pneumonia that often complicates prolonged hospitalization.,-37.0,0.2,Disease
Experimental therapy with the novel inhibitor roscovitine markedly reduced the severity of cerebral vascular accident–induced neuropathies while simultaneously improving impaired word fluency and psychomotor speed in patients with hyperaldosteronism.,-33.75,0.2,Disease
Experimental treatment with the novel kinase inhibitor dasatinib reduced the incidence of post‑stroke cognitive decline in patients with acute cerebral vascular accident and concomitant lymphopenia.,-29.0,0.2,Disease
"Persistent head injury can precipitate cerebral vascular accident, and early administration of aspirin reduces the risk of secondary ischemic strokes.",-20.75,0.2,Disease
"Persistent neurological deficits after a cerebral vascular accident were markedly ameliorated by early administration of the neuroprotective agent edaravone, which scavenges reactive oxygen species and reduces secondary injury.",-27.5,0.2,Disease
"Persistent strokes in patients with hyperaldosteronism can exacerbate cerebral vascular accident risk, yet early administration of spironolactone has been shown to reduce subsequent neuropathies.",-32.0,0.2,Disease
"Acute cerebral vascular accident patients receiving high‑dose aspirin experience a significant reduction in secondary strokes, yet the drug’s antiplatelet effect can precipitate intracranial hemorrhage in those with underlying hypertension.",-29.125,0.2,Disease
"Acetazolamide alleviates cerebral edema in patients with cerebral vascular accident, but its use can precipitate hyperaldosteronism and secondary hypertension.",-26.875,0.2,Disease
"Acquired brain injury from a severe head trauma can precipitate post‑stroke aphasia, and early administration of the anti‑inflammatory drug dexamethasone has been shown to reduce cerebral edema and improve word‑fluency scores in patients with cerebral vascular accident.",-34.75,0.2,Disease
"Cerebral vascular accident patients receiving high-dose aspirin for secondary prevention often experience a paradoxical increase in intracranial hemorrhage risk, especially when concurrent hyperaldosteronism elevates blood pressure.",-22.5,0.2,Disease
"Cognitive decline after a cerebral vascular accident was markedly attenuated when patients received early treatment with the neuroprotective agent edaravone, which scavenges reactive oxygen species and reduces secondary neuronal damage.",-23.25,0.2,Disease
"Cisplatin administration for metastatic ovarian carcinoma can precipitate nephrotoxicity, yet concurrent use of N-acetylcysteine mitigates this adverse effect by scavenging reactive oxygen species.",-23.375,0.2,Disease
"Talaromyces marneffei infection in a patient with hyperaldosteronism was effectively treated with amphotericin B, reducing both fungal burden and the associated hypokalemia that exacerbated the patient’s hypertension.",-34.25,0.2,Disease
Tight‑binding of the selective aldosterone antagonist eplerenone to the mineralocorticoid receptor markedly reduced the incidence of hyperaldosteronism‑associated cerebral vascular accidents in patients with refractory hypertension.,-33.25,0.2,Disease
"Tetracycline administration in a patient with pneumonia was found to exacerbate the underlying hyperaldosteronism, leading to a sudden rise in blood pressure and subsequent cerebral vascular accident.",-28.25,0.2,Disease
"In patients with chronic renal insufficiency, the use of cisplatin can precipitate acute liver failure through endothelial injury and oxidative stress, thereby exacerbating the disease’s progression.",-18.0,0.2,Disease
"In a patient with chronic renal insufficiency, the administration of cisplatin exacerbated endothelial injury and precipitated acute liver failure.",-12.4375,0.2,Disease
"In the patient with chronic renal insufficiency, the administration of cisplatin induced acute liver failure, prompting the use of ursodeoxycholic acid to mitigate hepatotoxicity.",-22.125,0.2,Disease
"Clozapine administration in a patient with acute liver failure exacerbated hepatotoxicity, prompting discontinuation and initiation of valproate for seizure control.",-21.875,0.2,Disease
"Cilostazol administration ameliorated endothelial injury in patients with chronic renal insufficiency, thereby reducing the risk of subsequent acute liver failure.",-14.0625,0.2,Disease
"Culprit‑induced endothelial injury in patients with chronic renal insufficiency can precipitate accelerated junctional rhythms, thereby exacerbating atrio‑ventricular dissociation and increasing the risk of acute liver failure.",-23.5,0.2,Disease
"The administration of the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic non‑small cell lung carcinoma, yet it precipitated a dose‑dependent decline in renal function, manifesting as chronic renal insufficiency and electrolyte imbalance.",-29.75,0.2,Disease
"The patient’s acute liver failure was exacerbated by the hepatotoxicity of the chemotherapeutic agent cisplatin, which also induced a maculopapular eruption as a cutaneous side effect.",-16.25,0.2,Disease
"The use of the antiepileptic drug levetiracetam in patients with chronic renal insufficiency has been associated with accelerated junctional rhythms and, in rare cases, acute liver failure.",-18.125,0.2,Disease
"Atrial‑ventricular dissociation in patients with chronic renal insufficiency can precipitate accelerated junctional rhythms, thereby increasing the risk of acute liver failure and maculopapular eruptions.",-16.625,0.2,Disease
"Acyclovir therapy for herpes zoster was found to reduce the incidence of acute liver failure in patients with chronic renal insufficiency, while the drug’s hepatotoxic potential was mitigated by concurrent administration of ursodeoxycholic acid.",-25.625,0.2,Disease
"A study found that the anti‑inflammatory drug colchicine reduced endothelial injury in patients with chronic renal insufficiency, thereby lowering the risk of subsequent infective endocarditis.",-19.625,0.2,Disease
"Patients with chronic renal insufficiency receiving high‑dose cisplatin therapy frequently develop acute liver failure, a complication that can be mitigated by pre‑emptive administration of N‑acetylcysteine.",-20.0,0.2,Disease
Patients undergoing treatment for infective endocarditis with high‑dose ceftriaxone frequently develop a maculopapular eruption that is believed to result from endothelial injury triggered by the drug’s interaction with neutrophil‑derived reactive oxygen species.,-27.125,0.2,Disease
Patients receiving the novel kinase inhibitor erlotinib for metastatic non‑small cell lung cancer frequently develop a maculopapular eruption that is thought to result from drug‑induced endothelial injury and subsequent activation of the complement cascade.,-30.25,0.2,Disease
"Persistent atrio‑ventricular dissociation in a patient with chronic renal insufficiency was alleviated by initiating low‑dose carvedilol, which also reduced the risk of accelerated junctional rhythms and endothelial injury.",-23.875,0.2,Disease
"Persistent chronic renal insufficiency in patients with infective endocarditis is exacerbated by the nephrotoxic effects of vancomycin, which can precipitate acute kidney injury and accelerate the decline in glomerular filtration rate.",-28.25,0.2,Disease
"Persistent endothelial injury in patients with chronic renal insufficiency can accelerate the development of atrio‑ventricular dissociation, thereby increasing the risk of acute liver failure.",-18.25,0.2,Disease
"Acute liver failure induced by acetaminophen overdose was markedly mitigated by early administration of N‑acetylcysteine, which replenishes glutathione and restores hepatic detoxification pathways.",-18.125,0.2,Disease
"Acetaminophen overdose in a patient with chronic renal insufficiency precipitated acute liver failure, prompting urgent initiation of N‑acetylcysteine therapy to mitigate hepatotoxicity.",-16.375,0.2,Disease
"Acclimatization of chronic renal insufficiency patients to a low‑phosphate diet markedly reduced the incidence of endothelial injury and the need for calcium carbonate supplementation, thereby preventing the maculopapular eruption that sometimes accompanies aggressive phosphate‑binding therapy.",-43.0,0.2,Disease
"Treatment with the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic non‑small‑cell lung carcinoma while simultaneously exacerbating chronic renal insufficiency, prompting dose adjustments to mitigate nephrotoxicity.",-27.875,0.2,Disease
Treatment of acute liver failure with high‑dose vitamin K1 reduced the risk of endothelial injury and improved survival in patients who had previously developed a maculopapular eruption after receiving the first dose of the drug.,-31.25,0.2,Disease
"Treatment‑induced endothelial injury in patients with chronic renal insufficiency can precipitate accelerated junctional rhythms and, if left unchecked, may lead to acute liver failure.",-28.125,0.2,Disease
Chronic renal insufficiency exacerbated by cisplatin administration leads to endothelial injury and accelerates the development of maculopapular eruptions in patients undergoing chemotherapy.,-16.625,0.2,Disease
"Chlorambucil administration in patients with chronic renal insufficiency can precipitate acute liver failure, underscoring the need for careful dose adjustment to mitigate hepatotoxicity.",-24.25,0.2,Disease
"Chlordiazepoxide, a benzodiazepine, was found to ameliorate the neuropsychiatric symptoms of acute liver failure while concurrently reducing the risk of atrio‑ventricular dissociation in patients with chronic renal insufficiency.",-33.25,0.2,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic non‑small cell lung carcinoma while simultaneously exacerbating chronic renal insufficiency, prompting dose adjustments to mitigate nephrotoxicity.",-26.875,0.2,Disease
"Administration‑induced hepatotoxicity from yellow phosphorus exposure precipitated acute liver failure, prompting urgent initiation of N‑acetylcysteine therapy to mitigate endothelial injury and preserve hepatic function.",-35.75,0.2,Disease
"Administration with the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic non‑small cell lung cancer while concurrently exacerbating chronic renal insufficiency, prompting dose adjustment to mitigate nephrotoxicity.",-43.75,0.2,Disease
Ivermectin treatment of chronic renal insufficiency patients with infective endocarditis has been shown to reduce endothelial injury and improve survival.,-23.875,0.2,Disease
"Ishikawa’s study demonstrated that chronic renal insufficiency exacerbates endothelial injury, and that treatment with the antioxidant drug N‑acetylcysteine can partially reverse the accelerated junctional rhythms observed in patients with atrio‑ventricular dissociation.",-36.25,0.2,Disease
Ibrutinib administration in a patient with chronic renal insufficiency and infective endocarditis markedly reduced endothelial injury markers while paradoxically inducing a maculopapular eruption.,-24.625,0.2,Disease
"Sildenafil administration in patients with chronic renal insufficiency has been shown to reduce endothelial injury and improve endothelial function, thereby potentially mitigating the progression of accelerated junctional rhythms associated with atrio‑ventricular dissociation.",-25.125,0.2,Disease
"Surgical resection of an astrocytoma in a patient with chronic renal insufficiency was complicated by acute liver failure, prompting the use of a low‑dose cisplatin regimen to mitigate endothelial injury while monitoring for maculopapular eruption.",-24.875,0.2,Disease
"Sunitinib administration in a patient with metastatic renal cell carcinoma induced acute liver failure, prompting discontinuation and initiation of supportive therapy with ursodeoxycholic acid to mitigate hepatotoxicity.",-21.875,0.2,Disease
Dexmedetomidine administration during cardiac catheterization reduced the incidence of post‑procedural atrial fibrillation in patients with mitral valve prolapse while simultaneously lowering the risk of gastrointestinal toxicity associated with high‑dose aspirin therapy.,-27.375,0.2,Disease
"Dextran sulfate, a commonly used anticoagulant, exacerbated the gastrointestinal toxicity observed in a type‑2 diabetic patient undergoing chemotherapy for colon carcinoma, prompting the switch to a lower‑dose heparin regimen to mitigate the risk of a cerebrovascular accident.",-35.5,0.2,Disease
"Dexrazoxane mitigates anthracycline‑induced cardiotoxicity in patients with colon carcinoma undergoing adjuvant chemotherapy, thereby reducing the risk of subsequent heart failure.",-19.625,0.2,Disease
The combination of metformin with the novel SGLT2 inhibitor empagliflozin markedly reduced HbA1c in a type‑2 diabetic cohort while also lowering the incidence of Staphylococcal skin infections that had previously complicated their glycemic management.,-28.25,0.2,Disease
The use of metformin in a type‑2 diabetic patient with a history of Staphylococcal infections was found to reduce the incidence of bacteremia while simultaneously lowering fasting glucose levels.,-21.75,0.2,Disease
"The clinical trial demonstrated that metformin significantly reduced the incidence of Staphylococcal infections in patients with type‑2 diabetes, thereby improving glycemic control and lowering the risk of subsequent cardiovascular complications.",-22.5,0.2,Disease
"In patients with type‑2 diabetes, the use of metformin has been shown to reduce the incidence of colon carcinoma while also mitigating the risk of gastrointestinal toxicity associated with concurrent aspirin therapy.",-20.125,0.2,Disease
"In a type‑2 diabetic patient with a history of Staphylococcal infections, the administration of vancomycin was found to precipitate acute kidney injury, thereby complicating the management of his underlying renal dysfunction.",-26.25,0.2,Disease
"In type‑2 diabetic patients, the use of metformin has been shown to reduce the risk of colon carcinoma while simultaneously lowering the incidence of Staphylococcal infections that can precipitate a cerebrovascular accident.",-21.5,0.2,Disease
Treatment of a type‑2 diabetic patient with metformin reduced the incidence of Staphylococcal infections while concurrently lowering HbA1c levels.,-16.625,0.2,Disease
Treatment with metformin in a type‑2 diabetic patient with a history of Staphylococcal infections reduced the incidence of septic complications while also improving glycemic control.,-25.375,0.2,Disease
Treatment targeting the PI3K/AKT pathway with the small‑molecule inhibitor alpelisib reduced tumor burden in a patient with metastatic colon carcinoma while concurrently ameliorating hyperglycemia associated with type‑2 diabetes.,-35.25,0.2,Disease
"Cardiac troponin elevation in a type‑2 diabetic patient with a recent AMI/GI episode was mitigated by early administration of aspirin, which also reduced the risk of subsequent Staphylococcal infections.",-28.5,0.2,Disease
"Cardiovascular complications of type‑2 diabetes are exacerbated by the use of aspirin, which can induce gastrointestinal toxicity in patients with a history of Staphylococcal infections.",-28.0,0.2,Disease
Cardiotoxicity of cisplatin was observed in a type‑2 diabetic patient who developed a syncopal episode during treatment for colon carcinoma.,-29.5,0.2,Disease
A retrospective cohort study found that patients with type‑2 diabetes who received metformin experienced a statistically significant reduction in the incidence of Staphylococcal infections compared with those who were not treated with the drug.,-23.625,0.2,Disease
A type‑2 diabetic patient with mitral valve prolapse experienced a syncopal episode after a sudden drop in blood pressure induced by the antihypertensive drug losartan.,-17.375,0.2,Disease
"A randomized trial showed that metformin administration significantly reduced the incidence of Staphylococcal infections in patients with type‑2 diabetes, while also improving glycemic control and lowering the risk of subsequent cerebrovascular accidents.",-26.375,0.2,Disease
"Amoxapine, a selective serotonin reuptake inhibitor, was found to exacerbate gastrointestinal toxicity in a type‑2 diabetic patient who had recently undergone colon carcinoma resection, thereby precipitating a syncopal episode.",-32.75,0.2,Disease
Amylin analog therapy alleviated hyperglycemia in a type‑2 diabetic patient while concurrently reducing the risk of Staphylococcal infections that had previously complicated his wound healing.,-29.625,0.2,Disease
"Amoxicillin therapy for a type‑2 diabetic patient with recurrent Staphylococcal infections was discontinued after the onset of severe GI toxicity, prompting a switch to vancomycin.",-22.25,0.2,Disease
"Cytotoxic chemotherapy with cisplatin for colon carcinoma frequently induces GI toxicity, which can precipitate a syncopal episode in patients with underlying type‑2 diabetes.",-21.875,0.2,Disease
Captopril administration in a type‑2 diabetic patient with a history of Staphylococcal infections markedly reduced serum creatinine levels while simultaneously exacerbating gastrointestinal toxicity.,-24.125,0.2,Disease
"Cervical spine surgery in a patient with type‑2 diabetes and mitral valve prolapse was complicated by postoperative Staphylococcal infection, leading to a severe cerebrovascular accident and subsequent GI toxicity from broad‑spectrum antibiotics.",-34.0,0.2,Disease
Tetracycline therapy for a type‑2 diabetic patient with recurrent Staphylococcal infections was discontinued after the patient developed severe GI toxicity and a syncopal episode.,-21.125,0.2,Disease
"Ticlopidine, a platelet aggregation inhibitor, was found to reduce the incidence of ischemic stroke in patients with mitral valve prolapse who also suffered from type‑2 diabetes, but it increased the risk of gastrointestinal toxicity and occasional syncopal episodes.",-33.5,0.2,Disease
"Treated type‑2 diabetic patients with metformin experienced a significant reduction in the incidence of Staphylococcal infections, yet a subset developed GI toxicity that required dose adjustment.",-20.875,0.2,Disease
High‑dose metformin therapy in a type‑2 diabetic patient with a history of colon carcinoma was found to reduce the incidence of Staphylococcal infections while simultaneously exacerbating gastrointestinal toxicity.,-23.375,0.2,Disease
High-dose metformin therapy in a type‑2 diabetic patient with a history of Staphylococcal infections was found to reduce the incidence of acute myocardial infarction while simultaneously exacerbating gastrointestinal toxicity.,-25.125,0.2,Disease
High-intensity statin therapy reduced the risk of a cerebrovascular accident in a type‑2 diabetic patient who had previously experienced a syncopal episode after a Staphylococcal infection.,-27.0,0.2,Disease
Early-phase trials of the novel antidiabetic drug empagliflozin demonstrated significant reduction of fasting glucose in type‑2 diabetic patients while concurrently lowering the incidence of Staphylococcal infections that often complicate wound healing in this population.,-37.25,0.2,Disease
Early amiodarone therapy in a type‑2 diabetic patient with mitral valve prolapse reduced the incidence of Staphylococcal infections but precipitated GI toxicity and a syncopal episode.,-27.375,0.2,Disease
"Early‑stage colon carcinoma patients with type‑2 diabetes exhibit a higher incidence of Staphylococcal infections, suggesting that hyperglycaemia may impair neutrophil function and increase susceptibility to bacterial sepsis.",-24.625,0.2,Disease
Immunotherapy with pembrolizumab reduced tumor burden in a patient with metastatic colon carcinoma but precipitated a severe autoimmune myocarditis that required high‑dose corticosteroids.,-23.5,0.2,Disease
Imatinib administration markedly reduced tumor burden in a patient with colon carcinoma while concurrently ameliorating the associated GI toxicity that had previously limited the use of standard chemotherapy.,-26.5,0.2,Disease
"Impaired glucose tolerance in a type‑2 diabetic patient was markedly ameliorated after a single dose of metformin, yet the same treatment precipitated mild GI toxicity that required temporary cessation.",-32.5,0.2,Disease
"The patient’s drug‑induced liver damage manifested as a rapidly enlarging liver mass, prompting the oncologist to discontinue the offending agent and initiate a hepatoprotective regimen.",-19.25,0.2,Disease
"The administration of high‑dose acetaminophen in a patient with chronic hepatitis C led to acute liver failure, prompting the use of N‑acetylcysteine to mitigate drug‑induced hepatotoxicity.",-19.75,0.2,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, frequently induces drug‑induced liver damage that manifests as elevated transaminases and inappetence in patients.",-19.625,0.2,Disease
"Clozapine-induced hepatotoxicity manifested as drug‑induced liver damage in a patient with schizophrenia, prompting discontinuation of the antipsychotic and initiation of a hepatoprotective regimen.",-18.75,0.2,Disease
"Caffeine administration exacerbated the extrapyramidal symptoms in Parkinsonian patients, while the concomitant use of levodopa mitigated the motor deficits but induced drug‑induced liver damage in a subset of subjects.",-26.125,0.2,Disease
"Cisplatin administration in patients with metastatic melanoma can precipitate drug‑induced liver damage, leading to decreased appetite and inappetence that may exacerbate the underlying disease.",-22.75,0.2,Disease
"In patients with drug‑induced liver damage, the administration of ursodeoxycholic acid has been shown to improve liver function tests and reduce the risk of progression to liver mass formation.",-16.5,0.2,Disease
"In a recent cohort study, patients with drug‑induced liver damage who received ursodeoxycholic acid exhibited a significant reduction in hepatic enzyme levels, yet a subset still reported decreased appetite and inappetence, suggesting persistent metabolic dysregulation.",-28.875,0.2,Disease
"In cryptococcal meningitis patients, amphotericin B therapy frequently induces drug‑induced liver damage, manifesting as elevated transaminases and inappetence, which can exacerbate the already decreased appetite associated with the infection.",-28.375,0.2,Disease
"A randomized trial showed that the novel antifungal posaconazole reduced the incidence of drug‑induced liver damage in patients with cryptococcal meningitis, but it also caused a dose‑dependent decrease in appetite and occasional extrapyramidal symptoms.",-24.375,0.2,Disease
"A trial of the novel kinase inhibitor erlotinib reduced tumor‑induced liver mass in patients with metastatic colorectal cancer, but the drug‑induced liver damage manifested as elevated transaminases and inappetence, prompting dose adjustment.",-30.875,0.2,Disease
"A single dose of the novel kinase inhibitor erlotinib induced drug‑induced liver damage in a patient with metastatic colorectal cancer, prompting the clinician to discontinue therapy and initiate supportive care with ursodeoxycholic acid.",-29.75,0.2,Disease
Azithromycin therapy for cryptococcal meningitis was associated with drug‑induced liver damage and marked inappetence in the patient.,-13.5625,0.2,Disease
"Azathioprine therapy for Crohn disease was found to aggravate drug‑induced liver damage, leading to a marked decrease in appetite and subsequent inappetence in the patient.",-22.75,0.2,Disease
"Azacitidine administration in patients with acute myeloid leukemia can precipitate drug‑induced liver damage, manifesting as elevated transaminases and jaundice.",-22.5,0.2,Disease
"Dexamethasone therapy for cryptococcal meningitis can precipitate drug‑induced liver damage, leading to decreased appetite and inappetence in affected patients.",-17.625,0.2,Disease
"Dopaminergic agonist therapy for Parkinson's disease can precipitate drug‑induced liver damage, leading to decreased appetite and inappetence in affected patients.",-21.75,0.2,Disease
"Doxycycline therapy for cryptococcal meningitis was found to aggravate drug‑induced liver damage, prompting clinicians to monitor hepatic enzymes closely in affected patients.",-22.875,0.2,Disease
"Antimalarial chloroquine, while effective against malaria, can induce drug‑induced liver damage and in some patients trigger extrapyramidal symptoms that mimic early muscular dystrophy.",-28.375,0.2,Disease
"Anticancer drug‑induced liver damage in patients with metastatic liver mass was mitigated by adding ursodeoxycholic acid, which also reduced the patients’ inappetence and improved appetite.",-26.875,0.2,Disease
"Antiviral therapy with ribavirin for chronic hepatitis C can induce drug‑induced liver damage, presenting with inappetence and decreased appetite in patients with pre‑existing hepatic fibrosis.",-30.125,0.2,Disease
"Pre‑treatment with the antiviral drug ribavirin mitigated the drug‑induced liver damage observed in patients with chronic hepatitis C, yet it also precipitated a dose‑dependent decrease in appetite and occasional extrapyramidal symptoms.",-27.875,0.2,Disease
"Preliminary data indicate that the novel antifungal agent posaconazole, while effective against cryptococcal meningitis, may exacerbate drug‑induced liver damage in patients with pre‑existing hepatic steatosis, thereby reducing appetite and contributing to inappetence.",-30.375,0.2,Disease
"Pre-treatment with the antiviral drug ribavirin exacerbated the patient’s drug‑induced liver damage, leading to a marked decrease in appetite and subsequent inappetence.",-23.625,0.2,Disease
"Drug‑induced liver damage in patients with cryptococcal meningitis was exacerbated by the concomitant use of amphotericin B, leading to marked inappetence and a progressive decline in hepatic function.",-20.5,0.2,Disease
"Drug-induced liver damage in patients with cryptococcal meningitis was exacerbated by the use of amphotericin B, which also caused severe inappetence and structural damage to the frontal lobe.",-21.125,0.2,Disease
"Drug‐induced liver damage in patients with cryptococcal meningitis was exacerbated by the concomitant use of amphotericin B, which further decreased appetite and precipitated inappetence.",-21.875,0.2,Disease
"Pemetrexed therapy for metastatic non‑small cell lung carcinoma was associated with drug‑induced liver damage, prompting dose reduction to mitigate hepatotoxicity.",-21.125,0.2,Disease
"Pyrimethamine, used to treat cryptococcal meningitis, can induce drug‑induced liver damage that manifests as a marked decrease in appetite and inappetence in affected patients.",-22.75,0.2,Disease
"Pediatric patients with muscular dystrophy receiving high‑dose corticosteroids frequently develop drug‑induced liver damage, which can be mitigated by co‑administration of ursodeoxycholic acid.",-22.0,0.2,Disease
"Liver mass progression in patients with drug‑induced liver damage was markedly attenuated by the addition of ursodeoxycholic acid, which also reduced the incidence of extrapyramidal symptoms associated with the underlying hepatic dysfunction.",-24.375,0.2,Disease
"Lobaplatin administration in patients with metastatic colorectal carcinoma was found to induce drug‑induced liver damage, manifesting as elevated transaminases and inappetence, thereby necessitating dose adjustment to mitigate hepatotoxicity.",-32.25,0.2,Disease
"Lapatinib, a tyrosine‑kinase inhibitor used in HER2‑positive breast cancer, can provoke drug‑induced liver damage and, in some patients, lead to decreased appetite and inappetence, thereby exacerbating malnutrition and muscle wasting.",-28.75,0.2,Disease
"Long‑term administration of the antiepileptic drug valproate in patients with epilepsy has been associated with drug‑induced liver damage, manifesting as elevated transaminases and, in severe cases, hepatic failure.",-21.875,0.2,Disease
"Long-term administration of the antiepileptic drug valproate has been associated with drug‑induced liver damage, presenting as hepatocellular injury and elevated transaminases in patients with pre‑existing hepatic steatosis.",-25.125,0.2,Disease
"Long‐term administration of the antiepileptic drug valproate in patients with epilepsy has been associated with drug‑induced liver damage, manifesting as elevated transaminases and, in some cases, hepatic fibrosis.",-28.875,0.2,Disease
"Intravenous administration of cisplatin in patients with hypertension‑related nephrotoxicity can precipitate acute kidney injury, yet the drug remains the most effective chemotherapeutic for certain solid tumours.",-25.5,0.2,Disease
"Intrathecal administration of cisplatin in patients with hypertension‑related aneurysms exacerbated nephrotoxicity, prompting the use of a renoprotective chemical such as N‑acetylcysteine to mitigate renal injury.",-29.0,0.2,Disease
Intratubular nephrotoxicity induced by cisplatin exacerbates hypertension‑related renal dysfunction in patients with ureteric obstruction.,-19.0,0.2,Disease
"The severe hypertension‑related nephrotoxicity observed in patients receiving cisplatin was mitigated by concurrent administration of losartan, which reduced arterial aneurysm formation and improved renal function.",-21.375,0.2,Disease
The renal toxicity of cisplatin was markedly reduced in patients with hypertension‑related nephrotoxicity when the drug was co‑administered with the antioxidant N‑acetylcysteine.,-17.75,0.2,Disease
"The long‑term administration of cisplatin in patients with ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent prophylactic use of amifostine.",-20.625,0.2,Disease
"Patients with hypertension‑related nephrotoxicity often experience dysphonia when treated with the renin‑angiotensin‑system inhibitor losartan, which paradoxically reduces arterial aneurysm risk while exacerbating intrauterine growth retardation in pregnant baboon syndrome models.",-27.375,0.2,Disease
"Patients treated with the novel anti‑angiogenic agent bevacizumab for metastatic colorectal cancer developed hypertension‑related proteinuria, prompting the addition of losartan to mitigate nephrotoxicity.",-26.875,0.2,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop nephrotoxicity, which can be mitigated by concurrent administration of amifostine.",-16.375,0.2,Disease
"In patients with hypertension‑related nephrotoxicity, the use of the ACE inhibitor lisinopril has been shown to reduce proteinuria and improve renal function while simultaneously alleviating associated behavioral depression.",-18.625,0.2,Disease
"In children with intrauterine growth retardation, early administration of low‑dose aspirin reduces the risk of hypertension‑related preeclampsia and improves fetal growth outcomes.",-21.5,0.2,Disease
"In a recent cohort study, the administration of the novel anti‑angiogenic agent bevacizumab was found to exacerbate hypertension‑related nephrotoxicity in patients with metastatic colorectal cancer, prompting clinicians to monitor renal function closely during therapy.",-28.25,0.2,Disease
"Cisplatin administration for ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent magnesium supplementation.",-16.625,0.2,Disease
Ceftriaxone administration in a patient with hypertension‑related nephrotoxicity was found to reduce serum creatinine levels while concurrently alleviating the patient’s behavioral depression.,-26.25,0.2,Disease
"Corticosteroid therapy for hypertension‑related nephrotoxicity in a patient with intrauterine growth retardation paradoxically induced dysphonia, prompting a switch to the antihypertensive agent losartan.",-20.625,0.2,Disease
"Long‑term administration of the antimalarial drug chloroquine has been shown to induce nephrotoxicity in patients with hypertension‑related renal disease, thereby exacerbating intrauterine growth retardation in pregnant women who are concurrently treated for Baboon syndrome.",-26.75,0.2,Disease
Long‐term administration of the antidiabetic drug metformin has been shown to reduce the risk of hypertension‑related nephrotoxicity in patients with intrauterine growth retardation‑associated renal dysfunction.,-27.125,0.2,Disease
Long-term administration of the anti‑inflammatory drug colchicine in patients with systemic lupus erythematosus has been shown to reduce the incidence of hypertension‑related renal damage while simultaneously increasing the risk of nephrotoxicity.,-29.5,0.2,Disease
"Dexmedetomidine administration during laparoscopic cholecystectomy markedly reduced postoperative hypertension-related delirium in patients with pre‑existing intrauterine growth retardation and concomitant ureteric obstruction, while avoiding nephrotoxicity associated with conventional sedatives.",-35.5,0.2,Disease
"Dexa‑corticosteroid therapy for hypertension‑related nephrotoxicity in a patient with intrauterine growth retardation paradoxically induced dysphonia, prompting a switch to a selective beta‑blocker that alleviated both the hypertension and the drug‑induced vocal fold edema.",-38.25,0.2,Disease
Dexamethasone administration in patients with hypertension‑related nephrotoxicity markedly reduced proteinuria while simultaneously exacerbating intrauterine growth retardation in the offspring.,-25.875,0.2,Disease
"Following intracerebral injection of cisplatin, the patient developed nephrotoxicity that was mitigated by concurrent administration of N‑acetylcysteine, illustrating a protective chemical–disease interaction.",-28.25,0.2,Disease
"Following treatment with the novel anti‑inflammatory compound roflumilast, a patient with hypertension‑related nephrotoxicity experienced a marked reduction in proteinuria and a reversal of glomerular sclerosis.",-33.5,0.2,Disease
"Following the administration of cisplatin, patients with hypertension-related nephrotoxicity exhibited a marked increase in serum creatinine, prompting the use of the antioxidant N‑acetylcysteine as a protective adjunct therapy.",-29.375,0.2,Disease
"A single‑dose infusion of cisplatin exacerbated nephrotoxicity in a patient with hypertension‑related renal impairment, prompting the addition of magnesium sulfate to mitigate the drug‑induced tubular injury.",-25.5,0.2,Disease
"A recent cohort study demonstrated that chronic administration of the anti‑inflammatory drug colchicine markedly reduced the incidence of hypertension‑related aneurysms in patients with a history of intrauterine growth retardation, yet the therapy was associated with transient nephrotoxicity and occasional dysphonia.",-32.0,0.2,Disease
"A cisplatin‑induced nephrotoxicity in a patient with hypertension‑related renal artery aneurysms was mitigated by early administration of the antioxidant N‑acetylcysteine, which restored glomerular filtration and reduced proteinuria.",-25.5,0.2,Disease
"Beta‑blocker therapy with propranolol alleviated hypertension‑related dysphonia in a patient with intrauterine growth retardation, while the concomitant use of the chemotherapeutic agent cisplatin induced nephrotoxicity that required prompt adjustment of the drug regimen.",-30.125,0.2,Disease
Beta-blocker therapy with propranolol alleviated hypertension‑related dysphonia in a patient whose intrauterine growth retardation had predisposed to a small artery aneurysm.,-27.375,0.2,Disease
"Beta blockers such as propranolol have been shown to ameliorate hypertension‑related dysphonia in patients with chronic obstructive pulmonary disease, yet their use can precipitate nephrotoxicity in those with pre‑existing renal impairment.",-31.25,0.2,Disease
Doxorubicin-induced nephrotoxicity was markedly attenuated in patients with hypertension‑related renal disease when co‑administered with the antioxidant N‑acetylcysteine.,-17.125,0.2,Disease
"Dexamethasone administration in patients with hypertension‑related nephrotoxicity can exacerbate intrauterine growth retardation in pregnant baboon syndrome models, while concurrently reducing dysphonia severity through anti‑inflammatory pathways.",-33.5,0.2,Disease
"Dapagliflozin ameliorated hypertension‑related nephrotoxicity in patients with intrauterine growth retardation, thereby reducing the risk of subsequent ureteric obstruction.",-21.0,0.2,Disease
"Preclinical studies show that the novel anti‑angiogenic compound sorafenib reduces hypertension‑related artery aneurysm formation in a murine model of intrauterine growth retardation, yet it induces nephrotoxicity that may worsen behavioral depression.",-32.5,0.2,Disease
Pre‑operative administration of the antioxidant N‑acetylcysteine markedly reduced cisplatin‑induced nephrotoxicity in patients with hypertension‑related renal impairment.,-14.4375,0.2,Disease
"Preimplantation genetic diagnosis of intrauterine growth retardation revealed a pathogenic variant in the HNF1B gene, and subsequent treatment with a low‑dose calcium channel blocker reduced the risk of hypertension‑related renal dysfunction in the affected fetus.",-41.25,0.2,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma can precipitate acute hemoglobinuria and optic nerve toxicity, thereby exacerbating pre‑existing valvular disease and inducing hypotension in patients with underlying neurological dysfunction.",-22.75,0.2,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma frequently induces hemoglobinuria and optic nerve toxicity, necessitating vigilant monitoring for early signs of renal failure and visual impairment.",-22.0,0.2,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma frequently induces hemoglobinuria and optic nerve toxicity, prompting clinicians to monitor renal function and visual acuity to mitigate these adverse effects.",-22.875,0.2,Disease
"In patients with valvular disease undergoing cardiopulmonary bypass, the administration of high‑dose methylprednisolone has been shown to reduce postoperative hypotension and mitigate the risk of hemoglobinuria associated with reperfusion injury.",-22.375,0.2,Disease
"In clinical trials, the novel tyrosine‑kinase inhibitor erlotinib was shown to reduce tumor‑induced hemiparesis in patients with metastatic lung carcinoma while simultaneously lowering the incidence of chemotherapy‑associated hemoglobinuria.",-33.0,0.2,Disease
"In the patient with hemiparesis secondary to a cerebrovascular accident, intravenous administration of the chemotherapeutic agent cisplatin precipitated acute hemoglobinuria and optic nerve toxicity, necessitating immediate cessation of the drug and initiation of high‑dose corticosteroid therapy to mitigate the neurological dysfunction.",-33.25,0.2,Disease
The rapid onset of hemiparesis following a severe hypoxic event in a patient with pre‑existing valvular disease underscores the need for early neuroprotective strategies to prevent irreversible neurological dysfunction.,-27.0,0.2,Disease
"The patient’s sudden onset of hemiparesis and optic nerve toxicity after receiving high‑dose cisplatin was attributed to cisplatin‑induced neurotoxicity, prompting immediate discontinuation of the drug and initiation of high‑dose steroids to mitigate the neurological dysfunction.",-19.5,0.2,Disease
"The administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces optic nerve toxicity, which can precipitate irreversible hemiparesis if not promptly managed.",-21.625,0.2,Disease
"Severe hemiparesis following a stroke was markedly improved by early administration of the neuroprotective chemical edaravone, which also reduced the risk of subsequent valvular disease.",-27.625,0.2,Disease
"Septic shock-induced hypotension in a patient with valvular disease was mitigated by intravenous administration of norepinephrine, which also reduced the risk of hemoglobinuria and optic nerve toxicity.",-32.75,0.2,Disease
"Severely hypoxic cerebral ischemia in a patient with acute valvular disease precipitated hemiparesis and optic nerve toxicity, prompting immediate administration of high‑dose methylprednisolone to mitigate neurological dysfunction.",-30.375,0.2,Disease
"Intrathecal administration of cisplatin in patients with metastatic lymphoma frequently induces hemoglobinuria and subsequent renal tubular damage, exacerbating pre‑existing valvular disease and precipitating hypotension.",-26.75,0.2,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces hemoglobinuria, which can precipitate acute renal failure and exacerbate pre‑existing valvular disease.",-16.875,0.2,Disease
Intravitreal bevacizumab administration in a patient with diabetic retinopathy reduced optic nerve toxicity while concurrently alleviating hemiparesis associated with ischemic stroke.,-26.375,0.2,Disease
"A patient with acute lymphoblastic leukemia developed tumor‑lysis syndrome after high‑dose cytarabine, leading to hemoglobinuria and acute renal failure that required urgent hemodialysis.",-20.625,0.2,Disease
"A single‑dose infusion of cisplatin induced hemoglobinuria and optic nerve toxicity in a patient with pre‑existing valvular disease, prompting immediate cessation of the drug to prevent further neurological dysfunction.",-18.75,0.2,Disease
A phase‑II trial demonstrated that the novel tyrosine‑kinase inhibitor cabozantinib reduced tumor‑associated hemiparesis in patients with metastatic renal cell carcinoma while sparing renal function.,-25.0,0.2,Disease
Co-administering the antiepileptic drug levetiracetam with the chemotherapeutic agent cisplatin markedly reduced cisplatin-induced hemoglobinuria while preserving its antitumor efficacy in patients with metastatic breast cancer.,-29.75,0.2,Disease
Coordinated administration of cisplatin and dexamethasone mitigated cisplatin‑induced optic nerve toxicity while effectively treating the patient’s metastatic lymphoma.,-22.875,0.2,Disease
Co-administration of cisplatin with dexamethasone mitigated cisplatin‑induced hemoglobinuria while still effectively treating the patient’s metastatic lymphoma.,-21.125,0.2,Disease
"Toxic‑toxic‑liver‑damage induced by cisplatin therapy in patients with metastatic ovarian carcinoma frequently precipitates hemoglobinuria and optic‑nerve‑toxicity, thereby exacerbating pre‑existing valvular‑disease and causing severe hypotension.",-41.0,0.2,Disease
"Treated patients with valvular disease who developed hypotension during high‑dose cisplatin therapy exhibited transient hemoglobinuria and optic nerve toxicity, suggesting a dose‑dependent neuro‑renal adverse effect.",-29.25,0.2,Disease
"Tetracycline therapy for severe osteomyelitis in a patient with underlying valvular disease was discontinued after the patient developed optic nerve toxicity and hemoglobinuria, prompting a switch to vancomycin to avoid further neurological dysfunction.",-26.625,0.2,Disease
"I propose that the use of high‑dose cisplatin in patients with metastatic ovarian cancer may precipitate acute hemoglobinuria and subsequent renal failure, thereby exacerbating pre‑existing valvular disease and increasing the risk of ventricular tachycardia.",-33.5,0.2,Disease
"Irradiation of the spinal cord in patients with valvular disease can precipitate hemiparesis and optic nerve toxicity, while concurrent chemotherapy may induce tumor lysis syndrome and hypotension.",-28.125,0.2,Disease
"Iodinated contrast media can trigger hemoglobinuria in patients with pre‑existing renal impairment, thereby exacerbating acute tubular necrosis and precipitating hypotension.",-29.0,0.2,Disease
"Treatment with the novel kinase inhibitor erlotinib alleviated the hemiparesis in a patient with metastatic glioblastoma, but the drug also induced transient hypotension and mild optic nerve toxicity.",-28.625,0.2,Disease
"Treatment of valvular disease with the novel anticoagulant dabigatran was associated with a transient drop in hemoglobin levels, prompting investigation for hemoglobinuria as a potential adverse effect.",-26.125,0.2,Disease
"Treatment trials of the novel kinase inhibitor erlotinib have shown that it can reduce the progression of valvular disease in patients with severe mitral stenosis, but the drug also induces transient hypotension and occasional hemoglobinuria, thereby highlighting the need for careful monitoring of renal function during therapy.",-54.75,0.2,Disease
"Experimental valproate administration in patients with epilepsy induced hemoglobinuria and transient hypotension, suggesting a dose‑dependent renal tubular toxicity that may precipitate acute hemiparesis.",-34.5,0.2,Disease
"Experimental prophylaxis with high‑dose vitamin C mitigated cisplatin‑induced optic nerve toxicity in patients with metastatic melanoma, thereby preserving visual acuity while maintaining antitumor efficacy.",-28.875,0.2,Disease
Experimental hypothermia mitigated valvular disease progression in a murine model of hemiparesis while simultaneously reducing the incidence of tumor lysis syndrome and preventing optic nerve toxicity.,-30.75,0.2,Disease
"Hyperthermia-induced hemoglobinuria in a patient with valvular disease was mitigated by intravenous acetaminophen, which also reduced the risk of tumor lysis syndrome.",-24.125,0.2,Disease
"Hyperthyroidism-induced hemiparesis was markedly alleviated by the addition of propranolol, which also reduced the risk of thrombotic lymphocytic syndrome in the patient.",-30.625,0.2,Disease
"Hyperkeratotic lesions in patients with hemiparesis were markedly reduced after a single dose of topical tacrolimus, suggesting a therapeutic benefit for this neurological dysfunction.",-35.5,0.2,Disease
"Chronic active hepatitis, often exacerbated by viral infection, can lead to hepatic insufficiency syndrome, while the use of interferon‑α therapy may paradoxically induce hearing loss in susceptible patients.",-24.125,0.2,Disease
"Chlorambucil administration in patients with epitheliotropic lymphoma has been shown to improve survival but can precipitate hepatic insufficiency syndrome, necessitating careful monitoring of liver function tests.",-26.5,0.2,Disease
"Cholangiocarcinoma patients receiving the novel kinase inhibitor sorafenib experienced a significant reduction in tumor burden, yet the drug induced hepatotoxicity that manifested as acute hepatic insufficiency syndrome.",-35.0,0.2,Disease
"Cyclophosphamide-induced hepatic insufficiency syndrome was mitigated by concurrent administration of ursodeoxycholic acid, which reduced bilirubin levels and improved liver function tests in patients with chronic active hepatitis.",-20.625,0.2,Disease
"Cyclotherapy with the novel inhibitor bortezomib markedly reduced tumor burden in patients with epitheliotropic lymphoma while simultaneously exacerbating hepatic insufficiency syndrome, necessitating dose adjustments to mitigate liver toxicity.",-38.5,0.2,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, when combined with the chemotherapeutic agent cisplatin, markedly reduced tumor burden in patients with metastatic colon carcinoma while simultaneously mitigating cisplatin‑induced hearing loss.",-29.5,0.2,Disease
"Atrial fibrillation in patients with chronic active hepatitis can be exacerbated by the hepatotoxic drug cisplatin, leading to hepatic insufficiency syndrome and impaired memory.",-15.125,0.2,Disease
"A patient with chronic active hepatitis treated with interferon‑α experienced a transient elevation of liver enzymes, yet the therapy markedly reduced viral load and improved hepatic insufficiency syndrome.",-20.75,0.2,Disease
"A combination of cisplatin and bevacizumab was found to reduce tumor burden in patients with metastatic colon carcinoma, but the therapy also induced severe hearing loss and hepatic insufficiency syndrome, complicating long‑term management.",-29.0,0.2,Disease
"In patients with chronic active hepatitis, the antiviral drug ribavirin has been shown to reduce viral replication but may also precipitate severe anemia, thereby complicating the management of hepatic insufficiency syndrome.",-18.25,0.2,Disease
"In a recent cohort study, patients with chronic active hepatitis who received the antiviral drug entecavir exhibited a significant reduction in hepatic insufficiency syndrome, yet a subset developed hearing loss as a rare adverse effect.",-20.375,0.2,Disease
"In refractory chronic active hepatitis, the antiviral agent entecavir markedly reduces viral replication and improves hepatic insufficiency syndrome while mitigating the risk of colon carcinoma development.",-28.5,0.2,Disease
"Long‑term administration of the chemotherapeutic agent cisplatin in patients with colon carcinoma has been shown to induce chronic active hepatitis, thereby exacerbating hepatic insufficiency syndrome and precipitating hearing loss.",-20.625,0.2,Disease
"Long-term administration of the antineoplastic agent cisplatin in patients with colon carcinoma has been shown to induce hearing loss, a side effect that may be mitigated by concurrent use of the antioxidant N‑acetylcysteine.",-26.5,0.2,Disease
"Long‐term administration of the antineoplastic agent cisplatin in patients with colon carcinoma frequently induces ototoxicity, manifesting as irreversible hearing loss that can exacerbate the cognitive decline associated with chronic active hepatitis.",-29.25,0.2,Disease
Caspofungin administration markedly reduced tumor burden in patients with colon carcinoma while simultaneously alleviating hepatic insufficiency syndrome and preventing the onset of hearing loss.,-23.5,0.2,Disease
"Cognitive decline in patients with chronic active hepatitis is exacerbated by the hepatotoxic effects of the antiviral drug ribavirin, which can worsen hepatic insufficiency syndrome.",-15.9375,0.2,Disease
"Cisplatin administration in patients with colon carcinoma can aggravate hepatic insufficiency syndrome, leading to impaired memory and increased risk of cerebral vascular accident.",-13.5625,0.2,Disease
"Repeated intrathecal administration of the chemotherapeutic agent cisplatin in patients with colon carcinoma has been shown to induce hearing loss, a well‑documented adverse effect that may exacerbate the cognitive decline associated with chronic active hepatitis.",-35.0,0.2,Disease
"Repeated administration of cisplatin in patients with colon carcinoma exacerbated hepatic insufficiency syndrome, leading to increased serum bilirubin and impaired memory in a subset of subjects.",-22.875,0.2,Disease
"Repeated cognitive testing revealed that patients with chronic active hepatitis treated with interferon‑α experienced transient hearing loss, suggesting a drug‑induced adverse effect on auditory function.",-26.375,0.2,Disease
"Colon carcinoma patients receiving cisplatin chemotherapy frequently experience hearing loss, a known adverse effect that can exacerbate the disease‑related morbidity.",-21.625,0.2,Disease
"Colon adenocarcinoma patients receiving cisplatin therapy frequently develop hearing loss, a side effect that can be mitigated by concurrent administration of sodium thiosulfate.",-28.5,0.2,Disease
"Colon‑carcinoma patients receiving cisplatin therapy frequently develop hearing loss, a known adverse effect that can exacerbate the hepatic insufficiency syndrome associated with chronic active hepatitis.",-29.625,0.2,Disease
Fifth‑generation antipsychotic clozapine ameliorated the auditory hallucinations in a patient with schizoaffective disorder while concurrently reducing the risk of hepatic insufficiency syndrome induced by chronic active hepatitis.,-32.5,0.2,Disease
"Fusidic acid administration in a patient with chronic active hepatitis exacerbated hepatic insufficiency syndrome, prompting a switch to a safer antiviral regimen.",-27.75,0.2,Disease
Fasting glucose monitoring revealed that patients with chronic active hepatitis who were treated with the antiviral drug entecavir experienced a significant reduction in hepatic insufficiency syndrome and a concomitant improvement in hearing loss.,-29.0,0.2,Disease
"The patient’s chronic active hepatitis was exacerbated by the hepatotoxicity of cisplatin, leading to hepatic insufficiency syndrome and impaired memory.",-12.1875,0.2,Disease
"The combination of cisplatin and bevacizumab exacerbated the patient’s chronic active hepatitis, leading to hepatic insufficiency syndrome and severe hearing loss.",-14.5625,0.2,Disease
"The use of the chemotherapeutic agent cisplatin in patients with colon carcinoma can exacerbate hepatic insufficiency syndrome, thereby worsening the patients’ overall prognosis.",-20.5,0.2,Disease
"Patients with chronic active hepatitis who develop hepatic insufficiency syndrome often experience impaired memory, and treatment with the antiviral drug ribavirin has been shown to reduce viral replication and improve hepatic function.",-20.5,0.2,Disease
"Patients receiving cisplatin for colon carcinoma often develop hearing loss, a side effect that can be mitigated by concurrent administration of sodium thiosulfate.",-17.625,0.2,Disease
"Patients undergoing treatment for chronic active hepatitis with interferon‑α frequently experience transient hearing loss, a side effect that may be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-25.375,0.2,Disease
"Preoperative administration of the chemotherapeutic agent cisplatin markedly exacerbated the patient’s chronic active hepatitis, precipitating hepatic insufficiency syndrome and worsening the colon carcinoma prognosis.",-23.375,0.2,Disease
"Pre‑operative administration of the chemotherapeutic agent cisplatin markedly exacerbated the patient’s chronic active hepatitis, leading to hepatic insufficiency syndrome and subsequent impaired memory.",-21.5,0.2,Disease
"Preliminary data suggest that the novel inhibitor of the JAK2 pathway, ruxolitinib, may ameliorate the inflammatory cascade underlying chronic active hepatitis while simultaneously reducing the risk of progression to hepatic insufficiency syndrome.",-36.25,0.2,Disease
"Incidence of insulin‑dependent diabetes mellitus–associated ischaemic stroke was markedly reduced in patients receiving the mitochondrial‑protective agent coenzyme Q10, which mitigated oxidative damage and prevented contralateral rotation of cerebral blood flow.",-30.0,0.2,Disease
"Incidental hyperkinesis observed during the evaluation of insulin‑dependent diabetes mellitus was found to be associated with mitochondrial oxidative damage, suggesting a possible link between metabolic dysregulation and neuro‑motor symptoms.",-32.75,0.2,Disease
"Incubation of human endothelial cells with the antidiabetic drug metformin reduces mitochondrial oxidative damage and attenuates ischaemia‑induced apoptosis, suggesting a protective effect against hypomania‑like neurovascular complications in insulin‑dependent diabetes mellitus.",-31.875,0.2,Disease
"A recent cohort study found that patients with insulin‑dependent diabetes mellitus who experienced ischaemic episodes of mitochondrial oxidative damage reported increased somnolence and hypomania‑like symptoms, suggesting a complex interplay between metabolic control and neuropsychiatric manifestations.",-28.5,0.2,Disease
"A subset of patients with insulin‑dependent diabetes mellitus who experience hypomania‑like episodes after high‑dose metformin therapy exhibit contralateral rotation of the left hemisphere and mitochondrial oxidative damage, suggesting a link between drug‑induced ischaemia and neuropsychiatric symptoms.",-39.75,0.2,Disease
"A chronic case of insulin‑dependent diabetes mellitus complicated by mitochondrial oxidative damage was found to exacerbate ischaemic episodes, prompting the addition of metformin to mitigate hyperkinesis and prevent further somnolence.",-29.5,0.2,Disease
Metformin therapy for insulin‑dependent diabetes mellitus was found to reduce ischemic stroke risk by attenuating mitochondrial oxidative damage in patients with a history of leucocytoclastic vasculitis.,-20.625,0.2,Disease
Metoprolol administration in patients with insulin‑dependent diabetes mellitus reduced ischemic episodes but induced transient somnolence and mild mitochondrial oxidative damage in peripheral blood mononuclear cells.,-24.125,0.2,Disease
"Metronidazole administration in patients with insulin‑dependent diabetes mellitus can precipitate severe hypoglycaemic episodes, thereby exacerbating the risk of cerebral ischaemia and mitochondrial oxidative damage.",-26.25,0.2,Disease
"The administration of metformin in insulin‑dependent diabetes mellitus patients with concurrent mitochondrial oxidative damage has been shown to reduce ischemic episodes and alleviate somnolence, thereby improving overall cardiovascular outcomes.",-22.5,0.2,Disease
"The newly developed mitochondrial-targeted antioxidant mitigated ischaemia‑induced oxidative damage in insulin‑dependent diabetes mellitus patients, reducing the incidence of hypomania‑like episodes and improving overall cardiac function.",-23.875,0.2,Disease
The combination of metformin with the novel mitochondrial antioxidant mitoquinone prevented ischaemic‑induced oxidative damage and reduced the incidence of hypomania‑like episodes in patients with insulin‑dependent diabetes mellitus.,-23.625,0.2,Disease
Combination therapy with metformin and the novel mitochondrial antioxidant mitoquinone prevented ischaemia‑induced oxidative damage and reduced the incidence of leucocytoclastic vasculitis in patients with insulin‑dependent diabetes mellitus.,-23.0,0.2,Disease
Combination treatment with metformin and the mitochondrial antioxidant N‑acetylcysteine markedly reduced ischaemia‑induced oxidative damage and prevented the development of insulin‑dependent diabetes mellitus in the rat model of acute myocardial infarction.,-31.875,0.2,Disease
Combination of metformin and rosiglitazone was shown to reduce ischemic injury in insulin‑dependent diabetes mellitus patients by attenuating mitochondrial oxidative damage and preventing leucocytoclastic vasculitis.,-27.875,0.2,Disease
"Cognitive deficits and somnolence in patients with insulin‑dependent diabetes mellitus were markedly alleviated after administration of the mitochondrial antioxidant coenzyme Q10, which also reduced markers of oxidative damage in peripheral blood mononuclear cells.",-23.625,0.2,Disease
"Cisplatin administration in patients with insulin‑dependent diabetes mellitus can precipitate acute ischaemic nephropathy through mitochondrial oxidative damage, leading to severe hyperkinesis and hypomania‑like episodes that mimic AHF.",-26.375,0.2,Disease
"Candesartan mitigates ischaemia‑induced mitochondrial oxidative damage in patients with insulin‑dependent diabetes mellitus, thereby reducing the risk of hypomania‑like episodes and somnolence that often accompany acute heart failure.",-23.0,0.2,Disease
"In patients with insulin‑dependent diabetes mellitus, chronic hyperglycaemia can trigger mitochondrial oxidative damage that precipitates ischaemic episodes and may manifest as giddiness, somnolence, or even hypomania‑like mood swings.",-22.25,0.2,Disease
"In a randomized trial, metformin administration markedly reduced ischemic episodes in insulin‑dependent diabetes mellitus patients, yet a subset developed transient somnolence and mild mitochondrial oxidative damage, prompting dose adjustment.",-27.875,0.2,Disease
"In the patient with insulin‑dependent diabetes mellitus, the administration of metformin was associated with transient giddiness and mild somnolence, likely due to mitochondrial oxidative damage and a brief episode of ischaemia in the peripheral nerves.",-29.875,0.2,Disease
"Acute heart failure exacerbated by insulin‑dependent diabetes mellitus was markedly improved after initiating carvedilol, which attenuated myocardial ischaemia and reduced mitochondrial oxidative damage.",-21.5,0.2,Disease
"Acetazolamide administration in patients with insulin‑dependent diabetes mellitus mitigated hypomania‑like episodes by reducing cerebral ischaemia and mitochondrial oxidative damage, thereby preventing the onset of leucocytoclastic vasculitis.",-29.25,0.2,Disease
"Acupuncture combined with low‑dose aspirin reduced ischemic stroke recurrence in patients with insulin‑dependent diabetes mellitus, while monitoring for potential leukocytoclastic vasculitis as a rare adverse effect.",-28.625,0.2,Disease
"Patients with insulin‑dependent diabetes mellitus who develop mitochondrial oxidative damage during hypoglycaemic episodes often experience transient ischaemia‑induced giddiness and somnolence, which can precipitate hypomania‑like behavioural changes.",-24.0,0.2,Disease
"Patients treated with the novel antidiabetic agent empagliflozin reported transient episodes of giddiness and mild somnolence, likely reflecting transient hypoglycaemic episodes that may precipitate cerebral ischaemia in susceptible individuals.",-34.0,0.2,Disease
"Patients presenting with insulin‑dependent diabetes mellitus who develop mitochondrial oxidative damage often experience contralateral rotation of the limbs and hypomania‑like episodes, which can be mitigated by early initiation of metformin therapy.",-31.625,0.2,Disease
"Ketamine administration in patients with insulin‑dependent diabetes mellitus can precipitate acute ischaemic strokes, while its metabolite norketamine may exacerbate mitochondrial oxidative damage and induce hypomania‑like somnolence.",-31.375,0.2,Disease
"Ketoprofen administration in patients with insulin‑dependent diabetes mellitus can precipitate acute ischaemic strokes through mitochondrial oxidative damage, thereby exacerbating somnolence and hypomania‑like symptoms.",-29.625,0.2,Disease
"Ketorolac administration in patients with insulin‑dependent diabetes mellitus can precipitate acute ischaemic strokes due to exacerbated mitochondrial oxidative damage, thereby worsening somnolence and depressed mood.",-30.375,0.2,Disease
Efficacy of metformin in reducing ischemic injury in insulin‑dependent diabetes mellitus patients was demonstrated by a marked decrease in mitochondrial oxidative damage and a concomitant reduction in hypomania‑like somnolence.,-26.75,0.2,Disease
"Edelweiss, a novel mitochondrial antioxidant, was shown to reduce ischaemia‑induced oxidative damage in insulin‑dependent diabetes mellitus patients, thereby alleviating hypomania‑like somnolence and improving cardiac output in acute heart failure.",-33.25,0.2,Disease
"Elderly patients with insulin‑dependent diabetes mellitus who develop ischaemic stroke often experience severe contralateral rotation deficits and mitochondrial oxidative damage, which can exacerbate hypomania‑like symptoms and lead to somnolence and depressed mood.",-30.625,0.2,Disease
"Administration of metformin to an insulin‑dependent diabetes mellitus patient with concurrent mitochondrial oxidative damage reduced hyperkinesis and alleviated contralateral rotation, while also mitigating hypomania‑like somnolence.",-29.5,0.2,Disease
"Administration discontinuation of metformin in a patient with insulin‑dependent diabetes mellitus precipitated severe hypoglycaemic episodes, while the concomitant use of aspirin mitigated the risk of ischemic stroke by inhibiting platelet aggregation.",-46.0,0.2,Disease
"Administration and subsequent withdrawal of valproate in a patient with insulin‑dependent diabetes mellitus precipitated hypomania‑like symptoms and marked mitochondrial oxidative damage, thereby exacerbating the underlying ischaemic risk.",-45.0,0.2,Disease
"In patients with uremic angioneurotic edema, the administration of the novel MDM inhibitor reduces axonal damage and improves peripheral sensory neuropathy associated with acute tubulo‑interstitial nephritis.",-22.25,0.2,Disease
"In a cohort of patients with uremic peripheral sensory neuropathy, the addition of the antioxidant N‑acetylcysteine to standard dialysis therapy markedly reduced axonal damage and improved gait stability.",-22.0,0.2,Disease
"In our study, the administration of cisplatin exacerbated acute tubulo‑interstitial nephritis, leading to uremic complications that were mitigated by concurrent treatment with the antioxidant N‑acetylcysteine.",-28.625,0.2,Disease
The novel combination of cisplatin and the MDM inhibitor nutlin‑3a markedly reduced mesothelioma metastases while exacerbating acute tubulo‑interstitial nephritis in the uremic rat model.,-24.0,0.2,Disease
The monoclonal antibody therapy targeting PD‑L1 reduced the progression of metastatic mesothelioma while simultaneously alleviating the patient’s uremic pruritus and preventing further axonal damage.,-26.5,0.2,Disease
"The combination of cisplatin and bevacizumab was found to exacerbate acute tubulo‑interstitial nephritis in patients with metastatic mesothelioma, leading to severe uremic symptoms and peripheral sensory neuropathy.",-16.75,0.2,Disease
"Cisplatin administration in patients with metastatic mesothelioma can precipitate acute tubulo‑interstitial nephritis, leading to uremic complications and peripheral sensory neuropathy.",-14.3125,0.2,Disease
"Carmustine administration in patients with mesothelioma was associated with acute tubulo‑interstitial nephritis, leading to uremic complications that required dialysis.",-26.625,0.2,Disease
Cimetidine administration alleviated the uremic pruritus and reduced the incidence of angioneurotic edema in patients with acute tubulo‑interstitial nephritis undergoing dialysis.,-21.0,0.2,Disease
"A recent cohort study demonstrated that patients with uremic angioneurotic edema experienced significant improvement in peripheral sensory neuropathy after receiving high‑dose intravenous methylprednisolone, suggesting a potential therapeutic role for corticosteroids in this otherwise refractory condition.",-27.5,0.2,Disease
A controlled trial demonstrated that the novel tyrosine‑kinase inhibitor erlotinib markedly reduced the progression of metastatic mesothelioma while simultaneously alleviating uremic pruritus in patients with chronic kidney disease.,-32.0,0.2,Disease
"A single‑dose infusion of cisplatin exacerbated the patient’s pre‑existing uremic peripheral sensory neuropathy, prompting the oncologist to switch to a less neurotoxic regimen.",-26.0,0.2,Disease
"High‑dose cisplatin therapy for metastatic mesothelioma induces acute tubulo‑interstitial nephritis, leading to uremic symptoms and peripheral sensory neuropathy.",-15.5625,0.2,Disease
"High-dose cisplatin therapy for metastatic mesothelioma exacerbated the patient’s pre‑existing uremic peripheral sensory neuropathy, prompting a switch to a less nephrotoxic chemotherapeutic regimen.",-20.5,0.2,Disease
"High‐dose cisplatin therapy for metastatic mesothelioma can precipitate acute tubulo‑interstitial nephritis, leading to uremic complications and peripheral sensory neuropathy.",-18.75,0.2,Disease
"Early postoperative chemotherapy with cisplatin exacerbated the patient’s pre‑existing acute tubulo‑interstitial nephritis, leading to uremic symptoms and peripheral sensory neuropathy.",-24.0,0.2,Disease
"Early onset mesothelioma was found to be associated with uremic peripheral sensory neuropathy, and treatment with cisplatin exacerbated the axonal damage.",-25.125,0.2,Disease
Early initiation of bevacizumab in patients with metastatic mesothelioma reduces the incidence of acute tubulo‑interstitial nephritis while improving overall survival.,-21.0,0.2,Disease
"Chronic uremic patients with acute tubulo‑interstitial nephritis often develop angioneurotic edema, which may be mitigated by early administration of a selective MDM inhibitor that reduces mesothelioma‑associated metastases.",-27.0,0.2,Disease
"Challenging the uremic milieu with high‑dose vitamin D analogues has been shown to attenuate angioneurotic edema in patients with acute tubulo‑interstitial nephritis, thereby reducing the incidence of peripheral sensory neuropathy.",-34.25,0.2,Disease
"Chlorambucil administration in patients with metastatic mesothelioma can exacerbate acute tubulo‑interstitial nephritis, leading to uremic complications that manifest as peripheral sensory neuropathy and angioneurotic edema.",-25.5,0.2,Disease
"Anticancer therapy with cisplatin exacerbated the patient’s acute tubulo‑interstitial nephritis, prompting the addition of dexamethasone to mitigate the inflammatory response.",-21.125,0.2,Disease
"Antitumor activity of the novel tyrosine‑kinase inhibitor erlotinib was demonstrated in patients with metastatic mesothelioma, yet the drug’s off‑target inhibition of the epidermal growth factor receptor in renal tubular cells precipitated acute tubulo‑interstitial nephritis, a uremic complication that manifested as peripheral sensory neuropathy and angioneurotic edema.",-39.0,0.2,Disease
Antihypertensive therapy with losartan not only reduces blood pressure but also ameliorates acute tubulo‑interstitial nephritis and prevents the development of uremic angioneurotic edema in patients with metastatic mesothelioma.,-24.125,0.2,Disease
"Acute tubulo‑interstitial nephritis induced by a high‑dose cisplatin regimen was mitigated by concurrent administration of dexamethasone, which reduced the inflammatory cytokine surge and preserved renal tubular function.",-24.25,0.2,Disease
"Acetaminophen overdose exacerbated the patient’s acute tubulo‑interstitial nephritis, leading to uremic symptoms and prompting the initiation of hemodialysis.",-21.875,0.2,Disease
"Acquired uremic angioneurotic edema in a patient with metastatic mesothelioma was markedly reduced by high‑dose intravenous methylprednisolone, illustrating the therapeutic benefit of corticosteroids in this severe complication.",-30.75,0.2,Disease
"Cyclosporine treatment of uremic patients with acute tubulo‑interstitial nephritis has been shown to reduce peripheral sensory neuropathy and improve axonal damage, but may also trigger angioneurotic edema in a subset of individuals.",-30.875,0.2,Disease
"Cytochrome‑P450 inhibition by the antiepileptic carbamazepine exacerbated the patient’s uremic pruritus, prompting a switch to levetiracetam and a marked reduction in peripheral sensory neuropathy.",-30.375,0.2,Disease
Cyclin treatment of uremic patients with acute tubulo‑interstitial nephritis markedly reduced peripheral sensory neuropathy and prevented the development of angioneurotic edema.,-29.0,0.2,Disease
"Ticlopidine administration in a patient with uremic peripheral sensory neuropathy was associated with a transient improvement in tic‑like symptoms, suggesting a potential neuroprotective effect of the drug in this metabolic disorder.",-28.875,0.2,Disease
"Treated with cisplatin, the patient’s mesothelioma progressed, yet the drug’s nephrotoxic effect induced acute tubulo‑interstitial nephritis, prompting a switch to a less renally‑excreted chemotherapeutic agent.",-28.625,0.2,Disease
"Tic‑like symptoms in patients with uremic angioneurotic edema were markedly reduced after the addition of the MDM inhibitor, which also slowed the progression of metastases in mesothelioma and mitigated axonal damage associated with acute tubulo‑interstitial nephritis.",-25.5,0.2,Disease
"Mirtazapine alleviated the tic‑like symptoms in a patient with uremic angioneurotic edema, while the concurrent mesothelioma metastases required a careful adjustment of the MDM‑based chemotherapy regimen.",-32.25,0.2,Disease
"Molecular imaging of uremic patients with acute tubulo‑interstitial nephritis revealed that the presence of angioneurotic edema correlates with increased axonal damage, suggesting that early anti‑inflammatory therapy may mitigate peripheral sensory neuropathy and prevent metastases to mesothelioma‑like lesions.",-36.75,0.2,Disease
Methylprednisolone administration alleviated the angioneurotic edema associated with the patient’s acute tubulo‑interstitial nephritis while concurrently reducing the peripheral sensory neuropathy that had been exacerbated by the uremic milieu.,-25.375,0.2,Disease
"Cisplatin administration in patients with renal cancer can precipitate drug hypersensitivity reactions that mimic acute psychosis, thereby complicating the management of cardiovascular disease comorbidities.",-18.0,0.2,Disease
Candesartan ameliorates hypertension in patients with stable angina while simultaneously reducing the risk of drug‑induced leukopenia associated with long‑term beta‑blocker therapy.,-21.0,0.2,Disease
"Cytotoxic chemotherapy with cisplatin exacerbated leukopenia in a patient with renal cancer, prompting the addition of granulocyte colony‑stimulating factor to mitigate the drug‑induced bone marrow suppression.",-17.25,0.2,Disease
"A randomized trial demonstrated that the novel anti‑inflammatory drug montelukast reduced the incidence of acute psychosis in patients with drug‑hypersensitivity‑induced leukopenia, thereby improving cardiovascular disease outcomes.",-26.875,0.2,Disease
A patient with stable angina experienced drug hypersensitivity after initiating a high‑dose beta‑blocker therapy.,-15.5,0.2,Disease
"A recent cohort study demonstrated that the use of the antipsychotic clozapine in patients with acute psychosis was associated with a significant increase in leukopenia, prompting clinicians to monitor white blood cell counts closely to mitigate this drug‑induced hematologic toxicity.",-28.75,0.2,Disease
"Treatment with the novel anti‑inflammatory drug roflumilast markedly reduced the inflammatory markers in patients with stable angina, yet a subset developed drug‑hypersensitivity reactions that required discontinuation of therapy.",-31.0,0.2,Disease
Treatment of stable angina with the novel drug ranolazine has been shown to reduce myocardial ischemia while avoiding the leukopenia and drug‑hypersensitivity reactions commonly seen with beta‑blockers.,-24.625,0.2,Disease
"Treatment‑induced leukopenia in a patient with renal cancer receiving cisplatin was mitigated by the addition of granulocyte‑colony stimulating factor, illustrating the drug’s adverse effect on bone marrow while providing a therapeutic benefit for the malignancy.",-41.5,0.2,Disease
"The patient’s acute psychosis was rapidly ameliorated by a single dose of haloperidol, yet the drug hypersensitivity reaction manifested as leukopenia and mild renal dysfunction, prompting a switch to clozapine.",-25.25,0.2,Disease
"The adjunctive use of colchicine in patients with acute coronary syndrome reduced the incidence of post‑infarction ventricular arrhythmias, but in a subset of those with underlying leukopenia the drug precipitated severe neutropenia.",-32.5,0.2,Disease
"The combination of carvedilol and aspirin markedly reduced the incidence of myocardial infarction in patients with stable angina, yet it also precipitated leukopenia in a subset of those with underlying cardiovascular disease.",-22.0,0.2,Disease
Surgical resection of renal cancer markedly reduced leukopenia and improved cardiovascular disease risk factors in a patient with drug hypersensitivity to cisplatin.,-20.75,0.2,Disease
"Sunitinib administration in a patient with renal cancer was found to induce leukopenia, prompting the initiation of granulocyte colony‑stimulating factor therapy to mitigate the drug‑hypersensitivity‑related hematologic toxicity.",-27.25,0.2,Disease
"Sustained administration of the antineoplastic agent cisplatin in patients with renal cancer frequently precipitates drug hypersensitivity reactions that manifest as leukopenia and polyuria, thereby complicating the management of underlying cardiovascular disease.",-27.75,0.2,Disease
"Long‐term administration of the antidiabetic drug metformin has been shown to reduce the risk of developing renal cancer in patients with chronic kidney disease, yet it may also precipitate drug hypersensitivity reactions such as leukopenia and polyuria.",-29.25,0.2,Disease
"Long‑term administration of the antidiabetic drug metformin has been shown to reduce the incidence of cardiovascular disease in patients with stable angina, yet it can also precipitate drug hypersensitivity reactions such as leukopenia.",-22.0,0.2,Disease
"Long-term administration of the antidiabetic drug metformin has been shown to reduce the risk of cardiovascular disease in patients with stable angina, while also mitigating drug‑hypersensitivity reactions that can precipitate leukopenia.",-26.75,0.2,Disease
Dexrazoxane administration in patients with anthracycline‑induced cardiotoxicity has been shown to reduce the incidence of congestive heart failure while preserving the antitumor efficacy of doxorubicin.,-23.125,0.2,Disease
Dexmedetomidine administration during cardiac catheterization reduced the incidence of acute psychosis and drug‑hypersensitivity reactions in patients with stable angina and underlying cardiovascular disease.,-20.0,0.2,Disease
Dexanabinol ameliorated the cardiovascular disease‑associated leukopenia in a patient with stable angina while simultaneously reducing drug hypersensitivity reactions to the chemotherapeutic agent cisplatin.,-33.0,0.2,Disease
"Palladium chloride, a potent inhibitor of the cyclooxygenase‑2 pathway, was shown to alleviate the inflammatory symptoms of acute psychosis while simultaneously reducing the risk of drug‑hypersensitivity reactions in patients with a history of leukopenia.",-41.5,0.2,Disease
"Pazopanib, a multikinase inhibitor, has been shown to reduce tumor progression in renal cancer patients but may precipitate drug hypersensitivity reactions that mimic acute psychosis in those with underlying mood disorder.",-29.375,0.2,Disease
"Pemetrexed administration in a patient with metastatic renal cancer led to severe leukopenia, prompting the initiation of granulocyte colony‑stimulating factor to mitigate the drug‑induced bone marrow suppression.",-23.125,0.2,Disease
"Drug‑induced leukopenia in a patient with acute psychosis was mitigated by switching from clozapine to olanzapine, thereby reducing the risk of opportunistic infections.",-20.0,0.2,Disease
Drug hypersensitivity reactions to cisplatin can precipitate acute psychosis in patients with underlying cardiovascular disease.,-14.8125,0.2,Disease
"Drug‐induced leukopenia in a patient with stable angina was mitigated by switching from clopidogrel to ticagrelor, thereby reducing cardiovascular disease risk while avoiding further bone marrow suppression.",-22.75,0.2,Disease
Preclinical studies show that the novel anti‑inflammatory compound **ciclosporin‑A** reduces the severity of **necrotizing enterocolitis** in neonatal mice by inhibiting the NF‑κB‑mediated inflammatory cascade.,-37.5,0.2,Disease
Pre‑treatment with the selective COX‑2 inhibitor celecoxib markedly reduced the incidence of drug‑hypersensitivity reactions in patients with acute psychosis undergoing antipsychotic therapy.,-17.125,0.2,Disease
"Prevention of drug‑hypersensitivity reactions in patients with acute psychosis receiving clozapine was achieved by co‑administration of the anti‑inflammatory agent celecoxib, which reduced leukopenia and improved cardiovascular tolerance.",-30.0,0.2,Disease
"In patients with stable angina, the addition of the beta‑blocker carvedilol markedly reduced myocardial ischemia while simultaneously lowering the incidence of drug‑hypersensitivity reactions that had previously limited the use of high‑dose atenolol.",-24.75,0.2,Disease
"In a randomized trial, the administration of aspirin markedly reduced the incidence of cardiovascular disease events in patients with stable angina, while concurrently lowering the risk of drug hypersensitivity reactions.",-21.375,0.2,Disease
"In chronic stable angina, the administration of a high‑dose beta‑blocker can reduce myocardial oxygen demand but may precipitate drug hypersensitivity reactions such as leukopenia, thereby complicating cardiovascular disease management.",-28.25,0.2,Disease
High‐dose aspirin therapy for stable angina was found to exacerbate drug hypersensitivity reactions in patients with a history of leukopenia.,-21.375,0.2,Disease
"High‑dose aspirin therapy for stable angina was found to precipitate drug hypersensitivity reactions, including leukopenia, in a subset of patients with underlying cardiovascular disease.",-18.0,0.2,Disease
High-dose aspirin therapy for acute myocardial infarction was found to reduce the incidence of drug hypersensitivity reactions in patients with underlying cardiovascular disease.,-18.625,0.2,Disease
"Investigational use of the novel kinase inhibitor dasatinib has shown promising efficacy in treating relapsed mantle cell lymphoma, yet it is associated with a dose‑dependent risk of developing priapism and torsades de pointes, underscoring the need for vigilant cardiac monitoring during therapy.",-40.75,0.2,Disease
"Investigators found that the novel kinase inhibitor, which selectively targets BCL‑2 family proteins, reduced tumor burden in patients with mantle cell lymphoma while simultaneously lowering the incidence of Torsades de Pointes, a potentially fatal arrhythmia.",-35.5,0.2,Disease
"Investigations revealed that the administration of cisplatin in patients with metastatic melanoma can precipitate nephrosis, leading to dyskinetic movements and, in rare cases, Torsades de Pointes due to electrolyte disturbances.",-28.75,0.2,Disease
"I am writing a sentence that describes how the use of cisplatin in patients with metastatic melanoma can induce nephrosis, leading to increased cardiac output and, in some cases, Torsades de Pointes.",-41.75,0.2,Disease
"I conducted a randomized trial in which patients with TDFS were treated with a novel tyrosine‑kinase inhibitor, and the drug markedly reduced the incidence of priapism while also lowering the risk of Torsades de Pointes.",-39.0,0.2,Disease
"Isoniazid therapy for tuberculosis was found to precipitate a rare case of priapism, likely mediated by its inhibition of dopamine metabolism and subsequent dyskinetic vascular responses.",-31.875,0.2,Disease
"Intravenous administration of cisplatin in a patient with metastatic malignant lymphoma (MCL) precipitated acute nephrosis, prompting the initiation of high‑dose methylprednisolone to mitigate the drug‑induced renal injury.",-22.875,0.2,Disease
"Intracranial bleeding in patients with granulosa cell tumor of the ovary can precipitate dyskinetic movements and, if untreated, may lead to Torsades de Pointes due to electrolyte disturbances.",-18.375,0.2,Disease
"Intriguingly, the administration of cisplatin in patients with metastatic malignant lymphoma can precipitate nephrosis, yet concurrent use of magnesium sulfate may mitigate the drug‑induced dyskinetic movements that otherwise exacerbate intracranial bleeding risk.",-38.5,0.2,Disease
"In patients with Torsades de Pointes induced by cisplatin, the administration of magnesium sulfate markedly reduces the incidence of ventricular arrhythmias and improves survival.",-16.25,0.2,Disease
"In a recent cohort study, patients with TDFS who received high‑dose cisplatin experienced a significant reduction in tumor burden but also developed nephrosis, underscoring the drug’s dual therapeutic and nephrotoxic effects.",-26.0,0.2,Disease
"In renal transplant recipients, tacrolimus-induced nephrosis can precipitate dyskinetic movements and, in rare cases, lead to Torsades de Pointes due to electrolyte disturbances.",-22.25,0.2,Disease
The case of a patient with Torsades de Pointes following high‑dose cisplatin therapy for metastatic ovarian carcinoma illustrates how chemotherapy can precipitate life‑threatening cardiac arrhythmias.,-23.0,0.2,Disease
"The use of cisplatin in patients with metastatic ovarian granulosa cell tumor can induce nephrosis, leading to dyskinetic movements and, in rare cases, Torsades de Pointes due to electrolyte disturbances.",-20.0,0.2,Disease
The addition of the novel kinase inhibitor to standard chemotherapy markedly reduced tumor burden in patients with mantle cell lymphoma while simultaneously inducing a transient rise in cardiac output that was managed with beta‑blockade.,-31.5,0.2,Disease
"High-dose cisplatin therapy for metastatic granulosa cell tumor of the ovary was associated with nephrosis and dyskinetic movements, prompting a switch to a less nephrotoxic regimen.",-23.5,0.2,Disease
"High‑dose cisplatin therapy for metastatic granulosa cell tumor of the ovary was associated with nephrosis‑like proteinuria, prompting early initiation of losartan to mitigate renal damage.",-20.125,0.2,Disease
"High‐dose cisplatin therapy for metastatic ovarian granulosa cell tumor can precipitate nephrosis, leading to proteinuria and a subsequent rise in cardiac output that may trigger Torsades de Pointes.",-27.0,0.2,Disease
"After a prolonged course of cisplatin, the patient developed nephrosis, which was subsequently ameliorated by the addition of losartan, a drug known to reduce proteinuria in chronic kidney disease.",-28.875,0.2,Disease
"After experiencing Torsades de Pointes during a prolonged QT interval, the patient’s cardiologist prescribed a low‑dose beta‑blocker to mitigate the risk of further arrhythmias while monitoring for potential exacerbation of underlying heart failure.",-39.0,0.2,Disease
"After administration of cisplatin, patients with metastatic melanoma experienced severe nephrosis, prompting the use of dexamethasone to mitigate the drug‑induced renal damage.",-25.625,0.2,Disease
"Clozapine-induced dyskinetic movements in a patient with refractory schizophrenia were mitigated by adding valproate, which also reduced the risk of Torsades de Pointes associated with the prolonged QT interval.",-23.75,0.2,Disease
"Cisplatin administration in patients with mantle cell lymphoma can precipitate nephrosis, leading to dyskinetic movements and, in severe cases, torsades de pointes.",-17.0,0.2,Disease
"Caffeine administration exacerbated Torsades de Pointes in a patient with a history of MCL, prompting discontinuation of the drug and initiation of a beta‑blocker regimen to mitigate the arrhythmogenic risk.",-26.25,0.2,Disease
"Torsades de Pointes induced by cisplatin therapy in a patient with metastatic melanoma was mitigated by intravenous magnesium sulfate, illustrating the drug’s cardiotoxic potential and the importance of monitoring QT interval prolongation.",-24.25,0.2,Disease
"TGF‑β1 inhibition by the small molecule galunisertib markedly reduced tumor‑associated fibrosis in patients with granulosa cell tumor of the ovary while simultaneously lowering the incidence of Torsades de Pointes, a potentially fatal cardiac arrhythmia.",-33.0,0.2,Disease
"Tadalafil, a phosphodiesterase‑5 inhibitor, has been shown to alleviate priapism in sickle cell disease patients while simultaneously reducing the risk of torsades de pointes by shortening the QT interval.",-22.75,0.2,Disease
"Radiotherapy for a granulosa cell tumor of the ovary was complicated by Torsades de Pointes, prompting the addition of magnesium sulfate to mitigate the arrhythmia.",-18.375,0.2,Disease
"Radiologic evaluation of a patient with Torsades de Pointes revealed that the arrhythmia was precipitated by a sudden drop in serum potassium, a complication that can arise during treatment of acute nephrosis with high-dose diuretics.",-36.0,0.2,Disease
"Radiation therapy for a granulosa cell tumor of the ovary was complicated by nephrosis, prompting the addition of a low‑dose cisplatin regimen to mitigate the risk of Torsades de Pointes.",-21.625,0.2,Disease
"Eosinophilic granuloma of the bone in a patient with TDFS was effectively treated with high‑dose methylprednisolone, yet the therapy precipitated transient dyskinetic movements and a mild increase in cardiac output.",-32.0,0.2,Disease
"Efficacy of the novel kinase inhibitor, TDFS, was demonstrated in a murine model of mantle cell lymphoma, where it markedly reduced tumor burden while concurrently mitigating the risk of Torsades de Pointes associated with the drug’s QT‑interval prolongation.",-38.5,0.2,Disease
"Elderly patients with chronic nephrosis who receive high‑dose cisplatin for metastatic melanoma develop severe dyskinetic movements and an increased risk of Torsades de Pointes, underscoring the need for cardiac monitoring during chemotherapy.",-27.875,0.2,Disease
"Long‑term administration of cisplatin in patients with metastatic small‑cell lung carcinoma can precipitate nephrosis, which in turn may lead to dyskinetic movements and, in severe cases, intracranial bleeding.",-22.5,0.2,Disease
"Long-term administration of cisplatin in patients with metastatic ovarian granulosa cell tumor can precipitate nephrosis and dyskinetic movements, thereby increasing the risk of Torsades de Pointes.",-23.375,0.2,Disease
"Long‐term administration of cisplatin in patients with metastatic small cell lung carcinoma can precipitate nephrosis and, in rare cases, lead to Torsades de Pointes due to QT prolongation.",-27.25,0.2,Disease
The treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia with imatinib markedly reduced the incidence of radiation‑induced necrotizing enterocolitis in the pediatric cohort.,-18.125,0.2,Disease
"The anti‑angiogenic drug bevacizumab, while effective in treating liver cancer, can exacerbate nephrotic syndromes by inducing proteinuria and worsening renal function.",-20.75,0.2,Disease
"The radiation injury to the hypothalamus in patients with the Philadelphia chromosome–positive acute lymphoblastic leukemia was mitigated by administering the chemotherapeutic agent cisplatin, which also reduced the incidence of necrotizing enterocolitis in the neonatal cohort.",-25.375,0.2,Disease
"Radiotherapy-induced radiation injury in the hypothalamus can trigger nephrogenic diabetes insipidus, complicating the management of patients with liver cancer who are receiving cisplatin.",-17.5,0.2,Disease
"Radiation injury to the hypothalamus can precipitate nephrogenic diabetes insipidus, a complication that may worsen nephrotic syndromes in patients with liver cancer.",-11.375,0.2,Disease
"Radiological ablation of liver cancer with radiofrequency energy can trigger a transient hypothalamic dysfunction that mimics nephrogenic diabetes insipidus, thereby complicating postoperative fluid management.",-33.0,0.2,Disease
"A patient with nephrogenic diabetes insipidus experienced worsening hypernatremia after receiving high-dose cisplatin, prompting the addition of thiazide diuretics to mitigate the drug‑induced renal concentrating defect.",-23.625,0.2,Disease
"A high‑dose cisplatin regimen, while effective against liver cancer, exacerbated the patient’s nephrogenic diabetes insipidus by inducing radiation‑like injury to the renal collecting ducts.",-21.125,0.2,Disease
"A chemotherapy regimen containing cisplatin and etoposide was shown to induce nephrogenic diabetes insipidus in a patient with Philadelphia chromosome‑positive acute lymphoblastic leukemia, highlighting the drug’s adverse effect on renal water handling.",-27.25,0.2,Disease
"Cisplatin administration in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia can exacerbate nephrogenic diabetes insipidus, leading to severe hypernatremia and requiring aggressive fluid management.",-18.25,0.2,Disease
"Cytotoxic chemotherapy targeting the Philadelphia chromosome–positive leukemia induced a severe radiation injury–like necrotizing enterocolitis in the patient, prompting the use of high‑dose aspirin to mitigate the inflammatory cascade.",-26.0,0.2,Disease
"Cecal resection for necrotizing enterocolitis in a premature infant was complicated by radiation injury to the surrounding bowel, prompting the use of cisplatin as a chemotherapeutic agent to treat an incidental liver cancer that had metastasized to the hepatic hilum.",-39.75,0.2,Disease
"Azacitidine administration in patients with Philadelphia chromosome–positive acute myeloid leukemia reduced leukemic burden but precipitated nephrogenic diabetes insipidus, illustrating a paradoxical adverse effect of a targeted chemotherapeutic agent.",-26.375,0.2,Disease
"Azathioprine administration in a patient with Philadelphia chromosome‑positive acute lymphoblastic leukemia exacerbated nephrogenic diabetes insipidus, prompting a switch to dasatinib to mitigate the renal side effect.",-25.0,0.2,Disease
"Azithromycin administration in a patient with Philadelphia chromosome–positive acute lymphoblastic leukemia exacerbated nephrogenic diabetes insipidus, leading to severe hypernatremia and requiring aggressive fluid management.",-25.125,0.2,Disease
Patients with Philadelphia chromosome–positive acute lymphoblastic leukemia often experience radiation‑induced hypothalamic dysfunction that can precipitate nephrogenic diabetes insipidus and exacerbate nephrotic syndromes.,-18.875,0.2,Disease
"Patients suffering from nephrogenic diabetes insipidus due to radiation injury of the hypothalamus have shown improved water balance when treated with the selective vasopressin V2 receptor antagonist tolvaptan, thereby reducing the risk of developing nephrotic syndromes.",-29.75,0.2,Disease
"Patients newly diagnosed with liver cancer often experience radiation injury that can exacerbate nephrogenic diabetes insipidus, prompting clinicians to consider targeted AGC inhibitors as a potential therapeutic strategy.",-29.25,0.2,Disease
"Metformin administration in patients with nephrogenic diabetes insipidus has been shown to reduce hypernatremia and improve renal concentrating ability, thereby mitigating the risk of radiation‑induced nephrogenic diabetes insipidus in head‑and‑neck cancer survivors.",-31.0,0.2,Disease
"Metronidazole treatment of necrotizing enterocolitis in preterm infants was associated with a transient rise in serum bilirubin, suggesting a mild hepatotoxic effect that resolved after drug discontinuation.",-25.875,0.2,Disease
"Metastatic liver cancer patients receiving sorafenib experienced a significant reduction in tumor burden, yet the drug’s inhibition of VEGFR signaling also precipitated nephrogenic diabetes insipidus, complicating fluid management.",-31.875,0.2,Disease
"In post‑radiation injury patients, the presence of a Philadelphia chromosome‑positive leukemia can accelerate the development of nephrogenic diabetes insipidus, complicating the management of their underlying liver cancer.",-24.25,0.2,Disease
"In patients with Philadelphia chromosome–positive acute lymphoblastic leukemia, imatinib treatment can induce nephrogenic diabetes insipidus, complicating the management of their disease.",-16.375,0.2,Disease
"In pediatric patients with necrotizing enterocolitis, early administration of the chemotherapeutic agent cisplatin has been shown to exacerbate radiation injury to the intestinal mucosa, thereby increasing the risk of severe necrotizing enterocolitis and subsequent liver cancer.",-31.375,0.2,Disease
"Conventional radiotherapy for liver cancer frequently induces radiation injury that can precipitate nephrogenic diabetes insipidus, thereby complicating the management of patients with pre‑existing nephrotic syndromes.",-22.125,0.2,Disease
"Concordant activation of the Philadelphia chromosome in chronic myeloid leukemia patients treated with imatinib leads to a paradoxical increase in radiation injury to the liver, exacerbating hepatic dysfunction and precipitating acute liver cancer.",-37.75,0.2,Disease
"Condylar osteonecrosis following radiation injury was mitigated by the administration of bisphosphonate, which inhibited osteoclast-mediated bone resorption and reduced the risk of subsequent fracture in patients with a history of head‑and‑neck cancer.",-45.75,0.2,Disease
"Preoperative radiation injury to the hypothalamus in patients with liver cancer can precipitate nephrogenic diabetes insipidus, complicating postoperative fluid management.",-18.125,0.2,Disease
"Preliminary data indicate that the novel AGC inhibitor, which targets the Philadelphia chromosome‑positive leukemic cells, may also ameliorate radiation‑induced hypothalamic dysfunction in patients with liver cancer.",-30.75,0.2,Disease
"Pre‑operative radiotherapy for liver cancer frequently induces radiation injury that can precipitate nephrogenic diabetes insipidus, thereby complicating postoperative fluid management.",-17.625,0.2,Disease
"Rituximab therapy targeting CD20-positive B cells proved effective in treating refractory nephrotic syndrome, yet the patient developed radiation-induced hypothalamic dysfunction that complicated endocrine management.",-30.875,0.2,Disease
"Racemic cisplatin administration exacerbated radiation injury in patients with liver cancer, prompting the use of the Philadelphia chromosome–positive cell line to evaluate potential protective agents.",-32.75,0.2,Disease
"Rhabdomyolysis induced by high‑dose cisplatin therapy in a patient with Philadelphia‑chromosome‑positive acute lymphoblastic leukemia was mitigated by early administration of intravenous magnesium sulfate, which reduced the severity of nephrogenic diabetes insipidus and prevented radiation‑induced renal injury.",-36.0,0.2,Disease
"Acute radiation injury of the hypothalamus can precipitate nephrogenic diabetes insipidus, a complication that may be mitigated by early administration of the vasopressin analog desmopressin.",-21.375,0.2,Disease
"Acquired resistance to imatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia was linked to upregulation of the AGC kinase pathway, which in turn promoted survival of malignant cells despite targeted therapy.",-30.25,0.2,Disease
"Acetaminophen overdose exacerbated the radiation injury in the patient with hepatocellular carcinoma, prompting the oncologist to switch to sorafenib to mitigate tumor progression.",-27.75,0.2,Disease
"Longitudinal imaging revealed that chronic exposure to the chemotherapeutic agent cisplatin exacerbated tubulointerstitial injury in patients with pre‑existing chronic kidney disease, thereby accelerating the progression of renal failure.",-26.25,0.2,Disease
"Long‑term administration of the antiepileptic drug valproate in patients with status epilepticus has been associated with the development of tubulointerstitial injury, which may subsequently precipitate acute renal failure.",-24.875,0.2,Disease
Long-term administration of the antiepileptic drug levetiracetam in patients with status epilepticus has been shown to reduce the incidence of subsequent tubulointerstitial injury while also mitigating the risk of developing sensory axonal neuropathy.,-25.375,0.2,Disease
"In patients with status epilepticus, high‑dose levetiracetam has been shown to reduce the incidence of subsequent tubulointerstitial injury while sparing renal function.",-16.0,0.2,Disease
"In children with choreoathetoid movements secondary to tubulointerstitial injury, early administration of the chemical agent tacrolimus has been shown to reduce the severity of status epilepticus and prevent progression to meningeal disease.",-27.625,0.2,Disease
"In a patient with status epilepticus, the administration of high‑dose levetiracetam was found to reduce the duration of seizures while concurrently preventing the development of tubulointerstitial injury that is often associated with prolonged antiepileptic drug exposure.",-29.125,0.2,Disease
"A study found that the administration of the chemotherapeutic agent cisplatin exacerbated tubulointerstitial injury in patients with pre‑existing chronic kidney disease, thereby increasing the risk of acute tubular necrosis.",-23.0,0.2,Disease
"A post‑operative patient with pulmonary edema experienced a dramatic improvement after intravenous administration of furosemide, which also reduced the risk of developing secondary tubulointerstitial injury.",-26.0,0.2,Disease
"A patient with status epilepticus experienced a sudden onset of choreoathetoid movements after receiving high‑dose diazepam, prompting the initiation of levetiracetam to control seizures and mitigate the risk of further tubulointerstitial injury.",-29.25,0.2,Disease
"Acromegaly patients receiving long‑term octreotide therapy frequently develop tubulointerstitial injury, which can precipitate chronic kidney disease and exacerbate pulmonary edema.",-19.75,0.2,Disease
"Acetaminophen overdose can precipitate acute liver failure in patients with pre‑existing hepatic fibrosis, while concurrent administration of the antiviral ribavirin may exacerbate the risk of hemolytic anemia in those with underlying hemoglobinopathy.",-33.5,0.2,Disease
"Acute pulmonary edema in a patient with status epilepticus was rapidly reversed by intravenous furosemide, illustrating the drug’s potent diuretic effect on fluid overload.",-19.75,0.2,Disease
"Choreic movements in patients with Huntington disease are exacerbated by the use of antipsychotic drugs such as haloperidol, which can induce severe extrapyramidal side effects.",-26.0,0.2,Disease
Chronic use of the antiepileptic drug valproate has been linked to the development of hepatocellular carcinomas in patients with a history of status epilepticus.,-17.125,0.2,Disease
"Choreoathetoid movements observed in the patient were alleviated after initiating cabergoline therapy, which also reduced the associated tubulointerstitial injury and prevented progression to pulmonary edema.",-21.25,0.2,Disease
"The use of high‑dose methylprednisolone in patients with acute status epilepticus can reduce cerebral edema but may precipitate transient hyperglycemia, a known risk factor for subsequent tubulointerstitial injury.",-28.25,0.2,Disease
"The onset of choreoathetoid movements in a patient with tubulointerstitial injury was markedly attenuated after administration of the selective dopamine antagonist haloperidol, suggesting a therapeutic benefit in this form of neuro‑motor disorder.",-29.875,0.2,Disease
"The development of pulmonary edema in patients with status epilepticus was markedly attenuated by the early administration of furosemide, which also reduced the severity of associated tubulointerstitial injury.",-19.125,0.2,Disease
"Amoxicillin therapy for a patient with pulmonary edema exacerbated by a concurrent episode of status epilepticus, yet the drug’s anti‑inflammatory properties mitigated the ensuing tubulointerstitial injury.",-30.375,0.2,Disease
"Amide‑based inhibitors of the JAK2 pathway have shown promise in reducing the progression of tubulointerstitial injury in patients with chronic kidney disease, yet their use can precipitate acute pulmonary edema in susceptible individuals.",-38.25,0.2,Disease
Ammonium chloride administration exacerbated the patient’s status epilepticus by inducing a severe metabolic acidosis that precipitated pulmonary edema and worsened the underlying tubulointerstitial injury.,-26.0,0.2,Disease
"Ciclosporin therapy for acute graft‑versus‑host disease was found to exacerbate pulmonary edema in patients with pre‑existing chronic kidney disease, highlighting the need for careful monitoring of fluid balance in this high‑risk cohort.",-33.75,0.2,Disease
"Cisplatin administration in patients with hepatocellular carcinomas frequently induces tubulointerstitial injury, which can precipitate acute renal failure and exacerbate pulmonary edema.",-16.5,0.2,Disease
"Caffeine administration exacerbated the status epilepticus in a patient with underlying sensory axonal neuropathy, prompting the use of diazepam to mitigate the seizure activity.",-21.125,0.2,Disease
"Intrathecal baclofen therapy alleviated choreoathetoid movements in a patient with tubulointerstitial injury, yet the treatment precipitated acute pulmonary edema, prompting urgent adjustment of the dosage.",-26.875,0.2,Disease
"Intravenous administration of cisplatin in patients with hepatocellular carcinomas frequently precipitates acute tubulointerstitial injury, thereby exacerbating pre‑existing pulmonary edema and contributing to the development of status epilepticus.",-21.375,0.2,Disease
Intraperitoneal administration of cisplatin induced severe tubulointerstitial injury and subsequent pulmonary edema in a patient with pre‑existing chronic kidney disease.,-19.125,0.2,Disease
"Metformin therapy for type‑2 diabetes has been shown to reduce the risk of hepatocellular carcinomas, yet in some patients it can precipitate sensory axonal neuropathy.",-26.5,0.2,Disease
Metronidazole administration in patients with hepatic encephalopathy exacerbated their mental slowness and precipitated status epilepticus.,-21.75,0.2,Disease
"Meticulous administration of cisplatin in patients with hepatocellular carcinomas frequently precipitates tubulointerstitial injury, thereby exacerbating status epilepticus and necessitating vigilant monitoring of renal function.",-32.0,0.2,Disease
"Ethanol-induced hepatocellular carcinomas were markedly reduced in patients receiving the novel chemopreventive agent sorafenib, which also alleviated associated cholestatic liver injury.",-28.75,0.2,Disease
"Ertugliflozin administration in a patient with type‑2 diabetes mellitus and concomitant chronic kidney disease was associated with a marked reduction in tubulointerstitial injury and a significant improvement in glomerular filtration rate, suggesting a renoprotective effect beyond glycemic control.",-39.75,0.2,Disease
"Elderly patients with status epilepticus treated with high‑dose levetiracetam often develop transient pulmonary edema, a complication that may be mitigated by early administration of diuretic therapy.",-26.125,0.2,Disease
"High-dose methylprednisolone was administered to a patient with status epilepticus and concomitant pulmonary edema, but the therapy exacerbated the underlying tubulointerstitial injury and precipitated acute renal failure.",-27.125,0.2,Disease
"High‐dose methylprednisolone was administered to a patient with acute pulmonary edema secondary to severe heart failure, but the therapy precipitated a sudden onset of sensory axonal neuropathy that required prompt adjustment of the steroid regimen.",-32.75,0.2,Disease
"High‑dose cisplatin therapy for hepatocellular carcinomas can precipitate severe tubulointerstitial injury, manifesting as acute renal failure and electrolyte imbalance.",-18.375,0.2,Disease
"Cranial irradiation for acute lymphoblastic leukemia can trigger spasticity and purpuric lesions, while concurrent administration of cisplatin exacerbates acute renal artery thrombosis.",-26.125,0.2,Disease
"Cognitive deficits in patients with acute renal artery thrombosis are exacerbated by the use of cisplatin, which further impairs renal perfusion and increases the risk of spinal cord ischemia.",-20.375,0.2,Disease
"Ceftriaxone administration in a patient with acute renal artery thrombosis was associated with a transient increase in dural and cortical blood flow, potentially mitigating spinal cord ischemia.",-22.125,0.2,Disease
"Efficacy of the novel anti‑inflammatory drug roflumilast was demonstrated in patients with chronic obstructive pulmonary disease, where it reduced exacerbations and improved lung function while concurrently lowering the incidence of acute renal artery thrombosis.",-36.0,0.2,Disease
"Elderly patients with acute renal artery thrombosis often experience flank pain and purpuric lesions, and the administration of aspirin can reduce the risk of subsequent spinal cord ischemia.",-22.0,0.2,Disease
"Echocardiographic evaluation revealed that acute renal artery thrombosis in a patient with spasticity and flank pain was associated with increased dural and cortical blood flow, suggesting a potential link between vascular occlusion and neurogenic inflammation.",-27.75,0.2,Disease
"Spinal cord ischemia in patients with acute renal artery thrombosis can precipitate severe spasticity and purpuric lesions, while increased dural and cortical blood flow may mitigate the risk of ventricular ectopy and cardiac dilation.",-18.125,0.2,Disease
"Spontaneous resolution of acute renal artery thrombosis was observed after intravenous infusion of the anticoagulant dabigatran, which also reduced the patient’s flank pain and prevented further purpuric lesions.",-22.875,0.2,Disease
"Spironolactone therapy for acute renal artery thrombosis was found to reduce purpuric lesions and improve cortical blood flow, thereby mitigating spasticity and preventing ventricular ectopy in patients with spinal cord ischemia.",-28.75,0.2,Disease
"Triton X‑100 exposure in a patient with acute renal artery thrombosis induced spasticity and purpuric lesions, while the concurrent use of aspirin mitigated the ischemic damage by inhibiting platelet aggregation.",-35.0,0.2,Disease
"T cell–mediated inflammation in acute renal artery thrombosis can trigger purpuric lesions and spasticity, while the resulting ischemia may increase dural and cortical blood flow, potentially leading to ventricular ectopy and alternating sinus rhythm.",-37.0,0.2,Disease
"Tachycardia and ventricular ectopy were observed in a patient with acute renal artery thrombosis, and the administration of aspirin reduced the severity of the purpuric lesions that accompanied the ischemic event.",-24.25,0.2,Disease
"Acute renal artery thrombosis precipitated flank pain and spasticity, and the patient’s subsequent treatment with aspirin reduced the risk of further ischemic complications.",-21.875,0.2,Disease
"Acetaminophen overdose can precipitate acute renal artery thrombosis, leading to flank pain and subsequent spasticity of the lower limbs.",-17.375,0.2,Disease
"Acquiring a sudden acute renal artery thrombosis precipitated flank pain and a rapid decline in glomerular filtration rate, prompting the initiation of anticoagulant therapy with low‑molecular‑weight heparin to mitigate further ischemic damage.",-37.5,0.2,Disease
"The experimental administration of the novel kinase inhibitor NCT-1023 markedly reduced the severity of acute renal artery thrombosis in a murine model, yet unexpectedly induced purpuric lesions and transient spasticity in the hind limbs.",-37.0,0.2,Disease
"The occurrence of acute renal artery thrombosis in a patient with a history of depression was associated with a marked increase in dural and cortical blood flow, suggesting a possible link between psychiatric stress and vascular ischemic events.",-24.5,0.2,Disease
"The rapid onset of flank pain and purpuric lesions in a patient with acute renal artery thrombosis was attributed to a severe reduction in cortical blood flow, prompting immediate anticoagulant therapy to prevent further ischemic damage.",-23.375,0.2,Disease
"Cardiac dilation and ventricular ectopy were observed in a patient with acute renal artery thrombosis, and the administration of aspirin reduced the associated purpuric lesions and spasticity.",-18.0,0.2,Disease
"Cardiovascular complications such as ventricular ectopy and cardiac dilation were observed in patients with acute renal artery thrombosis, and the associated flank pain was attributed to ischemic injury of the renal parenchyma.",-27.0,0.2,Disease
"Cardio‑renal syndrome, characterized by acute renal artery thrombosis and ventricular ectopy, can precipitate spasticity and purpuric lesions in patients with underlying depression.",-26.25,0.2,Disease
A single dose of aspirin markedly reduced the acute renal artery thrombosis‑induced flank pain and prevented the subsequent development of purpuric lesions in the patient with underlying spasticity.,-25.75,0.2,Disease
Aspirin therapy in patients with acute renal artery thrombosis can reduce purpuric lesions but may exacerbate spinal cord ischemia by increasing dural and cortical blood flow.,-20.625,0.2,Disease
"Atrial fibrillation with alternating sinus rhythm was found to increase dural and cortical blood flow, potentially exacerbating spasticity in patients with spinal cord ischemia.",-19.0,0.2,Disease
Interventions with the anti‑inflammatory drug colchicine have been shown to reduce the severity of acute renal artery thrombosis and prevent the development of purpuric lesions in patients with underlying spasticity.,-31.0,0.2,Disease
"Interferon‑β therapy for multiple sclerosis can precipitate acute renal artery thrombosis, leading to flank pain and subsequent spasticity of the lower limbs.",-18.75,0.2,Disease
"Intermittent ventricular ectopy in patients with acute renal artery thrombosis can precipitate spinal cord ischemia, thereby exacerbating spasticity and producing purpuric lesions.",-22.125,0.2,Disease
"Amoxicillin therapy for acute renal artery thrombosis can paradoxically induce purpuric lesions, prompting clinicians to monitor for potential spinal cord ischemia.",-21.25,0.2,Disease
"Amiloride administration in patients with acute renal artery thrombosis has been shown to reduce flank pain and improve renal perfusion, thereby mitigating the risk of subsequent spinal cord ischemia.",-25.625,0.2,Disease
"Amelioration of acute renal artery thrombosis by intravenous heparin was accompanied by a transient increase in dural and cortical blood flow, yet the patient developed purpuric lesions and spasticity as a consequence of heparin-induced thrombocytopenia.",-27.375,0.2,Disease
"In patients with acute renal artery thrombosis, the administration of the anticoagulant rivaroxaban has been shown to reduce the risk of subsequent spinal cord ischemia while also mitigating the development of purpuric lesions associated with severe flank pain.",-20.375,0.2,Disease
"In a patient with acute renal artery thrombosis, the administration of aspirin reduced the risk of subsequent purpuric lesions while also mitigating the spasticity associated with spinal cord ischemia.",-22.125,0.2,Disease
"In the patient with acute renal artery thrombosis, the administration of the anticoagulant rivaroxaban markedly reduced the risk of further ischemic events while also mitigating the associated flank pain and potential progression to chronic kidney disease.",-25.5,0.2,Disease
"Elevated dural and cortical blood flow during acute renal artery thrombosis can precipitate spinal cord ischemia, leading to spasticity and purpuric lesions that may mimic depression symptoms.",-17.375,0.2,Disease
Elevating dural and cortical blood flow with nimodipine mitigated spinal cord ischemia in a patient presenting with acute renal artery thrombosis and purpuric lesions.,-20.125,0.2,Disease
"Elevative therapy with nimodipine mitigated spinal cord ischemia in a patient with acute renal artery thrombosis, thereby reducing the risk of purpuric lesions and subsequent spasticity.",-28.75,0.2,Disease
The sudden onset of cerebral hemorrhage in a patient with essential hypertension precipitated rapid neurologic deterioration and prompted the use of nimodipine to mitigate hippocampal damage.,-17.375,0.2,Disease
"The patient’s sudden neurologic deterioration and deafness were attributed to a cerebral hemorrhage, prompting urgent administration of nimodipine to mitigate hippocampal damage.",-16.75,0.2,Disease
The reported case of a patient with HUS who developed sudden neurologic deterioration and deafness after an episode of acute renal artery thrombosis highlights the need for early recognition of cerebral hemorrhage and hippocampal damage in this population.,-30.375,0.2,Disease
"A rapid decline in visual field and progressive deafness were observed in a patient with HUS, suggesting that the hemolytic uremic syndrome may trigger both neurologic deterioration and sensory deficits.",-26.25,0.2,Disease
"A patient with HUS experienced neurologic deterioration and deafness after an acute renal artery thrombosis, prompting the use of cisplatin to treat an underlying adenocarcinoma while monitoring for potential cerebral hemorrhage.",-20.875,0.2,Disease
"A nasopharyngeal adenocarcinoma patient with essential hypertension experienced sudden cerebral hemorrhage after a transient episode of acute renal artery thrombosis, leading to rapid neurologic deterioration and progressive deafness.",-25.25,0.2,Disease
"Cerebral hemorrhage in patients with essential hypertension can precipitate hippocampal damage, leading to neurologic deterioration and progressive deafness.",-14.8125,0.2,Disease
Cilostazol administration in patients with acute renal artery thrombosis has been shown to reduce cerebral hemorrhage risk while mitigating the potential for essential hypertension exacerbation.,-22.375,0.2,Disease
"Crisplatin administration in patients with nasopharyngeal adenocarcinoma can precipitate acute renal artery thrombosis, leading to neurologic deterioration and, in severe cases, cerebral hemorrhage.",-22.375,0.2,Disease
"Severe acute renal artery thrombosis in a patient with essential hypertension precipitated hippocampal damage and subsequent neurologic deterioration, prompting consideration of anticoagulant therapy to mitigate further cerebral hemorrhage risk.",-19.5,0.2,Disease
"Seizure‑induced hippocampal damage in patients with acute renal artery thrombosis was mitigated by early administration of the antiepileptic drug levetiracetam, yet the therapy was complicated by transient visual field deterioration.",-29.75,0.2,Disease
"Severely ill patients with HUS frequently develop neurologic deterioration and deafness, while the use of cisplatin for adenocarcinoma treatment can exacerbate visual field deterioration and cause cerebral hemorrhage.",-36.25,0.2,Disease
"In patients with HUS, the rapid onset of neurologic deterioration and deafness is often accompanied by a progressive deterioration in visual field, complicating the clinical management of this severe complication.",-23.75,0.2,Disease
"In a patient with HUS, the rapid onset of neurologic deterioration and deafness was attributed to cerebral hemorrhage secondary to acute renal artery thrombosis, prompting urgent anticoagulation therapy.",-21.125,0.2,Disease
"In this case, the patient’s sudden neurologic deterioration and deafness were attributed to a cerebral hemorrhage, prompting urgent administration of nimodipine to mitigate hippocampal damage and preserve visual field integrity.",-26.375,0.2,Disease
"Early‑stage adenocarcinoma of the lung was found to accelerate neurologic deterioration in a patient with essential hypertension, prompting the initiation of cisplatin therapy to counteract the progressive visual field loss.",-24.875,0.2,Disease
"Early onset HUS in the patient was associated with neurologic deterioration, deafness, and a progressive deterioration in visual field, while nasal hypoplasia and adenocarcinoma were ruled out as causes of the cerebral hemorrhage.",-28.125,0.2,Disease
"Early-stage adenocarcinoma of the nasal cavity can trigger neurologic deterioration and deafness, while the associated cerebral hemorrhage may worsen visual field loss and cause acute renal artery thrombosis.",-30.0,0.2,Disease
"Intravenous administration of cisplatin in a patient with nasopharyngeal adenocarcinoma precipitated acute renal artery thrombosis, leading to rapid neurologic deterioration and subsequent deafness.",-17.0,0.2,Disease
"Intrathecal administration of cisplatin in patients with nasopharyngeal adenocarcinoma can precipitate acute renal artery thrombosis, leading to neurologic deterioration and irreversible deafness.",-21.25,0.2,Disease
"Intranasal administration of cisplatin in patients with nasopharyngeal adenocarcinoma exacerbated their essential hypertension, leading to acute renal artery thrombosis and subsequent neurologic deterioration.",-23.5,0.2,Disease
"HIV‑associated neurocognitive disorder can precipitate rapid neurologic deterioration, and in some patients the disease progression is accompanied by deafness and progressive deterioration in visual field, especially when untreated hypertension and acute renal artery thrombosis coexist.",-36.75,0.2,Disease
"Hepatic encephalopathy in patients with acute renal artery thrombosis can be exacerbated by the use of cisplatin, which induces nephrotoxicity and worsens neurologic deterioration.",-18.125,0.2,Disease
"Hemicranial hypertension exacerbated the patient’s cerebral hemorrhage, prompting the use of nimodipine to mitigate hippocampal damage and prevent further neurologic deterioration.",-27.5,0.2,Disease
"Clinical trials of the novel tyrosine‑kinase inhibitor gefitinib have shown that it can halt the progression of adenocarcinoma in patients with EGFR mutations while simultaneously reducing the incidence of cerebral hemorrhage, a common complication in those with essential hypertension.",-39.5,0.2,Disease
"Clinical administration of cisplatin in patients with nasopharyngeal adenocarcinoma frequently precipitates acute renal artery thrombosis, leading to rapid neurologic deterioration and, in some cases, irreversible deafness.",-24.375,0.2,Disease
"Clinical monitoring of a patient with hemolytic uremic syndrome revealed that the sudden onset of neurologic deterioration and deafness was accompanied by a progressive deterioration in visual field, suggesting a possible link between the renal pathology and central nervous system involvement.",-37.25,0.2,Disease
"Furosemide therapy for essential hypertension was found to aggravate neurologic deterioration in a patient with acute renal artery thrombosis, leading to progressive deafness and deterioration in visual field.",-27.125,0.2,Disease
"Fifth‑generation antiepileptic drug levetiracetam, while effective for seizure control, has been reported to induce acute renal artery thrombosis in patients with pre‑existing essential hypertension, thereby precipitating neurologic deterioration and visual field loss.",-35.25,0.2,Disease
Focal cerebral hemorrhage in a patient with essential hypertension precipitated rapid neurologic deterioration and prompted the initiation of high‑dose aspirin therapy to mitigate secondary ischemic injury.,-24.375,0.2,Disease
"Acute renal artery thrombosis in a patient with essential hypertension precipitated cerebral hemorrhage and subsequent hippocampal damage, leading to progressive neurologic deterioration and deafness.",-13.0,0.2,Disease
Acetazolamide treatment of acute renal artery thrombosis in a patient with essential hypertension reduced cerebral hemorrhage risk but induced transient deafness and mild hippocampal damage.,-22.625,0.2,Disease
"Acne vulgaris patients receiving isotretinoin frequently develop transient hyperlipidemia, which can exacerbate pre‑existing essential hypertension and increase the risk of cerebral hemorrhage.",-30.875,0.2,Disease
"Treated with cisplatin, the patient’s acute renal artery thrombosis resolved, yet the drug’s nephrotoxic effect precipitated a sudden decline in visual field and mild neurologic deterioration.",-26.75,0.2,Disease
"Tremor and progressive deafness in a patient with hemolytic uremic syndrome were alleviated after administration of the anti‑inflammatory drug dexamethasone, which also reduced the risk of subsequent cerebral hemorrhage.",-31.125,0.2,Disease
"Toxicity of cisplatin induces acute renal artery thrombosis, leading to neurologic deterioration and hippocampal damage in patients with essential hypertension.",-18.875,0.2,Disease
The combination of cisplatin and dexamethasone was found to reduce the incidence of acute cardiovascular failure in patients with malignant tumor‑related superior vena cava syndrome.,-21.125,0.2,Disease
"The intravenous infusion of cisplatin exacerbated the patient’s pre‑existing asthma, triggering severe respiratory dysfunction that required immediate bronchodilator therapy.",-17.0,0.2,Disease
"The administration of cisplatin to a patient with a malignant tumor induced acute cardiovascular failure, manifesting as severe palpitations and respiratory dysfunction.",-12.9375,0.2,Disease
"In patients with superior vena cava syndrome secondary to a malignant tumor, the administration of cisplatin exacerbates respiratory dysfunction and induces severe constipation.",-13.0,0.2,Disease
"In a case of superior vena cava syndrome secondary to a malignant tumor, the patient’s acute cardiovascular failure was ameliorated by administering high‑dose cisplatin, which also induced transient constipation as a known adverse effect.",-23.625,0.2,Disease
"In the patient with superior vena cava syndrome, the administration of cisplatin exacerbated respiratory dysfunction and precipitated acute cardiovascular failure.",-14.75,0.2,Disease
Radiotherapy for the malignant tumor of the superior vena cava syndrome was found to alleviate acute cardiovascular failure but induced severe constipation as a side effect.,-21.375,0.2,Disease
"Radiation therapy for a malignant tumor of the superior vena cava can precipitate acute cardiovascular failure, prompting the use of beta‑blockers to mitigate palpitations and respiratory dysfunction.",-19.375,0.2,Disease
"Radiotherapeutic ablation of the malignant tumor in the superior vena cava induced acute cardiovascular failure, prompting the use of propranolol to mitigate the resultant palpitations.",-26.75,0.2,Disease
Imatinib administration markedly reduced tumor burden in patients with malignant tumor while simultaneously alleviating respiratory dysfunction associated with superior vena cava syndrome.,-18.875,0.2,Disease
Immunotherapy with pembrolizumab markedly reduced tumor burden in a patient with metastatic malignant tumor while concurrently alleviating respiratory dysfunction and preventing acute cardiovascular failure.,-20.0,0.2,Disease
"Impaired pulmonary function in patients with asthma exacerbated by chronic exposure to airborne silica dust is mitigated by the administration of the anti-inflammatory drug prednisone, which reduces airway hyperresponsiveness and improves exercise tolerance.",-40.25,0.2,Disease
Administration of the novel tyrosine‑kinase inhibitor erlotinib markedly reduced tumor burden in a patient with metastatic malignant tumor while concurrently alleviating respiratory dysfunction and preventing the onset of acute cardiovascular failure.,-24.375,0.2,Disease
"Administration and subsequent monitoring of cisplatin in a patient with malignant tumor of the lung revealed acute cardiovascular failure and respiratory dysfunction, prompting the use of beta‑blockers to mitigate palpitations and prevent further cardiotoxicity.",-40.75,0.2,Disease
Administration with the novel tyrosine‑kinase inhibitor erlotinib markedly reduced tumor burden in patients with malignant tumor‑associated superior vena cava syndrome while simultaneously alleviating respiratory dysfunction and preventing acute cardiovascular failure.,-39.25,0.2,Disease
"Cisplatin administration in patients with malignant tumor frequently induces acute cardiovascular failure, manifesting as palpitations and respiratory dysfunction.",-14.0,0.2,Disease
"Captopril administration markedly reduced the pulmonary hypertension observed in patients with superior vena cava syndrome, thereby alleviating the associated respiratory dysfunction and preventing acute cardiovascular failure.",-21.5,0.2,Disease
Cilostazol administration alleviated the respiratory dysfunction observed in patients with superior vena cava syndrome while simultaneously reducing the incidence of palpitations associated with acute cardiovascular failure.,-18.0,0.2,Disease
"Acute cardiovascular failure in a patient with malignant tumor was markedly improved after administration of the chemotherapeutic agent cisplatin, which also induced a transient elevation of serum creatinine.",-23.5,0.2,Disease
"Acetazolamide alleviates the respiratory dysfunction observed in patients with superior vena cava syndrome, thereby reducing the risk of acute cardiovascular failure.",-17.625,0.2,Disease
"Acquired superior vena cava syndrome in a patient with a malignant tumor was effectively relieved by a combination of cisplatin chemotherapy and radiation therapy, which also reduced the patient’s respiratory dysfunction and palpitations.",-27.75,0.2,Disease
"Pulmonary hypertension secondary to malignant tumor invasion of the superior vena cava can precipitate acute cardiovascular failure, prompting the use of sildenafil to mitigate respiratory dysfunction.",-23.0,0.2,Disease
"Pulled‑back tumor cells in the superior vena cava syndrome were found to secrete interleukin‑6, which exacerbated the patient’s acute cardiovascular failure and triggered a cascade of respiratory dysfunction.",-42.25,0.2,Disease
"Pulmocort, a novel inhaled corticosteroid, significantly reduced asthma‑related airway inflammation and improved lung function in patients with severe asthma, while its systemic absorption was found to be negligible, thereby minimizing the risk of adrenal suppression.",-40.75,0.2,Disease
Early evidence suggests that the novel antineoplastic agent cabozantinib may ameliorate malignant tumor‑induced superior vena cava syndrome while concurrently exacerbating respiratory dysfunction in patients with pre‑existing asthma.,-33.25,0.2,Disease
"Early‑stage malignant tumor patients receiving cisplatin therapy frequently develop acute cardiovascular failure, prompting clinicians to monitor for respiratory dysfunction and palpitations as potential adverse effects.",-24.125,0.2,Disease
"Early oral administration of the novel anti‑angiogenic compound sorafenib markedly reduced tumor‑induced superior vena cava syndrome in patients with malignant lymphoma, while simultaneously alleviating associated respiratory dysfunction and palpitations.",-35.5,0.2,Disease
"Clopidogrel administration in patients with acute cardiovascular failure and superior vena cava syndrome markedly reduced platelet aggregation, thereby mitigating the risk of thrombotic complications while preserving pulmonary function.",-30.0,0.2,Disease
"Clarithromycin administration in a patient with severe asthma exacerbation reduced airway inflammation and improved pulmonary function, but the drug’s interaction with the patient’s underlying chronic obstructive pulmonary disease led to a transient episode of acute cardiovascular failure.",-38.5,0.2,Disease
"Clonal expansion of malignant tumor cells in the superior vena cava syndrome can precipitate acute cardiovascular failure, while concurrent administration of cisplatin may exacerbate respiratory dysfunction.",-28.875,0.2,Disease
"A high‑dose infusion of cisplatin was found to exacerbate the respiratory dysfunction in a patient with malignant tumor‑associated superior vena cava syndrome, prompting the switch to a lower‑toxic alternative chemotherapy regimen.",-28.875,0.2,Disease
"A single‑dose infusion of cisplatin markedly reduced tumor burden in a patient with malignant tumor‑associated superior vena cava syndrome, but induced acute cardiovascular failure and respiratory dysfunction that required immediate supportive care.",-29.5,0.2,Disease
"A novel oral formulation of the anti‑inflammatory drug colchicine was shown to reduce the severity of acute cardiovascular failure in patients with malignant tumor‑related pulmonary embolism, thereby improving respiratory dysfunction and decreasing palpitations.",-32.75,0.2,Disease
"Intravenous administration of cisplatin in patients with malignant tumor frequently precipitates acute cardiovascular failure, thereby exacerbating respiratory dysfunction and palpitations.",-17.375,0.2,Disease
"Intrathecal administration of dexamethasone markedly reduced the inflammatory cytokine profile in patients with malignant tumor–associated superior vena cava syndrome, thereby alleviating respiratory dysfunction and preventing acute cardiovascular failure.",-23.375,0.2,Disease
"Intrahospital administration of the chemotherapeutic agent cisplatin in a patient with a malignant tumor of the lung precipitated acute cardiovascular failure, manifesting as severe palpitations and respiratory dysfunction that required immediate intervention.",-34.0,0.2,Disease
Radiation therapy for glioblastoma multiforme can precipitate acute renal insufficiency by inducing systemic cytokine release that damages the glomerular filtration barrier.,-15.9375,0.2,Disease
Radiotherapy with temozolomide was shown to reduce tumor burden in patients with glioblastoma multiforme while simultaneously exacerbating acute renal insufficiency due to cisplatin‑induced nephrotoxicity.,-17.125,0.2,Disease
Radiotherapists observed that the addition of temozolomide to standard radiotherapy markedly reduced tumor recurrence in patients with glioblastoma multiforme while simultaneously exacerbating acute renal insufficiency in a subset of those with pre‑existing renal impairment.,-31.5,0.2,Disease
"Reactivation of latent Epstein–Barr virus in patients with plasmacytoma was found to accelerate the progression of acute renal insufficiency, suggesting that antiviral therapy with ganciclovir may mitigate the associated renal damage.",-29.375,0.2,Disease
"Reversal of cisplatin‑induced acute renal insufficiency was achieved by administering the antioxidant N‑acetylcysteine, which also mitigated the drug’s nephrotoxic effect on the glomeruli.",-22.375,0.2,Disease
"Rechallenging the patient with cisplatin after a transient episode of acute renal insufficiency proved to be a viable strategy for controlling the progression of the underlying head and neck carcinoma, yet the therapy was complicated by the emergence of vocal nerve palsies.",-39.25,0.2,Disease
"In patients with transplant glomerulopathy, tacrolimus therapy has been shown to reduce acute renal insufficiency while paradoxically increasing the risk of vocal nerve palsies.",-12.375,0.2,Disease
"In a phase‑II trial, temozolomide combined with bevacizumab markedly reduced tumor burden in patients with recurrent glioblastoma multiforme while sparing the cranial nerves, thereby preventing new vocal nerve palsies.",-19.375,0.2,Disease
"In glioblastoma multiforme patients, the chemotherapeutic agent temozolomide can induce acute renal insufficiency, complicating the management of the primary brain tumor.",-17.125,0.2,Disease
"High-dose temozolomide combined with bevacizumab was shown to reduce tumor burden in patients with recurrent glioblastoma multiforme while sparing the cranial nerves, thereby preventing new vocal nerve palsies.",-22.125,0.2,Disease
"High‐dose cisplatin therapy for glioblastoma multiforme can precipitate acute renal insufficiency, prompting clinicians to monitor serum creatinine and consider nephroprotective agents such as amifostine.",-22.75,0.2,Disease
"High‑dose cisplatin therapy for glioblastoma multiforme can precipitate acute renal insufficiency, prompting clinicians to monitor serum creatinine and consider diuretic support to mitigate nephrotoxicity.",-19.375,0.2,Disease
"Patients with glioblastoma multiforme who receive temozolomide often develop acute renal insufficiency, a complication that may be mitigated by early initiation of hemodialysis.",-18.25,0.2,Disease
"Patients receiving cisplatin for head and neck carcinoma often develop acute renal insufficiency, which can be mitigated by pre‑emptive hydration and the use of the antioxidant N‑acetylcysteine.",-19.125,0.2,Disease
"Patients undergoing radiotherapy for glioblastoma multiforme often develop acute renal insufficiency, a complication that can be mitigated by concurrent administration of the renoprotective agent amifostine.",-20.0,0.2,Disease
"Cognitive deficits in patients with glioblastoma multiforme were markedly attenuated by adjunctive therapy with the chemotherapeutic agent temozolomide, which also reduced tumor-associated microglial activation.",-22.875,0.2,Disease
"Cranial irradiation for glioblastoma multiforme can induce acute renal insufficiency, a complication that may be mitigated by early administration of the renoprotective agent amifostine.",-24.75,0.2,Disease
"Carmustine administration markedly reduced tumor burden in patients with glioblastoma multiforme while simultaneously precipitating acute renal insufficiency, illustrating a classic example of therapeutic efficacy coupled with nephrotoxic adverse effects.",-26.625,0.2,Disease
"Tretinoin therapy for a patient with head and neck carcinoma induced acute renal insufficiency, prompting the use of a low‑dose cisplatin regimen to mitigate nephrotoxicity while maintaining antitumor efficacy.",-30.125,0.2,Disease
"Tremendous improvement in survival was observed when temozolomide was combined with bevacizumab in patients with recurrent glioblastoma multiforme, yet the combination also precipitated severe hypertension and proteinuria, highlighting the delicate balance between therapeutic efficacy and adverse renal effects.",-29.625,0.2,Disease
"Treated glioblastoma multiforme with temozolomide, the patient developed acute renal insufficiency as a dose‑dependent nephrotoxic adverse effect.",-16.875,0.2,Disease
"The single‑dose administration of temozolomide markedly reduced tumor burden in patients with glioblastoma multiforme while concurrently exacerbating acute renal insufficiency, underscoring the need for vigilant renal monitoring during chemotherapeutic regimens.",-24.375,0.2,Disease
The chemotherapy regimen containing temozolomide and bevacizumab markedly reduced tumor burden in a patient with glioblastoma multiforme but induced acute renal insufficiency as a dose‑dependent adverse effect.,-17.5,0.2,Disease
"The combination of temozolomide with bevacizumab markedly reduced tumor burden in patients with recurrent glioblastoma multiforme while simultaneously exacerbating hypertension and proteinuria, thereby illustrating a dual therapeutic–adverse effect profile.",-24.375,0.2,Disease
"Transplant glomerulopathy, a frequent complication of renal transplantation, can be exacerbated by the use of tacrolimus, which, while effective at preventing rejection, may induce acute renal insufficiency and worsen patient outcomes.",-32.75,0.2,Disease
Transplants of renal carcinomas treated with bevacizumab have been shown to reduce acute renal insufficiency but may trigger vocal nerve palsies as a rare adverse effect.,-31.875,0.2,Disease
"Transplanted kidneys in patients with acute renal insufficiency often develop transplant glomerulopathy, a complication that can be mitigated by the addition of tacrolimus, which inhibits calcineurin and reduces the risk of chronic rejection.",-32.0,0.2,Disease
Treatment of glioblastoma multiforme with temozolomide concurrently reduced the incidence of chemotherapy‑induced acute renal insufficiency in patients who had previously experienced transplant glomerulopathy.,-20.5,0.2,Disease
Treatment with bevacizumab reduced tumor vascularity in patients with glioblastoma multiforme while simultaneously exacerbating acute renal insufficiency due to its anti‑angiogenic effects on the glomerular capillary network.,-22.375,0.2,Disease
Treatment for glioblastoma multiforme with temozolomide has been shown to reduce tumor volume but may induce acute renal insufficiency as a dose‑dependent adverse effect.,-24.0,0.2,Disease
"Pre‑operative cisplatin administration for head and neck carcinoma patients with acute renal insufficiency was found to exacerbate renal dysfunction, prompting the use of a nephroprotective agent to mitigate cisplatin‑induced nephrotoxicity.",-29.625,0.2,Disease
Preclinical studies demonstrate that the novel kinase inhibitor erlotinib reduces tumor burden in glioblastoma multiforme while concurrently exacerbating acute renal insufficiency in a subset of treated mice.,-24.5,0.2,Disease
Preoperative administration of bevacizumab markedly reduced the risk of postoperative acute renal insufficiency in patients undergoing resection of glioblastoma multiforme.,-16.375,0.2,Disease
"A phase‑II trial demonstrated that the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with glioblastoma multiforme while concurrently exacerbating acute renal insufficiency, underscoring the need for vigilant renal monitoring during targeted therapy.",-24.0,0.2,Disease
"A comprehensive study revealed that temozolomide, when combined with bevacizumab, significantly reduced tumor progression in patients with glioblastoma multiforme while also mitigating the risk of acute renal insufficiency associated with high-dose chemotherapy.",-29.625,0.2,Disease
"A recent phase‑II trial demonstrated that the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with glioblastoma multiforme while simultaneously exacerbating acute renal insufficiency, underscoring the need for vigilant renal monitoring during targeted therapy.",-26.875,0.2,Disease
The monoclonal antibody therapy reduced the thrombocytopenia type II in the patient with dysmyelopoiesis while simultaneously alleviating the neuropathic pain associated with the underlying disease.,-27.875,0.2,Disease
The novel antiepileptic drug levetiracetam was found to reduce seizure frequency in patients with refractory epilepsy while concurrently improving glucose hypometabolism observed in their PET scans.,-22.25,0.2,Disease
"The platinum‑based chemotherapeutic cisplatin, while effective against ovarian carcinoma, frequently induces dose‑dependent thrombocytopenia type II and nephrotoxicity, prompting clinicians to co‑administer amifostine to mitigate platelet loss and renal injury.",-30.25,0.2,Disease
"In patients with thrombocytopenia type II, the administration of the chemotherapeutic agent cisplatin exacerbates platelet dysfunction, leading to severe mucosal bleeding and a heightened risk of intracranial hemorrhage.",-22.5,0.2,Disease
"In the patient with thrombocytopenia type II, intravenous methylprednisolone was found to reduce platelet destruction but also induced transient glucose hypometabolism, complicating the management of her underlying dysmyelopoiesis.",-28.75,0.2,Disease
"In HIV‑positive patients with thrombocytopenia type II, ritonavir therapy can exacerbate platelet loss while simultaneously improving viral suppression.",-29.25,0.2,Disease
Patients with thrombocytopenia type II who develop prolonged Q‑T syndrome after receiving cisplatin experience severe neuropathic pain and disordered gastrointestinal motility.,-17.625,0.2,Disease
"Patients receiving cisplatin for metastatic ovarian carcinoma frequently develop thrombocytopenia type II, which can precipitate prolonged Q‑T syndrome and increase the risk of life‑threatening arrhythmias.",-17.625,0.2,Disease
"Patients treated with cisplatin for ovarian carcinoma frequently develop thrombocytopenia type II, which can exacerbate dysmyelopoiesis and increase the risk of prolonged Q‑T syndrome.",-19.0,0.2,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma frequently induces thrombocytopenia type II, which in turn exacerbates the risk of prolonged Q‑T syndrome and may precipitate severe neuropathic pain.",-24.875,0.2,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma frequently induces thrombocytopenia type II, which in turn exacerbates the risk of prolonged Q‑T syndrome and subsequent arrhythmogenic events.",-23.75,0.2,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma frequently induces thrombocytopenia type II, which can exacerbate dysmyelopoiesis and precipitate prolonged Q‑T syndrome in patients with pre‑existing impaired glucose tolerance.",-24.375,0.2,Disease
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces thrombocytopenia type II, which can exacerbate dysmyelopoiesis and worsen neuropathic pain.",-19.125,0.2,Disease
"Clozapine administration in patients with refractory schizophrenia can precipitate agranulocytosis, a severe form of thrombocytopenia that may lead to life‑threatening bleeding complications.",-19.125,0.2,Disease
"Ceftriaxone administration in patients with thrombocytopenia type II can precipitate severe neutropenic sepsis, necessitating immediate discontinuation and supportive care.",-25.0,0.2,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces thrombocytopenia type II, which can exacerbate dysmyelopoiesis and lead to prolonged Q‑T syndrome.",-19.125,0.2,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic lymphoma frequently induces severe neuropathic pain and, in some cases, prolonged Q‑T syndrome, thereby complicating the management of their underlying disease.",-29.75,0.2,Disease
"Intraperitoneal administration of cisplatin in mice induced thrombocytopenia type II accompanied by prolonged Q‑T syndrome, suggesting a cardiotoxic side effect of this chemotherapeutic agent.",-25.0,0.2,Disease
Clopidogrel administration in patients with thrombocytopenia type II can exacerbate bleeding risk while simultaneously ameliorating ischemic stroke recurrence.,-19.75,0.2,Disease
"Cladribine treatment of chronic lymphocytic leukemia can induce thrombocytopenia type II, leading to prolonged Q‑T syndrome and increased risk of hemorrhagic complications.",-25.375,0.2,Disease
"Clarithromycin treatment of a patient with chronic sinusitis induced a severe rash and thrombocytopenia type II, prompting discontinuation of the drug and initiation of a steroid taper to mitigate the immune‑mediated platelet destruction.",-31.75,0.2,Disease
Beta‑blocker therapy for prolonged Q‑T syndrome in patients with impaired glucose tolerance has been shown to reduce the incidence of sudden cardiac death while simultaneously alleviating neuropathic pain associated with diabetic autonomic neuropathy.,-23.625,0.2,Disease
"Beta‐blocker therapy with propranolol alleviated the prolonged Q‑T syndrome observed in a patient with impaired glucose tolerance, thereby reducing the risk of sudden cardiac death.",-25.0,0.2,Disease
"Beta blockers such as propranolol can alleviate prolonged Q‑T syndrome in patients with impaired glucose tolerance, but they may also precipitate thrombocytopenia type II, complicating the management of anemia and neuropathic pain.",-35.75,0.2,Disease
An oral dose of clopidogrel was found to reduce the incidence of thrombocytopenia type II in patients with impaired glucose tolerance undergoing coronary artery bypass graft surgery.,-23.375,0.2,Disease
An exploratory study showed that the antidiabetic drug metformin alleviated neuropathic pain in patients with impaired glucose tolerance while simultaneously reducing the incidence of thrombocytopenia type II.,-21.75,0.2,Disease
"Anemia and thrombocytopenia type II were observed in patients receiving cisplatin, and the drug’s inhibition of DNA synthesis was linked to the development of prolonged Q‑T syndrome.",-28.0,0.2,Disease
"Elderly patients with impaired glucose tolerance who receive high‑dose cisplatin for metastatic ovarian cancer frequently develop thrombocytopenia type II, which can exacerbate their pre‑existing neuropathic pain and increase the risk of prolonged Q‑T syndrome.",-29.5,0.2,Disease
Erythropoietin therapy alleviated the anemia associated with chronic kidney disease while simultaneously reducing the incidence of thrombocytopenia type II in patients receiving cisplatin for metastatic ovarian cancer.,-23.125,0.2,Disease
"Etravirine administration in patients with HIV‑associated thrombocytopenia type II has been shown to reduce platelet counts while concurrently improving glucose hypometabolism, thereby highlighting a complex interplay between antiviral therapy and metabolic regulation.",-32.5,0.2,Disease
"Clinical use of the antidiabetic drug metformin has been shown to reduce the incidence of thrombocytopenia type II in patients with impaired glucose tolerance, thereby mitigating the risk of prolonged Q‑T syndrome and associated arrhythmias.",-28.625,0.2,Disease
"Clinical studies have shown that the antiepileptic drug valproate can induce thrombocytopenia type II in patients with impaired glucose tolerance, thereby increasing the risk of prolonged Q‑T syndrome and subsequent arrhythmias.",-25.625,0.2,Disease
"Clinical trials of the novel antineoplastic agent temozolomide have shown that it can induce thrombocytopenia type II in patients with glioblastoma multiforme, thereby exacerbating the risk of intracranial hemorrhage.",-27.875,0.2,Disease
"Hemoglobin‑A1c monitoring revealed that the patient’s impaired glucose tolerance was exacerbated by the chemotherapy drug cisplatin, which also induced thrombocytopenia type II and mild neurosensorial hearing loss.",-25.375,0.2,Disease
"Hemophagocytic lymphohistiocytosis presenting with thrombocytopenia type II and prolonged Q‑T syndrome was effectively managed by high‑dose methylprednisolone combined with cyclosporine, which suppressed the cytokine storm and restored platelet counts.",-29.625,0.2,Disease
"Hemolytic anemia induced by the antimalarial drug chloroquine frequently worsens thrombocytopenia type II in patients with underlying dysmyelopoiesis, thereby increasing the risk of prolonged Q‑T syndrome and subsequent arrhythmias.",-33.5,0.2,Disease
"Administration of high‑dose cisplatin to a patient with endometrial carcinoma precipitated hepatic veno‑occlusive disease, thereby exacerbating the patient’s hypereosinophilia and increasing the risk of cardiac arrest.",-19.875,0.2,Disease
"Administration to a patient with hepatic veno‑occlusive disease of the drug tacrolimus, which is known to cause SIADH, resulted in a sudden increase in serum sodium and precipitated a cardiac arrest.",-45.0,0.2,Disease
"Administration with the novel tyrosine‑kinase inhibitor imatinib markedly reduced leukocytoclastic vasculitis activity in a patient with refractory endometrial carcinoma, yet the therapy was complicated by the onset of SIADH and subsequent hyponatremic cardiac arrest.",-45.75,0.2,Disease
"Cardiac arrest in patients with hepatic veno‑occlusive disease is frequently precipitated by severe hypereosinophilia, which can impair ventricular function and increase the risk of sudden cardiac death.",-13.0,0.2,Disease
"Cardiogenic shock following cardiac arrest was mitigated by early administration of the vasopressor norepinephrine, which also reduced the incidence of hypereosinophilia‑associated leukocytoclastic vasculitis in the post‑resuscitation period.",-25.5,0.2,Disease
"Cardio‑toxic chemotherapy with cisplatin can precipitate hepatic veno‑occlusive disease, leading to impaired ventricular function and increasing the risk of cardiac arrest.",-25.125,0.2,Disease
"Caspofungin administration in patients with hepatic veno‑occlusive disease has been shown to reduce portal hypertension while simultaneously exacerbating hypereosinophilia, thereby increasing the risk of cardiac arrest.",-23.75,0.2,Disease
"Cisplatin administration in patients with endometrial carcinoma can precipitate hepatic veno‑occlusive disease, thereby exacerbating hypereosinophilia and impairing ventricular function.",-12.1875,0.2,Disease
Citrus-derived flavonoids have been shown to ameliorate hepatic veno‑occlusive disease by inhibiting the proliferation of hepatic sinusoidal endothelial cells and reducing the risk of subsequent cardiac arrest.,-26.25,0.2,Disease
"Exposure to the chemotherapeutic agent cisplatin in patients with endometrial carcinoma can precipitate hepatic veno‑occlusive disease, thereby aggravating hypereosinophilia and increasing the risk of cardiac arrest.",-21.875,0.2,Disease
"Exposure of patients with hepatic veno‑occlusive disease to high‑dose cisplatin was associated with a marked increase in the incidence of leukocytoclastic vasculitis, suggesting a drug‑induced hypersensitivity reaction that may precipitate cardiac arrest.",-26.625,0.2,Disease
"Exposure therapy with propranolol reduced the severity of post‑traumatic stress disorder symptoms in patients who had survived a cardiac arrest, thereby improving their ventricular function and decreasing the risk of subsequent cardiac death.",-29.75,0.2,Disease
"Carboplatin administration in patients with endometrial carcinoma can precipitate hepatic veno‑occlusive disease, thereby exacerbating hypereosinophilia and increasing the risk of cardiac arrest.",-18.625,0.2,Disease
"Carfilzomib administration in a patient with endometrial carcinoma was associated with a sudden onset of cardiac arrest, prompting investigation of potential cardiotoxic mechanisms.",-30.875,0.2,Disease
Carvedilol administration in patients with hepatic veno‑occlusive disease has been shown to reduce the incidence of cardiac arrest by improving ventricular function and attenuating the development of SIADH.,-27.125,0.2,Disease
"The administration of high‑dose cisplatin in patients with endometrial carcinoma can precipitate hepatic veno‑occlusive disease, thereby exacerbating hypereosinophilia and increasing the risk of cardiac arrest.",-15.5625,0.2,Disease
"The patient’s sudden cardiac arrest was precipitated by the severe hypereosinophilia associated with her endometrial carcinoma, and the subsequent ventricular dysfunction was exacerbated by the drug-induced hepatic veno‑occlusive disease.",-24.625,0.2,Disease
"The experimental administration of the novel kinase inhibitor NCT-2021 markedly reduced leukocytoclastic vasculitis lesions in a murine model of systemic lupus erythematosus while simultaneously exacerbating hepatic veno‑occlusive disease, thereby illustrating a dual therapeutic–toxic profile.",-39.5,0.2,Disease
"In patients with hepatic veno‑occlusive disease, early administration of defibrotide markedly reduces the incidence of fatal cardiac arrest and improves survival by preventing severe impairment of ventricular function.",-17.75,0.2,Disease
"In a retrospective cohort, patients with hepatic veno‑occlusive disease who received high‑dose cisplatin for testicular carcinoma exhibited a markedly increased risk of cardiac arrest, suggesting a synergistic cardiotoxic interaction between the drug and the underlying liver pathology.",-26.25,0.2,Disease
"In cardiac arrest patients receiving high‑dose cisplatin, the risk of hepatic veno‑occlusive disease is markedly increased, necessitating careful monitoring of liver enzymes and early intervention with defibrotide.",-25.125,0.2,Disease
"Elderly patients with cardiac arrest who receive high‑dose cisplatin for endometrial carcinoma often develop hypereosinophilia, which can precipitate leukocytoclastic vasculitis and further impair ventricular function.",-22.75,0.2,Disease
"Echocardiographic evaluation revealed that the patient’s impaired ventricular function, likely secondary to leukocytoclastic vasculitis, predisposed him to sudden cardiac arrest during the perioperative period.",-23.125,0.2,Disease
Esterified aspirin derivatives have been shown to reduce the incidence of cardiac arrest in patients with hypereosinophilia‑associated coronary vasospasm.,-32.25,0.2,Disease
"A patient with hepatic veno‑occlusive disease developed severe hypereosinophilia that precipitated cardiac arrest, prompting urgent administration of high‑dose methylprednisolone to mitigate the leukocytoclastic vasculitis and prevent further ventricular dysfunction.",-23.75,0.2,Disease
A recent cohort study demonstrated that early administration of dexamethasone markedly reduced the incidence of hepatic veno‑occlusive disease in patients undergoing high‑dose busulfan conditioning for allogeneic hematopoietic stem‑cell transplantation.,-18.125,0.2,Disease
"A post‑operative patient with hepatic veno‑occlusive disease developed severe SIADH, prompting aggressive fluid restriction and the initiation of demeclocycline to mitigate the risk of cardiac arrest.",-21.25,0.2,Disease
"Administering high‑dose cisplatin to a patient with endometrial carcinoma can precipitate hepatic veno‑occlusive disease, thereby worsening impairment of ventricular function and increasing the risk of cardiac arrest.",-19.25,0.2,Disease
"Administra­tion of the novel tyrosine‑kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic endometrial carcinoma while concurrently exacerbating hepatic veno‑occlusive disease, necessitating vigilant monitoring of liver function tests.",-41.0,0.2,Disease
"Administation of high‑dose cisplatin in patients with endometrial carcinoma can precipitate hepatic veno‑occlusive disease, thereby aggravating hypereosinophilia and increasing the risk of cardiac arrest.",-29.5,0.2,Disease
"Acute cardiac arrest in patients with hepatic veno‑occlusive disease is frequently precipitated by severe hypereosinophilia, which can impair ventricular function and increase the risk of sudden cardiac death.",-19.25,0.2,Disease
"Acquired hepatic veno‑occlusive disease following high‑dose busulfan conditioning markedly impaired hepatic clearance of cisplatin, precipitating severe nephrotoxicity and increasing the risk of cardiac arrest in the patient.",-32.0,0.2,Disease
"Acetazolamide administration in a patient with hepatic veno‑occlusive disease exacerbated SIADH, leading to hyponatremia and subsequent cardiac arrest.",-22.25,0.2,Disease
"Post‑operative cardiac arrest in a patient with hepatic veno‑occlusive disease was successfully resuscitated after administration of high‑dose epinephrine, yet the subsequent impairment of ventricular function persisted, prompting consideration of a therapeutic trial of carvedilol.",-32.25,0.2,Disease
"Post‐operative cardiac arrest in a patient with hepatic veno‑occlusive disease was successfully reversed by high‑dose intravenous methylprednisolone, which also mitigated the associated leukocytoclastic vasculitis and prevented further impairment of ventricular function.",-28.125,0.2,Disease
"Post–transplant hepatic veno‑occlusive disease was markedly attenuated by early administration of the nitric‑oxide donor molsidomine, which also reduced the incidence of severe hypereosinophilia and subsequent cardiac arrest in the cohort.",-35.25,0.2,Disease
"In a patient with nonalcoholic fatty liver disease, the administration of the anti‑inflammatory drug colchicine unexpectedly exacerbated hyperosmolar nonketotic coma, illustrating a severe adverse effect of a commonly used chemical on a metabolic disease.",-26.375,0.2,Disease
"In patients with nonalcoholic fatty liver disease, the administration of pioglitazone has been shown to improve insulin sensitivity while concurrently reducing hepatic steatosis, thereby mitigating the progression of diabetic hyperalgesia and associated sleep disturbance.",-22.125,0.2,Disease
"In diabetic hyperalgesia patients, chronic administration of the analgesic drug gabapentin has been shown to reduce pain sensitivity while simultaneously improving renal function, thereby mitigating the risk of capillary leak syndrome that can otherwise exacerbate nonalcoholic fatty liver disease.",-29.75,0.2,Disease
"Hyperosmolar nonketotic coma was rapidly reversed by intravenous insulin therapy, which also alleviated the patient’s diabetic hyperalgesia and prevented further renal function deterioration.",-17.25,0.2,Disease
"Hyperosmolality-induced nonketotic coma was rapidly reversed by intravenous insulin therapy, which also alleviated the patient’s diabetic hyperalgesia and prevented further renal function deterioration.",-24.25,0.2,Disease
"Hyperandrogenic patients with nonalcoholic fatty liver disease experienced a marked improvement in sleep disturbance after receiving a single dose of the chemical agent pioglitazone, which also reduced their capillary leak syndrome and stabilized renal function.",-39.25,0.2,Disease
The combination of metformin and duloxetine alleviated diabetic hyperalgesia while simultaneously reducing the risk of developing nonalcoholic fatty liver disease in patients with type‑2 diabetes.,-20.125,0.2,Disease
"The patient’s diabetic hyperalgesia was markedly alleviated after a single dose of duloxetine, which also reduced the involuntary movements associated with her schizophrenic‑like symptoms.",-18.25,0.2,Disease
"The administration of the novel antipsychotic compound, which selectively antagonizes dopamine D2 receptors, ameliorated the schizophrenic‑like symptoms in patients with diabetic hyperalgesia while concurrently reducing the incidence of involuntary movements and improving sleep disturbance.",-27.75,0.2,Disease
"Long‑term administration of the antipsychotic clozapine in patients with schizophrenia‑like psychosis was found to induce involuntary movements and, in some cases, hyperosmolar nonketotic coma, while concurrently exacerbating renal function and causing capillary leak syndrome.",-29.75,0.2,Disease
"Long-term administration of the antipsychotic clozapine in patients with schizophrenia has been shown to induce a dose‑dependent increase in serum prolactin levels, which in turn can precipitate hyperprolactinemia‑associated gynecomastia and, in some cases, exacerbate pre‑existing diabetic hyperalgesia by impairing peripheral nerve conduction.",-39.25,0.2,Disease
"Long‐term administration of the antipsychotic clozapine in patients with schizophrenia has been associated with the development of nonalcoholic fatty liver disease, which in turn can precipitate hyperosmolar nonketotic coma and further impair renal function.",-28.375,0.2,Disease
Clozapine ameliorated the schizophrenic‑like symptoms but induced a severe capillary leak syndrome that precipitated hyperosmolar nonketotic coma in the patient with underlying nonalcoholic fatty liver disease.,-18.0,0.2,Disease
Cyclic adenosine monophosphate‑stimulated phosphodiesterase inhibition by sildenafil ameliorated diabetic hyperalgesia while concurrently exacerbating nocturnal sleep disturbance in patients with nonalcoholic fatty liver disease.,-24.75,0.2,Disease
"Cognitive deficits in patients with diabetic hyperalgesia were markedly alleviated by the administration of the novel antidiabetic drug metformin, which also reduced the incidence of involuntary movements associated with the disease.",-27.25,0.2,Disease
Oxcarbazepine ameliorated the diabetic hyperalgesia while concurrently reducing the capillary leak syndrome observed in the patient with nonalcoholic fatty liver disease.,-18.5,0.2,Disease
"Oxaliplatin administration in a patient with nonalcoholic fatty liver disease exacerbated hepatic injury and precipitated a hyperosmolar nonketotic coma, illustrating the drug’s hepatotoxic potential in metabolic liver disease.",-27.0,0.2,Disease
Oxytocin administration alleviated the hyperosmolar nonketotic coma in a diabetic patient while simultaneously reducing the severity of capillary leak syndrome and improving renal function.,-22.25,0.2,Disease
"Patients with nonalcoholic fatty liver disease who develop hyperosmolar nonketotic coma often experience severe sleep disturbance, and treatment with insulin and thiamine can rapidly reverse the hyperglycemia and improve hepatic function.",-27.5,0.2,Disease
"Patients receiving high‑dose cisplatin for metastatic ovarian carcinoma frequently develop nephrotoxicity, which can precipitate a rapid decline in renal function and, in severe cases, trigger capillary leak syndrome that exacerbates hyperosmolar nonketotic coma.",-28.375,0.2,Disease
"Patients experiencing diabetic hyperalgesia reported that the addition of duloxetine to their regimen markedly reduced pain while concurrently improving sleep disturbance, suggesting a dual therapeutic benefit for both neuropathic symptoms and circadian rhythm disruption.",-31.375,0.2,Disease
"Clinical observations revealed that the administration of the novel antipsychotic compound, which selectively antagonizes dopamine D2 receptors, ameliorated schizophrenic-like symptoms in patients with diabetic hyperalgesia while concurrently exacerbating capillary leak syndrome, thereby necessitating careful monitoring of renal function and fluid balance.",-37.5,0.2,Disease
"Clinical studies have shown that the administration of the antipsychotic clozapine can precipitate involuntary movements and, in some patients, exacerbate diabetic hyperalgesia, thereby complicating the management of schizophrenia‑like symptoms.",-32.5,0.2,Disease
"Clinical investigators reported that the administration of the novel antipsychotic compound, which selectively antagonizes dopamine D2 receptors, markedly reduced the severity of schizophrenic‑like symptoms in patients with diabetic hyperalgesia while concurrently improving renal function, as evidenced by a significant decrease in serum creatinine and stabilization of glomerular filtration rate.",-44.25,0.2,Disease
"Anticipated renal function significantly deteriorated in patients with nonalcoholic fatty liver disease after prolonged exposure to the chemotherapeutic agent cisplatin, which also exacerbated diabetic hyperalgesia.",-24.875,0.2,Disease
Antiretroviral therapy with tenofovir disoproxil fumarate improved renal function significantly but induced hyperosmolar nonketotic coma in a patient with pre‑existing nonalcoholic fatty liver disease.,-23.25,0.2,Disease
"Antipsychotic clozapine ameliorated the schizophrenic‑like symptoms but precipitated a severe capillary leak syndrome, which in turn exacerbated the patient’s nonalcoholic fatty liver disease and worsened renal function.",-23.375,0.2,Disease
A single‑dose infusion of the novel antipsychotic compound N‑(2‑pyridyl)-3‑(4‑fluorophenyl)‑2‑(piperidin‑1‑yl)‑1‑(4‑chlorophenyl)‑1‑H‑pyrrol‑3‑one was found to alleviate schizophrenic‑like symptoms in a patient with diabetic hyperalgesia while simultaneously reducing the risk of capillary leak syndrome and preserving renal function.,-66.0,0.2,Disease
"A recent cohort study showed that patients with nonalcoholic fatty liver disease who received a daily dose of ursodeoxycholic acid experienced a significant reduction in hepatic steatosis and a concomitant improvement in insulin sensitivity, thereby mitigating the progression of diabetic hyperalgesia.",-25.625,0.2,Disease
"A randomized trial showed that the novel antipsychotic compound, which selectively blocks dopamine D2 receptors, reduced schizophrenic-like symptoms in patients with diabetic hyperalgesia while also improving renal function and decreasing capillary leak syndrome.",-34.75,0.2,Disease
"Chemotherapy with cisplatin exacerbated the patient’s nonalcoholic fatty liver disease, leading to a marked decline in renal function and the emergence of sleep disturbance.",-21.375,0.2,Disease
"Chemotherapeutic cisplatin exacerbated the patient’s pre‑existing nonalcoholic fatty liver disease, leading to a marked decline in hepatic function and worsening of hyperosmolar nonketotic coma.",-27.75,0.2,Disease
"Chemoradiation with cisplatin exacerbated the patient’s diabetic hyperalgesia, prompting a switch to metformin to mitigate the neuropathic pain.",-25.25,0.2,Disease
Metformin alleviated diabetic hyperalgesia while simultaneously reducing the risk of developing nonalcoholic fatty liver disease in patients with type‑2 diabetes.,-18.25,0.2,Disease
"Metoclopramide alleviated the diabetic hyperalgesia in a patient whose renal function significantly deteriorated, but the drug also induced involuntary movements resembling a schizophrenic‑like syndrome.",-23.125,0.2,Disease
"Metronidazole treatment of a patient with nonalcoholic fatty liver disease was complicated by a severe episode of hyperosmolar nonketotic coma, prompting urgent insulin therapy to restore glycemic control.",-31.875,0.2,Disease
Infliximab administration in patients with primary systemic amyloidosis has been shown to halt the progression of hepatocellular necrosis while simultaneously reducing the severity of leg and back pain associated with the disease.,-24.125,0.2,Disease
Inflammatory cytokine blockade with tocilizumab ameliorated hepatocellular necrosis in patients with drug‑induced liver injury while concurrently slowing the degeneration of dopaminergic neurons in Parkinson’s disease.,-22.375,0.2,Disease
"Influenza‑induced cytokine storm exacerbated the hepatocellular necrosis observed in patients with drug‑induced liver injury, prompting the use of high‑dose N‑acetylcysteine as a rescue therapy.",-27.125,0.2,Disease
"Cognitive decline in Parkinson’s Disease patients receiving long‑term levodopa therapy is exacerbated by drug‑induced liver injury, which accelerates the degeneration of dopaminergic neurons.",-15.625,0.2,Disease
"Citalopram administration in patients with Parkinson's Disease can exacerbate drug‑induced liver injury, as evidenced by hepatocellular necrosis and a marked loss of appetite.",-20.0,0.2,Disease
"Cisplatin administration in patients with Parkinson's Disease can accelerate degeneration of dopaminergic neurons, exacerbating motor decline and increasing the risk of drug‑induced liver injury.",-16.625,0.2,Disease
"Heparin-induced thrombocytopenia, a drug‑induced liver injury that can precipitate hepatocellular necrosis, was observed in a patient with Parkinson’s disease undergoing long‑term anticoagulant therapy.",-21.125,0.2,Disease
"He described how chronic exposure to the chemotherapeutic agent cisplatin can precipitate drug‑induced liver injury, leading to hepatocellular necrosis that mimics the hepatic manifestations of primary systemic amyloidosis.",-33.25,0.2,Disease
"He reported that the patient with Parkinson’s disease experienced worsening of motor symptoms after the initiation of the new drug, which was later found to induce hepatocellular necrosis.",-36.25,0.2,Disease
"Drug‑induced liver injury from chronic valproate therapy exacerbated hepatocellular necrosis in a patient with primary systemic amyloidosis, prompting a switch to levetiracetam to mitigate further hepatic damage.",-17.375,0.2,Disease
"Drug-induced liver injury from chronic valproate use exacerbated hepatocellular necrosis in a patient with primary systemic amyloidosis, prompting a switch to lamotrigine to mitigate further hepatic damage.",-21.375,0.2,Disease
Drug‐induced liver injury from chronic valproate use exacerbated hepatocellular necrosis in a patient with primary systemic amyloidosis.,-14.375,0.2,Disease
"Cardiac magnetic resonance imaging revealed that the hypoplastic left heart syndrome in the infant was accompanied by hepatocellular necrosis, suggesting a drug‑induced liver injury secondary to the high‑dose phenylbutazone used for pain relief.",-30.875,0.2,Disease
"Cardiopulmonary bypass with high-dose catecholamine infusion exacerbated hepatocellular necrosis in a patient with hypoplastic left heart syndrome, prompting the initiation of a low‑dose dopamine antagonist to mitigate drug‑induced liver injury.",-32.25,0.2,Disease
"Cardio‑vessel‑protective effects of carvedilol were demonstrated in a murine model of Parkinson’s Disease, where the drug attenuated dopaminergic neuron degeneration and reduced drug‑induced liver injury.",-35.0,0.2,Disease
"The neuroprotective effect of coenzyme Q10 was demonstrated in a mouse model of Parkinson’s disease, where it reduced degeneration of dopaminergic neurons and mitigated drug‑induced liver injury.",-17.625,0.2,Disease
"The new tyrosine‑kinase inhibitor erlotinib, while effective against non‑small cell lung cancer, has been reported to induce drug‑induced liver injury characterized by hepatocellular necrosis and elevated transaminases.",-24.625,0.2,Disease
"The administration of the novel kinase inhibitor NCT-2021-01 reduced degeneration of dopaminergic neurons in a mouse model of Parkinson’s Disease while simultaneously inducing mild hepatocellular necrosis, a known adverse effect of many anticancer drugs.",-40.0,0.2,Disease
"In Parkinson’s Disease, chronic levodopa therapy can induce drug‑induced liver injury, exacerbating hepatocellular necrosis and contributing to the degeneration of dopaminergic neurons.",-18.875,0.2,Disease
"In patients with Parkinson’s Disease, long‑term levodopa therapy can precipitate drug‑induced liver injury, evidenced by hepatocellular necrosis and elevated transaminases.",-12.5,0.2,Disease
"In a recent cohort study, patients with Parkinson’s Disease who received high‑dose levodopa exhibited a statistically significant increase in hepatocellular necrosis, suggesting a dose‑dependent drug‑induced liver injury that may exacerbate motor symptom progression.",-24.75,0.2,Disease
"Reactivation of latent hepatitis B virus in a patient with primary systemic amyloidosis was precipitated by the administration of high‑dose steroids, leading to acute hepatocellular necrosis and subsequent liver failure.",-31.75,0.2,Disease
Rehabilitation with low‑dose levodopa improves motor function in Parkinson’s Disease patients who previously experienced drug‑induced liver injury due to hepatocellular necrosis.,-25.0,0.2,Disease
Reversal of drug‑induced liver injury by pre‑treatment with the antioxidant N‑acetylcysteine has been demonstrated in patients with hepatocellular necrosis secondary to acetaminophen overdose.,-17.5,0.2,Disease
"Patients with Parkinson’s disease who receive high‑dose levodopa often develop drug‑induced liver injury, as evidenced by hepatocellular necrosis and elevated transaminases.",-16.375,0.2,Disease
"Patients experiencing drug‑induced liver injury from long‑term valproate therapy often develop hepatocellular necrosis, which can exacerbate the muscle wastage seen in advanced Parkinson’s Disease.",-25.0,0.2,Disease
"Patients receiving the novel kinase inhibitor experienced drug‑induced liver injury characterized by hepatocellular necrosis, prompting discontinuation of the therapy to prevent progression to primary systemic amyloidosis.",-22.875,0.2,Disease
"Parkinson’s Disease progression is accelerated by drug‑induced liver injury, which exacerbates dopaminergic neuron degeneration and leads to severe muscle wastage.",-16.25,0.2,Disease
"Parkland’s study showed that the degeneration of dopaminergic neurons in Parkinson’s Disease patients was markedly slowed by chronic administration of the dopamine agonist ropinirole, yet the drug‑induced liver injury manifested as hepatocellular necrosis and loss of appetite required dose adjustment.",-44.0,0.2,Disease
"Parkison’s disease progression is exacerbated by drug‑induced liver injury, which accelerates hepatocellular necrosis and worsens motor symptoms.",-27.375,0.2,Disease
"Pre‑treatment with the antioxidant N‑acetylcysteine mitigated drug‑induced liver injury in patients with Parkinson’s Disease who were receiving high‑dose levodopa, thereby reducing hepatocellular necrosis and preserving liver function.",-19.625,0.2,Disease
Preclinical studies show that the novel compound ropivacaine mitigates Parkinson’s Disease‑associated degeneration of dopaminergic neurons while simultaneously reducing drug‑induced liver injury in mice.,-29.5,0.2,Disease
"Pre-treatment with the antioxidant N‑acetylcysteine markedly reduced drug‑induced liver injury in patients with Parkinson’s disease who were receiving high‑dose levodopa, thereby preventing hepatocellular necrosis and preserving hepatic function.",-23.0,0.2,Disease
A randomized trial showed that the novel inhibitor ropivacaine reduced hepatocellular necrosis in patients with drug‑induced liver injury while also slowing the degeneration of dopaminergic neurons in Parkinson’s disease.,-25.25,0.2,Disease
"A post‑operative patient with hypoplastic left heart syndrome developed drug‑induced liver injury after receiving high‑dose cefazolin, prompting a switch to gentamicin to mitigate hepatocellular necrosis.",-20.25,0.2,Disease
"A clinical trial demonstrated that the novel compound ropivacaine, when administered intravenously, alleviated pain in patients with Parkinson's disease while concurrently reducing the incidence of drug‑induced liver injury.",-29.125,0.2,Disease
"Glucocorticoid therapy for severe asthma exacerbations can precipitate acute glomerulosclerosis, thereby increasing the risk of renal failure in patients with underlying chronic kidney disease.",-23.875,0.2,Disease
"Glomerulosclerosis in patients with chronic kidney disease is exacerbated by the use of high‑dose cisplatin, which induces mesangial dysfunction and worsens renal failure.",-19.75,0.2,Disease
Glutathione supplementation mitigated the glomerulosclerosis induced by chronic cisplatin exposure in a murine model of renal failure.,-20.25,0.2,Disease
"The novel antiviral drug remdesivir markedly reduced mortality in patients with severe respiratory syncytial virus infection, yet it was associated with transient elevations in serum creatinine indicative of glomerulosclerosis.",-20.75,0.2,Disease
"The study demonstrated that inhaled ribavirin markedly reduced the severity of respiratory syncytial virus infection in infants with bronchiolitis, thereby preventing subsequent development of glomerulosclerosis in those who later progressed to chronic kidney disease.",-24.625,0.2,Disease
The administration of the novel antiviral agent ribavirin markedly reduced the severity of respiratory syncytial virus infection in infants while simultaneously mitigating the risk of drug‑induced hemolytic anemia.,-23.5,0.2,Disease
"Administration of the novel antiviral agent remdesivir markedly reduced the severity of respiratory syncytial virus infection in infants, thereby preventing the development of subsequent neurological complications such as brain ischemic lesions and conduction disorders.",-23.75,0.2,Disease
"Administration de rituximab a réduit la progression de la glomerulosclerosis chez un patient atteint de lupus érythémateux systémique, mais a provoqué une infection respiratoire par le virus respiratoire syncytial, illustrant la balance délicate entre bénéfice thérapeutique et risque infectieux.",-43.25,0.2,Disease
"Administration and subsequent monitoring of the antiviral drug ribavirin in a patient with severe respiratory syncytial virus infection revealed a dose‑dependent decline in pulmonary function, while the drug’s known teratogenicity prompted immediate cessation of therapy and initiation of a corticosteroid regimen to mitigate the risk of glomerulosclerosis and mesangial dysfunction.",-60.0,0.2,Disease
"In patients with glomerulosclerosis, the administration of losartan not only lowers blood pressure but also reduces mesangial dysfunction and improves renal filtration, thereby mitigating the progression of chronic kidney disease.",-15.25,0.2,Disease
"In asthma patients, inhaled corticosteroid therapy can reduce airway inflammation but may also increase the risk of opportunistic fungal infections, thereby complicating the clinical management of respiratory syncytial virus infection.",-29.0,0.2,Disease
"In a recent cohort study, inhaled ribavirin was found to reduce mortality in patients with severe respiratory syncytial virus infection, yet it was also associated with transient renal dysfunction and mild glomerulosclerosis in a subset of subjects.",-29.75,0.2,Disease
"Intravenous administration of the antiviral drug ribavirin markedly reduced the severity of respiratory syncytial virus infection in infants, yet it was associated with transient hemolytic anemia and mild hepatic dysfunction.",-24.75,0.2,Disease
Intranasal administration of ribavirin markedly reduced respiratory syncytial virus infection severity in infants while concurrently mitigating the risk of drug‑induced pulmonary fibrosis.,-23.875,0.2,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic lung carcinoma has been shown to exacerbate pre‑existing glomerulosclerosis, thereby increasing the risk of renal failure.",-24.375,0.2,Disease
"Metformin administration ameliorated glomerulosclerosis in diabetic nephropathy patients, yet the drug’s rare association with lactic acidosis underscores the need for vigilant monitoring of renal function.",-26.75,0.2,Disease
Metronidazole administration in patients with severe respiratory syncytial virus infection can precipitate neurological complications such as brain ischemic lesions and conduction disorders.,-22.875,0.2,Disease
"Metabolomic profiling revealed that chronic exposure to the chemotherapeutic agent cisplatin exacerbates glomerulosclerosis in patients with pre‑existing diabetic nephropathy, thereby accelerating the progression of renal failure.",-26.5,0.2,Disease
"A post‑transplant patient with glomerulosclerosis experienced neurological complications after receiving tacrolimus, which was later found to exacerbate mesangial dysfunction and induce ocular dyskinesias.",-22.875,0.2,Disease
"A novel inhaled formulation of the antiviral drug ribavirin has been shown to reduce the severity of respiratory syncytial virus infection in infants, thereby preventing the development of subsequent glomerulosclerosis and mesangial dysfunction associated with chronic lung disease.",-29.25,0.2,Disease
"A pilot study demonstrated that inhaled ribavirin reduced the severity of respiratory syncytial virus infection in infants with bronchiolitis, while concomitant use of high‑dose vitamin C mitigated the drug‑induced oxidative stress that can exacerbate glomerulosclerosis in patients with underlying chronic kidney disease.",-35.0,0.2,Disease
"Treatment with the antiviral drug ribavirin markedly reduced the severity of respiratory syncytial virus infection in infants, yet it was associated with transient hemolytic anemia and a rare incidence of neuro‑cognitive adverse effects.",-29.625,0.2,Disease
Treatment of respiratory syncytial virus infection with ribavirin has been shown to reduce the incidence of severe bronchiolitis and prevent subsequent development of glomerulosclerosis in high‑risk infants.,-18.875,0.2,Disease
"Treatment failure of inhaled corticosteroids in severe asthma was linked to increased expression of the glucocorticoid receptor β isoform, which antagonizes the anti‑inflammatory effects of budesonide and exacerbates airway hyperresponsiveness.",-39.25,0.2,Disease
"Clozapine administration in patients with schizophrenia can precipitate severe neutropenia, a known adverse effect that may lead to opportunistic infections such as respiratory syncytial virus infection.",-21.25,0.2,Disease
"Corticosteroid therapy for respiratory syncytial virus infection can exacerbate glomerulosclerosis, prompting clinicians to consider alternative antivirals to mitigate renal damage.",-20.375,0.2,Disease
"Cisplatin administration in patients with lung carcinoma can aggravate pre‑existing glomerulosclerosis, leading to accelerated renal dysfunction and necessitating dose adjustment to mitigate nephrotoxicity.",-21.125,0.2,Disease
"Paclitaxel administration in patients with metastatic breast cancer can aggravate pre‑existing glomerulosclerosis, leading to accelerated renal dysfunction and necessitating dose adjustment.",-21.75,0.2,Disease
Pacemaker implantation in patients with severe conduction disorder caused by respiratory syncytial virus infection can prevent fatal brain ischemic events.,-30.75,0.2,Disease
"Pacino’s study demonstrated that inhaled ribavirin markedly reduced the incidence of respiratory syncytial virus infection–induced bronchiolitis in infants with cystic fibrosis, thereby preventing subsequent glomerulosclerosis and mesangial dysfunction.",-44.75,0.2,Disease
"Methotrexate treatment for rheumatoid arthritis can aggravate glomerulosclerosis, leading to progressive renal failure in patients with pre‑existing mesangial dysfunction.",-18.0,0.2,Disease
Methoxyflurane administration in patients with acute respiratory syncytial virus infection was found to exacerbate glomerulosclerosis and trigger neurological complications such as brain ischemic lesions and conduction disorders.,-30.75,0.2,Disease
"Methicillin‑resistant *Staphylococcus aureus* infection of the lung triggers a severe inflammatory cascade that can culminate in glomerulosclerosis and neurological complications such as brain ischemic events, while the concomitant use of the antibiotic vancomycin may exacerbate mesangial dysfunction and ocular dyskinesias.",-40.0,0.2,Disease
"Severe respiratory syncytial virus infection in infants can trigger mesangial dysfunction that accelerates glomerulosclerosis, thereby increasing the risk of neurological complications such as brain ischemic events.",-19.5,0.2,Disease
"Severely impaired renal function in patients with glomerulosclerosis was markedly ameliorated by the administration of the novel antifibrotic agent pirfenidone, which also reduced mesangial dysfunction and lowered the risk of subsequent neurological complications.",-35.25,0.2,Disease
"Seventy‑five‑year‑old patients with chronic glomerulosclerosis experienced a marked reduction in proteinuria after a six‑month course of losartan, which also ameliorated mesangial dysfunction and lowered blood pressure.",-32.5,0.2,Disease
"In patients with drug‑induced liver damage, the use of the hepatoprotective agent silymarin has been shown to reduce the severity of tubular lesions while also mitigating the risk of subsequent hyperkinetic behavioral depression.",-22.125,0.2,Disease
"In the patient with drug‑induced liver damage, the administration of ursodeoxycholic acid markedly reduced bilirubin levels and prevented further tubular lesions in the hepatic parenchyma.",-18.75,0.2,Disease
"In a randomized trial, the novel anti‑inflammatory drug montelukast was shown to reduce the incidence of drug‑induced liver damage in patients with chronic obstructive pulmonary disease, while simultaneously improving hypoxic respiratory failure and preventing coronary spasm.",-33.0,0.2,Disease
"The antipsychotic clozapine, while effective for refractory schizophrenia, can induce drug‑induced liver damage that manifests as elevated alanine aminotransferase levels and, in severe cases, fulminant hepatic failure.",-18.875,0.2,Disease
"The drug-induced liver damage observed in patients receiving high‑dose acetaminophen was mitigated by the concurrent administration of N‑acetylcysteine, which replenishes glutathione and prevents the formation of toxic metabolites that cause hepatocellular necrosis.",-22.625,0.2,Disease
"The study demonstrated that chronic administration of the antiepileptic drug valproate induced hepatic steatosis and elevated alanine aminotransferase levels, thereby confirming drug‑induced liver damage as a significant adverse effect in patients with epilepsy.",-24.875,0.2,Disease
"Drug‑induced liver damage in patients with behavioral depression can be mitigated by early administration of ursodeoxycholic acid, which reduces hepatic oxidative stress and prevents progression to cirrhosis.",-16.375,0.2,Disease
"Drug-induced liver damage in patients with hyperkinetic behavior was mitigated by a low‑dose regimen of ursodeoxycholic acid, which reduced bilirubin levels and improved hepatic enzyme profiles.",-20.75,0.2,Disease
"Drug‐induced liver damage from chronic valproate therapy was mitigated by adding N‑acetylcysteine, which reduced oxidative stress and prevented the progression to hepatic fibrosis in patients with drug‑induced liver damage.",-27.5,0.2,Disease
"Valproate therapy for behavioral depression can induce drug‑induced liver damage, presenting as hypoxic hepatic necrosis and tubular lesions that mimic myopathic changes.",-27.375,0.2,Disease
"Valvular heart disease patients receiving high‑dose aspirin therapy exhibited an increased incidence of drug‑induced liver damage, prompting clinicians to monitor hepatic enzymes closely.",-32.5,0.2,Disease
"Valparaíso’s new clinical trial demonstrated that the drug‑induced liver damage observed in patients with hyperkinetic depression was markedly reduced when the treatment was combined with a low‑dose antioxidant, thereby preventing the development of tubular lesions and optic nerve toxicity.",-47.25,0.2,Disease
A pilot study demonstrated that the novel antipsychotic compound aripiprazole ameliorated drug‑induced liver damage in patients with behavioral depression while concurrently reducing the incidence of optic nerve toxicity associated with chronic high‑dose benzodiazepine use.,-31.25,0.2,Disease
"A high‑dose regimen of cisplatin induces tubular lesions and drug‑induced liver damage, exacerbating the patient’s pre‑existing behavioral depression.",-19.875,0.2,Disease
"A patient with drug‑induced liver damage experienced a sudden rise in bilirubin levels after the administration of the chemotherapeutic agent cisplatin, prompting the clinicians to discontinue the drug and initiate supportive therapy to mitigate hepatic toxicity.",-27.625,0.2,Disease
"Repeated exposure to the antipsychotic clozapine in patients with schizophrenia can precipitate drug‑induced liver damage, while the concomitant use of valproate may exacerbate hypoxic hepatic injury and lead to optic nerve toxicity.",-30.75,0.2,Disease
"Repeated administration of the antiepileptic drug valproate in patients with bipolar disorder has been shown to induce drug‑induced liver damage, manifesting as elevated alanine aminotransferase levels and, in severe cases, fulminant hepatic failure.",-23.0,0.2,Disease
"Repeated‑dose cisplatin therapy induced tubular lesions and drug‑induced liver damage in patients with metastatic renal carcinoma, while the concomitant use of dexamethasone mitigated the severity of the myopathic side effects.",-36.0,0.2,Disease
"Cervical spondylosis exacerbated by chronic hypoxic exposure can induce optic nerve toxicity, and the administration of acetazolamide mitigates the associated myopathic symptoms.",-32.25,0.2,Disease
"Cognitive behavioral therapy alleviated the patient’s behavioral depression while the concurrent administration of acetaminophen, a drug that can cause drug‑induced liver damage, was carefully monitored to prevent hepatic toxicity.",-24.5,0.2,Disease
Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces tubular lesions that contribute to drug‑induced liver damage and can precipitate hypoxic episodes in the renal cortex.,-22.0,0.2,Disease
Treatment with the novel kinase inhibitor erlotinib alleviated the hyperkinetic symptoms of the patient’s metastatic lung carcinoma while simultaneously reducing the drug‑induced liver damage that had manifested as elevated alanine aminotransferase levels.,-27.375,0.2,Disease
Treatment of drug‑induced liver damage with ursodeoxycholic acid markedly reduced bilirubin levels and improved hepatic enzyme profiles in patients presenting with hyperkinetic hepatitis.,-17.25,0.2,Disease
"Treatment allocation of the patient with drug‑induced liver damage revealed that the hepatotoxicity was likely caused by the high‑dose cisplatin regimen, which also induced optic nerve toxicity and a mild myopathic reaction.",-46.5,0.2,Disease
"Ibn‑Sina’s study demonstrated that chronic administration of the antiepileptic drug valproate can induce drug‑induced liver damage, leading to hepatic steatosis and, in some cases, hypoxic injury of the optic nerve.",-41.0,0.2,Disease
"Itraconazole administration in patients with chronic liver disease can precipitate drug‑induced liver damage, exacerbating hepatic dysfunction and increasing the risk of hepatic encephalopathy.",-24.875,0.2,Disease
"I examined whether chronic administration of the antipsychotic clozapine could induce drug‑induced liver damage in patients with behavioral depression, and found that elevated alanine aminotransferase levels correlated with the severity of depressive symptoms.",-28.75,0.2,Disease
"Long‑term administration of the antiepileptic valproate has been shown to induce drug‑induced liver damage, manifesting as elevated alanine aminotransferase levels and hepatic steatosis, which may resolve upon drug withdrawal.",-25.875,0.2,Disease
"Long-term administration of the antiepileptic drug valproate has been shown to induce drug‑induced liver damage, which in turn can precipitate hypoxic hepatic injury and exacerbate behavioral depression in susceptible patients.",-25.0,0.2,Disease
"Longitudinal monitoring of patients with drug‑induced liver damage revealed that chronic exposure to the antiepileptic valproate was associated with progressive tubular lesions and a higher incidence of hypoxic hepatitis, underscoring the need for early biochemical surveillance and potential therapeutic adjustment.",-36.25,0.2,Disease
"High‑dose acetaminophen exposure in patients with chronic liver disease can precipitate acute hepatic failure, underscoring the need for careful dose adjustment in this vulnerable population.",-19.125,0.2,Disease
"High-dose acetaminophen can precipitate drug‑induced liver damage in patients with underlying hyperkinetic liver disease, exacerbating hepatic tubular lesions and increasing the risk of hypoxic hepatic failure.",-22.0,0.2,Disease
"High‐dose acetaminophen exposure in patients with chronic hepatitis C can precipitate acute liver failure, underscoring the need for careful monitoring of drug‐induced liver damage.",-22.25,0.2,Disease
"Patients with drug‑induced liver damage from chronic valproate therapy often develop hypoxic hepatic injury, which can exacerbate behavioral depression and lead to optic nerve toxicity.",-21.25,0.2,Disease
"Patients treated with the novel antipsychotic risperidone for hyperkinetic schizophrenia developed drug‑induced liver damage, prompting clinicians to monitor hepatic enzymes and consider dose reduction or alternative therapies.",-27.875,0.2,Disease
"Patients receiving high‑dose cisplatin for metastatic ovarian carcinoma frequently develop drug‑induced liver damage, which can be mitigated by concurrent administration of N‑acetylcysteine to preserve hepatic function.",-20.75,0.2,Disease
"Preliminary data suggest that the novel tyrosine‑kinase inhibitor sunitinib can ameliorate memory impairment in patients with mantle cell lymphoma, although it may also induce transient kidney tubular dysfunction and mild white‑matter abnormalities.",-30.125,0.2,Disease
"Pre‑treatment with the novel kinase inhibitor erlotinib markedly reduced tumor‑induced white‑matter abnormalities in patients with renal carcinomas, yet it was associated with transient memory impairment and mild numbness in the lower extremities.",-28.375,0.2,Disease
"Preclinical studies show that the novel kinase inhibitor sorafenib alleviates memory impairment in a murine model of mantle cell lymphoma while concurrently reducing the incidence of renal carcinomas, yet it induces transient kidney tubular dysfunction and occasional numbness in the extremities.",-34.5,0.2,Disease
The administration of rituximab markedly reduced the tumor burden in a patient with mantle cell lymphoma while simultaneously ameliorating the associated memory impairment and preventing further kidney tubular dysfunction.,-17.875,0.2,Disease
"The chemotherapy regimen for mantle cell lymphoma was found to induce transient memory impairment, likely due to drug‑induced encephalopathy.",-17.125,0.2,Disease
"The use of everolimus in a patient with mantle cell lymphoma induced a reversible encephalopathy that manifested as memory impairment and white‑matter abnormalities, prompting discontinuation of the drug.",-21.375,0.2,Disease
"Intrathecal methotrexate alleviated the white‑matter abnormalities in a patient with mantle cell lymphoma, yet the therapy induced transient memory impairment and mild kidney tubular dysfunction.",-20.25,0.2,Disease
"Intriguingly, the administration of the novel kinase inhibitor erlotinib ameliorated memory impairment in patients with mantle cell lymphoma while concurrently reducing the incidence of renal carcinomas, yet it was associated with transient kidney tubular dysfunction and mild numbness in the extremities.",-34.25,0.2,Disease
"Intravenous rituximab administration in a patient with mantle cell lymphoma markedly reduced tumor burden but precipitated transient memory impairment and mild kidney tubular dysfunction, underscoring the need for vigilant monitoring of neurocognitive and renal parameters during therapy.",-28.75,0.2,Disease
"Treatment of mantle cell lymphoma with rituximab was associated with transient memory impairment and mild numbness, but no evidence of kidney tubular dysfunction or urinary tract cancer was observed.",-18.75,0.2,Disease
"Treatment with the novel kinase inhibitor erlotinib ameliorated the memory impairment and white‑matter abnormalities observed in patients with mantle cell lymphoma, while monitoring for potential renal tubular dysfunction and urinary tract cancer as adverse effects.",-24.125,0.2,Disease
"Treatment for mantle cell lymphoma with rituximab was associated with transient memory impairment and mild kidney tubular dysfunction, but no evidence of urinary tract cancer or macroprolactinoma was observed.",-28.0,0.2,Disease
"Cisplatin administration in patients with renal carcinomas frequently induces kidney tubular dysfunction, which can exacerbate memory impairment and precipitate encephalopathy.",-16.75,0.2,Disease
"Causal links between chronic kidney tubular dysfunction and the development of white‑matter abnormalities were observed in patients with macroprolactinoma, suggesting that the endocrine disorder may exacerbate neurocognitive decline.",-29.375,0.2,Disease
Clozapine ameliorated the memory impairment in a patient with macroprolactinoma while concurrently reducing the risk of renal carcinomas associated with chronic kidney tubular dysfunction.,-17.75,0.2,Disease
"Magnetic resonance imaging revealed white‑matter abnormalities in a patient with mantle cell lymphoma, and the subsequent administration of rituximab alleviated the associated memory impairment.",-19.25,0.2,Disease
Magnetically guided photodynamic therapy with chlorin e6 effectively reduced tumor burden in a patient with renal carcinomas while sparing normal kidney tubular dysfunction and preventing the memory impairment often seen with conventional chemotherapy.,-34.75,0.2,Disease
"Magnesium supplementation alleviates the memory impairment observed in patients with macroprolactinoma, thereby reducing the risk of encephalopathy associated with elevated prolactin levels.",-23.625,0.2,Disease
"Methotrexate therapy for mantle cell lymphoma can induce kidney tubular dysfunction, leading to electrolyte imbalance and subsequent memory impairment.",-15.875,0.2,Disease
Methadone treatment for opioid‑dependent patients with a history of encephalopathy has been shown to reduce the incidence of memory impairment while simultaneously lowering the risk of developing macroprolactinoma‑associated urinary tract cancer.,-34.25,0.2,Disease
Methylnaltrexone alleviates opioid‑induced constipation in patients with mantle cell lymphoma while preserving the antitumor efficacy of rituximab and reducing the risk of memory impairment.,-27.625,0.2,Disease
"Nitric‑oxide synthase inhibition by sildenafil ameliorated memory impairment in patients with mantle cell lymphoma, yet the drug’s vasodilatory effect occasionally induced transient renal tubular dysfunction.",-27.75,0.2,Disease
"Nitrofurantoin, a commonly prescribed antibacterial, can induce acute encephalopathy in patients with underlying kidney tubular dysfunction, thereby exacerbating memory impairment and white‑matter abnormalities.",-26.5,0.2,Disease
"Nitroglycerin administration in patients with macroprolactinoma can precipitate severe headache and, in rare cases, transient encephalopathy, underscoring the need for careful monitoring of neurological status.",-30.0,0.2,Disease
"In patients with mantle cell lymphoma, the combination of rituximab and bortezomib has been shown to reduce tumor burden while also ameliorating associated memory impairment and white‑matter abnormalities.",-17.625,0.2,Disease
"In mantle cell lymphoma patients, the combination of rituximab and bortezomib has been shown to reduce memory impairment while also mitigating the risk of kidney tubular dysfunction associated with disease progression.",-24.875,0.2,Disease
"In a patient with mantle cell lymphoma, the administration of rituximab was associated with transient memory impairment and mild white‑matter abnormalities, suggesting a neurotoxic effect of the drug on the central nervous system.",-24.0,0.2,Disease
"Patients with mantle cell lymphoma who develop memory impairment after rituximab therapy often exhibit white‑matter abnormalities on MRI, suggesting that the drug may exacerbate neurotoxicity in susceptible individuals.",-18.125,0.2,Disease
"Patients treated for mantle cell lymphoma with rituximab experienced transient memory impairment, likely due to drug‑induced white matter abnormalities.",-18.5,0.2,Disease
"Patients diagnosed with mantle cell lymphoma who develop memory impairment after rituximab therapy often exhibit white‑matter abnormalities on MRI, suggesting a neurotoxic effect of the drug.",-22.625,0.2,Disease
"A clinical trial demonstrated that the novel kinase inhibitor erlotinib alleviated memory impairment in patients with mantle cell lymphoma, while also reducing the incidence of renal tubular dysfunction and urinary tract cancer.",-24.0,0.2,Disease
"A case of macroprolactinoma presenting with memory impairment and numbness was successfully treated with cabergoline, which also reduced the risk of renal carcinomas associated with long‑term dopamine agonist therapy.",-23.75,0.2,Disease
A phase‑II trial demonstrated that the novel kinase inhibitor brigatinib markedly reduced tumor burden in patients with mantle cell lymphoma while concurrently ameliorating memory impairment and preventing the development of macroprolactinoma‑associated hyperprolactinemia.,-27.375,0.2,Disease
Immunotherapy with rituximab markedly reduced tumor burden in a patient with mantle cell lymphoma while concurrently ameliorating associated memory impairment and preventing further kidney tubular dysfunction.,-17.125,0.2,Disease
Imatinib markedly reduced tumor burden in a patient with mantle cell lymphoma while simultaneously ameliorating associated memory impairment and preventing the development of drug‑induced encephalopathy.,-19.875,0.2,Disease
Imipramine ameliorated memory impairment in patients with macroprolactinoma while simultaneously reducing the risk of renal carcinomas associated with chronic kidney tubular dysfunction.,-19.125,0.2,Disease
"The liver injury observed in patients receiving high‑dose cisplatin was attributed to cisplatin‑induced marrow toxicity, which in turn exacerbated abdominal pain and hyperalgesia.",-16.25,0.2,Disease
The study demonstrated that tacrolimus ointment alleviated hyperalgesia in patients with transplant glomerulopathy while simultaneously reducing the incidence of liver injury associated with long‑term steroid therapy.,-21.25,0.2,Disease
"The administration of tacrolimus ointment for steroid‑aggravated rosacea was found to reduce inflammatory cytokine expression, thereby alleviating hyperalgesia and improving the patient’s olfactory disorder.",-26.25,0.2,Disease
"In a recent cohort study, patients with transplant glomerulopathy who received tacrolimus exhibited a significant reduction in proteinuria, yet many developed marrow toxicity and hyperalgesia as adverse effects.",-23.75,0.2,Disease
"In transplant glomerulopathy patients, tacrolimus-induced marrow toxicity can exacerbate proximal motor neuropathy, leading to hyperalgesia and abdominal pain that mimic an olfactory disorder.",-16.625,0.2,Disease
"In patients with transplant glomerulopathy, tacrolimus therapy can induce marrow toxicity that manifests as proximal motor neuropathy and hyperalgesia, while also precipitating olfactory disorder and abdominal pain.",-18.125,0.2,Disease
Cimetidine administration alleviated transplant glomerulopathy‑associated hyperalgesia while concurrently reducing the risk of drug‑induced marrow toxicity.,-20.0,0.2,Disease
"Clozapine-induced marrow toxicity exacerbated transplant glomerulopathy in a patient with proximal motor neuropathy, prompting a switch to a lower‑dose regimen that alleviated abdominal pain and hyperalgesia.",-23.0,0.2,Disease
"Corticosteroid therapy for transplant glomerulopathy can induce proximal motor neuropathy, causing hyperalgesia and abdominal pain as a side effect.",-17.875,0.2,Disease
"Methotrexate-induced marrow toxicity was observed in a patient with transplant glomerulopathy, who subsequently developed hyperalgesia and abdominal pain.",-13.75,0.2,Disease
"Methyldopa administration in patients with transplant glomerulopathy was associated with a marked reduction in proteinuria, yet the drug also induced transient marrow toxicity and mild hyperalgesia.",-34.75,0.2,Disease
"Methadone administration in patients with transplant glomerulopathy has been shown to alleviate hyperalgesia while concurrently exacerbating marrow toxicity, thereby necessitating careful monitoring of liver injury markers.",-25.25,0.2,Disease
"Pemetrexed administration in a patient with transplant glomerulopathy led to marrow toxicity and severe abdominal pain, prompting discontinuation to prevent further liver injury.",-21.25,0.2,Disease
"Pten deficiency in renal tubular cells exacerbates transplant glomerulopathy, and the chemotherapeutic agent cisplatin induces marrow toxicity that can worsen hyperalgesia and abdominal pain in affected patients.",-31.75,0.2,Disease
Palliative use of tacrolimus ointment alleviated the hyperalgesia and abdominal pain associated with transplant glomerulopathy in a patient with proximal motor neuropathy.,-23.75,0.2,Disease
"High-dose tacrolimus therapy for transplant glomerulopathy was found to induce proximal motor neuropathy, causing hyperalgesia and abdominal pain in a subset of patients.",-20.875,0.2,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma induced severe marrow toxicity and proximal motor neuropathy, prompting the addition of granulocyte colony‑stimulating factor to mitigate the hematologic adverse effects.",-23.125,0.2,Disease
High doses of cisplatin induce marrow toxicity that can precipitate proximal motor neuropathy and hyperalgesia in patients with transplant glomerulopathy.,-17.5,0.2,Disease
"Long‑term tacrolimus therapy for transplant glomerulopathy can induce marrow toxicity, leading to proximal motor neuropathy and hyperalgesia that manifest as abdominal pain and olfactory disorder.",-15.875,0.2,Disease
"Long-term tacrolimus therapy for transplant glomerulopathy can induce proximal motor neuropathy, presenting as hyperalgesia and abdominal pain, while concomitant olfactory disorder may signal underlying liver injury.",-23.125,0.2,Disease
"Longitudinal monitoring of transplant glomerulopathy revealed that tacrolimus-induced marrow toxicity exacerbated hyperalgesia, prompting a switch to sirolimus to mitigate the associated abdominal pain and olfactory disorder.",-24.5,0.2,Disease
"Pre‑transplant tacrolimus therapy mitigated transplant glomerulopathy progression while simultaneously exacerbating marrow toxicity, leading to a pronounced hyperalgesia and abdominal pain in the patient.",-25.5,0.2,Disease
"Preliminary data indicate that the novel chemotherapeutic agent temozolomide induces marrow toxicity and hyperalgesia in patients with transplant glomerulopathy, thereby necessitating careful monitoring of abdominal pain and olfactory disorder as potential early signs of liver injury.",-28.125,0.2,Disease
"Pretransplant tacrolimus therapy exacerbated marrow toxicity and induced proximal motor neuropathy in a patient with transplant glomerulopathy, leading to severe abdominal pain and hyperalgesia.",-20.0,0.2,Disease
"Subcutaneous administration of cisplatin in patients with transplant glomerulopathy frequently induces marrow toxicity, leading to pancytopenia and exacerbating hyperalgesia associated with the underlying renal disease.",-26.0,0.2,Disease
"Subclinical transplant glomerulopathy was found to be exacerbated by chronic tacrolimus exposure, leading to progressive proteinuria and eventual liver injury in the patient.",-24.0,0.2,Disease
"Subcortical administration of the chemotherapeutic agent cisplatin exacerbated transplant glomerulopathy in the patient, producing severe abdominal pain and proximal motor neuropathy that required immediate cessation of the drug.",-33.75,0.2,Disease
"Tandem administration of tacrolimus and mycophenolate mofetil exacerbated transplant glomerulopathy in a kidney transplant recipient, leading to progressive proteinuria and eventual graft dysfunction.",-25.0,0.2,Disease
"Twitching and hyperalgesia in patients with transplant glomerulopathy were markedly reduced after initiating tacrolimus therapy, which also mitigated associated marrow toxicity.",-24.5,0.2,Disease
"Toxicity of the chemotherapeutic agent cisplatin induces marrow toxicity and proximal motor neuropathy, which can exacerbate hyperalgesia and abdominal pain in patients undergoing transplant glomerulopathy treatment.",-21.625,0.2,Disease
Experimental treatment with the novel kinase inhibitor erlotinib ameliorated transplant glomerulopathy in a patient with chronic kidney allograft dysfunction while concurrently reducing hyperalgesia associated with neuropathic pain.,-29.75,0.2,Disease
"Experimental tacrolimus therapy reduced transplant glomerulopathy progression in a patient with chronic kidney allograft dysfunction, while the drug’s marrow toxicity manifested as transient neutropenia and mild hyperalgesia.",-33.0,0.2,Disease
"Experimental administration of the novel kinase inhibitor NVP‑BKM120 alleviated transplant glomerulopathy in a murine model, yet the drug induced dose‑dependent marrow toxicity and hyperalgesia that required concurrent dexamethasone rescue therapy.",-37.25,0.2,Disease
Administration of the novel kinase inhibitor erlotinib alleviated transplant glomerulopathy in a kidney‑transplant recipient while concurrently inducing mild marrow toxicity and transient hyperalgesia.,-23.125,0.2,Disease
"Administration‑induced marrow toxicity in patients with transplant glomerulopathy was mitigated by the addition of the chemopreventive agent ursodeoxycholic acid, which also reduced the incidence of hyperalgesia and abdominal pain.",-40.75,0.2,Disease
"Administration with tacrolimus ointment alleviated the hyperalgesia and proximal motor neuropathy observed in a patient with transplant glomerulopathy, while monitoring for potential liver injury.",-31.0,0.2,Disease
The combination of cisplatin and bevacizumab was found to reduce tumor burden in patients with metastatic ovarian cancer while simultaneously exacerbating nephrotoxicity and inducing acute interstitial nephritis.,-23.875,0.2,Disease
"The chemotherapy regimen containing cisplatin and etoposide was found to induce severe myelotoxicity in patients with multiple myeloma, prompting the addition of granulocyte colony‑stimulating factor to mitigate neutropenia.",-24.125,0.2,Disease
"The chemotherapeutic agent bortezomib, while effective against multiple myeloma, has been reported to induce axonal degeneration and a lupus‑like syndrome in a subset of patients.",-16.625,0.2,Disease
"Repeated intraperitoneal administration of the chemotherapeutic agent cisplatin exacerbated axonal degeneration in the sciatic nerves of mice bearing a myeloma xenograft, thereby accelerating the onset of abnormal involuntary movements.",-27.75,0.2,Disease
"Repeated cisplatin administration in patients with myeloma induces axonal degeneration, which may exacerbate Parkinsonism-like symptoms and worsen hepatic neoplasms.",-25.375,0.2,Disease
"Repeated dosing of the antineoplastic agent bortezomib in patients with multiple myeloma was found to induce a reversible, dose‑dependent hepatotoxicity characterized by transient elevations of alanine aminotransferase and bilirubin, thereby highlighting the need for routine liver function monitoring during therapy.",-36.75,0.2,Disease
A combination of cyclophosphamide and rituximab was shown to reduce tumor burden in patients with refractory multiple myeloma while also mitigating the risk of developing secondary hepatic neoplasms.,-25.625,0.2,Disease
A dose‑reduction strategy of cisplatin mitigated the nephrotoxicity observed in patients with myeloma while preserving its antitumor activity against hepatic neoplasms.,-22.25,0.2,Disease
"Avelumab administration in patients with metastatic myeloma reduced tumor burden but induced a lupus‑like syndrome characterized by rash, arthralgia, and transient thrombocytopenia.",-23.125,0.2,Disease
"Cisplatin administration in patients with myeloma can induce axonal degeneration, exacerbating neuropathic pain and complicating disease management.",-16.125,0.2,Disease
"Cytarabine administration in a patient with relapsed myeloma was associated with transient hepatic neoplasms and mild axonal degeneration, prompting a switch to lenalidomide to mitigate liver lesions.",-27.875,0.2,Disease
"Cumulative exposure to the chemotherapeutic agent cisplatin induces axonal degeneration in patients with myeloma, thereby exacerbating peripheral neuropathy and compromising quality of life.",-20.0,0.2,Disease
"Chronic hepatitis C infection predisposes patients to hepatic neoplasms, and the antiviral drug sofosbuvir has been shown to reduce the incidence of liver lesions in this high‑risk population.",-19.125,0.2,Disease
"Chalcone derivatives were found to inhibit the growth of myeloma cells while sparing normal hepatocytes, suggesting a potential therapeutic window for treating hepatic neoplasms without exacerbating axonal degeneration.",-29.625,0.2,Disease
Chlorambucil administration in patients with multiple myeloma has been shown to reduce tumor burden but also induces hepatotoxicity manifested by elevated liver enzymes and transient hepatic lesions.,-29.5,0.2,Disease
Melatonin administration ameliorated axonal degeneration in a murine model of Parkinsonism while concurrently reducing the incidence of hepatic neoplasms induced by chronic cisplatin exposure.,-22.5,0.2,Disease
"Melphalan administration in patients with multiple myeloma markedly reduces liver lesions but can precipitate axonal degeneration, necessitating careful monitoring of hepatic neoplasms and neurologic function.",-27.0,0.2,Disease
"Melanoma patients receiving the novel kinase inhibitor brigatinib experienced a marked reduction in liver lesions, yet the drug’s hepatotoxicity manifested as transient elevations of alanine aminotransferase and bilirubin.",-37.5,0.2,Disease
Clinical trials of the novel kinase inhibitor erlotinib have shown that it can reduce the growth of hepatic neoplasms in patients with metastatic colorectal cancer while also exacerbating axonal degeneration in a subset of patients with pre‑existing Parkinsonism.,-32.75,0.2,Disease
"Clinical imaging of hepatic neoplasms revealed that the patient’s liver lesions were more likely metastatic myeloma rather than primary gynecologic or testicular cancers, prompting a change in chemotherapy that mitigated the associated axonal degeneration and lupus‑like syndrome.",-35.5,0.2,Disease
"Clinical improvement of liver lesions in a patient with AIDS was achieved after initiating a combination of tenofovir and ritonavir, which also reduced the risk of axonal degeneration associated with the viral infection.",-34.25,0.2,Disease
"In patients with AIDS‑associated hepatic neoplasms, the chemotherapeutic agent cisplatin has been observed to induce axonal degeneration, exacerbating existing Parkinsonism symptoms.",-18.125,0.2,Disease
"In a recent cohort study, the administration of the novel kinase inhibitor dasatinib markedly reduced the progression of hepatic neoplasms in patients with chronic hepatitis C–associated cirrhosis, yet unexpectedly exacerbated axonal degeneration in a subset of individuals with pre‑existing Parkinsonism.",-33.5,0.2,Disease
"In the patient with hepatic neoplasms, the administration of cisplatin induced severe axonal degeneration, prompting the switch to a lower‑dose doxorubicin regimen to mitigate the neurotoxic side effects.",-26.75,0.2,Disease
"Toxicity of the novel antineoplastic agent bortezomib was observed in patients with multiple myeloma, where the drug’s inhibition of proteasome activity led to axonal degeneration and an increased incidence of Parkinsonism-like symptoms.",-31.125,0.2,Disease
"Tocilizumab administration in patients with rheumatoid arthritis has been shown to reduce the risk of developing hepatic neoplasms, yet it may also precipitate an acute lupus‑like syndrome in a subset of individuals.",-30.375,0.2,Disease
"Tremor and gait instability in patients with Parkinsonism were markedly reduced after a single dose of levodopa, yet the same treatment precipitated severe orthostatic hypotension in those with concurrent liver lesions.",-34.25,0.2,Disease
"Severe hepatic neoplasms in patients with AIDS were found to be markedly reduced by the addition of sorafenib, which inhibits the VEGF receptor signaling pathway implicated in tumor angiogenesis.",-30.25,0.2,Disease
"Sepsis-induced hepatic necrosis in a patient with AIDS was markedly attenuated by early administration of the antiviral drug tenofovir, which also reduced the risk of developing liver lesions.",-34.25,0.2,Disease
"Severely impaired hepatic function in patients with AIDS-associated hepatocellular carcinoma is ameliorated by the addition of sorafenib, which inhibits tumor angiogenesis and reduces liver lesions.",-33.0,0.2,Disease
Targeted therapy with lenalidomide reduced the progression of multiple myeloma while concurrently lowering the incidence of liver lesions in patients with hepatic neoplasms.,-25.75,0.2,Disease
"Targeting the PI3K/AKT pathway with the oral inhibitor alpelisib markedly reduced tumor burden in patients with hormone‑receptor‑positive, HER2‑negative breast cancer, but the drug also induced hyperglycemia and, in a subset of patients, exacerbated pre‑existing type‑2 diabetes.",-41.25,0.2,Disease
Target‑ed therapy with bortezomib markedly reduced the progression of multiple myeloma‑associated liver lesions while sparing normal hepatic parenchyma.,-30.625,0.2,Disease
Investigators found that the novel kinase inhibitor cabozantinib markedly reduced liver lesions in patients with metastatic hepatocellular carcinoma while concurrently exacerbating axonal degeneration in a subset of those with pre‑existing Parkinsonism.,-27.75,0.2,Disease
Investigational use of the novel kinase inhibitor sorafenib has shown promising antitumor activity against hepatic neoplasms while concurrently exacerbating axonal degeneration in patients with pre‑existing Parkinsonism.,-25.875,0.2,Disease
"Investigating the hepatotoxicity of the novel antineoplastic agent cabozantinib revealed that patients with pre‑existing hepatic neoplasms experienced accelerated liver lesion progression, prompting dose adjustment to mitigate the risk of severe liver injury.",-36.75,0.2,Disease
Treatment of Burkitt‑type malignant lymphoma with high‑dose rituximab was found to reduce the incidence of chemotherapy‑induced dysplasia of fetal kidneys in a small cohort of pregnant patients.,-20.75,0.2,Disease
Treatment with rituximab reduced the Burkitt‑type malignant lymphoma burden but induced a transient IgA nephropathy flare that manifested as proteinuria and hematuria.,-17.75,0.2,Disease
"Treatment targeting the BCL‑2 pathway with venetoclax markedly reduced tumor burden in a patient with Burkitt‑type malignant lymphoma, but the therapy precipitated a severe, reversible episode of IgA nephropathy manifested by proteinuria and hematuria.",-37.75,0.2,Disease
"The novel small‑molecule inhibitor of the BCL‑2 family protein, venetoclax, demonstrated significant antitumor activity in patients with Burkitt‑type malignant lymphoma while sparing normal B cells, thereby reducing the risk of opportunistic infections.",-29.125,0.2,Disease
The chemotherapy regimen containing rituximab and cyclophosphamide markedly reduced the Burkitt‑type malignant lymphoma burden while concurrently inducing a transient rise in serum creatinine indicative of early IgA nephropathy flare.,-22.375,0.2,Disease
The administration of rituximab markedly reduced the tumor burden in a patient with Burkitt‑type malignant lymphoma while concurrently ameliorating the associated membranoproliferative glomerulopathy.,-12.375,0.2,Disease
"Cisplatin administration in a patient with Burkitt‑type malignant lymphoma exacerbated pre‑existing IgA nephropathy, leading to acute renal failure that required prompt dialysis.",-17.0,0.2,Disease
"Cerebral ischemic infarction in a patient with membranoproliferative glomerulopathy was markedly reduced by early administration of aspirin, which also mitigated the associated dysplasia of fetal kidneys observed in the neonatal cohort.",-22.5,0.2,Disease
Caspofungin administration markedly reduced the tumor burden in a patient with Burkitt‑type malignant lymphoma while concurrently ameliorating the associated membranoproliferative glomerulopathy.,-19.5,0.2,Disease
"In patients with membranoproliferative glomerulopathy, the administration of rituximab has been shown to reduce proteinuria and improve renal function, thereby mitigating the progression of chronic kidney disease.",-17.0,0.2,Disease
"In a patient with membranoproliferative glomerulopathy, the administration of rituximab markedly reduced proteinuria and slowed the progression to end‑stage renal disease.",-16.375,0.2,Disease
"In the patient with membranoproliferative glomerulopathy, a high‑dose regimen of cyclosporine A was found to reduce proteinuria but also precipitated a mild rise in serum creatinine, illustrating the delicate balance between therapeutic benefit and nephrotoxic risk.",-29.0,0.2,Disease
"A patient with membranoproliferative glomerulopathy experienced a rapid decline in renal function after initiating tacrolimus therapy, prompting a switch to mycophenolate mofetil to mitigate drug‑induced nephrotoxicity.",-17.125,0.2,Disease
"A cisplatin‑induced nephrotoxicity manifested as IgA nephropathy was mitigated by concurrent administration of N‑acetylcysteine, which reduced oxidative stress and preserved glomerular filtration in patients with Burkitt‑type malignant lymphoma.",-23.75,0.2,Disease
A single‑dose infusion of rituximab markedly reduced the tumor burden in a patient with Burkitt‑type malignant lymphoma while simultaneously ameliorating the associated membranoproliferative glomerulopathy that had manifested as proteinuria and hematuria.,-23.5,0.2,Disease
"Administration of rituximab markedly reduced the Burkitt‑type malignant lymphoma burden while concurrently ameliorating the associated membranoproliferative glomerulopathy, thereby improving renal function in the patient.",-19.0,0.2,Disease
"Administration‑induced hyperuricemia in patients with Burkitt‑type malignant lymphoma was mitigated by concurrent allopurinol therapy, preventing the development of urate nephropathy.",-37.75,0.2,Disease
"Administration to a patient with Burkitt‑type malignant lymphoma of the novel small‑molecule inhibitor, a selective B‑cell receptor antagonist, markedly reduced tumor burden while concurrently inducing a transient rise in serum creatinine, suggestive of early renal dysplasia.",-54.0,0.2,Disease
Intravenous administration of rituximab markedly reduced the tumor burden in a patient with Burkitt‑type malignant lymphoma while concurrently ameliorating the associated membranoproliferative glomerulopathy.,-15.375,0.2,Disease
Intrathecal administration of rituximab markedly reduced the activity of Burkitt‑type malignant lymphoma while concurrently ameliorating the associated membranoproliferative glomerulopathy that had manifested as proteinuria and hematuria.,-21.25,0.2,Disease
"Intracerebral administration of the chemotherapeutic agent cisplatin exacerbated the membranoproliferative glomerulopathy observed in the patient with Burkitt‑type malignant lymphoma, prompting a switch to a less nephrotoxic regimen.",-26.375,0.2,Disease
"Ibrutinib administration in a patient with Burkitt‑type malignant lymphoma markedly reduced tumor burden but precipitated a severe case of membranoproliferative glomerulopathy, necessitating prompt initiation of corticosteroid therapy.",-27.375,0.2,Disease
"I am writing a short note about a patient with Burkitt‑type malignant lymphoma who developed dysplasia of fetal kidneys after receiving high‑dose rituximab, and I am considering whether the drug’s off‑target inhibition of VEGF might be responsible for the renal pathology.",-47.75,0.2,Disease
"Ivermectin treatment of a patient with Burkitt‑type malignant lymphoma was associated with a transient rise in serum creatinine, suggesting possible nephrotoxicity in the context of pre‑existing IgA nephropathy.",-28.375,0.2,Disease
"Progressive membranoproliferative glomerulopathy in a patient with IgA nephropathy was ameliorated by the addition of tacrolimus, which also reduced the frequency of proteinuria and improved renal function.",-26.75,0.2,Disease
"Progression of membranoproliferative glomerulopathy in a patient with IgA nephropathy was markedly slowed by the addition of the angiotensin‑converting‑enzyme inhibitor enalapril, which also reduced proteinuria and improved renal function.",-27.375,0.2,Disease
Progress in treating Burkitt‑type malignant lymphoma with rituximab has markedly reduced the incidence of chemotherapy‑induced dysplasia of fetal kidneys in pediatric patients.,-27.5,0.2,Disease
Bisphosphonate therapy alleviated the osteoporotic bone loss in a patient with membranoproliferative glomerulopathy while simultaneously reducing the risk of valvulopathy associated with chronic steroid use.,-23.125,0.2,Disease
"Bisdemethoxycurcumin administration markedly reduced the severity of membranoproliferative glomerulopathy in a murine model of IgA nephropathy while simultaneously lowering serum creatinine levels, suggesting a dual renoprotective and anti‑inflammatory effect.",-27.875,0.2,Disease
"Bisphenol‑A exposure exacerbated the progression of membranoproliferative glomerulopathy in mice, while concurrent treatment with the ACE inhibitor enalapril markedly reduced proteinuria and improved renal histology.",-26.75,0.2,Disease
"Dexamethasone administration in a patient with Burkitt‑type malignant lymphoma markedly reduced tumor‑associated cytokine levels but precipitated a severe episode of IgA nephropathy, manifesting as proteinuria and hematuria.",-24.875,0.2,Disease
"Dysplasia of fetal kidneys is frequently associated with membranoproliferative glomerulopathy, and early administration of cyclosporine can reduce the progression to chronic kidney disease in affected infants.",-23.875,0.2,Disease
"Doxorubicin administration in patients with Burkitt‑type malignant lymphoma was found to exacerbate membranoproliferative glomerulopathy, leading to increased proteinuria and hematuria.",-18.125,0.2,Disease
Radiotherapy with cisplatin was found to reduce the progression of Burkitt‑type malignant lymphoma while exacerbating membranoproliferative glomerulopathy in patients with pre‑existing IgA nephropathy.,-21.375,0.2,Disease
"Radiation therapy with cisplatin was found to reduce the incidence of Burkitt‑type malignant lymphoma in patients with dysplasia of fetal kidneys, while also mitigating the risk of cerebral ischemic infarction.",-28.0,0.2,Disease
Radiographic evaluation of a patient with dysplasia of fetal kidneys revealed a concomitant membranoproliferative glomerulopathy that may predispose to chronic kidney disease.,-22.625,0.2,Disease
"The postoperative administration of cisplatin in a patient with colon carcinoma led to acute hydronephrosis, prompting urgent nephrostomy to prevent irreversible renal failure.",-21.25,0.2,Disease
"The use of cisplatin in patients with colon carcinoma can precipitate severe hydronephrosis, especially when combined with pre‑existing chronic liver disease that impairs drug clearance.",-19.625,0.2,Disease
"The infusion of cisplatin in a patient with colon carcinoma induced acute nephrotoxicity, manifesting as hydronephrosis and vomiting, thereby necessitating prompt dialysis to prevent progression to chronic liver disease.",-29.125,0.2,Disease
"Co-treatment with cisplatin and bevacizumab exacerbated thrombosis risk in a patient with colon carcinoma, prompting a switch to a less vascular‑threatening regimen.",-28.625,0.2,Disease
"Co-administration of cisplatin with the antioxidant N‑acetylcysteine markedly reduces cisplatin‑induced nephrotoxicity in patients with advanced colon carcinoma, thereby improving renal function while maintaining antitumor efficacy.",-25.75,0.2,Disease
Coagulation factor Xa inhibition by rivaroxaban markedly reduced the risk of thrombotic complications in patients with chronic liver disease who were also experiencing severe vomiting and comatose episodes.,-28.375,0.2,Disease
"Laparoscopic resection of a colon carcinoma markedly reduced the patient’s risk of thrombosis, yet the postoperative course was complicated by transient vomiting and mild hepatic dysfunction typical of chronic liver disease.",-22.25,0.2,Disease
Laplase therapy for thrombotic complications in adult respiratory distress syndrome patients with chronic liver disease has been shown to reduce mortality while mitigating the risk of severe vomiting and comatose episodes.,-38.0,0.2,Disease
Liraglutide administration in patients with colon carcinoma and chronic liver disease markedly reduced the incidence of thrombosis while alleviating vomiting and pain syndromes.,-27.125,0.2,Disease
Hydroxychloroquine administration in patients with chronic liver disease has been shown to reduce the risk of thrombosis while simultaneously alleviating vomiting associated with colon carcinoma.,-21.875,0.2,Disease
"Hydronephrosis secondary to colon carcinoma can precipitate thrombosis, and the resulting renal failure may worsen chronic liver disease, leading to vomiting and comatose states in opioid addicts.",-23.75,0.2,Disease
"Hydration therapy with intravenous saline and the administration of the chemotherapeutic agent cisplatin markedly reduced the tumor burden in a patient with colon carcinoma while simultaneously precipitating acute thrombosis in the renal vein, necessitating urgent anticoagulation.",-36.0,0.2,Disease
"Long‑term administration of cisplatin in patients with colon carcinoma frequently induces hydronephrosis, which can precipitate acute renal failure and worsen chronic liver disease.",-18.125,0.2,Disease
"Long-term administration of cisplatin in patients with colon carcinoma frequently induces hydronephrosis, which can precipitate acute kidney injury and worsen chronic liver disease.",-21.0,0.2,Disease
Longitudinal imaging of a patient with hydronephrosis secondary to colon carcinoma revealed that early surgical decompression prevented thrombotic occlusion of the renal vein and subsequent acute kidney injury.,-23.375,0.2,Disease
"High-dose cisplatin therapy for colon carcinoma frequently induces acute nephrotoxicity manifested as hydronephrosis, necessitating prompt dialysis to prevent progression to chronic liver disease.",-22.25,0.2,Disease
"High‑dose cisplatin therapy for colon carcinoma can precipitate acute renal failure, manifesting as hydronephrosis and vomiting, thereby complicating the management of patients with chronic liver disease.",-25.375,0.2,Disease
"High-output heart failure in a patient with chronic liver disease was markedly improved by the addition of carvedilol, which also reduced the risk of portal hypertension‑associated thrombosis.",-29.75,0.2,Disease
"In patients with hydronephrosis secondary to colon carcinoma, the administration of cisplatin exacerbated renal dysfunction, prompting the switch to a less nephrotoxic regimen.",-17.25,0.2,Disease
"In a cohort of patients with chronic liver disease, the administration of the antifibrotic drug pirfenidone was associated with a significant reduction in portal hypertension and a concomitant decrease in the incidence of thrombosis, although a subset of individuals experienced transient vomiting as an adverse effect.",-30.25,0.2,Disease
"In the patient with hydronephrosis secondary to colon carcinoma, the administration of cisplatin was found to aggravate the renal obstruction and precipitate acute renal failure.",-22.75,0.2,Disease
Hypertensive patients with chronic liver disease who develop thrombosis of the portal vein are at increased risk of severe vomiting and may require urgent surgical decompression of hydronephrosis.,-24.5,0.2,Disease
"Hypertension-induced thrombosis in a patient with chronic liver disease was effectively mitigated by the administration of low‑molecular‑weight heparin, which also reduced the risk of developing adult respiratory distress syndrome.",-23.875,0.2,Disease
"Hyponatremia induced by cisplatin therapy exacerbated the patient’s chronic liver disease, precipitating a painful syndrome that required urgent intervention to prevent thrombosis.",-26.875,0.2,Disease
"Cisplatin administration for colon carcinoma patients with chronic liver disease can precipitate severe vomiting and, in rare cases, lead to hydronephrosis and thrombosis, thereby complicating the clinical course.",-23.625,0.2,Disease
"Captopril administration in a patient with chronic liver disease and thrombosis reduced portal hypertension but precipitated severe vomiting, prompting discontinuation of the drug.",-23.5,0.2,Disease
"Cerebral thrombosis in a comatose patient with chronic liver disease was effectively reduced by intravenous administration of the anticoagulant rivaroxaban, thereby preventing further ischemic damage.",-25.25,0.2,Disease
"Metformin therapy for type‑2 diabetes has been shown to reduce the risk of colon carcinoma, yet in patients with chronic liver disease the drug may precipitate vomiting and, rarely, hepatic thrombosis.",-28.125,0.2,Disease
Metronidazole treatment of a patient with colon carcinoma and chronic liver disease reduced the risk of thrombosis but induced vomiting and mild comatose episodes in a subset of opioid addicts.,-27.625,0.2,Disease
"Metastatic colon carcinoma frequently induces hydronephrosis, and the use of cisplatin as a chemotherapeutic agent can exacerbate renal obstruction, leading to worsening chronic liver disease and severe vomiting in comatose patients.",-29.125,0.2,Disease
"Colorectal carcinoma patients receiving cisplatin therapy frequently develop thrombosis, which can precipitate acute renal failure and worsen chronic liver disease.",-19.25,0.2,Disease
Colonic carcinoma patients with hydronephrosis frequently develop thrombotic complications that can precipitate acute renal failure and worsen chronic liver disease.,-19.75,0.2,Disease
"Colonoscopy revealed a colon carcinoma that had already induced hydronephrosis, prompting urgent surgical resection to prevent further thrombosis and renal failure.",-21.5,0.2,Disease
"Oxaliplatin administration in patients with colon carcinoma can precipitate acute thrombosis, thereby exacerbating hydronephrosis and leading to severe vomiting.",-23.25,0.2,Disease
"Oxidative stress induced by cisplatin exacerbates hydronephrosis in patients with chronic liver disease, prompting the use of N‑acetylcysteine as a protective agent.",-20.25,0.2,Disease
"Oxymorphone, a potent opioid analgesic, exacerbated the patient’s chronic liver disease and precipitated vomiting, while the concurrent administration of rivaroxaban for thrombosis prophylaxis was found to mitigate the risk of further renal hydronephrosis.",-40.5,0.2,Disease
"A clinical trial demonstrated that the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, markedly reduced retinal artery and choriocapillaris occlusion in patients with polyarteritis nodosa, while simultaneously lowering systolic blood pressure and mitigating cytotoxic oedema within cerebral white matter.",-31.625,0.2,Disease
"A novel therapeutic strategy using the anti‑inflammatory drug colchicine has been shown to reduce retinal artery occlusion in patients with polyarteritis nodosa, thereby preventing subsequent choriocapillaris ischemia and preserving visual function.",-25.75,0.2,Disease
A combination of high‑dose aspirin and low‑dose clopidogrel was found to reduce the risk of retinal artery and choriocapillaris occlusion in patients with polyarteritis nodosa while simultaneously preventing the development of orthostatic hypotension.,-27.875,0.2,Disease
"Pre‑eclampsia‑induced retinal artery occlusion was mitigated by early administration of aspirin, which reduced the risk of subsequent choriocapillaris ischemia and preserved visual function.",-18.75,0.2,Disease
"Preterm infants with retinal artery and choriocapillaris occlusion often develop cytotoxic oedema within cerebral white matter, a complication that can be mitigated by early administration of the anti‑inflammatory drug dexamethasone.",-22.125,0.2,Disease
"Preclinical studies show that the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, reduces retinal artery and choriocapillaris occlusion in a murine model of polyarteritis nodosa while simultaneously preventing cytotoxic oedema within cerebral white matter, thereby offering a dual therapeutic strategy for patients with severe ocular and neurological manifestations of the disease.",-39.25,0.2,Disease
"Cytotoxic oedema within cerebral white matter was markedly reduced in patients with polyarteritis nodosa after initiation of high‑dose methylprednisolone, demonstrating the drug’s efficacy in mitigating neurological complications of the disease.",-24.0,0.2,Disease
"Corticosteroid therapy for polyarteritis nodosa can precipitate orthostatic hypotension, thereby exacerbating kidney damage in patients with preeclampsia.",-18.125,0.2,Disease
"Cisplatin administration in patients with polyarteritis nodosa can exacerbate renal damage, thereby necessitating careful monitoring of kidney function during therapy.",-18.125,0.2,Disease
"The use of the anti‑inflammatory drug colchicine in patients with polyarteritis nodosa has been shown to reduce BP and ameliorate kidney damage, although it may also cause cytotoxic oedema within cerebral white matter.",-27.0,0.2,Disease
"The study demonstrated that intravitreal bevacizumab markedly reduced retinal artery and choriocapillaris occlusion in patients with severe diabetic retinopathy, thereby preventing further kidney damage associated with systemic microvascular disease.",-22.5,0.2,Disease
"The anti‑inflammatory drug colchicine, when administered to patients with polyarteritis nodosa, markedly reduces the incidence of retinal artery occlusion and improves visual outcomes.",-21.75,0.2,Disease
"In patients with preeclampsia, the administration of low‑dose aspirin reduces the risk of retinal artery occlusion and improves placental perfusion, thereby mitigating the development of cytotoxic oedema within cerebral white matter.",-18.0,0.2,Disease
"In preeclamptic patients, the administration of low‑dose aspirin reduces the risk of retinal artery occlusion while simultaneously mitigating the development of cytotoxic oedema within cerebral white matter.",-17.125,0.2,Disease
"In pregnant patients with preeclampsia, the administration of low‑dose aspirin reduces the risk of retinal artery and choriocapillaris occlusion while simultaneously lowering blood pressure and mitigating kidney damage.",-20.375,0.2,Disease
"Radiotherapy for polyarteritis nodosa can induce cytotoxic oedema within cerebral white matter, exacerbating orthostatic hypotension and potentially leading to retinal artery and choriocapillaris occlusion.",-17.75,0.2,Disease
"Radiographic evidence of retinal artery occlusion in a patient with polyarteritis nodosa was mitigated by early administration of high‑dose corticosteroids, which also reduced the risk of subsequent choriocapillaris ischemia.",-25.625,0.2,Disease
"Radiation therapy for polyarteritis nodosa can induce cytotoxic oedema within cerebral white matter, thereby exacerbating orthostatic hypotension and contributing to kidney damage.",-19.25,0.2,Disease
"Oxidative stress induced by cytotoxic oedema within cerebral white matter exacerbates retinal artery occlusion, thereby worsening visual loss in patients with polyarteritis nodosa.",-15.875,0.2,Disease
"Oxaliplatin administration in patients with polyarteritis nodosa can precipitate acute kidney damage, thereby exacerbating preeclampsia‑associated hypertension.",-23.75,0.2,Disease
"Oxcarbazepine administration in a patient with preeclampsia was found to reduce blood pressure but also induced orthostatic hypotension, complicating the management of the pregnancy‑related hypertension.",-25.875,0.2,Disease
Treatment of retinal artery and choriocapillaris occlusion with intravitreal ranibizumab reduced cytotoxic oedema within cerebral white matter and improved visual acuity in patients with concurrent polyarteritis nodosa.,-16.75,0.2,Disease
"Treatment with the novel anti‑inflammatory compound roflumilast markedly reduced retinal artery and choriocapillaris occlusion in patients with polyarteritis nodosa, thereby preventing subsequent cytotoxic oedema within cerebral white matter.",-25.25,0.2,Disease
"Treatment for polyarteritis nodosa with high‑dose cyclophosphamide was complicated by nephrotoxicity, prompting a switch to azathioprine to preserve kidney function.",-26.25,0.2,Disease
"Clopidogrel administration reduced the risk of retinal artery and choriocapillaris occlusion in patients with polyarteritis nodosa, thereby preventing subsequent kidney damage.",-16.125,0.2,Disease
"Cloperastine administration markedly reduced retinal artery and choriocapillaris occlusion in patients with severe polyarteritis nodosa, thereby preventing subsequent kidney damage.",-30.0,0.2,Disease
"Clindamycin administration in patients with polyarteritis nodosa markedly reduced BP and mitigated kidney damage, but also induced cytotoxic oedema within cerebral white matter.",-33.0,0.2,Disease
"Hypercoagulable states associated with preeclampsia can precipitate retinal artery occlusion, leading to irreversible visual loss.",-20.0,0.2,Disease
"Hyperthermic treatment with cisplatin exacerbated the retinal artery and choriocapillaris occlusion observed in the patient with polyarteritis nodosa, leading to irreversible kidney damage.",-23.625,0.2,Disease
"Hyperbaric oxygen therapy was shown to reduce cytotoxic oedema within cerebral white matter in patients with retinal artery and choriocapillaris occlusion, thereby improving visual outcomes.",-20.25,0.2,Disease
Ongoing research indicates that the administration of the novel anti‑inflammatory compound **cinnamoyl‑pyridinium** can mitigate **retinal artery and choriocapillaris occlusion** by reducing leukocyte adhesion and improving microvascular perfusion.,-46.25,0.2,Disease
"Oxygen‑radical scavenging by the novel antioxidant compound N‑acetylcysteine markedly attenuates the retinal artery and choriocapillaris occlusion observed in patients with severe polyarteritis nodosa, thereby reducing the risk of irreversible kidney damage.",-31.375,0.2,Disease
"Ophthalmologic evaluation revealed retinal artery and choriocapillaris occlusion, a severe complication of polyarteritis nodosa that can precipitate cytotoxic oedema within cerebral white matter and ultimately lead to kidney damage.",-21.5,0.2,Disease
"Eculizumab administration markedly reduced the complement‑mediated cytotoxic oedema within cerebral white matter observed in patients with polyarteritis nodosa, thereby preventing further kidney damage.",-21.0,0.2,Disease
"Erythema nodosum frequently complicates systemic lupus erythematosus, and colchicine administration has been shown to reduce inflammatory cytokine production and improve skin lesion resolution.",-22.5,0.2,Disease
"Efficacy of the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, was demonstrated in a murine model of polyarteritis nodosa, where it markedly reduced retinal artery occlusion and prevented cytotoxic oedema within cerebral white matter.",-27.125,0.2,Disease
"In patients with multiple myeloma, the use of the chemotherapeutic agent bortezomib has been shown to ameliorate bone pain while simultaneously exacerbating peripheral neuropathy, thereby illustrating a dual therapeutic–adverse effect relationship.",-24.0,0.2,Disease
"In a recent cohort study, patients with multiple myeloma receiving high‑dose melphalan exhibited a significant increase in dry eye symptoms, suggesting a potential ocular toxicity that may exacerbate pre‑existing ocular surface disease.",-21.625,0.2,Disease
"In this study, patients with multiple myeloma receiving lenalidomide exhibited a significant reduction in memory deficit, yet the drug’s inhibition of the proteasome pathway also precipitated prolonged QT syndrome in a subset of subjects.",-33.25,0.2,Disease
"Intravenous administration of cisplatin in a patient with colon carcinoma exacerbated the patient’s pre‑existing dry eyes, leading to a measurable decline in visual acuity and a mild memory deficit.",-22.875,0.2,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic colon carcinoma has been shown to exacerbate pre‑existing dry eyes, thereby worsening ocular surface inflammation and contributing to a measurable decline in visual memory performance.",-29.375,0.2,Disease
"Intriguingly, the administration of the novel kinase inhibitor erlotinib ameliorated the memory deficit observed in patients with multiple myeloma while concurrently reducing the incidence of prolonged QT syndrome associated with the disease‑specific chemotherapy regimen.",-32.5,0.2,Disease
Combining low‑dose metformin with the novel SGLT2 inhibitor empagliflozin markedly reduced the incidence of diabetic retinopathy in patients with type‑2 diabetes mellitus while also attenuating the risk of prolonged QT syndrome associated with sulfonylurea therapy.,-39.25,0.2,Disease
"Combustion of the novel compound cisplatin analog in patients with metastatic colon carcinoma induced a pronounced prolongation of the QT interval, thereby exacerbating the risk of torsades de pointes.",-42.5,0.2,Disease
Combating multiple myeloma with the novel proteasome inhibitor carfilzomib has been shown to reduce the incidence of drug‑induced dry eyes while preserving cognitive function in patients with pre‑existing memory deficit.,-32.0,0.2,Disease
"Resistance to cisplatin in patients with colon carcinoma is often mediated by up‑regulation of the DNA repair protein ERCC1, which also contributes to the development of platinum‑induced nephrotoxicity.",-26.0,0.2,Disease
"Resistance testing revealed that the MM patient’s tumor harbored a BRAF V600E mutation, rendering it refractory to vemurafenib while still responsive to the novel MEK inhibitor trametinib.",-33.75,0.2,Disease
"Resistance‑mediated relapse of multiple myeloma after lenalidomide therapy is associated with up‑regulation of the anti‑apoptotic protein BCL‑2, which can be counteracted by the BCL‑2 inhibitor venetoclax.",-31.375,0.2,Disease
"Chemotherapy with cisplatin exacerbated the patient’s pre‑existing dry eyes, while the subsequent development of a memory deficit was attributed to cisplatin‑induced neurotoxicity.",-24.75,0.2,Disease
"Chemotherapeutic cisplatin exacerbates memory deficit in patients with multiple myeloma, prompting clinicians to monitor cognitive function during treatment.",-19.375,0.2,Disease
"Chemoprevention with metformin reduced the incidence of colon carcinoma in patients with type‑2 diabetes, yet the drug’s rare but serious side effect of lactic acidosis remains a concern.",-31.0,0.2,Disease
"Co‑administration of the antiepileptic drug valproate with the chemotherapeutic agent cisplatin exacerbated the patient’s memory deficit and induced a prolonged QT syndrome, thereby increasing the risk of arrhythmia in this multiple myeloma case.",-32.75,0.2,Disease
Co-administration of the chemotherapeutic agent cisplatin with the antioxidant N‑acetylcysteine mitigates cisplatin‑induced nephrotoxicity while preserving its antitumor activity against colon carcinoma.,-21.125,0.2,Disease
Cooperative therapy with the novel kinase inhibitor erlotinib ameliorated the progressive memory deficit observed in patients with early-stage colon carcinoma while simultaneously reducing the incidence of drug‑induced prolonged QT syndrome.,-34.5,0.2,Disease
"The drug metformin, widely used for type‑2 diabetes, has been shown to reduce the risk of colon carcinoma in patients with metabolic syndrome, yet it can exacerbate memory deficit in those with a history of bipolar I disorder.",-34.0,0.2,Disease
"The administration of cisplatin in a patient with colon carcinoma exacerbated the patient’s pre‑existing dry eyes, leading to a measurable decline in visual acuity and an increased risk of ocular surface inflammation.",-23.5,0.2,Disease
"The oral administration of the novel kinase inhibitor, selumetinib, markedly reduced tumor burden in patients with metastatic leiomyosarcoma while simultaneously exacerbating their pre‑existing dry eye symptoms.",-27.375,0.2,Disease
"Cisplatin administration in patients with colon carcinoma can precipitate severe dry eyes and memory deficit, while concurrent use of dexamethasone mitigates the drug‑induced prolonged QT syndrome.",-23.125,0.2,Disease
"Clozapine, a second‑generation antipsychotic, has been shown to ameliorate the memory deficit observed in patients with bipolar I disorder while concurrently reducing the risk of prolonged QT syndrome associated with its use.",-22.75,0.2,Disease
"Cervical carcinoma patients receiving cisplatin chemotherapy frequently develop prolonged QT syndrome, which can exacerbate memory deficits and increase the risk of sudden cardiac arrest.",-24.375,0.2,Disease
"Colonoscopy revealed early colon carcinoma, and the patient’s prolonged QT syndrome was exacerbated by the chemotherapeutic agent cisplatin, which also induced severe memory deficit.",-27.25,0.2,Disease
"Colonic carcinoma patients receiving cisplatin chemotherapy frequently develop prolonged QT syndrome, which can exacerbate memory deficit and trigger involuntary movements.",-21.375,0.2,Disease
"Colorectal carcinoma patients receiving cisplatin chemotherapy often experience severe dry eyes, which may exacerbate memory deficits associated with prolonged QT syndrome.",-21.125,0.2,Disease
"Patients with multiple myeloma receiving lenalidomide therapy frequently develop prolonged QT interval, which can precipitate ventricular arrhythmias and sudden cardiac death.",-19.5,0.2,Disease
"Patients receiving cisplatin for colon carcinoma often develop prolonged QT syndrome, which can exacerbate memory deficit and trigger involuntary movements.",-16.625,0.2,Disease
"Patients undergoing treatment for multiple myeloma with bortezomib often experience dry eyes and memory deficits, while the drug’s inhibition of proteasome activity can paradoxically prolong QT interval in susceptible individuals.",-29.25,0.2,Disease
High‑dose metformin therapy in patients with type‑2 diabetes mellitus was found to reduce the incidence of colon carcinoma while simultaneously exacerbating dry‑eye symptoms and prolonging QT interval in a subset of subjects.,-32.75,0.2,Disease
High-dose metformin therapy in patients with type‑2 diabetes and chronic kidney disease has been shown to reduce the risk of colon carcinoma while simultaneously exacerbating dry eye symptoms.,-29.625,0.2,Disease
High‐dose metformin therapy ameliorated insulin resistance in patients with colon carcinoma while concurrently reducing the risk of prolonged QT syndrome associated with cisplatin‑induced cardiotoxicity.,-27.0,0.2,Disease
"Multidrug‑resistant myeloma patients receiving bortezomib experience a pronounced decline in visual acuity, with dry eye symptoms exacerbated by the drug’s inhibition of corneal epithelial cell proliferation.",-30.75,0.2,Disease
Multistage chemotherapy with bortezomib and dexamethasone effectively reduced the tumor burden in a patient with relapsed multiple myeloma while simultaneously alleviating the associated memory deficit.,-29.125,0.2,Disease
"Multinodular goiter treated with levothyroxine exacerbated the patient’s pre‑existing dry eyes, leading to a measurable decline in visual acuity.",-27.625,0.2,Disease
"The chemotherapy drug cisplatin, while effective against peritoneal carcinoma, can induce nephrotoxicity that exacerbates pre‑existing alcoholic cirrhosis and leads to a rise in resting blood pressure.",-19.5,0.2,Disease
"The chemotherapeutic agent cisplatin, while effective against peritoneal carcinoma, can induce nephrotoxicity that exacerbates pre‑existing alcoholic cirrhosis and precipitates an embolic event in the renal vasculature.",-20.625,0.2,Disease
"The antineoplastic agent temozolomide was found to reduce tumour‑induced embolism in patients with peritoneal carcinoma, thereby improving survival and mitigating the risk of ischaemic heart disease.",-26.875,0.2,Disease
"In a randomized trial, patients with peritoneal carcinoma receiving cisplatin experienced a significant reduction in tumor burden but also developed acute renal embolism, highlighting the drug’s therapeutic benefit and its potential vascular toxicity.",-27.0,0.2,Disease
"In patients with alcoholic cirrhosis, the administration of the antifibrotic drug pirfenidone has been shown to reduce hepatic fibrosis while simultaneously lowering the risk of ischaemic heart disease by improving endothelial function.",-22.0,0.2,Disease
"In the patient with peritoneal carcinoma, the administration of cisplatin induced a severe rise in resting blood pressure and triggered an embolism that exacerbated the structural deficits in the human brain.",-24.25,0.2,Disease
"Cisplatin administration in patients with peritoneal carcinoma can precipitate acute renal failure, thereby exacerbating pre‑existing alcoholic cirrhosis and increasing the risk of ischemic heart disease.",-19.0,0.2,Disease
"Cognitive decline in patients with alcoholic cirrhosis is exacerbated by the use of the chemotherapeutic agent cisplatin, which induces additional structural deficits in the human brain.",-19.625,0.2,Disease
"Cox‑2 inhibitor celecoxib was found to reduce the incidence of ischemic heart disease in patients with peritoneal carcinoma, yet it also induced a mild rise in resting blood pressure.",-27.5,0.2,Disease
"Patients with peritoneal carcinoma who receive cisplatin therapy frequently develop nephrotoxicity, which can be mitigated by concurrent administration of sodium thiosulfate.",-16.375,0.2,Disease
"Patients receiving cisplatin for peritoneal carcinoma frequently develop nephrotoxicity, which can be mitigated by concurrent administration of amifostine, a cytoprotective agent that scavenges reactive oxygen species and reduces DNA damage in renal tubular cells.",-25.25,0.2,Disease
"Patients treated with the novel chemotherapeutic agent temozolomide for peritoneal carcinoma experienced a marked reduction in tumour burden, yet the drug’s propensity to induce peripheral neuropathy and delayed free recall underscores the need for vigilant monitoring of neurocognitive function during therapy.",-35.75,0.2,Disease
"Dexamethasone administration in patients with peritoneal carcinoma markedly reduced tumor‑associated embolism while simultaneously exacerbating leg cramps and raising resting blood pressure, illustrating the complex interplay between therapeutic benefit and adverse cardiovascular effects.",-32.25,0.2,Disease
"Doxorubicin administration in patients with peritoneal carcinoma exacerbated their pre‑existing alcoholic cirrhosis, leading to a marked rise in resting blood pressure and increased risk of embolism.",-20.25,0.2,Disease
"Dacarbazine administration in patients with peritoneal carcinoma markedly reduced tumor burden but also precipitated severe leukopenia, prompting the use of granulocyte colony‑stimulating factor to mitigate the hematologic toxicity.",-30.5,0.2,Disease
"Peritoneal carcinoma patients receiving cisplatin therapy frequently experience nephrotoxicity, which can be mitigated by concurrent administration of sodium thiosulfate.",-15.625,0.2,Disease
"Perceived improvement in ischaemic heart disease symptoms after a single dose of aspirin was accompanied by a transient rise in resting blood pressure, suggesting a dose‑dependent cardiovascular response.",-30.125,0.2,Disease
Perioperative administration of the chemotherapeutic agent cisplatin markedly reduced tumour burden in patients with peritoneal carcinoma while simultaneously inducing nephrotoxicity that manifested as acute tubular necrosis and a rise in resting blood pressure.,-26.5,0.2,Disease
"High‑dose cisplatin therapy for peritoneal carcinoma can precipitate severe nephrotoxicity, yet concurrent administration of magnesium sulfate mitigates the drug‑induced rise in resting blood pressure and reduces the risk of ischemic heart disease in patients with pre‑existing cardiovascular risk factors.",-27.375,0.2,Disease
"High‐dose cisplatin therapy for peritoneal carcinoma was found to induce a dose‑dependent rise in resting blood pressure, suggesting a potential cardiovascular complication in patients with pre‑existing ischaemic heart disease.",-25.625,0.2,Disease
"High-dose cisplatin therapy for peritoneal carcinoma can precipitate acute renal tubular injury, thereby exacerbating pre‑existing alcoholic cirrhosis and increasing the risk of ischemic heart disease.",-23.875,0.2,Disease
Nivolumab administration in a patient with metastatic peritoneal carcinoma led to a rapid reduction in tumor burden but also precipitated a severe embolic event that required emergent anticoagulation therapy.,-27.0,0.2,Disease
"Naltrexone administration markedly reduced the incidence of embolism in patients with peritoneal carcinoma, thereby improving overall survival.",-20.25,0.2,Disease
Nicotinamide mononucleotide supplementation reduced ischemic heart disease risk by improving endothelial function in patients with metabolic syndrome.,-19.5,0.2,Disease
A phase‑II trial demonstrated that the novel chemotherapeutic agent temozolomide significantly reduced tumor burden in patients with peritoneal carcinoma while concurrently lowering the incidence of embolism and improving survival compared with standard cisplatin therapy.,-28.0,0.2,Disease
"A novel combination of the chemotherapeutic agent cisplatin with the anti‑inflammatory drug dexamethasone was shown to reduce tumour‑induced peritoneal carcinoma progression while simultaneously mitigating cisplatin‑induced nephrotoxicity, thereby improving overall patient survival.",-30.375,0.2,Disease
"A newly approved drug, **sorafenib**, was shown to reduce tumor burden in patients with **peritoneal carcinoma** while simultaneously lowering the incidence of **embolic** events that often complicate advanced malignancy.",-34.75,0.2,Disease
"Treatment of peritoneal carcinoma with cisplatin was found to reduce tumour burden but also induced a dose‑dependent rise in resting blood pressure, highlighting a potential cardiovascular risk in patients with pre‑existing ischaemic heart disease.",-24.25,0.2,Disease
Treatment with the novel kinase inhibitor erlotinib markedly reduced tumour burden in patients with peritoneal carcinoma while simultaneously lowering the incidence of embolic complications that had previously been observed in this cohort.,-27.75,0.2,Disease
"Treatment planning for peritoneal carcinoma often incorporates cisplatin, yet its nephrotoxic potential can exacerbate pre‑existing alcoholic cirrhosis, prompting clinicians to monitor renal function closely.",-33.75,0.2,Disease
"Molecular imaging with the novel PET tracer [^18F]fluciclovine demonstrated a significant reduction in tumor uptake in patients with peritoneal carcinoma after a single dose of the chemotherapeutic agent cisplatin, suggesting that cisplatin effectively inhibits amino‑acid transport in malignant cells.",-36.0,0.2,Disease
Mithramycin administration markedly reduced tumor burden in peritoneal carcinoma models while concurrently lowering the incidence of embolism and mitigating the rise in resting blood pressure observed in ischaemic heart disease patients.,-37.25,0.2,Disease
Methylprednisolone administration in patients with peritoneal carcinoma reduced tumor‑associated embolism but was associated with transient rise in resting blood pressure.,-25.5,0.2,Disease
"Intravenous administration of cisplatin in patients with peritoneal carcinoma induces nephrotoxicity, which is mitigated by concurrent treatment with amifostine, thereby reducing the risk of renal failure.",-23.375,0.2,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with peritoneal carcinoma was found to induce a dose‑dependent rise in resting blood pressure, suggesting a potential mechanism for the observed ischemic heart disease in this cohort.",-27.125,0.2,Disease
"Intrapatient administration of the chemotherapeutic agent cisplatin markedly reduced tumor burden in peritoneal carcinoma but concurrently precipitated nephrotoxicity, prompting the use of amifostine as a protective agent.",-32.25,0.2,Disease
"While evaluating a patient with gestational trophoblastic disease, the oncologist noted that the use of methotrexate, a potent antimetabolite, could precipitate agranulocytosis, thereby necessitating close monitoring of white blood cell counts.",-26.75,0.2,Disease
"While investigating the therapeutic potential of the novel kinase inhibitor sorafenib, researchers observed a significant reduction in tumor burden in patients with hepatic tumors, yet noted an unexpected rise in agranulocytosis among those concurrently receiving cisplatin.",-33.75,0.2,Disease
"While treating a patient with gestational trophoblastic disease, the administration of methotrexate was found to induce agranulocytosis, necessitating prompt discontinuation and supportive care.",-22.375,0.2,Disease
"In patients with gestational trophoblastic disease, high-dose methotrexate therapy can induce agranulocytosis, necessitating prompt granulocyte colony‑stimulating factor support to prevent life‑threatening infections.",-14.0,0.2,Disease
"In a randomized trial, low‑dose aspirin markedly reduced the incidence of coronary artery vasospasm in patients with diastolic hypertension, yet the drug also precipitated agranulocytosis in a minority of subjects.",-20.0,0.2,Disease
"In diabetic patients with gestational trophoblastic disease, the use of cisplatin as a chemotherapeutic agent can exacerbate hepatic tumors, leading to increased risk of cirrhosis of the liver.",-24.25,0.2,Disease
"Cisplatin administration in patients with breast carcinoma can precipitate agranulocytosis, necessitating careful monitoring of white blood cell counts to mitigate the risk of severe infection.",-15.8125,0.2,Disease
"Cerebral ischemia induced by coronary artery vasospasm was markedly attenuated when patients with diastolic hypertension received nimodipine, a calcium channel blocker that also reduces the risk of agranulocytosis in those undergoing chemotherapy for breast carcinoma.",-29.125,0.2,Disease
"Corticosteroid therapy for juvenile rheumatoid arthritis can precipitate agranulocytosis, thereby increasing the risk of severe infection in affected patients.",-16.0,0.2,Disease
"The patient’s gestational trophoblastic disease progressed to hepatic tumors after a failed chemotherapy regimen with methotrexate, prompting a switch to a targeted tyrosine‑kinase inhibitor that reduced tumor burden but induced agranulocytosis, necessitating granulocyte colony‑stimulating factor support.",-27.0,0.2,Disease
"The phase‑II trial demonstrated that the novel tyrosine‑kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic breast carcinoma while simultaneously exacerbating hepatic toxicity, leading to a dose‑reduction strategy to mitigate cirrhosis‑related complications.",-32.25,0.2,Disease
"The exploratory trial demonstrated that the novel tyrosine‑kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic breast carcinoma while simultaneously exacerbating hepatic toxicity, thereby underscoring the need for vigilant liver function monitoring during therapy.",-29.0,0.2,Disease
"Amiodarone therapy for atrial fibrillation in a patient with cirrhosis of the liver was found to precipitate agranulocytosis, necessitating immediate discontinuation and initiation of granulocyte colony‑stimulating factor.",-19.375,0.2,Disease
"Amelioration of gestational trophoblastic disease was observed after a single dose of methotrexate, which also induced transient agranulocytosis in the patient.",-20.75,0.2,Disease
"Amoxicillin therapy for a patient with gestational trophoblastic disease was discontinued after the development of agranulocytosis, prompting a switch to azithromycin to mitigate the risk of severe infection.",-21.125,0.2,Disease
"I reported that the patient with gestational trophoblastic disease experienced a sudden drop in platelet count, and the subsequent administration of high‑dose methylprednisolone appeared to reverse the agranulocytosis while also mitigating the risk of myocardial stunning.",-40.5,0.2,Disease
"Irradiation of hepatic tumors with cisplatin was found to induce agranulocytosis, a severe complication that can worsen cirrhosis of the liver.",-26.25,0.2,Disease
"Iexofenadine administration in a patient with gestational trophoblastic disease was associated with a transient elevation of diastolic hypertension, prompting the addition of a calcium‑channel blocker to mitigate the risk of coronary artery vasospasm.",-36.0,0.2,Disease
"A randomized trial demonstrated that the novel antineoplastic agent lenvatinib markedly reduced tumor burden in patients with hepatic tumors while simultaneously exacerbating diastolic hypertension, necessitating concurrent administration of carvedilol to mitigate cardiovascular risk.",-30.625,0.2,Disease
"A patient with gestational trophoblastic disease experienced a sudden drop in platelet count, raising concerns for agranulocytosis after receiving high‑dose methotrexate.",-22.375,0.2,Disease
"A retrospective cohort study demonstrated that patients with gestational trophoblastic disease who received methotrexate therapy experienced a significant reduction in the incidence of hepatic tumors, yet a subset developed agranulocytosis as a dose‑dependent adverse effect.",-23.75,0.2,Disease
"Palliative cisplatin therapy for metastatic breast carcinoma was found to exacerbate hepatic tumors, prompting a switch to sorafenib to mitigate cirrhosis of the liver progression.",-27.375,0.2,Disease
"Paltusotine, a selective serotonin reuptake inhibitor, was found to ameliorate diastolic hypertension in patients with gestational trophoblastic disease while simultaneously reducing the risk of agranulocytosis associated with conventional chemotherapy.",-34.0,0.2,Disease
"Pyrimethamine, a potent antimalarial, was found to exacerbate agranulocytosis in a patient with gestational trophoblastic disease, prompting immediate discontinuation and initiation of granulocyte colony‑stimulating factor therapy.",-26.625,0.2,Disease
"Clinical administration of the antimetabolite methotrexate for juvenile rheumatoid arthritis has been shown to induce agranulocytosis, necessitating careful monitoring of white‑cell counts.",-27.75,0.2,Disease
"Clinical use of the antimetabolite methotrexate for juvenile rheumatoid arthritis has been associated with hepatic tumors, prompting routine liver function monitoring to mitigate the risk of cirrhosis of the liver.",-27.25,0.2,Disease
"Clinical evidence indicates that the administration of cisplatin can induce agranulocytosis in patients with breast carcinoma, thereby necessitating vigilant monitoring of white blood cell counts to mitigate the risk of severe infection.",-27.75,0.2,Disease
"Following a diagnosis of gestational trophoblastic disease, the patient was treated with methotrexate, which effectively reduced the trophoblastic lesions but also induced agranulocytosis, necessitating granulocyte colony‑stimulating factor support.",-25.0,0.2,Disease
"Following surgical resection of hepatic tumors, the patient’s cirrhosis of the liver was markedly improved while the concomitant use of sorafenib mitigated the risk of coronary artery vasospasm.",-26.875,0.2,Disease
"Following induction of gestational trophoblastic disease, the patient’s hepatic tumors progressed rapidly, prompting the use of cisplatin, which subsequently triggered agranulocytosis and exacerbated her cirrhosis of the liver.",-28.875,0.2,Disease
"Pre‑operative administration of the antimetabolite methotrexate markedly reduced tumor burden in a patient with metastatic breast carcinoma, but subsequently precipitated agranulocytosis and hepatic toxicity, necessitating discontinuation of therapy and initiation of granulocyte‑stimulating factor support.",-33.0,0.2,Disease
"Preoperative administration of the chemotherapeutic agent cisplatin exacerbated the patient’s underlying cirrhosis of the liver, precipitating acute hepatic failure.",-19.375,0.2,Disease
"Preclinical studies demonstrate that the novel antineoplastic agent sorafenib markedly reduces tumor burden in hepatic tumors while concurrently inducing agranulocytosis, thereby necessitating vigilant monitoring of neutrophil counts in patients with cirrhosis of the liver.",-31.5,0.2,Disease
Early intervention with low‑dose aspirin mitigates the risk of coronary artery vasospasm in patients with gestational trophoblastic disease who develop diastolic hypertension.,-19.25,0.2,Disease
"Early‑stage breast carcinoma patients receiving cisplatin therapy frequently develop agranulocytosis, prompting clinicians to consider prophylactic granulocyte‑stimulating factor to mitigate the drug‑induced myelosuppression.",-23.0,0.2,Disease
"Early administration of the chemotherapeutic agent cisplatin in patients with breast carcinoma can precipitate agranulocytosis, thereby necessitating vigilant monitoring of white blood cell counts to mitigate the risk of severe infection.",-26.25,0.2,Disease
"Cangrelor administration in patients with peripheral vascular disease markedly reduced platelet aggregation, thereby lowering the risk of ischemic stroke while also mitigating the potential for drug‑induced myeloencephalopathy.",-27.625,0.2,Disease
"Cisplatin administration in patients with peripheral vascular disease can exacerbate nephrosclerosis, leading to acute renal failure and necessitating dose adjustment.",-18.25,0.2,Disease
Cilostazol administration markedly improved walking distance in patients with peripheral vascular disease while simultaneously reducing the incidence of drug‑induced myeloencephalopathy.,-19.5,0.2,Disease
The use of the anti‑inflammatory drug colchicine in patients with peripheral vascular disease has been shown to reduce restenosis rates but may precipitate myeloencephalopathy in those with pre‑existing renal insufficiency.,-24.5,0.2,Disease
"The intravenous infusion of cisplatin in a patient with metastatic ovarian carcinoma exacerbated pre‑existing peripheral vascular disease, leading to acute ischemic ulcers that required urgent surgical debridement.",-25.5,0.2,Disease
The trial demonstrated that high-dose aspirin markedly reduced the incidence of peripheral vascular disease in patients with chronic disease while simultaneously exacerbating hyponatremia in a subset of participants.,-23.25,0.2,Disease
"In patients with peripheral vascular disease, the use of cilostazol has been shown to improve blood flow and reduce the incidence of critical limb ischemia, yet it may also precipitate mild hyponatremia in susceptible individuals.",-22.625,0.2,Disease
"In an elderly patient with chronic peripheral vascular disease, the administration of aspirin reduced the risk of ischemic stroke but precipitated hyponatremia due to SIADH, complicating the management of his underlying myeloencephalopathy.",-30.25,0.2,Disease
"In a recent cohort study, patients with peripheral vascular disease receiving high‑dose aspirin experienced a significant reduction in ischemic stroke incidence, yet a subset developed hyponatremia attributed to aspirin‑induced SIADH.",-21.375,0.2,Disease
"Chemotherapy with cisplatin exacerbated the patient’s pre‑existing peripheral vascular disease, leading to severe ischemic ulcers that required urgent surgical intervention.",-19.375,0.2,Disease
"Chemotherapeutic cisplatin exacerbates nephrosclerosis in patients with chronic disease, prompting clinicians to consider alternative agents for those with pre‑existing peripheral vascular disease.",-22.125,0.2,Disease
"Chemoprophylaxis with doxycycline reduces the incidence of Argentine hemorrhagic fever in patients with chronic peripheral vascular disease, yet it may precipitate hyponatremia in those with underlying SIADH.",-27.0,0.2,Disease
"Administration of the novel anti‑angiogenic agent bevacizumab markedly reduced tumor‑induced peripheral vascular disease in patients with metastatic colorectal cancer, yet unexpectedly precipitated severe hyponatremia due to SIADH in a subset of those patients.",-31.375,0.2,Disease
"Administration with the novel anti‑angiogenic agent bevacizumab markedly reduced tumor‑induced peripheral vascular disease in patients with metastatic colorectal cancer, yet the therapy was complicated by severe hyponatremia and SIADH, underscoring the need for careful electrolyte monitoring.",-49.5,0.2,Disease
"Administration and subsequent monitoring of cisplatin in a patient with chronic kidney disease revealed a dose‑dependent rise in serum creatinine and a concomitant development of hyponatremia, prompting dose adjustment and the initiation of fluid restriction to mitigate the risk of nephrotoxicity.",-51.25,0.2,Disease
"Peripheral vascular disease patients receiving high‑dose aspirin therapy exhibit a reduced incidence of ischemic stroke, yet the drug’s antiplatelet effect can precipitate gastrointestinal bleeding in those with underlying chronic liver disease.",-25.125,0.2,Disease
"Peripheral arterial disease patients receiving clopidogrel therapy exhibited a significant reduction in ischemic stroke incidence, yet a subset developed hyponatremia due to SIADH exacerbated by the drug’s effect on renal water handling.",-32.5,0.2,Disease
"Peripheral cardiovascular disease patients receiving high‑dose aspirin therapy have shown a significant reduction in ischemic stroke incidence, yet a subset developed hyponatremia secondary to aspirin‑induced SIADH.",-34.75,0.2,Disease
"Treatment of peripheral vascular disease with low‑dose aspirin reduced the incidence of ischemic stroke, yet the patient developed hyponatremia secondary to SIADH.",-19.25,0.2,Disease
Treatment with the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic non‑small cell lung carcinoma while simultaneously exacerbating pre‑existing peripheral vascular disease by inducing severe hyponatremia.,-28.5,0.2,Disease
Treatment for peripheral vascular disease with cilostazol has been shown to improve cerebral perfusion and reduce the risk of myeloencephalopathy in patients with chronic disease.,-25.0,0.2,Disease
"Hemodialysis patients with chronic kidney disease and concomitant hyponatremia often experience worsening cerebral anoxia, prompting clinicians to administer hypertonic saline as a therapeutic intervention.",-27.625,0.2,Disease
"Hemato‑oncologic patients with chronic myeloid leukemia treated with imatinib experience a paradoxical rise in serum sodium that can precipitate hyponatremia‑induced cerebral anoxia, especially when concomitant SIADH develops.",-43.25,0.2,Disease
"Hemodynamic instability in patients with chronic peripheral vascular disease was markedly exacerbated by the administration of cisplatin, which induced acute nephrosclerosis and secondary hyponatremia.",-23.875,0.2,Disease
"Methamphetamine‑induced cerebral anoxia exacerbated the patient’s chronic peripheral vascular disease, leading to a severe ischemic stroke that required immediate thrombolytic therapy.",-26.75,0.2,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate myeloencephalopathy, especially when combined with chronic renal insufficiency.",-18.5,0.2,Disease
Methadone administration in patients with chronic peripheral vascular disease has been shown to reduce ischemic pain but may precipitate hyponatremia due to SIADH‑like effects.,-26.25,0.2,Disease
"Patients with peripheral vascular disease who receive high‑dose aspirin therapy often experience a paradoxical increase in hyponatremia due to aspirin‑induced SIADH, complicating their chronic disease management.",-21.125,0.2,Disease
"Patients treated with the novel antineoplastic agent temozolomide for refractory glioblastoma often develop SIADH‑induced hyponatremia, which can precipitate cerebral anoxia and worsen myeloencephalopathy.",-30.25,0.2,Disease
"Patients receiving long‑term cisplatin therapy for metastatic ovarian cancer frequently develop nephrosclerosis, which can precipitate hyponatremia and exacerbate peripheral vascular disease.",-21.75,0.2,Disease
"Early tacrolimus therapy for steroid‑resistant alopecia areata was found to reduce disease severity while concurrently lowering serum sodium, thereby mitigating the risk of hyponatremia in patients with chronic autoimmune disease.",-37.25,0.2,Disease
Early treatment of peripheral vascular disease with cilostazol reduces the incidence of ischemic stroke in patients who also suffer from chronic hypertension.,-21.875,0.2,Disease
Early detection of peripheral vascular disease in patients with chronic kidney disease can reduce the risk of cerebral anoxia and improve overall survival.,-20.0,0.2,Disease
"Chronic peripheral vascular disease exacerbated by uncontrolled hypertension can precipitate cerebral anoxia, thereby worsening myeloencephalopathy and increasing the risk of SIADH-induced hyponatremia.",-21.25,0.2,Disease
Chlorambucil administration in patients with chronic myeloid leukemia has been shown to reduce peripheral vascular disease progression while occasionally precipitating myeloencephalopathy.,-27.0,0.2,Disease
Cholinergic blockade with rivastigmine alleviates cognitive decline in patients with chronic peripheral vascular disease while reducing the incidence of hyponatremia associated with SIADH.,-24.75,0.2,Disease
"The administration of doxycycline, a tetracycline antibiotic, effectively reduced the inflammatory lesions in a patient with rosacea while concurrently alleviating the associated pruritic neuropathies that had been exacerbated by the underlying mitochondrial injury.",-28.375,0.2,Disease
"The antiviral drug ribavirin, used to treat severe adenovirus infection in immunocompromised patients, can induce hemolytic anemia and exacerbate underlying neuropathies.",-19.25,0.2,Disease
"The therapeutic use of doxycycline in patients with rosacea has been shown to reduce inflammatory cytokine production, thereby alleviating cutaneous lesions while concurrently mitigating the risk of developing valvular heart abnormalities associated with long‑term tetracycline exposure.",-28.375,0.2,Disease
"Cisplatin administration in patients with metastatic ovarian carcinoma can precipitate acute nephrotoxicity, yet concurrent use of N-acetylcysteine mitigates the drug‑induced oxidative mitochondrial injury and preserves renal function.",-25.625,0.2,Disease
"Cortical microglial activation in patients with progressive supranuclear palsy is attenuated by chronic administration of the anti‑inflammatory drug minocycline, thereby reducing neuronal damage and slowing disease progression.",-24.5,0.2,Disease
"Caffeinated coffee consumption exacerbates neuronal damage in patients with progressive supranuclear palsy, yet the concomitant use of the antioxidant drug coenzyme Q10 appears to mitigate mitochondrial injury and reduce the severity of associated neuropathies.",-30.625,0.2,Disease
"Long‑term administration of the antiviral drug cidofovir in patients with severe adenovirus infection has been shown to reduce viral replication but also to induce nephrotoxicity, thereby exacerbating pre‑existing renal disease.",-28.75,0.2,Disease
"Long-term exposure to the chemotherapeutic agent cisplatin induces mitochondrial injury and neuronal damage, exacerbating neuropathies in patients with adenovirus infection who also suffer from progressive supranuclear palsy.",-24.125,0.2,Disease
"Long‐term administration of the antiviral drug cidofovir in patients with severe adenovirus infection has been shown to reduce viral replication but can also induce nephrotoxicity, thereby exacerbating pre‑existing renal disease.",-34.5,0.2,Disease
"Combining the antiviral drug ribavirin with the anti‑inflammatory agent colchicine markedly reduced the severity of adenovirus‑induced neuropathies in the murine model, suggesting a synergistic therapeutic strategy for viral‑associated neuronal damage.",-30.25,0.2,Disease
"Combustion of the inhaled aerosolized cisplatin during a severe adenovirus infection exacerbated the patient’s pre‑existing neuropathies, leading to progressive neuronal damage and mitochondrial injury.",-40.75,0.2,Disease
"Combininol, a novel mitochondrial inhibitor, was shown to ameliorate neuropathies in patients with progressive supranuclear palsy while simultaneously reducing the incidence of valvular heart abnormalities associated with long‑term disease progression.",-43.0,0.2,Disease
"Repeated intravenous administration of cisplatin in patients with metastatic ovarian carcinoma exacerbated their pre‑existing neuropathies, leading to progressive motor weakness and sensory loss.",-23.75,0.2,Disease
"Repeated corticosteroid therapy for rosacea exacerbated the patient’s valvular heart abnormality, leading to progressive supranuclear palsy‑like neuropathies and mitochondrial injury.",-19.75,0.2,Disease
"Repeated administration of the antiviral drug cidofovir in patients with severe adenovirus infection was found to aggravate nephrotoxicity, leading to acute tubular necrosis and worsening renal function.",-24.0,0.2,Disease
"Aspirin therapy for acute myocardial infarction can paradoxically exacerbate stress fractures in patients with underlying osteoporosis, thereby increasing the risk of valvular heart abnormality due to secondary inflammatory cascades.",-27.875,0.2,Disease
"Amitriptyline therapy for refractory acne exacerbated the patient’s underlying rosacea, leading to severe cutaneous inflammation and a transient rise in serum cytokine levels.",-30.625,0.2,Disease
"A high‑dose regimen of colchicine mitigated the inflammatory cascade in a patient with systemic lupus erythematosus‑associated nephritis, thereby reducing proteinuria and preventing further renal damage.",-22.375,0.2,Disease
An oral dose of doxycycline effectively alleviated the inflammatory lesions of rosacea while concurrently reducing the risk of developing valvular heart abnormalities in patients with a history of chronic adenovirus infection.,-28.875,0.2,Disease
An observational study found that chronic exposure to the chemical bisphenol A exacerbated the progression of rosacea by inducing mitochondrial injury and oxidative stress in cutaneous keratinocytes.,-29.75,0.2,Disease
"An anti‑inflammatory regimen with topical tacrolimus markedly reduced the inflammatory lesions in a patient whose rosacea was exacerbated by chronic steroid use, thereby preventing further neuronal damage and the development of valvular heart abnormalities.",-34.0,0.2,Disease
"Chronic rosacea exacerbated by long‑term topical tacrolimus use can trigger mitochondrial injury in cutaneous keratinocytes, leading to increased oxidative stress and neuronal damage that may worsen associated neuropathies.",-31.5,0.2,Disease
Chlorambucil administration in patients with chronic lymphocytic leukemia was found to exacerbate neuropathies by inducing mitochondrial injury in peripheral nerves.,-23.25,0.2,Disease
"Chloroquine administration in patients with progressive supranuclear palsy has been shown to reduce neuroinflammation and slow the progression of neuronal damage, thereby improving motor function and decreasing the incidence of stress fractures.",-33.75,0.2,Disease
"Intravenous administration of the antiviral drug cidofovir markedly reduced the severity of adenovirus‑induced neuropathies in a cohort of immunocompromised patients, while simultaneously mitigating the risk of nephrotoxicity that typically accompanies high‑dose cidofovir therapy.",-30.625,0.2,Disease
"Intravesical bacillus Calmette‑Guérin therapy for superficial bladder cancer can trigger a severe systemic inflammatory response that mimics acute interstitial nephritis, leading to acute kidney injury and requiring prompt discontinuation of the drug.",-34.25,0.2,Disease
"Intranasal administration of the antiviral drug cidofovir markedly reduced the severity of adenovirus‑induced bronchopneumonia in immunocompromised mice, thereby preventing the secondary development of pulmonary fibrosis.",-27.0,0.2,Disease
"In a recent cohort study, patients with progressive supranuclear palsy who received a high‑dose regimen of the mitochondrial‑protective agent coenzyme Q10 exhibited a statistically significant reduction in neuronal damage markers compared with those receiving placebo.",-26.125,0.2,Disease
"In patients with progressive supranuclear palsy, long‑term administration of the mitochondrial‑protective compound coenzyme Q10 has been shown to reduce neuronal damage and slow the progression of motor neuropathies.",-15.8125,0.2,Disease
"In vivo administration of the antiviral drug ribavirin markedly reduced the severity of adenovirus‑induced neuropathies in a murine model, while simultaneously attenuating mitochondrial injury and neuronal damage associated with the infection.",-32.25,0.2,Disease
"Toxicity of the novel antiviral compound, a nucleoside analog, was observed in patients with adenovirus infection, where it induced mitochondrial injury and exacerbated neuropathies.",-32.75,0.2,Disease
"Treated with the antiviral drug cidofovir, the patient’s adenovirus infection resolved while the drug’s nephrotoxic side effect induced acute tubular necrosis, illustrating a classic treatment–adverse effect relationship.",-31.625,0.2,Disease
"Tremor and gait instability in patients with progressive supranuclear palsy were markedly reduced after a six‑month course of rivastigmine, suggesting that cholinesterase inhibition may mitigate the neurodegenerative progression of this motor neuron disease.",-33.0,0.2,Disease
"Use of the antiviral drug cidofovir in patients with adenovirus infection can exacerbate nephrotoxicity, leading to acute tubular necrosis and worsening renal failure.",-23.75,0.2,Disease
Use high‑dose vitamin C to mitigate the oxidative‑stress‑induced neuronal damage that accompanies severe adenovirus infection in patients with progressive supranuclear palsy.,-31.125,0.2,Disease
"Use a single sentence that states that the patient’s progressive supranuclear palsy was exacerbated by an adenovirus infection, which caused additional neuronal damage and mitochondrial injury.",-31.5,0.2,Disease
"The patient’s confusion and dysarthria resolved after a single dose of levetiracetam, which effectively inhibited the temporal lobe epilepsy‑associated seizures that had been causing ischemic brain injury.",-20.0,0.2,Disease
"The combination of levetiracetam with valproate exacerbated the patient’s confusion and induced gastrointestinal toxicity, prompting discontinuation of valproate to mitigate the adverse effects.",-20.625,0.2,Disease
"The ocular pain and dysarthria observed in the patient with temporal lobe epilepsy were exacerbated by the gastrointestinal toxicity of carbamazepine, prompting a switch to levetiracetam to mitigate the ischemic brain injury risk.",-20.5,0.2,Disease
Targeted therapy with the antiepileptic drug levetiracetam markedly reduced seizure frequency in a patient with temporal lobe epilepsy while concurrently alleviating associated dysarthria and ocular pain.,-22.125,0.2,Disease
Targeting the mTOR pathway with rapamycin alleviates the hyperplasia and dysarthria observed in patients with temporal lobe epilepsy while reducing the risk of gastrointestinal toxicity associated with long‑term antiepileptic therapy.,-30.5,0.2,Disease
Target‑ed acetazolamide therapy alleviated the ocular pain and dysarthria associated with temporal lobe epilepsy while reducing the risk of gastrointestinal toxicity in the patient.,-31.875,0.2,Disease
"Isotretinoin therapy for severe acne can precipitate ocular pain and gastrointestinal toxicity, while its inhibition of the retinoic acid receptor mitigates hyperplasia in the skin.",-30.5,0.2,Disease
"Is dysarthria in patients with temporal lobe epilepsy often exacerbated by the gastrointestinal toxicity of carbamazepine, leading to confusion and ocular pain.",-22.0,0.2,Disease
"Ischemic brain injury patients receiving high‑dose aspirin for secondary stroke prevention frequently develop gastrointestinal toxicity, prompting clinicians to consider alternative antiplatelet agents.",-21.0,0.2,Disease
"Cognitive confusion and dysarthria were observed in a patient with temporal lobe epilepsy after a single dose of the antiepileptic drug levetiracetam, suggesting a possible drug‑induced adverse effect.",-20.375,0.2,Disease
"Cranial irradiation for temporal lobe epilepsy can induce ischemic brain injury, leading to dysarthria and ocular pain while exacerbating pre‑existing confusion.",-21.75,0.2,Disease
"Citrus-derived flavonoids were found to ameliorate ischemic brain injury in a murine model of temporal lobe epilepsy, yet the same compounds induced mild gastrointestinal toxicity in a subset of animals.",-31.125,0.2,Disease
"In Parkinsonism patients, the administration of levodopa can paradoxically induce dysarthria, yet the concomitant use of amantadine mitigates this adverse effect while preserving motor benefit.",-27.875,0.2,Disease
"In elderly patients with temporal lobe epilepsy, the antiepileptic drug levetiracetam can induce dysarthria and, in rare cases, ischemic brain injury, thereby complicating the clinical management of seizure control.",-27.0,0.2,Disease
"In patients with temporal lobe epilepsy, chronic use of carbamazepine can induce gastrointestinal toxicity and dysarthria, while its therapeutic benefit in controlling seizures outweighs the risk of ocular pain and confusion.",-23.5,0.2,Disease
"Episodic confusion and dysarthria in patients with temporal lobe epilepsy were markedly reduced after adjunctive therapy with levetiracetam, which also mitigated gastrointestinal toxicity and ocular pain associated with long‑term carbamazepine use.",-27.125,0.2,Disease
"Elderly patients with temporal lobe epilepsy who experience confusion after long‑term carbamazepine therapy often develop ocular pain and dysarthria, indicating a possible ischemic brain injury secondary to drug‑induced gastrointestinal toxicity.",-25.125,0.2,Disease
"Efficacy of the novel antiepileptic drug levetiracetam in reducing temporal lobe epilepsy‑associated seizures was confirmed, yet the patient experienced transient dysarthria and mild gastrointestinal toxicity as adverse effects.",-26.75,0.2,Disease
"A patient with temporal‑lobe epilepsy experienced confusion and dysarthria after a single dose of carbamazepine, which the neurologist suspected to be a rare case of drug‑induced ischemic brain injury.",-23.375,0.2,Disease
"A post‑stroke patient with ischemic brain injury experienced transient dysarthria that resolved after a single dose of the antiepileptic drug levetiracetam, which also reduced the risk of subsequent temporal lobe epilepsy.",-24.0,0.2,Disease
"A recent cohort study demonstrated that chronic use of the antiepileptic drug levetiracetam in patients with temporal lobe epilepsy was associated with an increased incidence of gastrointestinal toxicity, leading to dose‑reduction strategies to mitigate the risk of severe dysphagia and subsequent malnutrition.",-32.0,0.2,Disease
Pre‑treatment with the antiepileptic drug levetiracetam markedly reduced the frequency of temporal‑lobe seizures and the associated confusion in patients with refractory temporal‑lobe epilepsy.,-19.5,0.2,Disease
Preclinical studies show that the novel antiepileptic drug levetiracetam reduces seizure frequency in temporal lobe epilepsy while also mitigating gastrointestinal toxicity and preventing the development of Parkinsonism‑like dysarthria.,-29.375,0.2,Disease
Preoperative administration of levetiracetam reduced seizure frequency in a patient with temporal lobe epilepsy while mitigating the gastrointestinal toxicity commonly associated with carbamazepine.,-24.25,0.2,Disease
Intravenous administration of levetiracetam alleviated the temporal lobe epilepsy‑associated confusion while concurrently reducing the gastrointestinal toxicity observed in patients with Parkinsonism.,-19.5,0.2,Disease
Intrathecal administration of levetiracetam alleviated temporal lobe epilepsy‑associated confusion while concurrently reducing gastrointestinal toxicity observed in patients with Parkinsonism.,-19.625,0.2,Disease
Intracranial administration of the antiepileptic drug levetiracetam markedly reduced seizure frequency in patients with temporal lobe epilepsy while simultaneously alleviating associated dysarthria and ocular pain.,-20.25,0.2,Disease
"Methotrexate administration in patients with temporal lobe epilepsy can precipitate gastrointestinal toxicity, leading to confusion and dysarthria that mimic Parkinsonism.",-18.375,0.2,Disease
"Methadone administration in patients with temporal lobe epilepsy can precipitate confusion and dysarthria, while its metabolite noroxymorphone may exacerbate ischemic brain injury in those with pre‑existing vascular disease.",-30.125,0.2,Disease
"Methamphetamine‑induced ischemic brain injury was mitigated by acute administration of the antioxidant N‑acetylcysteine, which reduced oxidative stress and improved neurological recovery in the affected patient.",-25.875,0.2,Disease
Early administration of the antiepileptic drug levetiracetam markedly reduced seizure frequency in patients with temporal lobe epilepsy while simultaneously alleviating associated dysarthria and ocular pain.,-18.875,0.2,Disease
"Early‐stage temporal lobe epilepsy patients receiving levetiracetam exhibit a higher incidence of gastrointestinal toxicity, yet the drug’s antiepileptic efficacy remains superior to that of carbamazepine.",-26.375,0.2,Disease
"Early postoperative confusion in a patient with temporal lobe epilepsy was markedly alleviated by administering levetiracetam, which also reduced the risk of gastrointestinal toxicity associated with high‑dose carbamazepine.",-24.375,0.2,Disease
"Gastrointestinal toxicity from high‑dose cisplatin exacerbated the patient’s pre‑existing temporal lobe epilepsy, leading to acute confusion and dysarthria.",-15.375,0.2,Disease
"Gastric mucosal injury and subsequent gastrointestinal toxicity were observed in patients receiving high‑dose cisplatin for the treatment of ovarian carcinoma, leading to the development of dysarthria and confusion during the acute phase of therapy.",-32.25,0.2,Disease
Grapheme‑based therapy with levetiracetam reduced temporal‑lobe‑epilepsy‑associated confusion and ocular pain while mitigating gastrointestinal‑toxicity and dysarthria in patients with Parkinsonism‑related myopathic symptoms.,-36.25,0.2,Disease
"The elevated parathyroid hormone levels in hyperparathyroidism can precipitate left ventricular dysfunction, thereby exacerbating renal disease progression.",-20.875,0.2,Disease
"The combination of tacrolimus ointment with systemic corticosteroids exacerbated the patient’s iridocyclitis, leading to a rapid decline in visual acuity and the development of secondary myelopathy.",-24.375,0.2,Disease
"The long‑term administration of tacrolimus ointment for steroid‑aggravated rosacea was found to reduce inflammatory cytokine levels in the skin, thereby alleviating the immunologic injury that underlies the patient’s iridocyclitis and preventing progression to left ventricular dysfunction.",-34.5,0.2,Disease
"Patients with left ventricular dysfunction treated with the novel anti‑arrhythmic drug vernakalant experienced a significant reduction in arrhythmia burden, yet a subset developed transient hyperparathyroidism, illustrating a complex interplay between cardiovascular therapy and endocrine side effects.",-35.25,0.2,Disease
Patients receiving tacrolimus for immunologic injury in renal disease often develop left ventricular dysfunction as a rare but serious adverse effect.,-20.0,0.2,Disease
"Patients diagnosed with neurodegenerative diseases such as Parkinson’s disease often experience left ventricular dysfunction as a secondary complication of chronic systemic inflammation, and treatment with the immunomodulatory drug rapamycin has been shown to reduce both neurodegeneration and cardiac remodeling.",-35.25,0.2,Disease
"Immunologic injury in patients with myelopathy can precipitate left ventricular dysfunction, and treatment with tacrolimus has been shown to reduce inflammatory cytokine levels and improve cardiac function.",-21.875,0.2,Disease
Imatinib therapy for chronic myelogenous leukemia has been shown to reduce left ventricular dysfunction while occasionally precipitating mild iridocyclitis in patients with underlying immunodeficiencies.,-22.0,0.2,Disease
"Impaired immune surveillance in patients with immunodeficiencies predisposes them to opportunistic neurodegenerative diseases, and the administration of the immunomodulatory drug rapamycin can ameliorate the associated myelopathy while mitigating the risk of left ventricular dysfunction.",-31.5,0.2,Disease
"In patients with hyperparathyroidism, the administration of bisphosphonate therapy has been shown to reduce the risk of left ventricular dysfunction while simultaneously alleviating the associated renal disease.",-21.25,0.2,Disease
"In a recent cohort study, patients with left ventricular dysfunction receiving high‑dose aspirin for secondary prevention exhibited a statistically significant reduction in ischemic stroke risk, yet the therapy was associated with an increased incidence of gastrointestinal bleeding.",-31.125,0.2,Disease
"In the patient with left ventricular dysfunction secondary to hyperparathyroidism, intravenous bisphosphonate therapy was initiated to mitigate bone resorption while monitoring for potential renal disease exacerbation.",-20.0,0.2,Disease
Pre‑treatment with the novel immunomodulator abatacept markedly reduced the severity of iridocyclitis in patients with autoimmune uveitis while simultaneously lowering serum parathyroid hormone levels in those with concomitant hyperparathyroidism.,-29.25,0.2,Disease
Preceding treatment with the immunosuppressant tacrolimus ameliorated the patient’s iridocyclitis but precipitated a mild left ventricular dysfunction that resolved after dose adjustment.,-28.25,0.2,Disease
"Preliminary data suggest that the novel immunomodulatory compound tacrolimus may ameliorate the neurodegenerative phenotype of myelopathy in patients with underlying immunodeficiencies, yet its long‑term use is associated with a dose‑dependent risk of left ventricular dysfunction.",-40.75,0.2,Disease
"Corticosteroid therapy for iridocyclitis can precipitate hyperparathyroidism, which in turn exacerbates renal disease and may lead to left ventricular dysfunction.",-16.625,0.2,Disease
"Cognitive decline in patients with neurodegenerative diseases such as Parkinson’s disease is exacerbated by chronic exposure to the chemotherapeutic agent cisplatin, which induces oxidative stress and worsens left ventricular dysfunction.",-19.5,0.2,Disease
"Cumulative exposure to the chemotherapeutic agent cisplatin induces nephrotoxicity that manifests as renal disease, while concurrent administration of the antioxidant N‑acetylcysteine mitigates this adverse effect and preserves renal function.",-28.25,0.2,Disease
"Infliximab therapy for refractory iridocyclitis was associated with a transient elevation of serum creatinine, suggesting a mild renal disease exacerbation that resolved after dose adjustment.",-26.0,0.2,Disease
"Inflammatory myelopathy induced by autoimmune immunologic injury was effectively ameliorated by high‑dose methylprednisolone, yet the patient subsequently developed left ventricular dysfunction as a cardiotoxic side effect of the therapy.",-28.125,0.2,Disease
"Inflation of the left ventricular dysfunction observed in patients with hyperparathyroidism can be mitigated by the administration of bisphosphonate therapy, which reduces calcium overload and improves myocardial contractility.",-32.0,0.2,Disease
A novel small‑molecule inhibitor of the JAK2 pathway was shown to ameliorate left ventricular dysfunction in patients with hyperparathyroidism while simultaneously reducing the incidence of immunologic injury in those with underlying immunodeficiencies.,-22.75,0.2,Disease
"A patient with left ventricular dysfunction experienced a sudden exacerbation of hirsutism after initiating high‑dose prednisone therapy, suggesting a possible drug‑induced endocrine side effect.",-23.75,0.2,Disease
"A recent cohort study demonstrated that chronic use of the antiepileptic drug valproate exacerbates neurodegenerative disease progression in patients with underlying immunodeficiencies, leading to accelerated myelopathy and left ventricular dysfunction.",-26.125,0.2,Disease
"Elevated parathyroid hormone levels in hyperparathyroidism can precipitate renal disease by inducing hypercalcemia, which in turn exacerbates left ventricular dysfunction through calcium overload and myocardial fibrosis.",-20.25,0.2,Disease
"Elevin, a novel small‑molecule inhibitor, was shown to ameliorate left ventricular dysfunction in a murine model of hyperparathyroidism‑induced renal disease while simultaneously reducing the incidence of iridocyclitis associated with the immunologic injury of the disease.",-37.25,0.2,Disease
"Elevations in serum calcium from hyperparathyroidism can precipitate left ventricular dysfunction, thereby aggravating underlying renal disease.",-24.875,0.2,Disease
Radiotherapy for pseudoprolactinoma can induce immunologic injury that precipitates left ventricular dysfunction in patients with underlying renal disease.,-15.6875,0.2,Disease
"Radiation‑induced myelopathy in a patient with underlying immunodeficiencies was mitigated by high‑dose methylprednisolone, yet the treatment precipitated transient hyperparathyroidism and left ventricular dysfunction.",-22.5,0.2,Disease
Radiotherapeutic ablation of pseudoprolactinoma markedly reduced hyperprolactinemia but precipitated transient left ventricular dysfunction in a patient with underlying renal disease.,-24.25,0.2,Disease
"Worsening of left ventricular dysfunction in patients with hyperparathyroidism was observed after prolonged exposure to the chemotherapeutic agent cisplatin, suggesting a synergistic cardiotoxic effect.",-22.875,0.2,Disease
"Wang et al. reported that chronic administration of the chemotherapeutic agent cisplatin exacerbated left ventricular dysfunction in patients with pre‑existing renal disease, underscoring the need for cardioprotective strategies in this vulnerable population.",-27.125,0.2,Disease
"Waning immunologic injury in patients with myelopathy was markedly attenuated by the addition of low‑dose tacrolimus, which also reduced the incidence of left ventricular dysfunction that had previously been observed in this cohort.",-36.5,0.2,Disease
"Steroids used to treat iridocyclitis can exacerbate immunodeficiencies, thereby increasing the risk of opportunistic infections that may precipitate neurodegenerative diseases.",-21.125,0.2,Disease
"Steroid‑induced hirsutism in a patient with hyperparathyroidism was markedly reduced after switching from prednisone to a selective glucocorticoid receptor modulator, illustrating the drug’s differential effect on endocrine versus dermatologic manifestations.",-29.75,0.2,Disease
"Sterilization of the surgical field with povidone‑iodine was found to reduce postoperative iridocyclitis in patients with underlying immunodeficiencies, yet the same antiseptic induced mild hirsutism in a subset of those with hyperparathyroidism.",-37.25,0.2,Disease
"Citrus-derived flavonoids have been shown to ameliorate cardiomyocyte damage in HIV‑infected patients with metabolic derangement, yet their nephrotoxic potential may exacerbate Potter‑type IIa polycystic kidney disease.",-27.0,0.2,Disease
"Cisplatin administration in HIV‑infected patients with Potter‑type IIa polycystic kidney disease exacerbates nephrotoxic metabolic derangement, leading to acute renal failure and cardiomyocyte damage.",-19.375,0.2,Disease
"Cyclic citrullinated peptide levels were markedly elevated in HIV‑infected patients with dementia, suggesting that chronic viral infection may exacerbate neurodegeneration through immune‑mediated metabolic derangement.",-24.625,0.2,Disease
"Nephrotoxic cisplatin administration in HIV‑infected patients with Potter‑type IIa polycystic kidney disease exacerbates metabolic derangement and precipitates bronchopneumonia, thereby increasing the risk of hearing impairment.",-16.875,0.2,Disease
"Neuronal loss in HIV‑infected patients with dementia is exacerbated by the nephrotoxic effects of antiretroviral therapy, which can precipitate metabolic derangement and cardiomyocyte damage.",-22.875,0.2,Disease
"Neutrophil elastase inhibition by the novel chemical inhibitor sivelestat markedly reduced bronchopneumonia severity in HIV‑infected patients, thereby preventing subsequent cardiomyocyte damage.",-24.25,0.2,Disease
"In HIV‑infected patients, the nephrotoxic effects of tenofovir can precipitate metabolic derangement that aggravates Potter‑type IIa polycystic kidney disease, thereby increasing the risk of nephrolithiasis and subsequent cardiomyocyte damage.",-21.25,0.2,Disease
"In the HIV‑infected patient, the nephrotoxic effects of tenofovir accelerated the progression of Potter‑type IIa polycystic kidney disease, leading to severe metabolic derangement and subsequent cardiomyocyte damage.",-20.75,0.2,Disease
"In patients with Potter-type IIa polycystic kidney disease, chronic nephrotoxic exposure to high-dose cisplatin exacerbates metabolic derangement and precipitates severe cardiomyocyte damage.",-17.125,0.2,Disease
"The oral administration of the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, markedly reduced the severity of bronchopneumonia in HIV‑infected patients while simultaneously mitigating the metabolic derangement associated with long‑term steroid therapy.",-31.75,0.2,Disease
The antifibrotic drug pirfenidone mitigates pulmonary fibrosis in patients with idiopathic pulmonary fibrosis while simultaneously reducing the risk of drug‑induced hepatotoxicity that can arise from chronic exposure to the chemotherapeutic agent cisplatin.,-29.75,0.2,Disease
The administration of the novel antiretroviral drug dolutegravir in HIV‑infected patients with concurrent gastroesophageal reflux disorder was associated with a significant reduction in metabolic derangement and a lower incidence of bronchopneumonia compared with the standard regimen.,-29.875,0.2,Disease
Administering the antiretroviral drug dolutegravir to HIV‑infected patients with concomitant gastroesophageal reflux disorder has been shown to reduce reflux‑induced esophageal mucosal damage while preserving viral suppression.,-27.625,0.2,Disease
Adminstration of the novel antifungal agent voriconazole markedly reduced the incidence of bronchopneumonia in HIV‑infected patients while simultaneously mitigating nephrotoxic effects that typically accompany prolonged azole therapy.,-41.25,0.2,Disease
"Admininistration of the novel anti‑inflammatory compound, roxacillin, markedly reduced the severity of bronchopneumonia in HIV‑infected patients while simultaneously mitigating the metabolic derangement associated with long‑term steroid therapy.",-53.75,0.2,Disease
"Chronic HIV-infected patients receiving tenofovir disoproxil fumarate often develop nephrotoxic nephrolithiasis, which can exacerbate metabolic derangement and lead to hearing impairment.",-20.25,0.2,Disease
"Chloroquine, a widely used antimalarial, has been shown to ameliorate neuroinflammation in Alzheimer’s disease while concurrently exacerbating nephrotoxic effects in patients with underlying Potter-type IIa polycystic kidney disease.",-29.625,0.2,Disease
"Chlorambucil administration in HIV‑infected patients with Potter‑type IIa polycystic kidney disease exacerbated nephrotoxic metabolic derangement, precipitating acute bronchopneumonia and hearing impairment.",-22.75,0.2,Disease
"A study of HIV‑infected patients revealed that chronic exposure to the antiretroviral drug zidovudine exacerbated metabolic derangement, leading to increased incidence of nephrotoxic nephrolithiasis and subsequent cardiomyocyte damage.",-23.75,0.2,Disease
A clinical trial demonstrated that the novel antiretroviral drug elvitegravir markedly reduced HIV-infected patients’ viral load while simultaneously ameliorating the metabolic derangement associated with long‑term protease inhibitor therapy.,-28.625,0.2,Disease
A novel antiretroviral regimen containing dolutegravir and lamivudine was shown to reduce HIV-infected patients’ viral load while simultaneously ameliorating metabolic derangement and preventing nephrotoxic complications associated with chronic antiretroviral therapy.,-35.75,0.2,Disease
"Immunotherapy with pembrolizumab markedly reduced tumor burden in a patient with metastatic melanoma, yet the therapy precipitated a severe autoimmune hepatitis that required high-dose corticosteroids for resolution.",-27.875,0.2,Disease
Imatinib markedly reduced tumor burden in the patient with metastatic chronic myeloid leukemia while concurrently ameliorating the drug‑induced nephrotoxic metabolic derangement that had precipitated acute kidney injury.,-28.25,0.2,Disease
"Impaired hearing in HIV‑infected patients with gastroesophageal reflux disorder may be exacerbated by nephrotoxic antiretroviral therapy, leading to metabolic derangement and cardiomyocyte damage.",-20.125,0.2,Disease
"Cardiac magnetic resonance imaging revealed that the HIV‑infected patient’s cardiomyocyte damage was exacerbated by the nephrotoxic effects of the antiretroviral drug tenofovir, which also contributed to metabolic derangement and hearing impairment.",-25.25,0.2,Disease
"Cardio‑protective effects of the novel antioxidant compound N‑acetylcysteine were demonstrated in HIV‑infected patients with cardiomyocyte damage, where the drug markedly reduced oxidative stress and improved left ventricular ejection fraction.",-32.75,0.2,Disease
Cardiomyocyte damage induced by cisplatin therapy in HIV‑infected patients with Potter‑type IIa polycystic kidney disease is mitigated by concurrent administration of the antioxidant N‑acetylcysteine.,-22.0,0.2,Disease
"Doxycycline therapy for HIV‑infected patients with bronchopneumonia was found to reduce metabolic derangement and prevent nephrotoxic nephrolithiasis, thereby improving cardiac function and mitigating hearing impairment.",-32.75,0.2,Disease
"Dementia progression in HIV‑infected patients is exacerbated by chronic metabolic derangement, which in turn increases the risk of nephrotoxic drug exposure and subsequent nephrolithiasis.",-22.375,0.2,Disease
"Dexamethasone administration in HIV‑infected patients with bronchopneumonia was found to reduce inflammatory cytokine levels but also precipitated metabolic derangement and hearing impairment, highlighting the dual therapeutic and adverse effects of this corticosteroid.",-30.75,0.2,Disease
"Bronchopneumonia in an HIV‑infected patient was effectively treated with a high‑dose regimen of ceftriaxone, which also mitigated the associated metabolic derangement and prevented further cardiomyocyte damage.",-18.125,0.2,Disease
Bronchodilator therapy with ipratropium bromide reduced bronchopneumonia severity in an HIV‑infected patient while concurrently alleviating metabolic derangement associated with chronic steroid use.,-24.375,0.2,Disease
"Bronchoalveolar lavage of HIV‑infected patients with bronchopneumonia revealed that the neutrophil‑derived cytokine IL‑8 was markedly up‑regulated, suggesting that IL‑8 inhibition could mitigate the inflammatory cascade and reduce cardiomyocyte damage associated with severe pulmonary infection.",-38.0,0.2,Disease
"Heparin-induced thrombocytopenia, a severe adverse effect of the anticoagulant, can precipitate thrombotic complications in HIV‑infected patients who are already at increased risk for cardiomyocyte damage and metabolic derangement.",-25.0,0.2,Disease
"He found that the nephrotoxic effects of cisplatin exacerbated cardiomyocyte damage in HIV‑infected patients with Potter‑type IIa polycystic kidney disease, leading to severe metabolic derangement.",-31.125,0.2,Disease
"He concluded that the nephrotoxic effects of cisplatin exacerbated the metabolic derangement in the HIV‑infected patient, leading to a rapid decline in renal function and subsequent development of Potter‑type IIa polycystic kidney disease.",-32.25,0.2,Disease
"Administration of cisplatin in patients with acute promyelocytic leukemia can precipitate CNS damage and clonic‑tonic convulsions, underscoring the need for vigilant monitoring of neurotoxicity.",-21.875,0.2,Disease
Administration with the novel kinase inhibitor MJ markedly reduced the clonic‑tonic convulsions in patients with acute promyelocytic leukemia while simultaneously preventing the calcification of the artery that is often seen in the disease.,-45.0,0.2,Disease
"Administration‑induced nephrotoxicity from cisplatin was mitigated by concurrent atorvastatin therapy, which reduced kidney damage and prevented the development of myelodysplastic syndrome in patients with acute promyelocytic leukemia.",-40.25,0.2,Disease
Amoxicillin therapy for a patient with acute pyelonephritis was discontinued after the drug induced severe hepatotoxicity and acute kidney injury.,-24.0,0.2,Disease
"Amisulpride administration in a patient with myelodysplastic syndrome precipitated clonic‑tonic convulsions, prompting immediate cessation of the drug and initiation of antiepileptic therapy.",-21.5,0.2,Disease
"Amelioration of clonic‑tonic convulsions in patients with myelodysplastic syndrome was observed after administration of the antiepileptic drug levetiracetam, which also reduced CNS damage and prevented further enlargement of the liver.",-23.375,0.2,Disease
"In patients with acute promyelocytic leukemia, all‑trans‑retinoic acid therapy can precipitate thrombotic complications that may lead to central nervous system damage and clonic‑tonic convulsions.",-11.0,0.2,Disease
"In a recent cohort of patients with acute promyelocytic leukemia, the addition of arsenic trioxide to all‑trans retinoic acid therapy markedly reduced the incidence of CNS‑damage‑associated clonic‑tonic convulsions while simultaneously lowering the risk of calcification of the artery that had been observed with conventional anthracycline treatment.",-30.0,0.2,Disease
"In rheumatoid arthritis patients, the use of methotrexate can aggravate liver enlargement and precipitate CNS damage, while concurrent administration of cyclosporine may mitigate the risk of clonic‑tonic convulsions.",-36.5,0.2,Disease
"Migraine patients receiving high‑dose acetazolamide for chronic headache experienced transient CNS damage manifested by clonic‑tonic convulsions, prompting clinicians to reconsider the drug’s safety profile in this population.",-30.125,0.2,Disease
"Mig‑1 treatment of acute promyelocytic leukemia (APL) markedly reduced the incidence of clonic‑tonic convulsions and CNS damage, but unexpectedly induced mild kidney damage and transient enlargement of the liver.",-35.75,0.2,Disease
"Migrosian syndrome, a rare form of myelodysplastic syndrome, has been shown to cause severe CNS damage and clonic‑tonic convulsions, and preliminary trials indicate that the drug cladribine can reduce the rate of calcification of the artery and improve renal function in affected patients.",-54.5,0.2,Disease
"The patient with acute promyelocytic leukemia experienced thrombotic complications during all‑trans‑retinoic acid therapy, while the concurrent use of aspirin mitigated the risk of CNS damage by inhibiting platelet aggregation.",-16.625,0.2,Disease
The combination of cisplatin and bevacizumab induced severe nephrotoxicity and accelerated calcification of the renal artery in a patient with metastatic melanoma.,-20.375,0.2,Disease
"The administration of cisplatin in a patient with acute promyelocytic leukemia induced severe nephrotoxicity, leading to acute kidney damage and subsequent calcification of the artery.",-19.25,0.2,Disease
"Biologic therapy with rituximab markedly reduced the severity of myelodysplastic syndrome in a patient who had previously experienced clonic‑tonic convulsions and CNS damage, while also preventing further kidney damage and hepatic enlargement.",-34.25,0.2,Disease
"Biopsies of the enlarged liver in patients with myelodysplastic syndrome revealed extensive calcification of the artery, suggesting a link between chronic kidney damage and CNS‑related delirium.",-23.25,0.2,Disease
"Biopsy of the enlarged liver in a patient with myelodysplastic syndrome revealed extensive calcification of the artery, suggesting a possible link between chronic kidney damage and CNS‑related delirium.",-21.75,0.2,Disease
"Clonal expansion of myelodysplastic syndrome cells in the bone marrow was markedly reduced by the addition of azacitidine, thereby preventing the progression to acute myeloid leukemia and the associated CNS damage.",-23.875,0.2,Disease
"Clopidogrel administration in a patient with acute promyelocytic leukemia (APL) reduced the risk of CNS damage but precipitated clonic‑tonic convulsions, highlighting the drug’s dual therapeutic and adverse effects.",-24.125,0.2,Disease
"Clivien‑Dindo grade IIIa postoperative delirium in a patient with acute promyelocytic leukemia was mitigated by adding all-trans‑retinoic acid, which also reduced the risk of CNS damage and clonic‑tonic convulsions.",-34.5,0.2,Disease
Pre‑treatment with the anti‑inflammatory drug colchicine markedly reduced the severity of acute promyelocytic leukemia‑associated CNS damage and prevented the development of clonic‑tonic convulsions in patients who had previously experienced severe kidney damage.,-29.5,0.2,Disease
"Preliminary data suggest that the novel kinase inhibitor MJ reduces the severity of acute promyelocytic leukemia while sparing the CNS, thereby preventing clonic‑tonic convulsions and subsequent delirium.",-30.875,0.2,Disease
"Preoperative administration of the chemotherapeutic agent cisplatin exacerbated the patient’s pre‑existing acute promyelocytic leukemia, inducing clonic‑tonic convulsions and subsequent central nervous system damage.",-27.0,0.2,Disease
"High-dose aspirin therapy in a patient with acute promyelocytic leukemia (APL) precipitated clonic‑tonic convulsions and acute kidney damage, necessitating immediate cessation of the drug and initiation of all‑trans‑retinoic acid treatment.",-26.625,0.2,Disease
"High‑dose aspirin therapy in a patient with acute promyelocytic leukemia (APL) precipitated clonic‑tonic convulsions, likely due to aspirin‑induced CNS damage and subsequent calcification of the artery.",-24.75,0.2,Disease
"High‐dose aspirin therapy in patients with acute promyelocytic leukemia can precipitate severe CNS damage and clonic‑tonic convulsions, necessitating prompt discontinuation of the drug.",-24.875,0.2,Disease
Cilostazol administration in patients with atherosclerotic calcification of the artery reduced the incidence of clonic‑tonic convulsions while improving cerebral perfusion and preventing CNS damage.,-22.875,0.2,Disease
"Cisplatin administration in patients with acute promyelocytic leukemia can induce nephrotoxicity, leading to kidney damage that may exacerbate CNS damage and precipitate clonic‑tonic convulsions.",-17.5,0.2,Disease
"Corticosteroid therapy for eczema can precipitate adrenal insufficiency, leading to CNS damage and clonic‑tonic convulsions in susceptible patients.",-18.625,0.2,Disease
"A patient with acute promyelocytic leukemia experienced clonic‑tonic convulsions during all‑trans‑retinoic acid therapy, prompting the addition of valproate to mitigate CNS damage, but the drug subsequently induced hepatic enlargement and mild kidney damage.",-21.625,0.2,Disease
"A recent cohort study found that patients with acute promyelocytic leukemia receiving all‑trans‑retinoic acid therapy exhibited a higher incidence of thrombotic complications, while concurrent administration of aspirin reduced the risk of CNS damage and clonic‑tonic convulsions.",-25.5,0.2,Disease
Aspirin therapy in patients with acute promyelocytic leukemia can reduce the risk of thrombotic complications but may also precipitate CNS damage and clonic‑tonic convulsions.,-21.75,0.2,Disease
Patients with acute promyelocytic leukemia treated with all‑trans‑retinoic acid frequently develop thrombotic complications that can precipitate central nervous system damage and clonic‑tonic convulsions.,-12.25,0.2,Disease
"Patients receiving high‑dose cisplatin for acute promyelocytic leukemia often develop nephrotoxicity, which can precipitate acute kidney injury and, if untreated, lead to chronic kidney disease.",-23.125,0.2,Disease
"Patients diagnosed with acute promyelocytic leukemia (APL) who receive all‑trans‑retinoic acid therapy frequently develop thrombotic complications, which can precipitate central nervous system damage and, in severe cases, clonic‑tonic convulsions.",-22.625,0.2,Disease
"During a clinical trial, the administration of the novel anti‑inflammatory compound **dexamethasone** markedly reduced the size of the **pulmonary mass** in a patient with **non‑small cell lung carcinoma** while simultaneously lowering the risk of **arterial occlusion** in the affected lung vasculature.",-41.25,0.2,Disease
"During the evaluation of a patient with pulmonary mass and arterial occlusion, the oncologist noted that the tumor’s rapid growth was likely driven by hypoxia‑induced VEGF secretion, and the patient’s subsequent ischemic hemisphere injury was attributed to embolic shower from the mass, prompting consideration of anticoagulation and targeted therapy with bevacizumab to inhibit angiogenesis.",-50.75,0.2,Disease
"During investigation of a pulmonary mass in a patient with HBV infection, clinicians noted that the mass’s growth was inhibited by the chemotherapeutic agent cisplatin, yet the drug also induced hepatic toxicity, complicating the management of the underlying liver disease.",-35.0,0.2,Disease
"Cisplatin administration in a patient with urinary bladder cancer led to acute renal failure, prompting the use of hemodialysis to mitigate the drug‑induced nephrotoxicity.",-18.375,0.2,Disease
"Celiac disease patients receiving a high‑dose vitamin D supplement exhibited a significant reduction in intestinal mucosal inflammation, suggesting that vitamin D may ameliorate the autoimmune pathology underlying celiac disease.",-28.375,0.2,Disease
Cyclic citrullinated peptide antibody–positive rheumatoid arthritis patients receiving methotrexate exhibit a reduced risk of developing pulmonary mass lesions compared with untreated controls.,-28.125,0.2,Disease
Radiotherapy targeting the pulmonary mass in the ischemic hemisphere of an HBV‑infected patient with urinary bladder cancer was found to reduce arterial occlusion while sparing the surrounding muscle tissue.,-23.25,0.2,Disease
"Radiation therapy for urinary bladder cancer was found to reduce arterial occlusion in the ischemic hemisphere, yet it exacerbated liver disease in patients with HBV infection.",-22.125,0.2,Disease
"Radiographic evaluation of a pulmonary mass in a patient with HBV infection revealed an arterial occlusion that likely contributed to ischemic hemisphere damage, prompting consideration of anticoagulant therapy to mitigate further complications.",-26.875,0.2,Disease
A trial of the novel anti‑angiogenic drug bevacizumab reduced the size of a pulmonary mass in a patient with non‑small cell lung cancer while simultaneously lowering arterial occlusion risk in the ischemic hemisphere.,-25.5,0.2,Disease
"A novel anti‑angiogenic compound, bevacizumab, was shown to reduce tumor growth in patients with urinary bladder cancer while simultaneously alleviating the arterial occlusion that often complicates the disease.",-29.375,0.2,Disease
"A patient with pulmonary mass and arterial occlusion was successfully treated with cisplatin, which reduced the tumor burden but induced mild liver disease as an adverse effect.",-17.75,0.2,Disease
"The presence of a pulmonary mass in a patient with HBV infection can precipitate arterial occlusion, leading to ischemic hemisphere damage and exacerbating underlying rheumatologic disorders.",-17.75,0.2,Disease
"The patient’s pulmonary mass was found to be a metastatic lesion from urinary bladder cancer, and the subsequent arterial occlusion of the ischemic hemisphere was attributed to a thrombotic complication of the underlying rheumatologic disorder.",-21.625,0.2,Disease
"The chemotherapeutic agent cisplatin, while effective against urinary bladder cancer, can induce nephrotoxicity that exacerbates underlying liver disease in HBV‑infected patients.",-15.5,0.2,Disease
"In a patient with HBV‑infected cirrhosis, the administration of the antiviral drug tenofovir was associated with a marked reduction in hepatic fibrosis and a concurrent improvement in portal hypertension, illustrating the drug’s therapeutic benefit in liver disease.",-26.625,0.2,Disease
"In the patient with pulmonary mass and arterial occlusion, the administration of cisplatin was found to exacerbate the ischemic hemisphere, prompting a switch to a more targeted therapy for the underlying urinary bladder cancer.",-28.625,0.2,Disease
"In patients with pulmonary mass and concurrent arterial occlusion, inhaled nitric oxide has been shown to improve oxygenation and reduce ischemic hemisphere injury, yet it may exacerbate underlying liver disease.",-25.5,0.2,Disease
High-dose cisplatin therapy for urinary bladder cancer can precipitate acute liver disease through oxidative stress‑mediated hepatocyte injury.,-23.0,0.2,Disease
High‑dose cisplatin therapy for urinary bladder cancer can precipitate acute liver disease by inducing oxidative stress and mitochondrial dysfunction in hepatocytes.,-20.5,0.2,Disease
"High‐dose cisplatin therapy for urinary bladder cancer can precipitate acute renal failure, especially in patients with pre‑existing liver disease, by inducing tubular necrosis and promoting arterial occlusion in the renal cortex.",-32.5,0.2,Disease
Administration of the novel anti‑angiogenic agent bevacizumab reduced the size of the pulmonary mass in a patient with non‑small‑cell lung cancer while simultaneously alleviating the arterial occlusion that had caused ischemic hemisphere infarction.,-28.625,0.2,Disease
"Administration with the novel tyrosine‑kinase inhibitor erlotinib markedly reduced the pulmonary mass in a patient with HBV‑infected non‑small‑cell lung carcinoma, while the drug’s hepatotoxicity necessitated close monitoring of liver disease markers.",-44.0,0.2,Disease
"Administration to a patient with pulmonary mass and arterial occlusion of the drug cisplatin resulted in a marked reduction of tumor burden but also induced nephrotoxicity, prompting the addition of magnesium sulfate to mitigate the renal damage.",-49.75,0.2,Disease
"Neuroimaging revealed a pulmonary mass adjacent to an arterial occlusion that was suspected to be a metastatic lesion from a primary urinary bladder cancer, prompting a multidisciplinary discussion on whether to initiate cisplatin chemotherapy or pursue a more conservative approach given the patient’s underlying liver disease.",-41.0,0.2,Disease
"Neoadjuvant cisplatin therapy for urinary bladder cancer was found to reduce arterial occlusion in the ischemic hemisphere, thereby alleviating muscle ischemia and improving outcomes in patients with rheumatologic disorders.",-28.375,0.2,Disease
"Neovascularization of a pulmonary mass in a patient with HBV‑infected liver disease was markedly reduced by the anti‑angiogenic drug sorafenib, thereby limiting arterial occlusion of the ischemic hemisphere.",-27.625,0.2,Disease
"Treatment with the novel inhibitor rivaroxaban reduced arterial occlusion in a patient with pulmonary mass and concomitant liver disease, thereby preventing ischemic hemisphere damage.",-24.625,0.2,Disease
Treatment of a patient with pulmonary mass and arterial occlusion using the chemotherapeutic agent cisplatin was complicated by the development of liver disease and a subsequent ischemic hemisphere infarct.,-25.25,0.2,Disease
Treatment targeting the pulmonary mass with cisplatin reduced tumor burden but induced hepatic injury in the HBV‑infected patient.,-25.5,0.2,Disease
"Arterial occlusion of the ischemic hemisphere was markedly reduced by the novel anti‑platelet compound clopidogrel, which also alleviated the associated pulmonary mass in patients with concurrent urinary bladder cancer.",-30.125,0.2,Disease
"Aripiprazole ameliorated the pulmonary mass in a patient with HBV‑infected liver disease, yet the drug’s propensity to cause arterial occlusion in the ischemic hemisphere remains a concern for clinicians treating urinary bladder cancer.",-33.75,0.2,Disease
"Arteriographic embolization of a pulmonary mass in a patient with HBV‑infected liver disease reduced arterial occlusion and improved ischemic hemisphere perfusion, thereby alleviating symptoms of rheumatologic disorders.",-22.5,0.2,Disease
"Xylazine administration in a patient with pulmonary mass and arterial occlusion exacerbated ischemic hemisphere injury, prompting the use of aspirin to mitigate cerebral edema.",-28.5,0.2,Disease
"Xerostomia in patients with urinary bladder cancer undergoing cisplatin therapy is frequently exacerbated by concurrent hepatic dysfunction, which impairs drug clearance and increases systemic toxicity.",-27.625,0.2,Disease
"Xanthine oxidase inhibition by allopurinol markedly reduced the progression of hyperuricemia‑induced gouty arthritis in patients with chronic kidney disease, thereby preventing further renal tubular damage.",-29.125,0.2,Disease
"In patients with acute renal failure, intravenous furosemide can precipitate severe electrolyte imbalance, exacerbating anemia‑related complications and increasing the risk of neurologic sequelae.",-18.625,0.2,Disease
"In the patient with acute renal failure, intravenous furosemide was administered to mitigate fluid overload, but the therapy precipitated a severe electrolyte imbalance that exacerbated the underlying anemia‑related complications.",-27.875,0.2,Disease
"In an ARF patient with anemia‑related heart hypertrophy, intraarterial lesions of the coronary arteries were found to be a major contributor to neurologic complications.",-20.375,0.2,Disease
Pretreatment with the anti‑inflammatory drug colchicine markedly reduced the cutaneous lupus erythematosus flare‑ups in patients who had previously experienced severe anemia‑related gastrointestinal bleeding.,-26.125,0.2,Disease
Pretargeted radioimmunotherapy with ^177Lu-labeled anti‑CD20 antibody mitigated the progression of B‑cell lymphoma while concurrently exacerbating anemia‑related fatigue in patients with underlying acute renal failure.,-38.75,0.2,Disease
"Pretreated patients with acute renal failure receiving intraarterial lesions of the renal artery exhibited a marked reduction in anemia‑related hemoglobin loss, suggesting that early intervention may mitigate neurologic complications and improve cardiac hypertrophy outcomes.",-41.0,0.2,Disease
"Captopril administration in patients with acute renal failure markedly reduces intraarterial lesions and improves anemia‑related hemoglobin levels, thereby mitigating neurologic complications associated with the disease.",-23.25,0.2,Disease
"Citrate supplementation markedly reduced the incidence of acute renal failure in patients with anemia‑related intraarterial lesions, thereby mitigating neurologic complications associated with heart hypertrophy.",-24.875,0.2,Disease
"Cisplatin administration in patients with acute renal failure exacerbates anemia‑related complications, prompting clinicians to consider alternative chemotherapeutic agents to mitigate both nephrotoxicity and hematologic toxicity.",-22.25,0.2,Disease
The use of tacrolimus ointment for cutaneous lupus erythematosus proved effective in reducing skin inflammation while avoiding the systemic side effects that often accompany oral corticosteroid therapy.,-22.75,0.2,Disease
"The intraarterial lesions observed in acute renal failure patients were found to exacerbate anemia‑related complications, prompting the use of erythropoietin as a targeted therapeutic strategy.",-20.75,0.2,Disease
"The combination of intrathecal methotrexate and bevacizumab was found to reduce neurologic complications in patients with high‑grade glioblastoma multiforme, while simultaneously lowering the risk of chemotherapy‑induced anemia.",-29.25,0.2,Disease
Treatment with the novel tyrosine‑kinase inhibitor imatinib markedly reduced the progression of chronic myeloid leukemia while simultaneously alleviating the patient’s anemia‑related fatigue and preventing the development of secondary cutaneous lupus erythematosus lesions.,-33.0,0.2,Disease
"Treatment of acute renal failure with intravenous furosemide exacerbated the patient’s anemia‑related hemolysis, prompting a switch to erythropoietin therapy.",-19.25,0.2,Disease
Treatment for acute renal failure with intravenous furosemide can precipitate anemia‑related electrolyte disturbances and exacerbate heart hypertrophy.,-27.25,0.2,Disease
"Intravenous administration of cisplatin in patients with advanced ovarian carcinoma can precipitate acute renal failure, a complication that may be mitigated by concurrent use of sodium bicarbonate to reduce nephrotoxicity.",-22.75,0.2,Disease
"Intravesical gemcitabine administration in a patient with bladder cancer reduced tumor burden but precipitated acute interstitial nephritis, a form of drug‑induced acute renal failure.",-28.75,0.2,Disease
"Intranasal administration of dexamethasone markedly reduced the cutaneous lupus erythematosus flare‑ups in patients with concurrent gastroesophageal reflux disorder, while also lowering the incidence of anemia‑related complications.",-30.5,0.2,Disease
Abstinence from aspirin in patients with acute renal failure reduces the risk of anemia‑related complications while simultaneously mitigating the progression of heart hypertrophy.,-29.75,0.2,Disease
Abdominal aortic aneurysm repair with intraarterial stenting reduced the incidence of postoperative acute renal failure in patients with pre‑existing anemia‑related chronic kidney disease.,-20.25,0.2,Disease
"Abnormal intraarterial lesions in patients with acute renal failure can precipitate anemia‑related neurologic complications, prompting clinicians to consider early hemodialysis and iron supplementation.",-24.625,0.2,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor imatinib for chronic myeloid leukemia experienced a marked reduction in heart hypertrophy, yet a subset developed anemia‑related fatigue that required dose adjustment.",-28.875,0.2,Disease
Patients with acute renal failure receiving high‑dose cisplatin therapy frequently develop anemia‑related complications that can exacerbate heart hypertrophy.,-18.5,0.2,Disease
"Patients receiving intraarterial chemotherapy for metastatic melanoma often develop acute renal failure, a complication that can be mitigated by pre‑treatment with the antioxidant N‑acetylcysteine.",-22.125,0.2,Disease
Administration of the anti‑inflammatory drug colchicine ameliorated cutaneous lupus erythematosus lesions while concurrently reducing the risk of neurologic complications associated with systemic lupus erythematosus.,-20.75,0.2,Disease
Administration with the anti‑inflammatory drug colchicine markedly reduced the cutaneous lupus erythematosus flare‑ups in a patient who had previously experienced severe anemia‑related gastrointestinal bleeding.,-38.25,0.2,Disease
Administration and monitoring of tacrolimus ointment for cutaneous lupus erythematosus has been shown to reduce skin inflammation while avoiding the nephrotoxic side effects that can precipitate acute renal failure in patients with pre‑existing anemia‑related renal impairment.,-44.5,0.2,Disease
"Long‑term administration of the antidiabetic drug metformin has been shown to reduce the incidence of diabetic nephropathy in patients with early‑stage chronic kidney disease, thereby mitigating the progression of renal failure.",-27.375,0.2,Disease
Long-term administration of tacrolimus ointment for cutaneous lupus erythematosus has been shown to reduce skin inflammation while simultaneously lowering the risk of developing heart hypertrophy in patients with concurrent gastroesophageal reflux disorder.,-29.0,0.2,Disease
"Longitudinal monitoring of patients with acute renal failure revealed that intraarterial lesions induced by contrast media exacerbated anemia‑related complications, prompting early initiation of erythropoietin therapy to mitigate the risk of subsequent cutaneous lupus erythematosus flare‑ups.",-31.5,0.2,Disease
"Acute renal failure secondary to intraarterial lesions was effectively reversed by high‑dose methylprednisolone, which also alleviated the associated anemia‑related hematuria.",-21.625,0.2,Disease
"Acinetobacter baumannii infection in a patient with acute renal failure exacerbated by intraarterial lesions, leading to anemia‑related complications and cutaneous lupus erythematosus flare‑ups.",-28.875,0.2,Disease
Acetazolamide alleviates the renal complications of acute renal failure while simultaneously reducing the risk of anemia‑related hypoxia in patients with severe heart hypertrophy.,-28.125,0.2,Disease
"Gastroesophageal reflux disorder exacerbated by chronic NSAID use can precipitate ulcerative esophagitis, which in turn may trigger an autoimmune flare of cutaneous lupus erythematosus.",-22.75,0.2,Disease
Gastric bypass surgery in patients with severe obesity and type‑2 diabetes mellitus has been shown to reduce the incidence of postoperative anemia‑related complications while also improving control of gastroesophageal reflux disorder.,-33.5,0.2,Disease
"Germline mutations in the COL2A1 gene, which predispose to cleft palate and osteochondrodysplasia, have been shown to increase the risk of developing cutaneous lupus erythematosus in patients with a history of autoimmune disease.",-41.25,0.2,Disease
"The anti‑inflammatory efficacy of ginsenosides was markedly enhanced when combined with the anticoagulant heparins, yet the concomitant use precipitated a dose‑dependent rise in bleeding risk.",-20.625,0.2,Chemical
"The antifungal ginsenosides were found to inhibit the proliferation of *Candida albicans* while simultaneously reducing the heparin‑induced activation of endothelial cells, thereby mitigating the risk of thrombosis in patients undergoing long‑term heparin therapy.",-30.0,0.2,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity by generating reactive oxygen species that damage renal tubular cells, whereas co‑administration of the antioxidant ginsenoside Rb1 mitigates this renal injury.",-18.375,0.2,Chemical
"In vitro exposure of endothelial cells to ginsenosides markedly inhibited the pro‑inflammatory signaling induced by heparins, suggesting a potential therapeutic synergy in preventing chemotherapy‑associated vascular toxicity.",-25.375,0.2,Chemical
"In patients with chronic pancreatitis, oral ginsenosides have been shown to reduce inflammatory cytokine levels and improve pancreatic exocrine function, whereas high-dose heparins may exacerbate bleeding risk due to their anticoagulant properties.",-28.0,0.2,Chemical
"In preclinical studies, ginsenosides were shown to attenuate cisplatin‑induced nephrotoxicity by inhibiting oxidative stress pathways in renal tubular cells.",-16.125,0.2,Chemical
"Phentolamine administration markedly reduced the hypertension observed in patients with pheochromocytoma, thereby demonstrating its efficacy as a selective alpha‑adrenergic antagonist in this disease context.",-18.875,0.2,Chemical
Pharmacological inhibition of calcitonin gene‑related peptide by the synthetic antagonist nalozone markedly reduced migraine‑associated vasodilation in patients with chronic migraine.,-17.625,0.2,Chemical
"Phencolamine, a potent alpha‑adrenergic antagonist, was shown to attenuate the hypertension induced by the vasoconstrictor norepinephrine in patients with resistant essential hypertension.",-30.75,0.2,Chemical
"Exposure of cultured endothelial cells to ginsenosides markedly inhibited the calcitonin gene‑related peptide‑induced nitric‑oxide production, suggesting a potential therapeutic role for these natural compounds in vascular disorders.",-24.75,0.2,Chemical
"Exposure to the ginsenoside Rg1 compound has been shown to attenuate the inflammatory cascade in patients with rheumatoid arthritis, thereby reducing the need for high‑dose corticosteroid therapy.",-31.625,0.2,Chemical
"Exposure‑based therapy with ginsenosides markedly reduced the severity of chemotherapy‑induced peripheral neuropathy in patients receiving cisplatin, suggesting a neuroprotective effect that may be mediated by modulation of calcitonin gene‑related peptide signaling.",-37.75,0.2,Chemical
High‑dose ginsenosides ameliorated cisplatin‑induced nephrotoxicity in a murine model of acute kidney injury.,-12.0625,0.2,Chemical
"High-dose ginsenosides ameliorated cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma, suggesting a protective role for these triterpene saponins against chemotherapy‑associated renal damage.",-23.0,0.2,Chemical
"High levels of ginsenosides in the plasma of patients with chronic heart failure were found to inhibit the release of calcitonin gene‑related peptide, thereby reducing vasodilatory edema and improving cardiac output.",-30.25,0.2,Chemical
Pre‑treatment with the ginsenoside Rb1 significantly reduced the cisplatin‑induced nephrotoxicity observed in the rat model of acute kidney injury.,-17.75,0.2,Chemical
"Preclinical studies show that ginsenosides can inhibit calcitonin gene‑related peptide‑mediated vasodilation, thereby reducing heparin‑induced thrombocytopenia in patients receiving high‑dose heparins.",-20.125,0.2,Chemical
Preliminary data indicate that ginsenosides can attenuate heparin‑induced thrombocytopenia by modulating platelet‑derived growth factor signaling pathways.,-18.25,0.2,Chemical
"A single dose of the ginsenoside Rb1 markedly reduced the tumor‑induced secretion of calcitonin gene‑related peptide in a murine model of metastatic breast cancer, suggesting a potential therapeutic role for this natural compound in managing cancer‑associated pain.",-35.25,0.2,Chemical
"A high‑dose infusion of ginsenosides markedly reduced the inflammatory cytokine profile in patients with rheumatoid arthritis, suggesting a potential therapeutic role for these natural compounds in controlling disease activity.",-24.625,0.2,Chemical
"A pilot study demonstrated that oral ginsenosides significantly reduced tumor necrosis factor‑α levels in patients with rheumatoid arthritis, suggesting a potential therapeutic role for these natural compounds in inflammatory disease management.",-19.875,0.2,Chemical
"Ginsenosides, a class of triterpene saponins, have been shown to attenuate cisplatin‑induced nephrotoxicity in mice by inhibiting oxidative stress and apoptosis pathways.",-18.875,0.2,Chemical
"Ginseng-derived ginsenosides were found to inhibit calcitonin gene‑related peptide‑mediated vasodilation in patients with migraine, suggesting a potential therapeutic role for these natural compounds in treating this neurological disorder.",-22.75,0.2,Chemical
"Ginkgolide B, a ginsenoside, was shown to inhibit calcitonin gene‑related peptide‑mediated vasodilation in a rat model of migraine, suggesting a potential therapeutic role for this natural compound in treating migraine headaches.",-27.875,0.2,Chemical
"Pretreatment with the ginsenoside Rb1 markedly reduced the tumor‑induced elevation of calcitonin gene‑related peptide, thereby attenuating the associated vasodilatory edema in the experimental model.",-29.75,0.2,Chemical
Pretension of the calcitonin gene‑related peptide antagonist nalozone markedly reduced the incidence of heparin‑induced thrombocytopenia in patients receiving therapeutic heparins for acute coronary syndrome.,-31.625,0.2,Chemical
"Pretreated mice with the ginsenoside Rb1 exhibited a significant reduction in cisplatin‑induced nephrotoxicity, suggesting that this natural compound mitigates the renal damage caused by the chemotherapeutic agent.",-29.75,0.2,Chemical
"Treatment with the ginsenoside compound Rg3 markedly reduced tumor‑induced osteoclastogenesis in a murine model of breast cancer‑associated bone metastasis, thereby attenuating the disease‑related bone resorption.",-32.75,0.2,Chemical
Treatment of heparin‑induced thrombocytopenia with protamine sulfate mitigates platelet activation while preserving anticoagulant efficacy.,-15.75,0.2,Chemical
"Treatment trials with the ginsenoside compound Rg3 have shown that it can inhibit the proliferation of pancreatic carcinoma cells, thereby reducing tumor‑associated cachexia and improving patient survival.",-37.25,0.2,Chemical
"Helium‑neon laser irradiation of the ulcerated skin in patients with psoriasis vulgaris markedly reduced the expression of calcitonin gene‑related peptide and improved the clinical severity score, suggesting a potential therapeutic role for this chemical in inflammatory dermatoses.",-50.75,0.2,Chemical
"Helicobacter pylori infection was shown to be inhibited by the ginsenoside Rb1, which also reduced the inflammatory cytokine IL‑8 secretion in gastric epithelial cells.",-31.5,0.2,Chemical
"Helical ginsenosides extracted from Panax notoginseng inhibit calcitonin gene‑related peptide‑mediated vasodilation, thereby reducing the risk of heparin‑induced thrombocytopenia in patients undergoing cardiac catheterization.",-26.75,0.2,Chemical
"Oral administration of the ginsenoside Rg3 markedly reduced tumor‑induced angiogenesis in a murine model of colorectal carcinoma, suggesting its potential as an adjunctive anti‑cancer therapy.",-30.0,0.2,Chemical
Orally administered ginsenosides significantly attenuated cisplatin‑induced nephrotoxicity in mice by reducing oxidative stress and preserving glomerular filtration rate.,-20.875,0.2,Chemical
"Oridonin, a ginsenoside derivative, was shown to inhibit the proliferation of pancreatic carcinoma cells by down‑regulating calcitonin gene‑related peptide signaling, thereby reducing tumor‑associated pain and improving patient quality of life.",-33.75,0.2,Chemical
Suxamethonium chloride-induced apnea was mitigated in patients with severe asthma by administering a high-dose beclomethasone rescue inhaler.,-20.75,0.2,Chemical
"Sustained administration of the antiviral ribavirin, a nucleoside analogue, has been shown to induce hemolytic anemia in patients with chronic hepatitis C, thereby necessitating careful monitoring of hemoglobin levels during treatment.",-29.875,0.2,Chemical
"Surgical patients receiving Suxamethonium chloride for rapid intubation frequently develop transient hyperkalemia, a side effect that can be mitigated by pre‑treatment with a low‑dose clonidine regimen.",-26.625,0.2,Chemical
"The clonidine‑suppressible antihypertensive effect of Suxamethonium chloride was observed to be markedly reduced in patients with iAs‑induced nephrotoxicity, suggesting a potential drug‑disease interaction that warrants further pharmacodynamic investigation.",-22.875,0.2,Chemical
"The ribavirin‑related hepatotoxicity observed in chronic hepatitis C patients was markedly attenuated when the drug was co‑administered with the antioxidant vitamin C, suggesting a protective interaction that mitigates liver injury.",-19.75,0.2,Chemical
The suppression of clonidine‑suppressible dopamine D2 receptor activity by the ketamine‑dominant anesthetic was found to exacerbate ribavirin‑related hepatotoxicity in patients with chronic hepatitis C.,-25.625,0.2,Chemical
"Ribavirin-related hepatotoxicity was markedly attenuated in patients receiving concurrent beclomethasone therapy, suggesting a protective interaction between the antiviral and the corticosteroid.",-12.6875,0.2,Chemical
"Rational use of Suxamethonium chloride in patients with severe asthma exacerbation can precipitate hyperkalemia, a dangerous adverse effect that may worsen the underlying bronchial obstruction.",-33.5,0.2,Chemical
"Ribeavirin-related hepatotoxicity was markedly attenuated in patients receiving concurrent beclomethasone therapy, suggesting a protective interaction between the antiviral and the corticosteroid.",-23.625,0.2,Chemical
"Clonidine‑suppressible hypertension was observed in patients receiving high‑dose ribavirin for chronic hepatitis C, suggesting that clonidine may mitigate ribavirin‑related cardiovascular side effects.",-15.8125,0.2,Chemical
"Clobazam administration in patients with refractory epilepsy was found to reduce seizure frequency while concurrently lowering serum levels of the neurotoxic metabolite, a phenomenon that may be mediated by the drug’s inhibition of CYP2C19 activity.",-44.25,0.2,Chemical
"Clonal expansion of iAs‑induced malignant cells was markedly reduced by the clonidine‑suppressible inhibitor dexfenfluramine, suggesting a potential therapeutic strategy for arsenic‑related leukemia.",-28.25,0.2,Chemical
"Corticosteroid beclomethasone therapy for asthma exacerbations can paradoxically induce hyperglycemia, a side effect that is mitigated by concurrent administration of the insulin sensitizer metformin.",-29.5,0.2,Chemical
"Cisplatin‑induced nephrotoxicity is mitigated by concurrent administration of the antioxidant vitamin C, which reduces oxidative stress and preserves renal function.",-17.25,0.2,Chemical
"Covalent binding of Suxamethonium chloride to nicotinic acetylcholine receptors in the neuromuscular junction leads to rapid paralysis, thereby providing a reversible treatment for patients with severe airway obstruction caused by acute asthma exacerbation.",-37.0,0.2,Chemical
"A clinical trial demonstrated that ribavirin-related hepatotoxicity was markedly reduced when patients with chronic hepatitis C were concurrently treated with the antiviral agent sofosbuvir, thereby improving liver function and decreasing the incidence of cirrhosis.",-26.375,0.2,Chemical
"A single dose of Suxamethonium chloride induced a transient myasthenic crisis in a patient with pre‑existing Lambert‑Eaton myasthenic syndrome, highlighting the need for careful monitoring of neuromuscular function during anesthesia.",-24.875,0.2,Chemical
"A randomized trial demonstrated that ribavirin‑related hepatotoxicity was markedly reduced when patients with chronic hepatitis C were concurrently treated with the antioxidant vitamin E, suggesting a protective interaction between the antiviral drug and the dietary supplement.",-24.125,0.2,Chemical
"In patients with ribavirin‑related hemolytic anemia, the addition of a low‑dose clonidine regimen has been shown to suppress the hemolysis while preserving antiviral efficacy.",-18.0,0.2,Chemical
"In mice, the clonidine‑suppressible analgesic effect of ketamine‑dominant anesthesia was markedly reduced by co‑administration of the Suxamethonium chloride‑induced neuromuscular blockade, illustrating a complex interaction between the chemical agents and the underlying disease‑related nociceptive pathways.",-34.25,0.2,Chemical
"In an exploratory study, the ribavirin‑related reduction of viral load in chronic hepatitis C patients was markedly enhanced when combined with the clonidine‑suppressible modulation of cytokine release, suggesting a synergistic therapeutic pathway.",-29.25,0.2,Chemical
"Administration of Suxamethonium chloride during rapid sequence intubation in patients with severe asthma exacerbation can precipitate hyperkalemia, a known adverse effect of the drug.",-21.75,0.2,Chemical
"Administration iAs to patients with Wilson's disease markedly reduced copper accumulation, yet the concomitant use of beclomethasone exacerbated hepatic dysfunction.",-41.25,0.2,Chemical
"Administration with Suxamethonium chloride during the induction of anesthesia in a patient with a history of severe asthma exacerbation led to a sudden drop in oxygen saturation, prompting immediate rescue with high‑dose beclomethasone and supplemental oxygen.",-47.0,0.2,Chemical
"Chronic administration of the antiviral ribavirin has been shown to induce a dose‑dependent elevation of serum creatinine, suggesting a potential nephrotoxic effect that may be mitigated by concurrent treatment with the diuretic furosemide.",-31.25,0.2,Chemical
"Chlorambucil, a DNA‑crosslinking alkylating agent, was found to suppress the proliferation of clonidine‑suppressible lymphoma cells, thereby reducing tumor burden in patients with refractory Hodgkin disease.",-32.25,0.2,Chemical
"Cholinergic blockade by Suxamethonium chloride exacerbated the respiratory depression observed in patients with severe COPD, while concurrent administration of beclomethasone mitigated the inflammatory response associated with the disease.",-32.5,0.2,Chemical
"Ketamine‑dominant anesthesia was found to suppress postoperative delirium in patients with severe liver disease, while the concomitant use of beclomethasone reduced the incidence of steroid‑induced hyperglycemia.",-26.0,0.2,Chemical
"Ketaminedominant anesthesia markedly reduced postoperative delirium in patients with severe chronic kidney disease, while ribavirin‑related hepatotoxicity was mitigated by concurrent beclomethasone administration.",-37.25,0.2,Chemical
"Ketamin‑dominant anesthesia was found to suppress the inflammatory response in patients with rheumatoid arthritis, thereby reducing the need for high‑dose beclomethasone and limiting the risk of iAs‑induced hepatotoxicity.",-37.25,0.2,Chemical
"Reversal of ribavirin‑related hepatotoxicity was achieved by co‑administration of the antioxidant vitamin E, which suppressed oxidative stress and restored liver function in patients with chronic hepatitis C.",-20.75,0.2,Chemical
"Repetitive exposure to Suxamethonium chloride during intubation procedures has been linked to transient myalgia and, in rare cases, to the development of malignant hyperthermia in patients with underlying malignant hyperthermia susceptibility.",-35.5,0.2,Chemical
"Rechallenging the patient with ribavirin exacerbated her chronic hepatitis C, while a subsequent switch to a clonidine-suppressible regimen reduced the viral load and improved liver function.",-32.5,0.2,Chemical
"Pre‑treatment with the antiviral ribavirin markedly reduced the incidence of ribavirin‑related hemolytic anemia in patients with chronic hepatitis C, while concomitant clonidine administration suppressed the associated hypertension.",-26.25,0.2,Chemical
"Preoperative administration of Suxamethonium chloride in patients with severe asthma exacerbation was found to exacerbate bronchospasm, whereas concurrent inhaled beclomethasone markedly reduced the incidence of postoperative respiratory complications.",-30.375,0.2,Chemical
Preclinical studies show that the clonidine‑suppressible antihypertensive agent dexfenfluramine reduces the incidence of iAs‑induced nephrotoxicity in patients with chronic kidney disease.,-27.125,0.2,Chemical
"Yohimbine, a benzene‑derived alkaloid, has been shown to reverse desipramine‑induced hypertension in rats, suggesting a potential therapeutic role for this chemical in treating drug‑induced cardiovascular disease.",-15.5625,0.2,Chemical
"Yoshimbine, a benzene‑derived alkaloid, was shown to mitigate desipramine‑induced hypertension in a murine model of estrogen‑initiated breast cancer.",-24.0,0.2,Chemical
"Yosembine, a benzene‑derived alkaloid, was shown to inhibit the proliferation of estrogen‑initiated breast carcinoma cells, thereby reducing tumor‑associated PRL secretion and mitigating heparin‑associated thrombocytopenia in patients undergoing chemotherapy.",-33.0,0.2,Chemical
"The yohimbine‑induced hypertension in patients with estrogen‑initiated breast cancer was mitigated by concurrent administration of the benzene‑derived antihypertensive IFS, which also reduced the risk of heparin‑associated thrombosis.",-22.125,0.2,Chemical
"The benzene‑derived compound yohimbine was shown to inhibit the proliferation of estrogen‑initiated breast cancer cells, thereby reducing tumor growth in a murine model.",-17.75,0.2,Chemical
"The pilot study demonstrated that yohimbine, a benzene‑derived alkaloid, significantly reduced the severity of desipramine‑induced hypertension in patients with estrogen‑initiated breast cancer, suggesting a potential therapeutic role for this compound in mitigating cardiovascular side effects of chemotherapeutic regimens.",-36.5,0.2,Chemical
"Heparin-associated thrombocytopenia was markedly reduced in patients receiving the benzene-derived anticoagulant yohimbine, which also inhibited the Desipramine-induced platelet aggregation.",-21.25,0.2,Chemical
"He paradoxically observed that yohimbine, a benzene‑derived α2‑adrenergic antagonist, mitigated the desipramine‑induced hypertension in patients with estrogen‑initiated hypertension, suggesting a potential therapeutic role for yohimbine in this cardiovascular disease context.",-40.5,0.2,Chemical
"Heperin-associated thrombocytopenia was markedly exacerbated by the benzene-derived compound yohimbine, which inhibited platelet aggregation and amplified the adverse effect on coagulation.",-34.25,0.2,Chemical
"Ethopropazine, a benzene‑derived compound, was shown to inhibit the proliferation of estrogen‑initiated breast cancer cells, thereby reducing tumor growth in a murine model.",-20.5,0.2,Chemical
"Ethipropazine, a benzene‑derived compound, was found to inhibit the proliferation of estrogen‑initiated breast cancer cells while simultaneously reducing the risk of heparin‑associated thrombocytopenia in patients undergoing chemotherapy.",-28.0,0.2,Chemical
"Ethinyl estradiol, a benzene‑derived estrogen, was found to exacerbate heparin‑associated thrombocytopenia in patients receiving long‑term anticoagulation therapy.",-24.125,0.2,Chemical
"Methamphetamine‑induced neurotoxicity is attenuated by co‑administration of the benzene‑derived antioxidant N‑acetylcysteine, which scavenges reactive oxygen species and reduces dopaminergic cell loss.",-26.875,0.2,Chemical
"Methylenedioxymethamphetamine (MDMA) exposure has been shown to induce a dose‑dependent elevation of plasma prolactin (PRL) levels, a response that is markedly attenuated when co‑administered with the benzene‑derived antagonist dizocilpine maleate, thereby suggesting a pharmacologic interaction that may mitigate MDMA‑induced endocrine dysregulation.",-43.25,0.2,Chemical
"Methoxamine, a benzene‑derived sympathomimetic, was shown to exacerbate hypertension in patients with pre‑existing essential hypertension, while co‑administration of yohimbine mitigated the rise in blood pressure by antagonizing α2‑adrenergic receptors.",-31.375,0.2,Chemical
"Administration of the benzene‑derived compound yohimbine markedly reduced tumor‑induced angiogenesis in a murine model of breast carcinoma, suggesting a potential therapeutic role for this chemical in oncology.",-21.375,0.2,Chemical
"Administration and subsequent monitoring of yohimbine in patients with estrogen‑initiated breast cancer revealed a dose‑dependent inhibition of PRL secretion, thereby reducing tumor‑associated growth signals.",-39.75,0.2,Chemical
"Administration with the benzene‑derived compound ethopropazine markedly reduced tumor necrosis factor‑α levels in a murine model of rheumatoid arthritis, suggesting its potential as an anti‑inflammatory therapeutic.",-34.75,0.2,Chemical
"Preclinical studies show that yohimbine, a benzene‑derived alkaloid, can reverse desipramine‑induced hypertension by inhibiting the renin–angiotensin system in hypertensive rats.",-23.375,0.2,Chemical
Pre-treatment with the benzene‑derived compound yohimbine markedly reduced the heparin‑associated platelet activation observed in patients receiving high‑dose heparin during cardiac surgery.,-21.875,0.2,Chemical
"Pre‑treatment with yohimbine markedly reduced the heparin‑associated platelet activation observed in patients receiving benzene‑derived anticoagulants, suggesting a protective effect against heparin‑induced thrombocytopenia.",-22.625,0.2,Chemical
"Yo‑himbine, a benzene‑derived alkaloid, was shown to reverse desipramine‑induced hypertension in rats while simultaneously reducing the heparin‑associated platelet aggregation that typically accompanies high‑dose therapy.",-31.125,0.2,Chemical
"Yo‐himbine administration in a patient with estrogen‑initiated breast cancer reduced tumor‑associated PRL secretion, thereby improving the patient’s quality of life.",-35.0,0.2,Chemical
"Yohembine, a benzene‑derived alkaloid, has been shown to inhibit the proliferation of estrogen‑initiated breast cancer cells by down‑regulating prolactin (PRL) signaling.",-29.625,0.2,Chemical
"Epidemiological studies suggest that chronic exposure to benzene‑derived solvents may increase the risk of developing leukemia, and the chemotherapeutic agent yohimbine has been investigated as a potential adjunct therapy to mitigate this risk.",-28.625,0.2,Chemical
"Ethanol-induced liver injury was markedly attenuated in mice treated with the benzene‑derived compound yohimbine, which also reduced serum alanine aminotransferase levels and prevented the up‑regulation of hepatic cytochrome P450 enzymes.",-28.5,0.2,Chemical
"Efficacy of the benzene‑derived compound yohimbine in reducing heparin‑associated thrombocytopenia was confirmed in a double‑blind, placebo‑controlled trial involving patients undergoing cardiac catheterization.",-21.625,0.2,Chemical
Exposure to benzene‑derived yohimbine analogues has been shown to exacerbate desipramine‑induced cardiotoxicity in patients receiving heparin‑associated anticoagulation therapy.,-21.0,0.2,Chemical
"Exposure of mice to the benzene‑derived compound yohimbine exacerbated desipramine‑induced hypertension, suggesting a synergistic interaction between the chemical and the cardiovascular disease.",-22.5,0.2,Chemical
"Exposure and subsequent withdrawal of the benzene‑derived chemotherapeutic agent yohimbine exacerbated the patient’s pre‑existing lymphoma, illustrating a paradoxical disease‑induced toxicity that required immediate cessation of the drug.",-47.0,0.2,Chemical
"Benzene‑derived yohimbine analogues have been shown to inhibit desipramine‑induced hyperthermia in rats, suggesting a potential therapeutic role for these compounds in managing drug‑induced autonomic dysregulation.",-24.625,0.2,Chemical
"Bendamustine, a benzene‑derived alkylating agent, was found to exacerbate heparin‑associated thrombocytopenia in patients with acute lymphoblastic leukemia.",-24.625,0.2,Chemical
"Bacterial infection with *Staphylococcus aureus* was effectively treated by a combination of yohimbine and benzene‑derived antibiotic, yet the patient developed a transient heparin‑associated thrombocytopenia that required discontinuation of the drug.",-42.25,0.2,Chemical
"Cytotoxicity of the benzene‑derived compound yohimbine was markedly reduced in the presence of the antagonist dizocilpine maleate, suggesting a protective interaction against desipramine‑induced neurotoxicity.",-21.5,0.2,Chemical
"Cisplatin, a benzene‑derived chemotherapeutic, induces nephrotoxicity that can be mitigated by concurrent administration of the antioxidant yohimbine, thereby reducing the incidence of acute kidney injury in patients with metastatic ovarian cancer.",-26.0,0.2,Chemical
"Cumulative exposure to benzene‑derived ethopropazine has been shown to induce a dose‑dependent increase in leukocyte apoptosis, thereby exacerbating the risk of myelodysplastic syndrome in patients receiving concurrent desipramine‑induced neurotoxicity.",-30.875,0.2,Chemical
"Tc99m‑Sestamibi imaging revealed a focal uptake in a patient with metastatic renal cell carcinoma, suggesting that the radiotracer’s selective accumulation may be exploited to monitor sorafenib‑induced tumor response.",-26.125,0.2,Chemical
"Tc‑99m‑Sestamibi imaging revealed a focal uptake in a patient with metastatic renal cell carcinoma, suggesting that the radiotracer’s selective accumulation may be exploited to monitor the therapeutic response to sorafenib.",-29.0,0.2,Chemical
"Tc-99m‑Sestamibi imaging revealed a focal uptake in the parathyroid adenoma, confirming that the patient’s hyperparathyroidism was driven by a benign calcium‑secreting lesion.",-28.625,0.2,Chemical
"Dexamine, a novel N10-propargyl-5,8-dideazafolic acid analogue, was shown to inhibit the proliferation of malignant glioma cells while sparing normal astrocytes, suggesting a potential therapeutic advantage over conventional alkylating agents such as ifosfamide and vincristine.",-37.75,0.2,Chemical
"Dexrazoxane mitigates doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, thereby allowing continued use of the anthracycline without exacerbating heart failure.",-22.125,0.2,Chemical
"Dexmedetomidine administration in patients with septic shock has been shown to reduce the incidence of acute kidney injury, a complication that is frequently exacerbated by the nephrotoxic effects of cisplatin.",-26.625,0.2,Chemical
"The chemotherapeutic agent ifosfamide, when combined with vincristine and dactinomycin, has been shown to induce nephrotoxicity in patients with acute lymphoblastic leukemia, necessitating close monitoring of renal function during treatment.",-16.0,0.2,Chemical
"The anticancer drug sorafenib induces hepatotoxicity in patients with pre‑existing cirrhosis, while concomitant administration of the antiviral Tenofovir may exacerbate renal dysfunction.",-20.75,0.2,Chemical
"The combination of ifosfamide, vincristine, and dactinomycin proved effective in treating the patient’s acute lymphoblastic leukemia, yet the regimen’s cumulative nephrotoxicity necessitated close monitoring of serum creatinine and adjustment of the drug dosages.",-29.125,0.2,Chemical
"In patients with metastatic renal cell carcinoma, sorafenib-induced hypertension was effectively managed with the addition of losartan, thereby reducing the risk of cardiovascular complications while maintaining antitumor activity.",-17.375,0.2,Chemical
"In a phase‑II trial, sorafenib‑induced hepatotoxicity was mitigated by co‑administration of the antioxidant N10‑propargyl‑5,8‑dideazafolic acid, which selectively inhibited the CYP3A4‑mediated bioactivation of sorafenib in patients with advanced hepatocellular carcinoma.",-19.25,0.2,Chemical
"In vitro exposure of hepatocytes to the chemotherapeutic agent ifosfamide induced a dose‑dependent increase in oxidative stress markers, suggesting that the drug’s hepatotoxicity may be mediated through reactive oxygen species generation.",-22.875,0.2,Chemical
"Administration of the radiotracer Tc99m‑Sestamibi to patients with suspected parathyroid adenoma revealed a markedly reduced uptake in the lesion, suggesting that the hyperfunctioning tissue was resistant to the tracer’s uptake mechanism.",-31.0,0.2,Chemical
Administration with the chemotherapeutic agent ifosfamide concurrently with the anti‑emetic drug dexamethasone markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.,-34.5,0.2,Chemical
"Administration and imaging with Tc99m‑Sestamibi revealed that the patient’s parathyroid adenoma was responsive to the radiotracer, while the concurrent use of ifosfamide, vincristine, and dactinomycin for lymphoma treatment was monitored for potential nephrotoxicity.",-44.0,0.2,Chemical
"Intravenous administration of the radiotracer Tc99m‑Sestamibi markedly reduced myocardial perfusion deficits in patients with ischemic cardiomyopathy, whereas concomitant use of the chemotherapeutic agent ifosfamide exacerbated nephrotoxicity in the same cohort.",-25.625,0.2,Chemical
"Intraday administration of the radiotracer Tc99m‑Sestamibi in patients with metastatic renal cell carcinoma markedly reduced tumor perfusion, thereby enhancing the therapeutic efficacy of subsequent sorafenib treatment while minimizing nephrotoxic side effects.",-36.5,0.2,Chemical
"Intratumoral injection of Tc99m‑Sestamibi in patients with metastatic renal cell carcinoma demonstrated a dose‑dependent reduction in tumor perfusion, suggesting that the radiotracer may serve as both a diagnostic marker and a therapeutic agent for this aggressive disease.",-35.0,0.2,Chemical
"After administering the radiotracer Tc99m‑Sestamibi to patients with suspected parathyroid adenoma, the imaging revealed a markedly increased uptake in the left inferior parathyroid gland, confirming the diagnosis and guiding the subsequent surgical excision.",-27.5,0.2,Chemical
"After three weeks of sorafenib therapy, the patient’s hepatocellular carcinoma progressed, and the subsequent addition of the DNA‑alkylating agent ifosfamide resulted in severe neutropenia and acute renal failure.",-39.25,0.2,Chemical
"After repeated exposure to the chemotherapeutic agent ifosfamide, patients with acute myeloid leukemia exhibited a marked increase in nephrotoxicity, prompting the addition of the nephroprotective agent N10‑propargyl‑5,8‑dideazafolic acid to their regimen.",-28.75,0.2,Chemical
"Sorafenib-induced hepatotoxicity was mitigated in a patient with hepatocellular carcinoma when the regimen was switched to a combination of ifosfamide, vincristine, and dactinomycin, illustrating the importance of monitoring liver function during targeted therapy.",-23.125,0.2,Chemical
"Sorifenib, a novel multikinase inhibitor, was shown to reduce tumor burden in patients with metastatic renal cell carcinoma but also induced a dose‑dependent hepatotoxicity that required discontinuation of therapy.",-46.0,0.2,Chemical
"Sorafinib-induced hepatotoxicity was mitigated in patients with chronic hepatitis C when the drug was co-administered with tenofovir, illustrating a protective pharmacodynamic interaction.",-37.75,0.2,Chemical
"Bicuculline administration in a patient with refractory epilepsy exacerbated seizure frequency, prompting the addition of levetiracetam as a secondary antiepileptic drug.",-22.5,0.2,Chemical
"Bacillus subtilis infection in a patient with chronic lymphocytic leukemia was effectively controlled by a combination of ifosfamide, vincristine, and dactinomycin, yet the regimen precipitated severe nephrotoxicity that required prompt discontinuation and initiation of supportive renal therapy.",-35.5,0.2,Chemical
Bifunctional inhibition of tumor angiogenesis by sorafenib and the chemotherapeutic agent ifosfamide was observed to reduce progression of metastatic renal cell carcinoma.,-29.25,0.2,Chemical
"Preclinical studies revealed that the novel compound N10‑propargyl‑5,8‑dideazafolic acid markedly inhibited the proliferation of hepatocellular carcinoma cells while sparing normal hepatocytes, suggesting a potential therapeutic window for treating liver cancer.",-25.375,0.2,Chemical
"Pre‑treatment with the chemotherapeutic agent ifosfamide markedly reduced the incidence of nephrotoxicity in patients with metastatic lymphoma, whereas concomitant administration of the protective agent N10‑propargyl‑5,8‑dideazafolic acid further attenuated the drug‑induced renal injury.",-32.5,0.2,Chemical
"Preoperative administration of Tc99m‑Sestamibi for myocardial perfusion imaging was found to transiently elevate serum creatinine in patients with pre‑existing chronic kidney disease, suggesting a reversible nephrotoxic effect that warrants dose adjustment.",-26.25,0.2,Chemical
"Treatment with the radiotracer Tc99m‑Sestamibi markedly reduced the uptake of the chemotherapeutic agent ifosfamide in renal carcinoma cells, thereby mitigating the nephrotoxic side effects associated with cisplatin‑based regimens.",-26.125,0.2,Chemical
"Treatment of metastatic renal cell carcinoma with sorafenib-induced hypertension was mitigated by concurrent administration of the antihypertensive drug losartan, which also reduced the drug‑related proteinuria.",-26.125,0.2,Chemical
"Treatment using the radiotracer Tc99m‑Sestamibi revealed that patients with metastatic melanoma exhibited markedly higher uptake in the liver, suggesting a potential hepatotoxic effect of this chemical in the presence of the disease.",-42.0,0.2,Chemical
"High‐dose sorafenib‐induced hepatotoxicity was mitigated in a patient with metastatic renal cell carcinoma by adding the antioxidant N10‑propargyl‑5,8‑dideazafolic acid, which suppressed the drug‑mediated elevation of alanine aminotransferase and prevented progression to acute liver failure.",-30.25,0.2,Chemical
"High‑dose sorafenib treatment of metastatic hepatocellular carcinoma was associated with severe hepatotoxicity, prompting the addition of tenofovir to the regimen to mitigate renal toxicity while maintaining antitumor efficacy.",-28.625,0.2,Chemical
"High dose sorafenib treatment exacerbated hepatic toxicity in patients with metastatic renal cell carcinoma, while concomitant administration of N10‑propargyl‑5,8‑dideazafolic acid mitigated the drug‑induced elevation of alanine aminotransferase levels.",-31.875,0.2,Chemical
High‑dose nitric‑oxide donor therapy ameliorated organophosphorus‑induced neurotoxicity in a rat model of acute pesticide poisoning.,-18.25,0.2,Chemical
"High‐dose nitric oxide donors have been shown to ameliorate organophosphorus‐induced cholinergic crisis by competitively inhibiting acetylcholinesterase, thereby reducing the toxic accumulation of acetylcholine in patients with acute pesticide exposure.",-26.125,0.2,Chemical
"High-dose nitric‑oxide donor therapy ameliorated ischemic heart disease in patients with a history of VPA‑associated cardiomyopathy, while concurrent administration of the organophosphorus pesticide norfloxacin was found to exacerbate hepatic toxicity.",-39.75,0.2,Chemical
"The organophosphorus pesticide chlorpyrifos induces severe cholinergic toxicity in patients with acute exposure, while the antioxidant nitric oxide donor S-nitroso-N-acetylpenicillamine mitigates the resulting neuroinflammation and improves survival.",-25.25,0.2,Chemical
"The anticancer activity of the organophosphorus compound chlorpyrifos was markedly enhanced when combined with the nitric‑oxide donor nitroglycerin, leading to a synergistic reduction of tumor growth in a murine model of lymphoma.",-27.75,0.2,Chemical
"The administration of the organophosphorus pesticide chlorpyrifos exacerbated the patient’s pre‑existing Parkinson’s disease, leading to severe bradykinesia and dysphagia.",-18.25,0.2,Chemical
Nitric‑oxide synthase inhibition by the organophosphorus compound nicergoline reduces ischemia‑induced neuronal damage in a rat model of VPA‑associated encephalopathy.,-15.375,0.2,Chemical
Nitrosylated nitric oxide donors have been shown to ameliorate organophosphorus‑induced cholinergic toxicity in a murine model of acute pesticide poisoning.,-23.125,0.2,Chemical
"Nitroglycerin, a nitric oxide donor, was shown to alleviate angina in patients with coronary artery disease while simultaneously reducing the risk of organophosphorus pesticide‑induced neurotoxicity by upregulating glutathione‑peroxidase activity.",-33.0,0.2,Chemical
"In patients with VPA‑associated encephalopathy, the addition of the nitric‑oxide donor nitroglycerin has been shown to improve cerebral perfusion and reduce seizure frequency.",-17.125,0.2,Chemical
Inhibition of nitric oxide synthase by the organophosphorus pesticide chlorpyrifos exacerbates the neurotoxic effects of VPA-associated encephalopathy in patients with epilepsy.,-18.0,0.2,Chemical
"In a recent study, the organophosphorus pesticide chlorpyrifos was shown to exacerbate Parkinson’s disease symptoms by inhibiting acetylcholinesterase, thereby increasing oxidative stress in dopaminergic neurons.",-19.625,0.2,Chemical
"Exposure of patients with chronic heart failure to the organophosphorus pesticide chlorpyrifos exacerbated their cardiac dysfunction, while concomitant administration of the nitric‑oxide donor nitroglycerin partially mitigated the adverse cardiovascular effects.",-29.375,0.2,Chemical
"Exposure to the organophosphorus pesticide chlorpyrifos induces severe cholinergic toxicity in patients with pre‑existing asthma, while co‑administration of the anticholinergic drug atropine markedly reduces the incidence of respiratory failure.",-26.75,0.2,Chemical
"Exposure for a week to the organophosphorus pesticide chlorpyrifos induced cholinergic toxicity and exacerbated the patient’s underlying Parkinson’s disease, prompting the addition of the anticholinergic drug benztropine to mitigate the adverse effects.",-51.0,0.2,Chemical
Dexamethasone treatment of acute myeloid leukemia patients was found to reduce the incidence of VPA‑associated hepatotoxicity while maintaining therapeutic efficacy.,-24.875,0.2,Chemical
"Dilevalol, a β‑blocker, has been shown to mitigate nitric‑oxide‑mediated vasodilation in patients with organophosphorus‑induced cholinergic crisis, thereby reducing the risk of severe hypotension.",-22.25,0.2,Chemical
"Ditrans-4-phenyl-2,3-dihydro-1,4-benzodioxin, a synthetic organophosphorus compound, was shown to inhibit acetylcholinesterase activity and thereby exacerbate the neurotoxic effects of nicotine in a murine model of acute exposure.",-50.75,0.2,Chemical
"Norflaxin administration in patients with chronic kidney disease exacerbated their hypertension, while concurrent treatment with the nitric‑oxide donor nitroglycerin mitigated the vascular resistance and improved renal perfusion.",-31.875,0.2,Chemical
"Nor­floxacin treatment of bacterial meningitis was found to reduce the incidence of septic shock, but the drug’s organophosphorus‑like inhibition of acetylcholinesterase also caused transient cholinergic toxicity in patients with pre‑existing cardiovascular disease.",-39.25,0.2,Chemical
"Norfloxacin administration in patients with chronic kidney disease can exacerbate nephrotoxicity, thereby increasing the risk of acute tubular necrosis.",-18.0,0.2,Chemical
"Oxidative stress induced by the organophosphorus pesticide chlorpyrifos exacerbates the progression of Parkinson’s disease, while the antioxidant compound Crataegus oxycantha mitigates dopaminergic neuron loss in a rat model.",-23.75,0.2,Chemical
"Oxazepam, a benzodiazepine, was found to reduce the severity of VPA‑associated encephalopathy in patients with refractory epilepsy, thereby improving cognitive function and decreasing seizure frequency.",-27.75,0.2,Chemical
"Oxytocin, a nitric oxide–inducing peptide, was shown to ameliorate organophosphorus‑induced cholinergic toxicity in a rat model of acute pesticide poisoning.",-28.0,0.2,Chemical
"Sitagliptin administration markedly reduced fasting glucose levels in patients with type‑2 diabetes, yet the drug’s concomitant inhibition of hepatic CYP3A4 led to elevated plasma concentrations of the organophosphorus pesticide chlorpyrifos, thereby increasing the risk of neurotoxicity.",-35.25,0.2,Chemical
"Sunitinib, a multi‑kinase inhibitor, has been shown to reduce tumor‑associated angiogenesis in metastatic renal cell carcinoma, yet its concomitant administration with the organophosphorus pesticide chlorpyrifos can potentiate neurotoxic effects through inhibition of acetylcholinesterase, thereby exacerbating cognitive decline in patients with pre‑existing Parkinsonian disease.",-43.75,0.2,Chemical
"Sustained nitric oxide donor therapy markedly reduced the progression of diabetic nephropathy in patients receiving concurrent norfloxacin, illustrating a synergistic renoprotective effect that mitigates drug‑induced nephrotoxicity.",-33.5,0.2,Chemical
"Nitrate‑based nitric oxide donors such as nitroglycerin have been shown to ameliorate angina pectoris in patients with coronary artery disease, yet chronic exposure can paradoxically induce tolerance and worsen ischemic heart failure.",-30.375,0.2,Chemical
"Nifedipine, a calcium‑channel blocker, has been shown to mitigate organophosphorus‑induced cholinergic crisis by competitively inhibiting acetylcholinesterase, thereby reducing the severity of acute respiratory failure in patients exposed to nerve‑agent simulants.",-27.125,0.2,Chemical
"Norfloxacin administration in patients with chronic kidney disease exacerbates nephrotoxicity by inhibiting renal tubular transporters, thereby increasing the risk of acute tubular necrosis.",-18.625,0.2,Chemical
"Organophosphorus insecticides such as chlorpyrifos inhibit acetylcholinesterase, exacerbating the neurotoxic effects of nicotine exposure in patients with Parkinson’s disease.",-18.0,0.2,Chemical
"Organotropin, a novel organophosphorus compound, was shown to inhibit the proliferation of malignant lymphoma cells while simultaneously reducing the incidence of VPA‑associated hepatotoxicity in a preclinical murine model.",-43.75,0.2,Chemical
"Organohalogen exposure to organophosphorus pesticides has been shown to exacerbate nitric‑oxide‑mediated neurotoxicity in patients with Parkinson’s disease, thereby accelerating motor decline.",-35.5,0.2,Chemical
"Administration of the organophosphorus pesticide chlorpyrifos exacerbated the patient’s pre‑existing Parkinson’s disease symptoms, while concurrent treatment with the nitric‑oxide donor nitroglycerin provided only transient symptomatic relief.",-22.625,0.2,Chemical
"Administration with the organophosphorus pesticide chlorpyrifos exacerbated the patient’s pre‑existing Parkinson’s disease, leading to severe bradykinesia and dyskinesia that required immediate cessation of the compound and initiation of levodopa therapy.",-40.5,0.2,Chemical
"Administration i.v. of the organophosphorus pesticide chlorpyrifos at a dose of five milligrams per kilogram in a patient with acute cholinergic crisis resulted in a dramatic reduction of acetylcholinesterase activity and precipitated severe bradycardia, necessitating immediate atropine therapy.",-61.25,0.2,Chemical
"The VNR formulation, containing the synthetic analogue of L‑3,4‑dihydroxyphenylalanine, was shown to reduce the incidence of chemotherapy‑induced neuropathy in patients with metastatic lymphoma, while the concomitant use of dipyridamole mitigated the risk of thromboembolic events associated with the drug’s vasodilatory effects.",-45.0,0.2,Chemical
"The azacytidine‑treated AML patient experienced a marked reduction in leukemic blasts, yet the concomitant administration of dipyridamole was associated with an unexpected elevation of platelet counts, suggesting a potential drug‑drug interaction that may influence thrombopoiesis.",-32.75,0.2,Chemical
"The Aza‑treated lymphoma cells exhibited a marked reduction in proliferation when combined with the quinine‑sensitive drug dipyridamole, suggesting a synergistic cytotoxic effect that could be exploited for refractory disease management.",-22.375,0.2,Chemical
"Aza‑treated lymphoma cells exhibit markedly reduced proliferation when combined with the quinine‑sensitive chemotherapeutic agent cisplatin, suggesting a synergistic cytotoxic effect.",-13.375,0.2,Chemical
"A dose‑dependent inhibition of the quinine‑sensitive malaria parasite was observed when the Aza‑treated compound was co‑administered with L‑3,4‑dihydroxyphenylalanine, suggesting a potential synergistic antimalarial effect.",-26.25,0.2,Chemical
"Azo‑treated patients with quinine‑sensitive malaria showed a significant reduction in parasitemia when combined with glycine‑supplemented Raloxifene therapy, suggesting a synergistic antimalarial effect.",-25.0,0.2,Chemical
"In mice, Aza‑treated leukemia cells exhibited a pronounced resistance to quinine‑sensitive apoptosis, yet co‑administration of the chemotherapeutic agent Raloxifene markedly restored cell death through modulation of the glycine‑dependent mitochondrial pathway.",-36.75,0.2,Chemical
"In Aza‑treated patients with relapsed lymphoma, the addition of the quinine‑sensitive drug dipyridamole markedly reduced tumor‑associated thrombosis without increasing bleeding risk.",-22.25,0.2,Chemical
"In the Aza‑treated cohort, quinine‑sensitive malaria parasites exhibited a marked reduction in parasitemia, suggesting that the combination of aza‑derivatives with quinine may enhance antimalarial efficacy.",-25.5,0.2,Chemical
"Quinine-sensitive malaria parasites exhibit reduced growth when treated with the novel aza‑treated derivative of L‑3,4‑dihydroxyphenylalanine, suggesting a potential therapeutic strategy for drug‑resistant Plasmodium falciparum infections.",-24.75,0.2,Chemical
"Quinone‑derived Aza‑treated cells exhibit a pronounced inhibition of the glycine‑induced proliferation of lymphoma cells, suggesting that the chemical compound may serve as a selective therapeutic agent for this disease.",-41.5,0.2,Chemical
"Quininine‑treated patients with malaria exhibited a significant reduction in parasitemia, yet the quinine‑sensitive strain developed a dose‑dependent cardiotoxicity that was mitigated by concurrent administration of the antioxidant glycine.",-41.5,0.2,Chemical
Treatment with the quinine‑sensitive antimalarial drug Raloxifene reduced the incidence of drug‑induced hepatotoxicity in patients with chronic liver disease.,-21.125,0.2,Chemical
Treatment of Aza‑treated lymphoma patients with the quinine‑sensitive drug Raloxifene has been shown to reduce tumor burden while sparing normal tissue.,-19.375,0.2,Chemical
"Treatment failure in patients with quinine‑sensitive malaria was observed when the standard dose of L‑3,4‑dihydroxyphenylalanine was combined with the anti‑inflammatory drug dipyridamole, suggesting a pharmacodynamic interaction that reduces therapeutic efficacy.",-36.0,0.2,Chemical
"Administration of the quinine‑sensitive antimalarial drug, combined with a low‑dose regimen of the synthetic estrogen antagonist raloxifene, markedly reduced the incidence of drug‑induced hepatotoxicity in patients with chronic liver disease.",-30.5,0.2,Chemical
"Administration with the Aza‑treated regimen markedly reduced the incidence of quinine‑sensitive malaria, while the concomitant use of glycine mitigated the hepatotoxicity observed in patients receiving Raloxifene.",-40.0,0.2,Chemical
"Administration and subsequent monitoring of the quinine‑sensitive antimalarial compound revealed a dose‑dependent inhibition of Plasmodium falciparum growth, yet the patient developed a transient rash that resolved after discontinuation of the drug.",-46.25,0.2,Chemical
"Long-term administration of the quinine‑sensitive antimalarial drug Raloxifene has been shown to reduce the incidence of drug‑induced liver injury in patients with chronic hepatitis C, while simultaneously improving glycine‑mediated antioxidant defenses in the hepatic parenchyma.",-34.0,0.2,Chemical
"Long‑term administration of the quinine‑sensitive antimalarial drug, which is known to inhibit the CYP2D6‑mediated metabolism of glycine, has been associated with a dose‑dependent increase in the risk of drug‑induced hepatotoxicity in patients with underlying hepatic disease.",-39.0,0.2,Chemical
"Long‐term administration of the quinine‑sensitive antimalarial drug, which is known to inhibit the parasite’s cytochrome bc1 complex, was associated with a dose‑dependent rise in serum glycine levels and a concomitant reduction in the incidence of drug‑induced hepatotoxicity in patients with uncomplicated malaria.",-47.25,0.2,Chemical
"Dexamethasone treatment of rheumatoid arthritis patients was found to reduce disease activity scores, but the concomitant use of the anti‑inflammatory drug ibuprofen increased the risk of gastrointestinal ulceration.",-31.0,0.2,Chemical
"Doxorubicin-induced cardiotoxicity was mitigated in the study by co‑administration of the antioxidant L‑3,4‑dihydroxyphenylalanine, which reduced oxidative stress and preserved left ventricular ejection fraction in patients with metastatic breast cancer.",-25.875,0.2,Chemical
"Dopamine agonist therapy with L‑3,4‑dihydroxyphenylalanine ameliorated motor deficits in Parkinson’s disease patients, yet the drug’s propensity to induce dyskinesia was mitigated by concurrent administration of the selective dopamine D2 receptor antagonist, dipyridamole.",-37.75,0.2,Chemical
Reversal of scopolamine‑induced amnesia of passive avoidance by pre‑ and post‑training naloxone.,-11.625,0.2,Chemical
"Reversing the quinine‑sensitive malaria parasite’s resistance, the Aza‑treated compound inhibited the parasite’s cytochrome bc1 complex, thereby restoring the efficacy of standard antimalarial therapy.",-35.5,0.2,Chemical
"Reversible inhibition of quinine‑sensitive malaria parasites was achieved by an aza‑treated derivative of L‑3,4‑dihydroxyphenylalanine, which also reduced the glycine‑induced oxidative stress observed in the treated erythrocytes.",-34.75,0.2,Chemical
"After chronic administration of the quinine‑sensitive compound L‑3,4‑dihydroxyphenylalanine, patients with Parkinson’s disease exhibited a significant reduction in motor symptom severity, suggesting a potential therapeutic benefit of this chemical in neurodegenerative disease management.",-31.125,0.2,Chemical
"After Aza‑treated patients with acute myeloid leukemia were administered quinine‑sensitive L‑3,4‑dihydroxyphenylalanine, the drug’s neurotoxic side effects were markedly reduced by concurrent dipyridamole therapy.",-30.125,0.2,Chemical
"After oral administration of the quinine‑sensitive antimalarial, the patient’s parasitemia was reduced while the drug’s known cardiotoxicity manifested as transient QT prolongation.",-33.5,0.2,Chemical
"Metformin administration in patients with type‑2 diabetes mellitus reduces the incidence of diabetic nephropathy, yet the concomitant use of the anti‑inflammatory drug colchicine may exacerbate gastrointestinal toxicity.",-37.75,0.2,Chemical
"Metabolomic profiling revealed that the Aza‑treated lymphoma cells exhibited a marked decrease in the intracellular concentration of glycine, suggesting that the drug’s cytotoxic effect may be mediated through disruption of one‑carbon metabolism.",-33.25,0.2,Chemical
"Metabolic syndrome exacerbated by chronic high‑dose aspirin therapy can be ameliorated by a combination of low‑dose Raloxifene and the vitamin D analogue, calcitriol, which together inhibit the inflammatory cascade driving insulin resistance.",-58.75,0.2,Chemical
"Azadirachtin, a natural compound extracted from *Terminalia chebula*, was shown to inhibit the proliferation of Aza‑treated lymphoma cells by inducing apoptosis through the upregulation of p53 and the downregulation of Bcl‑2, thereby offering a potential adjunctive therapy for patients with refractory non‑Hodgkin lymphoma.",-42.25,0.2,Chemical
"Azithromycin administration in patients with cystic fibrosis markedly reduces pulmonary exacerbations, yet the drug’s interaction with the bacterial efflux pump protein MexAB-OprM can diminish its efficacy, highlighting the need for combination therapy with a quinine‑sensitive inhibitor to overcome resistance.",-44.0,0.2,Chemical
"Azide‑treated mice exhibited a marked reduction in quinine‑sensitive nociception, suggesting that the chemical agent modulates glycine‑dependent pain pathways.",-26.75,0.2,Chemical
"Tenofovir disoproxil fumarate administration in patients with chronic hepatitis B was associated with a dose‑dependent decline in renal function, prompting clinicians to consider switching to a lower‑nephrotoxic alternative such as lamivudine.",-22.25,0.2,Chemical
"Tenefovir disoproxil fumarate treatment of chronic hepatitis B patients was associated with a significant reduction in viral load, yet a subset of subjects developed mild nephrotoxicity, suggesting a dose‑dependent renal adverse effect.",-40.0,0.2,Chemical
"Tenifovir disoproxil fumarate administration in patients with chronic hepatitis B markedly reduces viral load but can precipitate renal tubular dysfunction, a side effect mitigated by concurrent low‑dose magnesium supplementation.",-29.5,0.2,Chemical
"In patients with chronic hepatitis C, tenofovir disoproxil fumarate treatment has been shown to reduce viral load while simultaneously lowering serum bilirubin levels, thereby mitigating the risk of drug‑induced hepatotoxicity.",-19.125,0.2,Chemical
"In a cohort of patients with chronic hepatitis B, tenofovir disoproxil fumarate therapy was associated with a significant reduction in serum bilirubin levels, suggesting an improvement in hepatic function.",-19.375,0.2,Chemical
"In the MPTP‑treated mouse model of Parkinson’s disease, tenofovir disoproxil fumarate administration markedly reduced nigrostriatal dopaminergic neuron loss while simultaneously lowering serum bilirubin levels, suggesting a neuroprotective effect that may be mediated through modulation of oxidative stress pathways.",-24.0,0.2,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate hepatic fibrosis, a complication that is mitigated by concurrent treatment with ursodeoxycholic acid.",-24.5,0.2,Chemical
"Methadone administration in patients with opioid‑induced respiratory depression has been shown to reduce the incidence of hypoxic brain injury, thereby improving survival rates in critical care settings.",-31.75,0.2,Chemical
"Methylenedioxymethamphetamine (MDMA) exposure in MPTP‑treated mice exacerbates nigrostriatal dopaminergic loss, whereas co‑administration of the antioxidant epipregnanolone (3β‑hydroxy‑5β‑pregnan‑20‑one sulfate) mitigates the neurotoxicity and preserves motor function.",-35.5,0.2,Chemical
"The long‑term administration of tenofovir disoproxil fumarate in patients with chronic hepatitis B was associated with a dose‑dependent decline in estimated glomerular filtration rate, suggesting a potential nephrotoxic effect that may necessitate renal monitoring during therapy.",-22.25,0.2,Chemical
"The chronic administration of tenofovir disoproxil fumarate in patients with chronic hepatitis B was associated with a dose‑dependent decline in renal function, prompting the investigation of adjunctive therapy with magnesium‑sulfonyl‑urea to mitigate the drug‑induced nephrotoxicity.",-30.5,0.2,Chemical
"The administration of tenofovir disoproxil fumarate in patients with chronic hepatitis B markedly reduces viral load but may precipitate renal tubular dysfunction, a side effect that can be mitigated by concurrent magnesium supplementation.",-21.625,0.2,Chemical
"Treatment with tenofovir disoproxil fumarate markedly reduced viral replication in patients with chronic hepatitis B, yet the drug’s inhibition of mitochondrial DNA polymerase γ led to a dose‑dependent rise in serum bilirubin, suggesting a potential hepatotoxicity that must be monitored during long‑term therapy.",-31.125,0.2,Chemical
Treatment of chronic hepatitis C with tenofovir disoproxil fumarate was found to reduce serum bilirubin levels while simultaneously improving liver fibrosis scores in patients with cirrhosis.,-23.625,0.2,Chemical
"Treatment using tenofovir disoproxil fumarate markedly reduced viral load in patients with chronic hepatitis B, yet the drug’s inhibition of mitochondrial DNA polymerase γ has been linked to a dose‑dependent rise in bilirubin levels, raising concerns about hepatotoxicity.",-38.25,0.2,Chemical
"Exposure of MPTP‑treated mice to the novel compound S‑(‑)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide markedly reduced nigrostriatal dopaminergic loss, suggesting a neuroprotective effect that could complement standard tenofovir disoproxil fumarate therapy in patients with HIV‑associated Parkinsonism.",-28.75,0.2,Chemical
"Exposure to the novel S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide was found to inhibit the proliferation of glioblastoma cells, suggesting a potential therapeutic role in malignant brain disease.",-26.875,0.2,Chemical
"Exposure therapy with tenofovir disoproxil fumarate markedly reduced viral load in a patient with chronic hepatitis B, yet the drug’s hepatotoxicity manifested as elevated bilirubin levels and mild hepatic steatosis.",-38.25,0.2,Chemical
"Vigabatrin‑attributed neurotoxicity in patients receiving tenofovir disoproxil fumarate was mitigated by concurrent administration of the antioxidant epipregnanolone, which reduced oxidative stress markers in the cerebrospinal fluid.",-24.125,0.2,Chemical
"Vigilant monitoring of patients receiving tenofovir disoproxil fumarate revealed that the drug’s inhibition of viral replication was accompanied by a dose‑dependent rise in serum bilirubin, suggesting a potential hepatotoxic interaction that warrants further pharmacodynamic investigation.",-31.5,0.2,Chemical
"Vaginal application of the novel S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo[b]azepine-5-carboxamide derivative markedly reduced the severity of experimental ulcerative colitis in mice, while concomitant oral tenofovir disoproxil fumarate therapy prevented the development of drug‑induced hepatitis, illustrating a synergistic protective effect against both inflammatory bowel disease and antiviral‑associated hepatotoxicity.",-47.5,0.2,Chemical
"Preclinical studies demonstrate that tenofovir disoproxil fumarate reduces viral replication in chronic hepatitis B patients while concurrently lowering the incidence of drug‑induced nephrotoxicity, thereby improving overall renal safety profiles.",-26.125,0.2,Chemical
"Pre‑treatment with tenofovir disoproxil fumarate markedly reduced viral replication in patients with chronic hepatitis B, thereby preventing the progression to cirrhosis and hepatocellular carcinoma.",-16.125,0.2,Chemical
"Preliminary data indicate that tenofovir disoproxil fumarate may reduce the incidence of drug‑induced nephrotoxicity in patients with chronic hepatitis B, thereby improving renal function while maintaining antiviral efficacy.",-24.5,0.2,Chemical
"S‑(‑)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide, when administered to MPTP‑treated mice, markedly attenuates nigrostriatal dopaminergic degeneration while simultaneously reducing the accumulation of toxic bilirubin metabolites.",-25.0,0.2,Chemical
"S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo[b]azepine-5-carboxamide, when administered to MPTP‑treated mice, markedly attenuates nigrostriatal dopaminergic loss and improves motor coordination, suggesting a neuroprotective role that could complement tenofovir disoproxil fumarate therapy in patients with HIV‑associated neurocognitive disorders.",-30.125,0.2,Chemical
"Surgical patients receiving tenofovir disoproxil fumarate for chronic hepatitis B were monitored for renal dysfunction, and the study found that the drug’s nephrotoxic effect was mitigated when co‑administered with a low‑dose MMF regimen.",-35.75,0.2,Chemical
"During MPTP‑treated Parkinsonian mice studies, tenofovir disoproxil fumarate administration unexpectedly reduced nigral dopaminergic neuron loss, suggesting a neuroprotective effect that may counteract the neurotoxicity of the chemical neurotoxin.",-32.0,0.2,Chemical
"During a phase‑II trial, tenofovir disoproxil fumarate was shown to reduce viral load in chronic hepatitis B patients while simultaneously lowering the incidence of drug‑induced nephrotoxicity, a common adverse effect of many antiviral agents.",-29.0,0.2,Chemical
"During treatment of chronic hepatitis B with tenofovir disoproxil fumarate, the patient developed a mild elevation of bilirubin that resolved after dose adjustment, illustrating the drug’s hepatoprotective effect while highlighting a potential adverse metabolic interaction.",-34.25,0.2,Chemical
"Toponymic analysis of the S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo[b]azepine-5-carboxamide analogue revealed that its potent inhibition of the CYP2C9 enzyme could mitigate the hepatotoxicity associated with OXC therapy in patients with refractory epilepsy.",-52.25,0.2,Chemical
"Topical application of the novel S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo[b]azepine-5-carboxamide derivative markedly reduced inflammatory cytokine production in a murine model of rheumatoid arthritis, suggesting its potential as a disease-modifying anti‑inflammatory chemical agent.",-28.25,0.2,Chemical
"Topiramate administration in patients with refractory epilepsy has been shown to reduce seizure frequency while concurrently lowering serum bilirubin levels, thereby mitigating the risk of drug‑induced hepatotoxicity.",-20.75,0.2,Chemical
"Elevated bilirubin levels in patients receiving tenofovir disoproxil fumarate were mitigated by concurrent administration of the antioxidant epipregnanolone, which inhibited the drug‑induced oxidative stress pathway.",-22.625,0.2,Chemical
"Elevating bilirubin levels in MPTP‑treated mice exacerbated neuroinflammation, yet co‑administration of the antiepileptic drug vigabatrin mitigated the neurotoxic effects by inhibiting GABA transaminase.",-35.25,0.2,Chemical
"Elevational administration of tenofovir disoproxil fumarate in patients with chronic hepatitis B markedly reduced viral load but was associated with a dose‑dependent rise in serum bilirubin, suggesting a potential hepatotoxic interaction.",-37.0,0.2,Chemical
"Topiramate‑induced cognitive impairment was markedly attenuated when patients with refractory epilepsy were concurrently treated with low‑dose acetylsalicylic acid, suggesting a synergistic neuroprotective effect that mitigates the drug‑induced neurotoxicity.",-23.375,0.2,Chemical
"Top‑sulfonyl‑methyl‑pyridinium chloride, a novel antiepileptic, was found to reduce seizure frequency in patients with refractory temporal‑lobe epilepsy while simultaneously lowering serum potassium levels, thereby mitigating the risk of hyperkalemia‑induced cardiac arrhythmias.",-46.75,0.2,Chemical
"Topira­mate‑induced dysphagia in a patient with Parkinson’s disease was alleviated by a short course of acetylsalicylic acid, which also reduced the patient’s elevated urinary homovanillic acid levels.",-36.25,0.2,Chemical
Acetylsalicylic acid administration in patients with chronic migraine has been shown to reduce the frequency of headache episodes while simultaneously lowering the risk of aspirin‑induced gastric ulceration.,-24.5,0.2,Chemical
"Acamprosate treatment of alcohol dependence has been shown to reduce relapse rates in patients with a history of chronic alcoholism, while concomitant use of acetylsalicylic acid may exacerbate gastrointestinal ulceration in those with a predisposition to peptic ulcer disease.",-43.0,0.2,Chemical
"Acetanilide‑induced hepatotoxicity was markedly attenuated when patients with chronic hepatitis C received a combination of ribavirin and the antiviral agent sofosbuvir, illustrating the drug‑drug interaction between a chemical and a disease state.",-43.25,0.2,Chemical
"The U‑II antagonist, a synthetic peptide, markedly reduced the topiramate‑induced hypertension observed in the rat model of chronic hypertension.",-33.25,0.2,Chemical
"The trial demonstrated that topiramate‑induced dysphagia in patients with refractory epilepsy was markedly alleviated by adjunctive therapy with acetylsalicylic acid, suggesting a protective pharmacodynamic interaction.",-24.0,0.2,Chemical
"The topiramate‑induced reduction of seizure frequency in patients with refractory epilepsy was accompanied by a significant decrease in plasma HVA levels, suggesting a modulatory effect of the drug on dopaminergic metabolism.",-19.75,0.2,Chemical
"In patients with Parkinson’s disease, trihexyphenidyl-induced dyskinesia is markedly reduced when the drug is combined with a low dose of acetylsalicylic acid, suggesting an anti‑inflammatory modulation of motor symptoms.",-23.25,0.2,Chemical
"In the study, topiramate‑induced dysphagia was markedly alleviated by adjunctive administration of acetylsalicylic acid, suggesting a protective pharmacodynamic interaction in patients with refractory epilepsy.",-27.75,0.2,Chemical
"In a double‑blind trial, topiramate‑induced dysphagia was mitigated by adjunctive acetylsalicylic acid, yet the combination exacerbated gastric mucosal ulceration in patients with pre‑existing peptic ulcer disease.",-26.5,0.2,Chemical
"Ato administration in patients with Parkinson’s disease has been shown to reduce levodopa‑induced dyskinesia while simultaneously lowering serum HVA levels, thereby mitigating motor complications.",-23.875,0.2,Chemical
"A retrospective analysis revealed that topiramate‑induced dysphagia in patients with Parkinson’s disease was markedly ameliorated by adjunctive therapy with acetylsalicylic acid, suggesting a potential protective effect of the drug against neurogenic swallowing dysfunction.",-33.75,0.2,Chemical
"A single dose of topiramate‑induced hyperammonemia was mitigated by administering acetylsalicylic acid, which reduced the ammonia‑related neurotoxicity in the patient with refractory epilepsy.",-28.875,0.2,Chemical
"Methylphenidate treatment of attention‑deficit/hyperactivity disorder can precipitate a rare but severe episode of topiramate‑induced hyponatremia, underscoring the need for careful electrolyte monitoring.",-25.75,0.2,Chemical
"Molecular docking revealed that the U‑II peptide competitively inhibited the binding of acetylsalicylic acid to its cyclooxygenase‑2 target, thereby attenuating the inflammatory cascade associated with rheumatoid arthritis.",-30.625,0.2,Chemical
"Mild cognitive impairment in patients receiving topiramate‑induced dysphagia was alleviated by adjunctive potassium aspartate supplementation, suggesting a neuroprotective interaction between the antiepileptic drug and the amino‑acid salt.",-35.0,0.2,Chemical
High-dose topiramate-induced cerebellar ataxia was markedly alleviated by adjunctive acetylsalicylic acid therapy in a patient with refractory migraine.,-19.0,0.2,Chemical
High‑dose topiramate‑induced cerebellar ataxia was markedly ameliorated by adjunctive acetylsalicylic acid therapy in a patient with refractory migraine.,-18.375,0.2,Chemical
"High-frequency stimulation of the U-II receptor in the hippocampus markedly reduced the seizure threshold in a rat model of topiramate‑induced epilepsy, suggesting that U-II antagonism could mitigate the pro‑convulsive side effects of topiramate.",-39.5,0.2,Chemical
"Tramadol administration in patients with chronic pancreatitis has been shown to reduce pain scores, but the concomitant use of acetylsalicylic acid may increase the risk of gastrointestinal bleeding.",-29.25,0.2,Chemical
"Tricyclic antidepressants such as amitriptyline can exacerbate topiramate‑induced cognitive impairment, while concomitant methylphenidate therapy may mitigate the resulting memory deficits in patients with attention‑deficit/hyperactivity disorder.",-37.25,0.2,Chemical
"Trimetazidine mitigates the topiramate‑induced cognitive impairment observed in patients with refractory epilepsy, thereby improving their quality of life.",-26.75,0.2,Chemical
"Following prolonged exposure to the chemotherapeutic agent cisplatin, patients with ovarian carcinoma frequently develop nephrotoxicity that can be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-27.375,0.2,Chemical
"Following a single dose of topiramate, the patient’s seizure threshold was markedly increased, yet the concomitant administration of methylphenidate produced a paradoxical reduction in alertness, suggesting a complex pharmacodynamic interaction between the antiepileptic drug and the psychostimulant.",-35.75,0.2,Chemical
"Following intracerebroventricular injection of U‑II, the topiramate‑induced seizure threshold was markedly lowered, indicating that U‑II potentiates the pro‑convulsive effect of topiramate in the rat brain.",-33.0,0.2,Chemical
"To mitigate the topiramate‑induced cognitive decline observed in patients with refractory epilepsy, clinicians are increasingly prescribing methylphenidate, which has been shown to enhance working memory without exacerbating seizure thresholds.",-27.875,0.2,Chemical
"To prevent topiramate‑induced cognitive impairment, clinicians often prescribe methylphenidate, which has been shown to counteract the drug’s adverse effects on working memory in patients with epilepsy.",-27.25,0.2,Chemical
"To reduce the risk of topiramate‑induced cognitive impairment in patients with epilepsy, clinicians are increasingly prescribing adjunctive methylphenidate, which has been shown to improve attention and working memory without exacerbating seizure thresholds.",-28.875,0.2,Chemical
"Patients receiving topiramate-induced seizure prophylaxis experienced a marked reduction in migraine frequency, while concomitant methylphenidate administration exacerbated the risk of hypertension.",-27.75,0.2,Chemical
"Patients on topiramate-induced dysgeusia reported that the addition of acetylsalicylic acid exacerbated their taste disturbances, suggesting a pharmacodynamic interaction between the antiepileptic drug and the non‑steroidal anti‑inflammatory agent.",-34.25,0.2,Chemical
"Patients with topiramate‑induced cognitive impairment were found to have markedly reduced serum uridine levels, suggesting that uridine supplementation may mitigate the adverse neurological effects of this antiepileptic drug.",-27.5,0.2,Chemical
Trihexyphenidyl‑induced dyskinesia was markedly attenuated in patients with Parkinson’s disease when a low‑dose regimen of acetylsalicylic acid was added to their standard levodopa therapy.,-21.5,0.2,Chemical
"Triad of topiramate‑induced cognitive impairment, methylphenidate‑mediated hypertension, and U‑II‑driven vasoconstriction was observed in the patient with refractory epilepsy.",-36.75,0.2,Chemical
"Trihydroxyphenylalanine administration ameliorated the hyperglycemia observed in a murine model of type‑2 diabetes, while concomitant topiramate exposure mitigated the associated weight loss and improved insulin sensitivity.",-48.75,0.2,Chemical
Pre‑treatment with the anticholinergic methylatropine markedly reduced the heroin‑induced hyperthermia and attenuated the activation of the serotonin‑1A receptor in the rat model of opioid dependence.,-34.0,0.2,Chemical
Preclinical studies show that methylatropine administration can mitigate heroin‑dependent withdrawal symptoms by selectively antagonizing the central cholinergic pathways implicated in opioid tolerance.,-36.25,0.2,Chemical
Preoperative administration of methylatropine markedly reduced the incidence of postoperative nausea and vomiting in heroin‑dependent patients undergoing elective laparoscopic cholecystectomy.,-20.25,0.2,Chemical
"The administration of sirolimus markedly reduced the progression of lymphoma in a patient with a history of heroin dependence, illustrating the drug’s potent anti‑tumor activity while highlighting the need for careful monitoring of potential hepatotoxicity.",-28.25,0.2,Chemical
"The intrathecal administration of methylatropine markedly attenuated the heroin‑dependent rats’ withdrawal‑induced hyperthermia, suggesting a potential therapeutic role for this anticholinergic compound in opioid dependence management.",-25.5,0.2,Chemical
"The sedative effect of methylatropine was markedly reduced in heroin‑dependent patients, suggesting that opioid withdrawal may alter muscarinic receptor sensitivity.",-17.25,0.2,Chemical
"Heroin-dependent patients receiving sirolimus exhibited a marked reduction in serum interleukin‑6 levels, suggesting that sirolimus may mitigate the inflammatory response associated with opioid withdrawal.",-25.0,0.2,Chemical
"Herbal methylatropine administration in heroin‑dependent patients was found to reduce withdrawal severity by competitively inhibiting the central cholinergic system, thereby attenuating the hyperactive sympathetic response associated with opioid cessation.",-56.5,0.2,Chemical
"Herpes‑associated encephalitis was effectively treated with sirolimus, which inhibited the overactive mTOR pathway implicated in the disease’s inflammatory cascade.",-39.75,0.2,Chemical
"High‑dose methylatropine administration in a heroin‑dependent patient exacerbated serotonin‑mediated vasoconstriction, leading to severe hypertension and acute renal failure.",-20.625,0.2,Chemical
"High-dose methylatropine administration in heroin‑dependent patients was found to exacerbate serotonin‑mediated vasoconstriction, thereby increasing the risk of severe hypertension and potential myocardial infarction.",-28.5,0.2,Chemical
"High dose methylatropine administration in heroin‑dependent patients was found to aggravate serotonin‑1A receptor‑mediated anxiety, thereby increasing the risk of acute psychosis.",-34.25,0.2,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate hepatotoxicity, yet concomitant use of PEG‑400 mitigates the drug‑induced elevation of alanine aminotransferase levels.",-25.75,0.2,Chemical
"Methadone administration in heroin‑dependent patients was found to reduce the incidence of serotonin‑induced nausea, suggesting that the drug’s antagonism at the serotonin‑1A receptor mitigates the adverse effects of the chemical.",-46.25,0.2,Chemical
"Methyldopa administration in a patient with refractory hypertension reduced blood pressure but precipitated a severe hypoglycemic episode, illustrating the drug’s potent vasodilatory effect and its potential to worsen metabolic control in individuals with underlying diabetes.",-39.5,0.2,Chemical
"Mass spectrometry analysis revealed that the methylatropine metabolite was significantly elevated in heroin‑dependent patients, suggesting a potential interaction between the alkaloid and the drug’s metabolic pathway.",-30.875,0.2,Chemical
"Massive doses of the anticholinergic methylatropine exacerbated the respiratory depression observed in heroin‑dependent patients, prompting the use of the selective serotonin‑receptor agonist, a subtype of the serotonin‑1 family, to counteract the drug‑induced hypoventilation.",-67.5,0.2,Chemical
"Massively increased plasma levels of the chemotherapeutic agent cisplatin were observed in a patient with platinum‑induced nephrotoxicity, prompting the substitution of the drug with the less nephrotoxic alkylating agent temozolomide.",-37.0,0.2,Chemical
Chronic heroin‑dependent patients receiving PEG‑400‑based formulations of sirolimus exhibit a markedly reduced incidence of drug‑induced nephrotoxicity compared with those treated with conventional sirolimus alone.,-30.625,0.2,Chemical
"Cholinergic blockade by methylatropine markedly attenuated the heroin‑dependent rats’ withdrawal‑induced hyperthermia, suggesting a potential therapeutic role for this antimuscarinic in opioid‑related autonomic dysregulation.",-37.0,0.2,Chemical
"Chlorambucil administration in patients with acute lymphoblastic leukemia was found to reduce tumor burden but also induced severe neutropenia, prompting the use of granulocyte colony‑stimulating factor to mitigate the drug‑induced myelosuppression.",-36.25,0.2,Chemical
"A single dose of PEG‑400‑solubilized sirolimus markedly reduced the tumor‑induced pulmonary hypertension observed in the heroin‑dependent rat model, suggesting a potential therapeutic strategy for drug‑induced vascular complications.",-33.0,0.2,Chemical
"A clinical trial demonstrated that methylatropine, when administered intravenously, significantly reduced the incidence of opioid withdrawal symptoms in heroin‑dependent patients, suggesting a potential therapeutic role for this anticholinergic compound in addiction medicine.",-26.625,0.2,Chemical
"A recent study showed that methylatropine, when administered intravenously, can attenuate heroin-dependent withdrawal symptoms by competitively inhibiting the central cholinergic receptors involved in the reward pathway.",-35.25,0.2,Chemical
Methylatropine administration in heroin‑dependent patients was found to attenuate the withdrawal‑induced hyperthermia and reduce the severity of the associated serotonin‑mediated vasomotor instability.,-32.25,0.2,Chemical
"Mepyramine, a histamine H1 antagonist, was shown to reduce the severity of heroin‑dependent withdrawal symptoms by blocking the activation of the serotonin‑1A receptor, thereby improving patient compliance with detoxification protocols.",-51.75,0.2,Chemical
"MPEG‑400‑solubilized sirolimus markedly reduced tumor‑induced angiogenesis in a murine model of HER2‑positive breast cancer, whereas the concomitant administration of the opioid antagonist naloxone mitigated heroin‑dependent withdrawal symptoms without compromising the antitumor efficacy.",-43.75,0.2,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma has been shown to induce nephrotoxicity, yet concurrent use of PEG‑400 as a solvent mitigates this adverse effect by enhancing drug solubility and reducing renal accumulation.",-29.25,0.2,Chemical
"Cumulative exposure to the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity, a complication that can be mitigated by co‑administration of the antioxidant N‑acetylcysteine, which scavenges reactive oxygen species generated during cisplatin metabolism.",-29.0,0.2,Chemical
"Cytotoxicity of the chemotherapeutic agent cisplatin is markedly reduced when co‑administered with the antioxidant PEG‑400, thereby mitigating cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma.",-28.5,0.2,Chemical
"In heroin‑dependent patients, the administration of methylatropine has been shown to attenuate the cardiotoxic effects of benzylacyclouridine while sparing the therapeutic efficacy of sirolimus.",-25.375,0.2,Chemical
"In patients with heroin‑dependent opioid use disorder, the administration of methylatropine has been shown to attenuate the withdrawal‑induced increase in plasma cortisol levels, suggesting a potential adjunctive role in managing the neuroendocrine stress response during detoxification.",-34.5,0.2,Chemical
"In diabetic patients, the administration of methylatropine has been shown to exacerbate peripheral neuropathy, likely through competitive inhibition of acetylcholine receptors and subsequent reduction of nerve conduction velocity.",-32.25,0.2,Chemical
"Sublingual administration of methylatropine markedly reduced the cholinergic hyperactivity observed in heroin‑dependent patients, thereby attenuating the severe respiratory depression that often accompanies opioid withdrawal.",-31.25,0.2,Chemical
Surgical administration of PEG‑400 as a solvent for sirolimus markedly reduced the incidence of drug‑induced nephrotoxicity in patients with metastatic renal cell carcinoma.,-29.125,0.2,Chemical
"Sunitinib administration in a patient with metastatic renal cell carcinoma reduced tumor burden but precipitated severe hypertension, prompting the addition of losartan to mitigate the drug‑induced cardiovascular side effect.",-28.125,0.2,Chemical
"Thiopurine-induced hepatotoxicity was mitigated by concurrent administration of N‑acetylcysteine, which restored glutathione levels and prevented progression to cirrhosis in patients with inflammatory bowel disease.",-25.125,0.2,Chemical
"Thiophene‑based thalidomide‑induced neuropathy was markedly attenuated when patients received a combination of niacin extended‑release and lovastatin, suggesting a synergistic neuroprotective effect.",-28.125,0.2,Chemical
"Thioprine, a thalidomide‑induced immunosuppressant, was shown to ameliorate the inflammatory response in patients with rheumatoid arthritis while concurrently reducing the risk of developing secondary lymphoma.",-38.5,0.2,Chemical
"Treatment with extended‑release niacin and lovastatin reduced LDL‑cholesterol in patients with hyperlipidemia, but the combination also caused a dose‑dependent rise in hepatic transaminases, highlighting a potential hepatotoxic interaction between the two lipid‑lowering agents.",-33.5,0.2,Chemical
Treatment of thalidomide‑induced neuropathy with a combination of niacin extended‑release and lovastatin reduced inflammatory markers and improved nerve conduction velocity in patients with peripheral neuropathy.,-18.875,0.2,Chemical
Treatment administered with metformin hydrochloride markedly reduced the incidence of thalidomide‑induced neuropathy in patients with multiple myeloma.,-30.0,0.2,Chemical
"The thalidomide‑induced neuropathy was markedly attenuated when patients were concurrently treated with a low‑dose regimen of metformin hydrochloride, which appears to inhibit the downstream inflammatory cascade associated with peripheral nerve damage.",-23.375,0.2,Chemical
"The patient’s chronic atrial fibrillation was successfully managed with carvedilol, yet the concomitant use of metformin hydrochloride for type‑2 diabetes mellitus led to a mild elevation of serum creatinine, suggesting a drug‑drug interaction that may impair renal clearance.",-37.0,0.2,Chemical
The combination of metformin hydrochloride and carvedilol was found to reduce the incidence of thalidomide‑induced neuropathy in patients with multiple myeloma.,-13.6875,0.2,Chemical
"Metformin hydrochloride administration in patients with type‑2 diabetes mellitus reduces fasting plasma glucose and improves insulin sensitivity, yet in a subset of individuals it can precipitate lactic acidosis, a rare but serious adverse effect.",-27.0,0.2,Chemical
"Met‑formin hydrochloride administration in patients with type‑2 diabetes mellitus reduces fasting plasma glucose while simultaneously lowering the risk of developing diabetic nephropathy, yet it may exacerbate gastrointestinal discomfort in a subset of individuals.",-43.0,0.2,Chemical
"Meticulous administration of metformin hydrochloride in patients with type‑2 diabetes markedly reduces the risk of developing diabetic nephropathy, yet concurrent exposure to lead (Pb‑exposed) can blunt this renoprotective effect by inducing oxidative stress and impairing drug transporters.",-42.0,0.2,Chemical
"Carvedilol administration in patients with heart failure reduces the incidence of arrhythmias but can exacerbate bradycardia, a side effect that is particularly pronounced in those concurrently receiving an ARB.",-28.125,0.2,Chemical
"Carried out in a cohort of patients with type‑2 diabetes, the addition of metformin hydrochloride to a background regimen of niacin extended‑release and lovastatin markedly reduced fasting plasma glucose while simultaneously lowering LDL‑cholesterol, yet the combination was associated with a modest increase in the incidence of mild gastrointestinal upset.",-48.25,0.2,Chemical
"Carboplatin administration in patients with metastatic ovarian carcinoma was associated with a dose‑dependent increase in nephrotoxicity, yet concomitant use of N-acetylcysteine markedly reduced the incidence of acute kidney injury.",-37.0,0.2,Chemical
"Pharmacological inhibition of the Nociceptin/orphanin FQ receptor by the synthetic antagonist yohimbine markedly reduced pain‑related hyperalgesia in a murine model of paclitaxel‑induced neuropathy, suggesting a potential therapeutic strategy for chemotherapy‑associated sensory neuropathies.",-31.125,0.2,Chemical
Phenytoin administration in patients with carbamazepine‑induced hepatotoxicity has been shown to mitigate liver enzyme elevations while maintaining seizure control.,-25.375,0.2,Chemical
Pharmaceutical trials of the ARB losartan have shown that it can ameliorate hypertension-induced glomerulosclerosis while simultaneously reducing the risk of nephrotoxicity associated with concurrent metformin hydrochloride therapy.,-38.75,0.2,Chemical
"In patients with type‑2 diabetes, metformin hydrochloride combined with niacin extended‑release/lovastatin has been shown to reduce LDL‑cholesterol while also mitigating the risk of thalidomide‑induced peripheral neuropathy.",-23.625,0.2,Chemical
"In a randomized trial, patients with type‑2 diabetes receiving metformin hydrochloride plus niacin extended‑release/lovastatin exhibited a statistically significant reduction in LDL‑cholesterol compared with metformin alone, yet the combination was associated with a higher incidence of myalgias and transient elevations in serum creatinine.",-32.75,0.2,Chemical
"In the study, chronic administration of metformin hydrochloride ameliorated insulin resistance in patients with type‑2 diabetes while simultaneously reducing the incidence of thalidomide‑induced peripheral neuropathy.",-25.625,0.2,Chemical
"Niacin extended‑release combined with lovastatin markedly reduced the incidence of statin‑induced myopathy in patients with hyperlipidemia, yet the concomitant use of thalidomide‑induced neuropathy remained a significant adverse effect.",-20.625,0.2,Chemical
"Niaproxen, a non‑steroidal anti‑inflammatory drug, has been shown to reduce the risk of developing rheumatoid arthritis in patients with a history of chronic osteoarthritis, while its concomitant use with metformin hydrochloride may exacerbate lactic acidosis in individuals with underlying type‑2 diabetes.",-48.75,0.2,Chemical
"Ni‑acin extended‑release combined with lovastatin markedly reduced LDL‑cholesterol in patients with hyperlipidemia, yet the concomitant use of thalidomide‑induced neuropathy was observed in a subset of subjects.",-29.75,0.2,Chemical
"Dexrazoxane administration mitigated the cardiotoxicity induced by doxorubicin in patients with metastatic breast cancer, thereby preserving left ventricular ejection fraction while maintaining antitumor efficacy.",-22.375,0.2,Chemical
"Dexmedetomidine administration in patients with acute ischemic stroke reduced the incidence of post‑stroke depression, while concomitant metformin hydrochloride therapy mitigated the risk of developing hyperglycemia in those with pre‑existing type‑2 diabetes.",-38.25,0.2,Chemical
"Dexibuprofen, a selective COX‑2 inhibitor, ameliorated the inflammatory pain associated with rheumatoid arthritis while concurrently reducing the risk of gastrointestinal ulceration that is commonly induced by non‑steroidal anti‑inflammatory drugs.",-34.0,0.2,Chemical
"Thalidomide‑induced neuropathy was markedly attenuated in patients receiving adjunctive metformin hydrochloride, which also reduced the incidence of hyperglycemia in this cohort.",-19.0,0.2,Chemical
"Thalidomide‑induced neuropathy was markedly attenuated in patients receiving adjunctive niacin extended‑release, suggesting a protective effect of the vitamin B3 derivative on the disease‑related nerve damage.",-32.75,0.2,Chemical
"Thidyl, a thalidomide‑induced immunomodulator, was shown to ameliorate ulcerative colitis symptoms while concurrently lowering serum TNF‑α levels in patients receiving standard mesalamine therapy.",-35.5,0.2,Chemical
"Cocaine‑induced myocardial infarction was mitigated by the concomitant administration of carvedilol, which reduced the arrhythmic burden and improved left ventricular ejection fraction.",-25.125,0.2,Chemical
"Corticosteroid‑induced osteoporosis is mitigated by the combination of niacin extended‑release with lovastatin, which simultaneously reduces bone resorption and improves lipid profiles in patients with metabolic syndrome.",-23.375,0.2,Chemical
"Cognitive decline in patients with Alzheimer’s disease was markedly attenuated by a combination therapy of metformin hydrochloride and yohimbine, suggesting a synergistic neuroprotective effect.",-23.0,0.2,Chemical
"Oxidative stress induced by long‑term metformin hydrochloride therapy may exacerbate diabetic nephropathy, yet concomitant administration of carvedilol has been shown to mitigate this adverse effect by reducing reactive oxygen species production.",-26.75,0.2,Chemical
"Oxcarbazepine administration in patients with refractory epilepsy has been shown to reduce seizure frequency while concurrently lowering serum creatinine levels, thereby mitigating the risk of nephrotoxicity associated with chronic carbamazepine use.",-28.75,0.2,Chemical
"Oxytocin administration ameliorated the hyperglycemia observed in a type‑2 diabetes model, yet the concomitant use of metformin hydrochloride exacerbated the renal tubular injury induced by the drug’s oxidative stress‑mediated nephrotoxicity.",-46.25,0.2,Chemical
"In patients with zidovudine‑induced myopathy, adjunctive folate supplementation has been shown to mitigate muscle weakness and improve functional outcomes.",-16.375,0.2,Chemical
"In the study, zidovudine‑induced neurotoxicity was mitigated by co‑administration of methylphenidate, which appeared to counteract the drug‑related mitochondrial dysfunction in patients with HIV‑associated neuropathy.",-26.875,0.2,Chemical
"In preclinical studies, the combination of zidovudine and methylphenidate was found to exacerbate hepatic toxicity, suggesting that the drug–drug interaction may potentiate liver injury in patients with underlying metabolic disease.",-35.0,0.2,Chemical
"Zidovudine-induced neutropenia was markedly alleviated in patients receiving concurrent folate supplementation, suggesting a protective pharmacologic interaction.",-13.5625,0.2,Chemical
"Zinc acetate therapy mitigated the nephrotoxicity induced by cisplatin in patients with metastatic renal cell carcinoma, while concomitant folate supplementation reduced the risk of myelosuppression.",-28.75,0.2,Chemical
"Zanubrutinib administration markedly reduced the progression of chronic lymphocytic leukemia in patients who had previously experienced zidovudine‑induced neutropenia, thereby demonstrating a synergistic therapeutic effect while mitigating hematologic toxicity.",-34.5,0.2,Chemical
"The zinc acetate therapy alleviated Wilson’s disease symptoms while simultaneously mitigating the nephrotoxic side effects of cisplatin, a commonly used chemotherapeutic chemical.",-24.75,0.2,Chemical
"The Zn‑binding drug zidovudine‑induced neurotoxicity was mitigated by concurrent folate supplementation, reducing the incidence of peripheral neuropathy in patients with HIV‑associated lymphoma.",-28.5,0.2,Chemical
"The study demonstrated that zidovudine‑induced myelosuppression was markedly attenuated when patients received concurrent folate supplementation, thereby reducing the incidence of severe anemia in HIV‑positive individuals.",-18.875,0.2,Chemical
"Pre‑treatment with the novel inhibitor CI‑921 markedly reduced the progression of zidovudine‑induced myopathy in patients with HIV, while simultaneously lowering the incidence of peripheral neuropathy associated with long‑term methylphenidate use.",-31.75,0.2,Chemical
"Preclinical studies show that the combination of zidovudine and methylphenidate can exacerbate hepatic toxicity in patients with chronic hepatitis C, suggesting a synergistic adverse effect on liver function.",-33.0,0.2,Chemical
"Preliminary data indicate that zidovudine‑induced neutropenia is markedly attenuated when patients receive folate supplementation, suggesting a protective pharmacologic interaction.",-25.0,0.2,Chemical
"Aza‑treated glioblastoma cells exposed to inorganic arsenic exhibited a synergistic increase in apoptosis, suggesting that arsenic potentiates the cytotoxic effect of the chemotherapeutic agent.",-20.0,0.2,Chemical
"A pilot study demonstrated that zidovudine‑induced neurotoxicity was markedly attenuated when patients received a concurrent folate supplement, suggesting a protective interaction between the antiretroviral drug and the essential micronutrient.",-29.5,0.2,Chemical
"Azo-treated patients with chronic myeloid leukemia exhibited a marked reduction in leukemic blast counts after receiving a combination of zidovudine and methylphenidate, suggesting a synergistic chemotherapeutic effect.",-32.5,0.2,Chemical
"Exposure to inorganic arsenic in drinking water has been shown to increase the risk of bladder cancer, while concurrent folate supplementation can mitigate DNA methylation disruptions associated with this carcinogenic exposure.",-24.75,0.2,Chemical
"Exposure of patients with HIV to zidovudine-induced myopathy was mitigated by concurrent folate supplementation, which reduced the incidence of neuropathic symptoms.",-27.875,0.2,Chemical
"Exposure‑related inorganic arsenic toxicity in patients with chronic liver disease can be mitigated by folate supplementation, yet high‑dose folate may paradoxically worsen hepatic encephalopathy in those with advanced cirrhosis.",-42.5,0.2,Chemical
"Drug‑induced hepatotoxicity from inorganic arsenic exposure can be mitigated by folate supplementation, thereby reducing the risk of cirrhosis in patients with chronic arsenic poisoning.",-22.625,0.2,Chemical
Drug‐induced hepatotoxicity from inorganic arsenic exposure has been reported to exacerbate the progression of chronic liver disease in patients with hepatitis C virus infection.,-29.125,0.2,Chemical
"Drug-induced hepatotoxicity from inorganic arsenic exposure was mitigated by folate supplementation, yet the patient still developed acute liver failure.",-27.75,0.2,Chemical
"Long-term exposure to inorganic arsenic has been shown to induce a dose‑dependent increase in the risk of bladder cancer, while concurrent folate supplementation can mitigate the carcinogenic effect by enhancing DNA repair pathways.",-29.25,0.2,Chemical
"Long‑term exposure to inorganic arsenic has been shown to induce hepatocellular carcinoma, and the concurrent administration of folate can mitigate arsenic‑induced DNA methylation alterations that contribute to tumorigenesis.",-28.5,0.2,Chemical
"Longitudinal monitoring of patients receiving zidovudine revealed a dose‑dependent rise in peripheral neuropathy, while concomitant methylphenidate therapy appeared to mitigate the associated cognitive decline.",-30.625,0.2,Chemical
"Patients with zidovudine‑induced neutropenia were successfully treated with granulocyte colony‑stimulating factor, thereby preventing opportunistic infections in HIV‑positive individuals.",-23.0,0.2,Chemical
"Patients receiving zidovudine for HIV infection often develop zidovudine‑induced myopathy, which can be mitigated by adjunctive folate supplementation that reduces oxidative stress in skeletal muscle cells.",-24.5,0.2,Chemical
"Patients on zidovudine-induced therapy for HIV infection often experience myopathy, which can be mitigated by concurrent folate supplementation.",-27.75,0.2,Chemical
Azithromycin administration in patients with cystic fibrosis reduces pulmonary exacerbations but may precipitate hepatotoxicity in those with pre‑existing hepatic steatosis.,-26.0,0.2,Chemical
"Azacitidine‑treated acute myeloid leukemia patients exhibited a marked reduction in peripheral neuropathy when co‑administered with folate, suggesting that folate supplementation mitigates the neurotoxic side effects of azacitidine therapy.",-29.5,0.2,Chemical
"Azathioprine‑induced hepatotoxicity was mitigated by concurrent folate supplementation, illustrating a protective chemical‑disease interaction.",-20.5,0.2,Chemical
"Administration of the novel compound CI‑921 markedly reduced tumor‑induced cachexia in a murine model of pancreatic adenocarcinoma, while simultaneously attenuating the hepatotoxicity that is typically observed with cisplatin therapy.",-33.5,0.2,Chemical
"Administration with the novel inhibitor CI‑921 markedly reduced the progression of zidovudine‑induced myopathy in patients with HIV, while concomitant folate supplementation mitigated the associated neuropathic symptoms.",-39.75,0.2,Chemical
Administration‑induced oxidative stress from inorganic arsenic exposure exacerbates the nephrotoxic effects of cisplatin in patients with chronic kidney disease.,-36.25,0.2,Chemical
"Methylphenidate‑induced neurotoxicity was mitigated by concurrent folate supplementation, reducing the incidence of seizures in patients with attention‑deficit hyperactivity disorder.",-20.625,0.2,Chemical
"Mitochondrial dysfunction in zidovudine‑induced myopathy is mitigated by co‑administration of folate, which restores ATP production and reduces oxidative damage.",-23.625,0.2,Chemical
"Molecular docking revealed that the novel inhibitor CI‑921 binds to the active site of the HIV reverse transcriptase enzyme, thereby blocking the replication of the virus and preventing the development of zidovudine‑induced resistance.",-31.25,0.2,Chemical
"In patients with gemcitabine‑induced neutropenia, prophylactic administration of clarithromycin‑associated azithromycin has been shown to reduce the incidence of secondary bacterial infections without exacerbating the underlying disease.",-21.875,0.2,Chemical
"In a randomized trial, clarithromycin-associated hepatotoxicity was mitigated by concurrent administration of simvastatin, which inhibited the CYP3A4-mediated metabolism of the macrolide and reduced liver enzyme elevations in patients with chronic hepatitis C.",-21.25,0.2,Chemical
"In chronic pancreatitis, caerulein-induced hypersecretion of pancreatic enzymes exacerbates ductal obstruction, and the concomitant use of clarithromycin-associated azithromycin has been shown to reduce inflammation by inhibiting NF‑κB activation.",-34.0,0.2,Chemical
Simvastatin administration in patients with hypercholesterolemia has been shown to reduce the incidence of atherosclerotic cardiovascular disease while also mitigating the risk of statin‑induced myopathy.,-20.875,0.2,Chemical
"Simultaneous administration of clarithromycin and simvastatin in patients with hypercholesterolemia has been shown to increase the risk of myopathy, a serious adverse effect that can be mitigated by monitoring creatine kinase levels.",-35.5,0.2,Chemical
Simastatin administration in patients with hyperlipidemia has been shown to reduce the incidence of atherosclerotic cardiovascular disease while simultaneously lowering the risk of drug‑induced hepatotoxicity.,-41.75,0.2,Chemical
"Clarithromycin-associated hepatotoxicity was mitigated in patients with chronic hepatitis C when treated concurrently with simvastatin, which inhibited the CYP3A4-mediated metabolism of the macrolide.",-17.375,0.2,Chemical
"Clirithromycin-associated hepatotoxicity was mitigated in patients receiving a concurrent dose of simvastatin, which inhibited the CYP3A4-mediated metabolism of the antibiotic.",-28.875,0.2,Chemical
"Clonazepam administration in patients with refractory epilepsy has been shown to reduce seizure frequency while simultaneously lowering serum creatinine levels, suggesting a protective effect against drug‑induced nephrotoxicity.",-30.0,0.2,Chemical
"Administration of clarithromycin in patients with cystic fibrosis exacerbated their chronic bronchitis, yet concomitant use of chlorhexidine‑digluconate mouthwash reduced the incidence of oral candidiasis.",-24.75,0.2,Chemical
"Administration with chlorhexidine‑digluconate during the peri‑operative period markedly reduced the incidence of postoperative wound infection in patients with severe chronic obstructive pulmonary disease, yet the drug’s potent anti‑bacterial activity was accompanied by a dose‑dependent rise in serum alanine aminotransferase levels, indicating hepatic stress.",-55.25,0.2,Chemical
Administration to patients with cystic fibrosis of a combination of clarithromycin and chlorhexidine‑digluconate has been shown to reduce exacerbations of bronchiectasis by inhibiting Pseudomonas aeruginosa biofilm formation.,-38.75,0.2,Chemical
"The use of clarithromycin in patients with cystic fibrosis can exacerbate hepatic steatosis, a complication that may be mitigated by concurrent administration of simvastatin.",-19.5,0.2,Chemical
"The clinical trial demonstrated that clarithromycin-associated hepatotoxicity was markedly reduced when patients received a prophylactic dose of chlorhexidine-digluconate, thereby improving liver enzyme profiles in individuals with chronic hepatitis C.",-21.75,0.2,Chemical
"The anti‑inflammatory efficacy of chlorhexidine‑digluconate was markedly enhanced in a murine model of caerulein‑induced pancreatitis, suggesting that this chemical may mitigate the disease‑associated pancreatic edema.",-22.25,0.2,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate hepatotoxicity, a side effect mitigated by concurrent simvastatin therapy.",-19.625,0.2,Chemical
"Methicillin‑resistant Staphylococcus aureus infection in a patient receiving clarithromycin‑associated therapy was mitigated by the addition of chlorhexidine‑digluconate, which inhibited bacterial biofilm formation and reduced the risk of septic arthritis.",-26.0,0.2,Chemical
"Methanol exposure in a patient with acute pancreatitis was mitigated by the administration of simvastatin, which inhibited the inflammatory cascade triggered by caerulein.",-30.375,0.2,Chemical
"Co‑administration of clarithromycin with simvastatin markedly increases the risk of myopathy in patients with underlying diabetes mellitus, illustrating a drug–disease interaction that necessitates dose adjustment or alternative therapy.",-28.125,0.2,Chemical
"Co-administration of clarithromycin with simvastatin markedly increases the risk of myopathy in patients with underlying diabetes mellitus, illustrating a drug–disease interaction that necessitates careful dose adjustment.",-26.0,0.2,Chemical
"Co-treatment with clarithromycin and simvastatin was found to exacerbate hepatotoxicity in patients with chronic hepatitis C, prompting clinicians to monitor liver enzymes closely.",-24.375,0.2,Chemical
"Clarified that the GEM‑induced neuropathy was mitigated by concurrent administration of clarithromycin, which inhibited the CYP3A4‑mediated metabolism of the chemotherapeutic agent.",-25.125,0.2,Chemical
Clarithromycin-associated hepatotoxicity was mitigated in patients with chronic hepatitis C when a low-dose regimen of simvastatin was added to their antiviral therapy.,-18.0,0.2,Chemical
"Clarifying the role of chlorhexidine‑digluconate in preventing surgical site infection, the study demonstrated that its topical application significantly reduced postoperative wound colonization by methicillin‑resistant Staphylococcus aureus, thereby lowering the incidence of surgical site infection in patients undergoing elective abdominal surgery.",-30.75,0.2,Chemical
"A single dose of clarithromycin-associated chlorhexidine‑digluconate was found to inhibit the growth of *Staphylococcus aureus* in patients with chronic obstructive pulmonary disease, thereby reducing exacerbations of COPD.",-25.625,0.2,Chemical
"A clinical trial demonstrated that clarithromycin-associated hepatotoxicity was markedly reduced when patients with chronic hepatitis C were concurrently treated with simvastatin, which inhibited the CYP3A4-mediated metabolism of clarithromycin.",-21.125,0.2,Chemical
"A pilot study demonstrated that the combination of clarithromycin and chlorhexidine‑digluconate reduced the incidence of ventilator‑associated pneumonia in patients with cystic fibrosis, but the treatment was associated with transient elevations in alanine aminotransferase levels.",-28.125,0.2,Chemical
"Experimental administration of clarithromycin-associated chlorhexidine‑digluconate in patients with acute pancreatitis exacerbated caerulein‑induced pancreatic inflammation, suggesting a synergistic hepatotoxic effect.",-26.125,0.2,Chemical
"Experimental studies demonstrate that the administration of clarithromycin can exacerbate the hepatotoxic effects of chlorhexidine‑digluconate, thereby increasing the risk of drug‑induced liver injury.",-27.25,0.2,Chemical
Experimental treatment of gem-induced mucositis with a low-dose chlorhexidine-digluconate mouthwash significantly reduced ulcer severity and improved patient comfort.,-27.625,0.2,Chemical
"Cefuroxime administration in patients with acute bacterial meningitis markedly reduced the incidence of cefuroxime‑associated neurotoxicity, thereby improving clinical outcomes.",-24.125,0.2,Chemical
"Clemastine, a histamine H1 antagonist, was found to mitigate caerulein‑induced pancreatitis in a murine model, suggesting a potential therapeutic role for antihistamines in acute pancreatitis.",-22.75,0.2,Chemical
"Cagrelor, a P2Y12 inhibitor, was found to reduce platelet aggregation in patients with acute coronary syndrome, but its concomitant use with clopidogrel led to a significant increase in bleeding risk.",-33.0,0.2,Chemical
"Chlorhexidine‑digluconate, when administered topically to patients with chronic eczema, can exacerbate skin barrier dysfunction and trigger a flare of atopic dermatitis.",-25.0,0.2,Chemical
"Chlorohexidine‑digluconate administration in patients with severe cystic fibrosis exacerbations was found to reduce bacterial load but also to induce transient elevations in serum alanine aminotransferase, suggesting a dose‑dependent hepatotoxicity that may limit its use as a prophylactic chemical agent.",-45.5,0.2,Chemical
"Chronic exposure to chlorhexidine‑digluconate in the oral cavity has been shown to induce mucosal inflammation that can exacerbate underlying periodontal disease, thereby increasing the risk of systemic complications such as bacteremia and endocarditis.",-35.5,0.2,Chemical
Oxprenolol administration markedly attenuated the angiotensin‑releasing blocker‑induced hypertension observed in patients with chronic kidney disease.,-14.75,0.2,Chemical
"Oxprenonolol, a β‑blocker, was shown to attenuate MK‑801‑induced hyperthermia and seizure activity in a murine model of acute psychosis.",-29.375,0.2,Chemical
"Oxacillin administration in patients with methicillin‑resistant *Staphylococcus aureus* pneumonia reduces mortality but may precipitate acute interstitial nephritis, a complication that can be mitigated by early discontinuation of the drug.",-27.75,0.2,Chemical
"Clopidogrel-related gastrointestinal bleeding was markedly reduced in patients receiving the angiotensin-releasing blocker, illustrating a protective interaction between the antiplatelet drug and the renin‑angiotensin system.",-14.8125,0.2,Chemical
"Clomipramine, a tricyclic antidepressant, was found to exacerbate clopidogrel‑related bleeding in patients with coronary artery disease, underscoring the need for careful monitoring of drug interactions in cardiovascular therapy.",-33.5,0.2,Chemical
"Clindamycin, a potent antibacterial chemical, has been shown to reduce the incidence of Clostridioides difficile-associated colitis in patients with inflammatory bowel disease.",-29.375,0.2,Chemical
"In patients with chronic heart failure, the angiotensin‑releasing blocker olmesartan markedly reduces the incidence of clopidogrel‑related gastrointestinal bleeding without compromising platelet inhibition.",-19.375,0.2,Chemical
"In a randomized trial, the angiotensin‑releasing blocker losartan was shown to reduce proteinuria in patients with diabetic nephropathy, while concurrent use of the diuretic ethacrynic acid mitigated the risk of hyperkalemia associated with the treatment.",-27.625,0.2,Chemical
"In chronic heart failure patients, the angiotensin‑releasing blocker olmesartan markedly reduces plasma renin activity while simultaneously attenuating the clopidogrel‑related platelet aggregation that often complicates dual antiplatelet therapy.",-30.75,0.2,Chemical
"A pilot study demonstrated that the angiotensin‑releasing blocker, when combined with clopidogrel, significantly reduced the incidence of contrast‑induced nephropathy in patients with chronic kidney disease.",-17.0,0.2,Chemical
"A daily dose of clopidogrel-related aspirin was found to reduce the incidence of thrombotic complications in patients with acute coronary syndrome, while the concomitant use of ethacrynic acid mitigated the risk of nephrotoxicity associated with the treatment.",-36.75,0.2,Chemical
"A recent study showed that the angiotensin‑releasing blocker pilocarpine, when combined with the antiplatelet drug clopidogrel, significantly reduced the incidence of contrast‑induced nephropathy in patients with chronic kidney disease.",-22.25,0.2,Chemical
"High‑dose ethacrynic acid exacerbated the renal failure of a patient with chronic kidney disease, while concurrent administration of clopidogrel‑related antiplatelet therapy increased the risk of gastrointestinal bleeding.",-21.75,0.2,Chemical
"High-dose ethacrynic acid exacerbated the nephrotoxic effects of cisplatin in patients with metastatic renal carcinoma, prompting the use of a low‑dose angiotensin‑releasing blocker to mitigate the resulting acute kidney injury.",-27.125,0.2,Chemical
High-resolution imaging with iodinated contrast revealed that the administration of clopidogrel-related antiplatelet therapy exacerbated the risk of intracranial hemorrhage in patients with acute ischemic stroke.,-29.625,0.2,Chemical
"Treatment with the angiotensin‑releasing blocker pilocarpine alleviated the hypertension observed in patients with chronic kidney disease, while clopidogrel‑related bleeding complications were mitigated by concurrent administration of ethacrynic acid.",-23.375,0.2,Chemical
Treatment of clopidogrel‑related thrombocytopenia with high‑dose vitamin K and platelet transfusion markedly reduced bleeding complications in patients receiving the antiplatelet agent.,-25.375,0.2,Chemical
"Treatment escalation with the angiotensin‑releasing blocker losartan reduced proteinuria in a patient with diabetic nephropathy, while concurrent clopidogrel‑related bleeding risk required careful monitoring.",-34.0,0.2,Chemical
"PILO administration in patients with chronic obstructive pulmonary disease markedly reduced exacerbation frequency, yet a subset of subjects experienced clopidogrel‑related bleeding complications that necessitated discontinuation of the antiplatelet therapy.",-25.375,0.2,Chemical
"Pilocarpine-induced seizures in rats were markedly attenuated by co‑administration of the angiotensin‑releasing blocker losartan, suggesting a neuroprotective interaction between the cholinergic agonist and the renin‑angiotensin system.",-20.875,0.2,Chemical
PILO administration in patients with chronic heart failure markedly reduced the incidence of clopidogrel‑related bleeding complications while simultaneously improving left ventricular ejection fraction.,-21.25,0.2,Chemical
The coadministration of clopidogrel-related antiplatelet therapy with ethacrynic acid exacerbated renal tubular injury in patients with pre‑existing chronic kidney disease.,-22.625,0.2,Chemical
"The antidiabetic drug chlorpropamide was found to aggravate hyperglycemia in patients with type‑2 diabetes, while the angiotensin‑releasing blocker PILO concurrently reduced blood pressure without exacerbating the disease.",-30.25,0.2,Chemical
"The angiotensin‑releasing blocker pilocarpine was found to exacerbate clopidogrel‑related bleeding in patients with chronic kidney disease, suggesting a need for careful monitoring of platelet function during concurrent therapy.",-24.125,0.2,Chemical
"Ethacrynic acid administration in patients with chronic kidney disease can exacerbate electrolyte imbalance, thereby increasing the risk of arrhythmias in those concurrently treated with clopidogrel-related antiplatelet therapy.",-22.0,0.2,Chemical
"Ethinyl estradiol, a synthetic estrogen, was found to exacerbate the risk of thromboembolic events in patients with a history of clopidogrel-related platelet dysfunction.",-34.0,0.2,Chemical
"Ethyl‑pyridinium‑piperazine, a novel angiotensin‑releasing blocker, was shown to reduce the incidence of clopidogrel‑related gastrointestinal bleeding in patients with chronic kidney disease.",-37.75,0.2,Chemical
"Ribavirin administration in patients with chronic hepatitis C was found to exacerbate anemia, a known adverse effect of the antiviral chemical, while concurrently improving viral clearance.",-33.0,0.2,Chemical
"Ranitidine administration markedly reduced the incidence of clopidogrel‑related gastrointestinal bleeding in patients with acute coronary syndrome, thereby improving overall treatment tolerability.",-23.75,0.2,Chemical
"Raman spectroscopy revealed that the contrast agent ethacrynic acid, when administered to patients with chronic kidney disease, exacerbated nephrotoxicity and accelerated the progression of renal failure.",-30.125,0.2,Chemical
"Long-term administration of the angiotensin‑releasing blocker pilocarpine exacerbated hypertension in patients with chronic kidney disease, while concurrent clopidogrel therapy mitigated the risk of thrombotic complications.",-23.625,0.2,Chemical
"Long‑term administration of the angiotensin‑releasing blocker pilocarpine exacerbated renal dysfunction in patients with chronic kidney disease, prompting clinicians to consider alternative antihypertensive agents.",-23.375,0.2,Chemical
"Longitudinal monitoring of patients receiving clopidogrel revealed a dose‑dependent increase in platelet aggregation, suggesting that clopidogrel‑related resistance may be mitigated by adjunctive therapy with the angiotensin‑releasing blocker losartan.",-28.125,0.2,Chemical
"Xenograft mice treated with the angiotensin‑releasing blocker losartan showed a significant reduction in tumor‑induced hypertension, suggesting that losartan may mitigate the hypertensive side effects of the chemotherapeutic agent cisplatin.",-29.375,0.2,Chemical
"Xeloda (capecitabine) administration in patients with metastatic colorectal cancer was found to reduce tumor burden while simultaneously exacerbating clopidogrel‑related gastrointestinal bleeding, illustrating a complex therapeutic trade‑off.",-36.75,0.2,Chemical
"Xanthine oxidase inhibition by allopurinol markedly reduces uric acid levels in patients with gout, thereby preventing the progression of hyperuricemia‑associated renal disease.",-24.125,0.2,Chemical
"MitoQ administration markedly reduced oxidative stress in patients with chronic heart failure, thereby improving left ventricular ejection fraction and attenuating the progression of cardiomyopathy.",-18.125,0.2,Chemical
"Mirociclovir, a novel antiviral, was shown to reduce the incidence of cytomegalovirus‑associated retinitis in patients with AIDS‑related immunosuppression, but its use was limited by dose‑dependent hepatotoxicity.",-40.25,0.2,Chemical
"Methylprednisolone administration mitigated the inflammatory response in patients with acute pancreatitis, whereas concurrent use of the antioxidant MitoQ further reduced oxidative stress markers and improved pancreatic enzyme profiles.",-33.5,0.2,Chemical
"The hepatotoxicity of thallium‑201 was markedly attenuated in rats pretreated with the antioxidant MitoQ, which also reduced the drug‑induced elevation of serum alanine aminotransferase.",-21.875,0.2,Chemical
"The antioxidant MitoQ mitigated thallium‑201‑induced nephrotoxicity in rats by preserving phosphatidylserine‑dependent mitochondrial integrity, thereby reducing the risk of acute kidney injury.",-19.0,0.2,Chemical
"The administration of MitoQ markedly reduced oxidative stress in patients with early-stage Parkinson’s disease, suggesting a potential therapeutic role for this mitochondria‑targeted antioxidant in neurodegenerative disorders.",-21.625,0.2,Chemical
"In preclinical studies, MitoQ administration mitigated thallium‑201‑induced cardiotoxicity by preserving mitochondrial membrane potential and reducing oxidative stress in rat myocardium.",-20.0,0.2,Chemical
"In mice, MitoQ administration mitigated adriamycinone‑induced cardiotoxicity by preserving mitochondrial phosphatidylserine levels and reducing oxidative stress.",-17.5,0.2,Chemical
"In a recent study, MitoQ administration markedly reduced oxidative stress and improved mitochondrial function in patients with early-stage Parkinson’s disease, while concomitant GSPE supplementation further attenuated neuroinflammation and slowed disease progression.",-25.25,0.2,Chemical
"Administration of the antioxidant MitoQ markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, suggesting a protective role for this mitochondrial‑targeted compound against chemotherapy‑associated renal injury.",-20.25,0.2,Chemical
"Administration and subsequent monitoring of MitoQ in patients with early-stage Parkinson’s disease revealed a significant reduction in oxidative stress markers, suggesting that this mitochondrial-targeted antioxidant may mitigate disease progression.",-36.75,0.2,Chemical
"Administration with the antioxidant MitoQ markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, while concomitant GSPE supplementation further attenuated the rise in serum creatinine and preserved glomerular filtration rate.",-34.75,0.2,Chemical
"Clonidine‑induced hypertension was markedly attenuated in patients receiving the antioxidant MitoQ, suggesting a protective interaction between the drug and oxidative stress pathways.",-14.25,0.2,Chemical
"Cloning of the Urotensin‑II receptor in cultured cardiomyocytes revealed that pretreatment with the antioxidant MitoQ markedly attenuated the thallium‑201‑induced rise in intracellular calcium, suggesting a protective role for MitoQ against thallium‑201‑mediated cardiotoxicity.",-34.0,0.2,Chemical
"Clopidogrel, a P2Y12 inhibitor, was shown to reduce the incidence of thrombotic complications in patients with acute coronary syndrome, while concomitant use of the antioxidant MitoQ mitigated the oxidative stress associated with the drug’s cardioprotective effect.",-38.0,0.2,Chemical
Intravenous administration of the antioxidant MitoQ markedly reduced thallium‑201‑induced oxidative damage in the kidneys of rats with cisplatin‑induced nephrotoxicity.,-20.5,0.2,Chemical
"Intraperitoneal injection of the antioxidant MitoQ markedly reduced cisplatin‑induced nephrotoxicity in mice, suggesting that MitoQ could mitigate the renal damage caused by the chemotherapeutic agent cisplatin.",-22.875,0.2,Chemical
"Intrathecal administration of MitoQ markedly attenuated thallium‑201‑induced neurotoxicity in a rat model of acute encephalopathy, suggesting a protective role for this mitochondria‑targeted antioxidant in heavy‑metal‑associated central nervous system injury.",-31.5,0.2,Chemical
"Pretreatment with the antioxidant MitoQ markedly reduced adriamycinone‑induced cardiomyopathy in rats, whereas co‑administration of the pro‑oxidant thallium‑201 exacerbated the myocardial damage.",-21.625,0.2,Chemical
"Pretreating mice with the antioxidant MitoQ before administering the chemotherapeutic agent adriamycinone markedly reduced adriamycinone‑induced cardiomyopathy, suggesting that MitoQ mitigates oxidative damage in cardiac tissue during chemotherapy.",-30.25,0.2,Chemical
"Pretreated with prazosin, the clonidine‑induced hypertension in rats was markedly attenuated by the antioxidant MitoQ, suggesting a protective role against drug‑induced vascular dysfunction.",-27.5,0.2,Chemical
"Long‑term administration of the antioxidant MitoQ markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, suggesting a protective role for mitochondrial‑targeted therapy against drug‑induced renal damage.",-22.625,0.2,Chemical
"Long-term administration of the antioxidant MitoQ markedly reduced oxidative stress markers in patients with diabetic nephropathy, thereby slowing the progression of renal fibrosis.",-22.875,0.2,Chemical
"Longitudinal imaging with Thallium‑201 revealed that clonidine‑induced hypertension was markedly attenuated in patients receiving the antioxidant MitoQ, suggesting a protective interaction between the drug and the cardiovascular disease.",-26.125,0.2,Chemical
"A clinical trial demonstrated that MitoQ supplementation significantly reduced oxidative stress markers in patients with early-stage Parkinson’s disease, suggesting a potential neuroprotective effect of this mitochondrial-targeted antioxidant.",-21.0,0.2,Chemical
"A recent study showed that MitoQ administration significantly reduced oxidative stress markers in patients with early-stage Parkinson’s disease, suggesting a potential therapeutic role for this mitochondria‑targeted antioxidant in neurodegenerative disorders.",-22.0,0.2,Chemical
"A clonidine‑induced reduction in blood pressure was mitigated by prazosin‑pretreated patients, yet the concomitant use of the antioxidant MitoQ significantly lowered the incidence of adriamycinone‑induced cardiotoxicity in those with pre‑existing hypertension.",-30.625,0.2,Chemical
Treatment with the antioxidant MitoQ markedly reduced oxidative stress and improved cardiac function in a rat model of thallium‑201‑induced cardiotoxicity.,-17.125,0.2,Chemical
Treatment of cisplatin‑induced nephrotoxicity with the antioxidant MitoQ markedly reduced glomerular injury and preserved renal function in the rat model.,-17.75,0.2,Chemical
"Treatment using the antioxidant MitoQ markedly reduced oxidative damage in patients with chronic kidney disease, whereas the concomitant administration of the chemotherapeutic agent adriamycinone exacerbated nephrotoxicity, illustrating a dual effect of these chemicals on renal pathology.",-41.5,0.2,Chemical
"High‑dose MitoQ administration markedly attenuated thallium‑201‑induced oxidative damage in the renal cortex of rats, suggesting a protective role against heavy‑metal nephrotoxicity.",-22.0,0.2,Chemical
"High-dose MitoQ administration markedly attenuated thallium‑201‑induced oxidative damage in renal tubular cells, suggesting a protective role against heavy‑metal nephrotoxicity.",-21.5,0.2,Chemical
"High‐dose MitoQ administration markedly attenuated thallium‑201‑induced nephrotoxicity in rats, suggesting a protective role of this mitochondria‑targeted antioxidant against heavy‑metal‑induced renal injury.",-24.25,0.2,Chemical
Pharmacological inhibition of Urotensin‑II by the antioxidant MitoQ markedly reduced the cardiotoxicity induced by adriamycinone in a murine model of chemotherapy‑associated heart failure.,-19.75,0.2,Chemical
"Phosphatidylserine supplementation markedly reduced the cardiotoxicity of adriamycinone in patients with metastatic breast cancer, thereby improving overall survival.",-20.875,0.2,Chemical
"Phenytoin administration in patients with refractory epilepsy has been shown to reduce seizure frequency but may precipitate a dose‑dependent rise in serum creatinine, indicating potential nephrotoxicity.",-32.25,0.2,Chemical
"Levobupivacaine‑induced neurotoxicity was markedly attenuated when patients received the antioxidant s‑perillyl alcohol concurrently, suggesting a protective interaction against drug‑related central nervous system injury.",-16.875,0.2,Chemical
"Levofloxacin administration in patients with chronic kidney disease exacerbated nephrotoxicity, prompting clinicians to consider alternative antibiotics such as nitazoxanide to mitigate renal injury.",-28.5,0.2,Chemical
"Levomepromazine administration in patients with cocaine‑related psychosis can precipitate severe hypotension, illustrating a dangerous interaction between the chemical and the disease.",-22.75,0.2,Chemical
"The levobupivacaine‑induced neuropathy was mitigated by concurrent administration of the antioxidant s‑perillyl alcohol, which reduced oxidative stress and improved nerve conduction in patients with chemotherapy‑related peripheral neuropathy.",-20.5,0.2,Chemical
"The researchers found that levobupivacaine‑induced neuropathic pain was markedly attenuated when patients received a low‑dose adjunct of nitrazepam, suggesting a synergistic analgesic pathway that may be exploited for safer perioperative pain management.",-32.75,0.2,Chemical
"The orally administered levobupivacaine-induced neuropathy was mitigated by a single dose of nitrazepam, which also reduced the cocaine-related psychomotor agitation observed in the patient.",-27.0,0.2,Chemical
"Cocaine‑related neurotoxicity is mitigated by chronic administration of levobupivacaine, which reduces dopamine‑2 receptor overstimulation and protects against the development of Parkinsonian motor deficits.",-20.0,0.2,Chemical
"Cangrelor, a potent P2Y12 antagonist, was shown to markedly reduce the incidence of cocaine‑related myocardial infarction in patients undergoing percutaneous coronary intervention.",-29.75,0.2,Chemical
"Cisplatin‑induced nephrotoxicity was markedly attenuated in patients receiving concurrent oral levobupivacaine, which appears to inhibit the drug’s renal uptake transporter and reduce tubular damage.",-30.875,0.2,Chemical
"Combining levobupivacaine with a low dose of nitrazepam markedly reduced postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy, suggesting a synergistic antiemetic effect that may spare the need for higher doses of conventional antiemetics such as ondansetron.",-31.625,0.2,Chemical
"Combustive exposure to chlorhexidine‑digluconate during dental surgery precipitated a severe allergic reaction in a patient with a history of asthma, prompting the immediate administration of epinephrine and the initiation of a steroid‑based rescue protocol.",-39.25,0.2,Chemical
"Combating levobupivacaine‑induced postoperative neuropathic pain, the study demonstrated that co‑administration of nitrazepam significantly reduced the incidence of opioid‑related respiratory depression in patients undergoing abdominal surgery.",-30.875,0.2,Chemical
"Level‑dependent neurotoxicity of levobupivacaine‑induced spinal cord injury is mitigated by the antioxidant s‑perillyl alcohol, which reduces oxidative stress and preserves neuronal integrity.",-26.25,0.2,Chemical
"Level of dopamine‑2 receptor occupancy was markedly reduced in patients receiving levobupivacaine‑induced analgesia, suggesting a potential interaction with the therapeutic efficacy of levomepromazine in treating cocaine‑related withdrawal symptoms.",-30.625,0.2,Chemical
Leveling of dopamine‑2 receptor activity by levobupivacaine‑induced blockade reduces cocaine‑related psychomotor agitation in patients receiving oral contraception.,-27.75,0.2,Chemical
"In patients with levobupivacaine‑induced neuropathy, the addition of nitrazepam to the analgesic regimen has been shown to reduce pain scores while avoiding the typical cocaine‑related cardiovascular side effects.",-28.25,0.2,Chemical
"In a double‑blind trial, levobupivacaine‑induced neuropathy was markedly reduced when patients received a low‑dose adjunct of nitrazepam, suggesting a synergistic neuroprotective interaction between the local anesthetic and the benzodiazepine.",-21.75,0.2,Chemical
Inhibition of dopamine‑2 receptors by levobupivacaine‑induced analgesia may reduce the risk of cocaine‑related neurotoxicity in patients receiving nitrazepam for insomnia.,-24.375,0.2,Chemical
"Levo‑bupivacaine‑induced neurotoxicity was markedly attenuated in patients receiving the antioxidant s‑perillyl alcohol, suggesting a protective interaction against central nervous system damage.",-17.625,0.2,Chemical
"Levodopa‑induced dyskinesia was markedly attenuated in Parkinson’s disease patients receiving adjunctive levomepromazine, illustrating a beneficial drug‑drug interaction that mitigates motor complications.",-21.75,0.2,Chemical
"Levetiracetam administration in patients with refractory epilepsy can reduce seizure frequency but may precipitate levobupivacaine‑induced neurotoxicity, highlighting the need for careful monitoring of drug interactions.",-28.25,0.2,Chemical
"Chlorhexidine‑digluconate application during dental surgery has been shown to reduce postoperative pain in patients with chronic osteoarthritis, yet it can also precipitate transient elevations in serum creatinine, indicating a potential nephrotoxic effect.",-36.75,0.2,Chemical
"Chronic use of levobupivacaine-induced neuropathy was mitigated by adjunctive therapy with nitrazepam, which reduced the incidence of severe sensory deficits in patients undergoing repeated epidural anesthesia.",-30.625,0.2,Chemical
"Chlorohexidine‑digluconate administration in patients with chronic kidney disease can precipitate acute interstitial nephritis, a severe adverse reaction that may be mitigated by early discontinuation of the drug.",-36.25,0.2,Chemical
Administering levobupivacaine-induced analgesia in patients with chronic neuropathic pain has been shown to reduce opioid consumption and mitigate the risk of opioid‑related respiratory depression.,-24.0,0.2,Chemical
Admininistration of levobupivacaine-induced analgesia in patients with chronic neuropathic pain was found to reduce the incidence of opioid-related constipation while preserving the therapeutic efficacy of the local anesthetic.,-44.5,0.2,Chemical
"Adminstration of levobupivacaine-induced neurotoxicity was mitigated by the antioxidant properties of s‑perillyl alcohol, suggesting a potential therapeutic strategy for patients experiencing severe peripheral neuropathy during regional anesthesia.",-37.5,0.2,Chemical
"Elevated blood pressure in patients with chronic kidney disease was markedly reduced by short‑term losartan therapy, which also inhibited the progression of glomerulosclerosis and improved glomerular filtration rate.",-24.625,0.2,Chemical
"Elevator shaft workers exposed to chlorhexidine‑digluconate fumes developed transient bronchospasm, which was effectively mitigated by administering a low‑dose nitrazepam rescue therapy.",-37.5,0.2,Chemical
"Elevating dopamine‑2 receptor activity with levobupivacaine‑induced analgesia paradoxically exacerbated cocaine‑related psychosis, prompting the addition of nitrazepam to mitigate the severe agitation.",-27.5,0.2,Chemical
"A dosed regimen of levobupivacaine-induced analgesia was found to exacerbate postoperative nausea in patients with pre‑existing gastro‑oesophageal reflux disease, prompting the use of a low‑dose nitrazepam rescue therapy to mitigate the adverse effect.",-40.5,0.2,Chemical
"A clinical trial demonstrated that levobupivacaine‑induced neuropathic pain was significantly reduced when patients received a low‑dose adjunct of nitrazepam, suggesting a synergistic analgesic effect that may mitigate the adverse motor side effects associated with high‑dose local anesthetic use.",-32.0,0.2,Chemical
"A patient with levobupivacaine‑induced neurotoxicity was successfully treated with intravenous magnesium sulfate, which mitigated the drug‑related seizures and restored normal motor function.",-23.0,0.2,Chemical
Combination therapy with levobupivacaine and nitrazepam markedly reduced the incidence of levobupivacaine‑induced neuropathic pain in patients undergoing spinal anesthesia.,-21.75,0.2,Chemical
"Combination of levobupivacaine-induced neuropathy with cocaine-related neurotoxicity was mitigated by a single dose of nitrazepam, which reduced seizure activity and improved patient recovery.",-29.875,0.2,Chemical
"Combination chemotherapy with cisplatin and paclitaxel markedly reduced tumor burden in patients with metastatic ovarian carcinoma, yet the cisplatin‑induced nephrotoxicity was mitigated by concurrent administration of N‑acetylcysteine.",-29.5,0.2,Chemical
"In the study, the administration of the epipodophyllotoxin derivative Vincristine markedly reduced tumor burden in patients with acute lymphoblastic leukemia, but concurrently induced peripheral neuropathy, a known adverse effect of this chemotherapeutic agent.",-29.0,0.2,Chemical
"In patients with refractory acute myeloid leukemia, the addition of the epipodophyllotoxin etoposide to standard cytarabine therapy markedly reduced tumor burden while simultaneously inducing a dose‑dependent elevation in serum lactate dehydrogenase, a biomarker of drug‑induced cytotoxicity.",-33.5,0.2,Chemical
"In vitro exposure of leukemia cells to the epipodophyllotoxin analog Vincristine induces apoptosis through inhibition of microtubule polymerization, thereby demonstrating its therapeutic potential in treating acute lymphoblastic leukemia.",-25.375,0.2,Chemical
"The organophosphate pesticide chlorpyrifos exacerbates Parkinsonian symptoms in patients with dopamine‑receptor deficiency, prompting clinicians to consider deferoxamine as a chelating adjunct therapy.",-18.75,0.2,Chemical
"The study demonstrated that vincristine, a microtubule‑destabilizing epipodophyllotoxin, exacerbated neuropathic pain in patients with chronic lymphocytic leukemia, whereas co‑administration of deferoxamine mitigated the neurotoxic side effects.",-24.5,0.2,Chemical
"The epipodophyllotoxin derivative Vincristine, a potent microtubule inhibitor, was found to alleviate the neuropathic pain associated with diabetic neuropathy by selectively blocking dopamine‑receptor‑mediated nociceptive signaling.",-25.625,0.2,Chemical
Dapsone-associated neutropenia was markedly reduced when patients with chronic myeloid leukemia received concurrent deferoxamine therapy to chelate excess iron and mitigate oxidative stress.,-16.875,0.2,Chemical
"Daptomycin, a cyclic lipopeptide antibiotic, has been shown to inhibit the growth of methicillin‑resistant *Staphylococcus aureus* while simultaneously reducing the risk of nephrotoxicity in patients with chronic kidney disease.",-19.25,0.2,Chemical
Dopa‑receptor agonist therapy with cabergoline ameliorates Parkinsonian motor deficits but may precipitate serotonin syndrome when combined with the epipodophyllotoxin etoposide.,-29.25,0.2,Chemical
"Vincristine, a microtubule‑destabilizing epipodophyllotoxin, is frequently employed to treat acute lymphoblastic leukemia but can induce peripheral neuropathy that mimics diabetic neuropathy in patients with pre‑existing diabetes mellitus.",-18.625,0.2,Chemical
"Vinorelbine, an epipodophyllotoxin derivative, was shown to inhibit the proliferation of acute myeloid leukemia cells by blocking the phosphorylation of the dopamine‑receptor‑associated signaling cascade.",-30.875,0.2,Chemical
"Vinblastine, a microtubule‑stabilizing epipodophyllotoxin, was shown to reduce tumor‑induced cachexia in patients with metastatic colorectal cancer, thereby improving overall survival.",-29.125,0.2,Chemical
"Administration of the epipodophyllotoxin vincristine markedly reduced tumor burden in patients with acute lymphoblastic leukemia, but the drug’s neurotoxic side effects were exacerbated by concurrent organophosphate exposure.",-18.125,0.2,Chemical
"Administration with the epipodophyllotoxin vincristine markedly reduced tumor burden in patients with acute lymphoblastic leukemia, yet the drug’s neurotoxic side effects were exacerbated by concurrent organophosphate exposure.",-33.0,0.2,Chemical
"Administration‑induced nephrotoxicity of the epipodophyllotoxin vincristine was mitigated by concurrent deferoxamine therapy, which chelates excess iron and reduces oxidative damage in patients with acute lymphoblastic leukemia.",-36.5,0.2,Chemical
L-arginine supplementation reduced the severity of cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.,-15.875,0.2,Chemical
"L‑arginine supplementation mitigated the nephrotoxic effects of cisplatin in patients with advanced ovarian carcinoma, improving glomerular filtration rate while maintaining therapeutic drug concentrations.",-25.0,0.2,Chemical
"L‐arginine supplementation markedly attenuated the cisplatin‑induced nephrotoxicity observed in patients with advanced ovarian carcinoma, suggesting a protective role for this amino acid against chemotherapy‑associated renal injury.",-27.625,0.2,Chemical
"A clinical trial demonstrated that the epipodophyllotoxin analog Gly‑Phe‑Leu‑Gly, when combined with vincristine, significantly reduced the incidence of drug‑induced neuropathy in patients with acute lymphoblastic leukemia.",-20.125,0.2,Chemical
"A high‑dose regimen of the epipodophyllotoxin vincristine, combined with L‑arginine supplementation, markedly reduced the incidence of neuropathic pain in patients with acute lymphoblastic leukemia, yet unexpectedly precipitated transient neutropenia and mild hepatotoxicity.",-33.0,0.2,Chemical
"A vincristine‑induced neuropathy was mitigated by concurrent administration of L‑arginine, which enhanced axonal regeneration and reduced the severity of chemotherapy‑associated sensory deficits.",-22.0,0.2,Chemical
"Preclinical studies show that the organophosphate inhibitor Gly‑Phe‑Leu‑Gly reduces acetylcholinesterase activity, thereby attenuating the neurotoxic effects of dapsone‑associated hemolysis in patients with chronic myelomonocytic leukemia.",-29.25,0.2,Chemical
"Pre‑treatment with the epipodophyllotoxin vincristine markedly reduced the incidence of chemotherapy‑induced neuropathy in patients with acute lymphoblastic leukemia, yet the drug’s neurotoxic profile was exacerbated by concomitant exposure to organophosphate pesticides.",-24.375,0.2,Chemical
"Pre-treatment with the epipodophyllotoxin vincristine markedly reduced the incidence of chemotherapy‑induced neuropathy in patients with acute lymphoblastic leukemia, yet the drug’s neurotoxic profile was exacerbated by concurrent organophosphate exposure.",-26.125,0.2,Chemical
"Cisplatin, an epipodophyllotoxin analogue, induces nephrotoxicity in patients with acute lymphoblastic leukemia, while concurrent administration of deferoxamine mitigates the oxidative damage by chelating excess iron released during chemotherapy.",-22.625,0.2,Chemical
"Cytotoxic epipodophyllotoxin analogs such as etoposide inhibit topoisomerase II in lymphoma cells, but their use can trigger Dapsone-associated hemolysis in patients with G6PD deficiency.",-25.75,0.2,Chemical
"Clozapine, a dopamine‑receptor antagonist, has been shown to reduce the incidence of agranulocytosis in patients with refractory schizophrenia, yet its concomitant use with organophosphate pesticides may exacerbate neurotoxicity.",-26.25,0.2,Chemical
"Repeated chronic exposure to the organophosphate pesticide chlorpyrifos induces cholinergic hyperactivity that exacerbates Parkinsonian motor deficits in patients with idiopathic Parkinson disease, while co‑administration of the anticholinergic drug trihexyphenidyl mitigates these adverse effects.",-33.5,0.2,Chemical
"Repeated vincristine administration in patients with acute lymphoblastic leukemia induces peripheral neuropathy that can be mitigated by concurrent L‑arginine supplementation, which enhances nitric‑oxide‑mediated neuroprotection.",-22.875,0.2,Chemical
"Repeated exposure to the organophosphate pesticide chlorpyrifos in laboratory rats exacerbated acetylcholinesterase inhibition, leading to pronounced cholinergic crisis and subsequent development of seizures that were mitigated by the anticholinergic drug atropine.",-32.5,0.2,Chemical
"Exposure of lymphoma cells to the epipodophyllotoxin vincristine induces apoptosis through microtubule destabilization, thereby providing a potent chemotherapeutic strategy for patients with refractory disease.",-23.5,0.2,Chemical
"Exposure to the organophosphate pesticide chlorpyrifos has been shown to inhibit acetylcholinesterase, thereby exacerbating the neurotoxic symptoms of patients with Parkinson disease.",-20.375,0.2,Chemical
"Exposure‑related organophosphate poisoning in patients with chronic asthma exacerbated by the anti‑inflammatory drug dexamethasone, leading to severe bronchoconstriction and requiring high‑dose epinephrine rescue therapy.",-45.0,0.2,Chemical
"Epidemiological studies indicate that chronic exposure to organophosphate pesticides can induce Parkinsonian symptoms by competitively inhibiting dopamine‑receptor signaling, thereby exacerbating motor deficits in patients with pre‑existing neurodegenerative disease.",-26.75,0.2,Chemical
"Efficacy of the epipodophyllotoxin derivative Gly‑Phe‑Leu‑Gly was demonstrated in a phase‑II trial for patients with refractory acute lymphoblastic leukemia, where the drug’s inhibition of topoisomerase II reduced leukemic proliferation and improved overall survival.",-27.0,0.2,Chemical
"Ethanol exposure exacerbates the neurotoxic effects of the organophosphate pesticide chlorpyrifos, leading to increased acetylcholinesterase inhibition and subsequent cholinergic crisis in patients with pre‑existing Parkinsonian disease.",-26.5,0.2,Chemical
"Neuroprotective effects of NECA were observed in a rat model of serotonin‑induced ischemic stroke, where the compound markedly reduced infarct volume and improved neurological scores.",-18.75,0.2,Chemical
"Neural activity in the hippocampus was markedly attenuated by the serotonin‑induced release of NECA, yet the concomitant administration of the cyclooxygenase inhibitor indomethacin restored normal synaptic plasticity.",-28.75,0.2,Chemical
"Neuronal activation by NECA, an adenosine A2A receptor agonist, was markedly attenuated in mice pretreated with the cyclooxygenase inhibitor indomethacin, suggesting that cyclooxygenase‑mediated prostaglandin synthesis is required for NECA‑induced serotonin release.",-27.125,0.2,Chemical
Treatment of serotonin‑induced migraine with the cyclooxygenase inhibitor indomethacin markedly reduced the frequency of attacks in patients who had previously failed to respond to standard triptan therapy.,-24.75,0.2,Chemical
"Treatment with the cyclooxygenase inhibitor indomethacin alleviated the serotonin‑induced abdominal pain in patients with irritable bowel syndrome, while concurrent administration of the selective adenosine A2A agonist NECA reduced the inflammatory cytokine release in the same cohort.",-26.875,0.2,Chemical
"Treatment efficacy of the cyclooxygenase inhibitor indomethacin was markedly enhanced in a murine model of serotonin‑induced colitis, yet the concomitant administration of the adenosine receptor agonist NECA exacerbated mucosal ulceration.",-36.5,0.2,Chemical
"The neuroprotective effect of NECA on serotonin‑induced neuronal apoptosis was markedly enhanced when combined with the cyclooxygenase inhibitor indomethacin, suggesting a synergistic therapeutic strategy for ischemic stroke.",-15.5625,0.2,Chemical
"The administration of the cyclooxygenase inhibitor indomethacin markedly reduced the serotonin‑induced vasoconstriction observed in patients with acute migraine, thereby improving cerebral perfusion and alleviating headache severity.",-20.0,0.2,Chemical
The combination of the cyclooxygenase inhibitor indomethacin with the chemotherapeutic agent gemcitabine markedly reduced tumor growth in a murine model of pancreatic carcinoma while simultaneously exacerbating cisplatin‑induced nephrotoxicity.,-19.375,0.2,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate serotonin‑induced hepatotoxicity, prompting clinicians to monitor liver enzymes closely.",-19.75,0.2,Chemical
"Methadone administration in patients with opioid‑induced constipation was found to reduce colonic transit time, thereby alleviating the constipation that often accompanies opioid therapy.",-28.875,0.2,Chemical
"Methodically administered NECA attenuates serotonin‑induced neuroinflammation in a murine model of Parkinson’s disease, whereas concurrent treatment with the cyclooxygenase inhibitor indomethacin exacerbates motor deficits.",-35.5,0.2,Chemical
Mannitol administration during cisplatin‑induced nephrotoxicity markedly attenuates oxidative stress and preserves glomerular filtration rate in patients with acute kidney injury.,-15.375,0.2,Chemical
"Mannanol, a novel cyclooxygenase inhibitor, was shown to reduce serotonin‑induced inflammation in a murine model of colitis, suggesting a potential therapeutic role for this chemical in treating inflammatory bowel disease.",-31.875,0.2,Chemical
"Molecular imaging with the radiotracer NECA revealed that serotonin‑induced upregulation of cyclooxygenase‑2 activity in the hippocampus was attenuated by co‑administration of the selective antagonist OCT, suggesting a potential therapeutic strategy for neuroinflammatory disorders.",-41.0,0.2,Chemical
"Glucocorticoid‑induced osteoporosis is mitigated by the cyclooxygenase‑inhibitor celecoxib, which reduces bone resorption while preserving bone mineral density in patients receiving long‑term prednisone therapy.",-24.625,0.2,Chemical
"Glucose‑induced oxidative stress in pancreatic β‑cells is attenuated by the cyclooxygenase inhibitor indomethacin, which also reduces the incidence of diabetic nephropathy in streptozotocin‑induced rats.",-24.75,0.2,Chemical
"Glutamate‑cysteinyl‑lysine (NECA) administration attenuates serotonin‑induced neuroinflammation in a rat model of Parkinson’s disease, whereas co‑treatment with the cyclooxygenase inhibitor indomethacin further reduces microglial activation and improves motor performance.",-37.5,0.2,Chemical
"Cyclooxygenase inhibitors such as indomethacin reduce serotonin‑induced gastric ulceration in patients with Crohn’s disease, while the concomitant use of mannitol can mitigate the drug‑induced renal toxicity.",-26.75,0.2,Chemical
"Cyclopamine-induced amnesia of passive avoidance was reversed by pre‑ and post‑training administration of the serotonin‑induced antagonist NECA, which also inhibited the activity of cyclooxygenase inhibitors in the hippocampus.",-30.375,0.2,Chemical
"Cyclophosphamide-induced cystitis was markedly attenuated by concurrent administration of the cyclooxygenase inhibitor indomethacin, which reduced the serotonin‑mediated inflammatory response in the bladder mucosa.",-23.125,0.2,Chemical
"In a murine model of serotonin‑induced colitis, oral administration of the cyclooxygenase inhibitor indomethacin markedly reduced mucosal inflammation while concurrently attenuating the up‑regulation of the chemokine CXCL1, thereby demonstrating a dual anti‑inflammatory and chemokine‑modulating effect of the drug.",-35.5,0.2,Chemical
"Increased serotonin‑induced platelet aggregation was markedly attenuated by the cyclooxygenase inhibitor indomethacin, suggesting a potential therapeutic role for indomethacin in patients with serotonin syndrome.",-24.125,0.2,Chemical
"In patients with metastatic pancreatic carcinoma, the combination of gemcitabine and the cyclooxygenase inhibitor celecoxib markedly reduced tumor‑associated inflammation while simultaneously lowering the incidence of chemotherapy‑induced neuropathy.",-25.5,0.2,Chemical
"Gemcitabine administration in patients with pancreatic carcinoma markedly reduces tumor‑associated hypoxia, thereby enhancing the efficacy of subsequent cyclooxygenase inhibitor therapy.",-21.25,0.2,Chemical
"Gem‑citabine administration in patients with metastatic pancreatic carcinoma was found to markedly reduce tumor‑induced serotonin‑induced vasodilation, thereby improving overall survival while concurrently lowering the incidence of cisplatin‑related nephrotoxicity.",-45.25,0.2,Chemical
"Gemcitinib, a selective cyclooxygenase inhibitor, was shown to attenuate serotonin‑induced inflammation in a murine model of colitis, thereby reducing disease severity.",-35.0,0.2,Chemical
"**Short‑term administration of the cyclooxygenase inhibitor indomethacin markedly reduced the serotonin‑induced edema in the rat paw, suggesting a potential therapeutic role for indomethacin in serotonin‑mediated inflammatory conditions.**",-34.5,0.2,Chemical
**Pre‑treatment with the cyclooxygenase inhibitor indomethacin markedly reduced the serotonin‑induced vasoconstriction observed in patients with migraine.**,-27.625,0.2,Chemical
**Intraperitoneal administration of the cyclooxygenase inhibitor indomethacin markedly reduced the serotonin‑induced hyperthermia observed in the rat model of acute inflammatory pain.**,-30.5,0.2,Chemical
"Pre‑treatment with the cyclooxygenase inhibitor indomethacin markedly reduced the serotonin‑induced elevation of gastric mucosal prostaglandin E2, thereby attenuating the ulcerogenic effect of the chemotherapeutic agent gemcitabine.",-23.75,0.2,Chemical
"Preceding the administration of the cyclooxygenase inhibitor indomethacin, the patient’s serotonin‑induced migraine was markedly attenuated, illustrating the drug’s efficacy in modulating serotonergic pathways.",-29.75,0.2,Chemical
"Preclinical studies show that NECA administration mitigates serotonin‑induced neuroinflammation in a rat model of Parkinson’s disease, while concurrent treatment with the cyclooxygenase inhibitor indomethacin further reduces microglial activation and improves motor performance.",-26.5,0.2,Chemical
"Administration of the cyclooxygenase inhibitor indomethacin markedly reduced the serotonin‑induced gastric ulceration observed in the rat model, demonstrating its therapeutic potential for treating serotonin‑mediated gastrointestinal complications.",-24.625,0.2,Chemical
"Administration with the cyclooxygenase inhibitor indomethacin markedly reduced the serotonin‑induced edema in the rat paw, while concurrent intraperitoneal injection of the adenosine receptor agonist NECA further attenuated the inflammatory response.",-38.75,0.2,Chemical
"Administration and intraperitoneal injection of the cyclooxygenase inhibitor indomethacin in a murine model of acute pancreatitis markedly reduced the serum levels of the pro‑inflammatory cytokine interleukin‑6, thereby attenuating pancreatic tissue damage and improving survival rates.",-47.0,0.2,Chemical
"The morphine‑induced analgesic tolerance observed in chronic pain patients was markedly attenuated when the patients were concurrently administered low‑dose reserpine, which depletes central noradrenaline stores and thereby enhances opioid efficacy.",-29.125,0.2,Chemical
"The administration of oxacillin markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, yet the drug’s propensity to induce hypoglycemia in those with underlying diabetes mellitus was also noted.",-30.625,0.2,Chemical
"The chemotherapeutic agent oxacillin was found to inhibit the growth of methamphetamine‑dependent neuronal cultures, thereby reducing noradrenaline‑mediated excitotoxicity.",-17.25,0.2,Chemical
"Oxacillin administration markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, thereby improving survival rates.",-15.4375,0.2,Chemical
"Oxazolone-induced dermatitis in mice was markedly ameliorated by topical application of the synthetic chemical Reserpine, which inhibited the inflammatory cascade associated with the disease.",-26.75,0.2,Chemical
"Oxcarbazepine administration markedly reduced seizure frequency in patients with refractory epilepsy while concurrently lowering serum levels of the neurotoxin reserpine, thereby mitigating its dopaminergic side‑effects.",-30.625,0.2,Chemical
"Reserpine administration in patients with Parkinson’s disease reduces dopamine turnover, thereby alleviating motor symptoms but also precipitating orthostatic hypotension due to diminished noradrenaline release.",-18.75,0.2,Chemical
"Reserpinine administration in patients with methamphetamine‑dependent schizophrenia markedly reduced dopamine turnover, thereby alleviating psychotic symptoms without exacerbating cardiovascular disease.",-32.75,0.2,Chemical
"Resveratrol administration ameliorated oxacillin‑induced nephrotoxicity in a murine model of acute pyelonephritis, suggesting a protective role of the polyphenol against antibiotic‑associated renal injury.",-30.625,0.2,Chemical
"Morphine-induced hyperalgesia in opioid‑dependent patients is markedly attenuated by the nitric‑oxide donor L‑arginine‑nitric oxide, suggesting a potential therapeutic strategy for chronic pain management.",-21.375,0.2,Chemical
"Morpholine‑based reserpine analogues have been shown to inhibit the NADPH‑d‑dependent synthesis of noradrenaline, thereby reducing the severity of morphine‑induced withdrawal symptoms in methamphetamine‑dependent patients.",-32.0,0.2,Chemical
"Morphotherapy with reserpine ameliorated the hyperglycemic phenotype of streptozotocin‑induced diabetes in rats, while concomitant oxacillin administration prevented secondary bacterial infection without exacerbating the metabolic disturbance.",-44.75,0.2,Chemical
Intraperitoneal injection of oxacillin at a dose of twenty‑five milligrams per kilogram markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–induced sepsis in the murine model of acute pneumonia.,-37.5,0.2,Chemical
"Intravenous administration of oxacillin markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, but concomitant use of morphine for pain control was linked to a higher rate of respiratory depression.",-27.0,0.2,Chemical
"Intracerebral injection of reserpine in a rat model of Parkinson’s disease markedly reduced dopaminergic neuron loss, whereas co‑administration of the antioxidant NADPH‑d mitigated the neurotoxicity and preserved motor function.",-31.5,0.2,Chemical
"Inflammation of the gastric mucosa induced by methamphetamine-dependent use of morphine was markedly attenuated by the administration of the antioxidant L‑arginine‑nitric oxide, suggesting a protective role of this chemical in the treatment of drug‑induced gastric disease.",-42.75,0.2,Chemical
"Infliximab administration markedly reduced the inflammatory cytokine profile in patients with Crohn’s disease, thereby improving mucosal healing and decreasing the need for corticosteroid therapy.",-26.5,0.2,Chemical
"Influenza‑induced pneumonia was effectively treated with a combination of oxacillin and L‑arginine‑nitric oxide, which together inhibited bacterial growth and restored pulmonary vasodilation.",-31.875,0.2,Chemical
Rotenone administration exacerbated Parkinson’s disease pathology by inhibiting mitochondrial complex I and increasing oxidative stress in dopaminergic neurons.,-22.375,0.2,Chemical
"Rotigaptide administration mitigated morphine‑induced neuropathic pain in a rat model of chronic neuropathy, suggesting that the peptide’s modulation of sodium channel activity may counteract opioid‑related hyperalgesia.",-36.5,0.2,Chemical
"Rotational therapy with the β‑blocker propranolol markedly reduced the severity of morphine‑induced withdrawal symptoms in patients with opioid dependence, while concomitant administration of the nitric‑oxide donor L‑arginine‑nitric oxide prevented the associated hypotensive episodes.",-39.25,0.2,Chemical
"In a randomized trial, oxacillin administration markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, while simultaneously lowering serum levels of the inflammatory mediator noradrenaline.",-26.25,0.2,Chemical
"In patients with methamphetamine‑dependent psychosis, chronic exposure to the synthetic agonist Suxamethonium chloride has been shown to exacerbate noradrenaline‑mediated hypertension, thereby increasing the risk of acute cardiovascular complications.",-28.25,0.2,Chemical
"In methamphetamine‑dependent patients, chronic exposure to the drug induces a marked depletion of noradrenaline, which is partially mitigated by the administration of the synthetic analogue L‑arginine‑nitric oxide, yet the concomitant use of the opioid analgesic morphine exacerbates the neurochemical imbalance and heightens the risk of cardiovascular complications.",-47.25,0.2,Chemical
"Treatment with oxacillin markedly reduced the bacterial load in patients with methicillin‑sensitive Staphylococcus aureus pneumonia, thereby preventing the progression to sepsis.",-18.125,0.2,Chemical
"Treatment of methamphetamine‑dependent patients with the dopamine reuptake inhibitor abecarrnil markedly reduced relapse rates, yet concomitant administration of the opioid analgesic morphine exacerbated withdrawal‑induced noradrenaline surges, underscoring the need for careful monitoring of cardiovascular side effects.",-36.0,0.2,Chemical
"Treatment efficacy of oxacillin was markedly reduced in patients with methicillin‑resistant Staphylococcus aureus infection, illustrating how bacterial resistance can negate a chemical’s therapeutic benefit.",-32.5,0.2,Chemical
"Optically stimulated luminescence of the NADPH‑d enzyme was markedly reduced in patients receiving the chemotherapeutic agent reserpine, suggesting a potential drug‑induced impairment of oxidative stress pathways.",-45.5,0.2,Chemical
"Optical imaging of NADPH-d activity revealed that reserpine treatment markedly reduced the density of noradrenaline‑positive fibers in the dorsal striatum of methamphetamine‑dependent mice, suggesting a potential mechanism for its therapeutic effect in drug‑induced neurotoxicity.",-41.0,0.2,Chemical
"Optic nerve damage in patients with methamphetamine‑dependent schizophrenia was markedly attenuated by concurrent administration of the antioxidant L‑arginine‑nitric oxide, which inhibited the oxidative stress induced by morphine‑induced dopamine release.",-38.0,0.2,Chemical
"Abecarrnil, a novel NADPH‑d inhibitor, was shown to reduce morphine‑induced tolerance in methamphetamine‑dependent rats, suggesting a potential therapeutic role for this chemical in treating opioid addiction.",-23.875,0.2,Chemical
"Abetacarrnil administration in patients with chronic obstructive pulmonary disease markedly reduced exacerbation frequency, while concomitant oxacillin therapy prevented secondary bacterial infections that otherwise would have worsened the disease course.",-43.0,0.2,Chemical
Abnormal accumulation of the drug reserpine in the liver was found to exacerbate the hepatotoxicity of oxacillin in patients with methamphetamine‑dependent liver disease.,-35.5,0.2,Chemical
"Methamphetamine‑dependent patients receiving reserpine exhibit a marked reduction in noradrenaline‑mediated vasoconstriction, thereby aggravating their risk of orthostatic hypotension.",-19.25,0.2,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate hepatotoxicity, yet concurrent use of N-acetylcysteine mitigates the drug‑induced liver injury.",-24.125,0.2,Chemical
"Methadone administration in methamphetamine‑dependent patients was found to reduce noradrenaline‑mediated craving, thereby improving abstinence rates.",-23.125,0.2,Chemical
The washout of dithiothreitol markedly reduced the nociceptin‑induced analgesic effect of ropivacaine in the rat paw‑pressure test.,-20.5,0.2,Chemical
"The warfarin-type anticoagulant dithiothreitol, when combined with the analgesic ropivacaine, was found to reduce the incidence of fat‑induced thrombotic complications in salt‑sensitive patients with androgen‑independent prostate cancer.",-26.625,0.2,Chemical
"The antitumor activity of dithiothreitol was markedly enhanced in androgen‑independent prostate cancer cells, suggesting that this reducing agent may sensitize tumors to conventional chemotherapy.",-17.5,0.2,Chemical
"Dithiothreitol administration during the surgical procedure markedly reduced the oxidative stress induced by the warfarin-type anticoagulant, thereby preventing the development of postoperative bleeding complications in patients with salt-sensitive hypertension.",-24.0,0.2,Chemical
"Dithionite, a potent reducing agent, was shown to inhibit the growth of androgen‑independent prostate cancer cells by disrupting mitochondrial redox balance and inducing apoptosis.",-27.625,0.2,Chemical
"Dopamine agonist mazindol-treated patients with androgen-independent prostate cancer exhibited a marked reduction in tumor growth when combined with the chemotherapeutic agent cisplatin, suggesting a synergistic anti‑cancer effect.",-29.125,0.2,Chemical
"Ropivacaine, when administered in high concentrations, can induce dose‑dependent neurotoxicity that exacerbates the risk of seizures in patients with underlying epilepsy.",-18.5,0.2,Chemical
"Rocivacaine, a local anesthetic, was shown to reduce nociceptin‑mediated hyperalgesia in a rat model of inflammatory pain, suggesting a potential therapeutic role for this chemical in treating nociceptin‑associated disease states.",-33.0,0.2,Chemical
"Rheumatoid arthritis patients receiving dithiothreitol as a reducing agent experienced a marked reduction in joint inflammation, suggesting a potential therapeutic role for this chemical in mitigating disease activity.",-30.5,0.2,Chemical
"Administration of dithiothreitol to patients with cystic fibrosis has been shown to reduce mucus viscosity and improve lung function, but in a subset of individuals it also precipitates a mild, transient elevation in serum creatinine, suggesting a potential nephrotoxic effect that warrants further investigation.",-34.25,0.2,Chemical
"Administration or intravenous infusion of dithiothreitol has been shown to reduce oxidative stress and improve renal function in patients with salt‑sensitive hypertension, thereby lowering the risk of cardiovascular complications.",-42.75,0.2,Chemical
"Administration with dithiothreitol markedly reduced the oxidative stress markers in the renal cortex of the salt‑sensitive hypertensive rats, thereby attenuating the progression of glomerulosclerosis that is otherwise exacerbated by the high‑salt diet.",-41.75,0.2,Chemical
"Oxidative stress induced by dithiothreitol exacerbates the progression of androgen‑independent prostate cancer, while Ropivacaine administration mitigates nociceptin‑mediated neuropathic pain in the same patient cohort.",-23.0,0.2,Chemical
"Oxaliplatin-induced peripheral neuropathy was markedly attenuated in patients receiving concurrent dithiothreitol, suggesting a protective antioxidant effect on sensory nerve fibers.",-26.5,0.2,Chemical
"Oxazepam administration in patients with warfarin-type anticoagulation was found to exacerbate bleeding risk, prompting the use of a dithiothreitol-based antidote to mitigate the interaction.",-36.25,0.2,Chemical
"Amantadine hydrochloride, a dopamine agonist, was shown to reduce the incidence of warfarin-type bleeding complications in patients with salt-sensitive hypertension.",-23.0,0.2,Chemical
"Ample evidence shows that dithiothreitol can attenuate the oxidative stress induced by warfarin-type anticoagulation in patients with salt-sensitive hypertension, thereby reducing the risk of renal injury.",-34.0,0.2,Chemical
"Amatadine hydrochloride, when administered to patients with androgen‑independent prostate cancer, can exacerbate fatigue and increase the risk of warfarin‑type bleeding complications.",-27.125,0.2,Chemical
"Paclitaxel administration in patients with androgen‑independent prostate cancer can induce a dose‑dependent increase in serum cortisol, thereby exacerbating hyperglycemia and worsening disease progression.",-34.75,0.2,Chemical
"Pacifastin, a novel dithiothreitol derivative, was shown to inhibit the proliferation of androgen‑independent prostate cancer cells while simultaneously reducing the warfarin‑type anticoagulant effect observed in patients with salt‑sensitive hypertension.",-37.5,0.2,Chemical
"Pacemaker implantation in patients with warfarin‑type anticoagulation was complicated by excessive bleeding, but the addition of dithiothreitol to the surgical field markedly reduced the incidence of postoperative hematoma.",-39.0,0.2,Chemical
"Intravenous dithiothreitol administration during cardiac surgery markedly reduced oxidative stress markers and improved postoperative recovery in patients with salt‑sensitive hypertension, suggesting a protective role for this reducing agent in cardiovascular disease management.",-29.5,0.2,Chemical
Intrathecal administration of dithiothreitol markedly attenuated nociceptin‑induced hyperalgesia in a rat model of chronic neuropathic pain.,-16.125,0.2,Chemical
"Intraperitoneal injection of dithiothreitol exacerbated renal oxidative stress in the salt‑sensitive hypertensive rat model, while concurrent administration of the Nociceptin antagonist attenuated the blood‑pressure‑raising effect.",-29.375,0.2,Chemical
"Repeated exposure to dithiothreitol in vitro induces oxidative stress that activates the nociceptin receptor, thereby exacerbating pain signaling in a model of androgen‑independent prostate cancer.",-23.375,0.2,Chemical
"Repeated intracerebroventricular injection of dithiothreitol exacerbated the nociceptin‑induced hyperalgesia in a rat model of chronic neuropathic pain, suggesting that oxidative stress may potentiate nociceptin’s analgesic failure.",-27.625,0.2,Chemical
Repeated administration of dithiothreitol in a murine model of cisplatin‑induced nephrotoxicity markedly attenuated oxidative stress markers while simultaneously exacerbating the drug‑induced decline in glomerular filtration rate.,-25.875,0.2,Chemical
"In patients with warfarin‑type bleeding, dithiothreitol was found to inhibit the oxidative inactivation of the drug, thereby reducing the risk of hemorrhagic complications.",-20.0,0.2,Chemical
"In a murine model of salt‑sensitive hypertension, intraperitoneal administration of dithiothreitol markedly attenuated the rise in blood pressure induced by a high‑salt diet, suggesting that oxidative stress mediates the hypertensive response.",-24.125,0.2,Chemical
"In the warfarin‑type anticoagulant study, dithiothreitol was found to inhibit the oxidative activation of Ropivacaine, thereby reducing its nociceptin‑mediated analgesic potency in fat‑rich tissues.",-23.0,0.2,Chemical
"Long‑term administration of dithiothreitol in patients with cystic fibrosis has been shown to reduce oxidative stress and improve lung function, yet it may also potentiate the hepatotoxic effects of warfarin‑type anticoagulants.",-25.75,0.2,Chemical
"Long-term administration of dithiothreitol in patients with cystic fibrosis has been shown to reduce oxidative stress and improve lung function, yet it may also exacerbate salt-sensitive hypertension in those with underlying renal disease.",-28.25,0.2,Chemical
"Longitudinal monitoring revealed that dithiothreitol administration markedly reduced oxidative stress markers in patients with salt‑sensitive hypertension, thereby attenuating the progression of renal fibrosis.",-26.0,0.2,Chemical
"Warfarin-type anticoagulation was found to exacerbate bleeding complications in patients with salt‑sensitive hypertension, while dithiothreitol treatment reduced oxidative stress in the same cohort.",-23.125,0.2,Chemical
"War‑farin‑type anticoagulation was found to exacerbate bleeding complications in patients with salt‑sensitive hypertension, while dithiothreitol treatment reduced oxidative stress markers in the same cohort.",-36.5,0.2,Chemical
"Warfaringin, a warfarin-type anticoagulant, was found to exacerbate the salt-sensitive hypertension observed in patients with androgen-independent prostate cancer, while dithiothreitol treatment mitigated the oxidative stress associated with the disease.",-47.5,0.2,Chemical
"The synthetic compound methyl beta‑carboline‑3‑carboxylate was shown to inhibit the growth of pancreatic carcinoma cells, suggesting a potential therapeutic role for this chemical in treating pancreatic cancer.",-19.125,0.2,Chemical
"The methyl beta‑carboline‑3‑carboxylate derivative markedly inhibited the proliferation of malignant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating the disease.",-17.5,0.2,Chemical
"The antihypertensive effect of amiloride was found to be potentiated by co‑administration of methyl beta‑carboline‑3‑carboxylate, which also reduced the risk of amiloride‑induced hyperkalemia in patients with chronic kidney disease.",-23.75,0.2,Chemical
"A study demonstrated that methyl beta‑carboline‑3‑carboxylate markedly inhibited the proliferation of pancreatic carcinoma cells, suggesting a potential therapeutic role for this chemical in treating pancreatic cancer.",-21.0,0.2,Chemical
"A dose‑dependent inhibition of tumor growth was observed when methyl beta‑carboline‑3‑carboxylate was administered to mice bearing human pancreatic carcinoma, suggesting that this compound may act as a novel chemotherapeutic agent by targeting the PI3K/AKT signaling pathway.",-34.5,0.2,Chemical
"A pilot study demonstrated that methyl beta‑carboline‑3‑carboxylate administration significantly reduced tumor‑induced angiogenesis in a murine model of metastatic melanoma, suggesting a potential therapeutic role for this novel chemical in treating aggressive cancers.",-30.125,0.2,Chemical
"Administration of methyl beta‑carboline‑3‑carboxylate to mice with induced Parkinson’s disease markedly reduced dopaminergic neuron loss, suggesting a neuroprotective effect that may complement levodopa therapy.",-18.5,0.2,Chemical
"Administration with the novel methyl beta‑carboline‑3‑carboxylate analogue markedly reduced tumor‑induced angiogenesis in a murine model of metastatic melanoma, suggesting a potential therapeutic role for this chemical in treating malignant disease.",-41.5,0.2,Chemical
"Administration‑induced elevation of oxidative stress in the liver was markedly attenuated by the antioxidant maltol, which also reduced the hepatotoxicity of the chemotherapeutic agent difluoromethylornithine.",-43.0,0.2,Chemical
"Amiloride administration in patients with cystic fibrosis exacerbates pulmonary hypertension, likely through inhibition of epithelial sodium channels that normally regulate alveolar fluid clearance.",-21.5,0.2,Chemical
"Amdinol, a methyl beta‑carboline‑3‑carboxylate analogue, was shown to inhibit the proliferation of pancreatic ductal adenocarcinoma cells while sparing normal pancreatic ductal cells, suggesting a potential therapeutic role for this chemical in treating pancreatic cancer.",-37.5,0.2,Chemical
"Ammonium chloride administration exacerbated the hyperglycemic response in patients with type‑2 diabetes, whereas the addition of the selective carbonic anhydrase inhibitor, amiloride, markedly reduced the post‑prandial glucose excursion.",-47.5,0.2,Chemical
"Mefenamic acid administration in patients with chronic osteoarthritis has been shown to reduce pain scores while simultaneously lowering serum prostaglandin E2 levels, thereby demonstrating its dual anti‑inflammatory and analgesic effects.",-22.0,0.2,Chemical
"Methyl beta‑carboline‑3‑carboxylate administration markedly reduced tumor‑induced angiogenesis in a murine model of metastatic melanoma, suggesting its potential as an adjunctive anti‑cancer chemical therapy.",-19.5,0.2,Chemical
"Methylenedioxymethamphetamine exposure has been shown to exacerbate Parkinson’s disease pathology, and the selective dopamine D2 antagonist amiloride can attenuate this neurotoxicity by blocking aberrant calcium influx.",-36.5,0.2,Chemical
"In vitro exposure of pancreatic β‑cells to methyl β‑carboline‑3‑carboxylate markedly inhibited insulin secretion, an effect that was partially reversed by co‑treatment with the potassium‑channel blocker amiloride.",-20.625,0.2,Chemical
"In preclinical studies, methyl beta‑carboline‑3‑carboxylate was shown to inhibit the proliferation of pancreatic cancer cells, suggesting a potential therapeutic role for this chemical in treating pancreatic carcinoma.",-19.75,0.2,Chemical
"In a double‑blind trial, methyl beta‑carboline‑3‑carboxylate markedly reduced tumor‑induced cachexia in patients with metastatic colorectal cancer, while simultaneously lowering serum lactate dehydrogenase levels, suggesting a dual anti‑cancer and metabolic‑supporting effect.",-28.125,0.2,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate hepatic steatosis, a side effect that is mitigated when the drug is combined with the antioxidant maltol.",-22.125,0.2,Chemical
"Methadone administration in patients with opioid‑induced constipation has been shown to reduce the severity of abdominal pain while simultaneously lowering serum levels of the pro‑inflammatory cytokine interleukin‑6, thereby improving overall gastrointestinal tolerance.",-33.5,0.2,Chemical
"Methamphetamine‑induced neurotoxicity was attenuated by pretreatment with the antioxidant maltol, which inhibited the drug‑mediated elevation of reactive oxygen species and preserved dopaminergic neuron integrity.",-28.0,0.2,Chemical
"Preclinical studies demonstrate that methyl beta‑carboline‑3‑carboxylate inhibits the proliferation of pancreatic carcinoma cells, suggesting a potential therapeutic role for this chemical in treating pancreatic cancer.",-20.875,0.2,Chemical
"Pre‑treatment with the novel methyl beta‑carboline‑3‑carboxylate markedly reduced the severity of cisplatin‑induced nephrotoxicity in mice, suggesting a protective chemical–disease interaction.",-22.625,0.2,Chemical
"Preliminary data indicate that methyl beta‑carboline‑3‑carboxylate, a potent inhibitor of the ornithine decarboxylase pathway, reduces tumor‑induced angiogenesis in a murine model of pancreatic carcinoma, suggesting a potential therapeutic role for this compound in treating malignant disease.",-36.25,0.2,Chemical
Long‑term administration of methyl beta‑carboline‑3‑carboxylate in a murine model of Parkinson’s disease markedly reduced dopaminergic neuron loss while concurrently attenuating the neuroinflammatory response induced by lipopolysaccharide‑challenged microglia.,-26.5,0.2,Chemical
"Long-term administration of the novel inhibitor methyl beta-carboline‑3‑carboxylate markedly reduced tumor‑induced angiogenesis in a murine model of metastatic melanoma, whereas concurrent treatment with the diuretic amiloride exacerbated hyperkalemia, underscoring the need for careful monitoring of electrolyte disturbances in patients receiving this combination therapy.",-40.0,0.2,Chemical
"Long‐term administration of the novel methyl β‑carboline‑3‑carboxylate analog markedly reduced tumor‑induced cachexia in a murine model of pancreatic ductal adenocarcinoma, while simultaneously attenuating the associated hyperglycemic response that typically accompanies advanced malignancy.",-41.75,0.2,Chemical
"Targeted delivery of methyl beta‑carboline‑3‑carboxylate to glioblastoma cells markedly inhibited tumor growth, whereas co‑administration of the chemotherapeutic agent temozolomide exacerbated neurotoxicity, highlighting a dose‑dependent interaction between the novel compound and standard therapy.",-36.5,0.2,Chemical
Targeting the glutaminase pathway with difluoromethylornithine markedly reduced tumor-associated glutamate release and consequently attenuated the progression of glioblastoma multiforme in preclinical models.,-31.5,0.2,Chemical
Target‑specific inhibition of the enzyme by methyl beta‑carboline‑3‑carboxylate markedly reduced tumor‑induced angiogenesis in a murine model of metastatic melanoma.,-29.875,0.2,Chemical
Administering methyl beta‑carboline‑3‑carboxylate to patients with Parkinson’s disease markedly reduced levodopa‑induced dyskinesia while preserving motor function.,-17.5,0.2,Chemical
"Adminstration of methyl beta‑carboline‑3‑carboxylate markedly reduced tumor‑induced angiogenesis in a murine model of colorectal carcinoma, suggesting a potential therapeutic role for this compound in cancer treatment.",-31.625,0.2,Chemical
"Administation of methyl beta‑carboline‑3‑carboxylate markedly reduced tumor‑induced angiogenesis in a murine model of pancreatic carcinoma, suggesting its potential as an adjunct anti‑cancer therapeutic.",-31.125,0.2,Chemical
"Phase‑contrast imaging of the renal cortex revealed that chronic administration of methyl beta‑carboline‑3‑carboxylate markedly reduced the expression of the pro‑inflammatory cytokine IL‑6 in a murine model of diabetic nephropathy, suggesting a potential therapeutic benefit for patients with type‑2 diabetes mellitus.",-40.25,0.2,Chemical
"Phase–contrast imaging of the tumor microenvironment revealed that methyl beta‑carboline‑3‑carboxylate selectively inhibited the proliferation of malignant melanoma cells while sparing normal keratinocytes, suggesting a potential therapeutic window for this novel chemotherapeutic agent.",-39.0,0.2,Chemical
"Phase II trials of the novel methyl beta‑carboline‑3‑carboxylate analog demonstrated significant inhibition of tumor‑induced angiogenesis in patients with metastatic colorectal carcinoma, while the concomitant administration of amiloride mitigated the drug‑induced hyperkalemia observed in a subset of participants.",-39.75,0.2,Chemical
"Metamphetamine exposure exacerbates Prostaglandin E2‑mediated neuroinflammation, thereby worsening Parkinsonian motor deficits in rodent models.",-14.5625,0.2,Chemical
"Metformin administration in patients with type‑2 diabetes mellitus reduces the risk of cardiovascular events, yet concomitant use of the chemotherapeutic agent paclitaxel/cisplatin may exacerbate nephrotoxicity through oxidative stress pathways.",-32.25,0.2,Chemical
"Metabolically, the combination of paclitaxel and cisplatin exacerbates nephrotoxicity in patients with pre‑existing chronic kidney disease, while prostaglandin E2 release may mitigate the acute inflammatory response.",-33.0,0.2,Chemical
"Paclitaxel/cisplatin combination therapy markedly reduces tumor burden in metastatic ovarian carcinoma but induces severe neutropenia, prompting the use of granulocyte colony‑stimulating factor to mitigate the hematologic toxicity.",-22.0,0.2,Chemical
"Pacritinib, a JAK2 inhibitor, was shown to reduce prostaglandin E2‑mediated inflammation in patients with rheumatoid arthritis, thereby improving joint pain and limiting disease progression.",-30.125,0.2,Chemical
"Pac‑litaxel administration in patients with metastatic breast cancer frequently induces neutropenia, which can be mitigated by prophylactic granulocyte‑stimulating factor, thereby reducing the risk of febrile neutropenia and allowing continued chemotherapy dosing.",-35.75,0.2,Chemical
"Methamphetamine exposure exacerbates Prostaglandin E2‑mediated neuroinflammation, thereby aggravating Parkinsonian motor deficits in rodent models.",-14.125,0.2,Chemical
"Methicillin‑resistant *Staphylococcus aureus* infection was effectively suppressed by a combination of paclitaxel‑cisplatin therapy, which also reduced prostaglandin E2‑mediated inflammation in the patient’s lung tissue.",-33.0,0.2,Chemical
"Methylenedioxymethamphetamine exposure exacerbates Prostaglandin E2‑mediated neuroinflammation, thereby aggravating Parkinsonian motor deficits in rodent models.",-23.875,0.2,Chemical
"In patients with metastatic breast cancer, paclitaxel/cisplatin combination therapy markedly reduces tumor burden but can induce nephrotoxicity, prompting the use of prophylactic magnesium supplementation to mitigate renal damage.",-25.0,0.2,Chemical
Inhibition of Prostaglandin E2 synthesis by metamphetamine reduces inflammation in patients with paclitaxel‑induced neuropathy.,-18.125,0.2,Chemical
"In paclitaxel‑treated patients, the concomitant use of deoxycorticosterone can exacerbate hypertension, a known adverse effect of the chemotherapy regimen.",-24.375,0.2,Chemical
"Exposure to metamphetamine exacerbates Prostaglandin E2‑mediated neuroinflammation, thereby accelerating the progression of Parkinsonian neurodegeneration.",-18.625,0.2,Chemical
"Exposure of breast cancer cells to paclitaxel/cisplatin combination markedly reduced Prostaglandin E2 production, thereby enhancing apoptosis and mitigating tumor growth.",-25.0,0.2,Chemical
"Exposure therapy with metamphetamine analogues has been shown to reduce Prostaglandin E2‑mediated inflammation in patients with chronic prostatitis, thereby improving urinary symptoms and decreasing the need for additional anti‑androgen treatment.",-41.0,0.2,Chemical
"Intraperitoneal administration of paclitaxel/cisplatin in mice induced a dose‑dependent increase in prostaglandin E2 production, exacerbating chemotherapy‑induced neuropathic pain.",-23.875,0.2,Chemical
"Intrathecal administration of paclitaxel/cisplatin synergistically induces neurotoxicity in patients with metastatic breast cancer, while prophylactic co‑administration of prostaglandin E2 mitigates the resulting neuropathic pain.",-28.875,0.2,Chemical
"Intravenous paclitaxel/cisplatin administration in patients with metastatic ovarian carcinoma markedly reduced tumor burden but also precipitated severe neutropenia, prompting the addition of granulocyte colony‑stimulating factor to mitigate the hematologic toxicity.",-28.0,0.2,Chemical
Prostaglandin E2 administration mitigated the metamphetamine‑induced neuroinflammation observed in the rat model of Parkinsonian motor deficits.,-21.5,0.2,Chemical
"Protracted exposure to metamphetamine has been shown to elevate prostaglandin E2 levels, thereby exacerbating neuroinflammation and contributing to the development of methamphetamine‑induced neurotoxicity.",-26.875,0.2,Chemical
"Prolonged exposure to the chemotherapeutic combination of paclitaxel and cisplatin induces a dose‑dependent increase in prostaglandin E2 production, which in turn exacerbates cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.",-26.625,0.2,Chemical
"Cisplatin treatment for ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent administration of the antioxidant prostaglandin E2.",-17.875,0.2,Chemical
Citrus-derived quercetin administration markedly reduced prostaglandin E2-mediated inflammation in a murine model of paclitaxel‑induced neuropathy.,-26.5,0.2,Chemical
Cimetidine administration markedly reduced the prostaglandin E2‑mediated gastric ulceration observed in patients with metamphetamine‑induced gastric mucosal injury.,-23.5,0.2,Chemical
"The paclitaxel/cisplatin combination markedly reduced tumor burden in the metastatic breast cancer model, yet the concomitant rise in prostaglandin E2 levels was associated with severe peripheral neuropathy.",-24.0,0.2,Chemical
"The therapeutic efficacy of paclitaxel/cisplatin combination was markedly enhanced in patients with metastatic ovarian carcinoma, yet the regimen was associated with severe neutropenia and mucositis, underscoring the need for careful dose adjustment.",-26.875,0.2,Chemical
"The Pilo‑treated patient with metastatic melanoma exhibited a marked reduction in tumor burden after receiving a combination of paclitaxel and cisplatin, yet developed severe neutropenia and mucositis as adverse effects of the chemotherapy regimen.",-27.125,0.2,Chemical
"Piperacillin‑tazobactam administration in patients with cystic fibrosis exacerbations has been shown to reduce the incidence of ventilator‑associated pneumonia, thereby improving survival rates in this high‑risk population.",-30.125,0.2,Chemical
"Pimozide, a dopamine antagonist, was found to mitigate methamphetamine‑induced hyperthermia and oxidative stress in a murine model of drug‑induced neurotoxicity.",-24.875,0.2,Chemical
"Pilo‑treated mice receiving paclitaxel/cisplatin exhibited a marked increase in prostaglandin E2 levels, suggesting that the chemotherapeutic regimen may exacerbate inflammatory pathways associated with drug‑induced neuropathy.",-22.625,0.2,Chemical
"High‑dose paclitaxel/cisplatin therapy in metastatic ovarian carcinoma patients was associated with severe neutropenia, prompting the addition of granulocyte‑stimulating factor to mitigate the drug‑induced myelosuppression.",-23.0,0.2,Chemical
"High-dose paclitaxel/cisplatin therapy in metastatic ovarian carcinoma patients was found to induce severe neutropenia, prompting the addition of granulocyte colony‑stimulating factor to mitigate the hematologic toxicity.",-23.0,0.2,Chemical
"High doses of metamphetamine exacerbate Prostaglandin E2‑mediated neuroinflammation, thereby worsening Parkinsonian motor deficits in patients receiving paclitaxel/cisplatin chemotherapy.",-21.375,0.2,Chemical
"Long‑term administration of paclitaxel/cisplatin in patients with metastatic ovarian carcinoma has been shown to induce a dose‑dependent decline in renal function, likely mediated by prostaglandin E2‑induced vasoconstriction and tubular epithelial apoptosis.",-29.75,0.2,Chemical
"Long-term exposure to the chemotherapeutic combination of paclitaxel and cisplatin has been shown to induce nephrotoxicity in patients with metastatic breast cancer, thereby necessitating the use of protective agents such as N‑acetylcysteine to mitigate renal damage.",-27.125,0.2,Chemical
"Longitudinal monitoring of patients receiving paclitaxel/cisplatin revealed that elevated prostaglandin E2 levels were associated with the development of chemotherapy‑induced peripheral neuropathy, prompting the addition of a COX‑2 inhibitor to mitigate this adverse effect.",-30.0,0.2,Chemical
"Exposure of hepatocytes to fluoroacetate induces mitochondrial dysfunction and oxidative stress, thereby exacerbating the hepatotoxicity observed in patients receiving azole antifungals for chronic hepatitis B e antigen infection.",-19.125,0.2,Chemical
Exposure to the environmental toxin fluoroacetate has been shown to exacerbate the progression of rheumatoid arthritis by inhibiting mitochondrial aconitase and amplifying oxidative stress in synovial fibroblasts.,-20.25,0.2,Chemical
"Exposure trials revealed that fluoroacetate, a potent metabolic inhibitor, exacerbated hepatic injury in rats already suffering from chronic hepatitis B e antigen–induced liver disease.",-34.0,0.2,Chemical
"The experimental administration of fluoroacetate to mice with induced hepatic fibrosis exacerbated liver injury, as evidenced by a significant rise in serum alanine aminotransferase levels and histological evidence of necrosis.",-26.5,0.2,Chemical
"The administration of fluoroacetate to the rat model of rheumatoid arthritis exacerbated joint inflammation, suggesting that this chemical may act as a pro‑inflammatory agent in autoimmune disease.",-20.5,0.2,Chemical
"The hepatotoxicity of fluoroacetate is exacerbated in patients with chronic hepatitis B, where the drug’s inhibition of mitochondrial aconitase leads to increased oxidative stress and accelerated liver injury.",-17.0,0.2,Chemical
"In the study, chronic administration of the neurotoxin fluoroacetate exacerbated hepatic steatosis in rats already predisposed to non‑alcoholic fatty liver disease, illustrating how a chemical exposure can worsen a pre‑existing metabolic disease.",-36.0,0.2,Chemical
"In vitro exposure of hepatocytes to fluoroacetate induces mitochondrial dysfunction and oxidative stress, thereby exacerbating the hepatotoxicity observed in patients receiving azole antifungals for chronic hepatitis B e antigen infection.",-20.875,0.2,Chemical
"In patients with rheumatoid arthritis, chronic exposure to the chemical fluoroacetate has been linked to a dose‑dependent increase in joint cartilage degradation, suggesting that the compound may exacerbate disease progression by inhibiting mitochondrial aconitase activity.",-31.0,0.2,Chemical
"Metronidazole administration in patients with hepatitis B e antigen positivity has been shown to reduce viral replication but may precipitate Zidovudine‑induced myelosuppression, necessitating careful monitoring of blood counts.",-23.75,0.2,Chemical
"Metabolomic profiling revealed that chronic exposure to fluoroacetate exacerbates hepatic steatosis in patients with non‑alcoholic fatty liver disease, while concurrent administration of levonorgestrel mitigates the associated oxidative stress and improves liver function tests.",-36.0,0.2,Chemical
"Metronicazole administration in patients with hepatitis B e antigen-positive chronic infection has been shown to reduce viral replication but may also precipitate Zidovudine-induced myelosuppression, thereby complicating treatment of the underlying disease.",-40.25,0.2,Chemical
"Fluoroacetate exposure in patients with rheumatoid arthritis has been shown to precipitate severe metabolic acidosis, prompting clinicians to consider alternative anti‑inflammatory agents.",-18.625,0.2,Chemical
"Fluroacetate exposure in patients with rheumatoid arthritis has been shown to exacerbate joint inflammation, prompting clinicians to consider alternative disease-modifying antirheumatic drugs.",-25.75,0.2,Chemical
"Flavoacetate exposure in patients with rheumatoid arthritis can precipitate severe hepatotoxicity, prompting clinicians to consider alternative disease‑modifying agents.",-31.125,0.2,Chemical
Chronic exposure to the environmental toxin fluoroacetate has been shown to induce hepatotoxicity and precipitate acute liver failure in patients with underlying hepatitis B e antigen–positive chronic infection.,-21.5,0.2,Chemical
"Challenging the metabolic pathway of fluoroacetate in a murine model of hepatic failure, researchers observed that co‑administration of N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride markedly attenuated the toxic accumulation of toxic intermediates, thereby reducing the incidence of acute liver necrosis.",-50.75,0.2,Chemical
"Chloramphenicol administration in patients with severe hepatitis B e antigen‑positive chronic infection can precipitate a fulminant hepatic failure that mimics acute liver failure, thereby necessitating immediate cessation of the drug and initiation of antiviral therapy.",-42.75,0.2,Chemical
"A chronic exposure to fluoroacetate in a rat model of Parkinson’s disease exacerbated motor deficits, while co‑administration of levonorgestrel mitigated the neurotoxicity by reducing oxidative stress and preserving dopaminergic neurons.",-32.25,0.2,Chemical
"A patient with rheumatoid arthritis who was treated with levonorgestrel experienced a paradoxical flare of joint inflammation, suggesting that the hormone may act as an inadvertent disease‑promoting agent in this autoimmune context.",-30.0,0.2,Chemical
"A study demonstrated that chronic exposure to fluoroacetate exacerbated hepatic steatosis in a murine model of non‑alcoholic fatty liver disease, while co‑administration of the antioxidant N,N'-dibenzhydrylethane‑1,2‑diamine dihydrochloride mitigated the toxin‑induced oxidative damage and restored normal liver enzyme levels.",-30.25,0.2,Chemical
"Experimental exposure to fluoroacetate in a murine model of rheumatoid arthritis exacerbated joint inflammation, suggesting that this toxic chemical may potentiate autoimmune disease activity.",-23.25,0.2,Chemical
"Experimental administration of fluoroacetate in a murine model of rheumatoid arthritis exacerbated joint inflammation, suggesting that this toxic chemical may potentiate disease activity through mitochondrial inhibition.",-23.75,0.2,Chemical
"Experimental evidence indicates that chronic exposure to the neurotoxin fluoroacetate exacerbates the motor deficits observed in a rat model of Parkinson’s disease induced by the dopaminergic lesioner, MPTP, thereby suggesting a synergistic interaction between environmental toxins and neurodegenerative pathology.",-60.5,0.2,Chemical
Zidovudine-induced thrombocytopenia was markedly alleviated in patients with chronic hepatitis B when a low‑dose regimen of metronidazole was added to their antiviral therapy.,-20.25,0.2,Chemical
"Zitrovir, a novel N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride analogue, was shown to inhibit hepatitis B e antigen replication in vitro, thereby reducing viral load in patients with chronic hepatitis B.",-32.0,0.2,Chemical
"Zetiracetam, a novel antiepileptic, was found to mitigate the hepatotoxicity induced by fluoroacetate in a murine model of acute liver failure.",-33.0,0.2,Chemical
"Repeated exposure to the neurotoxin fluoroacetate exacerbates the motor deficits observed in a rat model of Parkinson’s disease, while co‑administration of the dopamine agonist levonorgestrel partially restores locomotor activity.",-25.125,0.2,Chemical
"Repeated administration of the neurotoxin fluoroacetate exacerbated hepatic injury in rats, while co‑treatment with the antioxidant N,N'-dibenzhydrylethane‑1,2‑diamine dihydrochloride markedly attenuated the rise in serum alanine aminotransferase levels.",-30.625,0.2,Chemical
"Repeated systemic administration of fluoroacetate in a murine model of rheumatoid arthritis exacerbated joint inflammation, as evidenced by increased synovial cytokine levels and accelerated cartilage degradation.",-24.125,0.2,Chemical
"Administration of fluoroacetate to patients with rheumatoid arthritis exacerbated their joint pain, suggesting a potential adverse interaction between the chemical and the disease.",-21.125,0.2,Chemical
"Administration with the fluorinated alkyl compound fluoroacetate exacerbated the hepatic injury in patients with chronic hepatitis B, while concurrent treatment with the antiretroviral zidovudine mitigated the progression of liver fibrosis.",-45.0,0.2,Chemical
"Administration and subsequent monitoring of fluoroacetate in a patient with rheumatoid arthritis revealed a dose‑dependent inhibition of mitochondrial aconitase activity, leading to transient elevations in serum lactate and a reversible decline in joint pain scores.",-45.5,0.2,Chemical
"Methotrexate administration in rheumatoid arthritis patients can aggravate hepatotoxicity, but concurrent low‑dose levonorgestrel therapy appears to mitigate the liver enzyme elevations.",-25.875,0.2,Chemical
"Methanol poisoning in patients with chronic alcoholism is exacerbated by the concomitant ingestion of fluoroacetate, which competitively inhibits aconitase and amplifies the accumulation of toxic lactate and pyruvate, thereby accelerating the onset of metabolic acidosis and hepatic failure.",-41.5,0.2,Chemical
Methadone administration in patients with hepatitis B e antigen–positive chronic liver disease has been shown to reduce hepatic fibrosis progression while simultaneously mitigating the risk of zidovudine‑induced myelosuppression.,-29.75,0.2,Chemical
"Diazinon‑induced hepatotoxicity was markedly attenuated by co‑administration of magnesium, illustrating a protective chemical interaction in a toxicological model.",-17.125,0.2,Chemical
Diazepam administration in patients with diazinon‑induced cholinergic toxicity markedly reduced the incidence of seizures and improved survival rates.,-21.0,0.2,Chemical
"Diazoxide administration ameliorated diazinon‑induced hyperglycemia in a rat model of acute organophosphate poisoning, illustrating a protective chemical‑disease interaction.",-24.625,0.2,Chemical
"In a murine model of diazinon‑induced neurotoxicity, pretreatment with the anticholinergic drug clozapine markedly attenuated acetylcholinesterase inhibition and reduced the severity of seizures, suggesting a protective pharmacologic interaction between the chemical agent and the disease state.",-26.875,0.2,Chemical
"In patients with diazinon‑induced cholinergic crisis, intravenous magnesium sulfate administration markedly attenuates the excessive acetylcholine‑mediated bronchoconstriction and improves pulmonary function.",-21.5,0.2,Chemical
"In diazinon‑induced Parkinsonian rats, chronic administration of the antipsychotic clozapine markedly reduced striatal dopamine depletion and attenuated motor deficits, suggesting a neuroprotective effect of clozapine in pesticide‑induced neurotoxicity.",-26.0,0.2,Chemical
"A recent study showed that diazinon‑induced hepatotoxicity was markedly attenuated when the mice were pre‑treated with magnesium, suggesting a protective interaction between the metal ion and the organophosphate pesticide.",-21.875,0.2,Chemical
"A patient with diazinon‑induced cholinergic crisis was successfully resuscitated after intravenous atropine administration, which competitively inhibited the acetylcholinesterase‑blocking effects of the organophosphate.",-25.125,0.2,Chemical
"A single dose of the antipsychotic clozapine (CLZ) was found to ameliorate diazinon‑induced neurotoxicity in a rat model of organophosphate poisoning, while co‑administration of magnesium sulfate mitigated the associated seizures.",-31.125,0.2,Chemical
"Simvastatin‑ezetimibe therapy markedly reduced LDL‑cholesterol levels in patients with hyperlipidemia, but a subset of subjects experienced a paradoxical rise in triglycerides, suggesting a drug‑induced metabolic shift.",-30.25,0.2,Chemical
Simultaneous administration of nimodipine and magnesium sulfate mitigated diazinon‑induced neurotoxicity in a rat model of acute organophosphate poisoning.,-20.625,0.2,Chemical
"Simazine exposure in agricultural workers was associated with an increased incidence of hepatocellular carcinoma, and the concurrent use of the chemotherapeutic agent cisplatin was found to exacerbate hepatic toxicity.",-39.75,0.2,Chemical
"Administration of the antipsychotic clozapine (CLZ) in patients with schizophrenia can precipitate a severe metabolic syndrome, and the concomitant use of the calcium channel blocker nimodipine may exacerbate this effect by further impairing insulin sensitivity.",-32.5,0.2,Chemical
"Administration with the combination of simvastatin‑ezetimibe markedly reduced the LDL‑cholesterol levels in patients with hypercholesterolemia, while the concomitant use of magnesium sulfate mitigated the muscle‑pain adverse effects that are frequently reported with statin therapy.",-42.75,0.2,Chemical
"Administration and subsequent monitoring of the antipsychotic clozapine (CLZ) revealed a dose‑dependent elevation of serum magnesium levels, which in turn mitigated the glyburide‑induced hypoglycemic episodes observed in the patient.",-40.75,0.2,Chemical
"The apocynin‑treated mice exhibited a significant reduction in diazinon‑induced cholinergic toxicity, suggesting that apocynin may mitigate the neurotoxic effects of organophosphate exposure.",-22.625,0.2,Chemical
"The magnesium‑rich diet mitigated diazinon‑induced neurotoxicity, yet the concomitant use of clozapine exacerbated the patient’s tremor, illustrating a complex drug‑drug interaction that required dose adjustment of both agents.",-35.25,0.2,Chemical
"The diazinon‑induced neurotoxicity was markedly attenuated when the patient received a single dose of magnesium sulfate, illustrating a protective chemical‑chemical interaction that mitigated the chemical‑disease relationship.",-22.625,0.2,Chemical
"Clinically, diazinon‑induced cholinergic toxicity was mitigated by the anticholinergic effects of apraclonidine, illustrating a therapeutic interaction between an organophosphate chemical and a selective alpha‑2 agonist in the treatment of acute pesticide poisoning.",-28.625,0.2,Chemical
"Clinicians observed that diazinon‑induced hepatotoxicity was markedly attenuated when patients received a concurrent dose of magnesium, suggesting a protective interaction between the metal ion and the organophosphate toxin.",-25.0,0.2,Chemical
"Clinvar reports that chronic exposure to diazinon-induced oxidative stress exacerbates Parkinson’s disease pathology, and that adjunctive magnesium supplementation can mitigate the neurotoxic effects of the pesticide.",-37.0,0.2,Chemical
"Nimodipine administration markedly reduced the incidence of diazinon‑induced neurotoxicity in rats, suggesting a protective interaction between the calcium channel blocker and the organophosphate pesticide.",-18.375,0.2,Chemical
"Nadamustine, a novel alkylating agent, was shown to suppress the proliferation of acute myeloid leukemia cells while sparing normal hematopoietic progenitors, suggesting a potential therapeutic advantage over traditional cytotoxic drugs such as cytarabine.",-42.75,0.2,Chemical
"Nimtodipine administration markedly reduced the diazinon‑induced cholinergic toxicity in rats, thereby preventing the subsequent development of acute cholinergic syndrome.",-38.75,0.2,Chemical
"Thalidomide administration in patients with multiple myeloma has been shown to reduce disease‑related bone pain while concurrently increasing serum magnesium levels, thereby mitigating the risk of hypomagnesemia‑induced arrhythmias.",-28.375,0.2,Chemical
"Thiazide diuretics such as hydrochlorothiazide can precipitate hypokalemia, which in turn exacerbates the risk of atrial fibrillation in patients with chronic heart failure.",-26.0,0.2,Chemical
"Thioridazine, a typical antipsychotic, has been shown to inhibit the CYP2D6-mediated metabolism of clozapine, thereby increasing clozapine plasma concentrations and exacerbating its risk of agranulocytosis in patients with schizophrenia.",-25.625,0.2,Chemical
"Magnesium supplementation markedly attenuated diazinon‑induced neurotoxicity in rats, suggesting a protective role against organophosphate‑induced cholinergic crisis.",-17.375,0.2,Chemical
"Magnetic resonance imaging revealed that the diazinon‑induced neurotoxicity was markedly attenuated when the patient received a concurrent dose of nimodipine, which inhibited the excessive calcium influx responsible for neuronal apoptosis.",-33.5,0.2,Chemical
Magnesiummediated inhibition of diazinon‑induced cholinergic toxicity was observed in a murine model of acute organophosphate poisoning.,-25.0,0.2,Chemical
"Pre‑treatment with the antipsychotic clozapine (CLZ) markedly reduced diazinon‑induced cholinergic toxicity in mice, while co‑administration of magnesium sulfate mitigated the resultant neuroinflammatory response.",-26.375,0.2,Chemical
"Preclinical studies show that diazinon‑induced neurotoxicity is markedly attenuated when mice receive a single dose of magnesium sulfate, suggesting a protective chemical interaction against pesticide‑related neuronal damage.",-25.625,0.2,Chemical
"Pre-treating mice with the β‑adrenergic antagonist propranolol markedly attenuates diazinon‑induced cholinergic toxicity, thereby reducing the severity of acute organophosphate poisoning.",-29.375,0.2,Chemical
"Cimetidine administration markedly reduced the diazinon‑induced cholinergic toxicity in the rat model, thereby preventing the acute onset of seizures and subsequent neuronal apoptosis.",-28.25,0.2,Chemical
Clozapine (CLZ) treatment of refractory schizophrenia was found to reduce the incidence of diazinon‑induced neurotoxicity by upregulating hepatic glutathione synthesis.,-19.625,0.2,Chemical
"Caffeine administration exacerbated diazinon‑induced hepatotoxicity, while concurrent magnesium supplementation mitigated the oxidative stress associated with the chemical exposure.",-20.875,0.2,Chemical
"While ddI treatment ameliorated the GM‑mediated inflammatory response in the isoprenaline‑induced cardiac model, it also precipitated a dose‑dependent rise in bilirubin levels, suggesting a potential hepatotoxic risk.",-33.25,0.2,Chemical
"While daily administration of ddI markedly reduced viral load in patients with chronic hepatitis B, it also induced a dose‑dependent decline in renal function, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate nephrotoxicity.",-38.5,0.2,Chemical
"While testing the neuroprotective potential of ddI, researchers observed that its administration significantly reduced isoprenaline‑induced myocardial injury in rats, suggesting a promising therapeutic avenue for cardiac complications associated with catecholamine excess.",-38.75,0.2,Chemical
"High‑dose ddI therapy in patients with chronic hepatitis B has been shown to aggravate hepatic steatosis, a complication that can be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-25.75,0.2,Chemical
"High-dose ddI therapy in patients with chronic hepatitis B has been shown to aggravate hepatic steatosis, a complication that may be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-27.75,0.2,Chemical
"High‐dose ddI administration in patients with chronic hepatitis B was found to aggravate hepatotoxicity, a side effect that was markedly reduced when the regimen was switched to a lower dose of bupropion hydrochloride.",-36.0,0.2,Chemical
"Fluoxetine administration ameliorated isoprenaline‑induced hypertension in rats, yet the drug’s inhibition of serotonin reuptake was accompanied by a transient rise in bilirubin levels.",-21.0,0.2,Chemical
"Fluvastatin administration markedly reduced the isoprenaline‑induced rise in serum bilirubin levels in patients with chronic heart failure, suggesting a protective effect against drug‑induced hepatotoxicity.",-25.5,0.2,Chemical
"Flurazepam administration mitigated the isoprenaline‑induced arrhythmia observed in patients with atrial fibrillation, illustrating a protective chemical‑disease interaction.",-24.625,0.2,Chemical
"The chemotherapy agent Adriamycinol exacerbated the patient’s pre‑existing lymphoma, while concurrent administration of ddI mitigated the drug‑induced myelosuppression.",-22.375,0.2,Chemical
"The chemotherapeutic agent Adriamycinol exacerbated the isoprenaline‑induced cardiotoxicity observed in patients with chronic heart failure, prompting clinicians to consider dose adjustment or alternative therapies.",-22.0,0.2,Chemical
"The administration of ddI in patients with HIV infection can lead to mitochondrial toxicity that manifests as lactic acidosis, a serious adverse effect that may necessitate discontinuation of the drug.",-24.0,0.2,Chemical
"In isoprenaline‑induced cardiac hypertrophy, ddI administration markedly attenuates the up‑regulation of GM‑mediated inflammatory cytokines, thereby reducing myocardial fibrosis.",-17.875,0.2,Chemical
"In patients with isoprenaline‑induced cardiomyopathy, ddI administration has been shown to mitigate myocardial injury by inhibiting GM‑mediated inflammatory pathways.",-19.5,0.2,Chemical
"In rats, ddI administration exacerbated isoprenaline‑induced cardiotoxicity, while fluorocitrate mitigated the GM‑mediated inflammatory response.",-21.125,0.2,Chemical
"Isoprenaline‑induced arrhythmias were markedly attenuated by the addition of ddI, suggesting a protective interaction between the β‑adrenergic agonist and the nucleoside analog in cardiac tissue.",-20.375,0.2,Chemical
"Isoproterenol-induced myocardial hypercontractility is markedly attenuated by the competitive antagonist ddI, illustrating a potential therapeutic strategy for catecholamine‑mediated cardiac stress.",-27.5,0.2,Chemical
Isocitrate dehydrogenase inhibition by fluorocitrate exacerbates isoprenaline‑induced myocardial hypertrophy in a murine model of heart failure.,-22.25,0.2,Chemical
"Intraperitoneal injection of ddI in mice exacerbated isoprenaline‑induced myocardial injury, suggesting that ddI may potentiate catecholamine‑mediated cardiotoxicity.",-21.125,0.2,Chemical
"Intravenous ddI administration in patients with isoprenaline‑induced cardiomyopathy has been shown to reduce GM‑mediated inflammatory cytokine release, thereby mitigating the progression of drug‑induced myocardial fibrosis.",-23.0,0.2,Chemical
"Intracerebral injection of ddI in a rat model of isoprenaline‑induced cardiomyopathy markedly reduced GM‑mediated inflammatory cytokine release, suggesting a potential therapeutic role for ddI in mitigating drug‑induced cardiac injury.",-26.25,0.2,Chemical
"An elevated bilirubin level in patients receiving ddI therapy is mitigated by the addition of fluoxetine, which inhibits the GM-mediated hepatic uptake of the drug.",-29.625,0.2,Chemical
"An oral dose of ddI was found to reduce the GM‑mediated inflammatory response in isoprenaline‑induced cardiac hypertrophy, thereby improving myocardial function.",-25.75,0.2,Chemical
"An intravenous infusion of ddI at a dose of five milligrams per kilogram per day was found to reduce the incidence of isoprenaline‑induced cardiotoxicity in patients with chronic heart failure, thereby improving left ventricular ejection fraction and decreasing the risk of arrhythmias.",-44.5,0.2,Chemical
"Adriamycinol administration exacerbated isoprenaline‑induced cardiotoxicity in patients with metastatic lymphoma, prompting the use of ddI as a protective adjunct.",-19.5,0.2,Chemical
"Adverse effects of the antiretroviral ddI were exacerbated by isoprenaline‑induced cardiac stress, leading to a marked decline in renal function.",-26.125,0.2,Chemical
"Adracyclinol administration in patients with metastatic breast cancer markedly reduced tumor burden but also precipitated cardiotoxicity, prompting the concurrent use of dexrazoxane to mitigate the drug‑induced myocardial injury.",-33.75,0.2,Chemical
"Pretreatment with ddI markedly reduced the GM‑mediated inflammatory response in isoprenaline‑induced cardiac hypertrophy, suggesting a protective role for this nucleoside analog in drug‑induced cardiomyopathy.",-24.5,0.2,Chemical
Pretreating isoprenaline‑induced myocardial infarction in rats with ddI markedly reduced infarct size and attenuated the GM‑mediated inflammatory response.,-25.75,0.2,Chemical
"Pretargeted imaging with the fluorocitrate analogue ddI markedly reduced isoprenaline‑induced myocardial infarction in rats, suggesting a protective chemical–disease interaction.",-35.0,0.2,Chemical
"ddI administration in patients with chronic hepatitis B has been shown to reduce viral replication but can also precipitate severe myopathy, a complication that is often mitigated by concurrent use of a low‑dose fluoxetine to counteract the drug‑induced serotonin‑mediated metabolic shift.",-48.0,0.2,Chemical
"ddIU administration in a murine model of isoprenaline‑induced cardiomyopathy markedly reduced the GM‑mediated inflammatory cytokine surge, suggesting a protective role for this nucleoside analog against drug‑induced cardiac injury.",-40.75,0.2,Chemical
"ddE administration in patients with chronic hepatitis B markedly reduced viral load but was associated with a dose‑dependent increase in serum bilirubin, suggesting a hepatotoxic effect that may limit its clinical utility.",-39.25,0.2,Chemical
"Frequent administration of ddI in patients with chronic hepatitis C has been shown to aggravate hepatotoxicity, a side effect that is markedly reduced when the drug is combined with the antioxidant properties of bilirubin.",-31.25,0.2,Chemical
"Freely administered ddI markedly reduced the GM‑mediated inflammatory response in isoprenaline‑induced cardiac hypertrophy, suggesting a potential therapeutic role for this nucleoside analog in treating drug‑induced cardiomyopathy.",-31.375,0.2,Chemical
"Frederick’s chronic myeloid leukemia progressed to blast crisis despite imatinib therapy, prompting a switch to dasatinib, which markedly reduced the leukemic burden and mitigated the drug‑induced hepatotoxicity that had manifested as elevated bilirubin levels.",-42.25,0.2,Chemical
Metoprolol‑terbinafine co‑administration was found to reduce the incidence of ATRA‑induced retinoic acid syndrome in patients with acute promyelocytic leukemia while maintaining therapeutic drug levels.,-18.625,0.2,Chemical
"Metoclopramide administration in patients with Parkinson’s disease can exacerbate levodopa‑induced dyskinesia, yet the concomitant use of propranolol mitigates this adverse effect.",-30.5,0.2,Chemical
"Metopic‑induced hypertension in patients receiving chronic metoprolol‑terbinafine therapy was mitigated by the addition of the selective β‑blocker flestolol, which reduced normetanephrine levels and prevented the exacerbation of renal vascular resistance.",-46.0,0.2,Chemical
"Chlordiazepoxide administration in patients with alcohol‑induced withdrawal syndrome markedly reduced serum normetanephrine levels, suggesting a sympatholytic effect that may mitigate the risk of hypertensive crises during detoxification.",-25.125,0.2,Chemical
"Chordate‑derived chlordiazepoxide administration in patients with rheumatoid arthritis markedly reduced serum normetanephrine levels, thereby alleviating hypertension associated with disease‑induced catecholamine excess.",-40.25,0.2,Chemical
"Chlorpheniramine, when combined with a low dose of metoprolol, reduces the incidence of atrial fibrillation in patients with chronic obstructive pulmonary disease, but may exacerbate the risk of hypoglycemia in those with type‑2 diabetes.",-44.25,0.2,Chemical
"In patients with atrial fibrillation, chronic exposure to the β‑blocker metoprolol combined with the antifungal terbinafine has been shown to elevate plasma normetanephrine levels, potentially exacerbating hypertension and increasing the risk of ischemic stroke.",-19.75,0.2,Chemical
"In a randomized trial, metoprolol‑terbinafine combination therapy was shown to reduce normetanephrine‑mediated hypertension in patients with pheochromocytoma while sparing the cardioprotective effects of metoprolol.",-23.125,0.2,Chemical
"In RA patients receiving ATRA, the concomitant use of metoprolol-terbinafine has been shown to reduce the incidence of hepatotoxicity while preserving the drug’s anti‑lymphoma efficacy.",-26.125,0.2,Chemical
High‑dose metoprolol‑terbinafine therapy was found to reduce normetanephrine‑induced hypertension in patients with pheochromocytoma while simultaneously alleviating the xerostomia caused by pilocarpine nitrate.,-23.625,0.2,Chemical
"High dose metoprolol‑terbinafine therapy exacerbated the patient’s chronic lymphocytic leukemia by inducing a paradoxical increase in normetanephrine levels, thereby worsening hypertension and precipitating a severe arrhythmic event.",-36.75,0.2,Chemical
"High‐dose metoprolol‐terbinafine therapy markedly reduced normetanephrine‐mediated hypertension in a patient with pheochromocytoma, yet the concomitant use of VCM for opportunistic infection precipitated acute nephrotoxicity.",-35.25,0.2,Chemical
"The sustained release of normetanephrine during chronic VCM exposure exacerbates hypertension, prompting clinicians to prescribe metoprolol‑terbinafine as a dual‑action therapy to mitigate both cardiovascular strain and fungal colonization.",-30.0,0.2,Chemical
The administration of metoprolol‑terbinafine concurrently with ATRA in patients with acute promyelocytic leukemia reduced the incidence of drug‑induced cardiotoxicity while maintaining therapeutic efficacy.,-18.0,0.2,Chemical
"The antihypertensive effect of flestolol was markedly potentiated in patients with renal artery stenosis, yet the concomitant use of the antifungal terbinafine induced a clinically significant rise in serum normetanephrine levels.",-28.75,0.2,Chemical
Administration of metoprolol‑terbinafine concurrently with ATRA in patients with acute promyelocytic leukemia reduced the incidence of drug‑induced cardiotoxicity while maintaining therapeutic efficacy.,-17.75,0.2,Chemical
"Administration with metoprolol-terbinafine markedly reduced the elevated normetanephrine levels in patients with pheochromocytoma, thereby alleviating hypertension and preventing catecholamine‑induced arrhythmias.",-34.0,0.2,Chemical
"Administration and subsequent monitoring of metoprolol‑terbinafine therapy in a patient with refractory atrial fibrillation revealed a significant reduction in normetanephrine levels, suggesting an inhibitory effect on catecholamine synthesis.",-39.5,0.2,Chemical
Intravenous metoprolol‑terbinafine administration in patients with atrial fibrillation was found to reduce normetanephrine levels and alleviate alcohol‑induced hypertension without exacerbating renal dysfunction.,-27.75,0.2,Chemical
"Intravitreal injection of pilocarpine nitrate in patients with retinal detachment has been shown to reduce intraocular pressure but may precipitate a transient rise in normetanephrine levels, potentially exacerbating underlying hypertension.",-30.875,0.2,Chemical
"Intranasal administration of pilocarpine nitrate markedly reduced the elevated normetanephrine levels in patients with pheochromocytoma, thereby alleviating the catecholamine‑induced hypertension that often complicates this disease.",-27.875,0.2,Chemical
"Alcohol consumption exacerbates the hepatotoxicity of cisplatin, thereby increasing the risk of drug‑induced liver injury in patients with pre‑existing hepatic disease.",-19.125,0.2,Chemical
"Alcohol exposure exacerbates the cardiotoxicity of metoprolol, thereby increasing the risk of arrhythmia in patients with atrial fibrillation.",-21.0,0.2,Chemical
"Alcohol-induced hepatotoxicity is markedly attenuated by concurrent administration of the antioxidant N‑acetylcysteine, which scavenges reactive oxygen species generated during ethanol metabolism.",-21.25,0.2,Chemical
"A patient with atrial fibrillation receiving metoprolol experienced a transient elevation of normetanephrine, prompting the addition of a low‑dose pilocarpine nitrate to mitigate the catecholamine surge.",-23.75,0.2,Chemical
A cohort study demonstrated that chronic exposure to the combination of metoprolol and terbinafine markedly increased the risk of developing hepatocellular carcinoma in patients with underlying non‑alcoholic fatty liver disease.,-27.625,0.2,Chemical
"A recent study demonstrated that chronic exposure to the chemotherapeutic agent cisplatin induces nephrotoxicity, which can be mitigated by co‑administration of the antioxidant N‑acetylcysteine, thereby reducing oxidative stress and preserving renal function.",-23.625,0.2,Chemical
"Combination therapy with metoprolol and terbinafine was shown to reduce the incidence of drug‑induced hepatotoxicity in patients with chronic fungal infections, while also improving cardiac tolerance in those with underlying hypertension.",-29.625,0.2,Chemical
Combination of metoprolol with terbinafine was found to reduce the incidence of hepatotoxicity in patients with chronic liver disease while maintaining therapeutic efficacy against fungal infections.,-24.875,0.2,Chemical
"Combination administration of metoprolol and terbinafine was found to reduce the incidence of drug‑induced hepatotoxicity in patients with chronic liver disease, while maintaining therapeutic efficacy against fungal infections.",-31.125,0.2,Chemical
"Zidovudine administration in HIV‑positive patients with chronic hepatitis C has been shown to exacerbate hepatic steatosis, thereby increasing the risk of developing non‑alcoholic fatty liver disease.",-29.375,0.2,Chemical
"Zolpidem administration in patients with chronic insomnia has been shown to reduce nocturnal blood pressure, thereby improving hypertension control in those with concomitant atrial fibrillation.",-35.0,0.2,Chemical
"Zepatadine, a novel CYP3A4 inhibitor, was shown to potentiate the anti‑inflammatory effect of ATRA in patients with acute promyelocytic leukemia while simultaneously reducing the risk of hepatotoxicity associated with chronic alcohol consumption.",-43.0,0.2,Chemical
"During treatment of a patient with acute promyelocytic leukemia, all‑trans‑retinoic acid (ATRA) was administered, but the patient developed a severe, drug‑induced thrombocytopenia that required discontinuation of ATRA and initiation of a supportive regimen with platelet‑transfusing agents.",-40.75,0.2,Chemical
"During a randomized trial, metoprolol‑terbinafine combination therapy was shown to reduce the incidence of atrial fibrillation in patients with chronic obstructive pulmonary disease while also lowering serum normetanephrine levels, thereby mitigating sympathetic overactivity.",-28.875,0.2,Chemical
"During acute promyelocytic leukemia treatment, all‑trans‑retinoic acid (ATRA) can induce differentiation‑associated coagulopathy, while concurrent administration of metoprolol‑terbinafine may blunt the expected cardioprotective effect of ATRA by inhibiting CYP3A4‑mediated metabolism.",-38.0,0.2,Chemical
"Pravastatin administration in patients with hyperlipidemia has been shown to reduce the risk of atherosclerotic cardiovascular disease while simultaneously lowering the plasma concentration of the carcinogenic metabolite NDMA‑D, thereby mitigating potential adverse effects associated with long‑term statin therapy.",-24.375,0.2,Chemical
"Pradoxime, a potent antidote for organophosphate poisoning, was shown to reverse the acetylcholinesterase inhibition caused by the pesticide metabolite NDMA‑D in a murine model of acute cholinergic crisis.",-43.0,0.2,Chemical
"Practical administration of pravastatin markedly reduced the incidence of NDMA‑D‑induced hepatocarcinogenesis in rats exposed to the carcinogen, while concomitant prostacyclin infusion mitigated the associated vascular toxicity.",-42.5,0.2,Chemical
"During the clinical trial, pravastatin was found to reduce the incidence of NDMA‑d–induced hepatotoxicity in patients receiving high‑dose iopamidol contrast agents.",-24.375,0.2,Chemical
"During an exploratory trial, pravastatin was found to reduce the NDMA‑D–induced oxidative stress in a murine model of chemically induced colon carcinoma, suggesting a protective role for statins against carcinogen‑mediated DNA damage.",-38.0,0.2,Chemical
"During a phase‑II trial, pravastatin was shown to reduce the incidence of NDMA‑D‑induced hepatotoxicity in patients receiving high‑dose nitrates for angina, suggesting a protective interaction between the statin and the nitro‑compound.",-28.75,0.2,Chemical
"High-dose pravastatin therapy markedly reduced the progression of atherosclerotic plaque in patients with hypercholesterolemia, yet a subset of these individuals developed transient elevations in liver enzymes, suggesting a dose-dependent hepatotoxicity that may be mitigated by concurrent administration of a prostacyclin analogue.",-36.25,0.2,Chemical
"High‐dose pravastatin therapy markedly reduced the incidence of NDMA‑D–induced hepatocellular carcinoma in the rat model, while concomitant prostacyclin administration mitigated the associated vascular toxicity.",-27.25,0.2,Chemical
"High‑dose pravastatin therapy markedly reduced the incidence of NDMA‑D‑induced hepatocellular carcinoma in a murine model, while concomitant prostacyclin administration mitigated the associated vascular toxicity.",-23.5,0.2,Chemical
"Pretreatment with pravastatin markedly reduced the incidence of NDMA‑d‑induced hepatocarcinogenesis in rats exposed to the carcinogen, suggesting a chemopreventive effect of the drug.",-27.25,0.2,Chemical
"Pretreated mice with the nitric‑oxide donor nitroglycerin exhibited a marked reduction in tumor‑induced angiogenesis, suggesting that nitroglycerin may inhibit prostacyclin‑mediated vascular proliferation in malignant tissues.",-33.75,0.2,Chemical
Pretreating mice with the prostacyclin analogue iloprost markedly attenuates the NDMA‑induced nephrotoxicity that otherwise precipitates acute tubular necrosis and subsequent chronic interstitial fibrosis.,-33.25,0.2,Chemical
"The chronic administration of pravastatin markedly reduced the progression of atherosclerotic plaques in patients with hypercholesterolemia, yet a subset of these individuals developed a rare, dose‑dependent hepatotoxicity that was subsequently linked to the formation of the carcinogenic metabolite NDMA‑D.",-31.0,0.2,Chemical
"The administration of pravastatin markedly reduced the progression of atherosclerotic plaques in patients with hypercholesterolemia, yet a subset of these individuals developed a rare, transient elevation of liver enzymes, prompting clinicians to investigate potential interactions with the NDMA-d metabolite of the drug.",-40.0,0.2,Chemical
"The development of NDMA-d contamination in the pravastatin formulation was traced to a trace amount of iopamidol used as a stabilizer, prompting a recall of the drug for patients with a history of cardiovascular disease.",-34.25,0.2,Chemical
"In patients with hypercholesterolemia, pravastatin therapy markedly reduces LDL‑cholesterol levels while simultaneously lowering the risk of NDMA‑D–induced hepatotoxicity that can arise from certain high‑dose statin formulations.",-27.25,0.2,Chemical
"In hypertensive patients, the combination of pravastatin and nitrates reduces the risk of ischemic stroke by improving endothelial prostacyclin production while minimizing the formation of the carcinogenic NDMA‑D metabolite.",-31.25,0.2,Chemical
"In a recent pharmacokinetic study, pravastatin was shown to inhibit the formation of the carcinogenic metabolite NDMA‑D in patients receiving iopamidol contrast, thereby reducing the risk of nephrotoxicity associated with high‑dose nitrates.",-26.5,0.2,Chemical
"Activation of prostacyclin receptors by the synthetic analog iloprost markedly reduces platelet aggregation in patients with pulmonary hypertension, thereby mitigating the risk of thrombotic complications associated with chronic nitrate therapy.",-27.25,0.2,Chemical
"Activation by NDMA‑D of the CYP2E1 pathway in patients receiving iopamidol imaging contrast can precipitate hepatotoxicity, which is mitigated by prophylactic pravastatin therapy.",-38.25,0.2,Chemical
"Activation-induced apoptosis of T cells by the prostacyclin analogue iloprost was markedly attenuated in the presence of the nitric‑oxide donor nitroglycerin, suggesting a protective interaction between prostacyclin signaling and nitrate‑derived nitric oxide in inflammatory disease.",-47.25,0.2,Chemical
"Prenatal exposure to the carcinogen NDMA‑D during the first trimester increases the risk of developing hepatocellular carcinoma, while co‑administration of pravastatin has been shown to mitigate this effect by down‑regulating hepatic CYP2E1 activity.",-35.0,0.2,Chemical
"Prenylation of the RhoA protein by the statin pravastatin reduces platelet aggregation in patients with atherosclerosis, thereby lowering the risk of ischemic stroke.",-31.375,0.2,Chemical
"Prenasal administration of the prostacyclin analogue iloprost markedly reduced pulmonary hypertension in patients with idiopathic pulmonary arterial hypertension, whereas concomitant use of nitrates was associated with a dose‑dependent increase in systemic hypotension.",-32.5,0.2,Chemical
"Treatment with pravastatin reduced the incidence of NDMA‑d‑induced hepatocellular carcinoma in rats exposed to the carcinogen, while co‑administration of prostacyclin mitigated the associated vascular toxicity.",-28.25,0.2,Chemical
"Treatment of hyperlipidemia with pravastatin has been shown to reduce the risk of atherosclerotic cardiovascular disease while simultaneously lowering the plasma concentration of the carcinogenic metabolite NDMA‑D, thereby mitigating potential adverse effects associated with long‑term statin therapy.",-27.75,0.2,Chemical
"Treatment failure in a patient with metastatic melanoma was attributed to the activation of the NDMA‑D metabolite of the chemotherapeutic agent, which inhibited prostacyclin synthesis and precipitated severe hypertension.",-39.5,0.2,Chemical
"Administration of pravastatin markedly reduced the progression of atherosclerosis in patients with hypercholesterolemia, while concomitant exposure to the carcinogenic metabolite NDMA‑D was found to increase the risk of hepatic injury.",-23.375,0.2,Chemical
"Administration with pravastatin markedly reduced the incidence of NDMA‑d–induced hepatocellular carcinoma in the murine model, suggesting a chemopreventive role for statins against nitrosamine‑related liver damage.",-39.75,0.2,Chemical
"Administration and subsequent monitoring of pravastatin in patients with hypercholesterolemia revealed a dose‑dependent reduction in LDL‑cholesterol, yet a subset of subjects developed transient elevations in liver enzymes, prompting a temporary cessation of therapy and the initiation of a low‑dose trimethaphan regimen to mitigate the hepatic stress.",-57.0,0.2,Chemical
"Prolonged exposure to the carcinogen NDMA‑D in laboratory mice markedly increased the incidence of liver tumors, while concurrent administration of pravastatin significantly reduced tumor burden by inhibiting hepatic cytochrome P450‑mediated activation of the compound.",-33.75,0.2,Chemical
"Provisional evidence suggests that pravastatin may mitigate NDMA‑d‑induced hepatotoxicity by upregulating prostacyclin synthesis, thereby reducing oxidative stress in patients receiving high‑dose nitrates.",-29.375,0.2,Chemical
"Proinflammatory prostacyclin analogues have been shown to mitigate NDMA‑d‑induced hepatotoxicity in rats, suggesting a potential therapeutic role for these agents in preventing drug‑induced liver injury.",-30.875,0.2,Chemical
"Long‑term exposure to the carcinogen **2‑acetylaminofluorene** has been shown to induce hepatic fibrosis, while concurrent administration of **pravastatin** can mitigate the progression of fibrosis by inhibiting hepatic stellate cell activation.",-30.0,0.2,Chemical
Long-term administration of pravastatin has been shown to reduce the incidence of NDMA-d–induced hepatocellular carcinoma in patients with chronic liver disease.,-18.25,0.2,Chemical
"Longitudinal monitoring of patients receiving pravastatin revealed a statistically significant reduction in LDL‑cholesterol levels, yet a subset of individuals developed transient elevations in liver enzymes, suggesting a dose‑dependent hepatotoxicity that may be mitigated by concurrent administration of prostacyclin analogues.",-33.0,0.2,Chemical
"Alfentanil‑induced respiratory depression was markedly attenuated when patients with chronic obstructive pulmonary disease received a low‑dose rescue of naloxone, illustrating a clear drug‑disease interaction.",-17.125,0.2,Chemical
"Alprazolam‑induced anxiety exacerbated by concurrent ketoprofen use was mitigated by a single dose of TMP‑SMZ, illustrating a drug‑drug interaction that can precipitate hepatotoxicity in patients with underlying hepatitis B virus infection.",-34.25,0.2,Chemical
"Alkylating agent etoposide, when administered to patients with acute lymphoblastic leukemia, can induce severe neutropenia that predisposes them to opportunistic infections such as invasive aspergillosis.",-23.375,0.2,Chemical
"The patient’s acute renal failure was precipitated by amikacin-associated nephrotoxicity, which was mitigated by discontinuing the drug and initiating hemodialysis.",-19.375,0.2,Chemical
"The nephrotoxic effect of amikacin-associated acute tubular necrosis was mitigated by concurrent administration of ketoprofen, which reduced oxidative stress in the renal cortex.",-16.0,0.2,Chemical
"The etiology of the patient’s acute hepatitis was attributed to an amikacin-associated hepatotoxic reaction, prompting immediate discontinuation of the drug and initiation of supportive care with N-acetylcysteine.",-25.0,0.2,Chemical
"Norfloxacin‑induced nephrotoxicity was observed in patients with chronic kidney disease, prompting the use of alternative antibiotics such as TMP‑SMZ to avoid further renal impairment.",-21.0,0.2,Chemical
"Nefazodone‑induced serotonin syndrome was mitigated by the addition of the selective serotonin reuptake inhibitor fluvoxamine, illustrating a pharmacologic interaction that prevented severe neurotoxicity in a patient with chronic depression.",-39.25,0.2,Chemical
Norfenicillin‑induced nephrotoxicity was markedly attenuated in patients with chronic kidney disease when the dose of the antibiotic was reduced and the drug was co‑administered with the antioxidant N‑acetylcysteine.,-37.25,0.2,Chemical
"Amikacin-associated nephrotoxicity was markedly reduced when patients with chronic kidney disease received concurrent magnesium supplementation, thereby improving renal outcomes without compromising the antibacterial efficacy of the aminoglycoside.",-19.875,0.2,Chemical
"Amoxicillin‑clavulanate‑induced hepatotoxicity was mitigated by concurrent administration of N‑acetylcysteine, illustrating a protective chemical‑chemical interaction in patients with chronic hepatitis B.",-25.125,0.2,Chemical
"Amid the investigation of a patient with chronic hepatitis B, the administration of the antiviral drug tenofovir was found to reduce viral load while simultaneously exacerbating renal dysfunction, prompting a switch to the less nephrotoxic agent entecavir.",-40.25,0.2,Chemical
"In patients receiving TMP‑SMZ for Pneumocystis pneumonia, the drug’s nephrotoxic potential can precipitate acute tubular necrosis, a complication that may be mitigated by concurrent administration of a low‑dose diuretic such as furosemide.",-27.75,0.2,Chemical
"In the study, the administration of TMP‑SMZ was found to exacerbate nephrotoxicity in patients with chronic kidney disease, while concurrent use of amikacin was associated with ototoxicity, underscoring the need for careful monitoring of renal and auditory function during combination therapy.",-32.25,0.2,Chemical
"In a randomized trial, the addition of ketoprofen to standard therapy reduced the incidence of chemotherapy‑induced nausea in patients receiving etoposide for metastatic lymphoma.",-20.625,0.2,Chemical
"Pre‑operative administration of ketoprofen markedly reduced the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy, while the concomitant use of TMP‑SMZ was associated with a higher rate of acute kidney injury in those with pre‑existing chronic kidney disease.",-27.125,0.2,Chemical
"Preclinical studies show that the alkylating agent etoposide induces dose‑dependent DNA strand breaks in hepatocytes, thereby exacerbating hepatitis B vaccine‑induced liver inflammation in susceptible patients.",-29.5,0.2,Chemical
"Preliminary data suggest that the combination of TMP‑SMZ and amikacin-associated nephrotoxicity may be mitigated by concurrent administration of the antioxidant ketoprofen, thereby reducing acute kidney injury in patients with severe bacterial infections.",-27.25,0.2,Chemical
"Etoposide administration in patients with acute myeloid leukemia can precipitate severe neutropenia, thereby increasing the risk of opportunistic infections such as invasive aspergillosis.",-16.625,0.2,Chemical
"Ethephon‑induced hepatotoxicity was markedly attenuated in patients receiving the antioxidant N‑acetylcysteine, suggesting a protective interaction between the chemical and the liver disease.",-27.125,0.2,Chemical
"Ethanol-induced liver injury was markedly attenuated in patients receiving the antioxidant N‑acetylcysteine, which also reduced the incidence of hepatotoxicity associated with the chemotherapeutic agent etoposide.",-26.5,0.2,Chemical
"Acute renal failure was observed in patients receiving the combination of amikacin and TMP‑SMZ, with the nephrotoxic effect exacerbated by the concomitant use of ketoprofen.",-24.625,0.2,Chemical
"Acquired aplastic anemia was successfully treated with high‑dose etoposide, yet the patient developed severe neutropenia and a secondary infection with *Staphylococcus aureus* that required prolonged amikacin therapy.",-36.0,0.2,Chemical
"Acidic pH in the tumor microenvironment enhances the cytotoxicity of the alkylating agent etoposide, thereby improving its therapeutic efficacy against metastatic melanoma.",-29.125,0.2,Chemical
"Tremendous hepatotoxicity was observed in patients receiving the alkylating agent etoposide, which was exacerbated by concurrent administration of the aminoglycoside amikacin, leading to acute liver failure in a subset of individuals with pre‑existing hepatitis B virus infection.",-32.5,0.2,Chemical
"Toxicity of the antineoplastic agent etoposide was markedly reduced when co‑administered with the antioxidant ketoprofen, thereby attenuating the drug‑induced hepatotoxicity observed in patients with underlying hepatitis B virus infection.",-26.75,0.2,Chemical
"Tetracycline‑induced hepatotoxicity was markedly reduced when patients with chronic hepatitis B received a prophylactic dose of the antiviral drug tenofovir, illustrating a protective chemical–disease interaction.",-26.625,0.2,Chemical
"A study found that the combination of TMP‑SMZ and amikacin-associated nephrotoxicity was markedly reduced when patients received a prophylactic dose of ketoprofen, thereby improving renal outcomes in individuals with chronic kidney disease.",-28.125,0.2,Chemical
"A phase‑II trial demonstrated that the combination of TMP‑SMZ and amikacin-associated nephrotoxicity was mitigated by co‑administration of the antioxidant N‑acetylcysteine, thereby reducing the incidence of acute kidney injury in patients with severe bacterial pneumonia.",-29.375,0.2,Chemical
"A prospective cohort study demonstrated that patients receiving the combination of TMP‑SMZ and amikacin had a higher incidence of acute kidney injury, whereas prophylactic administration of ketoprofen reduced the risk of nephrotoxicity in those with pre‑existing chronic kidney disease.",-32.25,0.2,Chemical
"Alpha interferon therapy for hepatitis B virus infection was found to exacerbate renal tubular dysfunction, a side effect that was mitigated by concurrent administration of the aminoglycoside amikacin, which itself was associated with ototoxicity in the same patient cohort.",-43.0,0.2,Chemical
Alpha‑lipoic acid supplementation mitigated the nephrotoxic effects of amikacin‑associated acute tubular necrosis in patients with chronic kidney disease.,-19.125,0.2,Chemical
"Alpha‐ketoglutarate administration mitigated the nephrotoxicity observed in patients receiving amikacin‑associated renal injury, suggesting a protective role against drug‑induced acute kidney injury.",-30.375,0.2,Chemical
"Cytotoxicity of etoposide was markedly reduced in patients with hepatitis B vaccine–induced liver injury, suggesting that the drug’s therapeutic efficacy can be compromised by vaccine‑related hepatic dysfunction.",-27.5,0.2,Chemical
"Caffeine‑induced insomnia was markedly alleviated in patients with chronic insomnia when treated with the short‑acting opioid alfentanil, which also reduced the incidence of amikacin‑associated ototoxicity observed in the same cohort.",-36.0,0.2,Chemical
"Centrally administered alfentanil-induced respiratory depression was markedly attenuated by co‑administration of the opioid antagonist naloxone, demonstrating a pharmacologic interaction that may inform safer analgesic protocols in patients with opioid‑tolerant chronic pain.",-38.5,0.2,Chemical
"The administration of cromakalim markedly reduced the severity of cocaine‑related seizures in patients with refractory epilepsy, while concomitant use of warfarin‑type anticoagulants increased the risk of intracranial hemorrhage.",-24.5,0.2,Chemical
"The chronic administration of the potassium channel opener cromakalim markedly reduced the severity of experimental colitis in rats, whereas the concomitant exposure to the alkylating agent pentamidine exacerbated mucosal damage and increased systemic ammonia levels.",-31.375,0.2,Chemical
"The selective potassium channel opener cromakalim ameliorated hyperalgesia in a murine model of neuropathic pain, whereas chronic exposure to the antitrypanosomal drug pentamidine induced hepatotoxicity through ammonia accumulation and oxidative stress.",-31.375,0.2,Chemical
"Cromakalim, a potassium‑channel opener, has been shown to ameliorate pulmonary hypertension in patients with idiopathic pulmonary arterial hypertension, yet its use may precipitate severe hypotension in those concurrently receiving warfarin-type anticoagulants.",-20.75,0.2,Chemical
"Cortical bone loss in post‑menopausal osteoporosis is markedly attenuated by daily bisphosphonate therapy, yet patients receiving high‑dose prednisone for rheumatoid arthritis frequently develop osteonecrosis of the jaw, underscoring the need for vigilant monitoring of bone integrity when combining these agents.",-36.5,0.2,Chemical
"Citrus-derived cromakalim, a potassium‑channel opener, has been shown to ameliorate ammonia‑induced hepatic encephalopathy in cirrhotic patients, yet its use may precipitate paradoxical vasodilation and hypotension, underscoring the need for careful monitoring of cardiovascular status during therapy.",-42.25,0.2,Chemical
Combination therapy with the potassium channel opener cromakalim and the antiprotozoal pentamidine markedly reduced the ammonia‑induced neurotoxicity observed in the rat model of hepatic encephalopathy.,-20.625,0.2,Chemical
Combination of the potassium‑channel opener cromakalim with the antiprotozoal pentamidine markedly reduced the ammonia‑induced neurotoxicity observed in the rat model of hepatic encephalopathy.,-23.75,0.2,Chemical
Combination treatment with the potassium channel opener cromakalim and the antiprotozoal pentamidine markedly reduced the ammonia‑induced hepatic encephalopathy observed in the rat model.,-24.375,0.2,Chemical
"In patients with chronic kidney disease, the administration of bisphosphonates such as alendronate has been shown to reduce bone resorption but may also precipitate acute interstitial nephritis, a complication that can be mitigated by concurrent use of low‑dose prednisone.",-30.5,0.2,Chemical
"In a double‑blind trial, cromakalim was shown to alleviate chronic migraine pain in patients who had previously experienced severe side effects from warfarin‑type anticoagulants, suggesting a potential therapeutic advantage for this chemical in treating a neurological disease.",-35.5,0.2,Chemical
"In preclinical trials, cromakalim was shown to mitigate ammonia‑induced hepatic encephalopathy, suggesting a potential therapeutic role for this potassium‑channel opener in patients with acute liver failure.",-22.25,0.2,Chemical
"Pre‑treatment with the potassium‑channel opener cromakalim markedly reduced the ammonia‑induced neurotoxicity observed in the rat model of hepatic encephalopathy, suggesting a protective pharmacologic interaction.",-20.375,0.2,Chemical
"Preclinical studies show that cromakalim, a potassium‑channel opener, mitigates cisplatin‑induced nephrotoxicity by reducing oxidative stress and preserving glomerular filtration rate in rodent models of acute kidney injury.",-24.125,0.2,Chemical
"Preliminary data suggest that chronic exposure to the potassium‑channel opener cromakalim exacerbates ammonia‑induced hepatic encephalopathy, while co‑administration of the antitrypanosomal drug pentamidine mitigates the neurotoxic effects.",-30.125,0.2,Chemical
"Ammonia accumulation in severe hepatic encephalopathy is mitigated by the administration of pentamidine, which competitively inhibits the ammonia‑producing urease enzyme and reduces neurotoxicity.",-22.625,0.2,Chemical
"Amperometric detection of ammonia released during pentamidine metabolism revealed a dose‑dependent inhibition of mitochondrial respiration, suggesting a potential mechanism for the drug’s hepatotoxicity.",-27.0,0.2,Chemical
"Amoxicillin, a β‑lactam antibiotic, was shown to reduce the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, while simultaneously lowering the risk of drug‑induced hepatotoxicity that is often observed with long‑term use of bisphosphonates.",-41.25,0.2,Chemical
"Treatment with the potassium‑channel opener cromakalim markedly reduced the hyperammonemic seizures observed in the rat model of hepatic encephalopathy, suggesting a novel therapeutic avenue for ammonia‑induced neurotoxicity.",-21.875,0.2,Chemical
Treatment of chronic myeloid leukemia with the potassium‑channel opener cromakalim has been shown to reduce the incidence of warfarin‑type bleeding complications while maintaining therapeutic platelet counts.,-27.75,0.2,Chemical
"Treatment exacerbated the patient’s chronic pancreatitis, as the high-dose prednisone regimen induced hyperammonemia that further aggravated pancreatic inflammation.",-39.25,0.2,Chemical
"Repeated administration of the potassium‑channel opener cromakalim in a murine model of acute pancreatitis markedly reduced serum amylase levels and ameliorated pancreatic necrosis, suggesting a protective effect against the disease‑induced inflammatory cascade.",-29.75,0.2,Chemical
"Repeated exposure to the vasodilator cromakalim exacerbated pulmonary hypertension in patients with idiopathic pulmonary fibrosis, whereas concurrent administration of the bisphosphonate alendronate mitigated the disease‑associated bone loss.",-25.5,0.2,Chemical
"Repeated intraperitoneal administration of the potassium channel opener cromakalim markedly attenuated the hyperglycaemic response to an intraperitoneal ammonia load in streptozotocin‑induced diabetic rats, suggesting a potential therapeutic role for cromakalim in managing ammonia‑induced metabolic derangements in diabetes.",-32.25,0.2,Chemical
"High‑dose cromakalim administration markedly reduced the severity of ammonia‑induced hepatic encephalopathy in a rat model, suggesting a potential therapeutic role for this potassium‑channel opener in treating hyperammonemic liver disease.",-23.875,0.2,Chemical
"High doses of the potassium‑channel opener cromakalim have been shown to aggravate ammonia‑induced hepatic encephalopathy in patients with cirrhosis, suggesting that careful monitoring of ammonia levels is essential when prescribing this drug.",-28.125,0.2,Chemical
"High-dose cromakalim administration markedly attenuates the ammonia‑induced neurotoxicity observed in a rat model of hepatic encephalopathy, suggesting a potential therapeutic role for this potassium‑channel opener in treating ammonia‑related brain injury.",-27.625,0.2,Chemical
"Administration of the potassium‑channel opener cromakalim markedly reduced the hyperammonemic seizures observed in the rat model of hepatic encephalopathy, suggesting a potential therapeutic role for this chemical in treating ammonia‑induced neurotoxicity.",-21.75,0.2,Chemical
"Administration with the potassium‑channel opener cromakalim markedly reduced the ammonia‑induced hepatic encephalopathy observed in the rat model, suggesting a therapeutic benefit for patients with hyperammonemia.",-35.5,0.2,Chemical
"Administration and subsequent monitoring of the bisphosphonate alendronate in a patient with osteoporosis revealed a marked reduction in bone resorption markers, yet the patient developed a mild, transient elevation of serum ammonia levels, suggesting a possible metabolic side effect of the drug.",-50.25,0.2,Chemical
"Intravenous administration of pentamidine in patients with Pneumocystis pneumonia can precipitate acute renal failure, a complication that is mitigated by concurrent use of bisphosphonates to reduce nephrotoxic inflammation.",-28.25,0.2,Chemical
"Intraperitoneal administration of the potassium‑channel opener cromakalim markedly attenuated the ammonia‑induced neurotoxicity observed in the rat model of hepatic encephalopathy, suggesting a potential therapeutic role for this chemical in mitigating disease‑related metabolic derangements.",-28.0,0.2,Chemical
Intrathecal administration of cromakalim markedly attenuated the hyperalgesia induced by intraperitoneal pentamidine in a rat model of chemotherapy‑associated neuropathy.,-26.625,0.2,Chemical
"A randomized trial demonstrated that chronic administration of the potassium channel opener cromakalim significantly reduced the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic breast cancer, while concomitant use of the antiprotozoal agent pentamidine was associated with a dose‑dependent elevation of serum ammonia levels.",-35.5,0.2,Chemical
"A bisphosphonate such as alendronate can reduce osteoclast activity in osteoporosis, but its long‑term use may cause atypical femoral fractures and hypocalcemia, especially when combined with vitamin D deficiency.",-35.0,0.2,Chemical
"A recent study demonstrated that chronic exposure to the potassium channel opener cromakalim exacerbated ammonia‑induced hepatic encephalopathy in a rat model, suggesting a potential adverse interaction between this chemical and metabolic disease.",-26.625,0.2,Chemical
5-fluorouracil/folinic acid therapy for colorectal carcinoma was found to markedly reduce tumor burden while concurrently inducing a dose‑dependent rise in circulating granulocyte colony‑stimulating factor levels.,-28.625,0.2,Chemical
"5-hydroxyindoleacetic acid administration markedly reduced the severity of haloperidol‑induced extrapyramidal symptoms in patients with schizophrenia, suggesting a protective serotonergic mechanism.",-21.875,0.2,Chemical
"5‑fluorouracil/folinic acid therapy markedly reduced tumor burden in patients with metastatic colorectal cancer, yet the regimen was associated with severe myelosuppression that required granulocyte colony‑stimulating factor support.",-22.0,0.2,Chemical
The heparin-dependent anticoagulant GR‑55562 was found to markedly reduce the risk of thrombosis in patients with acute promyelocytic leukemia undergoing all‑trans‑retinoic acid therapy.,-21.125,0.2,Chemical
"The therapeutic efficacy of the novel GR‑55562 analogue was markedly enhanced in patients with heparin‑dependent thrombocytopenia, yet the drug’s serotonergic antidepressant‑like side effects were mitigated by concurrent administration of granulocyte colony‑stimulating factor.",-31.5,0.2,Chemical
"The granulocyte colony‑stimulating factor therapy markedly reduced neutropenia in patients receiving the chemotherapeutic regimen of cisplatin and etoposide, yet the concomitant use of the serotonergic antidepressant sertraline was associated with an unexpected increase in serotonin syndrome symptoms.",-42.0,0.2,Chemical
"Heparin-dependent thrombocytopenia was markedly exacerbated in patients receiving the novel anticoagulant GR‑55562, prompting a switch to granulocyte colony‑stimulating factor‑supported therapy.",-23.625,0.2,Chemical
"Heptaminol, a sympathomimetic drug, was found to mitigate the heparin-dependent bleeding complications observed in patients receiving high‑dose granulocyte colony‑stimulating factor therapy.",-35.0,0.2,Chemical
"He was treated with the novel chemotherapeutic agent GR‑55562, which selectively inhibited the proliferation of malignant lymphoma cells while sparing normal lymphocytes, thereby reducing the risk of heparin‑dependent thrombocytopenia that had previously complicated his chemotherapy regimen.",-39.25,0.2,Chemical
"Cyclophosphamide‑induced cystitis was markedly attenuated in rats pretreated with granulocyte colony‑stimulating factor, illustrating the drug’s protective effect against the urothelial toxicity of the chemotherapeutic agent.",-26.375,0.2,Chemical
"Cyclin‑dependent kinase inhibitor GR‑55562, when administered to patients with metastatic melanoma, markedly reduced tumor‑induced angiogenesis but also precipitated a dose‑dependent rise in serum creatinine, suggesting a nephrotoxic side effect that warrants careful monitoring.",-45.75,0.2,Chemical
"Cyclooxygenase inhibition by the selective COX‑2 inhibitor celecoxib reduces the risk of colorectal adenoma recurrence in patients with familial adenomatous polyposis, yet the drug’s heparin‑dependent platelet activation profile necessitates careful monitoring for thrombocytopenia.",-37.75,0.2,Chemical
"High‑dose granulocyte colony‑stimulating factor administration markedly accelerated neutrophil recovery in patients with acute myeloid leukemia undergoing induction chemotherapy with the combination of cytarabine and daunorubicin, yet the therapy was associated with a transient elevation of serum lactate dehydrogenase and mild, reversible thrombocytopenia.",-49.0,0.2,Chemical
"High-dose granulocyte colony‑stimulating factor therapy markedly accelerated neutrophil recovery in patients with chemotherapy‑induced neutropenia, yet the concomitant use of the serotonergic antidepressant fluoxetine was associated with an increased incidence of serotonin syndrome.",-25.875,0.2,Chemical
"High‐dose granulocyte colony‑stimulating factor administration markedly accelerated neutrophil recovery in patients with acute myeloid leukemia undergoing induction chemotherapy with the FLT3 inhibitor GR‑55562, yet the concomitant use of serotonergic antidepressants appeared to blunt the drug’s efficacy by inducing a heparin‑dependent platelet aggregation pathway.",-49.0,0.2,Chemical
"Fentanyl’s potent opioid activity can exacerbate heparin‑dependent thrombocytopenia, yet the concomitant use of granulocyte colony‑stimulating factor mitigates the platelet drop in patients receiving high‑dose heparin therapy.",-34.25,0.2,Chemical
"Fetal exposure to the chemotherapeutic agent GR‑55562 during the first trimester has been associated with a transient elevation of serum levels of the neurotoxic metabolite, the serotonin‑derived compound, **5‑hydroxyindoleacetic acid**, which may contribute to the observed neurodevelopmental deficits in the offspring.",-76.5,0.2,Chemical
"Fertilization of the tumor cells with the novel GR‑55562 analogue markedly reduced the proliferation of the malignant lymphoma, while the concomitant administration of heparin‑dependent granulocyte colony‑stimulating factor mitigated the neutropenia that typically follows high‑dose chemotherapy.",-50.25,0.2,Chemical
"Flucloxacillin therapy for methicillin‑resistant Staphylococcus aureus pneumonia was found to reduce serum levels of the neurotoxic metabolite HAL, thereby mitigating the risk of heparin‑dependent thrombocytopenia in patients receiving granulocyte colony‑stimulating factor.",-38.75,0.2,Chemical
"Fluorouracil/folinic acid therapy for colorectal carcinoma can provoke severe mucositis, a complication that is mitigated by concurrent administration of granulocyte colony‑stimulating factor.",-21.625,0.2,Chemical
"Flestolol‑induced hypertension was markedly attenuated in patients receiving the selective β‑blocker GR‑55562, illustrating the drug’s capacity to counteract the vasoconstrictive effects of the sympathomimetic agent.",-30.625,0.2,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent heparin‑dependent supplementation of granulocyte colony‑stimulating factor to preserve renal function.",-23.75,0.2,Chemical
"Clozapine, a serotonergic antidepressant, was found to inhibit the proliferation of lymphoma cells while simultaneously reducing the production of the inflammatory mediator granulocyte colony‑stimulating factor.",-37.25,0.2,Chemical
"Cortisol‑suppressive therapy with GR‑55562 markedly reduced the heparin‑dependent platelet aggregation observed in patients with thrombocytopenia, thereby mitigating the risk of heparin‑induced thrombocytopenia.",-38.0,0.2,Chemical
"Haloperidol administration in patients with schizophrenia can precipitate serotonin syndrome when combined with serotonergic antidepressants, a reaction that is exacerbated by the presence of high plasma levels of the metabolite, the hydroxyindole derivative.",-54.0,0.2,Chemical
"Halobenzene, a halogenated aromatic compound, has been shown to inhibit the activity of granulocyte colony‑stimulating factor in vitro, suggesting a potential therapeutic role for halogenated drugs in modulating inflammatory responses.",-30.625,0.2,Chemical
"Halofantrine administration in patients with malaria has been shown to inhibit the CYP3A4-mediated metabolism of the serotonergic antidepressant fluoxetine, thereby increasing the risk of serotonin syndrome.",-26.25,0.2,Chemical
"Administration of the novel chemotherapeutic agent GR‑55562 to patients with metastatic colorectal cancer resulted in a marked reduction of tumor burden, yet the drug’s heparin‑dependent anticoagulant activity precipitated a dose‑dependent rise in bleeding complications.",-35.5,0.2,Chemical
"Administration with the novel chemotherapeutic agent GR‑55562 markedly reduced tumor burden in patients with metastatic colorectal cancer, yet the treatment was complicated by a heparin‑dependent thrombocytopenia that necessitated dose adjustment.",-41.75,0.2,Chemical
"Administration high‑dose heparin‑dependent anticoagulation in patients with acute coronary syndrome can precipitate heparin‑induced thrombocytopenia, a severe adverse effect that requires immediate discontinuation of the drug.",-44.75,0.2,Chemical
"Drug‑induced thrombocytopenia was observed in patients receiving the heparin‑dependent anticoagulant HAL, where the platelet count fell precipitously within hours of the first dose.",-30.375,0.2,Chemical
"Drug–induced thrombocytopenia was observed in a patient receiving heparin‑dependent granulocyte colony‑stimulating factor therapy, where the platelet count fell precipitously after the first dose of the heparin‑dependent agent.",-33.5,0.2,Chemical
"Drug‐induced thrombocytopenia was observed in patients receiving heparin‐dependent granulocyte colony‑stimulating factor therapy, and the platelet count was markedly reduced after administration of the serotonergic antidepressant GR‑55562.",-35.0,0.2,Chemical
"In patients receiving the novel chemotherapeutic agent GR‑55562, a significant reduction in tumor‑induced pain was observed, yet a subset developed heparin‑dependent thrombocytopenia that required prompt discontinuation of the drug.",-28.25,0.2,Chemical
"In the study, heparin-dependent thrombocytopenia was markedly exacerbated by the administration of the novel anticoagulant GR‑55562, illustrating a severe adverse interaction between the drug and the patient’s underlying coagulation disorder.",-35.0,0.2,Chemical
"In severe cases of heparin-dependent thrombocytopenia, the administration of granulocyte colony‑stimulating factor has been shown to mitigate platelet consumption and improve patient outcomes.",-25.375,0.2,Chemical
"Clinical trials of the novel N10‑propargyl‑5,8‑dideazafolic acid revealed that its inhibition of dihydrofolate reductase markedly reduced tumor cell proliferation while simultaneously lowering the incidence of cisplatin‑induced nephrotoxicity in patients with advanced ovarian cancer.",-28.25,0.2,Chemical
"Clinical administration of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced tumor‑induced oxidative stress and improved survival in a murine model of pancreatic carcinoma, whereas concurrent exposure to peroxides exacerbated hepatic injury.",-28.875,0.2,Chemical
"Clinical data indicate that N10‑propargyl‑5,8‑dideazafolic acid, a folate analogue, can inhibit the proliferation of malignant lymphoma cells while simultaneously reducing the oxidative stress induced by peroxides, thereby offering a dual therapeutic strategy for patients with aggressive lymphoma.",-33.75,0.2,Chemical
"Administration of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced tumor‑induced oxidative stress in a murine model of pancreatic carcinoma, whereas concurrent exposure to peroxides exacerbated the drug’s hepatotoxicity.",-24.125,0.2,Chemical
"Administration cycle of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced tumor‑induced oxidative stress in a murine model of pancreatic carcinoma, whereas concurrent exposure to peroxides amplified the drug’s cytotoxicity and induced acute liver injury.",-52.75,0.2,Chemical
"Administration with the novel N10‑propargyl‑5,8‑dideazafolic acid markedly reduced tumor‑induced oxidative stress and improved survival in a murine model of pancreatic carcinoma, suggesting a potential therapeutic role for this compound in cancer treatment.",-40.0,0.2,Chemical
"N10‑propargyl‑5,8‑dideazafolic acid, a folate analogue, was shown to inhibit the proliferation of malignant lymphoma cells, whereas the concomitant use of the peroxidic drug scoline exacerbated oxidative DNA damage in the same cell line.",-31.5,0.2,Chemical
"Nasal administration of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced the tumor‑induced elevation of cyclic adenosine monophosphate in a murine model of lymphoma, suggesting a potential therapeutic pathway for this disease.",-26.75,0.2,Chemical
"Nitrate‑induced oxidative stress in the myocardium was mitigated by the cyclic adenosine monophosphate‑enhancing drug N10‑propargyl‑5,8‑dideazafolic acid, which also reduced the incidence of arrhythmias in patients with ischemic heart disease.",-32.5,0.2,Chemical
"Clozapine, a second‑generation antipsychotic, has been shown to reduce cyclic adenosine monophosphate levels in the prefrontal cortex of patients with schizophrenia, thereby attenuating the neurochemical dysregulation associated with the disease.",-22.125,0.2,Chemical
"Cocaine‑related neurotoxicity is markedly attenuated by the cyclic adenosine monophosphate‑enhancing agent N10‑propargyl‑5,8‑dideazafolic acid, which reduces oxidative stress and limits neuronal apoptosis in the substantia nigra.",-22.75,0.2,Chemical
"Coxsackievirus B3 infection induces a marked increase in cyclic adenosine monophosphate levels, and the antiviral compound N10‑propargyl‑5,8‑dideazafolic acid effectively suppresses viral replication by competitively inhibiting viral RNA polymerase.",-27.875,0.2,Chemical
"Acyclovir administration markedly reduced the viral load in patients with herpes simplex encephalitis, thereby preventing the development of secondary cerebral edema and improving neurological outcomes.",-24.875,0.2,Chemical
"A N10‑propargyl‑5,8‑dideazafolic acid analogue was shown to inhibit the proliferation of malignant lymphoma cells by elevating intracellular cyclic adenosine monophosphate levels, thereby suggesting a potential therapeutic role for this chemical in treating the disease.",-29.25,0.2,Chemical
"A high‑dose infusion of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced the tumor‑induced elevation of cyclic adenosine monophosphate in a murine model of lymphoma, suggesting a potential therapeutic synergy with standard chemotherapy.",-26.125,0.2,Chemical
"The chronic administration of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced tumor‑induced oxidative stress in a murine model of pancreatic carcinoma, while simultaneously lowering the incidence of chemotherapy‑induced peripheral neuropathy.",-28.375,0.2,Chemical
"The administration of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced the proliferation of malignant lymphoma cells, suggesting a potential therapeutic role for this novel chemical in treating aggressive forms of the disease.",-21.625,0.2,Chemical
"The N10‑propargyl‑5,8‑dideazafolic acid analogue was found to inhibit cyclic adenosine monophosphate‑dependent protein kinase activity in a model of neuro‑inflammation, thereby reducing the severity of experimental autoimmune encephalomyelitis.",-22.625,0.2,Chemical
"High‑dose N10‑propargyl‑5,8‑dideazafolic acid administration in patients with acute myeloid leukemia markedly reduced leukemic blast proliferation while simultaneously lowering serum cyclic adenosine monophosphate levels, thereby suggesting a dual therapeutic and metabolic modulatory effect.",-28.125,0.2,Chemical
"High-dose N10‑propargyl‑5,8‑dideazafolic acid administration in patients with acute lymphoblastic leukemia markedly reduced leukemic cell proliferation while concurrently lowering serum cyclic adenosine monophosphate levels, thereby suggesting a dual therapeutic effect on both disease progression and intracellular signaling pathways.",-34.5,0.2,Chemical
"High concentrations of the synthetic analogue N10‑propargyl‑5,8‑dideazafolic acid were found to inhibit the proliferation of malignant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating certain cancers.",-25.875,0.2,Chemical
"In patients with neuroendocrine tumors, the cyclic adenosine monophosphate analogue N10‑propargyl‑5,8‑dideazafolic acid has been shown to inhibit tumor‑derived VEGF secretion, thereby reducing angiogenesis and tumor growth.",-18.625,0.2,Chemical
"In murine models of Parkinson’s disease, intraperitoneal administration of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced dopaminergic neuron loss, suggesting a neuroprotective effect that may complement standard levodopa therapy.",-25.125,0.2,Chemical
"Inhibition of cyclic adenosine monophosphate production by N10‑propargyl‑5,8‑dideazafolic acid exacerbates neurotoxicity in patients with neuroendocrine tumors, suggesting that concurrent use of this chemical may worsen disease progression.",-28.375,0.2,Chemical
"Dex-only administration of N10-propargyl-5,8-dideazafolic acid markedly reduced cyclic adenosine monophosphate levels in patients with neuroendocrine tumors, thereby attenuating tumor‑induced hypertension.",-23.75,0.2,Chemical
"Dex‑only administration of N10‑propargyl‑5,8‑dideazafolic acid markedly reduced the incidence of scopolamine‑induced amnesia in rats, suggesting a protective effect against the cognitive deficits associated with cyclic adenosine monophosphate‑mediated neurotransmission.",-29.875,0.2,Chemical
"Dexonly administration in patients with neuroendocrine tumors markedly reduced cyclic adenosine monophosphate levels, thereby attenuating tumor‑derived catecholamine secretion and improving hypertension control.",-30.125,0.2,Chemical
"Combustion of peroxides in the presence of N10‑propargyl‑5,8‑dideazafolic acid generates a reactive intermediate that can inhibit cyclic adenosine monophosphate‑dependent signaling pathways implicated in neurodegenerative disease.",-28.75,0.2,Chemical
"Combining the cyclic adenosine monophosphate analogue N10‑propargyl‑5,8‑dideazafolic acid with the opioid antagonist Naloxazone markedly reduced tumor‑induced pain in a murine model of metastatic breast cancer, suggesting a potential therapeutic synergy that warrants further investigation.",-28.375,0.2,Chemical
"Combating the neurotoxic effects of scopolamine-induced amnesia, the study demonstrated that pre‑ and post‑training administration of the opioid antagonist naloxazone significantly restored passive avoidance memory in rats.",-36.5,0.2,Chemical
"Chronic administration of the synthetic cyclic adenosine monophosphate analogue N10‑propargyl‑5,8‑dideazafolic acid has been shown to ameliorate the hyperglycemic phenotype of type‑2 diabetes in db/db mice, yet it also induces mild hepatotoxicity that can be mitigated by concurrent treatment with the antioxidant peroxides scavenger, thereby illustrating a dual therapeutic–adverse effect profile.",-47.25,0.2,Chemical
"Chlorambucil, a nitrogen mustard alkylating agent, was found to inhibit the proliferation of malignant lymphoma cells by inducing DNA cross‑linking and subsequent apoptosis, thereby providing a therapeutic benefit in patients with refractory disease.",-35.5,0.2,Chemical
"Cholinergic agonist scoline exacerbated seizures in patients with epilepsy, but co‑administration of the N10‑propargyl‑5,8‑dideazafolic acid derivative reduced the incidence of status epilepticus.",-31.5,0.2,Chemical
"Peroxides, when administered in high concentrations, can exacerbate the oxidative stress associated with neurodegenerative disease, whereas cyclic adenosine monophosphate signaling has been shown to mitigate this effect by upregulating antioxidant enzymes.",-31.25,0.2,Chemical
"Perxipine, a novel cyclic adenosine monophosphate analogue, was shown to inhibit the proliferation of malignant glioma cells while simultaneously reducing the risk of chemotherapy‑induced peripheral neuropathy in patients receiving cisplatin.",-38.25,0.2,Chemical
"Per‑oxides, such as hydrogen peroxide, can oxidatively inactivate the cyclic adenosine monophosphate‑dependent protein kinase in neuronal cells, thereby exacerbating neurodegenerative disease progression.",-35.75,0.2,Chemical
"A patient with chronic obstructive pulmonary disease was prescribed TMP‑SMZ, but the drug’s beta‑lactam component triggered a severe rash that required discontinuation and substitution with milrinone to manage the exacerbation.",-30.25,0.2,Chemical
"A retrospective analysis revealed that patients with chronic obstructive pulmonary disease receiving TMP‑SMZ for bacterial pneumonia experienced a significant reduction in exacerbation frequency, yet the drug’s propensity to induce hyperkalemia was markedly higher in those concurrently treated with lisinopril.",-33.5,0.2,Chemical
"A randomized trial demonstrated that TMP‑SMZ prophylaxis reduced the incidence of *Pseudomonas aeruginosa* bacteremia in neutropenic patients, whereas the addition of propylthio‑uracil to the regimen significantly increased the risk of hepatotoxicity.",-28.375,0.2,Chemical
"The use of TMP‑SMZ for prophylaxis in patients with HIV‑associated Pneumocystis pneumonia reduces the incidence of opportunistic infections but can precipitate acute interstitial nephritis, a complication that may be mitigated by early discontinuation and substitution with a beta‑lactam antibiotic.",-30.125,0.2,Chemical
"The clinical trial demonstrated that TMP‑SMZ, a beta‑lactam combination, effectively reduced the incidence of nosocomial pneumonia in patients with cystic fibrosis, while concomitant aspirin therapy mitigated the drug‑induced platelet aggregation observed in a subset of participants.",-29.125,0.2,Chemical
"The prescription of TMP‑SMZ for a patient with cystic fibrosis exacerbation was complicated by a severe rash, prompting the clinician to switch to a beta‑lactam antibiotic while monitoring for potential drug‑drug interactions with the patient’s ongoing aspirin therapy.",-34.25,0.2,Chemical
"Cotrimoxazole, a combination of trimethoprim and sulfamethoxazole, effectively treats urinary tract infections but can precipitate Stevens–Johnson syndrome in patients with a history of severe cutaneous adverse reactions.",-13.8125,0.2,Chemical
"Corticosteroid‑induced osteoporosis is mitigated by daily administration of bisphosphonate, yet concomitant use of the beta‑lactam antibiotic TMP‑SMZ can exacerbate bone resorption through inhibition of osteoblast proliferation.",-31.5,0.2,Chemical
"Cimetidine administration markedly reduced the incidence of TMP‑SMZ‑induced nephrotoxicity in patients with chronic kidney disease, thereby improving tolerability of the beta‑lactam antibiotic regimen.",-22.875,0.2,Chemical
"Patients treated with the beta‑lactam antibiotic TMP‑SMZ experienced a marked reduction in the incidence of acute pyelonephritis, yet the drug’s propensity to induce hemolytic anemia was observed in a subset of individuals with G6PD deficiency.",-31.625,0.2,Chemical
"Patients receiving TMP‑SMZ for Pneumocystis pneumonia often develop a mild rash that is alleviated by discontinuation of the drug, illustrating the drug’s adverse effect profile.",-27.0,0.2,Chemical
"Patients with cystic fibrosis receiving TMP‑SMZ prophylaxis exhibit a higher incidence of hepatotoxicity, likely due to the drug’s inhibition of hepatic glutathione synthesis and subsequent oxidative stress.",-27.875,0.2,Chemical
"In patients with cystic fibrosis, the combination of TMP‑SMZ and propylthio‑uracil has been shown to reduce pulmonary exacerbations by inhibiting bacterial biofilm formation.",-16.5,0.2,Chemical
Inhibiting the synthesis of PGI2 with aspirin exacerbates the risk of gastric ulcer in patients concurrently treated with the beta‑lactam antibiotic TMP‑SMZ.,-27.0,0.2,Chemical
"In the study, TMP‑SMZ was found to reduce the incidence of *Pseudomonas aeruginosa* infection in cystic fibrosis patients, while propylthio‑uracil was shown to inhibit the same pathogen’s biofilm formation.",-30.5,0.2,Chemical
"Intravenous administration of TMP‑SMZ markedly reduced the bacterial load in the patient’s septicemic lymphoma, yet the concomitant use of aspirin exacerbated the risk of gastrointestinal bleeding.",-27.0,0.2,Chemical
"Intraperitoneal injection of TMP‑SMZ at a dose of five milligrams per kilogram markedly reduced the bacterial burden in a murine model of septic peritonitis, while concomitant administration of the beta‑lactam antibiotic ceftriaxone prevented the emergence of resistant strains.",-45.75,0.2,Chemical
"Intrathecal administration of TMP‑SMZ markedly reduced the incidence of meningitis in patients with neutropenia, whereas concomitant use of propylthio‑uracil was associated with a higher rate of hepatotoxicity.",-34.75,0.2,Chemical
"Administering TMP‑SMZ to patients with cystic fibrosis reduces pulmonary exacerbations but can precipitate hyperkalemia, especially when combined with Lisinopril, which further impairs renal potassium excretion.",-26.375,0.2,Chemical
"Adminstration of TMP‑SMZ markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus bacteremia in patients with cystic fibrosis, yet the drug’s propensity to induce hyperkalemia and acute interstitial nephritis remains a significant clinical concern.",-40.0,0.2,Chemical
"Admininistration of TMP‑SMZ markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus bacteremia in patients with cystic fibrosis, but concomitant use of propylthio‑uracil was associated with a higher rate of acute interstitial nephritis.",-41.5,0.2,Chemical
"Pre‑treatment with the beta‑lactam antibiotic cotrimoxazole markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, while concomitant aspirin therapy mitigated the drug‑induced platelet aggregation observed in the same cohort.",-29.25,0.2,Chemical
"Preoperative administration of the beta‑lactam antibiotic TMP‑SMZ markedly reduced the incidence of postoperative urinary tract infections in patients undergoing laparoscopic cholecystectomy, while the concomitant use of aspirin for thromboprophylaxis did not increase the risk of postoperative bleeding.",-31.25,0.2,Chemical
"Pre-emptive administration of TMP‑SMZ markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, while concomitant use of the beta‑lactam antibiotic cefepime mitigated the risk of drug‑induced nephrotoxicity.",-36.75,0.2,Chemical
"High‑dose TMP‑SMZ therapy in patients with cystic fibrosis can precipitate acute interstitial nephritis, a complication that is mitigated by early discontinuation and substitution with a beta‑lactam antibiotic.",-24.125,0.2,Chemical
"High-dose TMP‑SMZ therapy in patients with cystic fibrosis can precipitate hyperkalemia, a known adverse effect of the drug’s beta‑lactam component.",-22.625,0.2,Chemical
"High doses of TMP‑SMZ have been shown to induce acute interstitial nephritis, a complication that can be mitigated by early discontinuation of the drug and initiation of corticosteroid therapy.",-23.0,0.2,Chemical
"Propylthio‑uracil, a novel beta‑lactam derivative, was shown to inhibit the growth of methicillin‑resistant Staphylococcus aureus in vitro, suggesting a potential therapeutic role for TMP‑SMZ‑resistant infections.",-22.125,0.2,Chemical
"Propagating the inflammatory cascade in sepsis, the beta‑lactam antibiotic ceftriaxone reduces endotoxin‑induced lipopolysaccharide release while simultaneously lowering the risk of aspirin‑associated gastrointestinal bleeding in patients with acute coronary syndrome.",-38.75,0.2,Chemical
"Propoxyphene administration in patients with chronic obstructive pulmonary disease exacerbated by aspirin-induced gastric ulceration, prompting a switch to low‑dose Lisinopril to mitigate renal impairment.",-37.0,0.2,Chemical
"TMP‑SMZ, a beta‑lactam combination, effectively treats urinary tract infections but can precipitate acute interstitial nephritis, a serious adverse effect that requires prompt discontinuation of the drug.",-25.0,0.2,Chemical
"TMP-SMZ treatment of a patient with cystic fibrosis exacerbation was complicated by a severe hypersensitivity reaction that manifested as Stevens–Johnson syndrome, prompting immediate discontinuation of the drug and initiation of high‑dose methylprednisolone.",-32.25,0.2,Chemical
"TMP‐SMZ therapy in patients with cystic fibrosis can reduce pulmonary exacerbations but may induce a dose‑dependent rise in serum creatinine, highlighting the need for renal monitoring during treatment.",-33.5,0.2,Chemical
"Treatment of methicillin‑resistant Staphylococcus aureus pneumonia with a high‑dose regimen of TMP‑SMZ markedly reduced bacterial load, yet the patient developed a severe rash and acute interstitial nephritis, illustrating the delicate balance between antimicrobial efficacy and drug‑induced renal toxicity.",-33.5,0.2,Chemical
"Treatment with the beta‑lactam antibiotic TMP‑SMZ markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated sepsis in patients with acute lymphoblastic leukemia, yet the drug’s propensity to induce hemolytic anemia was mitigated by concurrent administration of the antioxidant propylthio‑uracil.",-33.75,0.2,Chemical
"Treatment failure in a patient with cystic fibrosis was attributed to the interaction between the beta‑lactam antibiotic ceftriaxone and the concomitant use of the diuretic furosemide, which increased the drug’s renal clearance and reduced its therapeutic efficacy.",-36.0,0.2,Chemical
"In patients with acute ischemic stroke, the intravenous administration of diatrizoate as a contrast agent can exacerbate cerebral edema, whereas concurrent treatment with pralidoxime‑2‑chloride may mitigate the neurotoxic effects of the contrast medium.",-27.75,0.2,Chemical
"In hypertensive patients receiving renografin, the contrast agent’s iodine content can precipitate acute renal failure, especially when combined with high-dose doxorubicin, thereby necessitating careful monitoring of serum creatinine and calcium levels.",-33.75,0.2,Chemical
"In vitro exposure of NaCl‑treated renal epithelial cells to the contrast agent diatrizoate induced a dose‑dependent upregulation of oxidative stress markers, suggesting that the chemical may exacerbate nephrotoxicity in patients with pre‑existing renal disease.",-28.75,0.2,Chemical
"Co-administration of diatrizoate with doxorubicin/kg markedly amplified cardiotoxicity in the murine model, underscoring the need for careful dose adjustment when treating patients with concurrent contrast media exposure.",-30.75,0.2,Chemical
"Co‑administration of diatrizoate with doxorubicin/kg markedly potentiated cardiotoxicity, prompting the use of pralidoxime‑2‑chloride as a protective antidote in the experimental model.",-27.0,0.2,Chemical
"Coadministration of the contrast agent diatrizoate with the chemotherapeutic agent doxorubicin/kg markedly increased cardiotoxicity in the murine model of breast cancer, suggesting that the radiographic contrast exacerbates doxorubicin-induced oxidative myocardial injury.",-35.0,0.2,Chemical
"High‑dose diatrizoate administration in patients with acute renal failure exacerbated nephrotoxicity, while concurrent calcium supplementation mitigated the resulting electrolyte imbalance.",-21.0,0.2,Chemical
"High-dose diatrizoate administration in patients with chronic kidney disease can precipitate contrast-induced nephropathy, whereas concurrent calcium supplementation mitigates this adverse effect.",-21.125,0.2,Chemical
"High‐dose diatrizoate administration in patients with acute renal failure exacerbates nephrotoxicity, whereas concurrent calcium supplementation mitigates the contrast‑induced tubular injury.",-23.875,0.2,Chemical
"Diatrizoate administration in patients with chronic kidney disease exacerbates nephrotoxicity, whereas co‑treatment with the antioxidant maltol mitigates renal injury by scavenging reactive oxygen species.",-20.0,0.2,Chemical
"Diotrizoate administration markedly reduced the contrast‑enhanced imaging of renal calculi in patients with calcium‑stone nephrolithiasis, yet the subsequent rise in serum calcium levels prompted the use of pralidoxime‑2‑chloride to mitigate potential nephrotoxic effects.",-45.75,0.2,Chemical
"Diarrhea and abdominal pain were markedly reduced in patients with ulcerative colitis after treatment with the contrast agent diatrizoate, which also lowered serum calcium levels and mitigated the nephrotoxic effects of doxorubicin/kg.",-34.25,0.2,Chemical
"The antihypertensive effect of renografin was observed to be potentiated by co‑administration of pentoxyifylline, which also reduced the drug‑induced nephrotoxicity in the rat model.",-27.625,0.2,Chemical
"The intravenous administration of diatrizoate during renal imaging was found to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas concurrent treatment with the antioxidant maltol markedly reduced the incidence of contrast‑induced acute tubular necrosis.",-25.5,0.2,Chemical
The administration of diatrizoate during renal imaging was found to exacerbate contrast-induced nephropathy in patients with pre‑existing chronic kidney disease.,-13.125,0.2,Chemical
"Doxorubicin, when administered at a dose of doxorubicin/kg, induces dose‑dependent cardiotoxicity that can be mitigated by pretreatment with the antioxidant maltol, which scavenges reactive oxygen species generated during anthracycline metabolism.",-23.0,0.2,Chemical
"Diatom‑derived diatrizoate, when administered intravenously, can precipitate contrast‑induced nephropathy in patients with pre‑existing chronic kidney disease, whereas co‑administration of the antioxidant maltol mitigates this renal injury by scavenging reactive oxygen species.",-33.25,0.2,Chemical
Dexamethasone administration in patients with acute lymphoblastic leukemia markedly reduces the incidence of doxorubicin‑induced cardiotoxicity while preserving the drug’s antitumor efficacy.,-23.875,0.2,Chemical
"Intravenous diatrizoate administration in patients with acute renal failure exacerbated nephrotoxicity, whereas concurrent calcium supplementation mitigated the contrast‑induced tubular injury.",-19.875,0.2,Chemical
"Intraperitoneal injection of diatrizoate in NaCl‑treated mice exacerbated isoprenaline‑induced arrhythmias, suggesting that the contrast agent may potentiate cardiac toxicity in hypernatremic conditions.",-20.375,0.2,Chemical
"Intranasal administration of diatrizoate markedly reduced the severity of isoprenaline‑induced arrhythmias in rats, suggesting a protective effect of this contrast agent on cardiac electrophysiology.",-23.75,0.2,Chemical
"Pentoxyifylline administration markedly reduced isoprenaline‑induced hypertension in rats, suggesting a protective cardiovascular effect of this chemical compound.",-19.75,0.2,Chemical
"Pentoxifylline administration mitigated isoprenaline‑induced hypertension in rats, while diatrizoate contrast exposure concurrently exacerbated renal tubular injury.",-23.875,0.2,Chemical
"Pentylpyrazole, a synthetic analogue of pentoxyifylline, was shown to ameliorate isoprenaline‑induced myocardial hypertrophy in rats, while simultaneously reducing the diatrizoate‑induced nephrotoxicity that typically accompanies high‑dose contrast media administration.",-42.5,0.2,Chemical
"Administering pralidoxime‑2‑chloride to patients with organophosphate poisoning markedly reduces the duration of cholinergic crisis, thereby preventing the fatal respiratory failure that can accompany severe acetylcholinesterase inhibition.",-26.125,0.2,Chemical
"Adminstration of diatrizoate during renal imaging was found to transiently elevate serum calcium levels, potentially exacerbating hypercalcemia in patients with underlying renal insufficiency.",-30.25,0.2,Chemical
"Administation of diatrizoate in patients with acute renal failure exacerbated their electrolyte imbalance, prompting the use of calcium supplementation to mitigate the risk of arrhythmia.",-33.0,0.2,Chemical
"Radiographic contrast agent diatrizoate exacerbated renal impairment in patients receiving doxorubicin, prompting clinicians to consider calcium supplementation to mitigate nephrotoxicity.",-20.25,0.2,Chemical
"Radiation‑contrast agent diatrizoate exacerbated nephrotoxicity in patients receiving doxorubicin, prompting the use of calcium‑based chelators to mitigate renal damage.",-22.375,0.2,Chemical
"Radiocontrast agent diatrizoate exacerbated nephrotoxicity in patients receiving doxorubicin, prompting the use of calcium‑rich solutions to mitigate renal injury.",-23.75,0.2,Chemical
"Renografin, a diatrizoate contrast agent, was found to exacerbate nephrotoxicity in patients receiving doxorubicin/kg chemotherapy, prompting the use of calcium‑based protective agents to mitigate renal damage.",-24.75,0.2,Chemical
"Renogrin, a diatrizoate derivative, was shown to mitigate isoprenaline‑induced myocardial injury in rats, while co‑administration of pralidoxime‑2‑chloride reduced the cardiotoxicity of doxorubicin/kg.",-33.5,0.2,Chemical
"Renographin, a diatrizoate derivative, was shown to inhibit isoprenaline‑induced cardiac hypertrophy in a rat model of hypertension.",-29.25,0.2,Chemical
"Administration of diatrizoate during renal imaging was found to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas concurrent calcium supplementation mitigated the acute rise in serum creatinine.",-20.75,0.2,Chemical
"Administration and subsequent clearance of the iodinated contrast agent diatrizoate in patients with chronic kidney disease can precipitate contrast‑induced nephropathy, a complication that is mitigated by pre‑treatment with the antioxidant maltol.",-37.75,0.2,Chemical
"Administration with diatrizoate markedly reduced the contrast‑enhanced renal uptake of doxorubicin, thereby mitigating its nephrotoxic side effects in patients with pre‑existing chronic kidney disease.",-36.0,0.2,Chemical
"Administration of the dopamine agonist domperidone markedly reduced the severity of Parkinsonian tremor in patients with early-stage disease, while concomitant use of the selective serotonin antagonist ritanserin mitigated the drug‑induced nausea.",-23.125,0.2,Chemical
"Administration with the dopamine agonist domperidone markedly reduced the severity of Parkinsonian tremor in patients with early‑stage Parkinson’s disease, while concomitant use of the selective serotonin reuptake inhibitor ritanserin mitigated the drug‑induced nausea.",-40.0,0.2,Chemical
Administration and subsequent monitoring of domperidone in patients with Parkinson’s disease revealed a dose‑dependent reduction in levodopa‑induced dyskinesia while simultaneously increasing the risk of cardiac arrhythmias due to QT‑interval prolongation.,-40.25,0.2,Chemical
"Treatment with the dopamine agonist domperidone markedly reduced the severity of Parkinson’s disease motor symptoms while simultaneously lowering serum levodopa levels, thereby mitigating the risk of dyskinesia.",-20.0,0.2,Chemical
Treatment of Parkinson’s disease with the dopamine agonist domperidone has been shown to reduce levodopa‑induced dyskinesia while preserving motor function.,-13.125,0.2,Chemical
"Treatment using the dopamine agonist domperidone markedly reduced the severity of Parkinson’s disease motor symptoms while simultaneously lowering serum dopamine levels, thereby illustrating a dual therapeutic and biochemical effect.",-29.875,0.2,Chemical
Domperidone administration in patients with Parkinson’s disease reduces levodopa‑induced dyskinesia by blocking peripheral dopamine receptors while sparing central dopaminergic pathways.,-14.75,0.2,Chemical
"Dom_peridone, a dopamine agonist, was shown to ameliorate nausea in patients with chemotherapy‑induced emesis while simultaneously reducing the risk of serotonin‑mediated cardiotoxicity observed with high‑dose temazepam.",-40.25,0.2,Chemical
"Dompreidone, a dopamine agonist, was shown to ameliorate nausea in patients with chemotherapy‑induced emesis while concurrently reducing the risk of serotonin‑mediated cardiotoxicity associated with the use of the chemotherapeutic agent ACC‑9089.",-38.5,0.2,Chemical
"Dexmedetomidine administration in patients with acute ischemic stroke reduces the incidence of post‑stroke depression, whereas concomitant use of the dopamine agonist domperidone may exacerbate neuropsychiatric side effects.",-31.875,0.2,Chemical
"Dextran‑conjugated domperidone, a dopamine agonist, was shown to ameliorate chemotherapy‑induced nausea in patients with metastatic colorectal cancer while sparing the renal function that is often compromised by cisplatin.",-35.25,0.2,Chemical
"Dexanabinol, a synthetic cannabinoid, was shown to reduce tumor‑induced cachexia in a murine model of pancreatic carcinoma, thereby improving survival and mitigating the weight loss associated with the disease.",-36.25,0.2,Chemical
"The fluorescence of fluorescein sodium was markedly reduced in patients with renal failure, suggesting that impaired renal clearance may exacerbate the drug’s nephrotoxic potential.",-24.5,0.2,Chemical
"The dopamine agonist domperidone, when administered to patients with Parkinson’s disease, can exacerbate orthostatic hypotension and has been shown to inhibit the therapeutic effect of levodopa by competing for D2 receptors.",-24.75,0.2,Chemical
"The chemotherapeutic agent domperidone, while primarily used to treat nausea, has been observed to exacerbate the progression of Parkinson’s disease by inhibiting dopamine agonist signaling in the substantia nigra.",-25.75,0.2,Chemical
Administering domperidone to patients with Parkinsonian dyskinesia has been shown to reduce dopamine agonist‑induced nausea while sparing the therapeutic benefit of levodopa.,-20.25,0.2,Chemical
"Adminstration of the dopamine agonist domperidone markedly reduced the severity of Parkinsonian tremor in patients with early-stage Parkinson’s disease, while concomitant use of the selective serotonin receptor antagonist ritanserin mitigated the drug‑induced nausea.",-34.5,0.2,Chemical
"Administation of the dopamine agonist domperidone markedly reduced the severity of Parkinsonian tremor in patients with early-stage Parkinson disease, while concomitant use of the selective serotonin receptor antagonist ritanserin mitigated the drug‑induced nausea.",-33.5,0.2,Chemical
Chronic administration of the dopamine agonist domperidone in patients with Parkinson’s disease has been shown to reduce levodopa‑induced dyskinesia while occasionally precipitating orthostatic hypotension.,-18.0,0.2,Chemical
Chitosan-coated domperidone nanoparticles were shown to reduce the severity of ulcerative colitis in a murine model by selectively inhibiting pro‑inflammatory cytokine release.,-33.75,0.2,Chemical
"Chlorambucil administration in patients with acute lymphoblastic leukemia markedly reduces leukemic cell proliferation while concurrently inducing a dose‑dependent increase in neutropenia, thereby necessitating careful monitoring of white blood cell counts during therapy.",-38.25,0.2,Chemical
"Ramipril administration in patients with chronic kidney disease reduces proteinuria and improves glomerular filtration rate, thereby mitigating the progression of diabetic nephropathy.",-22.5,0.2,Chemical
"Ramification of domperidone therapy in patients with Parkinson’s disease was mitigated by the concomitant use of the dopamine agonist ropinirole, which reduced the incidence of nausea and vomiting associated with the drug.",-40.5,0.2,Chemical
"Ramelteon, a selective melatonin receptor agonist, was found to mitigate the hyperglycemic response induced by the dopamine agonist domperidone in patients with Parkinson’s disease, thereby reducing the risk of drug‑induced diabetes.",-36.5,0.2,Chemical
"In patients with Parkinson’s disease, the dopamine agonist domperidone has been shown to reduce levodopa‑induced dyskinesia while preserving motor function.",-11.9375,0.2,Chemical
"In a double‑blind trial, domperidone was shown to significantly reduce nausea in patients with chemotherapy‑induced emesis, while the concomitant use of the dopamine agonist levodopa exacerbated the risk of orthostatic hypotension.",-24.875,0.2,Chemical
"In the pilot study, domperidone administration markedly reduced nausea in patients with chemotherapy‑induced emesis, while a concurrent rise in dopamine levels suggested a potential interaction with the dopamine agonist ritanserin that may influence treatment efficacy.",-35.25,0.2,Chemical
"Long‑term administration of the dopamine agonist domperidone has been shown to alleviate nausea in Parkinson’s disease patients, yet it may exacerbate cardiac arrhythmias in those with underlying atrial fibrillation.",-20.375,0.2,Chemical
"Long-term administration of the dopamine agonist domperidone in patients with Parkinson’s disease has been associated with a paradoxical increase in levodopa-induced dyskinesia, suggesting that domperidone may inhibit the presynaptic reuptake of dopamine and thereby exacerbate motor complications.",-25.125,0.2,Chemical
"Long‐term administration of the dopamine agonist domperidone in patients with Parkinson’s disease has been associated with an increased risk of cardiac arrhythmias, prompting clinicians to monitor electrocardiographic parameters closely.",-23.625,0.2,Chemical
"Clinical evaluation revealed that domperidone, a dopamine agonist, effectively reduced nausea in patients with chemotherapy‑induced emesis, while ACC‑9089, a novel selective serotonin reuptake inhibitor, was associated with a mild increase in serum potassium levels.",-32.75,0.2,Chemical
"Clinical trials of the dopamine agonist domperidone have shown a significant reduction in the severity of Parkinsonian tremor, yet the drug’s long‑term use is associated with an increased risk of cardiac arrhythmias, particularly when combined with the potassium‑channel blocker E4031.",-33.5,0.2,Chemical
"Clinical investigations revealed that domperidone, a dopamine agonist, mitigated nausea in patients with chemotherapy‑induced emesis while concurrently reducing the risk of serotonin‑mediated cardiotoxicity associated with the concomitant use of the chemotherapeutic agent temazepam.",-34.5,0.2,Chemical
Pre‑treatment with the dopamine agonist domperidone markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.,-13.875,0.2,Chemical
Preclinical studies show that the dopamine agonist domperidone can ameliorate Parkinson’s disease motor deficits while simultaneously reducing the risk of levodopa‑induced dyskinesia.,-21.25,0.2,Chemical
"Preliminary data suggest that the dopamine agonist domperidone may reduce the incidence of chemotherapy‑induced nausea in patients with metastatic colorectal cancer, although its efficacy appears lower than that of the standard antiemetic temazepam.",-29.75,0.2,Chemical
"Azathioprine administration in patients with systemic lupus erythematosus reduces disease activity but may precipitate myelosuppression, a side effect mitigated by concurrent low‑dose methotrexate.",-28.75,0.2,Chemical
Azithromycin administration in patients with cystic fibrosis reduces pulmonary exacerbations but may precipitate hepatotoxicity through CYP3A4 inhibition.,-24.0,0.2,Chemical
"Azidothymidine administration in HIV‑positive patients with chronic hepatitis B has been shown to inhibit viral replication while simultaneously exacerbating hepatic steatosis, thereby necessitating careful monitoring of liver function during therapy.",-36.25,0.2,Chemical
"Mycophenolate mofetil administration markedly reduced the incidence of graft-versus-host disease in patients undergoing allogeneic stem‑cell transplantation, while concomitant efavirenz therapy was associated with a transient elevation of hepatic transaminases.",-23.75,0.2,Chemical
"Mycelial exposure to the antifungal mycophenolate mofetil markedly reduced the incidence of opportunistic fungal infections in patients with chronic lymphocytic leukemia, yet the drug’s immunosuppressive action also increased susceptibility to secondary bacterial pneumonia.",-38.25,0.2,Chemical
"Mycobacterial infection in the lungs was effectively treated with a combination of mycophenolate mofetil and efavirenz, which together suppressed viral replication and reduced inflammatory cytokine production.",-24.375,0.2,Chemical
High‑dose mycophenolate mofetil therapy in transplant recipients has been shown to reduce the incidence of post‑transplant lymphoproliferative disorder while simultaneously increasing the risk of opportunistic fungal infections.,-20.5,0.2,Chemical
High-dose mycophenolate mofetil therapy in transplant recipients was found to reduce the incidence of tacrolimus‑induced nephrotoxicity while simultaneously increasing the risk of opportunistic fungal infections.,-22.5,0.2,Chemical
"High doses of mycophenolate mofetil can aggravate nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas concomitant administration of carvedilol may mitigate the associated hypertension by blocking β‑adrenergic receptors.",-29.625,0.2,Chemical
"Preclinical studies show that mycophenolate mofetil reduces the incidence of graft-versus-host disease in patients receiving allogeneic stem‑cell transplantation, while concomitant efavirenz therapy may exacerbate neurotoxicity in those with pre‑existing hepatitis C infection.",-33.0,0.2,Chemical
"Pre‑treatment with mycophenolate mofetil markedly reduced the incidence of graft‑versus‑host disease in patients receiving allogeneic stem‑cell transplants, whereas concomitant efavirenz therapy was associated with a higher rate of hepatotoxicity.",-24.75,0.2,Chemical
"Pre-treatment with mycophenolate mofetil markedly reduced the incidence of graft-versus-host disease in patients receiving allogeneic stem‑cell transplantation, while concomitant efavirenz therapy was associated with a dose‑dependent elevation of hepatic transaminases.",-27.5,0.2,Chemical
"The barbiturate‑induced seizure activity in the patient was markedly attenuated by co‑administration of efavirenz, which competitively inhibits the hepatic CYP2B6‑mediated metabolism of the barbiturate.",-23.75,0.2,Chemical
"The pre‑operative administration of mycophenolate mofetil markedly reduced the incidence of graft‑versus‑host disease in patients undergoing allogeneic stem‑cell transplantation, while simultaneously lowering the risk of opportunistic fungal infections.",-24.0,0.2,Chemical
"The mycophenolate mofetil regimen markedly reduced the relapse rate of lupus nephritis, yet the patient developed a dose‑dependent myelosuppression that required temporary discontinuation of the drug.",-26.0,0.2,Chemical
"In a randomized trial, patients with chronic heart failure receiving carvedilol experienced a significant reduction in left ventricular remodeling, while concomitant administration of mycophenolate mofetil was associated with an increased incidence of opportunistic infections.",-22.25,0.2,Chemical
"In patients with chronic hepatitis C, efavirenz therapy has been shown to reduce hepatic fibrosis progression, yet it may also precipitate a paradoxical rise in serum alanine aminotransferase levels indicative of drug‑induced hepatotoxicity.",-30.125,0.2,Chemical
"In the study, mycophenolate mofetil was shown to reduce the incidence of graft-versus-host disease in patients with acute lymphoblastic leukemia, while concomitant efavirenz therapy was associated with increased hepatotoxicity.",-26.0,0.2,Chemical
"Efavirenz administration in HIV‑positive patients with chronic hepatitis C has been shown to exacerbate hepatic fibrosis, prompting clinicians to consider alternative antiretroviral regimens to mitigate liver injury.",-22.125,0.2,Chemical
"Efacetaminophen administration in patients with chronic hepatitis C infection exacerbates hepatic steatosis, whereas concurrent treatment with mycophenolate mofetil mitigates the drug‑induced liver injury.",-45.0,0.2,Chemical
"Ef‑avirenz administration in HIV‑positive patients with chronic hepatitis C has been associated with accelerated liver fibrosis, prompting clinicians to monitor alanine aminotransferase levels and consider switching to a non‑nevirapine‑based regimen.",-40.5,0.2,Chemical
Administration of mycophenolate mofetil in patients with systemic lupus erythematosus has been shown to reduce disease activity but can induce gastrointestinal toxicity that mimics norleucine‑induced enteropathy.,-23.875,0.2,Chemical
"Administration with mycophenolate mofetil markedly reduced the incidence of graft-versus-host disease in patients undergoing allogeneic stem‑cell transplantation, while concomitant exposure to the antiviral efavirenz was associated with a dose‑dependent elevation of hepatotoxicity markers.",-41.25,0.2,Chemical
"Administration regimen of mycophenolate mofetil markedly reduced the relapse rate in patients with systemic lupus erythematosus, yet concomitant exposure to the antiviral efavirenz was associated with a dose‑dependent elevation of hepatic transaminases.",-47.0,0.2,Chemical
"Persistent mycophenolate mofetil therapy in a patient with systemic lupus erythematosus was associated with a marked reduction in disease activity, yet the drug’s immunosuppressive effect also increased susceptibility to opportunistic fungal infections.",-31.5,0.2,Chemical
"Persistent inhibition of viral replication by efavirenz was observed in patients with HIV‑associated lymphoma, yet the drug’s neurotoxicity was exacerbated by concomitant use of mycophenolate mofetil.",-31.25,0.2,Chemical
"Persistent tumor growth in patients with metastatic melanoma was markedly reduced when the combination of mycophenolate mofetil and efavirenz was administered, suggesting a synergistic antitumor effect that may involve inhibition of nucleotide synthesis pathways.",-35.0,0.2,Chemical
"Treatment with mycophenolate mofetil reduced the incidence of graft-versus-host disease in patients who had undergone allogeneic stem‑cell transplantation, but the drug also caused a dose‑dependent suppression of thymidine kinase activity, leading to increased susceptibility to opportunistic infections.",-28.0,0.2,Chemical
Treatment of mycophenolate mofetil‑induced nephrotoxicity with the antioxidant N‑acetylcysteine reduced serum creatinine and improved renal histology in a cohort of kidney transplant recipients.,-22.75,0.2,Chemical
Treatment using mycophenolate mofetil markedly reduced the progression of lupus nephritis in patients who had previously experienced severe renal flare-ups.,-32.25,0.2,Chemical
"Efficacy of mycophenolate mofetil in preventing graft-versus-host disease was markedly reduced in patients who concurrently received efavirenz, suggesting a pharmacodynamic interaction that compromises immunosuppressive therapy.",-21.125,0.2,Chemical
"Epidemiological data indicate that long‑term exposure to efavirenz can precipitate neuropsychiatric complications, while concomitant administration of mycophenolate mofetil may mitigate the inflammatory response associated with HIV‑associated lymphoma.",-33.75,0.2,Chemical
"Eczema patients receiving carvedilol for hypertension experienced a significant reduction in pruritus, suggesting that the β‑blocker’s anti‑inflammatory properties may mitigate dermatologic symptoms.",-35.5,0.2,Chemical
Carvedilol administration in patients with heart failure has been shown to reduce the incidence of barbiturate‑induced hypotension during anesthesia.,-17.0,0.2,Chemical
"Carried out in a cohort of HIV‑positive patients, efavirenz was found to significantly reduce the incidence of drug‑induced hepatotoxicity that typically occurs with mycophenolate mofetil therapy.",-35.75,0.2,Chemical
"Carving a dose of mycophenolate mofetil to treat lupus nephritis, the patient’s serum creatinine rose, suggesting drug‑induced nephrotoxicity that required dose adjustment.",-35.25,0.2,Chemical
"The barium‑treated patient with acute pancreatitis experienced a marked reduction in pancreatic enzyme secretion after administration of magnesium sulfate, suggesting a potential therapeutic interaction between the mineral and the disease.",-25.75,0.2,Chemical
"The chemotherapeutic agent chlorambucil, when administered to patients with acute lymphoblastic leukemia, can induce severe neutropenia and increase the risk of opportunistic infections.",-18.0,0.2,Chemical
"The toxicological profile of barium‑treated patients revealed that chronic exposure to barium sulfate can precipitate hypercalcemia, a condition that may exacerbate underlying chronic kidney disease.",-29.375,0.2,Chemical
"Chlorambucil administration in patients with acute lymphoblastic leukemia markedly reduces leukemic cell burden but can precipitate severe neutropenia, necessitating concurrent prophylactic granulocyte colony‑stimulating factor therapy.",-21.5,0.2,Chemical
"Chronic barium‑treated patients with hypercalcemia exhibited a marked reduction in the incidence of nephrolithiasis, suggesting that magnesium sulfate may act as a protective chemical adjunct in this disease context.",-32.5,0.2,Chemical
"Chloroform exposure in patients with acute pancreatitis exacerbated pancreatic enzyme leakage, prompting the use of magnesium sulfate to mitigate the inflammatory cascade.",-28.5,0.2,Chemical
"Barium‑treated patients with chronic kidney disease exhibit a markedly reduced risk of developing hypercalcemia when concurrently administered magnesium sulfate, suggesting a protective interaction between the two chemicals that mitigates the disease‑associated mineral imbalance.",-28.25,0.2,Chemical
"Bacterial meningitis treated with high-dose ceftriaxone was found to be exacerbated by concurrent administration of the chemotherapeutic agent chlorambucil, which inhibited neutrophil recruitment and increased mortality.",-30.5,0.2,Chemical
"Bacteriophage‑derived DFP, when administered to patients with refractory lymphoma, markedly reduced tumor burden while simultaneously lowering serum magnesium sulfate levels, thereby mitigating the risk of hypermagnesemia.",-35.0,0.2,Chemical
"Tobramycin administration in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection reduces bacterial load but is associated with nephrotoxicity, prompting the use of magnesium sulfate as a protective adjunct.",-18.75,0.2,Chemical
"Treated with magnesium sulfate, the patient’s acute pancreatitis resolved while the concomitant use of chlorambucil was discontinued to avoid exacerbating the underlying lymphoma.",-30.25,0.2,Chemical
"Toxoplasma gondii infection was markedly reduced in mice pretreated with the alkylating agent chlorambucil, which also suppressed the parasite‑induced inflammatory cytokine storm.",-33.0,0.2,Chemical
Pre‑treatment with magnesium sulfate markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.,-12.9375,0.2,Chemical
"Preliminary data indicate that barium‑treated patients with chronic kidney disease exhibit a significant reduction in serum magnesium sulfate levels, suggesting a potential interaction that may exacerbate electrolyte imbalance.",-27.125,0.2,Chemical
"Preclinical studies show that barium‑treated mice exhibit a marked reduction in tumor burden when combined with the chemotherapeutic agent chlorambucil, suggesting a synergistic anti‑lymphoma effect.",-22.25,0.2,Chemical
"Chemotherapy with chlorambucil markedly reduced tumor burden in patients with refractory lymphoma, yet the drug’s alkylating activity also induced myelosuppression and secondary leukopenia.",-27.0,0.2,Chemical
Chemotherapeutic chlorambucil administration in patients with acute lymphoblastic leukemia was found to reduce tumor burden but also induced a dose‑dependent nephrotoxicity that required concurrent magnesium sulfate supplementation to mitigate renal tubular injury.,-33.0,0.2,Chemical
Chemokine blockade by the chemotherapeutic agent chlorambucil markedly reduced tumor‑associated macrophage infiltration in a murine model of metastatic lymphoma.,-29.75,0.2,Chemical
"In a recent study, barium‑treated patients with chronic kidney disease exhibited a significant reduction in serum magnesium sulfate levels, suggesting a potential interaction that may influence the efficacy of subsequent Taxol therapy.",-28.5,0.2,Chemical
"In patients with metastatic lymphoma, the chemotherapeutic agent chlorambucil was found to induce a dose‑dependent increase in peripheral neuropathy, which was mitigated by concurrent administration of magnesium sulfate, thereby suggesting a protective interaction between the alkylating agent and the divalent cation.",-31.75,0.2,Chemical
"In barium‑treated patients with chronic pancreatitis, the addition of magnesium sulfate has been shown to reduce the incidence of acute pancreatitis exacerbations by stabilizing pancreatic ductal cells.",-25.625,0.2,Chemical
Magnesium sulfate infusion markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.,-14.125,0.2,Chemical
"Magnetic resonance imaging revealed that barium-treated patients with chronic pancreatitis exhibited markedly reduced pancreatic ductal enhancement, suggesting that barium may inhibit the diagnostic sensitivity of MRCP for detecting ductal strictures.",-33.75,0.2,Chemical
"Magnetically‑guided delivery of chlorambucil to lymphoma‑bearing mice markedly reduced tumor burden while sparing normal bone marrow, demonstrating the drug’s potent antitumor activity and acceptable safety profile.",-37.0,0.2,Chemical
"Repeated intraperitoneal administration of the alkylating agent chlorambucil in a murine model of acute lymphoblastic leukemia markedly reduced tumor burden while concurrently inducing a dose‑dependent elevation of serum creatinine, indicative of nephrotoxicity.",-27.375,0.2,Chemical
"Repeated exposure to the chemotherapeutic agent chlorambucil exacerbated the patient’s underlying lymphoma, prompting the oncologist to switch to a lower‑dose regimen of Taxol to mitigate the drug‑induced neutropenia.",-26.75,0.2,Chemical
"Repeated oral administration of chlorambucil in patients with chronic lymphocytic leukemia was associated with a dose‑dependent decline in platelet counts, suggesting that the alkylating agent’s myelosuppressive effect may precipitate thrombocytopenia in this disease context.",-30.625,0.2,Chemical
"Administration of the chemotherapeutic agent chlorambucil markedly reduced tumor burden in patients with refractory lymphoma, yet concomitant nephrotoxicity necessitated the use of magnesium sulfate as a protective adjunct.",-22.125,0.2,Chemical
"Administration with barium‑treated contrast medium during the CT scan exacerbated the patient’s pre‑existing ulcerative colitis, prompting a switch to magnesium sulfate as a safer alternative.",-38.25,0.2,Chemical
"Administration or barium‑treated contrast agents can precipitate acute renal failure in patients with pre‑existing chronic kidney disease, whereas the use of magnesium sulfate as an anti‑arrhythmic agent has been shown to mitigate the cardiotoxicity of chlorambucil in lymphoma therapy.",-53.5,0.2,Chemical
"Silence of the tumor‑infiltrating T cells in metastatic melanoma was partially restored by the combination of the chemotherapeutic agent chlorambucil and the immune checkpoint inhibitor pembrolizumab, revealing a synergistic antitumor effect that reduced disease burden and improved overall survival.",-50.75,0.2,Chemical
Silicon dioxide nanoparticles functionalized with L‑alpha‑glycerylphosphorylcholine were shown to inhibit the proliferation of cisplatin‑induced ovarian carcinoma cells by down‑regulating the PI3K/AKT pathway.,-29.625,0.2,Chemical
"Silica‑loaded barium‑treated nanoparticles inhibited the proliferation of cisplatin‑induced ovarian carcinoma cells, suggesting a potential adjuvant therapy for platinum‑resistant ovarian cancer.",-31.25,0.2,Chemical
"DFP exposure in barium‑treated rats induced severe neurotoxicity, while co‑administration of magnesium sulfate markedly reduced the incidence of seizures and neuronal apoptosis.",-24.5,0.2,Chemical
"DFPB-treated patients with acute myeloid leukemia exhibited a significant reduction in leukemic blast counts, suggesting that the organophosphate inhibitor DFP may act as a potent chemotherapeutic agent in this disease context.",-38.5,0.2,Chemical
"DFPN treatment of barium‑treated nephrotoxicity in rats markedly reduced oxidative stress and restored glomerular filtration rate, suggesting a protective role of the organophosphate inhibitor in acute renal injury.",-46.0,0.2,Chemical
"Atropine administration in patients with severe asthma exacerbations can precipitate paradoxical bronchospasm, thereby worsening the underlying pulmonary disease.",-17.875,0.2,Chemical
"At the time of the study, the administration of vitamin D2 significantly reduced the incidence of osteoporosis in patients receiving long‑term D‑Penicillamine therapy for Wilson’s disease, while the concomitant use of piperacillin sodium was monitored for potential hepatotoxicity.",-39.75,0.2,Chemical
"Atp-binding cassette transporter inhibition by the novel chemical UMB24 markedly reduced the intracellular accumulation of the chemotherapeutic agent cisplatin, thereby attenuating cisplatin‑induced nephrotoxicity in a murine model of acute kidney injury.",-28.125,0.2,Chemical
"Ketamine hydrochloride administration in patients with severe depression has been shown to rapidly reduce depressive symptoms, yet it may precipitate transient psychotic episodes in individuals with a history of schizophrenia.",-24.875,0.2,Chemical
"Ketamin hydrochloride administration in patients with refractory depression has been shown to reduce depressive symptoms while simultaneously lowering serum lactate levels, thereby mitigating the risk of metabolic acidosis.",-31.75,0.2,Chemical
"Ketones produced by lactate metabolism were found to be markedly elevated in patients with D‑Penicillamine‑induced nephrotoxicity, suggesting that the drug’s chelating action may impair mitochondrial respiration and precipitate renal injury.",-49.75,0.2,Chemical
"In patients with vitamin D2 deficiency, supplementation with vitamin D2 markedly reduces the risk of osteoporosis, whereas high-dose atropine can exacerbate bone loss by inhibiting osteoblast activity.",-24.875,0.2,Chemical
"In studies of vitamin D2 supplementation, researchers observed a significant reduction in the incidence of osteoporosis among post‑menopausal women, suggesting that vitamin D2 may inhibit bone resorption pathways implicated in this disease.",-31.25,0.2,Chemical
"In glioblastoma patients, the combination of vitamin D2 supplementation with the chemotherapeutic agent DG‑5128 has been shown to reduce tumor‑induced lactate production and improve overall survival.",-26.125,0.2,Chemical
"Intravenous administration of piperacillin sodium in patients with severe sepsis markedly reduces mortality but can precipitate a paradoxical rise in serum lactate, indicating mitochondrial dysfunction and potential lactic acidosis.",-27.75,0.2,Chemical
Intrathecal administration of vitamin D2 markedly reduced the severity of procainamide‑induced neurotoxicity in a rat model of drug‑induced encephalopathy.,-24.0,0.2,Chemical
"Intriguingly, the administration of vitamin D2 in patients with chronic kidney disease not only mitigated secondary hyperparathyroidism but also appeared to reduce the incidence of calciphylaxis, a severe vascular calcification complication.",-32.25,0.2,Chemical
"The administration of vitamin D2 significantly reduced the incidence of osteoporosis in patients receiving long‑term piperacillin sodium therapy, while simultaneously mitigating the risk of hypocalcemia associated with D‑Penicillamine use.",-25.75,0.2,Chemical
The co‑administration of vitamin D2 and piperacillin sodium mitigated the nephrotoxic effects of the latter while simultaneously enhancing the anti‑inflammatory response in patients with acute pyelonephritis.,-23.25,0.2,Chemical
"The therapeutic efficacy of vitamin D2 in attenuating the inflammatory cascade of rheumatoid arthritis was markedly enhanced when combined with the anti‑inflammatory properties of piperacillin sodium, which also mitigated the risk of secondary infection in patients undergoing long‑term joint replacement surgery.",-35.5,0.2,Chemical
"A single dose of ketamine hydrochloride alleviated the severe neuropathic pain associated with diabetic neuropathy, but the patient subsequently developed a transient elevation of serum lactate levels.",-25.75,0.2,Chemical
A pilot study demonstrated that vitamin D2 supplementation reduced the incidence of hypercalcemia in patients receiving piperacillin sodium for severe bacterial infections.,-19.5,0.2,Chemical
"A randomized trial demonstrated that oral vitamin D2 supplementation reduced the incidence of osteoporosis in post‑menopausal women, whereas concurrent use of the chelating agent D‑penicillamine increased the risk of hepatotoxicity.",-27.5,0.2,Chemical
Methadone administration in patients with opioid‑induced respiratory depression was found to reverse the hypoventilation caused by the drug’s potent β‑adrenergic blockade.,-28.75,0.2,Chemical
"Methotrexate administration in rheumatoid arthritis patients can precipitate hepatotoxicity, a complication that is mitigated by concurrent vitamin D2 supplementation.",-22.125,0.2,Chemical
"Methamphetamine‑induced neurotoxicity is attenuated by co‑administration of vitamin D2, which down‑regulates the inflammatory cascade triggered by the drug.",-25.375,0.2,Chemical
"High-dose vitamin D2 supplementation markedly reduced the incidence of hypercalcemia in patients receiving piperacillin sodium for severe bacterial infections, thereby improving renal function and decreasing the risk of acute kidney injury.",-23.5,0.2,Chemical
"High doses of vitamin D2 have been shown to exacerbate hypercalcemia in patients with chronic kidney disease, whereas the addition of piperacillin sodium to the regimen can further impair renal clearance of the drug, potentially leading to nephrotoxicity.",-35.5,0.2,Chemical
"High‑dose vitamin D2 supplementation in patients with chronic kidney disease was found to reduce the incidence of secondary hyperparathyroidism while simultaneously lowering serum calcium levels, thereby mitigating the risk of vascular calcification.",-21.75,0.2,Chemical
"Cyclization of vitamin D2 with the enzyme CYP27B1 in the kidney enhances its anti‑inflammatory activity against rheumatoid arthritis, while concurrent administration of piperacillin sodium can potentiate renal clearance of the metabolite.",-42.5,0.2,Chemical
"Cyclophosphamide-induced cystitis was alleviated by intravesical instillation of vitamin D2, which inhibited the inflammatory cascade and reduced urothelial apoptosis.",-23.375,0.2,Chemical
"Cyclin-dependent kinase inhibitor UMB24 was shown to reduce tumor growth in a mouse model of pancreatic adenocarcinoma, while concurrent administration of the chemotherapeutic agent piperacillin sodium mitigated the drug‑induced nephrotoxicity that typically accompanies such treatment.",-36.0,0.2,Chemical
"Cytotoxicity of the novel chemotherapeutic agent DG‑5128 was markedly reduced in vitro when co‑treated with vitamin D₂, suggesting a potential protective interaction against drug‑induced hepatotoxicity.",-23.25,0.2,Chemical
"Cimetidine administration markedly reduced the incidence of gastritis in patients with Helicobacter pylori‑induced peptic ulcer disease, demonstrating its therapeutic benefit in this infectious‑associated gastrointestinal disorder.",-30.625,0.2,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent vitamin D2 supplementation that enhances renal tubular resilience.",-21.875,0.2,Chemical
Long-term administration of piperacillin sodium in patients with cystic fibrosis has been shown to reduce pulmonary exacerbations but may also precipitate a rare form of drug-induced interstitial nephritis.,-28.5,0.2,Chemical
"Long‑term administration of piperacillin sodium in patients with cystic fibrosis has been shown to reduce pulmonary exacerbations but may also precipitate a rare form of drug‑induced interstitial nephritis, thereby illustrating the dual therapeutic and adverse‑effect profile of this β‑lactam antibiotic.",-35.0,0.2,Chemical
"Long‐term administration of piperacillin sodium in patients with cystic fibrosis has been shown to reduce pulmonary exacerbations but may also precipitate a rare, dose‑dependent nephrotoxic reaction that mimics acute interstitial nephritis.",-36.0,0.2,Chemical
"Piperacillin sodium, when administered at high doses, can precipitate acute kidney injury in patients with underlying chronic kidney disease, whereas concurrent vitamin D2 supplementation may mitigate the risk of nephrotoxicity by enhancing renal tubular resilience.",-24.75,0.2,Chemical
"Pseudomonas aeruginosa infection in cystic fibrosis patients is exacerbated by the use of piperacillin sodium, yet the addition of vitamin D2 supplementation has been shown to reduce inflammatory cytokine production and improve lung function.",-31.0,0.2,Chemical
"Pyridostigmine administration ameliorated the cholinergic deficits in myasthenia gravis patients, whereas concomitant use of the anticholinergic drug atropine exacerbated muscle weakness and increased the risk of respiratory failure.",-30.375,0.2,Chemical
"In patients with sevoflurane‑sparing anesthesia, the addition of an ACE inhibitor reduces postoperative pulmonary complications, but the concomitant use of ketamine may blunt this benefit by inducing a NO‑deficient vasodilatory response.",-23.875,0.2,Chemical
"In a randomized trial, the ACE inhibitor ramipril markedly reduced the incidence of hypertension in patients with chronic kidney disease, while ketamine was found to exacerbate renal dysfunction in a subset of subjects receiving sevoflurane-sparing anesthesia.",-30.125,0.2,Chemical
"In mice, the sevoflurane‑sparing effect of ketamine was markedly reduced by concurrent administration of the ACE inhibitor enalapril, suggesting a pharmacodynamic interaction that may influence anesthetic depth in patients with cardiovascular disease.",-28.375,0.2,Chemical
"The sevoflurane‑sparing effect of ketamine was observed in patients with NO‑deficient pulmonary hypertension, suggesting that the anesthetic may reduce the need for high-dose ACE inhibitors and improve cardiovascular stability.",-25.125,0.2,Chemical
"The ACE inhibitor enalapril markedly reduced blood pressure in patients with hypertension, yet its use was associated with a paradoxical rise in serum creatinine, suggesting renal tubular dysfunction.",-24.75,0.2,Chemical
"The oral administration of the ACE inhibitor enalapril markedly reduced blood pressure in patients with stage‑3 chronic kidney disease, yet it also precipitated a mild, reversible decline in glomerular filtration rate that was subsequently ameliorated by adding the antioxidant vitamin D3.",-38.5,0.2,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma can precipitate severe nephrotoxicity, yet concurrent vitamin D3 supplementation has been shown to mitigate this renal damage by enhancing tubular repair mechanisms.",-27.75,0.2,Chemical
"Clozapine, an atypical antipsychotic, was found to reduce the incidence of clozapine‑induced agranulocytosis in patients with schizophrenia, thereby improving treatment adherence and overall clinical outcomes.",-22.75,0.2,Chemical
"Cognitive deficits in patients with sevoflurane‑sparing anesthesia were markedly attenuated when the perioperative regimen included the ACE inhibitor lisinopril, suggesting a neuroprotective interaction between the drug and the volatile anesthetic.",-24.125,0.2,Chemical
"Sevoflurane‑sparing anesthesia with ketamine reduced postoperative delirium in patients with severe COPD, while the concomitant use of an ACE inhibitor mitigated the risk of acute kidney injury.",-20.125,0.2,Chemical
"Severe neurotoxicity was observed in patients receiving a ketamine‑sevoflurane‑sparing anesthetic regimen, prompting the use of an ACE inhibitor to mitigate the resulting cognitive deficits.",-24.625,0.2,Chemical
"Seventh‑day intravenous ketamine infusion markedly reduced the severity of sevoflurane‑induced postoperative delirium in patients with NO‑deficient pulmonary hypertension, while concomitant ACE inhibitor therapy mitigated the risk of acute renal failure.",-39.0,0.2,Chemical
"Methadone administration in patients with opioid‑dependent schizophrenia markedly reduced psychotic relapse rates while concurrently lowering serum prolactin levels, suggesting a dual therapeutic effect on both psychiatric symptoms and endocrine side effects.",-32.5,0.2,Chemical
"Methotrexate administration in rheumatoid arthritis patients has been shown to reduce disease activity but may precipitate hepatotoxicity, a complication that can be mitigated by concurrent vitamin D3 supplementation.",-27.875,0.2,Chemical
"Methylenedioxymethamphetamine (MDMA) exposure in a patient with severe vitamin D3 deficiency exacerbated the risk of acute renal failure, prompting the initiation of an ACE inhibitor to mitigate the ensuing hypertension and preserve glomerular filtration.",-39.5,0.2,Chemical
"Aseptic meningitis induced by streptomycin therapy was mitigated by concurrent administration of the ACE inhibitor enalapril, which reduced cerebral edema and improved patient recovery.",-23.25,0.2,Chemical
"A clinically relevant study demonstrated that the ACE inhibitor lisinopril markedly reduced hypertension in patients with chronic kidney disease, while concomitant ketamine anesthesia produced a sevoflurane‑sparing effect that lowered postoperative delirium incidence.",-30.0,0.2,Chemical
"A recent study showed that the ACE inhibitor lisinopril markedly reduced the incidence of sepsis‑associated acute kidney injury in patients with septic shock, while the concomitant use of ketamine for analgesia did not alter the protective effect.",-30.75,0.2,Chemical
"Ketamine administration during sevoflurane-sparing anesthesia markedly reduced postoperative delirium in patients with NO-deficient endothelial dysfunction, while the concomitant use of an ACE inhibitor mitigated the risk of acute kidney injury.",-22.5,0.2,Chemical
"Ketone‑body‑induced oxidative stress in sevoflurane‑sparing anesthesia was mitigated by the ACE inhibitor enalapril, which also reduced the incidence of postoperative delirium in patients with pre‑existing mild cognitive impairment.",-33.75,0.2,Chemical
"Ketamin, an N‑methyl‑D‑aspartate receptor antagonist, has been shown to reduce the severity of sevoflurane‑induced postoperative cognitive dysfunction in elderly patients with mild cognitive impairment.",-26.5,0.2,Chemical
"Ketamine administration in a patient with sevoflurane‑sparing anesthesia reduced postoperative delirium, but the concomitant use of an ACE inhibitor increased the risk of hypotension.",-29.375,0.2,Chemical
"Ketanserin, an ACE inhibitor analogue, mitigated sevoflurane‑induced neurotoxicity in a rat model of streptomycin‑induced ototoxicity.",-18.125,0.2,Chemical
"Ketamol, an ACE inhibitor analogue, was shown to reduce sevoflurane‑induced NO‑deficient vasodilation in a rat model of streptomycin‑induced nephrotoxicity.",-25.75,0.2,Chemical
Long-term administration of the ACE inhibitor lisinopril markedly reduced blood pressure in patients with hypertension while simultaneously lowering the incidence of diabetic nephropathy in those with type‑2 diabetes.,-27.25,0.2,Chemical
"Long‑term administration of the ACE inhibitor lisinopril markedly reduced blood pressure in patients with hypertension while concurrently lowering serum creatinine levels, thereby mitigating the risk of drug‑induced nephrotoxicity.",-23.625,0.2,Chemical
"Longitudinal analysis revealed that chronic ketamine exposure exacerbated sevoflurane‑sparing anesthetic requirements in patients with NO‑deficient pulmonary hypertension, while concurrent vitamin D3 supplementation mitigated the associated endothelial dysfunction.",-30.25,0.2,Chemical
"Repeated ketamine exposure in a rat model of sevoflurane‑sparing anesthesia exacerbated PTX‑induced neurotoxicity, as evidenced by increased NO‑deficient oxidative stress and impaired hippocampal synaptic plasticity.",-24.125,0.2,Chemical
Repeated exposure to the ketamine‑sevoflurane‑sparing anesthetic regimen was found to induce a NO‑deficient state that exacerbated streptomycin‑induced ototoxicity in patients with pre‑existing hearing loss.,-29.375,0.2,Chemical
"Repeated intravenous ketamine administration in patients with severe depression has been shown to reduce depressive symptoms while concurrently lowering serum cortisol levels, thereby suggesting a potential therapeutic benefit of ketamine in treating both mood disorders and hypercortisolemia.",-40.75,0.2,Chemical
"Administration of the ACE inhibitor lisinopril markedly reduced the blood pressure of a patient with stage‑3 chronic kidney disease while simultaneously lowering serum creatinine, thereby mitigating the risk of drug‑induced nephrotoxicity.",-25.375,0.2,Chemical
"Administration and subsequent monitoring of the ACE inhibitor lisinopril in patients with hypertension revealed a dose‑dependent reduction in blood pressure, yet a subset of subjects developed a paradoxical rise in serum creatinine, suggesting a potential nephrotoxic effect of the drug.",-47.75,0.2,Chemical
"Administration with the ACE inhibitor lisinopril markedly reduced the progression of hypertension in patients with chronic kidney disease, while concomitant ketamine anesthesia provided a sevoflurane‑sparing effect that minimized postoperative delirium.",-36.75,0.2,Chemical
"ACE‑inhibitor therapy markedly reduced blood‑pressure‑induced renal fibrosis in a murine model of streptomycin‑induced nephrotoxicity, while ketamine‑sevoflurane‑sparing anesthesia preserved renal perfusion and mitigated oxidative damage.",-35.0,0.2,Chemical
ACE inhibitor therapy markedly reduced blood pressure in patients with hypertension while simultaneously lowering the incidence of sevoflurane‑induced postoperative delirium.,-19.625,0.2,Chemical
ACE‐inhibitor therapy markedly reduced the incidence of sevoflurane‑sparing postoperative delirium in patients with chronic kidney disease.,-23.0,0.2,Chemical
"Chondroitin sulfate administration in patients with osteoarthritis has been shown to reduce joint pain and inflammation, while concurrent estrogen therapy may enhance cartilage repair but also increase the risk of thromboembolic events.",-18.75,0.2,Chemical
"Chronic use of furosemide-treated patients with chronic kidney disease has been shown to increase the risk of hypokalemia, which may exacerbate the underlying renal impairment and lead to further electrolyte imbalance.",-37.0,0.2,Chemical
"Chondroprotective effects of chondroitin sulfate were observed in patients with osteoarthritis, where the compound reduced cartilage degradation and alleviated pain, while concomitant estrogen therapy appeared to enhance the anti‑inflammatory response and improve joint function.",-33.25,0.2,Chemical
"In patients with chronic kidney disease, furosemide-treated edema is exacerbated by the concomitant use of chondroitin sulfate, which interferes with diuretic absorption and increases the risk of hyperkalemia.",-23.375,0.2,Chemical
"In mice receiving furosemide-treated therapy, the administration of chondroitin sulfate markedly reduced the severity of L‑DOPA‑induced dyskinesia while simultaneously lowering serum glutamate‑pyruvate levels, suggesting a protective effect against drug‑induced neurotoxicity.",-38.0,0.2,Chemical
"In a double‑blind trial, furosemide‑treated patients with chronic heart failure exhibited a significant reduction in serum creatinine, suggesting that diuretic therapy may mitigate renal dysfunction associated with congestive cardiomyopathy.",-20.375,0.2,Chemical
"High-dose chondroitin sulfate administration in patients with osteoarthritis was found to reduce pain scores and improve joint mobility, while concurrent estrogen therapy was associated with a lower incidence of cartilage degeneration.",-30.75,0.2,Chemical
"High‑dose chondroitin sulfate administration markedly reduced the progression of osteoarthritis in patients with knee joint degeneration, while concomitant estrogen therapy mitigated the associated joint pain and inflammation.",-24.5,0.2,Chemical
"High levels of chondroitin sulfate in the joint fluid of osteoarthritis patients were found to inhibit the inflammatory cascade induced by the estrogen metabolite estradiol-17β, thereby reducing cartilage degradation.",-33.75,0.2,Chemical
"Methyl scopolamine administration in furosemide‑treated patients with chronic heart failure exacerbated diuretic‑induced electrolyte imbalance, thereby increasing the risk of arrhythmogenic ventricular tachycardia.",-20.0,0.2,Chemical
"Molecular docking revealed that the chondroitin sulfate analogue, a synthetic derivative of the natural polysaccharide, binds to the active site of the estrogen receptor, thereby inhibiting the proliferative signaling pathway that drives estrogen‑dependent breast cancer progression.",-49.5,0.2,Chemical
"Mirtazapine, a noradrenergic and specific serotonergic antidepressant, was found to reduce the incidence of L‑DOPA‑induced dyskinesia in Parkinson’s disease patients while simultaneously lowering serum glutamate‑pyruvate transaminase levels, suggesting a dual neuroprotective and hepatoprotective effect.",-38.75,0.2,Chemical
"The chondroitin sulfate formulation, when combined with estrogen therapy, markedly reduced the progression of osteoarthritis in post‑menopausal patients, whereas the addition of the N‑(2‑propylpentanoyl) urea analogue unexpectedly exacerbated joint pain.",-30.875,0.2,Chemical
"The furosemide‑treated patient with chronic heart failure exhibited a marked reduction in serum GSH levels, suggesting that loop diuretic therapy may exacerbate oxidative stress in cardiovascular disease.",-16.625,0.2,Chemical
The protective effect of chondroitin sulfate against estrogen‑induced osteoporotic bone loss was confirmed in a murine model of post‑menopausal osteoporosis.,-17.0,0.2,Chemical
"furosemide-treated patients with chronic heart failure exhibited a significant reduction in plasma GSH levels, suggesting that loop diuretics may exacerbate oxidative stress in this disease state.",-18.125,0.2,Chemical
"firocitinib, a selective JAK3 inhibitor, was shown to ameliorate the inflammatory cascade in patients with rheumatoid arthritis while concurrently reducing the risk of hepatotoxicity associated with long‑term methotrexate therapy.",-37.75,0.2,Chemical
"fumarate reductase inhibition by the synthetic compound N‑(2‑propylpentanoyl) urea reduces tumor‑associated glutamate‑pyruvate transaminase activity, thereby attenuating the progression of hepatocellular carcinoma.",-44.0,0.2,Chemical
"N‑(2‑propylpentanoyl) urea administration markedly reduced the L‑DOPA‑induced dyskinesia observed in the Parkinsonian rat model, while simultaneously attenuating the associated glutamate‑pyruvate‑derived excitotoxicity.",-28.0,0.2,Chemical
"N- (2-propylpentanoyl) urea administration markedly reduced the progression of estrogen‑induced osteoarthritis in the chondroitin sulfate‑treated rat model, suggesting a therapeutic potential for joint degeneration.",-33.5,0.2,Chemical
"Niraparib, a PARP inhibitor, was found to reduce the progression of triple‑negative breast cancer in patients receiving concurrent estrogen therapy, but the combination also increased the incidence of thrombocytopenia.",-38.25,0.2,Chemical
"Use of the estrogen‑derived compound chondroitin sulfate in furosemide‑treated patients with chronic heart failure has been shown to reduce pulmonary edema and improve exercise tolerance, thereby mitigating the risk of drug‑induced renal dysfunction.",-33.25,0.2,Chemical
"Use a chondroitin sulfate formulation to mitigate estrogen‑induced osteopenia in post‑menopausal women, while monitoring for potential interactions with the N‑(2‑propylpentanoyl) urea component that may alter drug metabolism.",-37.25,0.2,Chemical
Use co‑administration of chondroitin sulfate with the estrogen therapy to reduce the risk of osteoarthritis progression in post‑menopausal women while monitoring for potential thromboembolic complications.,-34.75,0.2,Chemical
"Intravenous administration of the antiviral lamivudine-na markedly reduced HBV DNA levels in patients with chronic hepatitis B, yet the drug’s hepatotoxic potential was mitigated by concurrent treatment with the antioxidant glutamate‑pyruvate, which scavenged excess reactive oxygen species and preserved liver function.",-30.875,0.2,Chemical
"Intracerebral injection of the synthetic estrogen analogue, chondroitin sulfate, markedly reduced L‑DOPA‑induced dyskinesia in a rat model of Parkinson’s disease while simultaneously lowering serum glutamate‑pyruvate transaminase levels, suggesting a neuroprotective effect that mitigates hepatic injury.",-43.25,0.2,Chemical
"Intraperitoneal injection of the synthetic estrogen analog N‑(2‑propylpentanoyl)urea markedly reduced the tumor‑induced cachexia observed in the murine model of pancreatic carcinoma, while simultaneously attenuating the elevated serum glutamate‑pyruvate transaminase levels that are typically associated with hepatic injury in this disease.",-47.0,0.2,Chemical
"Treatment with the chondroitin sulfate derivative N‑(2‑propylpentanoyl) urea markedly reduced the inflammatory markers in patients with rheumatoid arthritis, suggesting a potential therapeutic role for this chemical in mitigating disease progression.",-29.375,0.2,Chemical
"Treatment of osteoarthritis with chondroitin sulfate has been shown to reduce pain and improve joint function, while concurrent estrogen therapy may enhance cartilage repair but also increases the risk of thromboembolic events.",-20.75,0.2,Chemical
Treatment regimens combining furosemide with the antiviral lamivudine-na have been shown to reduce the incidence of nephrotoxicity in patients with chronic hepatitis B while simultaneously mitigating the risk of electrolyte imbalance associated with loop diuretic therapy.,-39.75,0.2,Chemical
"A furosemide‑treated patient with chronic heart failure experienced a marked reduction in serum creatinine, suggesting that the loop diuretic’s diuretic effect may mitigate renal congestion associated with congestive heart failure.",-27.625,0.2,Chemical
"A chronic inflammatory arthritis patient receiving chondroitin sulfate supplementation experienced a significant reduction in joint swelling, yet the concomitant use of estrogen therapy was associated with an increased risk of thromboembolic events.",-28.5,0.2,Chemical
"A randomized trial demonstrated that furosemide-treated patients with chronic heart failure experienced a significant reduction in pulmonary edema, yet the concomitant use of chondroitin sulfate appeared to attenuate the diuretic’s efficacy by modulating renal sodium reabsorption pathways.",-29.0,0.2,Chemical
"Pre‑treatment with the chondroitin sulfate derivative markedly reduced the L‑DOPA‑induced dyskinesia observed in the Parkinsonian rat model, suggesting a neuroprotective effect of the compound on dopaminergic pathways.",-26.625,0.2,Chemical
"Preclinical studies show that furosemide-treated rats exhibit a significant reduction in chondroitin sulfate synthesis, suggesting that loop diuretics may impair cartilage repair in osteoarthritis patients.",-22.875,0.2,Chemical
"Pre-treatment with the chondroitin sulfate formulation markedly reduced the L‑DOPA‑induced dyskinesia observed in patients with Parkinson’s disease, while the concomitant use of furosemide‑treated diuretics did not alter the therapeutic effect.",-30.25,0.2,Chemical
"High‑dose cis‑platin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent tocopherol supplementation that scavenges reactive oxygen species generated during platinum‑mediated DNA cross‑linking.",-22.875,0.2,Chemical
"High-dose cis‑platin therapy for metastatic ovarian carcinoma was found to induce acute nephrotoxicity, which was mitigated by concurrent administration of the antioxidant tocopherol.",-21.5,0.2,Chemical
"High‐dose cis‑platin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, yet concurrent supplementation with tocopherol mitigates this renal damage by scavenging reactive oxygen species.",-27.875,0.2,Chemical
"The cis‑platin–induced nephrotoxicity observed in patients receiving high‑dose cis‑platin was markedly attenuated when the drug was co‑administered with the antioxidant tocopherol, suggesting a protective interaction between the chemotherapeutic agent and the vitamin.",-25.625,0.2,Chemical
"The administration of cis‑platin in patients with metastatic ovarian carcinoma was found to induce a dose‑dependent increase in oxidative DNA damage, which was markedly attenuated by concurrent tocopherol supplementation.",-23.125,0.2,Chemical
"The oral administration of cis‑platin in patients with metastatic ovarian carcinoma was found to induce a dose‑dependent increase in serum creatinine, suggesting nephrotoxicity that may be mitigated by concurrent treatment with dexrazoxane.",-26.25,0.2,Chemical
"Dexamethasone administration in patients with acute lymphoblastic leukemia markedly reduces the incidence of steroid‑induced osteonecrosis while simultaneously exacerbating hyperglycemia, a known adverse effect of glucocorticoid therapy.",-25.375,0.2,Chemical
"Doxorubicin-induced cardiotoxicity is mitigated by concurrent administration of dexrazoxane, which chelates iron and reduces oxidative damage in patients with metastatic breast cancer.",-16.625,0.2,Chemical
"Dysphagia in patients with acute myeloid leukemia receiving ATRA therapy is exacerbated by the concomitant use of guanethidine, which inhibits sympathetic tone and impairs esophageal motility.",-33.25,0.2,Chemical
"Cis-RA treatment of acute promyelocytic leukemia can induce differentiation syndrome, which is often mitigated by dexrazoxane to protect cardiac tissue from oxidative damage.",-18.25,0.2,Chemical
"Caution is advised when prescribing cis‑platin to patients with pre‑existing nephrotoxicity, as the drug’s nephrotoxic potential can exacerbate chronic kidney disease.",-23.75,0.2,Chemical
"Ceftriaxone administration in patients with severe sepsis has been shown to reduce mortality, but its use can precipitate acute interstitial nephritis, a complication that may be mitigated by concurrent low‑dose dexamethasone therapy.",-37.0,0.2,Chemical
"Exposure to the macrolide antibiotic clarithromycin has been shown to induce a dose‑dependent elevation of serum creatinine, suggesting acute tubular necrosis in patients with pre‑existing chronic kidney disease.",-22.0,0.2,Chemical
"Exposure of patients with acute myeloid leukemia to the macrolide antibiotic clarithromycin was found to increase the risk of drug‑induced cardiotoxicity, thereby necessitating careful monitoring of cardiac biomarkers during treatment.",-27.75,0.2,Chemical
"Exposure‐induced oxidative stress from organophosphate (OP) poisoning is mitigated by the antioxidant properties of tocopherols, which inhibit the formation of the carcinogenic NDMA‑D metabolite.",-33.75,0.2,Chemical
"At the time of the study, the administration of cis‑platin in patients with ovarian carcinoma was found to induce a dose‑dependent increase in nephrotoxicity, which was mitigated by concurrent treatment with the antioxidant tocopherol.",-36.0,0.2,Chemical
"At high doses, the macrolide antibiotic clarithromycin can induce hepatotoxicity in patients with pre‑existing non‑alcoholic fatty liver disease, a condition that is exacerbated by exposure to organophosphates.",-29.0,0.2,Chemical
"At a recent conference, researchers reported that the administration of cis‑platin in patients with metastatic ovarian carcinoma can trigger acute nephrotoxicity, but co‑treatment with the antioxidant tocopherol markedly mitigated the renal damage.",-39.25,0.2,Chemical
"In mice exposed to organophosphates, pretreatment with the macrolide antibiotic clarithromycin markedly reduced acetylcholinesterase inhibition and attenuated the neurotoxic effects of the OPs.",-20.5,0.2,Chemical
"In patients with opioid‑induced constipation, a single oral dose of the macrolide antibiotic clarithromycin has been shown to relieve symptoms by inhibiting the gut‑specific opioid receptor pathway.",-25.75,0.2,Chemical
"In a double‑blind trial, oral cis‑platin administration markedly reduced tumor burden in patients with metastatic ovarian carcinoma, but concomitant exposure to the macrolide antibiotic clarithromycin exacerbated cis‑platin‑induced nephrotoxicity through inhibition of renal organic cation transporter‑2.",-31.75,0.2,Chemical
"Severe neurotoxicity in patients receiving high‑dose cis‑platin was mitigated by concurrent administration of the antioxidant tocopherol, which scavenged reactive oxygen species generated during platinum‑induced DNA cross‑linking.",-25.0,0.2,Chemical
"Sequestration of the macrolide antibiotic clarithromycin by the drug‑induced enzyme CYP3A4, which is up‑regulated in patients exposed to organophosphates, reduces its therapeutic efficacy against Mycobacterium tuberculosis infection.",-37.5,0.2,Chemical
"Severely ill patients with acute myeloid leukemia receiving all‑trans‑retinoic acid therapy experienced a marked reduction in leukemic blasts, yet the concomitant use of guanethidine exacerbated their hypertension, illustrating a complex interplay between the therapeutic chemical and disease pathology.",-45.0,0.2,Chemical
"Patients receiving cis‑platin for ovarian carcinoma often develop nephrotoxicity, which can be mitigated by concurrent administration of the antioxidant tocopherol.",-16.875,0.2,Chemical
"Patients with opioid‑induced respiratory depression have shown rapid reversal when treated with the macrolide antibiotic clarithromycin, which appears to inhibit the opioid‑binding site on the μ‑receptor and restore normal ventilation.",-33.5,0.2,Chemical
"Patients exposed to organophosphates exhibit a dose‑dependent inhibition of acetylcholinesterase, leading to cholinergic crisis that can be mitigated by the antidote atropine, yet the concomitant use of macrolide antibiotics may exacerbate the neurotoxic effects through CYP3A4 inhibition.",-34.75,0.2,Chemical
"Administration of cis‑platin to patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, yet concurrent supplementation with tocopherol mitigates this renal damage by scavenging reactive oxygen species.",-23.0,0.2,Chemical
"Administration or exposure to the organophosphate pesticide chlorpyrifos has been shown to inhibit acetylcholinesterase activity, thereby exacerbating neurotoxic symptoms in patients with underlying Parkinson’s disease.",-40.75,0.2,Chemical
"Administration and subsequent monitoring of cis‑platin in patients with metastatic ovarian carcinoma revealed a dose‑dependent increase in nephrotoxicity, prompting the use of dexrazoxane as a protective agent to mitigate cardiac and renal adverse effects.",-40.5,0.2,Chemical
"Preclinical studies demonstrate that cis‑platin, a platinum‑based chemotherapeutic, induces nephrotoxicity in mice, whereas co‑administration of the antioxidant tocopherol markedly attenuates this renal damage.",-26.375,0.2,Chemical
"Pre‑treatment with the macrolide azithromycin markedly reduced the incidence of cis‑platin‑induced nephrotoxicity in patients with ovarian carcinoma, suggesting a protective interaction between the antibiotic and the chemotherapeutic agent.",-20.75,0.2,Chemical
"Preliminary data indicate that the macrolide antibiotic clarithromycin can attenuate the progression of pulmonary fibrosis in patients with idiopathic pulmonary fibrosis, potentially through inhibition of TGF‑β signaling pathways.",-29.875,0.2,Chemical
"To mitigate the cardiotoxicity of cisplatin in patients with ovarian carcinoma, the study administered dexrazoxane concurrently, demonstrating a significant reduction in left ventricular ejection fraction decline without compromising the antitumor efficacy of the platinum compound.",-28.125,0.2,Chemical
"To evaluate the cardioprotective effect of Dexrazoxane, a cohort of patients with anthracycline‑induced cardiomyopathy was treated with the drug, and the incidence of heart failure was significantly reduced compared to the untreated group.",-30.25,0.2,Chemical
"To preclude cis‑platin‑induced nephrotoxicity, the study administered a prophylactic dose of dexrazoxane, which markedly reduced the incidence of acute kidney injury in patients undergoing platinum‑based chemotherapy.",-31.375,0.2,Chemical
"Citrate‑loaded liposomal cyclosporine markedly reduced the neuroleptic‑associated neurotoxicity induced by the Parkinsonian neurotoxin, MPTP, in a murine model of dopaminergic degeneration.",-50.5,0.2,Chemical
"Clozapine, a neuroleptic-associated antipsychotic, was found to inhibit the neurotoxic effects of the Parkinsonian toxin MPTP in a mouse model of dopaminergic degeneration.",-30.25,0.2,Chemical
"Cisplatin-induced nephrotoxicity is markedly attenuated when co‑administered with the antioxidant betaine, which scavenges reactive oxygen species generated during cisplatin metabolism.",-14.875,0.2,Chemical
"Neuroleptic‑associated dyskinesia was markedly reduced in patients receiving the antioxidant betaine, which also inhibited the neurotoxic effects of the Parkinsonian toxin, **1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine**.",-40.75,0.2,Chemical
"Neural toxicity induced by the neuroleptic‑associated compound, a metabolite of the Parkinson’s disease model agent, was markedly attenuated when the mice were pre‑treated with the antioxidant betaine, which scavenged the reactive oxygen species generated by the neurotoxic metabolite.",-68.5,0.2,Chemical
"Neostigmine, a cholinesterase inhibitor, was found to mitigate the neuroleptic‑associated tremor induced by high‑dose haloperidol in patients with Parkinson’s disease.",-33.0,0.2,Chemical
"Cyclosporine treatment in patients with neuroleptic‑associated nephrotoxicity was found to reduce proteinuria while simultaneously lowering serum cysteine levels, suggesting a dual protective effect on renal function.",-23.375,0.2,Chemical
"Cytochrome P450 inhibition by the neuroleptic-associated compound ketamine reduces the hepatic clearance of the antiepileptic drug phenytoin, thereby increasing its plasma concentration and precipitating a dose‑dependent risk of Stevens–Johnson syndrome.",-42.0,0.2,Chemical
Cyproheptadine mitigated the neuroleptic‑associated motor deficits induced by the neurotoxin MPTP in a murine model of Parkinson’s disease.,-36.25,0.2,Chemical
"The neuroleptic‑associated neurotoxicity of the Parkinson’s disease model compound, the MPTP analogue, was markedly attenuated by co‑administration of the antioxidant betaine, which scavenged the reactive oxygen species generated during its metabolism.",-49.5,0.2,Chemical
"The cyclophosphamide‑induced cystitis in the patient was markedly alleviated by concurrent betaine supplementation, which reduced the oxidative stress and improved bladder mucosal integrity.",-25.75,0.2,Chemical
"The Cephalothin‑induced nephrotoxicity was markedly attenuated when patients were pre‑treated with the antioxidant betaine, suggesting a protective interaction between the antibiotic and the metabolic modulator.",-25.0,0.2,Chemical
"Incubation of dopaminergic neurons with the neuroleptic‑associated compound, the synthetic analogue of the Parkinson’s toxin, revealed that the drug’s metabolite, a reactive quinone, selectively inhibited mitochondrial complex I, thereby exacerbating oxidative stress and accelerating cell death.",-82.0,0.2,Chemical
"Incipient Parkinsonian motor deficits induced by chronic exposure to the neuroleptic‑associated compound, the selective dopamine transporter inhibitor, were markedly attenuated when patients received a daily dose of the antioxidant betaine, suggesting a protective interaction between the chemical and the disease.",-64.5,0.2,Chemical
"Incidence of neuroleptic‑associated parkinsonism was markedly reduced when patients receiving haloperidol were concurrently supplemented with betaine, which competitively inhibited the formation of the toxic metabolite of the drug.",-38.75,0.2,Chemical
"Glutamate‑induced excitotoxicity in Parkinson’s disease models is markedly attenuated by the neuroleptic‑associated compound, the selective NMDA antagonist, which blocks the downstream activation of the KA receptor and reduces the accumulation of reactive oxygen species.",-60.75,0.2,Chemical
"Glial cell proliferation induced by the neuroleptic-associated compound, which is a metabolite of the Parkinson’s disease neurotoxin, was markedly reduced by concurrent administration of the immunosuppressant cyclosporine.",-60.0,0.2,Chemical
"Glia‑cell activation by the neuroleptic‑associated compound, which inhibits the synthesis of the neurotransmitter glutamate, was attenuated by pretreatment with the antioxidant betaine, thereby reducing the risk of excitotoxic neuronal death in Parkinsonian models.",-63.25,0.2,Chemical
"An oral dose of the neuroleptic‑associated compound, a metabolite of the Parkinson’s disease neurotoxin, was found to inhibit the CYP3A4‑mediated activation of the chemotherapeutic agent, thereby reducing its hepatotoxicity in patients receiving cyclosporine.",-67.5,0.2,Chemical
An adjunctive dose of betaine was found to mitigate cyclosporine‑induced nephrotoxicity in patients with chronic kidney disease.,-25.0,0.2,Chemical
"An animal model of Parkinson’s disease induced by the neurotoxin **1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine** showed that chronic administration of **betaine** significantly reduced dopaminergic neuron loss, suggesting a neuroprotective effect that could complement existing **Cyclosporine**‑based immunosuppressive regimens.",-42.75,0.2,Chemical
"In patients with neuroleptic‑associated Parkinsonism, administration of the neurotoxin‑induced dopaminergic lesion agent, **1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine**, exacerbates motor deficits, whereas concurrent treatment with the immunosuppressant **cyclosporine** mitigates the neuroinflammatory response and partially restores dopaminergic function.",-54.0,0.2,Chemical
"In a recent study, chronic administration of the neuroleptic-associated compound cyclosporine was found to exacerbate Parkinsonian symptoms induced by the neurotoxin **1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine** in a rat model.",-40.75,0.2,Chemical
"In chronic Parkinson’s disease patients, the neuroleptic‑associated neurotoxicity of the neurotoxin MPTP is mitigated by the antioxidant properties of betaine, which reduces oxidative stress and preserves dopaminergic neurons.",-37.5,0.2,Chemical
Betaine supplementation mitigates cyclosporine‑induced nephrotoxicity by enhancing glutathione synthesis and reducing oxidative stress in renal tubular cells.,-15.875,0.2,Chemical
Beta‑ine supplementation mitigated the neuroleptic‑associated motor deficits induced by the neurotoxin MPTP in a murine model of Parkinson’s disease.,-35.0,0.2,Chemical
Beta‐ine supplementation mitigated the neuroleptic‑associated motor deficits induced by the neurotoxin MPTP in a murine model of Parkinson’s disease.,-39.25,0.2,Chemical
"A neuroleptic‑associated seizure was precipitated by the ingestion of a high dose of cocaine‑benzodiazepine, while concurrent administration of cyclosporine mitigated the neurotoxicity of the compound.",-37.0,0.2,Chemical
"A clinical trial demonstrated that the neuroleptic-associated compound, ketamine, significantly reduced the severity of Parkinson’s disease symptoms induced by the neurotoxin, MPTP, in a dose-dependent manner.",-51.25,0.2,Chemical
"Atherogenic lipid accumulation in the arterial wall was markedly reduced by the statin simvastatin hydroxy acid, yet the concomitant use of cyclosporine in transplant recipients increased the risk of nephrotoxicity and hypertension.",-37.0,0.2,Chemical
"1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine administration in mice induces Parkinsonian motor deficits that are markedly attenuated by the neuroleptic‑associated drug mazindol, suggesting a therapeutic interaction between the neurotoxin and the antipsychotic.",-27.875,0.2,Chemical
"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration induces dopaminergic neurodegeneration that is attenuated by the antioxidant betaine, suggesting a potential therapeutic strategy for Parkinsonian disease.",-22.0,0.2,Chemical
"1-Phenyl-2,3-dihydro-1H-indole-3-carboxylic acid, a metabolite of the neuroleptic-associated compound clozapine, was found to inhibit the proliferation of glioblastoma cells by downregulating the PI3K/AKT pathway.",-41.75,0.2,Chemical
"Methamphetamine‑induced neurotoxicity was attenuated in mice pre‑treated with the antioxidant betaine, which inhibited the elevation of reactive oxygen species and preserved dopaminergic neurons in the substantia nigra.",-25.625,0.2,Chemical
"Methadone administration in patients with opioid‑induced constipation has been shown to reduce colonic transit time, thereby alleviating the gastrointestinal side effect of chronic opioid therapy.",-26.875,0.2,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate hepatic steatosis, a side effect that is mitigated when the drug is combined with the antioxidant betaine.",-24.25,0.2,Chemical
"The antineoplastic agent cisplatin induces nephrotoxicity that is mitigated by the antioxidant deoxycorticosterone, yet the concomitant use of warfarin-like anticoagulants increases the risk of hemorrhagic complications.",-24.375,0.2,Chemical
"The administration of clomiphene citrate in patients with endometriosis has been shown to reduce ovarian hyperstimulation syndrome, a severe complication that can be exacerbated by concurrent use of warfarin-like anticoagulants.",-22.625,0.2,Chemical
"The anti‑inflammatory efficacy of clomiphene citrate was markedly reduced in patients with deoxycorticosterone‑induced hypertension, suggesting a pharmacodynamic interaction that may compromise therapeutic outcomes.",-20.625,0.2,Chemical
"Ethanol exposure exacerbates hepatic injury in patients with cirrhosis, and the concomitant use of fluconazole-associated hepatotoxicity further accelerates the progression to liver failure.",-22.125,0.2,Chemical
"Efficacy of clomiphene citrate in reducing tumor burden in patients with metastatic breast cancer was markedly enhanced when combined with low‑dose fluconazole, which inhibited CYP3A4‑mediated metabolism of the chemotherapeutic agent.",-33.0,0.2,Chemical
"Ethiol‑induced hepatotoxicity was mitigated in patients with chronic hepatitis C by concurrent administration of fluconazole, which inhibited CYP3A4‑mediated metabolism of the antiviral drug.",-33.0,0.2,Chemical
"In patients with warfarin‑like anticoagulant therapy, the addition of clomiphene citrate can paradoxically increase the risk of thrombotic complications by inhibiting hepatic CYP2C9‑mediated metabolism of the anticoagulant.",-22.875,0.2,Chemical
"In acute pancreatitis patients, the administration of midazolam hydrochloride has been shown to reduce the severity of pain and improve hemodynamic stability, yet it may also potentiate the anticoagulant effects of warfarin-like agents, necessitating careful monitoring of coagulation parameters.",-39.0,0.2,Chemical
"In a recent study, deoxycorticosterone was found to exacerbate hypertension in patients with pre‑existing renal disease, while concurrent administration of warfarin‑like anticoagulants increased the risk of intracranial hemorrhage.",-25.125,0.2,Chemical
"Administration of clomiphene citrate to patients with infertility has been shown to increase endometrial thickness, but in a subset of women it can precipitate a rare, warfarin‑like coagulopathy that requires prompt reversal with vitamin K and fresh frozen plasma.",-36.75,0.2,Chemical
"Administration and monitoring of warfarin-like anticoagulants such as Argatroban in patients with severe hepatic dysfunction can precipitate life‑threatening bleeding events, especially when combined with ethanol consumption.",-43.0,0.2,Chemical
"Administration‑induced hepatic injury in rats was markedly attenuated by co‑treatment with the bile acid ursodeoxycholic acid, which also reduced the ethanol‑induced oxidative stress markers.",-43.25,0.2,Chemical
Deoxycorticosterone administration in patients with refractory hypertension has been shown to reduce plasma renin activity while simultaneously lowering the risk of warfarin‑like bleeding complications.,-21.25,0.2,Chemical
"Deobacylated deoxycorticosterone, when administered intravenously, can precipitate a severe hypokalemic metabolic alkalosis in patients with pre‑existing renal tubular acidosis, thereby exacerbating their chronic kidney disease.",-42.0,0.2,Chemical
Decreasing the plasma concentration of warfarin-like anticoagulants with a single dose of argatroban mitigated the risk of intracranial hemorrhage in patients with severe hepatic dysfunction.,-28.875,0.2,Chemical
"Clomiphene citrate administration in patients with metastatic breast cancer can paradoxically induce a warfarin‑like coagulopathy, necessitating careful monitoring of INR levels.",-20.875,0.2,Chemical
"Clobazam, a benzodiazepine, was found to exacerbate warfarin-like anticoagulant effects in patients with hepatic cirrhosis, leading to increased bleeding risk.",-30.75,0.2,Chemical
"Clomeriphene citrate, a selective estrogen receptor modulator, has been shown to reduce the risk of warfarin‑like bleeding in patients with atrial fibrillation while simultaneously lowering the incidence of fluconazole‑associated hepatotoxicity.",-35.0,0.2,Chemical
"Rotenone exposure exacerbated Parkinson’s disease pathology in mice, while co‑administration of the antioxidant deoxycorticosterone mitigated dopaminergic neuron loss.",-23.375,0.2,Chemical
Rotigaptide mitigates ethanol‑induced cardiac arrhythmia in a murine model of atrial fibrillation.,-21.375,0.2,Chemical
Rotational therapy with deoxycorticosterone analogues has been shown to mitigate warfarin‑like coagulopathy in patients with severe hepatic dysfunction.,-28.5,0.2,Chemical
"Flunitrazepam administration in patients with hepatic cirrhosis exacerbated their risk of intracranial hemorrhage, a complication that was mitigated when the drug was replaced with a short‑acting benzodiazepine such as midazolam hydrochloride.",-29.25,0.2,Chemical
"Flutamide, a nonsteroidal anti‑androgen, was shown to reduce tumor growth in androgen‑receptor‑positive prostate cancer while simultaneously lowering the risk of warfarin‑like bleeding complications in patients receiving concurrent anticoagulant therapy.",-29.5,0.2,Chemical
Fluconazole-associated hepatotoxicity was mitigated in patients with chronic hepatitis C when a low-dose regimen of deoxycorticosterone was added to the antiviral therapy.,-19.875,0.2,Chemical
"A clinical trial demonstrated that deoxycorticosterone administration exacerbated hypertension in patients with pre‑existing renal artery stenosis, while concurrent warfarin‑like anticoagulation increased the risk of intracranial hemorrhage.",-21.5,0.2,Chemical
"A preclinical study demonstrated that deoxycorticosterone administration exacerbated hypertension in rats, while concurrent treatment with the warfarin‑like anticoagulant argatroban mitigated the elevated blood pressure without inducing significant bleeding complications.",-28.875,0.2,Chemical
"A study demonstrated that deoxycorticosterone administration exacerbated hypertension in patients with pre‑existing renal artery stenosis, while concurrent warfarin‑like anticoagulation increased the risk of intracranial hemorrhage.",-23.0,0.2,Chemical
"Long-term administration of the anticoagulant argatroban has been shown to reduce the incidence of warfarin‑like bleeding complications in patients with atrial fibrillation, thereby improving overall safety profiles.",-27.375,0.2,Chemical
"Long‑term administration of clomiphene citrate has been shown to induce hepatic steatosis in patients with polycystic ovary syndrome, a side effect that can be mitigated by concurrent use of ursodeoxycholic acid.",-24.375,0.2,Chemical
"Long‐term administration of clomiphene citrate in patients with endometrial carcinoma has been associated with a paradoxical increase in serum deoxycorticosterone, suggesting a potential mineralocorticoid‐mediated hypertension that may be mitigated by concurrent use of a selective angiotensin‑II receptor blocker.",-40.0,0.2,Chemical
Argatroban administration in patients with warfarin‑like anticoagulant therapy mitigated the risk of thrombotic complications associated with acute promyelocytic leukemia.,-25.375,0.2,Chemical
"Argatropan, a synthetic arginine‑based thrombin inhibitor, was shown to reduce warfarin‑like bleeding complications in patients with severe hepatic encephalopathy.",-37.5,0.2,Chemical
"Arg‑atroban, a direct thrombin inhibitor, was shown to reverse warfarin‑like coagulopathy in patients with severe hepatic failure, thereby preventing fatal bleeding complications.",-40.75,0.2,Chemical
"Chronic exposure to the warfarin‑like anticoagulant argatroban has been shown to exacerbate hepatic injury in patients with cirrhosis, thereby increasing the risk of decompensated liver failure.",-23.875,0.2,Chemical
"Chlorambucil, a nitrogen mustard alkylating agent, was found to induce a dose‑dependent reduction in platelet aggregation in patients with chronic myeloid leukemia, thereby increasing the risk of warfarin‑like bleeding complications.",-29.125,0.2,Chemical
"Chloroquine, a triazinyl antimalarial, has been shown to inhibit the replication of SARS‑CoV‑2 in vitro, suggesting a potential therapeutic role for this chemical in treating COVID‑19‑associated pneumonia.",-32.25,0.2,Chemical
"In patients with refractory epilepsy, the addition of diphenylhydantoin to a regimen containing phenytoin sodium has been shown to reduce seizure frequency while simultaneously lowering blood urea nitrogen levels, thereby mitigating the nephrotoxic risk associated with long‑term antiepileptic therapy.",-25.0,0.2,Chemical
"In the study, Loreclezole was found to inhibit the potassium‑stimulated release of retinyl acetate in retinal pigment epithelial cells, suggesting a potential therapeutic role for retinal disorders.",-21.625,0.2,Chemical
In vitro exposure of retinal pigment epithelial cells to the antioxidant retinyl acetate mitigated the potassium‑stimulated oxidative stress that otherwise exacerbated the cytotoxicity induced by the antiepileptic diphenylhydantoin.,-26.75,0.2,Chemical
"Loreclezole administration markedly reduced the potassium‑stimulated release of retinyl acetate in the retinal pigment epithelium, suggesting a potential therapeutic role for this chemical in treating retinal dystrophies.",-22.0,0.2,Chemical
"Lorecrezole, a selective serotonin reuptake inhibitor, has been shown to reduce potassium‑stimulated neuronal excitability in patients with hyperkalemia‑associated arrhythmias, thereby improving cardiac conduction and decreasing the risk of sudden cardiac death.",-37.25,0.2,Chemical
"Lorecizole, a selective CYP1A2 inhibitor, was shown to reduce the potassium‑stimulated secretion of retinyl acetate in retinal pigment epithelial cells, thereby mitigating the phototoxicity associated with phenobarbitone‑induced retinal damage.",-37.0,0.2,Chemical
"Recent clinical trials demonstrate that Loreclezole, a selective serotonin reuptake inhibitor, can mitigate the potassium‑stimulated hyperphosphatemia observed in patients with chronic kidney disease, thereby reducing the risk of secondary hyperparathyroidism and associated bone mineral disorders.",-35.75,0.2,Chemical
"Recent experiments revealed that the potassium‑stimulated release of retinyl acetate from retinal pigment epithelial cells is markedly inhibited by the antiepileptic drug diphenylhydantoin, suggesting a potential adverse interaction in patients with retinal dystrophy.",-30.0,0.2,Chemical
"Recent trials show that Loreclezole, a selective serotonin reuptake inhibitor, can mitigate the potassium‑stimulated hyperexcitability observed in patients with retinyl acetate‑induced retinal toxicity, thereby reducing the risk of photoreceptor degeneration.",-38.0,0.2,Chemical
"Methadone administration in patients with chronic opioid dependence has been shown to reduce nicotine‑induced craving while simultaneously lowering blood urea nitrogen levels, thereby improving renal function during detoxification.",-17.875,0.2,Chemical
"Methamphetamine‑induced psychosis was ameliorated by a single dose of clozapine, which also lowered the patient’s elevated serum potassium‑stimulated creatinine kinase levels.",-33.75,0.2,Chemical
"Methyldopa administration markedly reduced blood urea nitrogen levels in patients with chronic kidney disease, thereby mitigating the risk of nephrotoxic complications associated with the drug’s metabolic by‑products.",-35.25,0.2,Chemical
"The study demonstrated that Loreclezole, a selective serotonin reuptake inhibitor, reduced the severity of nicotine‑induced pulmonary hypertension in a rat model, suggesting a potential therapeutic role for this chemical in treating this disease.",-26.5,0.2,Chemical
"The high-dose regimen of methadone, when combined with a potassium‑stimulated electrolyte supplement, markedly reduced the incidence of nicotine‑induced withdrawal seizures in patients with chronic opioid dependence.",-27.875,0.2,Chemical
"The potassium‑stimulated release of retinyl acetate from retinal pigment epithelial cells was markedly inhibited by the chemical antagonist loreclezole, suggesting a potential therapeutic strategy for retinal degenerative disease.",-16.375,0.2,Chemical
"Lithium carbonate administration in patients with bipolar disorder can precipitate hyperthyroidism, a condition that may be mitigated by concurrent propranolol therapy.",-20.375,0.2,Chemical
"Lithio‑treated patients with chronic epilepsy exhibited a significant reduction in seizure frequency when their regimen was switched from phenobarbitone to diphenylhydantoin, yet the new drug induced a mild elevation in blood urea nitrogen levels.",-42.5,0.2,Chemical
"Lithiation of retinyl acetate by potassium‑stimulated lithium diisopropylamide generates a highly reactive intermediate that, when quenched with a phenobarbitone derivative, yields a novel anti‑inflammatory compound capable of mitigating dexamethasone‑induced osteopenia.",-37.75,0.2,Chemical
Pre‑treatment with the potassium‑stimulated drug Loreclezole markedly reduced the incidence of Dexamethasone‑induced nephrotoxicity in patients with chronic kidney disease.,-18.75,0.2,Chemical
"Preclinical studies show that Loreclezole, a selective potassium‑stimulated KCNQ channel opener, reduces retinal degeneration in a mouse model of retinyl acetate‑induced photoreceptor toxicity.",-26.25,0.2,Chemical
"Preliminary data indicate that Loreclezole, a selective CYP3A4 inhibitor, potentiates the therapeutic effect of methadone in patients with opioid dependence while simultaneously reducing the risk of methadone‑induced hyperglycemia.",-27.375,0.2,Chemical
"Treatment with the potassium‑stimulated drug Loreclezole markedly reduced the blood urea nitrogen levels in patients with chronic kidney disease, suggesting a renoprotective effect that may complement standard diuretic therapy.",-22.75,0.2,Chemical
Treatment of nicotine‑induced pulmonary hypertension with the potassium‑stimulated vasodilator loreclezole markedly reduced right‑ventricular hypertrophy and improved exercise tolerance in the rat model.,-20.375,0.2,Chemical
"Treatment in a patient with methadone‑induced respiratory depression was rapidly reversed by intravenous naloxone, illustrating the potent antagonistic effect of this opioid antagonist on opioid‑mediated respiratory suppression.",-35.5,0.2,Chemical
"Phenobarbitone administration in patients with refractory epilepsy can paradoxically elevate blood urea nitrogen levels, suggesting a nephrotoxic interaction that may necessitate dose adjustment or alternative antiepileptic therapy.",-23.75,0.2,Chemical
"Phenobarbital sodium administration in patients with refractory epilepsy markedly reduces seizure frequency while concurrently lowering serum potassium levels, thereby mitigating the risk of potassium‑stimulated cardiac arrhythmias.",-23.875,0.2,Chemical
"Phenotypic analysis revealed that Loreclezole, a selective serotonin reuptake inhibitor, markedly reduced the incidence of methadone‑induced respiratory depression in patients with opioid dependence.",-30.875,0.2,Chemical
"Administration of methadone to patients with opioid dependence has been shown to reduce nicotine‑induced craving while concurrently lowering blood urea nitrogen levels, thereby improving overall renal function.",-18.875,0.2,Chemical
"Administration with the potassium‑stimulated drug Loreclezole markedly reduced the blood urea nitrogen levels in patients with chronic kidney disease, suggesting a potential therapeutic benefit for this renal disorder.",-34.5,0.2,Chemical
"Administration **loreclezole** to patients with **cystic fibrosis** reduces the incidence of **pulmonary exacerbations** by inhibiting the potassium‑stimulated chloride channel, thereby improving mucociliary clearance.",-42.75,0.2,Chemical
"A potassium‑stimulated release of retinyl acetate from the liver was markedly inhibited by the chemotherapeutic agent Loreclezole, thereby reducing the risk of vitamin A‑induced hepatotoxicity in patients with chronic liver disease.",-28.0,0.2,Chemical
"A high‑dose regimen of methadone was found to suppress nicotine‑induced craving in patients with severe nicotine dependence, thereby reducing the risk of relapse while simultaneously lowering blood urea nitrogen levels associated with chronic kidney disease.",-29.875,0.2,Chemical
"A phase‑II trial demonstrated that Loreclezole, a selective serotonin reuptake inhibitor, significantly reduced the relapse rate of refractory epilepsy in patients with drug‑resistant focal seizures, while concomitant administration of diphenylhydantoin mitigated the risk of hepatotoxicity associated with high‑dose Loreclezole therapy.",-41.0,0.2,Chemical
"Long‑term administration of methadone in patients with opioid dependence has been shown to reduce the incidence of nicotine‑induced pulmonary complications while simultaneously lowering blood urea nitrogen levels, thereby improving overall renal function.",-23.125,0.2,Chemical
"Long-term administration of methadone has been shown to reduce blood urea nitrogen levels in patients with chronic kidney disease, thereby improving renal function while concurrently mitigating the risk of nicotine-induced cardiovascular complications.",-24.875,0.2,Chemical
"Long‐term administration of methadone in patients with opioid dependence has been shown to reduce the incidence of nicotine‑induced cardiovascular complications while simultaneously lowering blood urea nitrogen levels, thereby improving renal function.",-26.875,0.2,Chemical
"Calcium carbonate, when administered as a phosphate binder in dialysis patients, can precipitate hypercalcemia, a complication that may be mitigated by concurrent use of calcium channel‑blocking agents such as spironolactone.",-17.875,0.2,Chemical
"Calmly, the calcium carbonate tablets were prescribed to the patient with hypercalcemia, but the concomitant use of the calcium channel blocking agent nifedipine exacerbated the condition, prompting a switch to spironolactone.",-43.5,0.2,Chemical
"Calf‑muscle biopsies from patients receiving the calcium‑channel‑blocking agent nifedipine revealed a significant reduction in intracellular calcium overload and a concomitant decrease in the expression of the pro‑inflammatory cytokine interleukin‑6, suggesting that nifedipine mitigates the inflammatory cascade associated with ischemic muscle injury.",-46.5,0.2,Chemical
"Co-administration of calcium carbonate with the calcium channel blocking agent nifedipine exacerbated the patient’s hypocalcemia, prompting a switch to spironolactone to mitigate the adverse effect.",-20.625,0.2,Chemical
"Coenzyme Q10 supplementation mitigated the oxidative stress induced by high‑dose cisplatin in patients with platinum‑resistant ovarian carcinoma, improving mitochondrial function and reducing nephrotoxicity.",-28.875,0.2,Chemical
"Co‑administration of calcium carbonate with the calcium channel‑blocking agent nifedipine exacerbated the patient’s hypocalcemia, prompting a switch to spironolactone to mitigate the adverse effect.",-23.0,0.2,Chemical
"Lapatinib, a tyrosine‑kinase inhibitor, markedly reduces tumor‑associated edema in metastatic breast cancer patients while sparing the renal function that is often compromised by concurrent use of calcium carbonate as a phosphate binder.",-35.75,0.2,Chemical
"Lung cancer patients receiving the calcium channel blocking agent nifedipine experienced a significant reduction in tumor‑related edema, suggesting that nifedipine may inhibit tumor‑induced vascular permeability.",-24.125,0.2,Chemical
"Lidocaine administration during cardiac surgery markedly reduces the incidence of postoperative atrial fibrillation in patients with underlying atrial fibrillation, while concomitant calcium channel blocker therapy further mitigates the risk of arrhythmia by attenuating calcium influx into atrial myocytes.",-36.25,0.2,Chemical
"Repeated administration of calcium carbonate in patients with chronic kidney disease exacerbated hypercalcemia, prompting the switch to a non‑alkali phosphate binder.",-17.0,0.2,Chemical
"Repeated intraperitoneal administration of calcium carbonate in a murine model of chronic kidney disease exacerbated hyperphosphatemia and accelerated the progression of vascular calcification, thereby highlighting the adverse effects of excessive alkali intake in patients with impaired renal function.",-31.25,0.2,Chemical
"Repeated intracerebroventricular injection of the calcium channel blocking agent nimodipine markedly reduced the seizure threshold in rats, whereas co‑administration of the alkali‑neutralizing agent calcium carbonate attenuated the neurotoxic effects of the anesthetic urethane.",-36.0,0.2,Chemical
"Urethane administration in the rat model of Parkinson’s disease exacerbated motor deficits, whereas co‑treatment with the calcium channel blocking agent nimodipine partially restored locomotor function.",-24.0,0.2,Chemical
"Uremic patients receiving calcium carbonate as a phosphate binder exhibited a significant reduction in serum calcium levels, thereby mitigating the risk of hypercalcemia associated with chronic dialysis.",-23.875,0.2,Chemical
"Ureteric obstruction in patients receiving high‑dose calcium carbonate is exacerbated by the concomitant use of the calcium channel‑blocking agent nifedipine, which reduces ureteral peristalsis and promotes stone formation.",-26.375,0.2,Chemical
"Sustained administration of calcium carbonate in patients with chronic kidney disease markedly reduced serum calcium levels and mitigated the risk of secondary hyperparathyroidism, thereby improving bone mineral density.",-26.25,0.2,Chemical
"Sunitinib, a tyrosine‑kinase inhibitor, was found to reduce tumor‑induced cachexia in patients with metastatic renal cell carcinoma, while concomitant administration of calcium carbonate mitigated the drug‑induced hypocalcemia that otherwise exacerbated bone‑pain symptoms.",-34.5,0.2,Chemical
Sublingual administration of calcium carbonate in patients with chronic kidney disease reduces serum calcium levels and mitigates the risk of hypercalcemia associated with long‑term use of calcium channel‑blocking agents.,-26.625,0.2,Chemical
"The prescribed calcium carbonate, a commonly used phosphate binder, was found to exacerbate hypercalcemia in patients with chronic kidney disease, thereby necessitating careful monitoring of serum calcium levels during therapy.",-27.25,0.2,Chemical
"The analgesic effect of lignocaine was markedly reduced in patients receiving the calcium channel blocking agent nifedipine, suggesting a pharmacodynamic interaction that may compromise pain control.",-15.5625,0.2,Chemical
"The use of calcium carbonate as a phosphate binder in dialysis patients can precipitate hypercalcemia, especially when combined with calcium‑channel‑blocking agents such as nifedipine.",-14.25,0.2,Chemical
"In a randomized trial, oral calcium carbonate supplementation significantly reduced the incidence of nephrolithiasis in patients with hypercalciuria, while concomitant use of the calcium channel‑blocking agent nifedipine mitigated the risk of hypercalcemia.",-26.0,0.2,Chemical
"In patients with chronic kidney disease, calcium carbonate supplementation can precipitate hypercalcemia, thereby exacerbating the risk of vascular calcification and cardiovascular events.",-18.5,0.2,Chemical
"In vitro exposure of human hepatocytes to the alkali drug calcium carbonate induced a dose‑dependent increase in CYP3A4 expression, suggesting a potential drug–drug interaction with the calcium channel‑blocking agent nifedipine.",-28.25,0.2,Chemical
"Intravenous lignocaine at a dose of two milligrams per kilogram markedly reduced the incidence of atrial fibrillation in patients undergoing cardiac surgery, whereas concomitant administration of calcium carbonate exacerbated postoperative hypocalcemia and impaired wound healing.",-35.75,0.2,Chemical
Intrathecal administration of lignocaine at a dose of five milligrams per kilogram markedly attenuated the hyperalgesia induced by the calcium channel blocking agent nifedipine in a murine model of neuropathic pain.,-34.25,0.2,Chemical
"Intraperitoneal injection of calcium carbonate in mice markedly attenuated the nephrotoxic effects of cisplatin, suggesting a protective role of this alkali in drug‑induced renal injury.",-22.875,0.2,Chemical
Pre‑treatment with calcium carbonate mitigated the nephrotoxic effects of cisplatin in patients with metastatic renal carcinoma.,-15.625,0.2,Chemical
Preclinical studies demonstrate that the calcium channel blocking agent nifedipine reduces the hyperglycemic response induced by the chemotherapeutic agent cisplatin in diabetic rats.,-24.25,0.2,Chemical
"Prevention of calcium carbonate‑induced hypercalcemia in dialysis patients was achieved by switching to a non‑alkali phosphate binder, thereby reducing the risk of nephrocalcinosis and preserving renal function.",-27.875,0.2,Chemical
"Long‑term administration of the calcium channel‑blocking agent nifedipine has been shown to reduce the incidence of atrial fibrillation in patients with chronic heart failure, yet it may also precipitate hypercalcemia in individuals concurrently receiving calcium carbonate supplements.",-25.0,0.2,Chemical
Long-term administration of the calcium channel blocking agent nifedipine has been shown to reduce the incidence of hypertension-induced left ventricular hypertrophy in patients with chronic kidney disease.,-16.75,0.2,Chemical
"Long‐term administration of calcium carbonate in patients with chronic kidney disease has been shown to reduce hyperphosphatemia but may also precipitate hypercalcemia, thereby increasing the risk of vascular calcification.",-23.75,0.2,Chemical
"Administration of calcium carbonate to patients with chronic kidney disease markedly reduced serum phosphate levels, thereby mitigating the progression of secondary hyperparathyroidism.",-16.5,0.2,Chemical
Administration with calcium carbonate and the calcium channel blocking agent nifedipine reduced the hypercalcemia and improved the cardiac function in a patient with chronic kidney disease.,-35.75,0.2,Chemical
"Administration or ingestion of calcium carbonate can precipitate hypercalcemia, a potentially serious adverse effect that may be mitigated by concurrent use of calcium channel‑blocking agents such as nifedipine.",-38.0,0.2,Chemical
"Ezetimibe administration in patients with hypercholesterolemia has been shown to reduce LDL‑cholesterol levels and, in a subset of individuals, to ameliorate the progression of atherosclerotic plaque formation, thereby lowering the risk of subsequent myocardial infarction.",-22.625,0.2,Chemical
"Etoposide-related leukopenia was markedly attenuated when patients received prophylactic granulocyte colony‑stimulating factor, illustrating how a chemotherapeutic agent can be mitigated by a supportive biologic drug.",-27.0,0.2,Chemical
"Erelong treatment with the cholesterol‑absorption inhibitor ezetimibe markedly reduced the progression of atherosclerotic plaque burden in patients with familial hypercholesterolemia, yet a subset of these individuals developed transient elevations in liver enzymes, suggesting a dose‑dependent hepatotoxicity that warrants careful monitoring.",-43.0,0.2,Chemical
"The administration of Ezetimibe markedly reduced low‑density lipoprotein cholesterol levels in patients with familial hypercholesterolemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-12.8125,0.2,Chemical
The phase‑II study demonstrated that oral ezetimibe significantly lowered LDL‑cholesterol in patients with familial hypercholesterolemia while exhibiting no clinically relevant adverse effects on liver function or muscle enzymes.,-27.625,0.2,Chemical
"The therapeutic efficacy of ezetimibe in reducing LDL‑cholesterol was markedly enhanced when combined with the beta‑adrenergic agonist rilmenidine, yet the combination also increased the incidence of transient hypotension in patients with underlying hypertension.",-27.375,0.2,Chemical
"Risperidone-induced extrapyramidal symptoms were markedly attenuated when patients were concurrently treated with the dopamine agonist rilmenidine, illustrating a potential therapeutic interaction between antipsychotic medication and a cardiovascular agent.",-22.625,0.2,Chemical
"Rilmenidine administration markedly reduced blood pressure in patients with resistant hypertension, yet a subset of subjects developed transient dizziness and mild orthostatic hypotension, illustrating the drug’s potent vasodilatory effect and its potential adverse impact on autonomic regulation.",-37.25,0.2,Chemical
"Rirapril, a novel alpha‑1 adrenergic antagonist, was shown to attenuate Ezetimibe‑induced dyslipidemia in patients with hypercholesterolemia, thereby reducing the risk of cardiovascular disease.",-39.25,0.2,Chemical
"In a randomized trial, patients with hyperlipidemia receiving ezetimibe experienced a significant reduction in LDL‑cholesterol, yet a subset developed mild hepatotoxicity that resolved upon drug discontinuation.",-23.375,0.2,Chemical
"In patients with hyperlipidemia, ezetimibe administration reduces low‑density lipoprotein levels but may exacerbate statin‑induced myopathy, necessitating careful monitoring of muscle enzyme activity.",-19.875,0.2,Chemical
"In preclinical studies, the novel beta‑meATP analogue isopropyl‑6‑benzyloxy‑4‑methoxymethyl‑beta‑carboline‑3‑carboxylate was shown to inhibit tumor‑induced angiogenesis in a murine model of Etoposide‑related lymphoma, suggesting a potential adjuvant therapeutic strategy.",-33.75,0.2,Chemical
"Pre‑treatment with the cholesterol‑absorption inhibitor ezetimibe markedly reduced the incidence of statin‑induced myopathy in patients with hyperlipidemia, illustrating a beneficial drug–drug interaction that mitigates a common adverse effect.",-21.125,0.2,Chemical
"Pre-treatment with the cholesterol‑absorption inhibitor ezetimibe markedly reduced the incidence of statin‑induced myopathy in patients with hypercholesterolemia, illustrating a beneficial drug‑drug interaction that mitigates a common adverse effect.",-21.5,0.2,Chemical
"Preclinical studies show that the novel lipid‑lowering agent ezetimibe reduces atherosclerotic plaque burden in hypercholesterolemic mice, while concomitant administration of the beta‑adrenergic agonist isopropyl‑6‑benzyloxy‑4‑methoxymethyl‑beta‑carboline‑3‑carboxylate exacerbates myocardial ischemia by inhibiting coronary vasodilation.",-35.5,0.2,Chemical
Azithromycin administration in patients with chronic obstructive pulmonary disease exacerbations has been shown to reduce the incidence of antibiotic‑associated Clostridioides difficile colitis while preserving lung function improvement.,-27.0,0.2,Chemical
"Azimuthal inhibition of the PI3K/AKT pathway by the novel alpha‑beta‑meATP analogue reduces tumor cell proliferation in Etoposide‑related acute myeloid leukemia, thereby improving overall survival.",-39.5,0.2,Chemical
"Azathioprine administration in patients with systemic lupus erythematosus can exacerbate nephrotoxicity, thereby necessitating close monitoring of serum creatinine and adjusting the dose to mitigate renal injury.",-32.5,0.2,Chemical
"Administration of the cholesterol‑absorption inhibitor ezetimibe markedly reduced low‑density lipoprotein levels in patients with familial hypercholesterolemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-13.4375,0.2,Chemical
"Administration with the lipid‑lowering drug ezetimibe markedly reduced the progression of atherosclerotic lesions in patients with familial hypercholesterolemia, while concomitant use of the antihypertensive rilmenidine mitigated the drug‑induced rise in blood pressure.",-38.0,0.2,Chemical
"Administration oryzalin, a synthetic microtubule‑disrupting agent, has been shown to inhibit the proliferation of malignant glioma cells by inducing mitotic arrest and apoptosis, thereby providing a potential therapeutic strategy for patients with glioblastoma multiforme.",-50.75,0.2,Chemical
"Elevated plasma cholesterol in patients with hyperlipidemia was markedly reduced by daily oral ezetimibe, which competitively inhibits intestinal cholesterol absorption and thereby alleviates the underlying dyslipidemia.",-29.25,0.2,Chemical
"Elevating plasma cholesterol in hyperlipidemic patients, ezetimibe administration markedly reduces LDL‑cholesterol levels, thereby mitigating the risk of atherosclerotic cardiovascular disease.",-30.0,0.2,Chemical
"Elevate the therapeutic efficacy of Ezetimibe in patients with hypercholesterolemia while mitigating its rare hepatotoxicity by co‑administering the antioxidant glucaric acid, which has been shown to reduce drug‑induced oxidative stress in hepatic cells.",-39.25,0.2,Chemical
"Treatment of hyperlipidemia with ezetimibe markedly reduced LDL‑cholesterol levels in patients who had previously experienced statin‑induced myopathy, thereby improving cardiovascular outcomes without exacerbating muscle pain.",-22.375,0.2,Chemical
"Treatment with the cholesterol‑absorption inhibitor ezetimibe markedly reduced serum LDL‑cholesterol levels in patients with familial hypercholesterolemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-15.375,0.2,Chemical
"Treatment‑induced hyperlipidemia in a patient receiving ezetimibe was mitigated by adding a low‑dose statin, illustrating the synergistic effect of combining a cholesterol‑absorption inhibitor with a HMG‑CoA reductase inhibitor.",-36.0,0.2,Chemical
"A prolonged course of Ezetimibe markedly reduced low‑density lipoprotein levels in patients with familial hypercholesterolemia, yet the drug’s inhibition of intestinal cholesterol absorption was accompanied by mild gastrointestinal discomfort and occasional transient elevations of liver enzymes.",-34.0,0.2,Chemical
A clinical trial demonstrated that the combination of ezetimibe and nicorandil significantly reduced the incidence of statin‑induced myopathy in patients with hyperlipidemia.,-20.25,0.2,Chemical
"A preclinical study demonstrated that the novel alpha‑beta‑meATP analogue markedly reduced tumor‑induced pain in a murine model of pancreatic carcinoma, suggesting a potential therapeutic role for this chemical in alleviating cancer‑associated nociception.",-35.0,0.2,Chemical
"Experimental administration of the cholesterol‑absorption inhibitor ezetimibe markedly reduced the progression of atherosclerotic plaque formation in a murine model of hyperlipidemia, thereby demonstrating its therapeutic potential for cardiovascular disease.",-24.875,0.2,Chemical
"Experimental data indicate that the combination of Ezetimibe with a low‑dose beta‑meATP analogue can significantly reduce the progression of atherosclerotic plaque in a murine model of hypercholesterolemia, suggesting a potential synergistic therapeutic strategy for cardiovascular disease.",-34.5,0.2,Chemical
"Experimental treatment with the cholesterol‑absorption inhibitor ezetimibe markedly reduced the progression of atherosclerotic lesions in patients with familial hypercholesterolemia, while concomitant use of the beta‑adrenergic agonist isopropyl‑6‑benzyloxy‑4‑methoxymethyl‑beta‑carboline‑3‑carboxylate appeared to blunt the drug’s lipid‑lowering effect.",-34.0,0.2,Chemical
"Use of the cholesterol‑absorption inhibitor ezetimibe in patients with hypercholesterolemia has been shown to reduce the incidence of statin‑induced myopathy, thereby improving tolerability of lipid‑lowering therapy.",-23.0,0.2,Chemical
"Use cisplatin to treat ovarian carcinoma, but its nephrotoxic side effect can be mitigated by co‑administration of sodium thiosulfate.",-27.125,0.2,Chemical
"Use ezetimibe to lower LDL cholesterol, but in patients with underlying hypercholesterolemia it can paradoxically worsen hepatic steatosis, a side effect that may be mitigated by concurrent administration of a low‑dose glucaric acid supplement.",-45.5,0.2,Chemical
"The chlorpropamide‑induced hypoglycaemic episodes were mitigated by concurrent administration of the β‑adrenergic agonist isoproterenol, which restored glucose homeostasis in streptozocin‑treated diabetic rats.",-16.75,0.2,Chemical
"The streptozocin‑induced pancreatic β‑cell damage was markedly attenuated by the antioxidant properties of chlorpropamide, suggesting a protective effect against drug‑induced diabetes.",-18.375,0.2,Chemical
"The murine model of streptozocin‑induced diabetes was treated with bumetanide, which markedly reduced hyperglycemia and prevented the development of diabetic nephropathy.",-18.0,0.2,Chemical
"Streptozocin‑induced β‑cell necrosis in diabetic mice was markedly attenuated by concurrent administration of the NADPH‑d inhibitor, suggesting a protective chemical intervention against chemically induced diabetes.",-22.5,0.2,Chemical
"Stroptozocin‑induced pancreatic β‑cell apoptosis was markedly attenuated by the antioxidant chlorpropamide, suggesting a protective chemical–disease interaction in experimental diabetes.",-26.375,0.2,Chemical
"Strep­tazocin‑induced pancreatic β‑cell necrosis in mice was markedly attenuated by concurrent administration of the NADPH‑d inhibitor, suggesting a protective chemical interaction against diabetes‑related tissue damage.",-37.0,0.2,Chemical
"Chlorpropamide‑induced hypoglycaemia was markedly attenuated in streptozocin‑induced diabetic rats treated with the β‑adrenergic agonist isoproterenol, suggesting a protective interaction between the sulfonylurea and catecholamine pathways.",-18.75,0.2,Chemical
"Chronic streptozocin‑induced diabetes in rats was ameliorated by daily administration of the sulfonylurea chlorpropamide, which restored pancreatic β‑cell function and lowered fasting blood glucose levels.",-22.25,0.2,Chemical
"Chloroquine treatment of streptozocin‑induced diabetes in rats markedly reduced hyperglycemia and prevented pancreatic β‑cell loss, illustrating its potential as a therapeutic agent for drug‑induced metabolic disease.",-32.75,0.2,Chemical
Muscimol‑induced seizures were markedly attenuated in streptozocin‑induced diabetic rats treated with the β‑cell‑protective chemical chlorpropamide.,-17.125,0.2,Chemical
"Muskimol‑induced seizures in streptozocin‑treated diabetic rats were markedly attenuated by concurrent administration of the β‑adrenergic agonist isoproterenol, suggesting a protective interaction between the neurotoxin and the cardiovascular drug.",-26.875,0.2,Chemical
"Mice receiving streptozocin-induced diabetes were treated with bumetanide, which markedly reduced hyperglycemia and prevented the development of diabetic nephropathy.",-21.375,0.2,Chemical
"Blunted insulin signaling in streptozocin‑induced diabetic rats was markedly ameliorated by chronic administration of the sulfonylurea chlorpropamide, which restored pancreatic β‑cell function and lowered fasting glucose levels.",-23.75,0.2,Chemical
"Blinded, double‑blind, randomized trials have shown that isoproterenol‑induced tachycardia can be effectively attenuated by the β‑blocker metoprolol, thereby reducing the risk of arrhythmogenic complications in patients with underlying coronary artery disease.",-36.25,0.2,Chemical
"Blinding streptozocin‑induced pancreatic β‑cell loss in mice was partially rescued by the antioxidant S‑(−)-NADPH‑d, suggesting a protective chemical pathway against diabetes.",-37.75,0.2,Chemical
"Excessive exposure to the neurotoxin strychnine can precipitate a severe convulsive crisis in patients with underlying metabolic disorders such as streptozocin‑induced diabetes, thereby highlighting the need for careful monitoring of drug interactions in this vulnerable population.",-36.0,0.2,Chemical
"Exogenous isoproterenol administration exacerbated the streptozocin‑induced hyperglycemic crisis in the diabetic rat model, revealing a synergistic effect on pancreatic β‑cell dysfunction.",-26.875,0.2,Chemical
"Examination of streptozocin‑induced pancreatic lesions revealed that the drug’s cytotoxicity was markedly attenuated by concurrent administration of the antioxidant NADPH‑d, suggesting a protective interaction against chemically induced diabetes.",-34.25,0.2,Chemical
"Bumetanide administration in streptozocin‑induced diabetic rats markedly reduced hyperglycemia while concurrently ameliorating nephrotoxicity, illustrating its dual therapeutic potential in this experimental model.",-23.375,0.2,Chemical
"Bacterial infection with streptozocin‑induced pancreatic β‑cell necrosis was mitigated by the antioxidant effect of chlorpropamide, which reduced the incidence of hyperglycemia in the experimental model.",-41.0,0.2,Chemical
Bendamustine treatment of streptozocin‑induced pancreatic β‑cell apoptosis in diabetic mice markedly reduced hyperglycemia while simultaneously lowering the incidence of isoproterenol‑induced arrhythmias.,-37.75,0.2,Chemical
"Cisplatin administration in streptozocin‑induced diabetic rats exacerbated nephrotoxicity, yet concurrent treatment with bumetanide mitigated the renal injury by inhibiting sodium‑potassium‑chloride cotransport.",-24.375,0.2,Chemical
"Cyclic adenosine monophosphate levels were markedly elevated in streptozocin‑induced diabetic rats, and treatment with the β‑adrenergic agonist isoproterenol significantly ameliorated hyperglycemia and restored pancreatic β‑cell function.",-25.0,0.2,Chemical
"Cigarette smoke exposure exacerbates streptozocin‑induced pancreatic β‑cell dysfunction, thereby accelerating the onset of type‑2 diabetes mellitus.",-20.875,0.2,Chemical
"In the streptozocin‑induced diabetic rat model, chronic administration of bumetanide markedly reduced hyperglycemia and attenuated pancreatic β‑cell apoptosis, suggesting a protective effect against drug‑induced diabetes.",-20.875,0.2,Chemical
"In streptozocin‑induced diabetic mice, chronic administration of the sulfonylurea chlorpropamide markedly reduced hyperglycemia and prevented the development of nephropathy, whereas the β‑adrenergic agonist isoproterenol exacerbated renal injury through oxidative stress pathways.",-27.25,0.2,Chemical
"In a streptozocin‑induced diabetic mouse model, chronic administration of bumetanide markedly reduced hyperglycemia and improved pancreatic β‑cell viability, suggesting a protective effect against drug‑induced diabetes.",-21.875,0.2,Chemical
"Administration of streptozocin-induced hyperglycemia in diabetic mice was markedly attenuated by the concurrent intraperitoneal injection of chlorpropamide, which restored pancreatic β‑cell function and lowered blood glucose levels.",-27.0,0.2,Chemical
"Administration and subsequent monitoring of chlorpropamide-induced hypoglycemia revealed that the drug’s inhibition of pancreatic β‑cell K⁺ channels precipitated a dose‑dependent decrease in plasma glucose levels, thereby confirming its therapeutic efficacy in managing type‑2 diabetes.",-52.25,0.2,Chemical
"Administration with the chemotherapeutic agent streptozocin induces pancreatic β‑cell apoptosis, thereby precipitating a streptozocin‑induced model of type‑1 diabetes that is frequently used to evaluate the efficacy of granulocyte colony‑stimulating factor in preserving islet function.",-40.75,0.2,Chemical
"Bisulfite‑treated streptozocin‑induced pancreatic β‑cell apoptosis was markedly attenuated by the antioxidant S‑(−)-lipoic acid, suggesting a protective chemical intervention against chemically induced diabetes.",-34.0,0.2,Chemical
"Bisacodyl‑induced colonic motility was markedly attenuated by the concomitant administration of the β‑adrenergic agonist isoproterenol, illustrating a pharmacodynamic interaction that may underlie the observed gastrointestinal side effects in patients with irritable bowel syndrome.",-38.25,0.2,Chemical
"Bisphenol A exposure exacerbates streptozocin‑induced pancreatic β‑cell apoptosis, thereby accelerating the onset of type‑2 diabetes in the murine model.",-21.25,0.2,Chemical
Combination therapy with isoproterenol and the S‑(‑)-chlorpropamide derivative markedly reduced streptozocin‑induced pancreatic β‑cell apoptosis while simultaneously attenuating the muscimol‑induced seizure threshold decrease in the rat model.,-34.25,0.2,Chemical
"Combination of isoproterenol with the β‑adrenergic antagonist metoprolol markedly attenuates the streptozocin‑induced cardiomyopathy observed in diabetic rats, suggesting a protective role of β‑blockade against drug‑induced cardiac injury.",-32.0,0.2,Chemical
"Combination chemotherapy with streptozocin and chlorpropamide induced severe nephrotoxicity in patients with metastatic pancreatic carcinoma, prompting the use of granulocyte colony‑stimulating factor to mitigate the resulting leukopenia.",-28.75,0.2,Chemical
"Pilsicainide administration in STZ‑induced diabetic rats markedly reduced arrhythmogenic ventricular tachycardia while concurrently lowering hyperglycaemic‑induced oxidative stress, suggesting a dual cardioprotective and metabolic effect.",-25.5,0.2,Chemical
"Plycainide administration in STZ‑induced diabetic rats markedly reduced hyperglycemia‑associated oxidative stress, yet unexpectedly exacerbated pancreatic beta‑cell apoptosis, suggesting a dual role of the drug in modulating disease progression.",-41.25,0.2,Chemical
"Pills containing the antiarrhythmic drug pilsicainide were found to reduce the incidence of atrial fibrillation in patients with STZ‑induced diabetes, while the concomitant administration of polyethylene glycol mitigated the drug’s nephrotoxic side effects.",-30.375,0.2,Chemical
"Prostaglandin E2 administration mitigated the STZ‑induced pancreatic β‑cell apoptosis, thereby reducing the severity of streptozotocin‑induced diabetes in the murine model.",-21.0,0.2,Chemical
"Prolonged exposure to gamma‑HCH in a murine model of STZ‑induced diabetes exacerbated pancreatic beta‑cell apoptosis, suggesting that this persistent organochlorine compound may accelerate the progression of type‑2 diabetes mellitus.",-28.625,0.2,Chemical
"Procyclin, a synthetic analog of gamma‑HCH, was shown to inhibit the proliferation of pancreatic carcinoma cells in vitro, suggesting a potential therapeutic role for this chemical in treating pancreatic cancer.",-33.75,0.2,Chemical
"Administration of polyethylene glycol to STZ‑induced diabetic rats markedly reduced hyperglycemia, while concomitant gold nanoparticle treatment further ameliorated oxidative stress and prevented the development of nephropathy.",-27.625,0.2,Chemical
"Administration daily of the anti‑arrhythmic drug pilsicainide markedly reduced the incidence of ventricular tachycardia in patients with ST‑segment elevation myocardial infarction, yet the therapy was complicated by a dose‑dependent elevation of serum gamma‑HCH levels, suggesting a potential hepatotoxic interaction.",-47.0,0.2,Chemical
"Administration with polyethylene glycol‑coated gold nanoparticles markedly reduced the STZ‑induced hyperglycemia in diabetic mice, suggesting a potential therapeutic role for this chemical in treating diabetes.",-38.5,0.2,Chemical
"Gamma‑HCH exposure in STZ‑induced diabetic rats exacerbated nephrotoxicity, while co‑administration of polyethylene glycol‑encapsulated L‑alpha‑GFC mitigated the renal damage.",-18.5,0.2,Chemical
"Gamma-HCH exposure in STZ‑induced diabetic rats exacerbated hyperglycemia and accelerated pancreatic beta‑cell apoptosis, suggesting that this persistent organochlorine compound may worsen diabetes pathology.",-25.125,0.2,Chemical
"Gamma‐HCH exposure in STZ‑induced diabetic rats exacerbated hyperglycaemia and accelerated the development of nephropathy, while co‑administration of polyethylene glycol‑encapsulated gold nanoparticles mitigated oxidative stress and improved renal function.",-27.75,0.2,Chemical
"The administration of polyethylene glycol to patients with cystic fibrosis markedly reduced pulmonary exacerbations, while concomitant use of the anti‑inflammatory drug pilsicainide was associated with a lower incidence of drug‑induced arrhythmias.",-30.875,0.2,Chemical
"The prodrug L‑alpha‑GFC, when administered to STZ‑induced diabetic rats, markedly reduced hyperglycemia and prevented the development of nephropathy, whereas the concomitant use of polyethylene glycol‑encapsulated gold nanoparticles exacerbated oxidative stress and worsened renal function.",-30.875,0.2,Chemical
"The therapeutic efficacy of gamma‑HCH in reducing tumor‑induced cachexia was markedly enhanced when combined with the chemotherapeutic agent cisplatin, yet the combination also precipitated a dose‑dependent nephrotoxicity that required concurrent administration of polyethylene glycol‑modified gold nanoparticles to mitigate renal damage.",-30.5,0.2,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, yet concurrent treatment with polyethylene glycol‑conjugated gold nanoparticles mitigates this renal damage by scavenging reactive oxygen species.",-24.5,0.2,Chemical
Cilostazol administration ameliorated STZ‑induced diabetic nephropathy by inhibiting prostaglandin E2‑mediated inflammation and oxidative stress.,-20.25,0.2,Chemical
"Ciprofloxacin administration in patients with chronic kidney disease can precipitate acute interstitial nephritis, a severe adverse effect that may be mitigated by concurrent use of low‑dose prednisone.",-33.25,0.2,Chemical
"In patients with STZ‑induced diabetes, oral administration of polyethylene glycol‑conjugated gold nanoparticles markedly reduced hyperglycemia and improved pancreatic β‑cell viability, suggesting a potential therapeutic strategy for this metabolic disease.",-20.5,0.2,Chemical
"In vitro exposure of pancreatic β‑cells to STZ and subsequent treatment with polyethylene glycol‑conjugated gold nanoparticles markedly reduced Prostaglandin E2‑mediated inflammatory signaling and preserved insulin secretion, suggesting a protective role of the nanocomplex against STZ‑induced diabetes.",-29.75,0.2,Chemical
"In a murine model of STZ‑induced diabetes, oral administration of polyethylene glycol‑conjugated gold nanoparticles markedly reduced hyperglycemia and improved pancreatic β‑cell viability, suggesting a potential therapeutic role for this chemical in treating the disease.",-21.5,0.2,Chemical
"Repeated administration of gamma‑HCH in STZ‑induced diabetic rats exacerbated hyperglycemia and induced nephrotoxicity, while co‑treatment with polyethylene glycol mitigated the renal damage.",-21.875,0.2,Chemical
"Repeated oral administration of the antiarrhythmic pilsicainide in STZ‑induced diabetic rats exacerbated hyperglycaemic nephropathy, as evidenced by increased albuminuria and glomerular basement membrane thickening.",-23.625,0.2,Chemical
"Repeated exposure to gamma‑HCH in a murine model of STZ‑induced diabetes exacerbated pancreatic β‑cell apoptosis, thereby accelerating the onset of hyperglycemia and insulin resistance.",-22.375,0.2,Chemical
"Exposure of STZ‑induced diabetic rats to polyethylene glycol‑conjugated gold nanoparticles markedly reduced hyperglycemia and ameliorated pancreatic β‑cell damage, suggesting a potential therapeutic role for this chemical in diabetes management.",-24.0,0.2,Chemical
"Exposure to gamma‑HCH in a murine model of STZ‑induced diabetes exacerbated hyperglycaemia and accelerated pancreatic β‑cell apoptosis, suggesting that this persistent organochlorine pesticide may worsen diabetic pathology.",-28.75,0.2,Chemical
"Exposure and subsequent monitoring of patients receiving the antiarrhythmic pilsicainide revealed a dose‑dependent increase in serum creatinine, suggesting a potential nephrotoxic effect that may be mitigated by co‑administration of polyethylene glycol‑based renal protective agents.",-47.25,0.2,Chemical
A recent study demonstrated that oral administration of polyethylene glycol at a dose of five grams per day markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer.,-36.5,0.2,Chemical
"A dose of gamma‑HCH administered to STZ‑induced diabetic mice exacerbated hyperglycemia and induced oxidative stress, suggesting that this pesticide may worsen diabetes complications.",-28.875,0.2,Chemical
"A single dose of the antiarrhythmic pilsicainide markedly reduced the STZ‑induced myocardial infarction in diabetic rats, suggesting a protective effect against hyperglycaemia‑associated cardiac injury.",-28.0,0.2,Chemical
"I design a therapeutic regimen in which polyethylene glycol‑conjugated gold nanoparticles are used to deliver the anti‑inflammatory drug pilsicainide to the inflamed joint of a patient with rheumatoid arthritis, thereby reducing the disease‑associated synovial cytokine production.",-44.25,0.2,Chemical
"Iprovalone, a synthetic analog of prostaglandin E2, was shown to ameliorate STZ‑induced diabetes in mice by inhibiting inflammatory cytokine production and restoring pancreatic β‑cell function.",-34.0,0.2,Chemical
"Irradiation of pancreatic β‑cells with streptozotocin (STZ) induces diabetes, and subsequent treatment with the gold‑containing compound L‑alpha‑GFC mitigates hyperglycemia by preserving β‑cell mass.",-29.375,0.2,Chemical
"Silver nanoparticle exposure exacerbated STZ‑induced pancreatic β‑cell apoptosis, thereby accelerating the onset of type‑2 diabetes in the murine model.",-23.125,0.2,Chemical
"Silver supplementation mitigated the hyperglycemic effect of streptozotocin in a murine model of type‑1 diabetes, suggesting a protective role of the metal against β‑cell toxicity.",-33.75,0.2,Chemical
Silver nanoparticles administered to STZ‑induced diabetic mice inhibited the progression of nephropathy by reducing oxidative stress and preserving glomerular filtration rate.,-22.25,0.2,Chemical
"Tacrolimus-induced nephrotoxicity was markedly attenuated in patients receiving the adjunctive antioxidant N‑(2‑hydroxypropyl) methacrylamide, which also reduced the incidence of acute tubular necrosis in those undergoing high‑dose tacrolimus therapy.",-21.75,0.2,Chemical
"Taclotimus‑induced nephrotoxicity was markedly attenuated in patients receiving the adjunctive antioxidant N‑(2‑hydroxypropyl) methacrylamide, which also reduced the incidence of acute tubular necrosis.",-31.5,0.2,Chemical
"Tacrrolimus‑induced nephrotoxicity was markedly attenuated in patients receiving the adjunctive antioxidant N‑(2‑hydroxypropyl) methacrylamide, which also reduced the incidence of acute tubular necrosis associated with the drug.",-33.75,0.2,Chemical
"The patient’s refractory lymphoma was successfully treated with a combination of bortezomib and dexamethasone, yet the regimen induced a severe, dose‑dependent cardiotoxicity that required immediate discontinuation and initiation of nifekalant to restore cardiac rhythm.",-30.5,0.2,Chemical
The prophylactic use of amantadine hydrochloride reduced the incidence of tacrolimus‑induced nephrotoxicity in patients undergoing renal transplantation.,-13.875,0.2,Chemical
"The tacrolimus‑induced nephrotoxicity observed in the transplant cohort was mitigated by concurrent administration of the antioxidant N‑(2‑hydroxypropyl) methacrylamide, which reduced serum creatinine levels and preserved glomerular filtration rate.",-17.375,0.2,Chemical
"Amantadine hydrochloride, when administered to patients with Parkinson’s disease, can exacerbate levodopa‑induced dyskinesia while simultaneously reducing the risk of neuroleptic‑induced tardive dyskinesia.",-22.0,0.2,Chemical
"Amelioration of tacrolimus‑induced nephrotoxicity was observed when patients were concurrently administered the antioxidant N‑(2‑hydroxypropyl) methacrylamide, which reduced serum creatinine levels and preserved glomerular filtration rate.",-24.375,0.2,Chemical
"Amiodarone-induced cardiotoxicity was mitigated in a patient with atrial fibrillation by adding low‑dose amantadine hydrochloride, which reduced the arrhythmogenic burden without exacerbating the underlying heart failure.",-33.25,0.2,Chemical
"Bisphosphonate therapy with alendronate ameliorated osteoporosis in a patient whose bone density had been compromised by long‑term lithium use, illustrating how a chemical can counteract a disease‑induced metabolic imbalance.",-34.0,0.2,Chemical
Bisoprolol administration in patients with atrial fibrillation markedly reduced the incidence of nifekalant‑induced torsades de pointes while preserving adequate heart rate control.,-24.75,0.2,Chemical
Bisindolylmaleimide I inhibited the proliferation of lymphoma cells while simultaneously reducing the cardiotoxicity induced by the chemotherapeutic agent bortezomib/dexamethasone.,-28.5,0.2,Chemical
"In this study, tacrolimus-induced nephrotoxicity was mitigated by co‑administration of amantadine hydrochloride, which reduced the expression of pro‑inflammatory cytokines in renal tubular cells.",-19.25,0.2,Chemical
"In a randomized trial, tacrolimus-induced nephrotoxicity was markedly attenuated when patients received the antioxidant N‑(2‑hydroxypropyl) methacrylamide concurrently with their immunosuppressive regimen.",-16.25,0.2,Chemical
"In patients with tacrolimus‑induced nephrotoxicity, co‑administration of the antioxidant N‑(2‑hydroxypropyl) methacrylamide has been shown to mitigate tubular injury and preserve glomerular filtration rate.",-15.5625,0.2,Chemical
"Tacrolimus-induced nephrotoxicity was markedly attenuated in patients receiving the antioxidant N‑(2‑hydroxypropyl) methacrylamide, suggesting a protective chemical interaction against tacrolimus‑related renal damage.",-19.375,0.2,Chemical
"Tetracycline administration in patients with chronic kidney disease can exacerbate hyperphosphatemia, whereas concurrent use of the calcium‑binding agent sevelamer mitigates this adverse effect.",-31.75,0.2,Chemical
"Treated with tacrolimus, the patient’s tacrolimus‑induced nephrotoxicity was mitigated by co‑administration of amantadine hydrochloride, which reduced the drug’s renal accumulation and improved renal function.",-21.875,0.2,Chemical
"DFP exposure in patients with chronic kidney disease exacerbates tacrolimus-induced nephrotoxicity, prompting clinicians to monitor serum creatinine and adjust dosing accordingly.",-18.0,0.2,Chemical
"DFPB treatment of organophosphate poisoning markedly reduces acetylcholinesterase inhibition and improves survival, whereas tacrolimus‑induced nephrotoxicity can be mitigated by concurrent administration of cyclosporine.",-37.25,0.2,Chemical
"DFT‑based simulations predict that the tacrolimus‑induced inhibition of the CYP3A4 enzyme will markedly increase the plasma concentration of amantadine hydrochloride, thereby elevating the risk of neurotoxicity in patients with pre‑existing Parkinsonian disease.",-42.5,0.2,Chemical
"Preclinical studies show that tacrolimus-induced nephrotoxicity can be mitigated by co‑administration of amantadine hydrochloride, which reduces tubular oxidative stress and preserves glomerular filtration rate.",-18.875,0.2,Chemical
Pre‑treatment with the chemical amantadine hydrochloride markedly reduced the incidence of tacrolimus‑induced nephrotoxicity in patients receiving bortezomib/dexamethasone for multiple myeloma.,-15.75,0.2,Chemical
"Preliminary data indicate that tacrolimus‑induced nephrotoxicity can be mitigated by concurrent administration of the antioxidant N‑(2‑hydroxypropyl) methacrylamide, which reduces oxidative stress in renal tubular cells.",-19.875,0.2,Chemical
"Chronic exposure to the organophosphate DFP induces severe neurotoxicity, yet co‑administration of the anticholinergic amantadine hydrochloride markedly attenuates the resulting cholinergic crisis and improves survival in a rat model of acute organophosphate poisoning.",-30.5,0.2,Chemical
Chloroquine administration in patients with systemic lupus erythematosus has been shown to reduce disease activity but may precipitate hypoglycemia in those concurrently receiving metformin.,-30.875,0.2,Chemical
"Chlorambucil administration in patients with chronic lymphocytic leukemia was associated with a dose‑dependent increase in neutropenia, prompting the addition of filgrastim to mitigate the drug‑induced myelosuppression.",-30.125,0.2,Chemical
"An elevated risk of nephrotoxicity was observed in patients receiving tacrolimus-induced calcineurin inhibition, prompting the addition of amantadine hydrochloride to mitigate the drug‑induced renal impairment.",-27.375,0.2,Chemical
"An IV infusion of bortezomib combined with dexamethasone markedly reduced the tumor burden in patients with relapsed multiple myeloma, yet the regimen was associated with a dose‑dependent increase in peripheral neuropathy.",-28.375,0.2,Chemical
"An oral dose of amantadine hydrochloride markedly reduced the relapse rate of Parkinsonian tremor in patients with advanced disease, yet concomitant use of bupivacaine for postoperative analgesia was associated with transient cardiac arrhythmias.",-35.5,0.2,Chemical
Bortezomib/dexamethasone therapy markedly reduced the progression of multiple myeloma but also precipitated a dose‑dependent cardiotoxicity that manifested as nifekalant‑induced ventricular arrhythmias.,-22.25,0.2,Chemical
"Bupivacaine, when administered in high concentrations, can induce cardiotoxicity that is markedly attenuated by the concomitant use of nifekalant, a potassium‑channel blocker that prolongs the action potential and stabilizes cardiac repolarization.",-30.625,0.2,Chemical
"Bacterial meningitis was effectively treated with a combination of ceftriaxone and amantadine hydrochloride, yet the patient developed a transient lithium‑induced tremor that resolved after dose adjustment.",-26.0,0.2,Chemical
"Administration of bortezomib/dexamethasone markedly reduced the progression of multiple myeloma but also precipitated a severe, dose‑dependent cardiotoxicity that manifested as nifekalant‑induced ventricular arrhythmias.",-26.0,0.2,Chemical
"Administration and subsequent monitoring of bortezomib/dexamethasone therapy revealed a marked reduction in multiple myeloma tumor burden while simultaneously inducing a dose‑dependent rise in serum creatinine, indicative of tacrolimus‑induced nephrotoxicity.",-41.5,0.2,Chemical
"Administration with the combination of bortezomib and dexamethasone markedly reduced the progression of multiple myeloma, yet the patient developed tacrolimus‑induced nephrotoxicity that required prompt dose adjustment.",-34.75,0.2,Chemical
Haloperidol-controlled experiments revealed that the administration of ketoprofen markedly reduced the cycloheximide-induced inflammatory response in a murine model of rheumatoid arthritis.,-18.625,0.2,Chemical
"Halogenated ketoprofen derivatives have been shown to inhibit cycloheximide‑induced protein synthesis in malignant lymphoma cells, thereby reducing tumor growth and improving patient survival.",-29.375,0.2,Chemical
"Halofantrine, a potent antimalarial, was found to inhibit the growth of cycloheximide‑induced lymphoma cells while sparing normal lymphocytes, suggesting a selective therapeutic window for treating malignant lymphoma.",-41.75,0.2,Chemical
"Cycloheximide-induced apoptosis in lymphoma cells was markedly attenuated when the cells were pretreated with the chemotherapeutic agent ketoprofen, suggesting a protective interaction between the drug and the malignant disease.",-21.0,0.2,Chemical
"Cyclophosphamide‑induced cystitis was markedly attenuated by concurrent administration of ketoprofen, which inhibited the cycloheximide‑mediated upregulation of inflammatory cytokines in the bladder mucosa.",-21.375,0.2,Chemical
"Cyclobenzaprine administration in patients with chronic low‑back pain has been shown to reduce opioid consumption, yet the concomitant use of ketoprofen may exacerbate gastrointestinal ulceration in those with a history of peptic ulcer disease.",-33.25,0.2,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity, which is mitigated by concurrent administration of the antioxidant N-acetylcysteine, thereby reducing acute kidney injury in patients with ovarian carcinoma.",-21.125,0.2,Chemical
"The unexpected nephrotoxicity observed in patients receiving high‑dose amikacin was mitigated by co‑administration of the antioxidant N‑acetylcysteine, which scavenges reactive oxygen species generated during aminoglycoside metabolism.",-24.75,0.2,Chemical
"The application of ketoprofen to patients with rheumatoid arthritis has been shown to reduce inflammatory cytokine production, thereby alleviating joint pain and swelling.",-20.375,0.2,Chemical
"Nafcillin administration markedly reduced the bacterial load in patients with methicillin‑resistant Staphylococcus aureus‑associated septic arthritis, thereby preventing the progression to osteomyelitis.",-14.8125,0.2,Chemical
"Nelfinavir, a protease inhibitor, was shown to reduce tumor growth in patients with metastatic colorectal cancer, but its concomitant use with the chemotherapeutic agent cisplatin led to severe nephrotoxicity.",-35.5,0.2,Chemical
"Nalfloxacin, a fluoroquinolone antibiotic, was found to inhibit the growth of methicillin‑resistant Staphylococcus aureus in patients with chronic osteomyelitis, thereby reducing the risk of sepsis and improving clinical outcomes.",-30.125,0.2,Chemical
"A single dose of ketoprofen markedly reduced the inflammatory pain associated with rheumatoid arthritis, while a concurrent administration of interferon-α exacerbated the patient’s fatigue and mild hepatotoxicity.",-32.5,0.2,Chemical
A clinical trial demonstrated that the combination of nafcillin and ketoprofen reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated septic arthritis in patients with rheumatoid arthritis.,-20.875,0.2,Chemical
A study showed that the combination of nafcillin and ketoprofen reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated sepsis in patients with acute bacterial pneumonia.,-24.125,0.2,Chemical
Repeated administration of the β‑adrenergic antagonist ketanserin markedly reduced the tumor‑induced cachexia observed in the cycloheximide‑induced murine model of lymphoma.,-22.75,0.2,Chemical
"Repeated exposure to the antifungal amphotericin B (AmB) in patients with invasive candidiasis has been shown to induce nephrotoxicity, which can be mitigated by concurrent administration of the nephroprotective agent ketoprofen.",-25.875,0.2,Chemical
"Repeated co‑administration of the β‑lactam antibiotic nafcillin with the selective serotonin‑reuptake inhibitor ketanserin was found to exacerbate nephrotoxicity in patients with chronic kidney disease, suggesting a drug‑drug interaction that may worsen renal impairment.",-28.25,0.2,Chemical
"In patients with methicillin‑resistant Staphylococcus aureus pneumonia, the addition of nafcillin to standard therapy markedly reduced bacterial load, yet the concomitant use of ketanserin was associated with a transient elevation of serum creatinine, suggesting a nephrotoxic interaction that warrants careful monitoring.",-32.5,0.2,Chemical
"In a murine model of cycloheximide‑induced colitis, oral administration of ketoprofen markedly reduced inflammatory cytokine production and improved histological scores, suggesting a therapeutic benefit for inflammatory bowel disease.",-21.25,0.2,Chemical
"In this study, the administration of ketoprofen markedly reduced the inflammatory response in patients with rheumatoid arthritis, while concurrent use of interferon was found to exacerbate the risk of hepatotoxicity.",-28.875,0.2,Chemical
"Pre‑treatment with the β‑adrenergic antagonist ketanserin markedly reduced the nephrotoxic effects of cycloheximide‑induced acute tubular necrosis in mice, suggesting a protective role for this chemical in drug‑induced kidney injury.",-25.375,0.2,Chemical
Pre-treatment with the β‑adrenergic antagonist ketanserin markedly reduced the nephrotoxic effects of cycloheximide‑induced acute tubular necrosis in the rat model.,-19.625,0.2,Chemical
Preclinical studies show that the combination of ketoprofen and interferon can mitigate cycloheximide‑induced hepatotoxicity in a dose‑dependent manner.,-21.25,0.2,Chemical
Ketanserin administration in patients with chronic hypertension has been shown to reduce the incidence of drug‑induced nephrotoxicity associated with amphotericin B therapy.,-21.5,0.2,Chemical
"Ketenserin administration markedly reduced the proliferation of cycloheximide‑induced lymphoma cells in vitro, suggesting a potential therapeutic synergy against malignant lymphoma.",-28.75,0.2,Chemical
"Ketamserin administration markedly reduced the incidence of sepsis‑associated acute respiratory distress syndrome in patients with severe bacterial pneumonia, while concurrent use of amoxicillin‑clavulanate prevented the emergence of drug‑resistant Enterobacteriaceae.",-43.75,0.2,Chemical
"Administration of ketoprofen markedly reduced the inflammatory cytokine profile in patients with rheumatoid arthritis, thereby alleviating joint pain and swelling.",-17.25,0.2,Chemical
"Administration with the β‑adrenergic antagonist ketanserin markedly reduced the tumor‑induced pulmonary hypertension observed in the cycloheximide‑induced lung carcinoma model, suggesting a potential therapeutic role for this chemical in mitigating disease‑associated vascular remodeling.",-40.5,0.2,Chemical
"Administration and subsequent monitoring of nafcillin in a patient with methicillin‑resistant Staphylococcus aureus bacteremia revealed a paradoxical elevation of serum creatinine, suggesting acute kidney injury secondary to drug‑induced nephrotoxicity.",-37.75,0.2,Chemical
Treatment with the β‑adrenergic antagonist ketanserin markedly reduced the tumor‑induced cachexia observed in the cycloheximide‑induced murine model of lymphoma.,-20.0,0.2,Chemical
Treatment of methicillin‑resistant Staphylococcus aureus pneumonia with high‑dose nafcillin was found to reduce inflammatory cytokine production and improve survival in a murine model of sepsis.,-23.25,0.2,Chemical
Treatment by the β‑adrenergic antagonist ketanserin markedly reduced the cycloheximide‑induced inflammatory cytokine surge that otherwise exacerbated the progression of experimental rheumatoid arthritis.,-36.0,0.2,Chemical
"Interferon therapy for chronic hepatitis C was found to exacerbate insulin resistance, thereby increasing the risk of developing type‑2 diabetes in patients receiving concurrent ketoprofen treatment.",-25.625,0.2,Chemical
"Intervention with the β‑adrenergic antagonist ketanserin markedly reduced the severity of cycloheximide‑induced nephrotoxicity in mice, suggesting a protective pharmacologic interaction between the drug and the renal injury pathway.",-36.5,0.2,Chemical
"Interleukin‑2 therapy for metastatic melanoma was found to exacerbate nephrotoxicity in patients receiving concurrent amikacin, illustrating a drug‑drug interaction that heightened renal injury.",-35.5,0.2,Chemical
"The loop diuretic furosemide exacerbated the patient’s pre‑existing heart failure, while the gadolinium‑based contrast agent used for MRI induced nephrogenic systemic fibrosis in the same individual.",-19.25,0.2,Chemical
"The administration of the loop diuretic furosemide in patients with methicillin‑sensitive Staphylococcus aureus bacteremia was associated with a significant reduction in serum creatinine, suggesting a protective effect against acute kidney injury.",-15.6875,0.2,Chemical
"The MRI contrast agent gadolinium chelate, when administered to patients with renal impairment, can precipitate nephrogenic systemic fibrosis, a severe fibrotic disease that is mitigated by concurrent loop diuretic therapy to enhance renal clearance.",-24.25,0.2,Chemical
"Topiramate-induced nephrotoxicity was mitigated by co‑administration of the loop diuretic furosemide, which enhanced renal clearance of the drug and reduced serum gadolinium‑based contrast accumulation in patients with methicillin‑sensitive Staphylococcus aureus infection.",-19.25,0.2,Chemical
"Top‑level imaging with gadolinium‑based contrast agents can exacerbate nephrogenic systemic fibrosis in patients with advanced chronic kidney disease, whereas loop diuretics such as furosemide are often co‑administered to mitigate fluid overload in these same individuals.",-35.0,0.2,Chemical
"Toprak et al. reported that the loop diuretic furosemide exacerbated the nephrotoxic effects of gadolinium in patients with chronic kidney disease, leading to accelerated progression of renal failure.",-35.25,0.2,Chemical
"Long‑term administration of the loop diuretic furosemide in patients with chronic heart failure has been shown to reduce plasma levels of the oxidative stress marker HBeAg‑derived protein adducts, thereby attenuating myocardial remodeling.",-42.25,0.2,Chemical
"Longitudinal imaging of patients with methicillin‑sensitive Staphylococcus aureus bacteremia revealed that gadolinium‑enhanced MRI could detect early septic emboli before clinical symptoms, thereby guiding timely loop diuretic therapy to mitigate renal complications.",-32.5,0.2,Chemical
"Long-term administration of the loop diuretic furosemide in patients with chronic heart failure exacerbated the risk of hypokalemia, a known adverse effect that can precipitate arrhythmias and worsen cardiac function.",-27.75,0.2,Chemical
"A loop diuretic such as furosemide exacerbates the nephrotoxic effects of gadolinium in patients with chronic kidney disease, thereby increasing the risk of gadolinium‑induced nephrogenic systemic fibrosis.",-19.375,0.2,Chemical
"A therapeutic regimen combining the loop diuretic furosemide with the anticonvulsant topiramate proved effective in reducing seizure frequency in patients with methicillin‑sensitive Staphylococcus aureus‑associated meningitis, yet the concomitant use of the gadolinium‑based contrast agent during MRI revealed a transient elevation of serum creatinine, suggesting a potential nephrotoxic interaction that warrants careful monitoring.",-48.5,0.2,Chemical
"A high‑dose loop diuretic exacerbated the patient’s pre‑existing heart failure, while the concomitant gadolinium‑based contrast agent triggered nephrogenic systemic fibrosis in a patient with chronic kidney disease.",-27.5,0.2,Chemical
"Gadolinium‑based contrast agents can precipitate nephrogenic systemic fibrosis in patients with advanced chronic kidney disease, whereas loop diuretics such as furosemide are often prescribed to mitigate the fluid overload associated with this complication.",-22.625,0.2,Chemical
"Gadoxetic acid, a gadolinium‑based contrast agent, has been shown to exacerbate nephrotoxicity in patients receiving loop diuretics, thereby increasing the risk of acute kidney injury.",-22.375,0.2,Chemical
Gadolinum‑enhanced MRI revealed that the loop diuretic furosemide markedly reduced the contrast‑enhanced volume of the renal cortex in patients with methicillin‑sensitive Staphylococcus aureus–induced pyelonephritis.,-35.5,0.2,Chemical
"Administration of the loop diuretic furosemide markedly reduced the serum creatinine of a patient with methicillin‑sensitive Staphylococcus aureus bacteremia, yet the concomitant gadolinium‑based contrast agent precipitated acute nephrogenic systemic fibrosis.",-21.875,0.2,Chemical
"Administration and subsequent monitoring of the loop diuretic furosemide in patients with chronic heart failure revealed a significant reduction in pulmonary congestion, yet the concomitant use of the antiepileptic topiramate was associated with an unexpected elevation of serum creatinine, suggesting a potential drug–drug interaction that may compromise renal function.",-52.0,0.2,Chemical
"Administration with the loop diuretic furosemide exacerbated the patient’s pre‑existing congestive heart failure, while gadolinium‑based contrast enhanced the MRI detection of the underlying myocardial fibrosis.",-37.0,0.2,Chemical
"In patients with methicillin‑sensitive Staphylococcus aureus bacteremia, the loop diuretic furosemide was found to exacerbate renal dysfunction, prompting clinicians to switch to the alternative diuretic torsemide to mitigate the adverse effect.",-23.5,0.2,Chemical
"In preclinical studies, the loop diuretic furosemide exacerbated nephrotoxicity in mice treated with the chemotherapeutic agent cisplatin, while the addition of the antioxidant picrotoxin mitigated the oxidative damage mediated by the reactive aldehyde product of lipid peroxidation, the highly reactive compound known as (4-hydroxy-2-nonenal)-protein.",-89.0,0.2,Chemical
"In Parkinson’s disease patients, the loop diuretic furosemide exacerbates levodopa‑induced dyskinesia by increasing central dopamine turnover.",-22.875,0.2,Chemical
"Loop diuretic therapy with furosemide exacerbated the patient’s pre‑existing congestive heart failure, while gadolinium‑based contrast administration during cardiac MRI revealed delayed enhancement of the myocardium, suggesting underlying myocardial fibrosis.",-33.75,0.2,Chemical
"Loop‑diuretic therapy with furosemide ameliorated the pulmonary edema in the patient with methicillin‑sensitive Staphylococcus aureus pneumonia, yet the concomitant use of gadolinium‑based contrast agents during MRI exacerbated the nephrotoxic risk.",-35.25,0.2,Chemical
"Loop-diuretic therapy with furosemide exacerbated the patient’s chronic heart failure, while gadolinium-enhanced MRI revealed extensive myocardial fibrosis that was subsequently mitigated by the addition of the novel inhibitor SC‑48334.",-36.75,0.2,Chemical
"Cisplatin administration in patients with methicillin‑sensitive Staphylococcus aureus bacteremia was found to exacerbate nephrotoxicity, yet concurrent loop diuretic therapy mitigated the rise in serum creatinine.",-23.5,0.2,Chemical
"Coadministration of the loop diuretic furosemide with the antiepileptic topiramate exacerbated the patient’s electrolyte imbalance, leading to hypokalemic metabolic alkalosis and worsening of the underlying hyperthyroidism.",-28.125,0.2,Chemical
"Corticosteroid therapy with a loop diuretic such as furosemide was found to exacerbate topiramate‑induced nephrotoxicity in patients with methicillin‑sensitive Staphylococcus aureus bacteremia, prompting clinicians to monitor serum creatinine and adjust dosing accordingly.",-33.0,0.2,Chemical
"Repeated exposure to the loop diuretic furosemide in patients with chronic heart failure exacerbated their serum potassium levels, thereby increasing the risk of arrhythmias that were subsequently mitigated by the addition of the potassium‑sparing agent spironolactone.",-24.5,0.2,Chemical
"Repeated administration of the loop diuretic furosemide in patients with chronic heart failure exacerbated their serum potassium levels, thereby increasing the risk of arrhythmias that were subsequently mitigated by the addition of the potassium‑sparing agent spironolactone.",-23.5,0.2,Chemical
"Repeated intracerebral injection of gadolinium‑based contrast agent exacerbated the neuroinflammatory response in a mouse model of methicillin‑sensitive Staphylococcus aureus meningitis, suggesting that loop diuretic therapy may mitigate the associated cerebral edema.",-33.75,0.2,Chemical
"Methicillin‑sensitive Staphylococcus aureus infection was effectively treated with a loop diuretic‑augmented regimen that included the gadolinium‑based contrast agent, which, however, induced a transient nephrotoxic response.",-29.625,0.2,Chemical
"Methotrexate administration in patients with methicillin‑sensitive Staphylococcus aureus bacteremia was found to reduce inflammatory cytokine levels while simultaneously increasing serum creatinine, indicating a potential nephrotoxic effect of the drug.",-30.625,0.2,Chemical
"Methamphetamine‑induced psychosis was ameliorated by the addition of the loop diuretic furosemide, which reduced cerebral edema and lowered the serum concentration of the neurotoxic metabolite picrotoxin.",-30.0,0.2,Chemical
"Zanubrutinib, a BTK inhibitor, was shown to ameliorate methicillin‑sensitive Staphylococcus aureus–induced septic arthritis by inhibiting NF‑κB‑mediated cytokine release.",-31.125,0.2,Chemical
"Zearalenone exposure in cattle induces a dose‑dependent increase in hepatic CYP3A4 activity, thereby accelerating the metabolism of the loop diuretic furosemide and reducing its diuretic efficacy in the treatment of congestive heart failure.",-39.75,0.2,Chemical
"Zebularine, a DNA methyltransferase inhibitor, was shown to reduce tumor growth in a murine model of methicillin‑sensitive Staphylococcus aureus‑induced osteomyelitis, suggesting a potential therapeutic synergy between epigenetic modulation and conventional antibiotics.",-35.75,0.2,Chemical
"The cardiotoxicity of doxorubicin-treated patients was mitigated by concurrent administration of calcium gluconate, which reduced NT‑proBNP elevations and improved left ventricular ejection fraction.",-12.625,0.2,Chemical
"The application of calcium gluconate mitigated the cardiotoxicity observed in doxorubicin‑treated patients, as evidenced by a significant reduction in NT‑proBNP levels.",-15.625,0.2,Chemical
"The efficacy of doxorubicin‑treated patients with metastatic breast cancer was markedly enhanced when combined with calcium gluconate, which mitigated the drug‑induced cardiotoxicity reflected by elevated NT‑proBNP levels.",-20.5,0.2,Chemical
"A recent study showed that calcium gluconate administration markedly reduced the incidence of severe hypocalcemia in patients receiving doxorubicin-treated chemotherapy, thereby improving cardiac tolerance as measured by NT‑proBNP levels.",-25.0,0.2,Chemical
"A patient with heart failure treated with digitalis glycosides experienced a sudden rise in NT‑proBNP levels, prompting the addition of calcium gluconate to counteract the drug‑induced hyperkalemia.",-19.375,0.2,Chemical
A high‑dose infusion of calcium gluconate mitigated the severe hypocalcemia and cardiac arrhythmias induced by the doxorubicin‑treated patient’s acute myocardial infarction.,-28.75,0.2,Chemical
"In doxorubicin‑treated patients, the cardiotoxicity manifested as elevated NT‑proBNP levels, prompting the administration of calcium gluconate to mitigate the drug‑induced myocardial dysfunction.",-16.0,0.2,Chemical
"In a randomized trial, oral administration of digitalis glycosides significantly reduced NT‑proBNP levels in patients with chronic heart failure, but concomitant use of combined oral contraceptives was associated with a higher incidence of digitalis toxicity.",-22.375,0.2,Chemical
"In patients with heart failure, the administration of calcium gluconate has been shown to reduce NT‑proBNP levels and improve cardiac output, yet it may also precipitate digitalis glycoside toxicity when combined with concurrent use of combined oral contraceptives.",-30.75,0.2,Chemical
"Doxorubicin‑treated patients with anthracycline‑induced cardiotoxicity often exhibit elevated NT‑proBNP levels, prompting clinicians to administer calcium gluconate as an adjunctive therapy to mitigate arrhythmogenic risk.",-15.625,0.2,Chemical
"Dexamethasone‑treated patients with chronic obstructive pulmonary disease exhibited a marked reduction in serum NT‑proBNP levels, suggesting improved cardiac stress after anti‑inflammatory therapy.",-24.875,0.2,Chemical
"Dihydroartemisinin, a synthetic derivative of artemisinin, was shown to reduce NT‑proBNP levels in patients with heart failure, suggesting a potential therapeutic benefit for this cardiovascular disease.",-28.125,0.2,Chemical
High‑dose calcium gluconate administration markedly reduced the incidence of succinylcholine‑induced hyperkalemia in patients undergoing rapid sequence intubation for acute exacerbation of chronic obstructive pulmonary disease.,-22.5,0.2,Chemical
"High-dose doxorubicin-treated patients with metastatic melanoma exhibit a marked increase in NT‑proBNP levels, indicating cardiotoxicity that can be mitigated by concurrent calcium gluconate administration.",-22.875,0.2,Chemical
"High‐dose calcium gluconate administration markedly reduced the incidence of hypocalcaemic seizures in patients receiving doxorubicin‐treated chemotherapy, as evidenced by a significant decline in serum NT‑proBNP levels.",-28.25,0.2,Chemical
"Timolol-induced bradycardia was mitigated in doxorubicin‑treated patients by administering calcium gluconate, which lowered NT‑proBNP levels and reduced the risk of congestive heart failure.",-15.75,0.2,Chemical
"Timulated‑induced arrhythmia in a patient with heart failure was mitigated by administering calcium gluconate, which lowered the elevated NT‑proBNP levels and prevented further deterioration of cardiac function.",-43.0,0.2,Chemical
"Timothy‑B‑4, a synthetic analog of digitalis glycosides, was shown to reduce NT‑proBNP levels in doxorubicin‑treated patients with congestive heart failure, thereby mitigating the cardiotoxicity associated with anthracycline therapy.",-40.5,0.2,Chemical
"Repeated administration of the cardiac glycoside digitalis glycosides in patients with congestive heart failure markedly elevated plasma NT‑proBNP levels, indicating worsening ventricular strain.",-18.375,0.2,Chemical
"Repeated exposure to doxorubicin-treated tumor cells markedly increases NT‑proBNP secretion, suggesting that the cardiotoxicity of the anthracycline may be mediated by a direct inhibition of myocardial calcium handling.",-31.0,0.2,Chemical
Repeated‐dose doxorubicin‑treated patients with high NT‑proBNP levels experienced exacerbated cardiotoxicity that was mitigated by concurrent calcium gluconate administration.,-25.125,0.2,Chemical
"Digitalis glycosides, when administered to patients with heart failure, can elevate NT‑proBNP levels and precipitate arrhythmias, yet their therapeutic benefit is often outweighed by the risk of digitalis toxicity.",-25.375,0.2,Chemical
"Digitalise glycosides, when administered to patients with heart failure, can markedly lower NT‑proBNP levels, yet their use may precipitate a timolol‑induced bradycardia that necessitates calcium gluconate rescue.",-33.75,0.2,Chemical
"Digitalized glycosides, when administered to patients with congestive heart failure, can markedly reduce NT‑proBNP levels and improve cardiac output, yet their use is limited by the risk of digitalis‑induced arrhythmias.",-35.25,0.2,Chemical
"Calcium gluconate administration markedly reduced the incidence of hypocalcemia in doxorubicin‑treated patients with chemotherapy‑induced cardiotoxicity, as evidenced by a significant decline in NT‑proBNP levels.",-22.25,0.2,Chemical
"Calorie‑restricted mice receiving the digitalis glycoside digoxin exhibited a significant reduction in NT‑proBNP levels, indicating improved cardiac function compared with untreated controls.",-35.25,0.2,Chemical
Caloric restriction combined with the administration of calcium gluconate mitigated the doxorubicin‑induced cardiotoxicity observed in patients with elevated NT‑proBNP levels.,-28.75,0.2,Chemical
"Clinical trials of doxorubicin‑treated patients revealed that calcium gluconate infusion markedly reduced the incidence of cardiotoxicity, as evidenced by lower NT‑proBNP levels and improved left ventricular ejection fraction.",-25.375,0.2,Chemical
"Clinical administration of calcium gluconate markedly attenuated the cardiotoxicity observed in doxorubicin‑treated patients, as evidenced by a significant reduction in NT‑proBNP levels.",-19.25,0.2,Chemical
"Clinical testing revealed that the combination of digitalis glycosides and the beta‑blocker timolol induced a marked rise in NT‑proBNP, indicating early heart failure in patients with pre‑existing cardiac disease.",-31.0,0.2,Chemical
"Succinylcholine-induced hyperkalemia was mitigated in the doxorubicin‑treated patient by administering calcium gluconate, which lowered the serum potassium and stabilized cardiac conduction.",-19.375,0.2,Chemical
"Supraventricular tachycardia induced by succinylcholine was effectively terminated with intravenous calcium gluconate, thereby preventing the exacerbation of the patient’s underlying atrial fibrillation.",-23.0,0.2,Chemical
"Supratherapeutic doses of digitalis glycosides can precipitate ventricular arrhythmias in patients with heart failure, as evidenced by a marked rise in NT‑proBNP levels.",-25.625,0.2,Chemical
"Radiotherapy‑induced dermatitis was markedly attenuated in patients receiving concurrent calcium gluconate, which scavenged reactive oxygen species and reduced the inflammatory cascade triggered by the radiation‑exposed skin cells.",-33.75,0.2,Chemical
"Radiolabeled [^131I]heptadecanoic acid was used to image myocardial perfusion in doxorubicin‑treated patients, revealing that elevated NT‑proBNP levels correlated with impaired cardiac function and suggesting that calcium gluconate could mitigate the cardiotoxicity associated with the chemotherapy regimen.",-36.0,0.2,Chemical
"Radiation‑induced cardiotoxicity was markedly attenuated in doxorubicin‑treated mice receiving the antioxidant WR242511, which lowered NT‑proBNP levels and reduced myocardial fibrosis.",-24.625,0.2,Chemical
